Citrus Sinensis ID: 040413
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 795 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.937 | 0.951 | 0.457 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.967 | 0.904 | 0.446 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.962 | 0.903 | 0.443 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.950 | 0.907 | 0.427 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.962 | 0.907 | 0.435 | 1e-180 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.925 | 0.866 | 0.430 | 1e-177 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.923 | 0.868 | 0.415 | 1e-176 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.919 | 0.896 | 0.441 | 1e-174 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.974 | 0.904 | 0.415 | 1e-172 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.955 | 0.902 | 0.407 | 1e-167 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/800 (45%), Positives = 511/800 (63%), Gaps = 55/800 (6%)
Query: 18 SIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIS-DTVVWV 76
+I L+ A D + ++ ++DG+ +VS FE+GFFSPG S+ RYLGIWYK+IS TVVWV
Sbjct: 17 TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWV 76
Query: 77 ANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMT---RKAG--SPVAQLLDTGNLV 131
ANR+ P++D + TL + +G+L + N +N IWSS+ + +KA +P+ Q+LDTGNLV
Sbjct: 77 ANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLV 136
Query: 132 LRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHR 191
+R+ S + ++WQS D+P D LPGMK G + TGL R+ TSWR+ DDPS GNYT++
Sbjct: 137 VRN---SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNK 193
Query: 192 LDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSY--SYLYEPTVVDNEDEIYYRYDSYN 249
+D + +P+ SV + +GPWNG+ F P+ + +Y V E+E+YY Y N
Sbjct: 194 MDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLEN 253
Query: 250 SPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCEC 309
++ ++LNP+G +QR W + W + S C + CG+ C+I+++P C C
Sbjct: 254 PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRC 313
Query: 310 LMGFKL---ESQLNQTRPRSCVRSHLVDC-TNRDRFVMIDDIKLPDLEEVLLNESMNLKE 365
L GF ++ + CVR +DC D F+ I +KLPD +++M+L E
Sbjct: 314 LKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNE 373
Query: 366 CEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETK 425
C+ CL+NCTC AY+ + GG GC++WFGDL+DIR+ + NGQ +Y+R+ +SE+ET
Sbjct: 374 CKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY--NENGQDLYVRLASSEIETL 431
Query: 426 KSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAATANFSTENKLGE 485
+ + + +++R E D P L +VS AT+ FS NKLG+
Sbjct: 432 QRE-------SSRVSSRKQE-----------EEDLELPFLDLDTVSEATSGFSAGNKLGQ 473
Query: 486 GGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545
GGFGPVYKG L GQEVAVKRLS S QG+EEFKNEIKLIAKLQHRNLV++LG C++ EE
Sbjct: 474 GGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEE 533
Query: 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605
++LIYEY PNKSLD F+FD + L W RV +I+ IA+G+LYLH+ SRLR+IHRDLKA
Sbjct: 534 RMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKA 593
Query: 606 SNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSF 665
SN+LLD DMN KISDFG+A+ GGDE ++ T R+VGTYGYMSPEY G FS+KSDVFSF
Sbjct: 594 SNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSF 653
Query: 666 GVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPILQNEASYLI--LNRY 722
GVL+LE +S +RN F N + L LLG AW + +D+A+E+ID + NE+ I + R
Sbjct: 654 GVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAV-NESCTDISEVLRV 712
Query: 723 INVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLK-------NTILPA 775
I++ LLCVQ+D DRP M VV ++ + + L P+QP F + R L N +P+
Sbjct: 713 IHIGLLCVQQDPKDRPNM-SVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPS 771
Query: 776 NGETGACSVSCLTLSVMDAR 795
N + T+SV+D R
Sbjct: 772 N--------NFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/830 (44%), Positives = 505/830 (60%), Gaps = 61/830 (7%)
Query: 22 SIAADTITPSR--FIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISD-TVVWVAN 78
SI+A+T++ S I +VS FELGFF PG YLGIWYK IS T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTR-KAGSP-VAQLLDTGNLVLRDNF 136
R+ P+ S TL I S NLV+L+ + +WS+N+T SP VA+LLD GN VLRD+
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSK 144
Query: 137 SSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHV 196
+S + +G LWQSFD P+DTLLP MKLGWD KTG R+ SW+S DDPS G+++ +L+
Sbjct: 145 NS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 197 LPKLCTYNGSVKLLCSGPWNGVAFQAAPS---YSYLYEPTVVDNEDEIYYRYDSYNSPII 253
P++ +N ++ SGPWNG+ F P + Y+ +++E+ Y + S +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVF-NFTTSKEEVTYSFRITKSDVY 262
Query: 254 MMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCECLMGF 313
L ++ SG +QR W E W F+ P C + CG C + +P C C+ GF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322
Query: 314 KLES-QLNQTRPRS--CVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAEC 370
K + Q+ R S CVR L+ C D FV + +KLPD ++ + +KECE +C
Sbjct: 323 KPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKC 382
Query: 371 LKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETKKSQD- 429
L++C C A+AN+ + G GSGC+ W G+L DIR GQ +Y+R+ A+++E K+++
Sbjct: 383 LRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNY--AKGGQDLYVRLAATDLEDKRNRSA 440
Query: 430 -------------MLQFDI-------------------NMSIATR---ANEFCKGNKAAN 454
+L F I + + +R NE ++
Sbjct: 441 KIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHI 500
Query: 455 SK---TRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS 511
S+ T D P+ V+ AT NFS NKLG+GGFG VYKG+L +GQE+AVKRLS S
Sbjct: 501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560
Query: 512 GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPL 571
QG +EFKNE+KLIA+LQH NLVRLL CC++ EK+LIYEY+ N SLD LFD + S L
Sbjct: 561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620
Query: 572 GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631
W+ R +I IA+GLLYLHQ SR R+IHRDLKASNILLDK M PKISDFGMA++FG DE
Sbjct: 621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680
Query: 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLL 690
++ T+++VGTYGYMSPEYA G+FS+KSDVFSFGVLLLE +SSKRN F N+D L LL
Sbjct: 681 TEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740
Query: 691 GRAWDLWKDDRAWELIDPILQNEASYLILN---RYINVALLCVQEDAVDRPTMFEVVSML 747
G W WK+ + E+IDPI+ + +S + R I + LLCVQE A DRPTM V+ ML
Sbjct: 741 GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800
Query: 748 TNETVNLPHPQQPAFSSIRGLKNTILPANGETG--ACSVSCLTLSVMDAR 795
+E+ +P P+ P + R L +T ++ + + +V+ +T+SV+DAR
Sbjct: 801 GSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/821 (44%), Positives = 491/821 (59%), Gaps = 56/821 (6%)
Query: 27 TITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIS-DTVVWVANRNRPIFD 85
+ T S I + ++S SQ FELGFF+P S YLGIWYK I T VWVANR+ P+
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTR-KAGSPVA-QLLDTGNLVLRDNFSSNSSEG 143
SN TL I S NLVI + + +WS+N+T SPVA +LLD GN VLRD+ +N G
Sbjct: 91 SNGTLKI-SDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDS-KNNKPSG 148
Query: 144 HLWQSFDHPSDTLLPGMKLGWDLKTG-LERYQTSWRSADDPSPGNYTHRLDIHVLPKLCT 202
LWQSFD P+DTLL MK+GWD K+G R SW++ DDPS G+++ +L P+
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 203 YNGSVKLLCSGPWNGVAFQAAPSYSYL--YEPTVVDNEDEIYYRYDSYNSPIIMMLKLNP 260
YN SGPW G F + P + + + +N ++ Y Y + I +L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSS 268
Query: 261 SGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCECLMGFKLESQLN 320
+G +QRL W E W+ + P C + CG C + +P C C+ GF+ ++
Sbjct: 269 TGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMNEQA 328
Query: 321 QTRPRS--CVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLKNCTCRA 378
R S CVR + C RD FV + ++LPD E +++ + LKECE CLK C C A
Sbjct: 329 ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTA 388
Query: 379 YANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETK--KSQDMLQFDIN 436
+AN+ + GGSGC++W G L DIR GQ +Y+RV A ++E K KS+ ++ I
Sbjct: 389 FANTDIRNGGSGCVIWSGGLFDIRNY--AKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIG 446
Query: 437 MSIA---------------------------------TRANEFCKGNKAANSKTRDSWF- 462
+SI + NE K +++ SK + +
Sbjct: 447 VSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYL 506
Query: 463 --PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKN 520
P+ +++ AT NFST+NKLG+GGFG VYKG L +G+E+AVKRLS S QG +EF N
Sbjct: 507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
E++LIAKLQH NLVRLLGCC++ EK+LIYEY+ N SLD LFD + S L W+ R +I
Sbjct: 567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
IA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMA++FG +E ++ T+R+V
Sbjct: 627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKD 699
GTYGYMSPEYA G+FS+KSDVFSFGVLLLE +S KRN F N++ L LLG W WK+
Sbjct: 687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 746
Query: 700 DRAWELIDPI----LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755
+ E++DPI L +E + R I + LLCVQE A DRP M V+ ML +ET +P
Sbjct: 747 GKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 806
Query: 756 HPQQPAFSSIRGLKNTILPANGE-TGACSVSCLTLSVMDAR 795
P++P F R ++ + C+V+ +TLSV+DAR
Sbjct: 807 QPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/825 (42%), Positives = 486/825 (58%), Gaps = 69/825 (8%)
Query: 23 IAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISD-TVVWVANRNR 81
I+ DTI + +RDGE ++S+ +RF GFFS G S+ RY+GIWY QIS T+VWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PIFDSNATLTIGSSGNLVILNLKNGT--IWSSNMTRKAGSP--VAQLLDTGNLVLRDNFS 137
PI D++ + + GNL + N T IWS+N++ P VA L D GNLVL D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 SNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVL 197
S W+SFDHP+DT LP M+LG+ K GL+R TSW+S DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKLCTYNGSVKLLCSGPWNGVAFQAAPSY--SYLYEPTVVDNEDEIYYRYDSYNSPIIMM 255
P+L Y G G W G + P Y++ + V+NEDE+ + Y ++ +I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 256 LKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSI--DKTPNCECLMGF 313
+N +G + R W R+ W F+S P C + CG N C KT C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 314 KLESQLN---QTRPRSCVRSHLVD-CTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAE 369
+ + + + C + C+ +D FV + +K+PD + ++ ++ LKEC+
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 370 CLKNCTCRAYANS--KVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEV----- 422
CLKNC+C AYA++ + G GCL W G ++D R + N+GQ YIRV E+
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYL--NSGQDFYIRVDKEELARWNR 430
Query: 423 --------------------------------ETKKSQDMLQFDINMSIATRANEFCKGN 450
E +KS N A +F +
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSAN--FAPVPFDFDESF 488
Query: 451 KAANSKTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ 510
+ K R+ P+F L ++ AAT NFS++NKLG GGFGPVYKG L N E+AVKRLS
Sbjct: 489 RFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRN 548
Query: 511 SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP 570
SGQG+EEFKNE+KLI+KLQHRNLVR+LGCC+ELEEK+L+YEY+PNKSLD F+F + +
Sbjct: 549 SGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAE 608
Query: 571 LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630
L W R+ ++ IA+G+LYLHQ SRLR+IHRDLKASNILLD +M PKISDFGMA++FGG+
Sbjct: 609 LDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGN 668
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690
+++ T R+VGT+GYM+PEYA +G FSIKSDV+SFGVL+LE ++ K+N+ F + +S L+
Sbjct: 669 QMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAF-HEESSNLV 727
Query: 691 GRAWDLWKDDRAWELIDPILQNEA-SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
G WDLW++ A E+ID ++ E + + I + LLCVQE+A DR M VV ML +
Sbjct: 728 GHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGH 787
Query: 750 ETVNLPHPQQPAFSSIRGLKNTILPANGETGACSVSCLTLSVMDA 794
NLP+P+ PAF+S R GE GAC +SV D
Sbjct: 788 NATNLPNPKHPAFTSAR-------RRGGENGACLKGQTGISVNDV 825
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1627), Expect = e-180, Method: Compositional matrix adjust.
Identities = 362/831 (43%), Positives = 492/831 (59%), Gaps = 66/831 (7%)
Query: 21 LSIAADTI--TPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIS-DTVVWVA 77
S++ +T+ T S I + ++S SQ FELGFF+P S YLGIWYK I T VWVA
Sbjct: 23 FSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVA 82
Query: 78 NRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTR-KAGSPVA-QLLDTGNLVLRDN 135
NR+ P+ SN TL I S NLVI + + +WS+N+T SPVA +LLD GN +LRD
Sbjct: 83 NRDNPLSSSNGTLKI-SGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD- 140
Query: 136 FSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIH 195
S+ LWQSFD P+DTLL MKLGWD KTG R SW++ DDPS G ++ +L+
Sbjct: 141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 196 VLPKLCTYNGSVKLLCSGPWNGVAFQAAP---SYSYL-YEPTVVDNEDEIYYRYDSYNSP 251
P+ + L SGPWNG+ F + P Y+ Y T +++E+ Y Y +
Sbjct: 197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTA--SKEEVTYSYRINKTN 254
Query: 252 IIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCECLM 311
+ L LN +G +QRL W E W+ + P C + CG C + PNC C+
Sbjct: 255 LYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIK 314
Query: 312 GFK-LESQLNQTRPRS--CVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEA 368
GFK + Q R S C+R + C RD F + +KLPD +++ + LK C+
Sbjct: 315 GFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374
Query: 369 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETK--K 426
CL++C C A+AN+ + GGSGC++W +++D+R GQ +Y+R+ A+E+E K K
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNY--AKGGQDLYVRLAAAELEDKRIK 432
Query: 427 SQDMLQFDINMSIA---------------------------------TRANEFCKGNKAA 453
++ ++ I +SI + N+ +
Sbjct: 433 NEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGY 492
Query: 454 NSKTRDSWFPMFSLASV---SAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ 510
SK + S + L + + AT NFS +NKLG+GGFG VYKGRL +G+E+AVKRLS
Sbjct: 493 TSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKM 552
Query: 511 SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP 570
S QG +EF NE++LIAKLQH NLVRLLGCC++ EK+LIYEY+ N SLD LFD + S
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 571 LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630
L W+ R +I IA+GLLYLHQ SR R+IHRDLKASN+LLDK+M PKISDFGMA++FG +
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTL 689
E ++ T+R+VGTYGYMSPEYA G+FS+KSDVFSFGVLLLE +S KRN F N++ L L
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732
Query: 690 LGRAWDLWKDDRAWELIDPI----LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
LG W WK+ E++DPI L ++ + R I + LLCVQE A DRP M V+
Sbjct: 733 LGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 792
Query: 746 MLTNETVNLPHPQQPAFSSIRG-LKNTILPANGETGACSVSCLTLSVMDAR 795
ML +ET +P P++P F R L+ + C+V+ +TLSV+DAR
Sbjct: 793 MLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 351/815 (43%), Positives = 489/815 (60%), Gaps = 79/815 (9%)
Query: 22 SIAADTITPSRFIRDG---EKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISD-TVVWVA 77
S+AA+TI +RDG + LVS + FELGFFSPG S +R+LGIWY I D VVWVA
Sbjct: 23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82
Query: 78 NRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNM---TRKAGSPVAQLLDTGNLVLRD 134
NR PI D + L I + GNLV+L+ KN T+WSSN+ T + V + DTGN VL
Sbjct: 83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVL-- 140
Query: 135 NFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDI 194
S ++ +W+SF+HP+DT LP M++ + +TG SWRS DPSPGNY+ +D
Sbjct: 141 --SETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDP 198
Query: 195 HVLPKLCTYNGS-VKLLCSGPWNGVAFQAAPSYS----YLYEPTVVDNEDE---IYYRYD 246
P++ + G+ + SG WN F P+ S YLY + DE +Y+ Y
Sbjct: 199 SGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYV 258
Query: 247 SYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPN 306
+ +++ K+ +G + L WNE W F S PD C + CG +C + +
Sbjct: 259 PSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNG 318
Query: 307 -CECLMGFKLESQLNQTRPRSCVRSHLVDC-----TNRDRFVMIDDIKLPDLEEVLLNES 360
C C+ G++ S N +R C R + C D F+ + +KLPD E + +
Sbjct: 319 ICSCIHGYEQVSVGNWSR--GCRRRTPLKCERNISVGEDEFLTLKSVKLPDFE-IPEHNL 375
Query: 361 MNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPAS 420
++ ++C CL+NC+C AY+ GG GC++W DLVD+++ G S++IR+ S
Sbjct: 376 VDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQF--EAGGSSLHIRLADS 429
Query: 421 EV-ETKKSQDMLQFDINMSI----------------ATRANEFCKGNKAANSKTRD---- 459
EV E +K++ + + + + + +C N + D
Sbjct: 430 EVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKS 489
Query: 460 ----------------------SWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLH 497
S P+FSL +++ AT +F EN+LG GGFGPVYKG L
Sbjct: 490 KETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE 549
Query: 498 NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557
+G+E+AVKRLS +SGQG++EFKNEI LIAKLQHRNLVRLLGCC E EEK+L+YEYMPNKS
Sbjct: 550 DGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKS 609
Query: 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617
LD FLFD K++ + W+ R +IE IA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPK
Sbjct: 610 LDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPK 669
Query: 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
ISDFGMA++FGG++ ++ T R+VGTYGYMSPEYA +GLFS+KSDV+SFGVLLLE +S KR
Sbjct: 670 ISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKR 729
Query: 678 NTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDR 737
NT +++ +L+G AW L+ R+ EL+DP ++ S R I+VA+LCVQ+ A +R
Sbjct: 730 NTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAER 789
Query: 738 PTMFEVVSMLTNETVNLPHPQQPAFSSIRGLKNTI 772
P M V+ ML ++T L P+QP F+S R +N+I
Sbjct: 790 PNMASVLLMLESDTATLAAPRQPTFTSTR--RNSI 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 619 bits (1597), Expect = e-176, Method: Compositional matrix adjust.
Identities = 331/797 (41%), Positives = 482/797 (60%), Gaps = 63/797 (7%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISD-TVVWVANRNRPIF 84
+TI S+ ++DG+ + S +RF GFFS G SK RY+GIWY Q+S+ T+VWVANR+ PI
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 DSNATLTIGSSGNLVILNLKNGT--IWSSNMTRKAGSP--VAQLLDTGNLVLRDNFSSNS 140
D++ + + GNL + NGT IWS+++ P VA+L D GNLVL D + S
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 141 SEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKL 200
W+SF+HP++TLLP MK G+ ++G++R TSWRS DP GN T+R++ P++
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 201 CTYNGSVKLLCSGPWNGVAFQAAPSYS--YLYEPTVVDNEDEIYYRYDSYNSPIIMMLKL 258
Y G +G W G + P + +++ + V+N DE+ Y ++ + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 259 NPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPN--CECLMGFKLE 316
N +G +QR WN R+ W F+S P+ C I+ CG N C T C CL G++ +
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 317 SQLN---QTRPRSCVRSHLVD-CTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLK 372
+ + + C R C ++ F + +K+P+ V ++ ++ LKECE CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 373 NCTCRAYANS--KVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETKKSQD- 429
NC+C AYA++ + G GCL W G+++D R + ++GQ Y+RV SE+
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYL--SSGQDFYLRVDKSELARWNGNGA 436
Query: 430 --------------------MLQFDINMSIATRANEFCKGNKAANS-------------- 455
++ F + + + + KA +S
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 456 -----KTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ 510
K+R P+F L++++ AT NF+ +NKLG GGFGPVYKG L NG E+AVKRLS
Sbjct: 497 EELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKS 556
Query: 511 SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP 570
SGQG+EEFKNE+KLI+KLQHRNLVR+LGCC+E EEK+L+YEY+PNKSLD F+F + +
Sbjct: 557 SGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAE 616
Query: 571 LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630
L W R+ +I I +G+LYLHQ SRLR+IHRDLKASN+LLD +M PKI+DFG+A++FGG+
Sbjct: 617 LDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGN 676
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690
+++ T R+VGTYGYMSPEYA G FSIKSDV+SFGVL+LE ++ KRN+ F +SL L+
Sbjct: 677 QIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE-ESLNLV 735
Query: 691 GRAWDLWKDDRAWELIDPILQNEA-SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
WD W++ A E+ID ++ E + + +++ LLCVQE++ DRP M VV ML +
Sbjct: 736 KHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGH 795
Query: 750 ETVNLPHPQQPAFSSIR 766
++LP P+ PAF++ R
Sbjct: 796 NAIDLPSPKHPAFTAGR 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 611 bits (1576), Expect = e-174, Method: Compositional matrix adjust.
Identities = 350/793 (44%), Positives = 490/793 (61%), Gaps = 62/793 (7%)
Query: 21 LSIAADTITPSRFIRDGEKLVSSSQRFELGFFS---PGKSKYRYLGIWYKQISDTVVWVA 77
+++ + ITP F++DG+ L S Q F+LGFFS + ++R+LG+WY + VVWVA
Sbjct: 21 VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVA 79
Query: 78 NRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKA-----GSPVAQLLDTGNLVL 132
NRN P++ ++ L + S G+L + + ++ +WSS+ + +P+ ++ +GNL+
Sbjct: 80 NRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI- 138
Query: 133 RDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRL 192
SS+ E LWQSFD+P +T+L GMKLG + KT +E +SW++ DPSPG++T L
Sbjct: 139 ----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSL 194
Query: 193 DIHVLPKLC-TYNG----SVKLLCSGPWNGVAFQAAPSY---SYLYEPTVVDNEDEIYYR 244
D LP+L NG S +L G WNG++F AP+ + L++ + E+ Y
Sbjct: 195 DTRGLPQLILRKNGDSSYSYRL---GSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYS 251
Query: 245 YDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSID-- 302
+ + I+ L LN +GK+ R I + N W + + P+ C + CGA +VC I+
Sbjct: 252 WTPRHR-IVSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICGAYAVCGINSK 309
Query: 303 KTPNCECLMGFKLES--QLNQTR-PRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLN- 358
TP+C CL GFK +S + N +R CV +C +D FV +KLPD +
Sbjct: 310 NTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDA 369
Query: 359 -ESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRV 417
M L++C+ +C NC+C AYAN+ + GG GCL+WFGDLVD+R+ + GQ VYIR+
Sbjct: 370 KNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREY--SSFGQDVYIRM 427
Query: 418 PASEVETKKSQDMLQ------------------FDINMSIATRANEFCKGNKAANSKTRD 459
+++E K + + F + R F KG + D
Sbjct: 428 GFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKG-----IEEED 482
Query: 460 SWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFK 519
P+F ++S AT +FS N LG GGFGPVYKG+L +GQE+AVKRLS+ SGQG+EEFK
Sbjct: 483 LDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFK 542
Query: 520 NEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV 579
NE+KLIAKLQHRNLVRLLGCCI+ EE +LIYEYMPNKSLD F+FD + + L W+ R+ +
Sbjct: 543 NEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNI 602
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
I +A+G+LYLHQ SRLR+IHRDLKA N+LLD DMNPKISDFG+AK FGGD+ +S T R+
Sbjct: 603 INGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRV 662
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWK 698
VGTYGYM PEYA G FS+KSDVFSFGVL+LE ++ K N F + D L LLG W +W
Sbjct: 663 VGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWV 722
Query: 699 DDRAWELIDPILQNEASYLI-LNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHP 757
+DR E+ + E S + + R I+VALLCVQ+ DRPTM VV M +++ +LPHP
Sbjct: 723 EDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLPHP 781
Query: 758 QQPAFSSIRGLKN 770
QP F + R + +
Sbjct: 782 TQPGFFTNRNVPD 794
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 605 bits (1560), Expect = e-172, Method: Compositional matrix adjust.
Identities = 350/843 (41%), Positives = 498/843 (59%), Gaps = 68/843 (8%)
Query: 14 VFLLSIKLSIAADTI--TPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISD 71
+ L+ LSI +T+ T S I + LVS FE+GFF S++ YLG+WYK++SD
Sbjct: 22 MILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTN-SRW-YLGMWYKKVSD 79
Query: 72 -TVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTR-KAGSPV-AQLLDTG 128
T VWVANR+ P+ ++ TL I S NLV+L+ N +W +N+TR SPV A+LL G
Sbjct: 80 RTYVWVANRDNPLSNAIGTLKI-SGNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANG 138
Query: 129 NLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNY 188
N V+RD+ ++++SE +LWQSFD+P+DTLLP MKLG++LKTGL R+ TSWRS+DDPS GN+
Sbjct: 139 NFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNF 197
Query: 189 THRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPS---YSYLYEPTVVDNEDEIYYRY 245
+++L+ LP+ + + SGPWNG+ F P SY+ ++N +E+ Y +
Sbjct: 198 SYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVY-NFIENNEEVAYTF 256
Query: 246 DSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGP-DYFCQIFGSCGANSVCSIDKT 304
N+ L L G QRL W W F+S P D C + CG + C ++ +
Sbjct: 257 RMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTS 316
Query: 305 PNCECLMGFK---LESQLNQTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESM 361
P C C+ GF ++ + C+R + C+ D F + +KLP+ ++ S+
Sbjct: 317 PVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCSG-DGFTRMKKMKLPETTMATVDRSI 375
Query: 362 NLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRK-AIGHNNGQSVYIRVPAS 420
+KEC+ C+ +C C A+AN+ + GGSGC++W L DIR A +GQ +Y+R+ A+
Sbjct: 376 GVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAA 435
Query: 421 EVETKK--SQDMLQFDINMSIATRANEFC----KGNKAANS------------------- 455
++ K+ S ++ + +S+ FC K +A S
Sbjct: 436 DIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMV 495
Query: 456 -----------KTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAV 504
K + P+ + +V AT NFS+ NKLG+GGFG VYKGRL +G+E+AV
Sbjct: 496 LSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAV 555
Query: 505 KRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD 564
KRLS S QG +EF NE+ LIA+LQH NLV++LGCCIE +EK+LIYEY+ N SLD +LF
Sbjct: 556 KRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFG 615
Query: 565 TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
+ S L W R + +A+GLLYLHQ SR R+IHRDLK SNILLDK+M PKISDFGMA
Sbjct: 616 KTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMA 675
Query: 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT 684
++F DE ++ T ++VGTYGYMSPEYA G+FS KSDVFSFGV++LE +S K+N F N
Sbjct: 676 RIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNL 735
Query: 685 DSLT-LLGRAWDLWKDDRAWELIDPILQNEASYLI-------LNRYINVALLCVQEDAVD 736
D LL W WK+ RA E++DP++ + S + + I + LLCVQE A
Sbjct: 736 DYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEH 795
Query: 737 RPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLKNTILPANG----ETGACSVSCLTLSVM 792
RP M VV M +E +P P+ P + +R + P++ E + +V+ T SV+
Sbjct: 796 RPAMSSVVWMFGSEATEIPQPKPPGY-CVRRSPYELDPSSSWQCDENESWTVNQYTCSVI 854
Query: 793 DAR 795
DAR
Sbjct: 855 DAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1514), Expect = e-167, Method: Compositional matrix adjust.
Identities = 337/827 (40%), Positives = 466/827 (56%), Gaps = 67/827 (8%)
Query: 24 AADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIS-DTVVWVANRNRP 82
+++ T + IR+G+ L+S + FELGFF+P S RY+GIWYK I TVVWVANR +P
Sbjct: 28 TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKP 87
Query: 83 IFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSE 142
+ D L I GNLVI+N +N TIWS+N+ ++ + VA L TG+LVL S +
Sbjct: 88 LLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVL---CSDSDRR 144
Query: 143 GHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCT 202
W+SF++P+DT LPGM++ + G R W+S DPSPG Y+ +D ++
Sbjct: 145 KWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVI 204
Query: 203 YNGSVKLLCSGPWNGVAFQAAPSY----SYLYE---PTVVDNEDEIYYRYDSYNSPIIMM 255
+ G + SGPWN F P +Y+Y + D + +Y+ Y + +S +
Sbjct: 205 WEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLR 264
Query: 256 LKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDK---TPNCECLMG 312
+ P G ++ WN+ W + P C+ + CG SVC K + C C+ G
Sbjct: 265 FWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDG 324
Query: 313 FKLESQL---NQTRPRSCVRSHLVDCTN------RDRFVMIDDIKLPDLEEVLLNESMNL 363
F+ Q N+ C R ++C D F ++ IK+PD V+L+ N
Sbjct: 325 FEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NS 382
Query: 364 KECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVE 423
+ C+ C ++C+C+AYA G GC++W DL+D+ G S+ IR+ S++
Sbjct: 383 ETCKDVCARDCSCKAYALVV----GIGCMIWTRDLIDMEHF--ERGGNSINIRLAGSKLG 436
Query: 424 TKKSQDMLQFDINMSIATRANEFC--------KGNKAANSKTRDSW-------------- 461
K L + I C K KA K +D
Sbjct: 437 GGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSP 496
Query: 462 -------------FPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLS 508
P+FS SV++AT +F+ ENKLG+GGFG VYKG G+E+AVKRLS
Sbjct: 497 IKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLS 556
Query: 509 SQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKE 568
+S QGLEEFKNEI LIAKLQHRNLVRLLGCCIE EK+L+YEYMPNKSLD FLFD K+
Sbjct: 557 GKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQ 616
Query: 569 SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
L W R VI IA+GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDFGMA++F
Sbjct: 617 GSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFN 676
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT 688
+ + T R+VGTYGYM+PEYA +G+FS KSDV+SFGVL+LE +S ++N F TD +
Sbjct: 677 YRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGS 736
Query: 689 LLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
L+G AW LW + E+IDPI+++ R I+V +LC Q+ + RP M V+ ML
Sbjct: 737 LIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLE 796
Query: 749 NETVNLPHPQQPAFSSIRGLKNTILPANGETGACSVSCLTLSVMDAR 795
++T LP P+QP F S + L +G A SV+ +T + + R
Sbjct: 797 SQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVA-SVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 795 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.959 | 0.951 | 0.533 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.977 | 0.935 | 0.495 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.966 | 0.710 | 0.494 | 0.0 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.916 | 0.412 | 0.5 | 0.0 | |
| 359493730 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.950 | 0.981 | 0.483 | 0.0 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.928 | 0.917 | 0.496 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.920 | 0.932 | 0.500 | 0.0 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.973 | 0.945 | 0.479 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.927 | 0.940 | 0.492 | 0.0 | |
| 359493723 | 867 | PREDICTED: G-type lectin S-receptor-like | 0.949 | 0.870 | 0.489 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/780 (53%), Positives = 539/780 (69%), Gaps = 17/780 (2%)
Query: 1 MGNLPFSYSFISCVFLLSIK-LSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKY 59
M +LPF + F S +F+ S+ LS +AD ITP ++DG+ L+S SQ FELGFFSPG SKY
Sbjct: 1 MESLPF-FIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGS 119
RY+GIWYK+ +TVVWVANRN P+ D LTI + GNLV+L+ IWSSN +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRS 179
PVAQLLD+GNLV+RDN SS ++E + WQSFD PSDTLLPGMKLGW+LKTG ERY +WRS
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 ADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPS-YSYLYEPTVVDNE 238
DPSPG++T+RLDIH LP+L GSVK + SGPWNG+ F P ++ ++EP +V NE
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 239 DEIYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSV 298
DEIYY Y N+ + L LN SG ++RL+ +N+GW +S P C+ +G CGAN +
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 299 CSIDKTPNCECLMGFKL--ESQL---NQTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLE 353
C +P CECL GFK E +L N R C +DC + + F+ + +KLPDL
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLL 359
Query: 354 EVLLNESMNLKECEAECLKNCTCRAYANSKVTGGG--SGCLMWFGDLVDIRKAIGHNNGQ 411
E LNESMNLKECEAEC KNC+C A+A + ++GGG SGCLMWFG+L+DIR+ G GQ
Sbjct: 360 EFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQ 419
Query: 412 SVYIRVPASEVETKKS---QDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLA 468
++IRVPASE+E +S + ML+ + S++ F G + + P+F L
Sbjct: 420 DIHIRVPASELEMARSSKRKKMLKTALVASMSALLGIFVSG---MDRRKEGMEAPLFDLD 476
Query: 469 SVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL 528
+++ AT NF+ ++ +G GGFG VYKG+L GQE+AVK+LS SGQG+EEF+NE+ LIAKL
Sbjct: 477 TIATATNNFAPDSIIGAGGFGSVYKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKL 536
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
QHRNLV LLG CI EE++LIYEYMPNKSLD F+FD + + LGW+ R +I IA+GLL
Sbjct: 537 QHRNLVGLLGSCIHREERMLIYEYMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLL 596
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
YLHQ S+L+++HRDLK SN+LLD ++ PKISDFG+A++ G D ++KT+R++GTYGYM+P
Sbjct: 597 YLHQDSKLQIVHRDLKPSNVLLDSNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAP 656
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELID 707
EYA G FS+KSDVFS GVLLLE +S K+N F + D LLG AW +W + RA ELID
Sbjct: 657 EYAIDGKFSVKSDVFSLGVLLLEIISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELID 716
Query: 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRG 767
L++ + L R I V LLCVQ+ DRP M VV ML NE LP P+QP F RG
Sbjct: 717 TGLEDTSGKSQLLRCIQVGLLCVQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFFIERG 776
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/825 (49%), Positives = 532/825 (64%), Gaps = 48/825 (5%)
Query: 10 FISCVFLLSIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQI 69
+S VF LSI S A ++I ++ + DG+ LVSS FELGFFSPG S+ RY+GIWYK+I
Sbjct: 16 LLSIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKI 74
Query: 70 SD-TVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTG 128
S TVVWVANRN P+ DS+ L GNL +N NGTIWSSN++R A +PVAQLLDTG
Sbjct: 75 SSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTG 134
Query: 129 NLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNY 188
NLV+R + N E LWQSFD+P D+ LPGMK G TGL RY TSW+S DPS G Y
Sbjct: 135 NLVVRAE-NDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKY 193
Query: 189 THRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQA----APSYSYLYEPTVVDNEDEIYYR 244
T++LD + LP+ GSV SGPWNG+ F P+ Y +E V N++EIYY+
Sbjct: 194 TNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFE--FVFNQEEIYYK 251
Query: 245 YDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKT 304
Y NS ++ + L+P G +QR W +R W ++ + C F CGA+ VC+I+ +
Sbjct: 252 YQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNS 311
Query: 305 PNCECLMGFK---LESQLNQTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESM 361
P C+CL F+ LE + CVR +DC+N + F+ IK+PD + N+++
Sbjct: 312 PACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTI 371
Query: 362 NLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASE 421
NL+ECE CLKNC+C AYAN V GGSGC++WFGDL+DIR+ + NGQ +YIR+ AS
Sbjct: 372 NLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQY--NENGQDIYIRIAASV 429
Query: 422 VET------KKSQDMLQFDINMSIATRANEFC----------------KGNKAAN----- 454
++ KK ++ +++ +A C +GN N
Sbjct: 430 IDKPVKSRGKKRVRIIVIPVSL-VAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPEQDR 488
Query: 455 ---SKTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS 511
S+ D P+F LA+++ AT FS NKLG+GGFGPVYKG L +GQE+AVKRLS +S
Sbjct: 489 TKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAVKRLSKRS 548
Query: 512 GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPL 571
QG+ EF+NE+ IAKLQHRNLV+LLGCCIELEE++LIYEYMPNKSLD F+FD + L
Sbjct: 549 RQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFDKRRNMLL 608
Query: 572 GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631
W R +I IA+GLLYLHQ SRLR+IHRDLKASNILLD +MNPKISDFGMA+ FGGDE
Sbjct: 609 DWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMARSFGGDE 668
Query: 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLL 690
+ T RIVGTYGYMSPEYA GLFS+KSDVFSFGVL+LE +S ++N F + + L LL
Sbjct: 669 TSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGFRHAEHKLNLL 728
Query: 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750
G AW L K+ R +LID + + + R I VALLCVQ+ DRP M VV ML+++
Sbjct: 729 GHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPEDRPKMSIVVLMLSSD 788
Query: 751 TVNLPHPQQPAFSSIRGLKNTILPANGETGACSVSCLTLSVMDAR 795
V LP P++P F + R L N + + SV+ LT ++++AR
Sbjct: 789 IV-LPQPKEPGFFTERDLSNDS-SSTIKHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/789 (49%), Positives = 511/789 (64%), Gaps = 21/789 (2%)
Query: 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIF 84
AD+I + I D E LVSS Q FELGFFSPG SK RYLGIWYK T VWVANRN PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGH 144
DS LTI ++G LV+LN IWS N++R +PVAQLL+TGNLVLRD S+ +S+ +
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDG-SNETSKSY 414
Query: 145 LWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYN 204
+WQSFD PSDT+LPGMK+GW+LKTGL+R TSW+S+DDPS G++++ DI+VLP L
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKLLCSGPWNGVAFQAAPSY-SYLYEPTVVDNEDEIYYRYDSYNSPIIMMLKLNPSGK 263
GS K++ SGPWNG+ F + +Y+ V N DE+Y Y+S N+ II L LN SG
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 264 IQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCECLMGFKLESQLNQ-- 321
+QRL+ + ++ W+ +S P C+ +G CGAN +C I K CECL GF +SQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 322 -TRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLKNCTCRAYA 380
C R +DC + FV + +KLPDL + + ++L+EC+ CL NC+C AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 381 NSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETKKSQDMLQFDINMSIA 440
+ G G GCLMW GDL+DIR+ + + +YIR+ SE+ +Q + I + I+
Sbjct: 655 YTNPNGSG-GCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIS 713
Query: 441 TRANEFCKG-------------NKAANSKTRDSWFPMFSLASVSAATANFSTENKLGEGG 487
T + G SK + P+F L +++ AT NFS NK+G GG
Sbjct: 714 TFSGILTLGLSFWFRFWKKRTMGTDQESKKENLELPLFDLPTIATATNNFSNTNKIGAGG 773
Query: 488 FGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547
FG VYKG L G VAVKRLS S QG++EFKNE LIAKLQH+NLVRLLGCCI+ EE+I
Sbjct: 774 FGSVYKGNLPEGVAVAVKRLSKNSAQGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERI 833
Query: 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607
L+YEYMPNKSLD F+FD + + L W+ R ++ IA+GLLYLHQ SR ++IHRDLK SN
Sbjct: 834 LLYEYMPNKSLDYFIFDQNRRALLAWDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSN 893
Query: 608 ILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGV 667
ILLD ++NPKISDFG+A++FG +E++++TKRIVGTYGYMSPEY G FSIK DVFSFGV
Sbjct: 894 ILLDDNLNPKISDFGLARIFGENEMETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGV 953
Query: 668 LLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVA 726
LLLE +S ++N FS+ D LLG AW LW+ +RA EL+D L++ + R I V
Sbjct: 954 LLLEIVSGEKNRGFSHPDHHHNLLGHAWLLWEQNRALELMDACLEDSCVASQVLRCIQVG 1013
Query: 727 LLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLKNTILPANGETGACSVSC 786
LLCVQ DRP M V+ ML NE LP P+ P F + R +T +G+ S +
Sbjct: 1014 LLCVQNLPADRPAMSSVIFMLGNEGATLPQPKHPGFFTERSSVDTD-TMSGKIELHSENA 1072
Query: 787 LTLSVMDAR 795
+T+S++ R
Sbjct: 1073 VTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/772 (50%), Positives = 494/772 (63%), Gaps = 43/772 (5%)
Query: 19 IKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDT-VVWVA 77
+++S+A DTI ++ I DGE + S+ FELGFFSPG SK RYLGIWYK+ S VVWVA
Sbjct: 18 LRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKASKKPVVWVA 77
Query: 78 NRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFS 137
NR PI DS+ L + G LV++N NG +W+S +R A P AQLL++GNLV+R N +
Sbjct: 78 NRESPITDSSGVLKVTQPGILVLVNGTNGILWNSTSSRSAQDPNAQLLESGNLVMR-NGN 136
Query: 138 SNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVL 197
E LWQSFD+P DTLLPGMKLG + GL+RY +SW+SADDPS GN+T+ +D
Sbjct: 137 DRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGNFTYWIDPSGF 196
Query: 198 PKLCTYNGSVKLLCSGPWNGVAFQAAPS------YSYLYEPTVVDNEDEIYYRYDSYNSP 251
P+L NG GPWNG+ F P YSY Y V NE EIYY Y NS
Sbjct: 197 PQLLLRNGLAVAFRPGPWNGIRFSGIPQLTINPVYSYEY----VSNEKEIYYIYSLVNSS 252
Query: 252 IIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCECLM 311
+IM L L P G QR IW ++ N W ++ + C + CG N +C ID++PNCEC+
Sbjct: 253 VIMRLVLTPDGAAQRSIWTDKKNEWTLYSTAQRDQCDNYAICGVNGICKIDQSPNCECMK 312
Query: 312 GFKLESQLN---QTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEA 368
GF+ + Q N + CVRS +DC D FV +KLPD NESMNLKEC +
Sbjct: 313 GFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFNESMNLKECAS 372
Query: 369 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETKKSQ 428
CL NC+C AYANS + GGGSGCL+WFGDL+DIR NGQ Y+R+ A+++ET K +
Sbjct: 373 LCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFT--ENGQEFYVRMAAADLETTKEK 430
Query: 429 -----------------DMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVS 471
+L F M ++ E +G + P+F L ++
Sbjct: 431 RLGNRLNSIFVNSLILHSILHFAAYMEHNSKGGENNEGQEHLE-------LPLFDLDTLL 483
Query: 472 AATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHR 531
AT NFS++NKLGEGGFGPVYKG L GQE+AVK +S S QGL+EFKNE++ IAKLQHR
Sbjct: 484 NATNNFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESIAKLQHR 543
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
NLV+LLGCCI E++LIYE+MPNKSLD+F+FD + L W R +I IAQGLLYLH
Sbjct: 544 NLVKLLGCCIHGRERLLIYEHMPNKSLDLFIFDQMRRRVLDWPKRFLIINGIAQGLLYLH 603
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+ SRLR+IHRDLKA NILLD +M PKISDFG+ FGG+E+++ T R+ T GYMSPEYA
Sbjct: 604 RDSRLRIIHRDLKAENILLDNEMIPKISDFGITGSFGGNEIETNTTRVARTLGYMSPEYA 663
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDRAWELIDPIL 710
++GL+S KSDVFSFGVL+LE +S KRN F++ L+LLG AW + +DR+ E ID +
Sbjct: 664 REGLYSTKSDVFSFGVLVLEIVSGKRNKGFNHPYHDLSLLGHAWTFFMEDRSSEFIDASM 723
Query: 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAF 762
N + + IN+ LLCVQ DRP+M VV ML +E LP P++P F
Sbjct: 724 GNTCNLSEVLCSINLGLLCVQRFPEDRPSMHSVVLMLGSEGA-LPQPKEPYF 774
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/799 (48%), Positives = 510/799 (63%), Gaps = 43/799 (5%)
Query: 9 SFISCVFLLS-----IKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLG 63
+ + VF+ S +++S A DTI ++ IRDGE + S+ F+LGFFSPG SK RYLG
Sbjct: 3 ALATVVFIFSYVFSLLRISTAVDTINVNQHIRDGETITSAGGTFQLGFFSPGDSKNRYLG 62
Query: 64 IWYKQIS-DTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVA 122
IWYK+++ TVVWVANR P+ DS+ L + G LV+++ NG +W+SN +R A P A
Sbjct: 63 IWYKKVAPQTVVWVANRESPLTDSSGVLKVTQQGTLVVVSGTNGILWNSNSSRSAQDPNA 122
Query: 123 QLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADD 182
QLL++GNLV+R N + + E LWQSFD+P DTLLPGMK GW+ TGL+RY +SW+SADD
Sbjct: 123 QLLESGNLVMR-NGNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKSADD 181
Query: 183 PSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSYS--YLYEPTVVDNEDE 240
PS GN+T+ +D+ P+ NG +GPWNGV F P + L+ V NE E
Sbjct: 182 PSKGNFTYGIDLSGFPQPFLRNGLTVKFRAGPWNGVRFGGIPQLTNNSLFTFDYVSNEKE 241
Query: 241 IYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCS 300
IY+ Y NS + + L P G +R W ++ N W ++ + C + CG +C
Sbjct: 242 IYFIYYLVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYSTAQRDDCDNYAICGVYGICK 301
Query: 301 IDKTPNCECLMGFKLESQLNQTRP---RSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLL 357
ID++P CEC+ GF+ + Q N + CVRS +DC D FV +KLPD
Sbjct: 302 IDESPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRNSWF 361
Query: 358 NESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRV 417
+ESMNLKEC + CL+NC+C AYANS + GGGSGCL+WF DL+DIR NGQ Y R+
Sbjct: 362 DESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIRDFT--QNGQEFYARM 419
Query: 418 PASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAATANF 477
ASE M ++ E +G + + P+F+LA++ AT NF
Sbjct: 420 AASESGY------------MDHKSKEGENNEGQEHLD-------LPLFNLATLLNATNNF 460
Query: 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
S ENKLGEGGFGPVYKG L GQE+AVK +S S QGL+EFKNE++ I KLQHRNLV+LL
Sbjct: 461 SEENKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESITKLQHRNLVKLL 520
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
GCCI E++LIYEYMPNKSLD+++FD + L W R +I IA+GLLYLHQ SRLR
Sbjct: 521 GCCIHGRERLLIYEYMPNKSLDLYIFDHMRSRVLDWPKRFLIINGIARGLLYLHQDSRLR 580
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+IHRDLKA NILLD +M PKISDFG+A+ FGG+E ++ T R+VGT GYMSPEYA +GL+S
Sbjct: 581 IIHRDLKAENILLDNEMTPKISDFGIARSFGGNETEANTTRVVGTLGYMSPEYASEGLYS 640
Query: 658 IKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPILQNEASY 716
KSDVFSFGVLLLE +S KRN FS+ D L LLG AW L+ + + E ID + N +
Sbjct: 641 TKSDVFSFGVLLLEIVSGKRNRRFSHPDHDLNLLGHAWTLYIEGGSLEFIDTSIVNTCNL 700
Query: 717 LILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLKNTILPAN 776
+ + R INV LLCVQ DRP+M V+ ML +E P P++P F + R + + AN
Sbjct: 701 IEVLRSINVGLLCVQRFPDDRPSMHSVILMLGSEGAP-PRPKEPCFFTDRNM----MEAN 755
Query: 777 GETGACSVSCLTLSVMDAR 795
+G T+++++AR
Sbjct: 756 SSSGIQP----TITLLEAR 770
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/775 (49%), Positives = 504/775 (65%), Gaps = 37/775 (4%)
Query: 1 MGNLPFSYSFISCVFLLSIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYR 60
+G L F +S++ + +++S A D+IT ++ I+DGE ++S+ FELGF G SK +
Sbjct: 34 LGKLVFLFSYVISI----LRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQ 89
Query: 61 YLGIWYKQISD-TVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGS 119
YLGIWYK+++ TVVWVANR P+ DS+ L + G+LVILN NG IWSSN +R A +
Sbjct: 90 YLGIWYKKVTPRTVVWVANRELPVTDSSGVLKVTDQGSLVILNGSNGLIWSSNSSRSARN 149
Query: 120 PVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRS 179
P AQLLD+GNLV++ S+ + LWQSFD+P DTLLPGMK G + TGL+RY +SW+S
Sbjct: 150 PTAQLLDSGNLVIKSGNDSDP-DNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKS 208
Query: 180 ADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSY--SYLYEPTVVDN 237
DDPS G++T+ LD P+L +GS + SGPWNG+ F P + ++ + V N
Sbjct: 209 NDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFN 268
Query: 238 EDEIYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANS 297
E E+Y+ Y NS ++ L LNP+G +QRLIW R W V+ + C + CGA S
Sbjct: 269 EKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYS 328
Query: 298 VCSIDKTPNCECLMGF--KLESQLNQTR-PRSCVRSHLVDCTNRDRFVMIDDIKLPDLEE 354
C+I ++P C C+ GF K Q + CVR +DC D FV +KLPD
Sbjct: 329 TCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRN 388
Query: 355 VLLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVY 414
NESMNLKEC + CL+NC+C AY NS + GGGSGCL+WFGDL+D+++ NGQ Y
Sbjct: 389 SWFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFT--ENGQDFY 446
Query: 415 IRVPASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAAT 474
IR+ ASE+E N + D P+F L ++ AT
Sbjct: 447 IRMAASELELNNE----------------------GAETNERQEDLELPLFDLDTILNAT 484
Query: 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
NFS NKLGEGGFGPVYKG L +G+E+AVKRLS +S QGL+EFKNE+ I+KLQHRNLV
Sbjct: 485 HNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLV 544
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+LLGCCI EEK+LIYEYMPNKSL+ F+FD + L W R +I IA+GLLYLHQ S
Sbjct: 545 KLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDS 604
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
RLR+IHRDLKA N+LLD +MNP+ISDFGMA+ FGG+E Q++TKR+VGTYGYMSPEYA G
Sbjct: 605 RLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGYMSPEYAIDG 664
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPILQNE 713
++S+KSDVFSFGVLLLE +S KRN F++ D L LLG AW L+ + ELID + +
Sbjct: 665 VYSVKSDVFSFGVLLLEIISGKRNRGFNHPDHDLNLLGHAWTLYMERTPLELIDASVGDT 724
Query: 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGL 768
+ + R +NV LLCVQ DRP M VV ML++E L P++P F + R +
Sbjct: 725 YNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGA-LRQPKEPGFFTERNM 778
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/767 (50%), Positives = 497/767 (64%), Gaps = 35/767 (4%)
Query: 10 FISCVFLLSIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQI 69
F + + +K S A DTI PS+ + DG+ LVS FELGFFSPG SK RYLGIWYK I
Sbjct: 18 FNTSFLIFQLKFSTALDTIAPSQSLSDGKTLVSREGSFELGFFSPGISKNRYLGIWYKNI 77
Query: 70 S-DTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVA-QLLDT 127
TV+WVANR PI DS+ LTI ++ NL++++ +N +WSSN T A SP+ QLLD+
Sbjct: 78 PLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQLLDS 137
Query: 128 GNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGN 187
GNLVLRD S S +LWQSFDHPSDTL+PGMKLGWDL+TGLER +SWRS+DDPSPG+
Sbjct: 138 GNLVLRDEKSD--SGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSPGD 195
Query: 188 YTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSY--SYLYEPTVVDNEDEIYYRY 245
T + + P+ + GS + SGPW G+AF AP + +++ V +EDE+Y Y
Sbjct: 196 LTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYLSY 255
Query: 246 DSYNSPIIMMLKLNPSGKIQR-LIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKT 304
+ N + +N + + WNE W ++ S P C + SCGAN C I+
Sbjct: 256 NLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIINDL 315
Query: 305 PNCECLMGFKLESQLN---QTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESM 361
P C CL FK +S CVR+ ++C D FV +K PD LN+SM
Sbjct: 316 PICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNKSM 375
Query: 362 NLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASE 421
NL EC A+CL+NC+C AY+NS V GGGSGC++W+G L+DIR+ GQ +YIR+ SE
Sbjct: 376 NLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPA--GGQELYIRMNPSE 433
Query: 422 VETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAATANFSTEN 481
E + D + + + D P F A + AT NFS EN
Sbjct: 434 SEMDQQNDQI---------------------TDGENEDLELPQFEFAKIVNATNNFSIEN 472
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
KLG+GGFGPVYKG L +GQE+AVKRLS SGQG +EFKNE+ LI KLQHRNLV+LLGC I
Sbjct: 473 KLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNLVKLLGCSI 532
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
+ EE++L+YEYMPNKSLD FLFD K L W R +I IA+GLLYLHQ SRLR+IHR
Sbjct: 533 QREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNIICGIARGLLYLHQDSRLRIIHR 592
Query: 602 DLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSD 661
DLK+SN+LLDKDMNPKISDFG+A+ FGGD+ + T R+VGTYGYM+PEYA GLFS+KSD
Sbjct: 593 DLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSD 652
Query: 662 VFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPILQNEASYLILN 720
VFSFG++LLE ++ K++ F + D SL+L+G AW LWK+ + EL+D + + + +
Sbjct: 653 VFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKEGKPLELVDGLAEESWNLSEVM 712
Query: 721 RYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRG 767
+ I+++LLCVQ+ DRP+M VV ML E LP P++P F RG
Sbjct: 713 KCIHISLLCVQQYPEDRPSMASVVLMLGGERT-LPKPKEPGFFKDRG 758
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/830 (47%), Positives = 521/830 (62%), Gaps = 56/830 (6%)
Query: 9 SFISCVFLLS-----IKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLG 63
+F+ V + + +++SI DTIT ++ I D E + S+ FELGFFSP SK+RYLG
Sbjct: 3 AFVRVVVIFTYVFSLLRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLG 62
Query: 64 IWYK-QISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVA 122
I YK +++ VVWVANR P+ DS+ L + S G LV+L+ N T+WSS +R A +P A
Sbjct: 63 IRYKKELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNA 122
Query: 123 QLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADD 182
QLLD+GNLV+++ N E LWQSFD+P +TLLPGMKLGW+ TGL+RY +SW+SADD
Sbjct: 123 QLLDSGNLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADD 181
Query: 183 PSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSYS--YLYEPTVVDNEDE 240
PS G +T+ +D P++ N SV SGPWNG+ F P ++ +Y V NE E
Sbjct: 182 PSIGTFTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKE 241
Query: 241 IYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCS 300
IY+ Y NS ++ L L P G QR W + W + S + C + CGAN +C
Sbjct: 242 IYFIYYLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICK 301
Query: 301 IDKTPNCECLMGFKLESQLNQTRP---RSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLL 357
ID++P CEC+ GF+ Q N CVRS +DC DRFV +KLPD
Sbjct: 302 IDQSPKCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWF 361
Query: 358 NESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRV 417
NESMNLKEC + CL+NC+C AY NS ++G GSGCL+WFG+L DIR+ NGQ Y+R+
Sbjct: 362 NESMNLKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFA--ENGQEFYVRM 419
Query: 418 PASE--------VETKKSQDMLQFDINMSIA----------------TRANEFCKGNKAA 453
ASE + +KK Q + I++SI + KG
Sbjct: 420 SASESDAFSSTNISSKKKQKQV-IVISISITGIVLLILVLTWYMLKKMKQQLKRKGYMEH 478
Query: 454 NSKTRDS-------WFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKR 506
NS ++ P+F LA++ AT NFS++NKLGEGGFGPVYKG L +G+E+AVKR
Sbjct: 479 NSDGGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGGFGPVYKGILEDGEEIAVKR 538
Query: 507 LSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTP 566
LS S QGL+EFKNE++ IAKLQHRNLV+LLGCCI EK+LIYEY+PNKSLD+F+FD
Sbjct: 539 LSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPNKSLDLFIFDQM 598
Query: 567 KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626
+ L W R +I IA+GLLYLHQ SRLR+IHRDLKA N+LLD DMNPKISDFG+A+
Sbjct: 599 RGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMNPKISDFGIARS 658
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD- 685
FGG+EL + T R+ GT GYMSPEYA +GL+S KSDV+SFGVL+LE S KRN FS+ D
Sbjct: 659 FGGNELXASTTRVAGTLGYMSPEYASEGLYSTKSDVYSFGVLVLEIXSGKRNRGFSHPDH 718
Query: 686 SLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
L LLG AW L+ + + E ID + N + + R INV LLCVQ DRP+M VV
Sbjct: 719 DLNLLGHAWTLYIEGGSSEFIDASIANTYNLSEVLRSINVGLLCVQRFPDDRPSMHSVVL 778
Query: 746 MLTNETVNLPHPQQPAFSSIRGLKNTILPANGETGACSVSCLTLSVMDAR 795
ML++E LP P++P F + R + E + S S T++ ++AR
Sbjct: 779 MLSSEGA-LPRPKEPCFFTDRSMM--------EVNSSSGSHTTITQLEAR 819
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1880), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/775 (49%), Positives = 512/775 (66%), Gaps = 38/775 (4%)
Query: 6 FSYSFISCVFLLSIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIW 65
F YSF+ L +I++S A D I+P +FI DG+ +VS+ Q FELGFFSPG S RYLGIW
Sbjct: 16 FVYSFL----LSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIW 71
Query: 66 YKQIS-DTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQL 124
YK+ S TVVWVANR PIFD + L + G L++LN +WSSN T +PVAQL
Sbjct: 72 YKKFSTGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQL 131
Query: 125 LDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPS 184
L++GNLV++D SN E LWQSFD+P DT LP MKLG +L TGL+ +SW+S DDP+
Sbjct: 132 LESGNLVVKDGNDSNP-ESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPA 190
Query: 185 PGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAA----PSYSYLYEPTVVDNEDE 240
G Y+ +D +L G +G WNG+ F A P+ Y YE V N+ E
Sbjct: 191 RGEYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYE--FVLNDKE 248
Query: 241 IYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCS 300
+Y+ ++ NS + +N SG ++RL W + + W +F+ + C + CG+N+ C+
Sbjct: 249 VYFNFELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCN 308
Query: 301 IDKTPNCECLMGFKLESQLN---QTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLL 357
IDK+P C CL GF+ +S + Q CVR + C + FV +KLPD
Sbjct: 309 IDKSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWY 368
Query: 358 NESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRV 417
N S++LKEC+ CLK C+C AYAN+ V GGGSGCL+WFGDL+D+R+ + N GQ +YIR+
Sbjct: 369 NTSISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFV--NTGQDLYIRM 426
Query: 418 PASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAATANF 477
AS + K +++L+ D + ++S+ + P+ L++++ AT NF
Sbjct: 427 AASYL--GKMKNILEMDYD----------------SHSRKEELELPIIDLSTIAKATGNF 468
Query: 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
S+ KLGEGGFG VYKG L+ GQ++AVKRLS SGQG+EEFKNE+ LIAKLQHRNLV+LL
Sbjct: 469 SSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRNLVKLL 527
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
GCCIE +E++LIYEYMPNKSLD F+FD + L W TR+ +I+ IA+GLLYLHQ SRLR
Sbjct: 528 GCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQDSRLR 587
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+IHRDLKASN+LLD DMNPKISDFGMA++FGG++ ++ TKR+VGTYGYM+PEYA +GLFS
Sbjct: 588 IIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANTKRVVGTYGYMAPEYAVEGLFS 647
Query: 658 IKSDVFSFGVLLLETLSSKRNTD-FSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716
+KSD+FSFGVL+LE +S ++N FS+ L L+G AW LW ++R+ EL D L +
Sbjct: 648 VKSDIFSFGVLVLEIVSGRKNRGFFSHNHHLNLVGHAWKLWMEERSLELTDNTLGASHAL 707
Query: 717 LILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLKNT 771
+ RYI+V LLCVQ+ DRP M V ML E+ +LP P+QP F R + T
Sbjct: 708 SEIIRYIHVGLLCVQQQPDDRPNMSTAVLMLGGES-SLPQPKQPGFFLERNVPRT 761
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493723|ref|XP_002280706.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/803 (48%), Positives = 511/803 (63%), Gaps = 48/803 (5%)
Query: 9 SFISCVFLLS-----IKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLG 63
+F+ V + + +++SI DTIT ++ I D E + S+ FELGFFSP SK+RYLG
Sbjct: 3 AFVRVVVIFTYVFSLLRISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLG 62
Query: 64 IWYK-QISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVA 122
I YK +++ VVWVANR P+ DS+ L + S G LV+L+ N T+WSS +R A +P A
Sbjct: 63 IRYKKELNRAVVWVANRENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNA 122
Query: 123 QLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADD 182
QLLD+GNLV+++ N E LWQSFD+P +TLLPGMKLGW+ TGL+RY +SW+SADD
Sbjct: 123 QLLDSGNLVMKNGNDGNP-ENFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADD 181
Query: 183 PSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSYS--YLYEPTVVDNEDE 240
PS G +T+ +D P++ N SV SGPWNG+ F P ++ +Y V NE E
Sbjct: 182 PSIGTFTYGIDPSGSPQIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKE 241
Query: 241 IYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCS 300
IY+ Y NS ++ L L P G QR W + W + S + C + CGAN +C
Sbjct: 242 IYFIYYLVNSSLLTRLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICK 301
Query: 301 IDKTPNCECLMGFKLESQLNQTRP---RSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLL 357
ID++P CEC+ GF+ Q N CVRS +DC DRFV +KLPD
Sbjct: 302 IDQSPKCECMKGFRPRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWF 361
Query: 358 NESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRV 417
NESMNLKEC + CL+NC+C AY NS ++G GSGCL+WFG+L DIR+ NGQ Y+R+
Sbjct: 362 NESMNLKECASLCLRNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFA--ENGQEFYVRM 419
Query: 418 PASE--------VETKKSQDMLQFDINMSIA----------------TRANEFCKGNKAA 453
ASE + +KK Q + I++SI + KG
Sbjct: 420 SASESDAFSSTNISSKKKQKQV-IVISISITGIVLLILVLTWYMLKKMKQQLKRKGYMEH 478
Query: 454 NSKTRDS-------WFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKR 506
NS ++ P+F LA++ AT NFS++NKLGEGGFGPVYKG L +G+E+AVKR
Sbjct: 479 NSDGGETSEGQEHLELPLFELATLLNATNNFSSDNKLGEGGFGPVYKGILEDGEEIAVKR 538
Query: 507 LSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTP 566
LS S QGL+EFKNE++ IAKLQHRNLV+LLGCCI EK+LIYEY+PNKSLD+F+FD
Sbjct: 539 LSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPNKSLDLFIFDQM 598
Query: 567 KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626
+ L W R +I IA+GLLYLHQ SRLR+IHRDLKA N+LLD DMNPKISDFG+A+
Sbjct: 599 RGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMNPKISDFGIARS 658
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD- 685
FGG+EL + T R+ GT GYMSPEYA +GL+S KSDV+SFGVL+LE LS KRN FS+ D
Sbjct: 659 FGGNELGASTTRVAGTLGYMSPEYASEGLYSTKSDVYSFGVLVLEILSGKRNRGFSHPDH 718
Query: 686 SLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
L LLG AW L+ + + E ID + N + + R INV LLCVQ DRP+M VV
Sbjct: 719 DLNLLGHAWTLYIEGGSSEFIDASIANTYNLSEVLRSINVGLLCVQRFPDDRPSMHSVVL 778
Query: 746 MLTNETVNLPHPQQPAFSSIRGL 768
ML++E LP P++P F + R +
Sbjct: 779 MLSSEGA-LPRPKEPCFFTDRSM 800
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 795 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.945 | 0.960 | 0.450 | 2.5e-175 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.471 | 0.441 | 0.494 | 4.6e-174 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.454 | 0.426 | 0.502 | 1.4e-170 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.470 | 0.443 | 0.492 | 7e-169 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.417 | 0.394 | 0.525 | 4.6e-148 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.416 | 0.398 | 0.492 | 2e-145 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.477 | 0.448 | 0.485 | 5.6e-141 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.964 | 0.952 | 0.399 | 2.1e-139 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.405 | 0.392 | 0.498 | 3.5e-139 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.416 | 0.409 | 0.471 | 2.2e-135 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1703 (604.5 bits), Expect = 2.5e-175, P = 2.5e-175
Identities = 357/793 (45%), Positives = 496/793 (62%)
Query: 18 SIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQIS-DTVVWV 76
+I L+ A D + ++ ++DG+ +VS FE+GFFSPG S+ RYLGIWYK+IS TVVWV
Sbjct: 17 TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWV 76
Query: 77 ANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMT---RKAG--SPVAQLLDTGNLV 131
ANR+ P++D + TL + +G+L + N +N IWSS+ + +KA +P+ Q+LDTGNLV
Sbjct: 77 ANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLV 136
Query: 132 LRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHR 191
+R+ S + ++WQS D+P D LPGMK G + TGL R+ TSWR+ DDPS GNYT++
Sbjct: 137 VRN---SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNK 193
Query: 192 LDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSY--SYLYEPTVVDNEDEIYYRYDSYN 249
+D + +P+ SV + +GPWNG+ F P+ + +Y V E+E+YY Y N
Sbjct: 194 MDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLEN 253
Query: 250 SPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCEC 309
++ ++LNP+G +QR W + W + S C + CG+ C+I+++P C C
Sbjct: 254 PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRC 313
Query: 310 LMGFKLESQLNQTR---PRSCVRSHLVDC-TNRDRFVMIDDIKLPDLEEVLLNESMNLKE 365
L GF ++ CVR +DC D F+ I +KLPD +++M+L E
Sbjct: 314 LKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNE 373
Query: 366 CEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVPASEVETK 425
C+ CL+NCTC AY+ + GG GC++WFGDL+DIR+ + NGQ +Y+R+ +SE+ET
Sbjct: 374 CKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY--NENGQDLYVRLASSEIET- 430
Query: 426 KSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAATANFSTENKLGE 485
LQ + + +++R E D P L +VS AT+ FS NKLG+
Sbjct: 431 -----LQRE-SSRVSSRKQE-----------EEDLELPFLDLDTVSEATSGFSAGNKLGQ 473
Query: 486 GGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRXXXXXXXXXX 545
GGFGPVYKG L GQEVAVKRLS S QG+EEFKNEIKLIAKLQHRNLV+
Sbjct: 474 GGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEE 533
Query: 546 XXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605
PNKSLD F+FD + L W RV +I+ IA+G+LYLH+ SRLR+IHRDLKA
Sbjct: 534 RMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKA 593
Query: 606 SNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSF 665
SN+LLD DMN KISDFG+A+ GGDE ++ T R+VGTYGYMSPEY G FS+KSDVFSF
Sbjct: 594 SNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSF 653
Query: 666 GVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPILQNEASYLI-LNRYI 723
GVL+LE +S +RN F N + L LLG AW + +D+A+E+ID + + + + R I
Sbjct: 654 GVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVI 713
Query: 724 NVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLK-NTILPANGETGAC 782
++ LLCVQ+D DRP M VV ML++E + L P+QP F + R L + + N E +
Sbjct: 714 HIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLD-PRQPGFFNERNLLFSDTVSINLEIPSN 772
Query: 783 SVSCLTLSVMDAR 795
+ T+SV+D R
Sbjct: 773 NFQ--TMSVIDPR 783
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 4.6e-174, Sum P(2) = 4.6e-174
Identities = 194/392 (49%), Positives = 257/392 (65%)
Query: 411 QSVYIRVPASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASV 470
+S+ I P + + + S+D+L ++ I++R + + N T D P+ V
Sbjct: 469 RSILIETPIVDHQLR-SRDLLMNEV--VISSRRHISRENN------TDDLELPLMEFEEV 519
Query: 471 SAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH 530
+ AT NFS NKLG+GGFG VYKG+L +GQE+AVKRLS S QG +EFKNE+KLIA+LQH
Sbjct: 520 AMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQH 579
Query: 531 RNLVRXXXXXXXXXXXXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
NLVR + N SLD LFD + S L W+ R +I IA+GLLYL
Sbjct: 580 INLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYL 639
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
HQ SR R+IHRDLKASNILLDK M PKISDFGMA++FG DE ++ T+++VGTYGYMSPEY
Sbjct: 640 HQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEY 699
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPI 709
A G+FS+KSDVFSFGVLLLE +SSKRN F N+D L LLG W WK+ + E+IDPI
Sbjct: 700 AMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPI 759
Query: 710 LQNEAS----YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSI 765
+ + +S + IL R I + LLCVQE A DRPTM V+ ML +E+ +P P+ P +
Sbjct: 760 ITDSSSTFRQHEIL-RCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLE 818
Query: 766 RGLKNTILPANGETG--ACSVSCLTLSVMDAR 795
R L +T ++ + + +V+ +T+SV+DAR
Sbjct: 819 RSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 1.4e-170, Sum P(2) = 1.4e-170
Identities = 187/372 (50%), Positives = 245/372 (65%)
Query: 434 DINMSIATRANEFCKGNKAANSKTRDSWF---PMFSLASVSAATANFSTENKLGEGGFGP 490
D+ S + NE K +++ SK + + P+ +++ AT NFST+NKLG+GGFG
Sbjct: 477 DLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGI 536
Query: 491 VYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRXXXXXXXXXXXXXXX 550
VYKG L +G+E+AVKRLS S QG +EF NE++LIAKLQH NLVR
Sbjct: 537 VYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 596
Query: 551 XXMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610
+ N SLD LFD + S L W+ R +I IA+GLLYLHQ SR R+IHRDLKASN+LL
Sbjct: 597 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 656
Query: 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLL 670
DK+M PKISDFGMA++FG +E ++ T+R+VGTYGYMSPEYA G+FS+KSDVFSFGVLLL
Sbjct: 657 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 716
Query: 671 ETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPI----LQNE-ASYLILNRYIN 724
E +S KRN F N++ L LLG W WK+ + E++DPI L +E ++ IL R I
Sbjct: 717 EIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEIL-RCIQ 775
Query: 725 VALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRG-LKNTILPANGETGACS 783
+ LLCVQE A DRP M V+ ML +ET +P P++P F R L+ + C+
Sbjct: 776 IGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECT 835
Query: 784 VSCLTLSVMDAR 795
V+ +TLSV+DAR
Sbjct: 836 VNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 7.0e-169, Sum P(2) = 7.0e-169
Identities = 193/392 (49%), Positives = 254/392 (64%)
Query: 411 QSVYIRVPASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASV 470
+S+ I+ P V+ +SQD L IN + +R +G + K+ P+ L ++
Sbjct: 463 RSITIQTP--NVDQVRSQDSL---INDVVVSR-----RGYTSKEKKSEYLELPLLELEAL 512
Query: 471 SAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH 530
+ AT NFS +NKLG+GGFG VYKGRL +G+E+AVKRLS S QG +EF NE++LIAKLQH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572
Query: 531 RNLVRXXXXXXXXXXXXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
NLVR + N SLD LFD + S L W+ R +I IA+GLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
HQ SR R+IHRDLKASN+LLDK+M PKISDFGMA++FG +E ++ T+R+VGTYGYMSPEY
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDDRAWELIDPI 709
A G+FS+KSDVFSFGVLLLE +S KRN F N++ L LLG W WK+ E++DPI
Sbjct: 693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPI 752
Query: 710 ----LQNE-ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSS 764
L ++ ++ IL R I + LLCVQE A DRP M V+ ML +ET +P P++P F
Sbjct: 753 NIDSLSSKFPTHEIL-RCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCI 811
Query: 765 IRG-LKNTILPANGETGACSVSCLTLSVMDAR 795
R L+ + C+V+ +TLSV+DAR
Sbjct: 812 GRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.6e-148, Sum P(2) = 4.6e-148
Identities = 175/333 (52%), Positives = 224/333 (67%)
Query: 463 PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEI 522
P+FS SV++AT +F+ ENKLG+GGFG VYKG G+E+AVKRLS +S QGLEEFKNEI
Sbjct: 511 PIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEI 570
Query: 523 KLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEE 582
LIAKLQHRNLVR MPNKSLD FLFD K+ L W R VI
Sbjct: 571 LLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGG 630
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT 642
IA+GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDFGMA++F + + T R+VGT
Sbjct: 631 IARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702
YGYM+PEYA +G+FS KSDV+SFGVL+LE +S ++N F TD +L+G AW LW +
Sbjct: 691 YGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKT 750
Query: 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAF 762
E+IDPI+++ R I+V +LC Q+ + RP M V+ ML ++T LP P+QP F
Sbjct: 751 KEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTF 810
Query: 763 SSIRGLKNTILPANGETGACSVSCLTLSVMDAR 795
S + L +G A SV+ +T + + R
Sbjct: 811 HSFLNSGDIELNFDGHDVA-SVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 2.0e-145, Sum P(2) = 2.0e-145
Identities = 165/335 (49%), Positives = 224/335 (66%)
Query: 463 PMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEI 522
P+F ++ AT NFS NKLG+GGFG VYKGRL G ++AVKRLS SGQG+EEF NE+
Sbjct: 498 PLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEV 557
Query: 523 KLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEE 582
+I+KLQHRNLVR MP LD +LFD K+ L W+TR +I+
Sbjct: 558 VVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDG 617
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT 642
I +GL+YLH+ SRL++IHRDLKASNILLD+++NPKISDFG+A++F G+E + T R+VGT
Sbjct: 618 ICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGT 677
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDR 701
YGYM+PEYA GLFS KSDVFS GV+LLE +S +RN+ F N + L AW LW
Sbjct: 678 YGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGE 737
Query: 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPA 761
L+DP++ E + R ++V LLCVQ+ A DRP++ V+ ML++E NLP P+QPA
Sbjct: 738 DIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPA 797
Query: 762 FSSIRGLKNTILPANGETGA-CSVSCLTLSVMDAR 795
F RG + ++G++ S++ ++L+ + R
Sbjct: 798 FIPRRGTSE--VESSGQSDPRASINNVSLTKITGR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 5.6e-141, Sum P(2) = 5.6e-141
Identities = 190/391 (48%), Positives = 254/391 (64%)
Query: 406 GHNNGQSVYIRVPASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMF 465
G N +V+ + T+ Q+ DI+ SI R ++ + K+ K ++
Sbjct: 468 GRNIKDAVHGSWRSRHSSTQSQQNSAMLDISQSI--RFDDDVEDGKSHELK-------VY 518
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLI 525
SL + AT+NFS NKLGEGGFGPVY G L G+EVAVKRL SGQGLEEFKNE+ LI
Sbjct: 519 SLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILI 578
Query: 526 AKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ 585
AKLQHRNLVR MPNKSLD FLF+ K+ L W+ R +IE IA+
Sbjct: 579 AKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIAR 638
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
GLLYLH+ SRLRV+HRDLKASNILLD DM PKISDFGMA+MFGGD+ Q T R+VGT+GY
Sbjct: 639 GLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGY 698
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS-NTDSLTLLGRAWDLWKDDRAWE 704
MSPEYA +G+FS+KSDV+ FGVL+LE ++ KR F + DSL + G AW W +D A E
Sbjct: 699 MSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAE 758
Query: 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSS 764
LIDP+++ S + R I++ALLCVQ+ A +RP + V+ ML+N++ +LP+P+ P
Sbjct: 759 LIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLM- 817
Query: 765 IRGLKNTILPANGETGACSVSCLTLSVMDAR 795
+RG + ++ + + S+ +T++ + R
Sbjct: 818 LRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1364 (485.2 bits), Expect = 2.1e-139, P = 2.1e-139
Identities = 326/816 (39%), Positives = 463/816 (56%)
Query: 12 SCVFLLSIKLSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISD 71
+C+ LL I + I S + + L S +ELGFFSP ++ +Y+GIW+K+I
Sbjct: 7 ACLLLLIIFPTCGYAAINTSSPLSIRQTLSSPGGFYELGFFSPNNTQNQYVGIWFKKIVP 66
Query: 72 -TVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNL 130
VVWVANR+ P+ S A LTI S+G+L++L+ K IWS+ + A+LLDTGN
Sbjct: 67 RVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHAELLDTGNF 126
Query: 131 VLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTH 190
V+ D+ S N LWQSF+H +T+LP L +D G +R T+W+S DPSPG ++
Sbjct: 127 VVIDDVSGNK----LWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEFSL 182
Query: 191 RLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSY--SYLYEPTVVDNE--DEIYYRYD 246
+ + + GSV GPW F SY+ +VV + + Y
Sbjct: 183 EITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFSYS 242
Query: 247 SYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPN 306
+ + + + L P GK+ +++W++ NN W++ S P+ C ++G CG +C P
Sbjct: 243 TLRNYNLSYVTLTPEGKM-KILWDDGNN-WKLHLSLPENPCDLYGRCGPYGLCVRSDPPK 300
Query: 307 CECLMGF--KLESQLNQTRPRS-CVRSHLVDCTNR----------DRFVMIDDIKLPDLE 353
CECL GF K + + + S CVR + C + D F + D+K PDL
Sbjct: 301 CECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPDLH 360
Query: 354 EVLLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHNNGQSV 413
+ +N ++C CL NC+C A+A G GCL+W G+L D + + ++G+ +
Sbjct: 361 QFA--SFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADTVQFL--SSGEFL 412
Query: 414 YIRVPASEVE-TKKSQDMLQFDINMSI-------ATRANEF-CKGNKA-ANSKTRD--SW 461
+IR+ +SE+ + + + ++ +++SI A + K N A N R S
Sbjct: 413 FIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSG 472
Query: 462 FPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNE 521
F + ++ AT NFS NKLG+GGFGPVYKG+L +G+E+ VKRL+S SGQG EEF NE
Sbjct: 473 VNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNE 532
Query: 522 IKLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNKSLDIFLFDTPKESPLGWETRVRVIE 581
I LI+KLQHRNLVR M NKSLDIF+FD + L W R +I+
Sbjct: 533 ITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQ 592
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
IA+GLLYLH+ SRLRVIHRDLK SNILLD MNPKISDFG+A+MF G + Q T+R+VG
Sbjct: 593 GIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVG 652
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAWDLWKDD 700
T GYMSPEYA GLFS KSD++SFGVL+LE +S KR + F D S LL WD W +
Sbjct: 653 TLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAYTWDSWCET 712
Query: 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQP 760
L+D L + + R + + LLCVQ +AVDRP +V+SMLT+ T +LP P+QP
Sbjct: 713 GGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSAT-DLPVPKQP 771
Query: 761 AFSSIRGLKNT-ILPANGETGACSVSCLTLSVMDAR 795
F+ + L + +L AN + SV+ +T S++ R
Sbjct: 772 IFA-VHTLNDMPMLQANSQD-FLSVNEMTESMIQGR 805
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 3.5e-139, Sum P(2) = 3.5e-139
Identities = 164/329 (49%), Positives = 219/329 (66%)
Query: 438 SIATRANEFCKGNKAANSKTRD-SWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRL 496
S+ ++ N +G ++ +++D S F + + AT NFS NKLG+GGFG VYKG+L
Sbjct: 460 SLVSKDN--VEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKL 517
Query: 497 HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRXXXXXXXXXXXXXXXXXMPNK 556
+G+E+AVKRL+S S QG EEF NEIKLI+KLQHRNL+R M NK
Sbjct: 518 QDGKEIAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNK 577
Query: 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616
SLDIF+FD K+ + W TR +I+ IA+GLLYLH+ S LRV+HRDLK SNILLD+ MNP
Sbjct: 578 SLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNP 637
Query: 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
KISDFG+A++F G++ Q T +VGT GYMSPEYA G FS KSD++SFGVL+LE ++ K
Sbjct: 638 KISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGK 697
Query: 677 RNTDFS-NTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY--LILNRYINVALLCVQED 733
+ FS D+ LL AWD W ++ L+D L + S + R +++ LLCVQ
Sbjct: 698 EISSFSYGKDNKNLLSYAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQ 757
Query: 734 AVDRPTMFEVVSMLTNETVNLPHPQQPAF 762
A+DRP + +V+SMLT+ T +LP P QP F
Sbjct: 758 AIDRPNIKQVMSMLTS-TTDLPKPTQPMF 785
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 2.2e-135, Sum P(2) = 2.2e-135
Identities = 158/335 (47%), Positives = 214/335 (63%)
Query: 431 LQFDINMSIATRANEFCKGNKAANS-KTRD-SWFPMFSLASVSAATANFSTENKLGEGGF 488
L++ + +++ + ++ N + +D S F + ++ AT NFS NKLG+GGF
Sbjct: 448 LRYKVKHTVSAKISKIASKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGF 507
Query: 489 GPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRXXXXXXXXXXXXX 548
G VYKG+L +G+E+AVKRLSS SGQG EEF NEI LI+KLQH+NLVR
Sbjct: 508 GSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLL 567
Query: 549 XXXXMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNI 608
+ NKSLD FLFD+ K + W R +IE IA+GL YLH+ S LRVIHRDLK SNI
Sbjct: 568 VYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNI 627
Query: 609 LLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVL 668
LLD+ MNPKISDFG+A+M+ G E Q T+R+ GT GYM+PEYA G+FS KSD++SFGV+
Sbjct: 628 LLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVI 687
Query: 669 LLETLSSKRNTDFS-NTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVAL 727
LLE ++ ++ + FS TLL AW+ W + +L+D + + L + R + + L
Sbjct: 688 LLEIITGEKISRFSYGRQGKTLLAYAWESWCESGGIDLLDKDVADSCHPLEVERCVQIGL 747
Query: 728 LCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAF 762
LCVQ DRP E++SMLT T +L P+QP F
Sbjct: 748 LCVQHQPADRPNTMELLSMLTT-TSDLTSPKQPTF 781
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4575 | 0.9371 | 0.9514 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XI001046 | hypothetical protein (802 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 795 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-43 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-38 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-28 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-26 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-25 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 6e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 8e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.003 | |
| pfam01163 | 186 | pfam01163, RIO1, RIO1 family | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 6e-56
Identities = 96/283 (33%), Positives = 136/283 (48%), Gaps = 43/283 (15%)
Query: 480 ENKLGEGGFGPVYKGRL-----HNGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNL 533
KLGEG FG VYKG L EVAVK L S Q +EEF E +++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
V+LLG C E E +++ EYMP L +L + L + +IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTKRIVGTYGYMSPEYAQ 652
IHRDL A N L+ +++ KISDFG+++ ++ D + K ++ +M+PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA-WDLWKDDRAWELID---- 707
+G F+ KSDV+SFGVLL E + LG + + E +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEYLKKGYR 222
Query: 708 -PILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
P N Y + L C ED DRPT E+V +L
Sbjct: 223 LPKPPNCPPELY-------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 95/282 (33%), Positives = 133/282 (47%), Gaps = 42/282 (14%)
Query: 480 ENKLGEGGFGPVYKGRL-----HNGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNL 533
KLGEG FG VYKG+L EVAVK L S Q +EEF E +++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
V+LLG C E E ++ EYM L +L L + +IA+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
IHRDL A N L+ +++ KISDFG+++ D+ K + +M+PE ++
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKE 177
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA-WDLWKDDRAWELID----- 707
G F+ KSDV+SFGVLL E + LG + ++ E +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLEYLKNGYRL 222
Query: 708 PILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
P N Y ++ L C ED DRPT E+V +L
Sbjct: 223 PQPPNCPPELY-------DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 8e-55
Identities = 101/282 (35%), Positives = 143/282 (50%), Gaps = 34/282 (12%)
Query: 481 NKLGEGGFGPVYKGRLHNGQ----EVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVR 535
KLGEG FG VYKG+L EVAVK L S + ++F E +++ KL H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFL------FDTPKESPLGWETRVRVIEEIAQGLLY 589
LLG C E E L+ EYM L +L F +P++S L + + +IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTKRIVGTYGYMSP 648
L + +HRDL A N L+ +D+ KISDFG+++ ++ D + KT + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 649 EYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706
E + G+F+ KSDV+SFGVLL E TL + SN + L L + L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYR--LP 227
Query: 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
P + Y + L C Q D DRPT E+V L
Sbjct: 228 KPEYCPDELY-------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 80/193 (41%), Positives = 111/193 (57%), Gaps = 11/193 (5%)
Query: 483 LGEGGFGPVYKGRLHN-GQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
LGEGGFG VY R G++VA+K + S LEE EI+++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600
+ L+ EY SL L + E L + +R++ +I +GL YLH +IH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 601 RDLKASNILLDKD-MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQQGLFSI 658
RDLK NILLD D K++DFG++K+ D+ KT IVGT YM+PE +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 659 KSDVFSFGVLLLE 671
KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-50
Identities = 75/200 (37%), Positives = 110/200 (55%), Gaps = 13/200 (6%)
Query: 482 KLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVR 535
KLGEG FG VYKG L +VAVK L + + EEF E ++ KL H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
LLG C + E ++ EYMP L FL L + +++ +IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+HRDL A N L+ +++ KISDFG+++ ++ D + + + +M+PE + G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179
Query: 655 LFSIKSDVFSFGVLLLETLS 674
F+ KSDV+SFGVLL E +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 4e-48
Identities = 88/273 (32%), Positives = 126/273 (46%), Gaps = 23/273 (8%)
Query: 477 FSTENKLGEGGFGPVYKGRLHN-GQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ KLG G FG VYK + G+ VAVK L S+ + + + EI+++ +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
VRL+ + + L+ EY L +L + PL + ++ +I +GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQ 652
+IHRDLK NILLD++ KI+DFG+AK S VGT YM+PE
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLG 172
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR-AWDLWKDDRAWELIDPILQ 711
+ K DV+S GV+L E L+ FS + L L L E
Sbjct: 173 GNGYGPKVDVWSLGVILYELLT--GKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVV 744
EA LI C+ +D RPT E++
Sbjct: 231 EEAKDLIKK--------CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 69/198 (34%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ KLGEG FG VY R G+ VA+K + + + E EIK++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLLYLHQY 593
RL + ++ L+ EY L L + S E R + +I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS----EDEARFYLRQILSALEYLHS- 115
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
++HRDLK NILLD+D + K++DFG+A+ E K VGT YM+PE
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLG 170
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ D++S GV+L E
Sbjct: 171 KGYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 481 NKLGEGGFGPVYKGRLH-NGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
LG G FG VY G+ +AVK LS S + LE + EI++++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 538 GCCIELEEK-ILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYS 594
G + E+ + I+ EY+ SL L K E +R +I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP----EPVIRKYTRQILEGLAYLH--- 118
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
++HRD+K +NIL+D D K++DFG AK G E T + GT +M+PE +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 655 LFSIKSDVFSFGVLLLETLSSKR 677
+ +D++S G ++E + K
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 60/115 (52%), Positives = 72/115 (62%), Gaps = 6/115 (5%)
Query: 70 SDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGN 129
+ TVVWVANR P+ DS+ TL + S GNLV+ + +WSSN + K VA L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPS 184
LVL DN S LWQSFDHP+DTLLPG K G ++ G R TSW+S DPS
Sbjct: 61 LVLYDN--SGKV---LWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 481 NKLGEGGFGPVYKGRLHN-----GQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLV 534
+LGEG FG V R G++VAVK L+ S Q +F+ EI+++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 535 RLLGCCIELEEKI--LIYEYMPNKSLDIFLFDTPKESP-LGWETRVRVIEEIAQGLLYLH 591
+ G C + + LI EY+P+ SL +L + + + + +I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYMSPE 649
R IHRDL A NIL++ + KISDFG+AK+ D K + Y +PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLS 674
+ FS SDV+SFGV L E +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 61/122 (50%), Positives = 70/122 (57%), Gaps = 6/122 (4%)
Query: 31 SRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATL 90
S + G+ LVSS FELGFF Y I YK S TVVWVANR+ P S+ TL
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTL 59
Query: 91 TIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFD 150
T+ S GNLVI + +WSSN TR G+ V LLD GNLVL D S LWQSFD
Sbjct: 60 TLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD-----SDGNFLWQSFD 114
Query: 151 HP 152
+P
Sbjct: 115 YP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 73/198 (36%), Positives = 113/198 (57%), Gaps = 6/198 (3%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
F+ E KLG G FG V++G N VA+K L S ++F+ E++ + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
C E +I E M SL FL +P+ L + + + ++A+G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
IHRDL A NIL+ +D+ K++DFG+A++ D S K+I Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 657 SIKSDVFSFGVLLLETLS 674
S KSDV+SFG+LL E +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 66/197 (33%), Positives = 108/197 (54%), Gaps = 11/197 (5%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
F K+G+GGFG VYK R G+EVA+K + +S + E+ NEI+++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLLYLHQYS 594
G ++ +E ++ E+ SL L T + E+++ V +E+ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLT---ESQIAYVCKELLKGLEYLHSN- 117
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+IHRD+KA+NILL D K+ DFG++ +VGT +M+PE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGK 172
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 173 PYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRN 532
N+ + +G G FG VYKG L G VA+K++S + + L+ EI L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 533 LVRLLGCCIELEEKILIY-EYMPNKSLDIFLFDTPKES-PLGWETRVRV-IEEIAQGLLY 589
+V+ +G IE + + I EY N SL K+ P E+ V V + ++ QGL Y
Sbjct: 61 IVKYIGS-IETSDSLYIILEYAENGSL----RQIIKKFGPFP-ESLVAVYVYQVLQGLAY 114
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
LH+ VIHRD+KA+NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPE 169
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ S SD++S G ++E L+
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 56/121 (46%), Positives = 71/121 (58%), Gaps = 7/121 (5%)
Query: 31 SRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATL 90
S + G+ LVS + FELGFF+ + Y I YK S TVVWVANR+ P+ D + TL
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNPVSD-SCTL 58
Query: 91 TIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFD 150
T+ S GNLV+ + +WSSN T G+ V LLD GNLV+ D S LWQSFD
Sbjct: 59 TLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD-----SDGNFLWQSFD 113
Query: 151 H 151
+
Sbjct: 114 Y 114
|
Length = 114 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 74/198 (37%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
E KLG G FG V+ G + +VAVK L + E F E +++ KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
C E E ++ EYM SL FL + + L V + +IA+G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQ 653
IHRDL A NIL+ +++ KI+DFG+A++ DE ++ G + +PE A
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANY 178
Query: 654 GLFSIKSDVFSFGVLLLE 671
G F+IKSDV+SFG+LL E
Sbjct: 179 GRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 69/194 (35%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 482 KLGEGGFGPVYKG-RLHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
K+GEG G VYK G+EVA+K RL Q+ + + NEI ++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82
Query: 539 CCIELEEKILIYEYMPNKSL-DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ +E ++ EYM SL DI T + V E+ QGL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHS---QN 136
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
VIHRD+K+ NILL KD + K++DFG A + +SK +VGT +M+PE ++ +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 658 IKSDVFSFGVLLLE 671
K D++S G++ +E
Sbjct: 195 PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 34/277 (12%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLH--NGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHR 531
++ LG+G G VYK R H G+ A+K++ + ++ E+K + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVR-HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLY 589
+V+ G + E ++ EYM SL L K E L + R +I +GL Y
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-----QILKGLDY 114
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
LH + +IHRD+K SN+L++ KI+DFG++K+ + + VGT YMSPE
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPE 170
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
Q +S +D++S G+ LLE K F + +EL+ I
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK--FPFLPPGQPSF-------------FELMQAI 215
Query: 710 LQNEASYLILNRY----INVALLCVQEDAVDRPTMFE 742
L + + C+Q+D RP+ E
Sbjct: 216 CDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 4e-32
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 20/311 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQH-R 531
++ KLGEG FG VY R + VA+K L+ + + +E F EI+++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
N+V+L + L+ EY+ SL+ L ++ PL + ++ +I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 592 QYSRLRVIHRDLKASNILLDKDMN-PKISDFGMAKMFGGD----ELQSKTKRIVGTYGYM 646
+IHRD+K NILLD+D K+ DFG+AK+ + + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 647 SPEYAQQGLF---SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703
+PE S SD++S G+ L E L+ F + + + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTP 233
Query: 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFS 763
L P+ + LI ++ + +D +R + +S + L
Sbjct: 234 SLASPLSPSN-PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 764 SIRGLKNTILP 774
L
Sbjct: 293 KPDDSAPLRLS 303
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 76/231 (32%), Positives = 120/231 (51%), Gaps = 32/231 (13%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLH--NGQE----VAVKRL-SSQSGQGLEE 517
L++V F E LGEG FG VYKG L N + VA+K L + + +E
Sbjct: 2 IPLSAV-----RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE 54
Query: 518 FKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLF-------------D 564
F+ E +L++ LQH N+V LLG C + + +++EY+ + L FL D
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 565 TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
+S L + + +IA G+ YL S +HRDL A N L+ + + KISDFG++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 625 K-MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ ++ D + ++K ++ +M PE G F+ +SD++SFGV+L E S
Sbjct: 172 RDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 483 LGEGGFGPVYKGRLHNGQE------VAVKRLSSQSGQGLEE-FKNEIKLIAKLQHRNLVR 535
LGEG FG V+ G ++ + VAVK L + + F+ E +L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFL-----------FDTPKESPLGWETRVRVIEEIA 584
G C E + I+++EYM + L+ FL L +++ +IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT-- 642
G++YL + +HRDL N L+ D+ KI DFGM++ D + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 643 --YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE F+ +SDV+SFGV+L E +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 86/284 (30%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 481 NKLGEGGFGPVYKG--RLHNGQE--VAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+LG G FG V KG + +G+E VAVK L G +EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEE----IAQGLLYLH 591
L+G C E +L+ E P L +L E V ++E +A G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRR-------EIPVSDLKELAHQVAMGMAYLE 112
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM--FGGDELQSKT--KRIVGTYGYMS 647
+HRDL A N+LL KISDFGM++ G D ++ T + + Y +
Sbjct: 113 S---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---A 166
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
PE G FS KSDV+S+GV L E S +K + + + +L L + + +
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQE 226
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
I I+ C + DRPT E+ S
Sbjct: 227 IYSIML----------------SCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 81/277 (29%), Positives = 132/277 (47%), Gaps = 38/277 (13%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGL-EEFKNEIKLIAKLQHRNLVRLLGCC 540
K+G+G FG VYKG L EVAVK S L +F E +++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600
++ + ++ E +P SL FL K++ L + +++ + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 601 RDLKASNILLDKDMNPKISDFGMAKMFGGD--ELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
RDL A N L+ ++ KISDFGM++ G + K+I + +PE G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID-------PILQ 711
+SDV+S+G+LL ET S +T + + + E I+ P L
Sbjct: 175 ESDVWSYGILLWETF-SLGDTPYPG-------------MSNQQTRERIESGYRMPAPQLC 220
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
E Y ++ C D +RP+ E+ + L
Sbjct: 221 PEEIYRLML-------QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 96/286 (33%), Positives = 142/286 (49%), Gaps = 48/286 (16%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRLS----SQSGQG-LEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VY+G L +G AVK +S Q+GQ +++ + EI L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 537 LGCCIELEEKILIY-EYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
LG E E+ + I+ E +P SL L + + E + TR +I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY-AQ 652
R +HRD+K +NIL+D + K++DFGMAK S K G+ +M+PE AQ
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRN-TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
QG + + +D++S G +LE + K + ++ +GR+ +L I L
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL-------PPIPDHLS 228
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHP 757
+EA I L C+Q D RPT + L L HP
Sbjct: 229 DEAKDFI--------LKCLQRDPSLRPT----AAEL------LEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 75/200 (37%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
KLG G FG V+ G + +VA+K L S E F E L+ +LQH LVRL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
+ E +I EYM N SL FL TP+ L + + +IA+G+ ++ R I
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY--GYMSPEYAQQGLFS 657
HRDL+A+NIL+ + + KI+DFG+A++ +E T R + + +PE G F+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFT 181
Query: 658 IKSDVFSFGVLLLETLSSKR 677
IKSDV+SFG+LL E ++ R
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 85/267 (31%), Positives = 131/267 (49%), Gaps = 33/267 (12%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
KLG G FG V++G +N VAVK L + ++F E +++ KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 542 ELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600
LEE I I E M SL +L L + + ++A G+ YL + IH
Sbjct: 72 -LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 601 RDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQGLFS 657
RDL A N+L+ ++ K++DFG+A++ D +++ G + +PE A FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 658 IKSDVFSFGVLLLETLSSKR--NTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715
IKSDV+SFG+LL E ++ R +N + L + D+ + + P +
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV---------DQGYRMPCPPGCPKEL 233
Query: 716 YLILNRYINVALLCVQEDAVDRPTMFE 742
Y I+ L C +ED DRPT FE
Sbjct: 234 YDIM-------LDCWKEDPDDRPT-FE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
++G+G FG VY R +G+ +K LS+ S + E+ NE+K++ KL H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 538 GCCIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRV-RVIEEIAQGLLYLHQYSR 595
E + K+ I EY L + KE E ++ ++ L YLH SR
Sbjct: 66 ESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SR 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+++HRD+K NI L + K+ DFG++K+ +KT +VGT Y+SPE Q
Sbjct: 123 -KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKP 179
Query: 656 FSIKSDVFSFGVLLLETLSSKR 677
++ KSD++S G +L E + K
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 31/271 (11%)
Query: 483 LGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542
LG G FG V+ G+ +VA+K + + ++F E K++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRD 602
++ EYM N L +L + + LG E + + ++ + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 603 LKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQGLFSIK 659
L A N L+ +D K+SDFG+A+ D+ S GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 660 SDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL 717
SDV+SFGVL+ E S + FSN++ + + + L++ P L Y
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---------PKLAPTEVYT 232
Query: 718 ILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
I+ C E DRP +++S LT
Sbjct: 233 IMY-------SCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 31/263 (11%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
++G G FG V+ G ++VA+K + + E+F E +++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
E L++E+M + L +L + ET + + ++ +G+ YL + VIHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 602 DLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQGLFSI 658
DL A N L+ ++ K+SDFGM + D+ S T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716
KSDV+SFGVL+ E S + + SN++ + + + L+K P L +++ Y
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---------PRLASQSVY 231
Query: 717 LILNRYINVALLCVQEDAVDRPT 739
++ C +E DRP+
Sbjct: 232 ELMQH-------CWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 70/217 (32%), Positives = 115/217 (52%), Gaps = 9/217 (4%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRN 532
+F NK+G+G FG V+K R + + A+K+ LS + + EE +E +++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
++R ++ + ++ EY N L L + PL + R +I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+++HRD+K+ N+ LD N KI D G+AK+ + + T IVGT Y+SPE +
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689
++ KSDV++ GV+L E + K D +N +L L
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 15/198 (7%)
Query: 483 LGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542
+G+G FG V G + GQ+VAVK L S + F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRD 602
++ EYM SL +L + + + ++ ++ +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 603 LKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY--GYMSPEYAQQGLFSIKS 660
L A N+L+ +D+ K+SDFG+AK + Q + G + +PE ++ FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTKS 180
Query: 661 DVFSFGVLLLETLSSKRN 678
DV+SFG+LL E S R
Sbjct: 181 DVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 483 LGEGGFGPVYKG----RLHNGQ-EVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VYKG + VA+K L ++ + +E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
LG C+ + LI + MP L ++ + +G + + +IA+G+ YL +
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
R++HRDL A N+L+ + KI+DFG+AK+ DE + + +M+ E ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 657 SIKSDVFSFGVLLLETLS 674
+ KSDV+S+GV + E ++
Sbjct: 189 THKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 84/268 (31%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
KLG G FG V+ G +N +VAVK L + ++ F E L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
+ E +I EYM SL FL + + + + +IA+G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 602 DLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSD 661
DL+A+N+L+ + + KI+DFG+A++ +E ++ + +PE G F+IKSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSD 186
Query: 662 VFSFGVLLLETLSSKR--NTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLIL 719
V+SFG+LL E ++ + SN+D ++ L R + + P ++N L
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-----------PRMENCPDEL-- 233
Query: 720 NRYINVALLCVQEDAVDRPTMFEVVSML 747
++ C +E A +RPT + S+L
Sbjct: 234 ---YDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 89/290 (30%), Positives = 129/290 (44%), Gaps = 34/290 (11%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLHNGQE------VAVKRLSSQSGQGLE-EFKNEIKLIAK 527
+N LG G FG V+ + +E V VK L + L+ EF+ E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL------FDTPKESPLGWETRVRVIE 581
L H+N+VRLLG C E E +I EY L FL + K PL + +V +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
+IA G+ +L S R +HRDL A N L+ K+S ++K E K + +
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALI 180
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR--NTDFSNTDSLTLLGRAWDLWKD 699
+++PE Q+ FS KSDV+SFGVL+ E + S+ + L L A L
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-AGKL--- 236
Query: 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
EL P Y ++ R C + DRP+ E+VS L
Sbjct: 237 ----ELPVPEGCPSRLYKLMTR-------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 69/198 (34%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG V R G+ A+K L + + +E E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
+ EEK+ L+ EY P L L KE E R R EI L YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLH---SL 112
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+I+RDLK NILLD D + K++DFG+AK + S+T GT Y++PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGY 170
Query: 657 SIKSDVFSFGVLLLETLS 674
D +S GVLL E L+
Sbjct: 171 GKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 78/201 (38%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 483 LGEGGFGPV--YKGRLHN---GQEVAVKRLSSQSGQGLEE-FKNEIKLIAKLQHRNLVRL 536
LGEG FG V Y N G+ VAVK L + GQ +K EI ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 537 LGCCIELEEKI--LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
GCC E K LI EY+P SL +L PK L + ++I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHK-LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMF-GGDELQSKTKRIVGTYGYMSPEYAQQ 653
IHRDL A N+LLD D KI DFG+AK G E + + + E ++
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 654 GLFSIKSDVFSFGVLLLETLS 674
FS SDV+SFGV L E L+
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 84/294 (28%), Positives = 125/294 (42%), Gaps = 35/294 (11%)
Query: 471 SAATANFSTENKLGEGGFGPVYKG--RLHNG----QEVAVKRL-SSQSGQGLEEFKNEIK 523
+ + LG G FG VY+G R +G +VAVK L S S Q +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDT-PKE---SPLGWETRVRV 579
+++K H+N+VRL+G E + ++ E M L FL + P+ S L + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAKMFGGDELQSKT 636
++A+G YL + IHRD+ A N LL KI+DFGMA+ K
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAW 694
R + +M PE G+F+ K+DV+SFGVLL E S +N + + +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
L D P+ Y I+ C Q DRP ++ +
Sbjct: 239 RL---DPPKGCPGPV------YRIMTD-------CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 85/277 (30%), Positives = 137/277 (49%), Gaps = 32/277 (11%)
Query: 480 ENKLGEGGFGPVYKGRLH-NGQE---VAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLV 534
E +G G FG V +GRL G++ VA+K L + S + +F E ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
RL G + ++I EYM N SLD FL + + V ++ IA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK--RIVGTYGYMSPEYAQ 652
+ +HRDL A NIL++ ++ K+SDFG+++ E TK +I + +PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIA 181
Query: 653 QGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
F+ SDV+SFG+++ E +S + D SN D + + + + L P+
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV---------EDGYRLPPPMD 232
Query: 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
A Y ++ L C Q+D +RPT ++VS L
Sbjct: 233 CPSALYQLM-------LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 71/210 (33%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 483 LGEGGFGPVYKGRLHN-------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLV 534
LG G FG VY+G + VAVK L + Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP----LGWETRVRVIEEIAQGLLYL 590
+LLG C+ E + +I E M L +L D E L + + + ++A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 591 HQYSRLRVIHRDLKASNILL-----DKDMNPKISDFGMAK-MFGGDELQSKTKRIVGTYG 644
Q + IHRDL A N L+ D D KI DFG+A+ ++ D + + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE G F+ +SDV+SFGVL+ E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 74/215 (34%), Positives = 118/215 (54%), Gaps = 34/215 (15%)
Query: 483 LGEGGFGPVYKGRLH--NGQEVAVKR--LSSQSGQG-------LEEFKNEIKLIAKLQHR 531
+G G FG VY G ++ +G+ +AVK+ L S S L+ EI L+ +LQH
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFL-----FDTPKESPLGWETRVR-VIEEIAQ 585
N+V+ LG ++ + + EY+P S+ L F+ ET VR + +I +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---------ETLVRNFVRQILK 117
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR----IVG 641
GL YLH +R +IHRD+K +NIL+D KISDFG++K + L +KT + G
Sbjct: 118 GLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ +M+PE +Q ++ K+D++S G L++E L+ K
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 39/271 (14%)
Query: 481 NKLGEGGFGPVYKGRLH--NGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRNLVR 535
+LG G G V K H G+ +AVK + + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVL-HRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPK---ESPLGWETRVRVIEEIAQGLLYLHQ 592
G + + EYM SLD L + E LG ++ + +GL YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH- 117
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+ ++IHRD+K SNIL++ K+ DFG++ G + S K VGT YM+PE Q
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQ 172
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+S+KSD++S G+ L+E + + N + EL+ I+
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-------------ELLQYIVNE 219
Query: 713 EASYLILNRY----INVALLCVQEDAVDRPT 739
L ++ + LC+ +D +RP+
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 10/197 (5%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
+G G VY L N ++VA+KR+ + ++E + E++ +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 539 CCIELEEKILIYEYMPNKS-LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ +E L+ Y+ S LDI P+ L V++E+ +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYMSPEYAQQGL 655
IHRD+KA NILL +D + KI+DFG++ GGD + K VGT +M+PE +Q
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 656 -FSIKSDVFSFGVLLLE 671
+ K+D++SFG+ +E
Sbjct: 183 GYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 32/207 (15%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
F KLGEG +G VYK GQ VA+K + + L+E EI ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62
Query: 536 LLGCCIELEEKILIYEYMPNKS-LDIF--LFDTPKESPLGWETRVRVIEEIA-------Q 585
G + + ++ EY S DI T E EEIA +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE------------EEIAAILYQTLK 110
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYG 644
GL YLH + IHRD+KA NILL+++ K++DFG++ ++ +K ++GT
Sbjct: 111 GLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRNTVIGTPF 164
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+M+PE Q+ ++ K+D++S G+ +E
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 70/235 (29%), Positives = 117/235 (49%), Gaps = 23/235 (9%)
Query: 482 KLGEGGFGPVYKGRLHN---GQE---VAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+LGEG FG V+ HN Q+ VAVK L S ++F+ E +L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFL---------FDTPKESPLGWET---RVRVIEEI 583
G C E ++++EYM + L+ FL ++ G T + + +I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY 643
A G++YL + L +HRDL N L+ + + KI DFGM++ + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT--DFSNTDSLTLLGRAWDL 696
+M PE F+ +SD++SFGV+L E + + SNT+++ + + +L
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 89/305 (29%), Positives = 130/305 (42%), Gaps = 57/305 (18%)
Query: 482 KLGEGGFGPVYKGRLHNGQE-----------------VAVKRL-SSQSGQGLEEFKNEIK 523
KLGEG FG V+ Q+ VAVK L S E+F E+K
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL--------FDTPKESPLGWET 575
++++L N+ RLLG C +I EYM N L+ FL L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 576 RVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGD--EL 632
+ + +IA G+ YL L +HRDL N L+ K+ KI+DFGM++ ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692
Q R +M+ E G F+ KSDV++FGV L E L+ R + + LT
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY---EHLT---- 238
Query: 693 AWDLWKDDRAWELIDPILQNEASYLILNR--------YINVALLCVQEDAVDRPTMFEVV 744
D + E +++ + L R Y + L C + D DRPT E+
Sbjct: 239 ------DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY-ELMLECWRRDEEDRPTFREIH 291
Query: 745 SMLTN 749
L
Sbjct: 292 LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 26/211 (12%)
Query: 483 LGEGGFGPVYKGRLHNG----QEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LGEG FG V +G+L +VAVK +L + +EEF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 537 LGCCIELEEK------ILIYEYMPNKSLDIFLF-----DTPKESPLGWETRVRVIEEIAQ 585
+G C E ++I +M + L FL P++ PL +T ++ + +IA
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIAL 124
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDEL-QSKTKRIVGTY 643
G+ YL S IHRDL A N +L +DM ++DFG++ K++ GD Q + ++
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PV 179
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ E +++ KSDV++FGV + E +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 33/212 (15%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEF----KNEIKLIAKLQHRNLVR 535
++GEG +G VYK R G+ VA+K++ ++ + E F EIKL+ KL+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62
Query: 536 LLGCCIELEEK--ILIYEYMPNKSLDIF-LFDTPKESPLGWETRVRVI-EEIAQGLLYLH 591
L + +++EYM + D+ L D+P E E++++ +++ +GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSP-EVKFT-ESQIKCYMKQLLEGLQYLH 117
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-- 649
++HRD+K SNIL++ D K++DFG+A+ + T R++ T Y PE
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 650 -----YAQQGLFSIKSDVFSFGVLLLETLSSK 676
Y + D++S G +L E K
Sbjct: 174 LGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-26
Identities = 87/295 (29%), Positives = 142/295 (48%), Gaps = 39/295 (13%)
Query: 482 KLGEGGFGPVYKGRLHNGQE-----------------VAVKRLSSQSGQGLE-EFKNEIK 523
KLGEG FG V+ ++ VAVK L + + +F EIK
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD-TPKESP-------LGWET 575
++++L+ N++RLL CI + +I EYM N L+ FL P+E+ + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 576 RVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQS 634
+ + +IA G+ YL S L +HRDL N L+ K+ KI+DFGM++ ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAW 694
+ R V +MS E G F+ SDV++FGV L E L+ + +S ++
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 695 DLWKDD-RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
+ ++D R L P L ++ Y + L C + +A +RP+ E+ + L
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLY-------KLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 38/217 (17%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFK----NEIKLIAKLQHR 531
+ KLGEG +G VYK R G+ VA+K++ + E EI L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 532 NLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA----QG 586
N+V+LL E K+ L++EY + L +L P +I+ I +G
Sbjct: 59 NIVKLLDVIHT-ERKLYLVFEYC-DMDLKKYLDKRPGPLSP------NLIKSIMYQLLRG 110
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
L Y H + R++HRDLK NIL+++D K++DFG+A+ F G L++ T +V T Y
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYR 165
Query: 647 SPE-------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+PE Y S D++S G + E ++ K
Sbjct: 166 APEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 72/200 (36%), Positives = 108/200 (54%), Gaps = 11/200 (5%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
KLG G FG V+ G + +VAVK L + E F E +++ KL+H LV+L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
E E ++ EYM SL FL D + L V + ++A G+ Y+ R+ I
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY--GYMSPEYAQQGLFS 657
HRDL+++NIL+ + KI+DFG+A++ +E T R + + +PE A G F+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181
Query: 658 IKSDVFSFGVLLLETLSSKR 677
IKSDV+SFG+LL E ++ R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/198 (31%), Positives = 109/198 (55%), Gaps = 13/198 (6%)
Query: 478 STENKLGEGGFGPVYKG--RLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ ++KLG G +G VY+G + ++ VAVK L + +EEF E ++ +++H NLV+
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
LLG C +I E+M +L +L + ++ + + + +I+ + YL + +
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 124
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQ 653
IHRDL A N L+ ++ K++DFG++++ GD + K + + +PE
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAY 179
Query: 654 GLFSIKSDVFSFGVLLLE 671
FSIKSDV++FGVLL E
Sbjct: 180 NKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLV 534
F+ +G+G FG VYK Q VA+K + ++ +E+ + EI+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ G ++ + +I EY S D K L ++ E+ GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
IHRD+KA+NILL ++ + K++DFG++ SK VGT +M+PE +Q
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMAPEVIKQS 173
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 174 GYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G +G VY R L +A+K + + + ++ EI L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 542 ELEEKILIY-EYMPNKSLDIFLFD-----TPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
E I+ E +P SL L E + + T+ +I +GL YLH
Sbjct: 76 E-NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHD--- 126
Query: 596 LRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+++HRD+K N+L++ KISDFG +K G + T+ GT YM+PE +G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKG 184
Query: 655 L--FSIKSDVFSFGVLLLETLSSK 676
+ +D++S G ++E + K
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 71/214 (33%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 483 LGEGGFGPVYKGRL-----HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
LG+G FG V R + G+ VAVK+L + + L +F+ EI+++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 538 GCCIEL--EEKILIYEYMPNKSLDIFL------FDTPKESPLGWETRVRVIEEIAQGLLY 589
G C L+ EY+P SL +L D K +I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS--------QICKGMEY 123
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG----- 644
L R +HRDL NIL++ + KI DFG+ K+ Q K V G
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP----QDKEYYKVREPGESPIF 176
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE--TLSSK 676
+ +PE + FS+ SDV+SFGV+L E T S K
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKR-----LSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG VY + G+E+AVK+ S ++ + + + EI+L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 537 LGCCIELEEKILIY-EYMPNKSL--DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
GC + +E + I+ EYMP S+ + + E+ TR +I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH-- 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ-SKTKRIVGTYGYMSPEYAQ 652
++HRD+K +NIL D N K+ DFG +K + K + GT +MSPE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 653 QGLFSIKSDVFSFGVLLLETLSSK 676
+ K+DV+S G ++E L+ K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+LG G FG V+ G+ +VA+K ++ + E+F E K++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
+ + ++ E+M N L +L ++ L + + + +++ +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 602 DLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT--KRIVGTYGYMSPEYAQQGLFSIK 659
DL A N L+ K+SDFGM + DE S + K V + PE +S K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV---KWSPPEVFNFSKYSSK 181
Query: 660 SDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL 717
SDV+SFGVL+ E + + SN + + ++ R + L++ P L + Y
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------PKLASMTVY- 231
Query: 718 ILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
V C E RPT E++ +T
Sbjct: 232 ------EVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 84/278 (30%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 482 KLGEGGFGPVYKGRLHNGQ----EVAVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLVRL 536
KLG+G FG V +G VAVK L S +++F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI----EEIAQGLLYLH 591
G + L + ++ E P SL D ++ LG + + +IA G+ YL
Sbjct: 62 YG--VVLTHPLMMVTELAPLGSL----LDRLRKDALG-HFLISTLCDYAVQIANGMRYLE 114
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYMSPE 649
R IHRDL A NILL D KI DFG+ + D + V + + +PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPE 170
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
+ FS SDV+ FGV L E + + L G L K D+ E ++
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQI-LKKIDKEGERLE-- 221
Query: 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ EA NV L C + DRPT + L
Sbjct: 222 -RPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 39/283 (13%)
Query: 483 LGEGGFGPVYKGRLHN------GQEVAVKRLS--SQSGQGLEEFKNEIKLIAKLQHRNLV 534
LG+G FG VY+G VA+K ++ + + +E F NE ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFL-------FDTPKESPLGWETRVRVIEEIAQGL 587
RLLG + +++ E M L +L + P P + +++ EIA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTKRIVGTYGYM 646
YL + +HRDL A N ++ +D+ KI DFGM + ++ D + K ++ +M
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 188
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
+PE + G+F+ KSDV+SFGV+L E TL+ + SN + L + L D
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL---DLPEN 245
Query: 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
D +L+ + +C Q + RPT E+VS L
Sbjct: 246 CPDKLLE-------------LMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 6e-25
Identities = 32/67 (47%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 335 CTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMW 394
C D F+ + ++KLPD +++ S+ LKECE CL NC+C AYA + + GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 395 FGDLVDI 401
G+LVD+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLE-EFKNEIKLIAKLQHRNL 533
++LGEG G V K RL N + A+K +++ L+ + E+++ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 534 VRLLGCCI-ELEEKILI-YEYMPNKSLDIFLFDTPK------ESPLGWETRVRVIEEIAQ 585
V+ G + E I I EY SLD K E LG ++ E + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLK 116
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
GL YLH ++IHRD+K SNILL + K+ DFG++ G+ + S GT Y
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFY 169
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLE 671
M+PE Q +SI SDV+S G+ LLE
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS------SQSGQGLEEFKNEIKLIAKLQHRNLVR 535
LG G F Y+ R + G +AVK+++ S+ + +E + EI+L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
+LG E L E+M S+ L K + E++ +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 596 LRVIHRDLKASNILLDKD-MNPKISDFGMA-----KMFGGDELQSKTKRIVGTYGYMSPE 649
++IHRD+K +N+L+D +I+DFG A K G E Q + ++GT +M+PE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFMAPE 178
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSK---RNTDFSN 683
+ + DV+S G +++E ++K SN
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 45/232 (19%)
Query: 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFK-----NEIKLIAKL- 528
+F +GEG F V + +E A+K L + Q ++E K E +++ +L
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLN 59
Query: 529 QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRVIEE 582
H +++L + EE + + EY PN L ++ D TR E
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-------CTRF-YAAE 110
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL---------- 632
I L YLH +IHRDLK NILLDKDM+ KI+DFG AK+ +
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 633 --------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ + VGT Y+SPE + SD+++ G ++ + L+ K
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 2e-24
Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 2/105 (1%)
Query: 212 SGPWNGVAFQAAP--SYSYLYEPTVVDNEDEIYYRYDSYNSPIIMMLKLNPSGKIQRLIW 269
SGPWNG+ F P Y +N +E+YY Y N+ I L L+ G ++R W
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFTW 62
Query: 270 NERNNGWEVFFSGPDYFCQIFGSCGANSVCSIDKTPNCECLMGFK 314
+ W +F+S P C ++G CG C ++ +P C C+ GF
Sbjct: 63 IPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 19/198 (9%)
Query: 483 LGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G FG VYK + G A K + +S + LE+F EI ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 542 ELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLRVI 599
E K+ I E+ +LD + + E L E ++R + ++ + L +LH + +VI
Sbjct: 73 -YENKLWILIEFCDGGALDSIMLEL--ERGLT-EPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 600 HRDLKASNILLDKDMNPKISDFGM-AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS- 657
HRDLKA NILL D + K++DFG+ AK LQ K +GT +M+PE F
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQ-KRDTFIGTPYWMAPEVVACETFKD 182
Query: 658 ----IKSDVFSFGVLLLE 671
K+D++S G+ L+E
Sbjct: 183 NPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 80/279 (28%), Positives = 133/279 (47%), Gaps = 29/279 (10%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ E KLG G FG V+ + +VAVK + S +E F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 535 RLLGCCIELEEKILIYEYMPNKSL-DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
+L + E +I E+M SL D D + PL + +IA+G+ ++ Q
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ IHRDL+A+NIL+ + KI+DFG+A++ +E ++ + +PE
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINF 177
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRA-WELIDPIL 710
G F+IKSDV+SFG+LL+E ++ R SN + + L R + + + + EL +
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN--- 234
Query: 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+ + C + +RPT + S+L +
Sbjct: 235 --------------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 69/198 (34%), Positives = 107/198 (54%), Gaps = 7/198 (3%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG+G FG V+ G + VA+K L + E F E +++ KL+H LV+L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
E E ++ EYM SL FL L V + +IA G+ Y+ R+ +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRDL+A+NIL+ +++ K++DFG+A++ +E ++ + +PE A G F+IK
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 660 SDVFSFGVLLLETLSSKR 677
SDV+SFG+LL E + R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 17/198 (8%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
++G G +G VYK R + G+ VA+K + + G E + EI ++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 540 CIELEEKILIYEYMPNKSL-DIF--LFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
+ ++ ++ EY SL DI+ E + + R E +GL YLH+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHE---T 120
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ---Q 653
IHRD+K +NILL +D + K++DFG++ +K K +GT +M+PE A +
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 654 GLFSIKSDVFSFGVLLLE 671
G + K D+++ G+ +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 8e-24
Identities = 78/244 (31%), Positives = 122/244 (50%), Gaps = 29/244 (11%)
Query: 470 VSAATANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQSGQGL-EEFKNEI 522
++ +T F E LGE FG VYKG L Q VA+K L ++ L EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 523 KLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLF-------------DTPKES 569
+ ++LQH N+V LLG + + +I+ Y + L FL D +S
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 570 PLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFG 628
L V ++ +IA G+ +L S V+H+DL N+L+ +N KISD G+ + ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSS--KRNTDFSNTDS 686
D + ++ +MSPE G FSI SD++S+GV+L E S + +SN D
Sbjct: 177 ADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235
Query: 687 LTLL 690
+ ++
Sbjct: 236 IEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 83/274 (30%), Positives = 131/274 (47%), Gaps = 41/274 (14%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+LG G FG V G+ +VA+K + S +EF E K++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE---EIAQGLLYL--HQYSRL 596
+ ++ EYM N L +L + K +++E ++ +G+ YL Q+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRF-----QPSQLLEMCKDVCEGMAYLESKQF--- 121
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQ 653
IHRDL A N L+D K+SDFG+++ DE S VG+ + PE
Sbjct: 122 --IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLY 175
Query: 654 GLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
FS KSDV++FGVL+ E +L F+N++++ + + L++ P L
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---------PHLA 226
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
+E Y I+ C E A +RPT +++S
Sbjct: 227 SEKVYAIMYS-------CWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 75/279 (26%), Positives = 129/279 (46%), Gaps = 46/279 (16%)
Query: 483 LGEGGFGP--VYKGRLHNGQ----EVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG +Y+ + EV + RLS + + NEI +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 537 LGCCIELEEKILI-YEYMPNKSL-------DIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
++ + +LI EY +L LF+ E + W + +I +
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFE---EEMVLW-----YLFQIVSAVS 115
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
Y+H+ ++HRD+K NI L K K+ DFG++K+ G + ++T +VGT YMSP
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSP 170
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708
E Q ++ KSD+++ G +L E L+ KR D +N L + + + +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQ--GNYTPVVS 223
Query: 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ +E L+ + +Q+D RPT EV+
Sbjct: 224 VYSSELISLVHS--------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/194 (34%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 483 LGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLE-EFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G FG V+KG L + VAVK Q L+ +F +E +++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
+ + ++ E +P D F K+ L + V+ + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 602 DLKASNILLDKDMNPKISDFGMAKMF-GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
DL A N L+ ++ KISDFGM++ G S K+I + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 661 DVFSFGVLLLETLS 674
DV+S+G+LL ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQ 529
NF E K+G+G F VYK L +G+ VA+K++ + ++ EI L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV-RVIEEIAQGLL 588
H N+++ L IE E ++ E L + K+ L E + + ++ L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
++H R++HRD+K +N+ + K+ D G+ + F + + VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSP 175
Query: 649 EYAQQGLFSIKSDVFSFGVLLLE 671
E + ++ KSD++S G LL E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 476 NFSTENKLGEGGFGPVYK-GRLHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRN 532
+F KLG+G +G VYK RL + Q A+K L S S + E+ NEI+++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 533 LVR-----LLGC--CIELEEKILIYEYMPNKSLDIFLFDTPK-ESPLGWETRVRVIEEIA 584
++ L G CI + EY P L + K + + R+ ++
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
+GL LH+ +++HRDLK++NILL + KI D G++K+ ++ K +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPH 166
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
YM+PE + +S KSD++S G LL E
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR---LHNGQE---VAVKRLSSQ-SGQGLEEFKNEIKLIAKL 528
N +G+G FG V++ R L + VAVK L + S +F+ E L+A+
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD-------------------TPKES 569
H N+V+LLG C + L++EYM L+ FL
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 570 PLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFG 628
PL ++ + +++A G+ YL S + +HRDL N L+ ++M KI+DFG++ ++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
D ++ + +M PE ++ +SDV+++GV+L E S
Sbjct: 183 ADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-23
Identities = 82/270 (30%), Positives = 137/270 (50%), Gaps = 21/270 (7%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+ KLG+G FG V+ G + +VA+K L + E F E +++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
E E ++ E+M SL FL + + L V + +IA G+ Y+ R+ I
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRDL+A+NIL+ ++ KI+DFG+A++ +E ++ + +PE A G F+IK
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183
Query: 660 SDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLIL 719
SDV+SFG+LL E L +K + + +L + +R + + P E+ + ++
Sbjct: 184 SDVWSFGILLTE-LVTKGRVPYPGMVNREVLEQV------ERGYRMPCPQGCPESLHELM 236
Query: 720 NRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
LC ++D +RPT + S L +
Sbjct: 237 K-------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 85/308 (27%), Positives = 138/308 (44%), Gaps = 44/308 (14%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRN 532
F+ ++G G FG VY R + + VA+K++S Q E++++ E++ + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ GC + L+ EY + DI + K+ PL + QGL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKK-PLQEVEIAAICHGALQGLAYLHS 133
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY-- 650
+ R IHRD+KA NILL + K++DFG A L S VGT +M+PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVIL 184
Query: 651 -AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
+G + K DV+S G+ +E ++R N ++++ L I
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH----------------I 226
Query: 710 LQNEASYLILNR----YINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSI 765
QN++ L N + N C+Q+ DRP+ E +L + V P I
Sbjct: 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE---LLKHRFVLRERPPTVIIDLI 283
Query: 766 RGLKNTIL 773
+ K+ +
Sbjct: 284 QRTKDAVR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 17/198 (8%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+GEG FG V +G + GQ+VAVK + + F E ++ KL H+NLVRLLG +
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
I++ E M +L FL T + + ++ ++A+G+ YL +++HR
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 602 DLKASNILLDKDMNPKISDFGMAKM--FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
DL A NIL+ +D K+SDFG+A++ G D + K + +PE + FS K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSSK 177
Query: 660 SDVFSFGVLLLETLSSKR 677
SDV+S+GVLL E S R
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 11/211 (5%)
Query: 483 LGEGGFGPVYKGRLHNGQ-EVAVKRLSSQSGQGLEEF--KNEIKLIAKLQHRNLVRLLGC 539
+G G FG V+ R Q V +K++ + E +NE +++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
+E + +++ EY P +L ++ S L +T ++ Q LL LH ++
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDT---ILHFFVQILLALHHVHTKLIL 123
Query: 600 HRDLKASNILLDK-DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
HRDLK NILLDK M KI DFG++K+ +SK +VGT Y+SPE + ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689
KSD+++ G +L E S KR + +N +L L
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 50/291 (17%)
Query: 482 KLGEGGFGPVYKGRLHNGQE---------------VAVKRLSSQ-SGQGLEEFKNEIKLI 525
KLGEG FG V+ E VAVK L + + +F EIK++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 526 AKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE---- 581
++L++ N++RLLG C+ + +I EYM N L+ FL ES + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 582 -----EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSK 635
+IA G+ YL + L +HRDL N L+ KI+DFGM++ ++ GD + +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD 695
R V +M+ E G F+ SDV++FGV L E + + +S
Sbjct: 189 -GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS------------- 234
Query: 696 LWKDDRAWELIDPILQNEASYLIL-------NRYINVALLCVQEDAVDRPT 739
L D++ E +N+ + L + + + C D DRPT
Sbjct: 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 6e-23
Identities = 85/303 (28%), Positives = 141/303 (46%), Gaps = 47/303 (15%)
Query: 482 KLGEGGFGPVYKGRLHNGQE-----------------VAVKRLSSQSGQGLE-EFKNEIK 523
KLGEG FG V+ + N Q+ VAVK L + + +F E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESP 570
++++L+ N++RLLG C++ + +I EYM N L+ FL P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 571 L---GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-M 626
L + + + V +IA G+ YL S L +HRDL N L+ +++ KI+DFGM++ +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686
+ GD + + R V +M+ E G F+ SDV++FGV L E L + +
Sbjct: 189 YAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247
Query: 687 LTLLGRAWDLWKDD-RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
++ A + ++D R L P + Y ++ L C D +RP+ ++ +
Sbjct: 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM-------LQCWSRDCRERPSFSDIHA 300
Query: 746 MLT 748
LT
Sbjct: 301 FLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 8e-23
Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 480 ENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ +LGEG FG V+ +N VAVK L + ++F+ E +L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLF-----------DTPKES--PLGWETRVRVI 580
V+ G C + + I+++EYM + L+ FL P+++ LG + +
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
+IA G++YL + +HRDL N L+ ++ KI DFGM++ D + R+
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 641 G----TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689
G +M PE F+ +SDV+SFGV+L E + + F +++ +
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 64/202 (31%), Positives = 112/202 (55%), Gaps = 19/202 (9%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFK-NEIKLIAKLQ---HRNLV 534
++GEG +G VYK R L+ G+ VA+K++ S +G+ EI L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 535 RLLGCC--IELEEKI---LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
RLL C + ++ L++E++ ++ L +L PK L ET ++ ++ +G+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDF 122
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
LH + R++HRDLK NIL+ D KI+DFG+A+++ + +V T Y +PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPE 176
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
Q ++ D++S G + E
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 77/238 (32%), Positives = 122/238 (51%), Gaps = 24/238 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+++ K+GEG +G VYKGR GQ VA+K RL S+ EI L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDI--FLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
+V L ++ LI+E++ S+D+ +L PK + E + +I QG+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H RV+HRDLK N+L+D K++DFG+A+ F G ++ T +V T Y +PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172
Query: 651 AQQG-LFSIKSDVFSFGVLLLETLSSKR---NTDFSNTDSLTLLGRAW-----DLWKD 699
+S D++S G + E +++K+ + D S D L + R D+W
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAE-MATKKPLFHGD-SEIDQLFRIFRILGTPTEDVWPG 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKAS 606
+ E+M SLD K P+ E ++ + +GL YL Y+ R++HRD+K S
Sbjct: 79 CMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYL--YNVHRIMHRDIKPS 133
Query: 607 NILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFG 666
NIL++ K+ DFG++ G+ + S VGT YMSPE Q G +++KSDV+S G
Sbjct: 134 NILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189
Query: 667 VLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL-------IL 719
+ ++E K FSN D L +L+ I+Q L L
Sbjct: 190 ISIIELALGKFPFAFSNIDDDGQDDPMGIL-------DLLQQIVQEPPPRLPSSDFPEDL 242
Query: 720 NRYINVALLCVQEDAVDRPTMFEVVSM 746
+++ C+ +D +RPT ++ +M
Sbjct: 243 RDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 481 NKLGEGGFGPVYK-GRLHNGQEVAVKRLS--SQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
+G+G FG V K R +G+ + K + + + + ++ +E+ ++ +L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 538 GCCIELEEKILIY---EYMPNKSLDIFLFDTPKE-SPLGWETRVRVIEEIAQGLLYLH-- 591
I +Y EY L + KE + E R++ ++ L H
Sbjct: 66 DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
V+HRDLK +NI LD + N K+ DFG+AK+ G D S K VGT YMSPE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQL 182
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
+ KSD++S G L+ E
Sbjct: 183 NHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 79/282 (28%), Positives = 140/282 (49%), Gaps = 41/282 (14%)
Query: 480 ENKLGEGGFGPVYKG--RLHNGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKLQHRNLV 534
+ +G G FG V++G ++ +EVAV + + G + ++F +E ++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKE-SPLGWETRVRVIEEIAQGLLYLHQY 593
RL G + + ++I EYM N +LD +L D E S V ++ IA G+ YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL--- 123
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG------YMS 647
S + +HRDL A NIL++ ++ K+SDFG++++ D + T T G + +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTA 178
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
PE F+ SDV+SFG+++ E +S + D SN + + + + + L
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---------NDGFRL 229
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
P+ A Y ++ L C Q+D RP ++V++L
Sbjct: 230 PAPMDCPSAVYQLM-------LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 31/221 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN---GQE---VAVKRLSSQSGQGLEEFKNEIKLIAKLQ 529
N + +LGEG FG V+ +N Q+ VAVK L S ++F E +L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLF------------DTPKESPLGWETRV 577
H ++V+ G C+E + I+++EYM + L+ FL + P E L +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQML 123
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
+ ++IA G++YL + +HRDL N L+ +++ KI DFGM++ D +
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYY 176
Query: 638 RIVG----TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R+ G +M PE F+ +SDV+S GV+L E +
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 25/211 (11%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVK----------RLSSQSGQGLEEFKNEIKLIAKLQHR 531
+G+G +G VY + G+ +AVK R S+ ++ ++EI+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 532 NLVRLLGCCIELEEKILIY-EYMPNKSLDIFLFDTPK-ESPLGWETRVR-VIEEIAQGLL 588
N+V+ LG EE + I+ EY+P S+ L + E L VR E++ +GL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL-----VRFFTEQVLEGLA 122
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
YLH ++HRDLKA N+L+D D KISDFG++K + + G+ +M+P
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 649 E--YAQQGLFSIKSDVFSFGVLLLETLSSKR 677
E ++ +S K D++S G ++LE + +R
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 63/191 (32%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G V R H+G++VAVK + + Q E NE+ ++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600
+ EE ++ E++ +L D ++ L E V E + Q L YLH VIH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 601 RDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
RD+K+ +ILL D K+SDFG D K K +VGT +M+PE + + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 661 DVFSFGVLLLE 671
D++S G++++E
Sbjct: 199 DIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLV 534
F+ ++G+G FG VYKG + +EV A+K + + + +E+ + EI ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
R G ++ + +I EY+ S D K PL ++ EI +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R IHRD+KA+N+LL + + K++DFG+A + Q K VGT +M+PE +Q
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 177 AYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 68/202 (33%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 483 LGEGGFGPVY------KGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+L+ +++ KRL + +G E E +++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETR-VRVIEEIAQGLLYLHQYS 594
+ + + L+ M L +++ +E+P E R +I GL +LHQ
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R+I+RDLK N+LLD D N +ISD G+A + QSKTK GT G+M+PE Q
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 655 LFSIKSDVFSFGVLLLETLSSK 676
+ D F+ GV L E ++++
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 482 KLGEGGFGPVYKGRLH-----NGQEVAVKRLSS-QSGQGLEEFKNEIKLIAKLQHRNLVR 535
+LGE FG +YKG L+ + Q VA+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETR--------------VRVIE 581
LLG + + +++EY+ L FL S +G + + +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTKRIV 640
+IA G+ YL + +H+DL A NIL+ + ++ KISD G+++ ++ D + + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE G FS SD++SFGV+L E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 28/212 (13%)
Query: 481 NKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQG--LEEFKNEIKLIAKLQHRNLVRLL 537
NK+G G FG VY L G+ +AVK + Q ++E +E+K++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 538 GCCIELE-EKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYS 594
G +E+ EK+ I+ EY +L+ L E +RV ++ +GL YLH +
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSH- 118
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG------GDELQSKTKRIVGTYGYMSP 648
++HRD+K +NI LD + K+ DFG A G+E+QS + GT YM+P
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAP 172
Query: 649 EYAQQGLFSIK---SDVFSFGVLLLETLSSKR 677
E G +D++S G ++LE + KR
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 53/177 (29%), Positives = 94/177 (53%), Gaps = 12/177 (6%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQG--LEEFKNEIKLIAKLQHRNLVRLLG 538
++GEG G V+K + G+ VA+K+++ + +G + EIK + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
+L+ EYMP+ L L D + P + + + + +G+ Y+H +
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEA-QVK-SYMRMLLKGVAYMHA---NGI 120
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE--YAQQ 653
+HRDLK +N+L+ D KI+DFG+A++F +E + + + V T Y +PE Y +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGAR 176
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 483 LGEGGFGPVY------KGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+++ +++ KRL + G+ + NE K++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE-EIAQGLLYLHQYS 594
E ++ + L+ M L +++ P E R +I GL +LHQ
Sbjct: 59 -AYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-- 113
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R+++RDLK N+LLD N +ISD G+A G K K GT GYM+PE Q
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGE 169
Query: 655 LFSIKSDVFSFGVLLLETLSSK 676
++ D F+ G L E ++ +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 10/207 (4%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
++ SV ++ K+G+G G VY + GQEVA+K+++ Q E NEI +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+ + +H N+V L + +E ++ EY+ SL D E+ + V E
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+M+PE + + K D++S G++ +E
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 79/280 (28%), Positives = 136/280 (48%), Gaps = 35/280 (12%)
Query: 482 KLGEGGFGPVY----KGRLHNGQE--VAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLV 534
+LG+G FG VY KG + + E VA+K ++ + S + EF NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLF-------DTPKESPLGWETRVRVIEEIAQGL 587
RLLG + + ++I E M L +L + P ++P + +++ EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
YL+ + +HRDL A N ++ +D KI DFGM + + K + + +MS
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
PE + G+F+ SDV+SFGV+L E TL+ + SN L + L K D ++
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM 249
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
+ +++ +C Q + RP+ E++S
Sbjct: 250 LFELMR----------------MCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 67/196 (34%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 483 LGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542
+G+G FG V G + G +VAVK + + + + F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 543 LEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHR 601
+ + I EYM SL +L + S LG + ++ ++ + + YL + +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 602 DLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSD 661
DL A N+L+ +D K+SDFG+ K Q K V + +PE ++ FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSD 181
Query: 662 VFSFGVLLLETLSSKR 677
V+SFG+LL E S R
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 485 EGGFGPVYKGRLHNG-----QEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLG 538
EG FG ++ G L + +EV VK + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 539 CCIELEEK-ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE------EIAQGLLYLH 591
CIE E ++Y YM +L +FL + + + +IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDE--LQSKTKRIVGTYGYMSP 648
+ VIH+D+ A N ++D+++ KI+D +++ +F D L R V +M+
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMAL 188
Query: 649 EYAQQGLFSIKSDVFSFGVLLLE 671
E +S SDV+SFGVLL E
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 43/275 (15%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHRN 532
FS ++G G FG VY R + N + VA+K++S QS + ++ E++ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA-QGLLYLH 591
++ GC + L+ EY + D L + K+ PL E + + A QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQ-EVEIAAVTHGALQGLAYLH 132
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY- 650
++ +IHRD+KA NILL + K+ DFG A + + VGT +M+PE
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVI 183
Query: 651 --AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708
+G + K DV+S G+ +E ++R N ++++ L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------------- 225
Query: 709 ILQNEASYLILNR----YINVALLCVQEDAVDRPT 739
I QNE+ L + N C+Q+ DRPT
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 3e-21
Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 43/280 (15%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRN 532
F+ ++G G FG VY R + + VA+K++S Q E++++ E+K + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA-QGLLYLH 591
+ GC + L+ EY + D L + K+ PL E + I A QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQ-EVEIAAITHGALQGLAYLH 142
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY- 650
++ +IHRD+KA NILL + K++DFG A + S VGT +M+PE
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVI 193
Query: 651 --AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708
+G + K DV+S G+ +E ++R N ++++ L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------------- 235
Query: 709 ILQNEASYLILNR----YINVALLCVQEDAVDRPTMFEVV 744
I QNE+ L N + N C+Q+ DRPT E++
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--EIKLIAKLQHRNLVRLLG 538
K+GEG +G VYK R G+ VA+K++ + EIKL+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLR 597
+ L++E+M + L + D + P E+ ++ ++ QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLP---ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQQGLF 656
++HRDLK N+L++ + K++DFG+A+ FG V T Y +PE +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 657 SIKSDVFSFGVLLLETLS 674
S D++S G + E LS
Sbjct: 177 STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR------LHNGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKL 528
N LGEG FG V K VAVK L + L + +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL---------------------FDTPK 567
H ++++L G C + +LI EY SL FL D P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627
E L + +I++G+ YL + ++++HRDL A N+L+ + KISDFG+++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
++ K + +M+ E +++ +SDV+SFGVLL E ++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 13/206 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
NF K+GEG +G VYK R G+ VA+K RL +++ EI L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
+V+LL I E K+ L++E++ ++ L F+ +P S + + ++ QGL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCH 117
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-Y 650
+ RV+HRDLK N+L++ + K++DFG+A+ F G +++ T +V T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSK 676
+S D++S G + E ++ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 71/205 (34%), Positives = 108/205 (52%), Gaps = 22/205 (10%)
Query: 483 LGEGGFGPVYKGRL-----HNGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLVRL 536
LGEG FG V R + G++VAVK L +SG + + K EI+++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 537 LGCCIELEEK--ILIYEYMPNKSLDIFLFDTPK-ESPLGWETRVRVIEEIAQGLLYL--H 591
G C E LI E++P+ SL +L P+ ++ + + +++ +I +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE--LQSKTKRIVGTYGYMSPE 649
QY +HRDL A N+L++ + KI DFG+ K D+ K + Y +PE
Sbjct: 129 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLS 674
Q F I SDV+SFGV L E L+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLHNGQE----VAVKRLSS-QSGQGLEEFKNEIKLIAKLQ 529
+ E +G G FG V GRL + VA+K L + + + +F +E ++ +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
H N++ L G + + +++ EYM N SLD FL + V ++ IA G+ Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG----- 644
L S + +HRDL A NIL++ ++ K+SDFG++++ D + T R G
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPI 173
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT--DFSNTDSLTLLGRAWDLWKDDR 701
+ +PE F+ SDV+S+G+++ E +S + SN D + + +
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---------EE 224
Query: 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ L P+ A + ++ L C Q+D +RP ++VS+L
Sbjct: 225 GYRLPAPMDCPAALHQLM-------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 82/298 (27%), Positives = 140/298 (46%), Gaps = 39/298 (13%)
Query: 482 KLGEGGFGPVYKGRLHN---GQ---EVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLV 534
+LG+G FG VY+G + G+ VAVK ++ S S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLF-------DTPKESPLGWETRVRVIEEIAQGL 587
RLLG + + +++ E M + L +L + P P + +++ EIA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
YL+ + +HRDL A N ++ D KI DFGM + + K + + +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
PE + G+F+ SD++SFGV+L E +L+ + SN L + L + D E
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 249
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFS 763
+ +++ +C Q + RPT E+V++L ++ HP P S
Sbjct: 250 VTDLMR----------------MCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 65/207 (31%), Positives = 114/207 (55%), Gaps = 25/207 (12%)
Query: 483 LGEGGFGPVYKGRLHNGQ---EVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
LGEG FG V +G+L+ +VAVK +++ + +E+F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 538 GCCIELEEK------ILIYEYMPNKSLDIFLF-----DTPKESPLGWETRVRVIEEIAQG 586
G C++ E ++I +M + L FL D P+ P + V+ + +IA G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIASG 124
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDEL-QSKTKRIVGTYG 644
+ YL S IHRDL A N +L+++MN ++DFG++ K++ GD Q + ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVK 179
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+++ E +++ KSDV+SFGV + E
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWE 206
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-21
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 324 PRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLKNCTCRAYANSK 383
P +C + D F+ + D+KLPD + +++L+EC CL NC+C AYA +
Sbjct: 2 PLNCGGD-----GSTDGFLKLPDVKLPDNASAIT--AISLEECREACLSNCSCTAYAYNN 54
Query: 384 VTGGGSGCLMWFGDLVDIRKAIGHNNGQSVYIRVP 418
G GCL+W G L ++R G ++Y+R+
Sbjct: 55 ---GSGGCLLWNGLLNNLRSLSS--GGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 482 KLGEGGFGPVYKG--RLHNGQ-EVAVKRLSSQSGQGL-EEFKNEIKLIAKLQHRNLVRLL 537
+LG G FG V KG ++ Q +VA+K L +++ + + +E E +++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
G C E E +L+ E L+ FL E + V ++ +++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEGKN--- 115
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY--GYMSPEYAQQGL 655
+HRDL A N+LL KISDFG++K G D+ K R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA-RSAGKWPLKWYAPECINFRK 174
Query: 656 FSIKSDVFSFGVLLLETLS 674
FS +SDV+S+G+ + E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 65/198 (32%), Positives = 106/198 (53%), Gaps = 19/198 (9%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFK-NEIKLIAKLQHRNLVRLL 537
K+GEG +G VYK R G+ VA+K RL ++ +G+ EI L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 538 GCCIELEEKILIYEYMPNKSLDIFL---FDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ L++E+ LD+ L D+ + L + ++ QG+ Y H +
Sbjct: 65 DVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
RV+HRDLK N+L+D++ K++DFG+A+ F G +++ T +V T Y +PE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGS 174
Query: 655 -LFSIKSDVFSFGVLLLE 671
+S D++S G + E
Sbjct: 175 RQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 64/198 (32%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 483 LGEGGFGPVYKG-RLHNGQEV----AVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VYKG + G+ V A+K L+ +G + EF +E ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
LG C+ + L+ + MP+ L ++ + + +G + + +IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
R++HRDL A N+L+ + KI+DFG+A++ GDE + +M+ E F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 657 SIKSDVFSFGVLLLETLS 674
+ +SDV+S+GV + E ++
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 83/284 (29%), Positives = 126/284 (44%), Gaps = 32/284 (11%)
Query: 481 NKLGEGGFGPVYKGRLHNGQEVA---VKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
+++G G FG V G H G A VK L +S + F E++ +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV--RVIEEIAQGLLYLHQYS 594
LG CIE +L+ E+ P L +L + V R+ E+A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPEYA-- 651
IH DL N L D++ KI D+G+A + + D +K V +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 652 -QQGLFSIK----SDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
Q L S+++S GV + E T + + D S+ L + R D+ +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI-------K 229
Query: 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
L P L + S +R+ V C D RPT EV +LT
Sbjct: 230 LPKPQLDLKYS----DRWYEVMQFCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 69/228 (30%), Positives = 120/228 (52%), Gaps = 24/228 (10%)
Query: 482 KLGEGGFGPVYKGR-LHNGQE-VAVKRL---SSQSGQGLEEFKNEIKLIAKLQ---HRNL 533
++GEG +G V+K R L NG VA+KR+ + + G L + E+ ++ L+ H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 66
Query: 534 VRLLGCCI----ELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
VRL C + E K+ L++E++ ++ L +L P E + ET ++ ++ +GL
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLD 124
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
+LH + RV+HRDLK NIL+ K++DFG+A+++ Q +V T Y +P
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 178
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696
E Q ++ D++S G + E +R F + + LG+ D+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 480 ENKLGEGGFGPVYKGRL-HNGQE---VAVKRLSS-QSGQGLEEFKNEIKLIAKLQHRNLV 534
E +G G FG V +GRL G+ VA+K L S + + +F +E ++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
L G + ++I E+M N +LD FL + V ++ IA G+ YL S
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---S 123
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG---TYGYMSPEYA 651
+ +HRDL A NIL++ ++ K+SDFG+++ D +G + +PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 652 QQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
F+ SDV+S+G+++ E +S + D SN D + + ++ + L P+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---------EQDYRLPPPM 234
Query: 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
A + ++ L C Q+D RP ++VS L
Sbjct: 235 DCPTALHQLM-------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
S+ SV ++ K+G+G G VY + GQEVA+K+++ Q E NEI +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+ + ++ N+V L + +E ++ EY+ SL D E+ + V E
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+M+PE + + K D++S G++ +E + +
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
S+ SV ++ K+G+G G VY + GQEVA+++++ Q E NEI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+ + ++ N+V L + +E ++ EY+ SL D E+ + V E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 126
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+M+PE + + K D++S G++ +E + +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 71/273 (26%), Positives = 133/273 (48%), Gaps = 35/273 (12%)
Query: 483 LGEGGFGPVYKGRLHN--GQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQH---RNLVRL 536
+G G +G VY+G H G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
G ++ +I EY S+ + K P+ + +I E+ L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI--VGTYGYMSPEYAQQG 654
VIHRD+KA+NIL+ N K+ DFG+A + Q+ +KR VGT +M+PE +G
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 655 -LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713
+ K+D++S G+ + E + N +S+ D+ RA L + P L++
Sbjct: 177 KYYDTKADIWSLGITIYEM--ATGNPPYSDVDAF----RAMMLIPKSKP-----PRLEDN 225
Query: 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746
+L ++ C+ E+ +R + E++
Sbjct: 226 GYSKLLREFV---AACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 55/225 (24%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN-----------EIK 523
+ KLGEG + VYK R G+ VA+K++ L E K EIK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIK 54
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMP--------NKSLDIFLFDTPKESPLGWET 575
L+ +L+H N++ LL L++E+M +KS+ + D
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKS-------- 106
Query: 576 RVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG--GDELQ 633
+ +GL YLH ++HRDLK +N+L+ D K++DFG+A+ FG ++
Sbjct: 107 ---YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETL 673
+ V T Y +PE LF + D++S G + E L
Sbjct: 161 HQ----VVTRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 59/199 (29%), Positives = 111/199 (55%), Gaps = 19/199 (9%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
+LG+G FG VYK + G A K + ++S + LE++ EI+++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLRVI 599
+ ++ E+ P ++D + + + E +++VI ++ + L YLH +++I
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR--IVGTYGYMSPEYA-----Q 652
HRDLKA N+LL D + K++DFG++ +++ +R +GT +M+PE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 653 QGLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ L+E
Sbjct: 189 DTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 10/212 (4%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
++ S+ ++ K+G+G G V+ + GQEVA+K+++ Q E NEI +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+ +L++ N+V L + +E ++ EY+ SL D E+ + V E
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ N+LL D + K++DFG + QSK +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+M+PE + + K D++S G++ +E + +
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ K+GEG G V G++VAVK++ + Q E NE+ ++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 534 VRLLGCCIELEEKILIYEYMPNKSL-DIFLFDTPKESPLGWETRVRVIEE-IA------- 584
V + + +E ++ E++ +L DI T R+ EE IA
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV-------------THTRMNEEQIATVCLAVL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
+ L +LH VIHRD+K+ +ILL D K+SDFG + + K +VGT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPY 180
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+M+PE + + + D++S G++++E
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGL------EEFKNEIKLIAKLQHRNLV 534
LG+G +G VY G + GQ +AVK++ + L E+ + E+ L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ LG C++ + E++P S+ L + PL + ++I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAK---MFGGDELQSKT-KRIVGTYGYMSPEY 650
V+HRD+K +N++L + K+ DFG A+ G S K + GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSK 676
+ + KSD++S G + E + K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 483 LGEGGFGPVYKGRL------HNGQEVAVKRL-SSQSGQGLEEFKNEI---KLIAKLQHRN 532
LGEG FG V K + VAVK L + + L + +E+ K+I K H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETRVRV 579
++ LLG C + ++ EY + +L FL P E L + V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
++A+G+ +L + IHRDL A N+L+ +D KI+DFG+A+ + KT
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 58/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLV 534
F+ ++G+G FG V+KG + Q+V A+K + + + +E+ + EI ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ G ++ + +I EY+ S D + P +++EI +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+ IHRD+KA+N+LL + + K++DFG+A + Q K VGT +M+PE QQ
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 177 AYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-20
Identities = 79/272 (29%), Positives = 133/272 (48%), Gaps = 35/272 (12%)
Query: 481 NKLGEGGFGPVY-KGRLHNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRNLVRL 536
+++G G FG VY H + VAVK++S Q E++++ E+K + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA-QGLLYLHQYSR 595
GC ++ L+ EY + D L + K+ PL E + I A QGL YLH ++
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASD--LLEVHKK-PLQ-EVEIAAITHGALQGLAYLHSHNM 142
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY---AQ 652
IHRD+KA NILL + K++DFG A S VGT +M+PE
Sbjct: 143 ---IHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMD 193
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+G + K DV+S G+ +E ++R N ++++ L + + ++D P LQ+
Sbjct: 194 EGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSAL---YHIAQND------SPTLQS 242
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVV 744
+++ C+Q+ +RP E++
Sbjct: 243 NEWTDSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 31/195 (15%)
Query: 471 SAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL---SSQSGQGLEEFKNEIKLIA 526
+ ++ KLGEG FG VYK R + G+ VA+K++ + + G + + EIK++
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62
Query: 527 KLQHRNLVRLLGCCIE-----LEEKILIYEYMPNKSLDIF-LFDTPKESPLGWETRVRV- 579
KL+H N+V L+ +E ++ +Y P D+ L + P V++
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---------SVKLT 113
Query: 580 -------IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632
+ ++ +G+ YLH+ ++HRD+KA+NIL+D KI+DFG+A+ + G
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 633 QSKTKRIVGTYGYMS 647
K GT Y +
Sbjct: 171 NPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLV 534
F+ K+G+G FG V+KG + Q+V A+K + + + +E+ + EI ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ G ++ + +I EY+ S D + PL ++ EI +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+ IHRD+KA+N+LL + K++DFG+A + Q K VGT +M+PE +Q
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 177 AYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHR 531
+F +G+G FG V + + A+K ++ Q +N E +++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYL 590
LV L + E L+ + + L L K S E +V+ I EI L YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS----EEQVKFWICEIVLALEYL 116
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H +IHRD+K NILLD+ + I+DF +A D L T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEV 170
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKR 677
+ +S+ D +S GV E L KR
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 482 KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLE-EFKNEIKLIAKLQHRNLVRLLGC 539
++G G FG V+ GRL + VAVK L+ +F E +++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESP-LGWETRVRVIEEIAQGLLYLHQYSRLRV 598
C + + ++ E + FL E P L + ++++E A G+ YL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT---KRIVGTYGYMSPEYAQQGL 655
IHRDL A N L+ + KISDFGM++ D + + T K+I + +PE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQI--PVKWTAPEALNYGR 172
Query: 656 FSIKSDVFSFGVLLLETLS 674
+S +SDV+SFG+LL E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 21/226 (9%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQ-GLE-EFKNEIKLIAKLQ---HRNLVR 535
++G G +G VYK R H+G VA+K + Q+ + GL E+ L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 536 LLGCCIEL----EEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
L+ C E K+ L++E++ ++ L +L P L ET ++ + +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFL 124
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H ++HRDLK NIL+ K++DFG+A+++ Q +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696
Q ++ D++S G + E +R F LG+ +DL
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQLGKIFDL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 70/209 (33%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRL-----SSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VY G+E+AVK++ S ++ + + + EI+L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 537 LGCCIELEEKIL--IYEYMPNKSLDIFLFDTPKE-SPLGWETRVRVIEEIAQGLLYLHQY 593
GC + EEK L EYMP S+ D K L R +I QG+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAK------MFGGDELQSKTKRIVGTYGYMS 647
++HRD+K +NIL D N K+ DFG +K M G + K + GT +MS
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG-----TGIKSVTGTPYWMS 177
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
PE + K+DV+S ++E L+ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRL-----SSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG VY + G+E+A K++ S ++ + + + EI+L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 537 LGCCIELEEKIL--IYEYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
GC + EK L EYMP S+ L + ES TR +I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-----QILEGMSYLHS 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR-IVGTYGYMSPEYA 651
++HRD+K +NIL D N K+ DFG +K + R + GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSK 676
+ K+DV+S G ++E L+ K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
++ ++G G +G VYK R LH G+ AVK + + G + EI ++ + +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSL-DIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQ 592
G + E+ + EY SL DI+ P E + + R E QGL YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHS 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA- 651
++ HRD+K +NILL + + K++DFG+A +K K +GT +M+PE A
Sbjct: 125 KGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAA 179
Query: 652 --QQGLFSIKSDVFSFGVLLLE 671
+ G ++ D+++ G+ +E
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 7e-19
Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLHNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRN 532
LGEG FG V K R VAVK L + + L + +E++L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL-----------FDTPK--ESPLGWETRVRV 579
++ LLG C + +I EY +L FL FD K E L ++ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
++A+G+ YL SR R IHRDL A N+L+ +D KI+DFG+A+ + KT
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFG+L+ E +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRL-----SSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG VY G+E+AVK++ S ++ + + + EI+L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 537 LGCCIELEEKIL--IYEYMPNKSLDIFLFDTPKE-SPLGWETRVRVIEEIAQGLLYLHQY 593
GC + E+ L E+MP S+ D K L + +I +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ-SKTKRIVGTYGYMSPEYAQ 652
++HRD+K +NIL D N K+ DFG +K L + K + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 653 QGLFSIKSDVFSFGVLLLETLSSK 676
+ K+D++S G ++E L+ K
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 57/157 (36%), Positives = 87/157 (55%), Gaps = 10/157 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
NF KLGEG + VYKGR G+ VA+K L ++ G + EI L+ +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
+VRL I E K+ L++EYM +K L ++ L T ++ +G+ + H
Sbjct: 60 IVRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
+ RV+HRDLK N+L++K K++DFG+A+ FG
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQH 530
ANF E K+G G F VY+ + + VA+K++ + ++ EI L+ +L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV-RVIEEIAQGLLY 589
N+++ L IE E ++ E L + K+ L E V + ++ + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
+H SR RV+HRD+K +N+ + K+ D G+ + F + + +VGT YMSPE
Sbjct: 122 MH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
+ ++ KSD++S G LL E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 482 KLGEGGFGPVYKG--RLHNGQE-VAVKRLSSQSGQGL--EEFKNEIKLIAKLQHRNLVRL 536
+LG G FG V KG ++ ++ VAVK L + + +E E ++ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
+G C E E +L+ E L+ FL K + + ++ +++ G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG-----YMSPEYA 651
+HRDL A N+LL KISDFG++K G DE K K T+G + +PE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECM 170
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
FS KSDV+SFGVL+ E S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 28/202 (13%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--EIKLIAKLQ-HRNLVRLL 537
+LG+G FG VY R G+ VA+K++ + EE N E+K + KL H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 538 GCCIELEEKILIYEYMPNKSLDIF-LFDTPKESPLGWETRVR-VIEEIAQGLLYLHQ--Y 593
E +E ++EYM +++ L K P E+ +R +I +I QGL ++H+ +
Sbjct: 65 EVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHGF 120
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK---TKRIVGTYGYMSPE- 649
HRDLK N+L+ KI+DFG+A+ E++S+ T V T Y +PE
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEI 169
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
+ +S D+++ G ++ E
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 28/218 (12%)
Query: 477 FSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQH 530
F+ LG+G FG V + +L + Q+VAVK L + S +EEF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 531 RNLVRLLGCCIELEEK------ILIYEYMPNKSLDIFLF-----DTPKESPLGWETRVRV 579
N+++L+G + K ++I +M + L FL + P PL +T VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL--QTLVRF 118
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQ--SKT 636
+ +IA G+ YL S IHRDL A N +L+++M ++DFG++ K++ GD + +
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
K V +++ E +++ SDV++FGV + E ++
Sbjct: 176 KLPV---KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 61/197 (30%), Positives = 106/197 (53%), Gaps = 15/197 (7%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
+LG+G FG VYK + G A K + ++S + LE++ EI ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLRVI 599
++ E+ ++D + + E PL E ++RV+ ++ + L YLH+ ++I
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLEL--ERPLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY-----AQQG 654
HRDLKA NIL D + K++DFG++ + +GT +M+PE ++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K+DV+S G+ L+E
Sbjct: 184 PYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 67/212 (31%), Positives = 116/212 (54%), Gaps = 26/212 (12%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFK-NEIKLIAKLQHRNL 533
+ K+GEG +G VYK R + +A+K++ Q +G+ EI L+ ++QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE----EIAQGLL 588
VRL + E+++ L++EY LD+ L SP + R+I+ +I +G+
Sbjct: 64 VRLQDV-VHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA 116
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
Y H + RV+HRDLK N+L+D+ N K++DFG+A+ F G +++ T +V T Y +
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRA 171
Query: 648 PEY---AQQGLFSIKSDVFSFGVLLLETLSSK 676
PE ++ +S D++S G + E ++ K
Sbjct: 172 PEILLGSRH--YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 483 LGEGGFGPVYKGRLH--NGQEV--AVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLL 537
+G+G FG VY G L +GQ++ AVK L+ + + +E+F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 538 GCCIELE-EKILIYEYMPNKSLDIFLFDTPKESP-----LGWETRVRVIEEIAQGLLYLH 591
G C+ E +++ YM + L F+ +P +G+ +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRS-ETHNPTVKDLIGFGLQV------AKGMEYLA 115
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY--GYMSPE 649
+ +HRDL A N +LD+ K++DFG+A+ E S +M+ E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLS 674
Q F+ KSDV+SFGVLL E ++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-18
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 480 ENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
EN + G G YKG+ + NG + VK ++ + +EI + KLQH N+V+L+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
C + LI+EY+ K+L L L WE R ++ IA+ L +LH V
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+ +L I++D P + + + D TK + + Y++PE + +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISS-AYVAPETRETKDITE 857
Query: 659 KSDVFSFGVLLLETLSSKRNTD--FSNTDSLTLLGR------AWDLWKDDRAWELIDPIL 710
KSD++ FG++L+E L+ K D F S+ R D+W IDP +
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW--------IDPSI 909
Query: 711 QNEASYLILNRYI----NVALLCVQEDAVDRPTMFEVVSML 747
+ + S + I N+AL C D RP +V+ L
Sbjct: 910 RGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNG---QEVAVKRLSSQSGQG-LEEFKNEIKLIAKL-QHRNLV 534
++ +GEG FG V K R+ + A+KR+ + + +F E++++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDT-------------PKESPLGWETRVRVIE 581
LLG C L EY P+ +L FL + S L + +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG+++ G E+ K
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ SDV+S+GVLL E +S
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQS--GQGLEE-FKNEIKLIAKLQHRNLVRLLG 538
LG GGFG V ++ + A+K + + G +E +E +++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 539 CCIELEEKI-LIYEYMPNKSL-----DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ ++ I ++ EY L D LFD + R I + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------YTARF-YIACVVLAFEYLH- 110
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+I+RDLK N+LLD + K+ DFG AK + KT GT Y++PE
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIIL 165
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
+ D +S G+LL E L+ F D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTG--RPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 72/289 (24%), Positives = 135/289 (46%), Gaps = 35/289 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNG-------QEVAVKRLS-----SQSGQGLEEFKNEIK 523
++ LG G FG VYK R N +E+ V + + + + + +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 524 LIAK-LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGW-ETRV-RVI 580
+I + L+H N+VR +E + ++ + + L F++ KE + E R+ +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIF 119
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
++ L YLH+ R ++HRDL +NI+L +D I+DFG+AK + SK +V
Sbjct: 120 VQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLTSVV 174
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD 700
GT Y PE + + K+DV++FG +L + F +T+ L+L
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNMLSL----------- 221
Query: 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
A ++++ + + + +V C+ DA RP + +V +M+++
Sbjct: 222 -ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+F ++G G +G VYK R ++ G+ A+K + + G+ + EI ++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSL-DIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQ 592
G + ++ + E+ SL DI+ P ES + + +R E QGL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLHS 124
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA- 651
+ +HRD+K +NILL + + K++DFG++ +K K +GT +M+PE A
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAA 179
Query: 652 --QQGLFSIKSDVFSFGVLLLE 671
++G ++ D+++ G+ +E
Sbjct: 180 VERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 5e-18
Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCC 540
+G G +G VYKGR + GQ A+K + +G EE K EI ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 541 IE-----LEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
I+ +++++ L+ E+ S+ + +T K + L E + EI +GL +LHQ+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH- 130
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-- 652
+VIHRD+K N+LL ++ K+ DFG++ D + +GT +M+PE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 653 ---QGLFSIKSDVFSFGVLLLE 671
+ KSD++S G+ +E
Sbjct: 187 ENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 7e-18
Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQE-----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQH 530
F LG G FG VYKG E VA+K L + S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP--LGWETRVRVIEEIAQGLL 588
++ RLLG C+ + LI + MP L D +E +G + + +IA+G+
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
YL + R++HRDL A N+L+ + KI+DFG+AK+ G DE + + +M+
Sbjct: 124 YLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E +++ +SDV+S+GV + E ++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 67/214 (31%), Positives = 113/214 (52%), Gaps = 26/214 (12%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL---SSQSGQGLEEFKNEIKLIAKLQH 530
F N++GEG +G VY+ R +G+ VA+K++ + + G + + EI L+ L+H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRH 65
Query: 531 RNLVRLLGCCI--ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGL 587
N+V L + L+ L+ EY + L L + P +P E++V+ + ++ +GL
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMP--TPFS-ESQVKCLMLQLLRGL 121
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
YLH+ +IHRDLK SN+LL KI+DFG+A+ + G + T ++V T Y +
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRA 176
Query: 648 PEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
PE L + D+++ G +L E L+ K
Sbjct: 177 PEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 480 ENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKL-QHRNLV 534
E+ +GEG FG V + + A+K L + + +F E++++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDT---------PKE----SPLGWETRVRVIE 581
LLG C + EY P +L FL + KE S L + ++
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++A G+ YL S + IHRDL A N+L+ +++ KI+DFG+++ G+E+ K
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ KSDV+SFGVLL E +S
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 46/216 (21%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCC 540
+GEG +G VYK R GQ VA+K + EE K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 541 IELEEKI------LIYEY--------------MPNKSLDIFLFDTPKESPLGWETRVRVI 580
I+ L+ E K L KE + + ++
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL--------KEEWIAY-----IL 119
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
E +GL YLH+ +VIHRD+K NILL K+ K+ DFG++ D + +
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFI 174
Query: 641 GTYGYMSPE-----YAQQGLFSIKSDVFSFGVLLLE 671
GT +M+PE + +SDV+S G+ +E
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 475 ANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSS---QSGQGLEEFKNEIKLIAKLQH 530
ANF E K+G G F VY+ L +G VA+K++ + + EI L+ +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV-RVIEEIAQGLLY 589
N+++ IE E ++ E L + K+ L E V + ++ L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
+H SR RV+HRD+K +N+ + K+ D G+ + F + + +VGT YMSPE
Sbjct: 122 MH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
+ ++ KSD++S G LL E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 31/219 (14%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFK----NEIKLIAKLQHR 531
F ++GEG +G VYK R G+ VA+K++ + + E F EIK++ +L HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 532 NLVRLLGCCIE----LEEK------ILIYEYMPNKSLDIFLFDTPKESPL---GWETRVR 578
N+V L + L+ K L++EYM + + + ES L +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL------ESGLVHFSEDHIKS 120
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638
++++ +GL Y H+ + L HRD+K SNILL+ K++DFG+A+++ +E + T +
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 639 IVGTYGYMSPE-YAQQGLFSIKSDVFSFGVLLLETLSSK 676
++ T Y PE + + DV+S G +L E + K
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 482 KLGEGGFGPV-YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G V H G++VAVK++ + Q E NE+ ++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600
+ +E ++ E++ +L D + + E V + + L YLH VIH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 601 RDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
RD+K+ +ILL D K+SDFG + K K +VGT +M+PE + + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 661 DVFSFGVLLLETLSSK 676
D++S G++++E + +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 476 NFSTENKLGEGGFGPVY--KGRLHNGQEVAVK-RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+ K+GEG FG +Y K + + V + L+ + E K E+ L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSL-------DIFLFDTPKESPLGWETRVRVIEEIAQ 585
+V E ++ EY L LF ++ L W +I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSW------FVQISL 112
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
GL ++H +++HRD+K+ NI L K+ M K+ DFG+A+ + T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689
Y+SPE Q ++ K+D++S G +L E + K + +N L L
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 480 ENKLGEGGFGPVY---------KGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH 530
+ +LG+G FG VY + RL +E+ V L+ + E +L++KL H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDH 61
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
+V+ +E + +I EY + LD L + E +V E Q LL +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV--CEWFIQLLLGV 119
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H + R++HRDLKA NI L ++ KI DFG++++ G + T GT YMSPE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176
Query: 651 AQQGLFSIKSDVFSFGVLLLE 671
+ + KSD++S G +L E
Sbjct: 177 LKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-17
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLHNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRN 532
LGEG FG V K + + VAVK L + + L + +E++++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL-----------FDTPK--ESPLGWETRVRV 579
++ LLG C + ++ EY +L +L FDT K E L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
++A+G+ YL + + IHRDL A N+L+ +D KI+DFG+A+ + KT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 483 LGEGGFGPVYKG-RLHNGQE----VAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRL 536
LG G FG V+KG + G VA+K + +SG Q +E + + + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
LG C + L+ + P SL + L + + +IA+G+ YL ++
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
R++HR+L A NILL D +I+DFG+A + D+ + +M+ E G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 657 SIKSDVFSFGVLLLETLS 674
+ +SDV+S+GV + E +S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQE-VAVKRLSSQSGQGLEEFK---NEIKLIAKLQHRN 532
F ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTP--KESPLGWETRVRVIEEIAQGLLYL 590
LV+LL + E L EY+P L + E R + E + L
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFE-AVDAL 117
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H L IHRDLK N L+D + K++DFG++K + + +VG+ YM+PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEV 169
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD------LWKD----- 699
+ + D +S G +L E L S + + W ++ D
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
Query: 700 -DRAWELI 706
D AW+LI
Sbjct: 230 SDEAWDLI 237
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLL 537
LG+G FG V L E+ AVK L +E E +++A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 538 GCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE-EIAQGLLYLHQYSR 595
C + ++++ + EY+ L +F E R R EI GL +LH+
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDL-MFHIQRSGRFD---EPRARFYAAEIVLGLQFLHERG- 116
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+I+RDLK N+LLD + + KI+DFGM K + GG T GT Y++PE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSY 170
Query: 654 GLFSIKSDVFSFGVLLLETL 673
+ D ++ GVLL E L
Sbjct: 171 QPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 483 LGEGGFGPVYKGRLHN------GQEVAVKRLSSQSGQGLEE-FKNEIKLIAKL-QHRNLV 534
LG G FG V + + +VAVK L + E +E+K+++ L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
LLG C ++I EY L FL +ES L E + ++A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQ 652
IHRDL A N+LL KI DFG+A+ M + + R+ +M+PE
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+++ +SDV+S+G+LL E S
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLHNGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKL-QHRN 532
LGEG FG V K + VAVK L + + L + +E++++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL-----------FDTPK--ESPLGWETRVRV 579
++ LLG C + +I EY +L +L +D + + + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
++A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+A+ + KT
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVL+ E +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 483 LGEGGFGPVYKGRLHNG---QEVAVKRLSSQSGQG-LEEFKNEIKLIAKL-QHRNLVRLL 537
+GEG FG V K R+ + A+KR+ + + +F E++++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIA 584
G C L EY P+ +L FL + S L + + ++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG+++ G E+ K
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+ E +++ SDV+S+GVLL E +S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 483 LGEGGFGPVY--------KGRLHNGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKL-QHRN 532
LGEG FG V K + + +VAVK L S + + L + +E++++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD----------TPKESP---LGWETRVRV 579
++ LLG C + +I EY +L +L P + P L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
++A+G+ YL + + IHRDL A N+L+ +D KI+DFG+A+ + KT
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+SFGVLL E +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 47/154 (30%), Positives = 86/154 (55%), Gaps = 17/154 (11%)
Query: 482 KLGEGGFGPVYKGRLHNGQE-VAVKRLSSQS-GQGLEEFK-NEIKLIAKLQHRNLVRLLG 538
K+GEG +G V+K + E VA+KR+ +G+ EI L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE----EIAQGLLYLHQYS 594
++ L++EY ++ L + FD+ + +++ ++ +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDS-----CNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
V+HRDLK N+L++K+ K++DFG+A+ FG
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 482 KLGEGGFGPVYKGRLHNGQ----EVAVKRLSSQSGQGL-EEFKNEIKLIAKLQHRNLVRL 536
+GEG FG VY+G + + VAVK + + + E+F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
+G E ++ E P L +L K S L + + +++ L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL-QVNKYS-LDLASLILYSYQLSTALAYLES---K 126
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQG 654
R +HRD+ A N+L+ K+ DFG+++ + SK K + +M+PE
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI---KWMAPESINFR 183
Query: 655 LFSIKSDVFSFGVLLLETLS 674
F+ SDV+ FGV + E L
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 30/206 (14%)
Query: 486 GGFGPVYKGRLHN-GQEVAVKRLSSQSGQG---LEEFKNEIKLIAKLQHRNLVRLLGCCI 541
G +G V+ + + G A+K + +++ E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 542 ELEEKI-LIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRV-IEEIAQGLLYLHQYS 594
+ ++ + L+ EY+P L L D E R+ I EI L YLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLD---------EDVARIYIAEIVLALEYLHSNG 113
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKM------FGGDELQSKTKRIVGTYGYMSP 648
+IHRDLK NIL+D + + K++DFG++K+ ++ + + KRIVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E S D +S G +L E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 41/193 (21%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFK----NEIKLIAKLQHRNLVR 535
K+G+G FG V+K R Q VA+K++ E F EIK++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 536 LLGCCIELEEK--------ILIYEY--------MPNKSLDIFLFDTPKESPLGWETRVRV 579
L+ C L++E+ + NK++ F + +V
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------KV 124
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK---T 636
++ + GL Y+H R +++HRD+KA+NIL+ KD K++DFG+A+ F + T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 637 KRIVGTYGYMSPE 649
R+V T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 476 NFSTENKLGEGGFGPVY----KGRLHNGQEVAVKRLSS----QSGQGLEEFKNEIKLIAK 527
NF LG G +G V+ G G+ A+K L Q + E + E +++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQ 585
++ + L + + K+ LI +Y+ L L+ + E+ VRV I EI
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----ESEVRVYIAEIVL 116
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
L +LHQ L +I+RD+K NILLD + + ++DFG++K F +E + + GT Y
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEY 172
Query: 646 MSPEYAQQGL--FSIKSDVFSFGVLLLETLS 674
M+PE + G D +S GVL E L+
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-15
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 24/194 (12%)
Query: 499 GQEVAVKRLSSQSGQGLEE---FKNEIKLIAKLQHRNLVRLL--GCCIELEEKIL--IYE 551
G EVA+K L + + + + F+ E L A+L H N+V LL G +L ++E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFE 59
Query: 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL- 610
Y+P ++L L + L R++ ++ L H ++HRDLK NI++
Sbjct: 60 YVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113
Query: 611 --DKDMNPKISDFGMAKMFGG----DELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVF 663
+ K+ DFG+ + G D ++T ++GT Y +PE + + SD++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 664 SFGVLLLETLSSKR 677
++G++ LE L+ +R
Sbjct: 174 AWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 10/191 (5%)
Query: 482 KLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
K+GEG G V + + G+ VAVK++ + Q E NE+ ++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600
+ +E ++ E++ +L D + + E V + + L LH VIH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 601 RDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKS 660
RD+K+ +ILL D K+SDFG E+ + K +VGT +M+PE + + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRR-KSLVGTPYWMAPELISRLPYGPEV 197
Query: 661 DVFSFGVLLLE 671
D++S G++++E
Sbjct: 198 DIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 25/224 (11%)
Query: 475 ANFSTENKLGEGGFGPVYKG--RLHNGQE--VAVKRL-SSQSGQGLEEFKNEIKLIAKLQ 529
+ E LG G FG + +G +L + +E VA+ L + S + F E + +
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
H N+VRL G +++ EYM N +LD FL E L + ++ +A G+ Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG----- 644
L S + +H+ L A +L++ D+ KIS F + + K++ I T
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTMSGKSPV 172
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTD 685
+ +PE Q FS SDV+SFG+++ E +S + D S D
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 42/123 (34%), Positives = 69/123 (56%), Gaps = 13/123 (10%)
Query: 551 EYMPNKSLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNI 608
E+M SLD L + E+ LG ++ + +GL YL + + +++HRD+K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNI 131
Query: 609 LLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVL 668
L++ K+ DFG++ G + S VGT YMSPE Q ++++SD++S G+
Sbjct: 132 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 669 LLE 671
L+E
Sbjct: 188 LVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLI 525
L+++ F +G G +G VYKGR + GQ A+K + + EE K EI ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINML 66
Query: 526 AKL-QHRNLVRLLGCCIEL------EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR 578
K HRN+ G I+ ++ L+ E+ S+ + +T K + L +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAY 125
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638
+ EI +GL +LH + +VIHRD+K N+LL ++ K+ DFG++ D +
Sbjct: 126 ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 180
Query: 639 IVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLE 671
+GT +M+PE + +SD++S G+ +E
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 18/181 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN----EIKLIAKLQH 530
+ +GEG +G V K R G+ VA+K+ E+ K E+K++ +L+H
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRH 59
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP--LGWETRVRVIEEIAQGLL 588
N+V L L++EY+ L++ + SP L + I ++ Q +
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELL-----EASPGGLPPDAVRSYIWQLLQAIA 114
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
Y H +IHRD+K NIL+ + K+ DFG A+ T V T Y +P
Sbjct: 115 YCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAP 170
Query: 649 E 649
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 75/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 483 LGEGGFGPVYKG-RLHNGQE----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG G FG VYKG + +G+ VA+K L + S + +E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP--LGWETRVRVIEEIAQGLLYLHQYS 594
LG C+ + L+ + MP L D +E+ +G + + +IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+R++HRDL A N+L+ + KI+DFG+A++ DE + +M+ E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 655 LFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
F+ +SDV+S+GV + E T +K + LL ++ L P +
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---------EKGERLPQPPICT 237
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
Y+I+ + C D+ RP E+V +
Sbjct: 238 IDVYMIMVK-------CWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 54/217 (24%)
Query: 483 LGEGGFGPVYKGRLH--NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL---- 536
LG G +G V K R H G +AVKR+ + + ++ Q R L+ L
Sbjct: 9 LGRGAYGVVDKMR-HVPTGTIMAVKRIRAT-------------VNSQEQKRLLMDLDISM 54
Query: 537 -LGCCIEL---------EEKILIYEYMPNKSLDIF---LFDTPK---ESPLGWETRVRVI 580
C E + I + + SLD F ++D E LG ++
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIA 109
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI- 639
I + L YLH S+L VIHRD+K SN+L++++ K+ DFG++ G + S K I
Sbjct: 110 VSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTID 163
Query: 640 VGTYGYMSPE-----YAQQGLFSIKSDVFSFGVLLLE 671
G YM+PE Q+G + +KSDV+S G+ ++E
Sbjct: 164 AGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQ----SGQGLEEFKNEIKLIAKLQHRNLVRLL 537
LG G FG V R +G+ A+K LS Q +E NE +++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 538 GCCIELEEKILIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
G + L+ EY+P L L F P R ++ L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-------VARF-YAAQVVLALEYLHS 119
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
L +++RDLK N+LLD D KI+DFG AK ++ +T + GT Y++PE
Sbjct: 120 ---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIIL 171
Query: 653 QGLFSIKSDVFSFGVLLLETL 673
+ D ++ G+L+ E L
Sbjct: 172 SKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 59/221 (26%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 482 KLGEGGFGP--VYKGRLHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
K+GEG FG + K + +G++ +K + S S + EE + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 538 GCCIELEEKILIYEYMPNKSLDIF---------LFDTPKESPLGWETRVRVIEEIAQGLL 588
E ++ +Y D++ LF P++ L W +I L
Sbjct: 66 ESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLF--PEDQILDW------FVQICLALK 115
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
++H +++HRD+K+ NI L KD K+ DFG+A++ ++T +GT Y+SP
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSP 170
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689
E + ++ KSD+++ G +L E + K + N +L L
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLHNGQE-VAVKRLSSQ---SGQGLEEFKNEIKLIAKLQH 530
+ +G G FG V+ R + A+K ++ + + NE +++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 531 RNLVRLLGCCIELEEKIL--IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
++RL E +++ L + EY+P L +L ++ + S T + EI L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCALE 115
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
YLH +++RDLK NILLDK+ + K++DFG AK +L+ +T + GT Y++P
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSK 676
E Q + D ++ G+L+ E L
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKR-LSSQSGQGLEEFK-NEIKLIAKLQHRN-LVRLL 537
K+GEG +G VYK R + G+ VA+K+ +G+ EI L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 538 GCCIELEEKI------LIYEYMPNKSLDIFLFDTPKESPLGWETRV--RVIEEIAQGLLY 589
+EEK L++EY+ + L F+ + + + ++ +G+ +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
H++ V+HRDLK N+L+DK KI+D G+ + F ++S T IV T Y +P
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYRAP 180
Query: 649 EYAQQGL-FSIKSDVFSFGVLLLETL 673
E +S D++S G + E
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 477 FSTENKLGEGGFGPVYKGRLHN---GQEVAVKRL--SSQSGQGLEEFK-NEIKLIAKLQH 530
+ E +G G +G VYK + N G+E A+K+ + G+ + EI L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 531 RNLVRLLGCCIELEEKI--LIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGL 587
N+V L+ +E +K L+++Y + I F K + ++ +I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMAKMF--------GGDELQSK 635
YLH V+HRDLK +NIL+ + KI D G+A++F D
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 636 TKRIVGTYGYMSPE 649
+V T Y +PE
Sbjct: 174 --PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 42/108 (38%), Positives = 60/108 (55%), Gaps = 9/108 (8%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRI 639
EIA GL +LH +I+RDLK N++LD + + KI+DFGM K +FGG T+
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTF 161
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
GT Y++PE + D ++FGVLL E L+ + D + D L
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 483 LGEGGFGPVYKGR----LHNGQEVAVKRLSSQSGQGLEEF--KNEIKLIAKLQHRNLVRL 536
LG+G FG V+ R GQ A+K L + + + K E ++A++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
+ E K+ LI +++ + D+F KE E + E+A L +LH
Sbjct: 64 -HYAFQTEGKLYLILDFL--RGGDLFT-RLSKEVMFTEEDVKFYLAELALALDHLH---S 116
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
L +I+RDLK NILLD++ + K++DFG++K E K GT YM+PE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRG 174
Query: 656 FSIKSDVFSFGVLLLETLS 674
+ +D +SFGVL+ E L+
Sbjct: 175 HTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 38/209 (18%)
Query: 483 LGEGGFGPVYKGRLHN--GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQH-RNLVRLLG 538
+G G FG V K LH G +AVKR+ S + + ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 539 -------C--CIELEEKIL--IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
C C+EL + L Y+Y+ + E LG ++ + L
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVI-----PEEILG-----KIAVATVKAL 120
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK-RIVGTYGYM 646
YL + L++IHRD+K SNILLD++ N K+ DFG++ G + S K R G YM
Sbjct: 121 NYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYM 174
Query: 647 SPE----YAQQGLFSIKSDVFSFGVLLLE 671
+PE A+ G + ++SDV+S G+ L E
Sbjct: 175 APERIDPSARDG-YDVRSDVWSLGITLYE 202
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 483 LGEGGFGPV------YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+++ +++ KR+ + G+ + NE +++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI--EEIAQGLLYLHQYS 594
+ L+ M L ++ + G+E V EI GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQE- 121
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R+++RDLK NILLD + +ISD G+A + K VGT GYM+PE +
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNE 176
Query: 655 LFSIKSDVFSFGVLLLETLSSK 676
++ D ++ G LL E ++ +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 37/207 (17%)
Query: 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
N++G G G VYK G+ A+K + + + EI+++ + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 539 CCIELEEKILIYEYMPNKSLD-------IFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
E ++ E+M SL+ FL D V +I G+ YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD--------------VARQILSGIAYLH 185
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG--DELQSKTKRIVGTYGYMSPE 649
R ++HRD+K SN+L++ N KI+DFG++++ D S VGT YMSPE
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYMSPE 238
Query: 650 YA----QQGLFS-IKSDVFSFGVLLLE 671
G + D++S GV +LE
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 34/217 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL---SSQSGQGLEEFKNEIKLIAKLQHR 531
+ N++ EG +G VY+ R G+ VA+K+L + G + + EI ++ KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHP 64
Query: 532 NLVRL----LGCCIELEEKI-LIYEYMPN--KSLDIFLFDTPKESPLGWETRVRVIEEIA 584
N+V + +G ++ KI ++ EY+ + KSL +T K+ L E + ++ ++
Sbjct: 65 NIVTVKEVVVGSNLD---KIYMVMEYVEHDLKSL----METMKQPFLQSEVKC-LMLQLL 116
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
G+ +LH ++HRDLK SN+LL+ KI DFG+A+ + G L+ T+ +V T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLW 171
Query: 645 YMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
Y +PE L K D++S G + E L+ K
Sbjct: 172 YRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG V RL +G+ AVK L +E E ++++ ++ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 539 CCIELEEKIL-IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE-EIAQGLLYLHQYSRL 596
CC + +++ + E++ L +F K E R R EI L++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG-- 116
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+I+RDLK N+LLD + + K++DFGM K +F G T GT Y++PE Q+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEM 171
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
L+ D ++ GVLL E L + N D L
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 483 LGEGGFGPV------YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+++ + + KR+ + G+ + NE +++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSR 595
+ L+ M L +++ +P E R EI GL LH+ +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN- 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
++RDLK NILLD + +ISD G+A K+ G+ ++ + VGT GYM+PE
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQ 176
Query: 655 LFSIKSDVFSFGVLLLETLSSK 676
+++ D + G L+ E + +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 54/179 (30%), Positives = 93/179 (51%), Gaps = 27/179 (15%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKR-LSSQSGQGLEEFK-NEIKLIAKLQHRNLVRLLG 538
K+GEG +G V+K R GQ VA+K+ + S+ +++ EI+++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL-- 65
Query: 539 CCIELEEKI----LIYEYMPNKSLDIFLFDTPKESPLGW--ETRVRVIEEIAQGLLYLHQ 592
IE+ + L++EY D + + +++P G ++I + Q + + H+
Sbjct: 66 --IEVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYMSPE 649
++ IHRD+K NIL+ K K+ DFG A++ GD+ V T Y +PE
Sbjct: 119 HN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD----YVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 43/111 (38%), Positives = 63/111 (56%), Gaps = 3/111 (2%)
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q LL +H +IHRD+K++NILL + K+ DFG +KM+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL---TLLGR 692
Y++PE ++ +S K+D+FS GVLL E L+ KR D N + + TL GR
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261
|
Length = 496 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 41/94 (43%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRI 639
EI GL +LH+ +I+RDLK N+LLDKD + KI+DFGM K M G + K
Sbjct: 104 EIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTF 156
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT Y++PE + ++ D +SFGVLL E L
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 483 LGEGGFGPV------YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+++ +++ KRL +SG+ + + EI L+ N +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55
Query: 537 LGCCIELEEKI---LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
+ E K L+ M L +++ E L E + +I G+L+LH
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHS- 113
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+ +++RD+K N+LLD N ++SD G+A ++ G ++ T+R GT GYM+PE +
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPEILK 167
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683
+ +S D F+ G + E ++ + T F +
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR--TPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-14
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG V L EV A+K L ++ E +++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 539 CCIELEEKIL-IYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
CC + ++++ + EY+ L +F + E R R E+ L++LH++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG-- 116
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
VI+RDLK NILLD + + K++DFGM K + G T GT Y++PE Q+
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIAPEILQEL 171
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
+ D ++ GVL+ E ++ + + N D L
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 52/149 (34%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 482 KLGEGGFGPVYKGRLHNG---QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
++G G FG V G +++G +V VK L S S Q +F E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV--RVIEEIAQGLLYLHQYSR 595
G C E+ +L+ E+ P L +L K + + R+ EIA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMA 624
IH DL N LL D+ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 53/234 (22%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRNLVRLLG 538
+G G +G V G++VA+K+LS + Q K E++L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 539 CCIELEEKILIYEYMPNKSLDIF-------------LFDTPKESPLGWETRVRVIEEIAQ 585
+ P SL+ F L + K L + ++ +I +
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
GL Y+H +IHRDLK SNI +++D KI DFG+A+ + V T Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVATRWY 181
Query: 646 MSPE-------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692
+PE Y Q D++S G ++ E L+ K T F +D + L R
Sbjct: 182 RAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK--TLFPGSDHIDQLKR 227
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQGLE-EFKNEIKLIAKLQHRNLVRLLGCC 540
LG G G VYK L + +AVK + L+ + +E++++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 541 IELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
+E +I I E+M SLD++ E LG R+ + +GL YL L+++
Sbjct: 69 F-VENRISICTEFMDGGSLDVY--RKIPEHVLG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIK 659
HRD+K SN+L++ K+ DFG++ + S K VGT YM+PE + I
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 660 SDVFSFGVLLLE 671
SDV+S G+ +E
Sbjct: 174 SDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 49/172 (28%), Positives = 87/172 (50%), Gaps = 13/172 (7%)
Query: 482 KLGEGGFGPVYKGRLHN-GQEVAVKR-LSSQSGQGLEEFK-NEIKLIAKLQHRNLVRLLG 538
+GEG +G V K + GQ VA+K+ L S+ + +++ EI+++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPK-ESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ L++E++ + LD D K + L + + +I +G+ + H ++
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
+IHRD+K NIL+ + K+ DFG A+ V T Y +PE
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQGL-EEFKNEIKLIAKLQHRNL 533
+ + +GEG +G V G +VA+K++S Q + EIK++ + +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 534 VRLLGCCI-----ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
+ +L + ++ E M L+ K L + + +I +GL
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT-KRIVGTYGYMS 647
Y+H + V+HRDLK SN+LL+ + + KI DFG+A++ + + V T Y +
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 648 PE--YAQQGLFSIKSDVFSFGVLLLETLSSK 676
PE +G ++ D++S G +L E LS++
Sbjct: 178 PEIMLNSKG-YTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 483 LGEGGFGPV------YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+++ +++ KR+ + G+ + NE +++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI--EEIAQGLLYLHQYS 594
+ L+ M L +++ G++ V EI GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH--- 119
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
R R+++RDLK NILLD + +ISD G+A ++ G+ ++ + VGT GYM+PE +
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKN 175
Query: 654 GLFSIKSDVFSFGVLLLETLSSK 676
++ D + G L+ E + K
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 467 LASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN----- 520
+V T + +G G FG V R GQ VA+K++ ++ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 521 ----EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETR 576
E+KL+ L+H N++ L I E I Y + L L PL +
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFI 110
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636
+ +I +GL Y+H V+HRDLK SNIL++++ + KI DFG+A++ +
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQM 162
Query: 637 KRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSK 676
V T Y +PE Q+ + ++ D++S G + E L K
Sbjct: 163 TGYVSTRYYRAPEIMLTWQK--YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 459 DSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEF 518
D P A A+ ++ L G G V+ GQ V Q G L E
Sbjct: 50 DGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTTLIE- 107
Query: 519 KNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR 578
L+ + H +++R+ + ++ +P+ S D++ + T + PL + +
Sbjct: 108 ---AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALI 161
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK------MFGGDEL 632
+ ++I +GL YLH R+IHRD+K NI ++ I D G A+ F G
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--- 215
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ GT +PE + ++ K+D++S G++L E L+
Sbjct: 216 ------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--EIKLIAKLQ-HRNLVRL 536
K+GEG F V K + G+ A+K + + + LE+ N EI+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 537 LGCCIELEEK--ILIYEYMPNKSLDIFLFDTPK--ESPLGWETRVR-VIEEIAQGLLYLH 591
+ + + L++E M D+ L++ K + PL E RV+ + ++ + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-Y 650
R + HRD+K NIL+ D K++DFG + G T+ I T Y +PE
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECL 170
Query: 651 AQQGLFSIKSDVFSFGVLLLETLS 674
G + K D+++ G + E LS
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 60/251 (23%), Positives = 113/251 (45%), Gaps = 51/251 (20%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKR--LSSQSGQGLEEFKN------------EIKLI 525
LGEG +G V K G+ VA+K+ + S ++ + E+K++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 526 AKLQHRNLVRLLGCCIELEEKILIYEYMPN---KSLD--IFLFDTPKESPLGWETRVRVI 580
+++H N++ L+ +E + L+ + M + K +D I L ++ + ++
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC---------IL 125
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI- 639
+I GL LH++ +HRDL +NI ++ KI+DFG+A+ +G +
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 640 -----------VGTYGYMSPEY---AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
V T Y +PE A++ F++ D++S G + E L+ K F +
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK--PLFPGEN 238
Query: 686 SLTLLGRAWDL 696
+ LGR ++L
Sbjct: 239 EIDQLGRIFEL 249
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 47/173 (27%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIKLIAKLQHRN 532
+G G +G V G++VA+K++S F + EIKL+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 533 LVRLLGCCI-----ELEEKILIYEYMPN------KSLDIFLFDTPKESPLGWETRVRVIE 581
++ LL + + ++ E M KS PL + ++
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS----------PQPLT-DDHIQYF- 108
Query: 582 EIAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631
+ Q GL YLH VIHRDLK SNIL++ + + KI DFG+A+ DE
Sbjct: 109 -LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 27/203 (13%)
Query: 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG V+ L Q A+K L +E E ++++ + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 539 CCIELEEKIL-IYEYMPNKSLDIFL-----FDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
C + +E + + EY+ L + FD P+ + EI GL +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYA--------AEIICGLQFLHS 114
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEY 650
+++RDLK NILLD D + KI+DFGM K M G +KT GT Y++PE
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEI 167
Query: 651 AQQGLFSIKSDVFSFGVLLLETL 673
++ D +SFGVLL E L
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 483 LGEGGFGPV------YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+GGFG V G+++ +++ KR+ + G+ + NE +++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
E ++ + L+ M L +++ + + E+ GL L R
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---R 120
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R+++RDLK NILLD + +ISD G+A ++ G+ ++ + VGT GYM+PE
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNE 176
Query: 655 LFSIKSDVFSFGVLLLETL 673
++ D + G L+ E +
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 482 KLGEGGFGPVYKGRLHN---GQEVAVKRLSSQ-SGQGL--EEFKNEIKLIAKLQHRNLVR 535
+G+GG G VY ++ + VA+K++ S L + F E K+ A L H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 536 LLGCCIELEEKILIYEYMP---NKSLDIFLFDT-PKES---PLGWETRV----RVIEEIA 584
+ C + +Y MP +L L KES L +T V + +I
Sbjct: 67 VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE------------- 631
+ Y+H S+ V+HRDLK NILL I D+G A +E
Sbjct: 124 ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 632 -LQSKTK--RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
S T +IVGT YM+PE S +D+++ GV+L + L+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEV----AVKRLSS----QSGQGLEEFKNEIKLIAK 527
NF LG G +G V+ R G + A+K L Q + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQ 585
++ + L + E K+ LI +Y+ + L+ S E VR EI
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
L +LH +L +++RD+K NILLD + + ++DFG++K F +E + +T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 646 MSPEYAQ-QGLFSIKSDVFSFGVLLLE--------TLSSKRNT 679
M+PE + +G D +S G+L+ E TL +RNT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRI 639
EI GL +LH +I+RDLK N++LD+D + KI+DFGM K +FG ++
Sbjct: 104 EIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTF 156
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT Y++PE Q ++ D +SFGVLL E L
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGL--EEFKNEIKLIAKLQHRNL 533
+F ++LG G G V K + + ++L + + E++++ + +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLYLH 591
V G E + E+M SLD L + + E LG +V + +GL YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLR 120
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+ + +++HRD+K SNIL++ K+ DFG++ G + S VGT YMSPE
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERL 174
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
Q +S++SD++S G+ L+E
Sbjct: 175 QGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 39/93 (41%), Positives = 58/93 (62%), Gaps = 8/93 (8%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
EI GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + K VG
Sbjct: 105 EIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVG 157
Query: 642 TYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETL 673
T+GYM+PE Q+G+ + +D FS G +L + L
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEV----AVKRLSS----QSGQGLEEFKNEIKLIAK 527
NF LG G +G V+ R +G + A+K L Q + E + E +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQ 585
++ + L + + K+ LI +Y+ L L + E V++ EI
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
L +LH +L +I+RD+K NILLD + + ++DFG++K F DE++ + GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 646 MSPEYAQQGL--FSIKSDVFSFGVLLLETLS 674
M+P+ + G D +S GVL+ E L+
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 46/213 (21%)
Query: 483 LGEGGFGPV----YKGRLHNGQEVAVKRLSSQ---SGQGLEEFKNE--IKLIA-KLQHRN 532
LG G FG V YK G+ A+K L + +E E I A +H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSL------DIFLFDTPKESPLGWETRVRVI---EE 582
LV L C + E+ + + EY L D+F + R +
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-------------SEPRAVFYAAC 109
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIV 640
+ GL YLH+ ++++RDLK N+LLD + KI+DFG+ K M GD +T
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFC 162
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT +++PE + ++ D + GVL+ E L
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 53/215 (24%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHR--NLVRL 536
+G G G VYK R G +AVK++ + EE K ++ ++ K H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79
Query: 537 LGC---------CIELEE------KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE 581
G C+EL I +P E LG ++
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIP-------------EDILG-----KMTV 121
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK-RIV 640
I + L YL + + VIHRD+K SNILLD N K+ DFG++ G + SK K R
Sbjct: 122 AIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSA 175
Query: 641 GTYGYMSPEY----AQQGLFSIKSDVFSFGVLLLE 671
G YM+PE + I++DV+S G+ L+E
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 44/123 (35%), Positives = 68/123 (55%), Gaps = 13/123 (10%)
Query: 551 EYMPNKSLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNI 608
E+M SLD L + E LG +V + +GL YL + + +++HRD+K SNI
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNI 135
Query: 609 LLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVL 668
L++ K+ DFG++ G + S VGT YMSPE Q +S++SD++S G+
Sbjct: 136 LVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 669 LLE 671
L+E
Sbjct: 192 LVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 40/106 (37%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
EIA GL +LH +I+RDLK N++LD + + KI+DFGM K D + +KT G
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCG 163
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
T Y++PE + D ++FGVLL E L+ + + + D L
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 62/233 (26%), Positives = 90/233 (38%), Gaps = 59/233 (25%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS-------SQSGQGLEEFKNEIKLIAKLQHRNLV 534
+G G FG V+ R GQ A+K L +Q E +I A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE--RDILADAD--SPWIV 64
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEE------IAQGL 587
+L + EE + L+ EYMP L + R V E IA+ +
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELV 111
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKR------- 638
L L +L IHRD+K NIL+D D + K++DFG+ K D
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 639 ------------------IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
VGT Y++PE + + ++ D +S GV+L E L
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 39/106 (36%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
EI+ GL +LH R +I+RDLK N++LD + + KI+DFGM K D + ++T G
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCG 163
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
T Y++PE + D +++GVLL E L+ + D + D L
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 43/115 (37%), Positives = 63/115 (54%), Gaps = 14/115 (12%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
EI GL ++H +R V++RDLK +NILLD+ + +ISD G+A F + K VG
Sbjct: 105 EIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVG 157
Query: 642 TYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETL------SSKRNTDFSNTDSLTL 689
T+GYM+PE Q+G + +D FS G +L + L + D D +TL
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 23/168 (13%)
Query: 517 EFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE---YMPNKSLDI----FLFDTP--- 566
+ +NEI + +L H N++++ E+IL E YM + D F++D
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 567 KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626
K+ PL +TR +++++ + Y+H ++IHRD+K NI L+ D + DFG A
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
F E ++ VGT SPE + +D++S G++LL+ LS
Sbjct: 317 F-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 57/161 (35%), Positives = 89/161 (55%), Gaps = 19/161 (11%)
Query: 472 AATANFSTENKLGEGGFGPVYKG--RLHNGQEVAVKRLSSQSGQGLEEFK--NEIKLIAK 527
AAT+ + E KLGEG + VYKG R+ NGQ VA+K +S ++ +G+ F E L+
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVP-FTAIREASLLKG 59
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWET-RVRV-IEEIA 584
L+H N+V LL I +E + ++EYM L + P G VR+ + ++
Sbjct: 60 LKHANIV-LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625
+GL Y+H ++HRDLK N+L+ K++DFG+A+
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
KLGEG + VYKGR GQ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
I ++ + L++EY+ + L ++ D L + ++ +GL Y HQ R
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAK 625
V+HRDLK N+L+ + K++DFG+A+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVA---VKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
++G G FG V ++ VA VK L ++ S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETR-------VRVIEEIAQGLLYL 590
G C+E +L++EY L +L S W R R+ EIA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPE 649
H+++ L H DL N L D+ K+ D+G+ + D ++++ + V +++PE
Sbjct: 116 HKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171
Query: 650 YA---QQGLFSIK----SDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDD 700
GL + + S+V++ GV L E + + S+ + L + + D
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK-------D 224
Query: 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
+ +L P L+ S R+ V C R T EV +LT
Sbjct: 225 QQVKLFKPQLELPYS----ERWYEVLQFCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 481 NKLGEGGFGPVYKGRLHNGQE-VAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
KLGEG + V+KGR + VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ L++EY+ +K L ++ D + + + +I +GL Y H R +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT-KRIVGTYGYMSPE-YAQQGL 655
V+HRDLK N+L+++ K++DFG+A+ + +KT V T Y P+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 656 FSIKSDVFSFGVLLLETLSSK 676
+S + D++ G + E S +
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 483 LGEGGFGPVYKGRLHNGQE----VAVKRLSS----QSGQGLEEFKNEIKLIAKLQHRNLV 534
LG+GG+G V++ R G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 535 RLLGCCIELEEKILIYEYMPNKSL-------DIFLFDTPKESPLGWETRVRVIEEIAQGL 587
L+ + LI EY+ L IF+ DT + EI+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC----------FYLSEISLAL 113
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGY 645
+LHQ +I+RDLK NILLD + K++DFG+ K + G + T GT Y
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEY 166
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
M+PE + D +S G L+ + L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 481 NKLGEGGFGPVYKGRLH-NGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
+KLGEG + VYKGR VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ L++EY+ +K L +L D + + + ++ +GL Y H R +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAK 625
V+HRDLK N+L+++ K++DFG+A+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 18/196 (9%)
Query: 483 LGEGGFGPVYKGRLHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
+ + K + VAVK+ L S S + L+ + EI +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 541 IELEEKILIYEYMPNKSLDIFLFDTPKES-PLGWETRVR-VIEEIAQGLLYLHQYSRLRV 598
I E ++ M S + L E P E + +++++ L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHS---KGF 122
Query: 599 IHRDLKASNILLDKDMNPKISDF-GMAKMFGGDELQSK----TKRIVGTYGYMSPEYAQQ 653
IHR +KAS+ILL D +S M + Q K V ++SPE QQ
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 654 GL--FSIKSDVFSFGV 667
L ++ KSD++S G+
Sbjct: 183 NLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 483 LGEGGFGPVYKGRLHN----GQ----EVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
LG+G F ++KG G+ EV +K L E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
G C+ +E I++ EY+ SLD +L + W ++ V +++A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 595 RLRVIHRDLKASNILL-----DKDMNP---KISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+ H ++ A N+LL K NP K+SD G++ E+ +RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171
Query: 647 SPEYAQQGL-FSIKSDVFSFGVLLLETLS 674
PE + S+ +D +SFG L E S
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 483 LGEGGFGPVYKGRLHN---------GQEVAVKR-LSSQSGQGLEEFKNEIKLIAKLQHRN 532
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
LV+L G C+ E I++ EY+ LD+FL L W ++ V +++A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 593 YSRLRVIHRDLKASNILLDKDMNP-------KISDFGMAKMFGG-DELQSKTKRIVGTYG 644
+++H ++ NIL+ + K+SD G+ +E +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169
Query: 645 YMSPEYAQQGLFSIKS--DVFSFGVLLLE 671
+++PE + G S+ D +SFG LLE
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 482 KLGEGGFGPVYKGRLH-NGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
KLGEG + VYKG+ NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
E L++EY+ D+ + L E + ++ +GL Y+HQ +
Sbjct: 71 IIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAK 625
+HRDLK N+L+ K++DFG+A+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 49/262 (18%)
Query: 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQH 530
++F LG G FG V + G+ A+K L + + ++ E ++ +L H
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWE--TRVRVI-------- 580
+V ++ + + L E +G E T +R
Sbjct: 78 PFIVNMM------------CSFQDENRVYFLL-----EFVVGGELFTHLRKAGRFPNDVA 120
Query: 581 ----EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636
E+ YLH +I+RDLK N+LLD + K++DFG AK ++ +T
Sbjct: 121 KFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRT 172
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK----RNTDFSNTDSLTLLGR 692
+ GT Y++PE Q D ++ GVLL E ++ +T F + + L GR
Sbjct: 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-LAGR 231
Query: 693 -AWDLWKDDRAWELIDPILQNE 713
+ W D RA +L+ +LQ +
Sbjct: 232 LKFPNWFDGRARDLVKGLLQTD 253
|
Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 8/162 (4%)
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
EI ++ + HR ++ L+ K + MP D+F + + PL E + +
Sbjct: 136 EIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
+ + L YLH +IHRD+K NI LD+ N + DFG A +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS 682
GT SPE + K+D++S G++L E +S K T F
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 43/191 (22%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL----- 536
LG G G V+ + VAVK++ Q ++ EIK+I +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 537 ---------LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
+G EL ++ EYM + L + ++ PL E + ++ +GL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 588 LYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
Y+H + V+HRDLK +N+ ++ +D+ KI DFG+A RI +
Sbjct: 128 KYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLA-------------RI------V 165
Query: 647 SPEYAQQGLFS 657
P Y+ +G S
Sbjct: 166 DPHYSHKGYLS 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 481 NKLGEGGFGPVYKGRLH--NGQEVAVK--RLSSQSGQGLEEFK-NEIKLIAKLQHR---- 531
++LG+G +G VYK LH G +A+K RL L+E K N+I + + H+
Sbjct: 7 DELGKGNYGSVYKV-LHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSP 59
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE-EIAQGLLYL 590
+V G + EYM SLD L+ + E +R I + +GL +L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
+ +IHRD+K +N+L++ + K+ DFG++ G+ + S K +G YM+PE
Sbjct: 119 KE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPER 172
Query: 651 ------AQQGLFSIKSDVFSFGVLLLE 671
Q ++++SDV+S G+ +LE
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G +G V G VAVK+LS QS + E++L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 540 CIELEEKILIYEYMPNKSLDIF-------------LFDTPKESPLGWETRVRVIEEIAQG 586
+ P +SL+ F L + K L + +I +I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
L Y+H +IHRDLK SN+ +++D KI DFG+A+ DE+ V T Y
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYR 184
Query: 647 SPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690
+PE + ++ D++S G ++ E L+ + T F TD + L
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 63/277 (22%), Positives = 120/277 (43%), Gaps = 42/277 (15%)
Query: 491 VYKGRLHNGQEVAVKRL---SSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG----CCIEL 543
+YKG N +EV ++ ++ +NEIK + ++ N++++ G +L
Sbjct: 36 IYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDL 603
LI EY L L KE L ++T++ + + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 604 KASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS---IKS 660
+ + L+ ++ KI G+ K+ L S + V Y S + +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 661 DVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILN 720
D++S GV+L E + F N + + ++LI I +N + L L+
Sbjct: 204 DIYSLGVVLWEIFT--GKIPFENLTTKEI-------------YDLI--INKNNSLKLPLD 246
Query: 721 --RYI-NVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754
I + C D++ RP + E++ L+ +
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFYI 283
|
Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEE--FKNEIKLIAKLQHRNLVR---- 535
+G+G +G V R +G++ +K+L+ ++ E + E +L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 536 ----------LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ 585
++G C E +Y + + + P+ + W +IA
Sbjct: 68 WEGEDGLLYIVMGFC----EGGDLYHKLKEQKGKLL----PENQVVEW------FVQIAM 113
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
L YLH+ ++HRDLK N+ L + K+ D G+A++ + T ++GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
MSPE ++ KSDV++ G + E + K + + +SL
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 18/196 (9%)
Query: 483 LGEGGFG-PVYKGRLHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
+GEG FG + +++ Q+ A+K + +S +E+ + E L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 541 IELEEKILIYEYMPNKSLDIFLFDT-----PKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
++ EY L + P+++ L W ++ G+ ++H+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV------QMCLGVQHIHEK-- 119
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
RV+HRD+K+ NI L ++ K+ DFG A++ + T VGT Y+ PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176
Query: 656 FSIKSDVFSFGVLLLE 671
++ KSD++S G +L E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 483 LGEGGFGPV-YKGRLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G +G V G +VA+K+L QS + E++L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 540 C---IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLLYLHQYSR 595
+ L+ Y MP D L K L E R++ ++ ++ +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLS-EDRIQFLVYQMLKGLKYIHAAG- 138
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+IHRDLK N+ +++D KI DFG+A+ + S+ V T Y +PE +
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWM 191
Query: 656 -FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690
++ D++S G ++ E L+ K F D L L
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK--PLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 483 LGEGGFGPVYKGRLHNGQEV----AVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
+G G + V RL ++ VK+ + ++ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
C + ++ L+ EY+ L +F ++ L E EI L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG--- 116
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+I+RDLK N+LLD D + K++D+GM K G T GT Y++PE + +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 658 IKSDVFSFGVLLLETLSSKRNTD 680
D ++ GVL+ E ++ + D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 475 ANFSTENKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHR 531
+ + +G G +G V +G++VA+K++ + E+K++ +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSL--DIFLFDTPKES----------PLGWETRVRV 579
N++ + IL P + D+++ ES PL E
Sbjct: 65 NIIAIR--------DIL----RPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF 112
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
+ ++ +GL Y+H + VIHRDLK SN+L+++D +I DFGMA+ G ++ K
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYF 167
Query: 640 ----VGTYGYMSPEYAQQGLFSI-----KSDVFSFGVLLLETL 673
V T Y +PE L S+ D++S G + E L
Sbjct: 168 MTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 40/109 (36%), Positives = 62/109 (56%), Gaps = 7/109 (6%)
Query: 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627
+ PL E + ++A+G+ +L SR + IHRDL A NILL ++ KI DFG+A+
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 628 --GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
D ++ R+ +M+PE +++ +SDV+SFGVLL E S
Sbjct: 224 YKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 75/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFK-NEIKLIAKLQHRNLVRLLGCC 540
K+G G +G VYK + +G++ L G G+ EI L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 541 IELEEK--ILIYEYMPNKSLDIFLF-------DTPKESPLGWETRVRVIEEIAQGLLYLH 591
+ ++ L+++Y + I F P + P G ++ +I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK--SLLYQILDGIHYLH 125
Query: 592 QYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGD-ELQSKTKRIVGTYGYM 646
V+HRDLK +NIL+ + KI+D G A++F + + +V T+ Y
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 647 SPEYAQQGLFSIKS-DVFSFGVLLLETLSSK-----RNTDF--SNTDSLTLLGRAWDL-- 696
+PE K+ D+++ G + E L+S+ R D SN L R +++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 697 WKDDRAWELIDPILQNEASYLI----LNRYINVALLCVQEDAVDRP 738
+ D+ WE I + E S L+ N Y N +L+ E +P
Sbjct: 243 FPADKDWEDIKKM--PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 483 LGEGGFGPV---YKGRLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
+G G +G V Y RL Q+VAVK+LS QS E++L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 538 GCCI------ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
E L+ M +I + + + +I ++ +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIH 135
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK SN+ +++D +I DFG+A+ DE+ V T Y +PE
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIM 187
Query: 652 QQGL-FSIKSDVFSFGVLLLETLSSK 676
+ ++ D++S G ++ E L K
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 14/194 (7%)
Query: 483 LGEGGFGPVYKGRLHNGQE-VAVKRLSSQSGQGLEEFKN----EIKLIAKLQHRNLVRLL 537
+GEG +G V K R +E VA+K+ EE K E+K++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ L++EY+ L++ +E P G +V I Q + +H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELL-----EEMPNGVPPE-KVRSYIYQLIKAIHWCHKND 120
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
++HRD+K N+L+ + K+ DFG A+ + T+ V T Y SPE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE-YVATRWYRSPELLLGAPYG 179
Query: 658 IKSDVFSFGVLLLE 671
D++S G +L E
Sbjct: 180 KAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 55/197 (27%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIKLIAKL-Q 529
KLG+G +G V+K + VA+K++ + F+N EI + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 530 HRNLVRLLGCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEI--- 583
H N+V+LL I+ E IY EYM E+ L R ++E++
Sbjct: 66 HPNIVKLLNV-IKAENDKDIYLVFEYM--------------ETDLHAVIRANILEDVHKR 110
Query: 584 ------AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
+ L Y+H S VIHRDLK SNILL+ D K++DFG+A+ EL+ +
Sbjct: 111 YIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPE 165
Query: 638 RI-----VGTYGYMSPE 649
V T Y +PE
Sbjct: 166 NPVLTDYVATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 483 LGEGGFGPVYKGRLHNGQEV----AVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
+G G + V RL + + VK+ + ++ + E + + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 539 CCIELEEKIL-IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
C + E ++ + EY+ L +F ++ L E EI+ L YLH+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+I+RDLK N+LLD + + K++D+GM K G T GT Y++PE + +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 658 IKSDVFSFGVLLLETLSSKRNTD 680
D ++ GVL+ E ++ + D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 40/107 (37%), Positives = 60/107 (56%), Gaps = 3/107 (2%)
Query: 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627
+SPL E + ++A+G+ +L SR + IHRDL A NILL ++ KI DFG+A+
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
D + +M+PE +++ +SDV+SFGVLL E S
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 483 LGEGGFGPVYKG-RLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLLG- 538
+G G +G V G++VA+K+LS QS + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 539 --CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
+ +E Y MP D+ PL + ++ ++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+IHRDLK N+ +++D KI DFG+A+ ++ V T Y +PE +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 657 SIKS-DVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690
++ D++S G ++ E L+ K T F D L L
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK--TLFKGKDYLDQL 224
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 19/221 (8%)
Query: 464 MFSLASVSAATANFSTENKLGEGGFGPVYK-GRLHNGQEVAVKRLSSQSGQGLEEFKNEI 522
M L S+ T + +G+G +G VYK +G AVK L S EE + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 523 KLIAKL-QHRNLVRLLGCCIELEEKI-----LIYEYMPNKSLDIFLFDTPKESPLGWETR 576
++ L H N+V+ G + ++ + L+ E S+ + G
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLD 126
Query: 577 VRVIEEIAQG-LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635
+I I G LL L R+IHRD+K +NILL + K+ DFG++ L+
Sbjct: 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 636 TKRIVGTYGYMSPEY---AQQGLFS--IKSDVFSFGVLLLE 671
T VGT +M+PE QQ +S + DV+S G+ +E
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFK-NEIKLIAKLQHRNLVRLLGCC 540
K+G G +G VYK + +G++ L G G+ EI L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 541 IELEEK--ILIYEYMPNKSLDIFLF-------DTPKESPLGWETRVR-VIEEIAQGLLYL 590
+ ++ L+++Y + I F P + P + V+ ++ +I G+ YL
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP---RSMVKSLLYQILDGIHYL 124
Query: 591 HQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGD-ELQSKTKRIVGTYGY 645
H V+HRDLK +NIL+ + KI+D G A++F + + +V T+ Y
Sbjct: 125 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 646 MSPEYAQQGLFSIKS-DVFSFGVLLLETLSSK 676
+PE K+ D+++ G + E L+S+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQ--EVAVKRLSSQS---GQGLEEFKNEIKLIAKLQH 530
+F+ LG G FG V N VA+KR + ++ +E K++ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGL 587
V L G + L+ E++ FL P + + ++ +I E Q L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
+++RDLK N+LLDKD K++DFG AK+ + ++T + GT Y++
Sbjct: 151 ---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIA 196
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETL 673
PE +D ++ G+ + E L
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLS-------SQSGQGLEEFKNEIKLIAKLQHRNLV 534
+G G FG V R + ++V A+K LS S S F E ++A +V
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF----FWEERDIMAHANSEWIV 106
Query: 535 RLLGCCIELEEKIL--IYEYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIAQGLLYL 590
+L ++K L + EYMP L + +D P++ W R E+ L +
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-ARF-YTAEVVLALDAI 158
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPE 649
H IHRD+K N+LLDK + K++DFG KM ++ T VGT Y+SPE
Sbjct: 159 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPE 213
Query: 650 Y----AQQGLFSIKSDVFSFGVLLLETL 673
G + + D +S GV L E L
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 483 LGEGGFGPVYK-GRLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLL-- 537
+G G FG V+ +G+ VA+K++ + Q+ + E+K++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 538 ------GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYL 590
EE ++ E M + I + P S V+V + +I +GL YL
Sbjct: 68 LQPPHIDP---FEEIYVVTELMQSDLHKIIVSPQPLSS-----DHVKVFLYQILRGLKYL 119
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H ++HRD+K N+L++ + KI DFG+A++ DE + T+ +V Y Y +PE
Sbjct: 120 HS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175
Query: 651 ---AQQGLFSIKSDVFSFGVLLLETLSSK 676
++ ++ D++S G + E L +
Sbjct: 176 LMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRNLVRLLG 538
LG+G FG V R +G+ A+K L + +E + E +++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLR 597
+ + EY+ L F +E E R R EI L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+++RDLK N++LDKD + KI+DFG+ K D KT GT Y++PE + +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYG 173
Query: 658 IKSDVFSFGVLLLETLSSKRNTDFSNTD 685
D + GV++ E + + F N D
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-09
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 8/83 (9%)
Query: 337 NRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMW- 394
+ D FV + + KLP ++++ +L+EC ++CL NC+CR++ + G GCL+W
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWS 57
Query: 395 FGDLVDIRKAIGHNNGQSVYIRV 417
L D R + G +Y ++
Sbjct: 58 ESSLGDARL--FPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++A+G+ +L SR + IHRDL A NILL ++ KI DFG+A+ D +
Sbjct: 187 QVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++I+SDV+SFGVLL E S
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 41/113 (36%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 574 ETRVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632
E R R EI L YLH S V++RDLK N++LDKD + KI+DFG+ K D
Sbjct: 94 EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
KT GT Y++PE + + D + GV++ E + + F N D
Sbjct: 152 TMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 483 LGEGGFGPVY-KGRLHNGQEVAVKRLSSQSGQGLEEFKNEIK----LIAKLQHRNLVRLL 537
+G+G FG V R +G AVK L ++ +E + + L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
E+ + +Y+ L F +E E R R E+A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL-EPRARFYAAEVASAIGYLHS---L 115
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+I+RDLK NILLD + ++DFG+ K G E + T GT Y++PE ++ +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 657 SIKSDVFSFGVLLLETL 673
D + G +L E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 574 ETRVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632
E R R EI L YLH V++RDLK N++LDKD + KI+DFG+ K G
Sbjct: 94 EDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISD 148
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
+ K GT Y++PE + + D + GV++ E +
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 39/113 (34%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 574 ETRVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632
E R R EI L YLH V++RD+K N++LDKD + KI+DFG+ K D
Sbjct: 94 EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 150
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
KT GT Y++PE + + D + GV++ E + + F N D
Sbjct: 151 TMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 15/147 (10%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV--RLLGC 539
L G VY L E V +++ +G + + E+ ++ L + L ++L
Sbjct: 5 LLKGGLTNRVY--LLGTKDEDYVLKINPSREKG-ADREREVAILQLLARKGLPVPKVLAS 61
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
L+ E++ ++LD + S E + + E++A+ L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLD-------EVSE---EEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKM 626
H DL NIL+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 46/194 (23%)
Query: 499 GQEVAVKRLSSQSGQGLEEFKN---------EIKLIAKLQHRNLVRLLGCCIELEEKILI 549
GQ VA+K+LS F+N E+ L+ + H+N++ LL
Sbjct: 41 GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 550 YEYMPNKSLDIF--------LFDTPK----ESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
+ P KSL+ F L D + L E ++ ++ G+ +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
+IHRDLK SNI++ D KI DFG+A+ G + T +V Y Y +PE +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYK 195
Query: 658 IKSDVFSFGVLLLE 671
D++S G ++ E
Sbjct: 196 ENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 40/163 (24%)
Query: 481 NKLGEGGFGPVYKGRLH-NGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
+KLGEG + V+KGR VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 538 GCCIELEEKILIYEYMPNK---------------SLDIFLFDTPKESPLGWETRVRVIEE 582
L++EY+ + ++ IF+F +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMF------------------Q 111
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625
+ +GL Y H + +++HRDLK N+L+++ K++DFG+A+
Sbjct: 112 LLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 11/95 (11%)
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
I E+ G+ LHQ +IHRD+K N+L+D+ + K++DFG+++ G E K+
Sbjct: 103 IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKF 153
Query: 640 VGTYGYMSPEYAQQGLFSIK-SDVFSFGVLLLETL 673
VGT Y++PE G+ K SD +S G ++ E L
Sbjct: 154 VGTPDYLAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 37/117 (31%), Positives = 63/117 (53%), Gaps = 7/117 (5%)
Query: 564 DTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623
DT PL + +R ++AQG+ +L + IHRD+ A N+LL KI DFG+
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 624 AK--MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678
A+ M + + R+ +M+PE +++++SDV+S+G+LL E S ++
Sbjct: 259 ARDIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIK--------LIAKLQHRNL 533
+G+G FG V + +G+ AVK L ++ K E K L+ ++H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK----KKEQKHIMAERNVLLKNVKHPFL 58
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQ 592
V L ++ + +Y+ L F + P E R R EIA L YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGEL-FFHLQRERSFP---EPRARFYAAEIASALGYLHS 114
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
L +I+RDLK NILLD + ++DFG+ K G E T GT Y++PE +
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+ + D + G +L E L
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 48/226 (21%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIKLIAKLQHRN 532
+G G +G V + ++VA+K++++ F N EIKL+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 533 LVRLLGCCI-----ELEEKILIYEYMPNKSLDIFLFDTPKES-PLGWETRVRVIEEIAQG 586
++ + + ++YE M D L + S L + + ++ +G
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
L Y+H + V+HRDLK SN+LL+ + + KI DFG+A+ ++ T+ +V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRWYR 175
Query: 647 SPE-------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
+PE Y +I DV+S G + E L R F D
Sbjct: 176 APELLLNCSEYTT----AI--DVWSVGCIFAELL--GRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 483 LGEGGFGPVY-KGRLHNGQEVAVKRLSSQSGQGLEEFKNEIK----LIAKLQHRNLVRLL 537
+G+G FG V R +G+ AVK L + +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
E+ + +++ L F +E E R R EIA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS---I 115
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+++RDLK NILLD + ++DFG+ K G T GT Y++PE ++ +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 657 SIKSDVFSFGVLLLETL 673
D + G +L E L
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 483 LGEGGFGPVYKGRLHNGQEV--AVKRLSSQSGQGLEEFKNEIK----LIAKLQHRNLVRL 536
+G+G FG V R H +E AVK L ++ +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSR 595
++ + +Y+ L + +E E R R EIA L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL---FYHLQRERCF-LEPRARFYAAEIASALGYLHS--- 114
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
L +++RDLK NILLD + ++DFG+ K E T GT Y++PE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 656 FSIKSDVFSFGVLLLETL 673
+ D + G +L E L
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 483 LGEGGFGPVYKGRLHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+G G FG V R + Q+V +L S+ + F E + I + V L C
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 540 CIELEEKI-LIYEYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
+ ++ + ++ EYMP L + +D P++ W A+ +L L +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSM 161
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVGTYGYMSPEYAQQ-- 653
+IHRD+K N+LLDK + K++DFG KM ++ T VGT Y+SPE +
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQG 219
Query: 654 --GLFSIKSDVFSFGVLLLETL 673
G + + D +S GV L E L
Sbjct: 220 GDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 499 GQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI------ELEEKILIY 550
G VAVK+LS Q+ + E+ L+ + H+N++ LL E ++ L+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610
E M + + L E ++ ++ G+ +LH +IHRDLK SNI++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLL 670
D KI DFG+A+ + + T +V Y Y +PE + D++S G ++
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 671 ETLSSKRNTDFSNTDSL 687
E + K + F TD +
Sbjct: 214 ELV--KGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L C + E ++ + E++ L +F ++ L E EI+ L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+I+RDLK N+LLD + + K++D+GM K + GD T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRG 170
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTD 680
+ D ++ GVL+ E ++ + D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVG 641
IA+ +L +H +L +HRD+K N+LLD + + +++DFG KM +QS VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 642 TYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETL 673
T Y+SPE Q G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 44/222 (19%)
Query: 483 LGEGGFGPVYKGRLH-----------------------NGQE--VAVKRLSSQSGQGLEE 517
LG+G +Y GRL NG+E V +K L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 518 FKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
F L++++ H +L + G C+ E I++ E++ + LD+ L P+ W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNP--KISDFGMAKMFGGD 630
V +++A L YL + ++H ++ A NILL + +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLE 671
+ + +RI +++PE G S +D +SFG LLE
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 42/219 (19%)
Query: 482 KLGEGGFGPV----YKGRLHNGQEVAVKRLSSQSGQGL--EEFKNEIKLIAKLQ-HRNLV 534
+LG+G +G V + VA+K++++ + + + E+KL+ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV----------IEEIA 584
C +++ +++ N +++L++ E+ L R I +I
Sbjct: 66 ----CLYDMD---IVFPGNFN---ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGT 642
GL Y+H + V+HRDLK N+L++ D KI DFG+A+ F E V T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 643 YGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
Y +PE + S +S DV+S G +L E L K
Sbjct: 173 RWYRAPEI----MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 50/214 (23%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
+G+G FG VY+ R + + + A+K LS K EI + + + +G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----------KKEI-----VAKKEVAHTIG--- 42
Query: 542 ELEEKILIYEYMPNKSLDI---FLFDTPKE----------SPLGW---------ETRVRV 579
E IL+ + + F F T + L W E R +
Sbjct: 43 --ERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF 100
Query: 580 -IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638
I E+ L +LH+Y +++RDLK NILLD + + DFG++K D T
Sbjct: 101 YIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT 155
Query: 639 IVGTYGYMSPE-YAQQGLFSIKSDVFSFGVLLLE 671
GT Y++PE + ++ D +S GVL+ E
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 483 LGEGGFGPVYKGRLHN---GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLG 538
+G+G +G V+K + N G + AVK L EE + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFK--VLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYG 82
Query: 539 CCIELEEKI-----LIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLLYLHQ 592
+ + K L+ E S+ + K E + ++ E GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY-- 650
+ IHRD+K +NILL + K+ DFG++ L+ T VGT +M+PE
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIA 197
Query: 651 AQQGL---FSIKSDVFSFGVLLLE 671
+Q L + + DV+S G+ +E
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 31/93 (33%), Positives = 51/93 (54%)
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q +L L + +++HRDLK++NI L K+ DFG +K + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
Y++PE ++ +S K+D++S GV+L E L+ R
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 574 ETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633
+R R A+ L L + VI+RDLK NILLD + + DFG+ K+ D+
Sbjct: 92 LSRARFY--TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-- 147
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
KT GT Y++PE ++ D ++ GVLL E L+
Sbjct: 148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVG 641
+A+ +L + +L +HRD+K N+LLDK+ + +++DFG ++ +QS VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 642 TYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETL 673
T Y+SPE Q +G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++A+G+ +L + IHRDL A NILL KI DFG+A+ D
Sbjct: 222 QVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++ +SDV+S+G+LL E S
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 500 QEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI------ELEEKILIYE 551
+ VA+K+LS Q+ + E+ L+ + H+N++ LL E ++ L+ E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611
M + + L E ++ ++ G+ +LH +IHRDLK SNI++
Sbjct: 103 LMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
D KI DFG+A+ G + T +V Y Y +PE + D++S G ++ E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 672 TLSSK 676
+ K
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 458 RDSWFPMFSLA-SVSAATANFSTENKLGEGGFGPV---YKGRLHNGQEVAVKRLSS--QS 511
RD+ F + S + +G G G V Y L + VA+K+LS Q+
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQN 63
Query: 512 GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIF--------LF 563
+ E+ L+ + H+N++ LL + P KSL+ F L
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELM 111
Query: 564 DTPK----ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619
D + L E ++ ++ G+ +LH +IHRDLK SNI++ D KI
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
DFG+A+ G + T +V Y Y +PE + D++S G ++ E +
Sbjct: 169 DFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 63/245 (25%), Positives = 98/245 (40%), Gaps = 60/245 (24%)
Query: 476 NFSTENKLGEGGFGPVYKGRL----HNGQEVAVKRLSS----QSGQGLEEFKNEIKLIAK 527
+F + +G G FG V RL G A+K+L + Q + + E ++A+
Sbjct: 2 DFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAE 57
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIA 584
+ +V+L + E + LI EY+P + L DT E ETR IA
Sbjct: 58 ADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETRFY----IA 108
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS---------- 634
+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 635 --------------------KTKRI------VGTYGYMSPEYAQQGLFSIKSDVFSFGVL 668
K R VGT Y++PE Q ++ + D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 669 LLETL 673
+ E L
Sbjct: 229 MYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++A+G+ +L + +HRDL A N+LL + KI DFG+A+ D
Sbjct: 245 QVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE L++ SDV+S+G+LL E S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 63/250 (25%), Positives = 103/250 (41%), Gaps = 61/250 (24%)
Query: 476 NFSTENKLGEGGFGPV-YKGRLHNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHR 531
+F T +G+G FG V + G+ A+K L L K E ++A+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIAQGLLY 589
+V L + + LI E++P L L +DT E TR +A+ +L
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFY----MAECVLA 113
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-------------KMFGGDELQS-- 634
+ +L IHRD+K NIL+D+ + K+SDFG++ K+ G ++
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 635 -------------------------KTKRI-----VGTYGYMSPE-YAQQGLFSIKSDVF 663
K +R+ VGT Y++PE + QQG + + D +
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWW 232
Query: 664 SFGVLLLETL 673
S G ++ E L
Sbjct: 233 SLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 548 LIYEYMPNKSLDIFL--FDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605
++ EYMP L + +D P++ W A+ +L L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHSMGFIHRDVKP 170
Query: 606 SNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ----GLFSIKSD 661
N+LLDK + K++DFG + + + VGT Y+SPE + G + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 662 VFSFGVLLLETL 673
+S GV L E L
Sbjct: 230 WWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS------SQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+G+G +G V H G++VA+K+++ S + + L E IKL+ L+H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE----IKLLRLLRHPDIV- 62
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE-------------- 581
E K ++ + DI++ ES L +VI+
Sbjct: 63 --------EIKHIMLPPSRREFKDIYVVFELMESDLH-----QVIKANDDLTPEHHQFFL 109
Query: 582 -EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTKRI 639
++ + L Y+H + V HRDLK NIL + D KI DFG+A+ F
Sbjct: 110 YQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 640 VGTYGYMSPEYAQQGLFSIKS----DVFSFGVLLLETLSSK 676
V T Y +PE G F K D++S G + E L+ K
Sbjct: 167 VATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKN-----EIKLIAKLQHRNLVRL 536
K+G G FG V+ + QE + + S +GL+E + E+ ++ +L+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 537 LGCCI-ELEEKILI-YEYMPNKSLD------IFLFDTPKESPLGWETRVRVIEEIAQGLL 588
+ + + +K+ I E+ L +F +E + V + ++ L
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDITRQLLHALA 132
Query: 589 YLHQY----SRLRVIHRDLKASNILLD-------------KDMN----PKISDFGMAKMF 627
Y H + RV+HRDLK NI L ++N KI DFG++K
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 628 GGDELQSKTKRIVGTYGYMSPEYA--QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
G ++S VGT Y SPE + + KSD+++ G ++ E S K T F +
Sbjct: 193 G---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKAN 247
Query: 686 SLTLL 690
+ + L
Sbjct: 248 NFSQL 252
|
Length = 1021 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEE----FKNEIKLIAKLQHR 531
+F ++ +G G FG V R ++ ++ +S +E F+ E +++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
+ +L + + L+ EY P L L E E + +A+ +L +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFD-EDMAQFY--LAELVLAIH 116
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFG-MAKMFGGDELQSKTKRIVGTYGYMSPEY 650
++ +HRD+K N+L+D+ + K++DFG A++ + SK VGT Y++PE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEV 174
Query: 651 AQ------QGLFSIKSDVFSFGVLLLETL 673
+G + ++ D +S GV+ E +
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRIVG 641
+A+ ++ + +L +HRD+K NIL+D + + +++DFG K+ +QS VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165
Query: 642 TYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETL 673
T Y+SPE Q +G + + D +S GV + E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-06
Identities = 22/53 (41%), Positives = 36/53 (67%), Gaps = 3/53 (5%)
Query: 574 ETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626
E V+ I E+A L YLH++ +IHRDLK N+L+ + + K++DFG++K+
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 568 ESP-LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626
ESP L + V ++A G+ +L + +HRDL A N+L+ + KI DFG+A+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
D +M+PE L++ SDV+SFG+LL E +
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 31/170 (18%)
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK-ESPLGWETRVR-VIEEIAQGL 587
+ N ++L L+ +LI +Y+ D LFD K E L E V+ +I ++ + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLS-EAEVKKIIRQLVEAL 122
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
LH++ +IH D+K N+L D+ + + D+G+ K+ G GT Y
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYF 173
Query: 647 SPEYAQQGLFSIKSDV--FSF-----GVLLLETLSSKRNTDFSNTDSLTL 689
SPE IK SF GVL E L+ K + L L
Sbjct: 174 SPE-------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 462 FPMFSLASV------SAATANFSTENKLGEGGFGPVYKGRLHN-----GQEVAVKRLSSQ 510
MF LA + S +F KLGEG FG VYK L N + +K+ +++
Sbjct: 113 VDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATE 171
Query: 511 SGQGLEEFKNE------IKLIAKLQHRNLVRLLGCCIELEEKILIYEY---------MPN 555
G +E + NE A + L + + +E L++ Y M +
Sbjct: 172 YGA-VEIWMNERVRRACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQS 228
Query: 556 K----SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY-LHQYSRLRVIHRDLKASNILL 610
K +++ +L ++ P G E ++I+ I + +L+ L ++HRD+K NI+
Sbjct: 229 KEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288
Query: 611 DKDMNP-KISDFGMA 624
+ KI D G A
Sbjct: 289 SEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 16/105 (15%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM---------FGG--- 629
E L YLH Y ++HRDLK N+L+ + K++DFG++K+ + G
Sbjct: 109 ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165
Query: 630 -DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
D + K++ GT Y++PE + + D ++ G++L E L
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 44/159 (27%), Positives = 63/159 (39%), Gaps = 39/159 (24%)
Query: 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607
LI E++P + L K+ L E I E + +HQ L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131
Query: 608 ILLDKDMNPKISDFGMA--------------------KMFGGDELQSKTK---------- 637
+LLD + K+SDFG+ F + SK K
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 638 ---RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
VGT Y++PE Q ++ D +S GV++ E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 44/159 (27%), Positives = 63/159 (39%), Gaps = 39/159 (24%)
Query: 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607
LI E++P + L K+ L E I E + +HQ L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131
Query: 608 ILLDKDMNPKISDFGMA--------------------KMFGGDELQSKTK---------- 637
+LLD + K+SDFG+ F + SK K
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 638 ---RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
VGT Y++PE Q ++ D +S GV++ E L
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
E ++ + H ++++L G + LI +P D++ + K + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILAIE 188
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
+ + + YLH+ R+IHRD+KA NI ++ + + DFG A F D +K
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
GT +PE + + D++S G++L E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 19/156 (12%)
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEI 583
++ ++ H+++V L G C+ E I++ E++ LD+F+ K L + +V +++
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQL 114
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILL-----DKDMNP--KISDFGMAKMFGGDELQSKT 636
A L YL ++H ++ NILL D + P K+SD G+ Q
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECV 169
Query: 637 KRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLE 671
+RI +++PE + SI +D +SFG L E
Sbjct: 170 ERI----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 44/135 (32%)
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF------------ 627
I E+ + +H ++ IHRD+K NIL+D+D + K++DFG+ F
Sbjct: 107 IAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 628 -----------------GGDELQSKTKR------------IVGTYGYMSPEYAQQGLFSI 658
L+ +R +VGT Y++PE + ++
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223
Query: 659 KSDVFSFGVLLLETL 673
D +S GV+L E L
Sbjct: 224 LCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 67/246 (27%)
Query: 483 LGEGGFGPV-YKGRLHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG G FG V ++ A+K L + + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEE------IAQGLLYLHQ 592
+ + + +Y+P + L R+ V E IA+ L +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI------------RMEVFPEVLARFYIAELTLAIES 116
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG------------------------ 628
++ IHRD+K NIL+D D + K++DFG+ F
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 629 ---------GDELQSKTKR------------IVGTYGYMSPEYAQQGLFSIKSDVFSFGV 667
GD L++ +R +VGT Y++PE + ++ D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 668 LLLETL 673
+L E L
Sbjct: 237 ILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 3e-04
Identities = 16/48 (33%), Positives = 28/48 (58%), Gaps = 1/48 (2%)
Query: 749 NETVNLPHPQQPAFSSIRGLKNTILPANGETG-ACSVSCLTLSVMDAR 795
+ET +P P+QP F R T ++ + + +V+ +T+SV+DAR
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 53/220 (24%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN-EIKLIAKLQHRNLVRLLG 538
N +G G FG VY+ + ++VA+K++ ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 539 C----CIELEEKIL----IYEYMP-------------NKSLDIFLFDTPKESPLGWETRV 577
C + EK + + E++P N +L +FL V
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL--------------V 172
Query: 578 RVIE-EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAK-MFGGDELQS 634
++ ++ + L Y+H S+ + HRDLK N+L+D + + K+ DFG AK + G Q
Sbjct: 173 KLYSYQLCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QR 226
Query: 635 KTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETL 673
I + Y +PE ++ D++S G ++ E +
Sbjct: 227 SVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 67/246 (27%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG G FG V R + A+K L + + K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEE------IAQGLLYLHQ 592
+ + + +Y+P + L R+ + E IA+ +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAELTCAVES 116
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG------------------------ 628
++ IHRD+K NIL+D+D + K++DFG+ F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 629 ---------GDELQSKTKR------------IVGTYGYMSPEYAQQGLFSIKSDVFSFGV 667
GD L+ +R +VGT Y++PE + ++ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 668 LLLETL 673
+L E L
Sbjct: 237 ILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 60/249 (24%)
Query: 482 KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRNLVRLL 537
LG+G G V+ RL G+ A+K L + + K E +++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 538 GCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ--------GLL 588
+ E + L+ +Y P L L P + + EE+A+ L
Sbjct: 68 -ASFQTETYLCLVMDYCPGGELFRLLQRQPGK---------CLSEEVARFYAAEVLLALE 117
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM---------------------- 626
YLH L +++RDLK NILL + + +SDF ++K
Sbjct: 118 YLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 627 -----FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL-------S 674
+E ++ VGT Y++PE D ++ G+LL E L
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 675 SKRNTDFSN 683
S R+ FSN
Sbjct: 235 SNRDETFSN 243
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 6/153 (3%)
Query: 520 NEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV 579
+E +L+ +L H ++ LL + L+ +P D++ + + PLG V
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639
++ + Y+H +IHRD+K N+L++ + + DFG A G I
Sbjct: 266 ARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLET 672
GT +PE ++ D++S G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 9e-04
Identities = 16/66 (24%), Positives = 25/66 (37%), Gaps = 8/66 (12%)
Query: 348 KLPDLEEVLLNESMN-LKECEAECLKN---CTCRAYANSKVTGGGSGCLMW-FGDLVDIR 402
L + + N EC C KN +C+A+ +K CL + F + +R
Sbjct: 11 TLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFVFAKARK---QCLWFPFNSMSGVR 67
Query: 403 KAIGHN 408
K H
Sbjct: 68 KEFSHG 73
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 29/78 (37%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 483 LGEGGFGPVYK------GRLHNGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKL-QHRNLV 534
LG G FG V + G+ N VAVK L +S E +E+K+++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 535 RLLGCCIELEEKILIYEY 552
LLG C ++I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 38/160 (23%), Positives = 61/160 (38%), Gaps = 36/160 (22%)
Query: 491 VYKGRLHNGQEVAVK--RLSSQSGQGLEE-------FKNE-------IKLIAKLQHRNLV 534
VY +G+ VAVK R S+ + + F+N + A+ + RNL
Sbjct: 64 VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123
Query: 535 RLLGCC------IELEEKILIYEYMPNKSLDIFLFDTP----KESPLGWETRVRVIEEIA 584
R I +L+ E++ + L P K+ PL E + E++
Sbjct: 124 RAYEAGVRVPEPIAFRNNVLVMEFIGDDGL-------PAPRLKDVPLELEEAEGLYEDVV 176
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
+ + L Y ++H DL NIL+ P I D A
Sbjct: 177 EYMRRL--YKEAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|201633 pfam01163, RIO1, RIO1 family | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 47/165 (28%)
Query: 491 VYKGRLHNGQEVAVK-----RLSSQSG----QGLEEFKNE-------IKLIAKLQHRNLV 534
VY +G++VAVK S + G F++ ++L A+ + RNL
Sbjct: 2 VYHAYSEDGKKVAVKIYRTGTTSFKKRKRYRDGDFRFRDSKTSWRYLVRLWAEKEFRNLK 61
Query: 535 RLLGCC------IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWE-TRVRVI--EEIAQ 585
RL I + +L+ E++ + G R++ + EE A+
Sbjct: 62 RLYEAGVPVPKPIAVNRHVLVMEFIGDD---------------GVPAPRLKDVELEEEAE 106
Query: 586 GLLY--LHQ----YSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
+ + + Y ++H DL N+L+D D P I D A
Sbjct: 107 EIYDEIIREMRRLYQEAGLVHGDLSEYNVLVDDD-KPVIIDVPQA 150
|
This is a family of atypical serine kinases which are found in archaea, bacteria and eukaryotes. Activity of Rio1 is vital in Saccharomyces cerevisiae for the processing of ribosomal RNA, as well as for proper cell cycle progression and chromosome maintenance. The structure of RIO1 has been determined. Length = 186 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 24/113 (21%), Positives = 47/113 (41%), Gaps = 26/113 (23%)
Query: 519 KNEIKLIAKLQHRNLVRLLGCC------IELEEKILIYEYMPNKSLDIFLFDTPKESPLG 572
+ E +++AK R G ++ + +++ EY+ + L L
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 573 WETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625
E R ++ E+ + + LH + ++H DL SNI+L DFG+ +
Sbjct: 91 EEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 35/126 (27%), Positives = 53/126 (42%), Gaps = 23/126 (18%)
Query: 567 KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNP------- 616
K P ++I + L Y H + L ++H DLK NIL+ D ++P
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALP 281
Query: 617 ------KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLL 670
+I D G DE S+T IV T Y SPE + +D++S G ++
Sbjct: 282 PDPCRVRICDLGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336
Query: 671 ETLSSK 676
E + K
Sbjct: 337 ELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 795 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.38 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.27 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.26 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.81 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.71 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.11 | |
| PLN02236 | 344 | choline kinase | 97.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.92 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.87 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.71 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.52 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.89 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=433.87 Aligned_cols=287 Identities=46% Similarity=0.755 Sum_probs=252.1
Q ss_pred CCCcccHHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeee
Q 040413 461 WFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540 (795)
Q Consensus 461 ~~~~~~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 540 (795)
....|++.++..+|++|...++||+|+||.||+|.+++++.||||++.....+...+|.+|+.+|.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443145699999999999999999999999
Q ss_pred eecc-eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 541 IELE-EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 541 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
.+.+ +.+||||||++|+|+++|+..... +++|..+++|+.++|+||+|||+....+||||||||+|||||++.++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775443 89999999999999999999999888899999999999999999999999
Q ss_pred ccccccccCCCccccceeee-cccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcccccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRI-VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLW 697 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~ 697 (795)
|||+|+..... ....... .||.+|+|||++..+..+.|+||||||++++||++|+++.+... .....+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431 1111122 79999999999999999999999999999999999999887654 33444677777888
Q ss_pred cccchhhccCcccc-chhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 698 KDDRAWELIDPILQ-NEASY-LILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 698 ~~~~~~~~id~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
......+++|+.+. +..+. .+..++..++.+|++.+|.+||+|.||+++|+.+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 88899999999987 55554 6888899999999999999999999999999665
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=391.99 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=215.8
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+|++|.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999987 78999999999774 4556788999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|+|+.++|.+++. ++.++++.+++.+++||+.||.|||+++ |||||||..|++|+++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999883 6678999999999999999999999998 999999999999999999999999999987644
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCC-cchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ....+++|||.|.|||++....++..+||||+||++|-||.|++||+...- +....+.. .+
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-~~-------------- 234 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-NE-------------- 234 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-cC--------------
Confidence 3 234568999999999999999999999999999999999999999986542 22211110 00
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
-..|.....+..+||.++|+.+|.+|||+++|+.|-
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 112234556788999999999999999999999973
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=369.69 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=210.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-eeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-EKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E 551 (795)
.+.+.++.||+|..|+||++.++ +++.+|+|++... .+...+++.+|++++++.+||+||++++.|.... ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35666789999999999999887 6888999999544 4455688999999999999999999999999988 5999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||++|||+.++.. .+.+++...-+|+.+|++||.|||+ ++ ||||||||+||||+..|.+||+|||.+..+.+.
T Consensus 159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999843 3569999999999999999999996 55 999999999999999999999999999876544
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
..++.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+........ ...++++...
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-------------~~~~Ll~~Iv 295 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-------------DIFELLCAIV 295 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-------------CHHHHHHHHh
Confidence 44568999999999999999999999999999999999999999876522111 1122222222
Q ss_pred cch---hhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 711 QNE---ASY-LILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~---~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.++ .+. ..+.++++++..||+.||.+||++.|+++|-
T Consensus 296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 211 122 3667899999999999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.38 Aligned_cols=256 Identities=26% Similarity=0.328 Sum_probs=208.2
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcc-------cHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQ-------GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.+.|.+.+.||+|+||.|-+|.. ++++.||||++++..-. ....+.+|+++|++|+|||||++++++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 46788899999999999999955 58999999999875211 22335799999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC---CCceeeccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFG 622 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFG 622 (795)
.|+||||++||.|-+.+.. .+.+.+..-+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999888743 456778888999999999999999999 9999999999999765 789999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCC---CCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWK 698 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~ 698 (795)
+|+..+.. ..+.+.+|||.|.|||++.+.. +..|+|+||+||+||-+++|.+||.....+. .......-++..
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 99987633 3456789999999999997653 3358899999999999999999997554322 211111000000
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....-.++.++.+++|.+||..||++|||+.|+++|-+--
T Consensus 402 ------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 402 ------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 0112235677889999999999999999999999987654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=368.41 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=203.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.+|...+.||+|+||+||+|+++ ++.+||||.+.+. .+...+.+..|+.+|+.++|||||++++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 67889999999999999999876 6899999999776 56677888999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC------CCceeecccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD------MNPKISDFGMAK 625 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~------~~~kl~DFGla~ 625 (795)
||.||+|..|++ ..+.+++..++.++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999994 3457999999999999999999999999 9999999999999864 568999999999
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.+..... ..+.+|++-|||||++....|+.|+|+||+|+|+||+++|+.||+..+..++....+ +..
T Consensus 164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~-----k~~----- 230 (429)
T KOG0595|consen 164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK-----KGN----- 230 (429)
T ss_pred hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-----ccc-----
Confidence 8875543 345799999999999999999999999999999999999999998776544432111 000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+....+......+.+++...++.+|.+|-+..+-..+
T Consensus 231 ---~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 231 ---EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ---cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 11111222223334456666666666666655554443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=376.61 Aligned_cols=260 Identities=31% Similarity=0.509 Sum_probs=213.2
Q ss_pred CCcccccccCCCceeEEeeeccCCceEEEEEecccCcc--cHHHHHHHHHHHHhcCCCceeeeeeeeeecc-eeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ--GLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-EKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 552 (795)
++.+.+.||+|+||+||+|.++....||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455669999999999999876555999999865322 2568999999999999999999999999988 79999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-CceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~ 631 (795)
|++|+|.++++.. ....+++..++.++.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999664 46789999999999999999999999873 99999999999999997 99999999998765332
Q ss_pred cccceeeecccCCcCChhhhc--cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQ--QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.......||+.|||||++. ...|+.|+||||||+++|||+||+.||......... . . .+...
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~-~-~------------v~~~~ 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA-S-A------------VVVGG 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH-H-H------------HHhcC
Confidence 2223368999999999999 679999999999999999999999999765531111 0 0 01111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
.....+...+..+..++.+||+.||+.||++.+++..|+.+....
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 112223336677889999999999999999999999998764433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.85 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=217.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|+++++||+|+||+||.++.+ +++.+|+|++++. .....+..++|..||.+++||+||+++..|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999765 6889999999875 334577899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+||+.||.|.-+| +++..++++.++.++.+|+.||.|||+++ ||||||||+|||||.+|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999998888 45678999999999999999999999999 99999999999999999999999999985432
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ...+.+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.......... .+
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~------~k-------- 241 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK------GK-------- 241 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc------Cc--------
Confidence 2 2344568999999999999999999999999999999999999999987663222111000 00
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHHh--hc------ccCCCCCCCCCCccc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRP----TMFEVVSML--TN------ETVNLPHPQQPAFSS 764 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~L--~~------~~~~~~~~~~p~~~~ 764 (795)
+ ...+.-...+..+++.++|+.+|++|. .+.+|-+|- .. ...++.+|..|....
T Consensus 242 ~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 242 L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence 0 112222456788999999999999995 566665552 11 123455566665433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=347.00 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=209.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|+.+.++|+|+||+||+++++ +|+.||||++....+ ...+-..+|+++|+.|+|||+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888899999999999999887 699999999976533 334567899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|++..-|+++- .....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.+|.+||+|||+|+.+...
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99988777654 23356889999999999999999999999 999999999999999999999999999987632
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhccccccc--------ccccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDL--------WKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~--------~~~~~ 701 (795)
....+.++.|.+|+|||.+.+ ..|...+||||+||++.||++|.+-|+... .+++..+...... +....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 123345789999999999877 789999999999999999999999998765 3333332221111 11111
Q ss_pred h-hhccCcccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 A-WELIDPILQ-----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~-~~~id~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
. ..+.=|... +..-+....-+++++..||+.||++|++-++++.|
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 000001111 11112334467899999999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=346.27 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=210.8
Q ss_pred cCCcccccccCCCceeEEeee-ccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeee-eeeecce-eEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLG-CCIELEE-KILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 549 (795)
.+|+++++||.|.||.||+++ +.+|..+|.|.+.-. +.+..+....|+.+|+.|+|||||+.++ -+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468999999999999999996 458999999988633 4455677889999999999999999998 4555555 8999
Q ss_pred EeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 550 YEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYS-RLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~-~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
||++..|+|.+++... +..+.+++..+++++.|++.||.++|++- +.-|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999663 45678999999999999999999999832 224999999999999999999999999999998
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... .....+|||.||+||.+....|+.|+||||+||++|||+.-++||.+.+-..+. . ....++.
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~---~---KI~qgd~----- 245 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC---K---KIEQGDY----- 245 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH---H---HHHcCCC-----
Confidence 75542 334589999999999999999999999999999999999999999765311111 0 0111111
Q ss_pred ccccchhh-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 708 PILQNEAS-YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 708 ~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...+ ...+..+..+|..|+..||+.||+...+++.+..
T Consensus 246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122 4567889999999999999999997666665544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=365.47 Aligned_cols=252 Identities=28% Similarity=0.357 Sum_probs=213.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
..+|.+.+.||+|+|++|++|+.+ .+++||||++.+. .+.-.+.+.+|-.+|.+| .||.|++|+..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 468999999999999999999654 7999999999764 233456688999999999 89999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|+||+++|.|-++|. +.+.+++..++.++.||+.||+|||++| ||||||||+|||||.++++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999984 4478999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCccc-----------cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 629 GDELQ-----------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 629 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
..... ......+||..|.+||++.....+..+|+|+||||+|+|+.|++||...++.........
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~---- 301 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA---- 301 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH----
Confidence 43221 112458999999999999999999999999999999999999999987664332211111
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.-+.+...++.+.+|+.++|..||.+|+|.++|.+|.
T Consensus 302 ------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 ------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11122333446678999999999999999999999984
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.40 Aligned_cols=254 Identities=33% Similarity=0.492 Sum_probs=215.9
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
+.+.+++.||+|.||.||.|.++...+||+|.++.. ....+.|.+|+++|++|+|++||+++++|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345667899999999999999988889999999764 3456789999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
.|+|.++|.. .....+...+...++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+...++.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999976 34567889999999999999999999998 9999999999999999999999999999766655543
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCC-CcchhhcccccccccccchhhccCccccc
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSN-TDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
... ..-...|.|||.+..+.++.|+|||||||+|+||+| |+.|++... .+.. +.++.-.+-
T Consensus 361 ~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------~~le~GyRl 423 (468)
T KOG0197|consen 361 SEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------ELLERGYRL 423 (468)
T ss_pred cCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----------------HHHhccCcC
Confidence 322 334667999999999999999999999999999998 666655443 2222 233333334
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..|..++.++.+|+..||+.+|++|||++.+...|+..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 45666788899999999999999999999999888776
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.69 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=211.6
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHH-HHHHHHHHHhcC-CCceeeeeeeeeecc-eeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEE-FKNEIKLIAKLQ-HRNLVRLLGCCIELE-EKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 548 (795)
..++|.++++||.|+||.||+|+. ..+..||||++++.-....+- =.||++.|++|+ |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999965 478899999998765443332 358999999998 999999999999988 9999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|||||+ .+|.+++.+. ++.+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 4687877553 788999999999999999999999999 9999999999999989999999999999876
Q ss_pred CCccccceeeecccCCcCChhhh-ccCCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcccccccccccchhh--
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWKDDRAWE-- 704 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~-- 704 (795)
... ..+.++.|.+|+|||++ +.+.|+.++|+|++|||++|+.+-++.|++.+ .+++..+..+..-.......+
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 443 33457899999999976 56889999999999999999999999988765 333333322222221111111
Q ss_pred ----ccC---ccc----cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 705 ----LID---PIL----QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 705 ----~id---~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+. |.. -...-.....++.+++.+|+.+||++|||+.|.++|-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111 000 0111123667889999999999999999999999983
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.67 Aligned_cols=266 Identities=26% Similarity=0.328 Sum_probs=210.1
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.+|..+++||+|.||.||+|++ ++|+.||||+++.... .......+|++.|+.++|+||++++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4788889999999999999965 5899999999976422 224568899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
||+. +|+..+.+ +...+...+++.++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 68777754 4567999999999999999999999998 9999999999999999999999999999987554
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcccccccccccchhh-----
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWKDDRAWE----- 704 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~----- 704 (795)
.... ..+-|.+|+|||.+.+ ..|+..+|+||.|||+.||+-|.+.|.+.. .+++..+-++..-...+...+
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 3222 2378999999998876 679999999999999999999998887655 333332222222111111100
Q ss_pred ------ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 705 ------LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 705 ------~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.......+..-........+++..++.+||.+|++++|+++|--
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 01111111122344556799999999999999999999999843
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.17 Aligned_cols=266 Identities=24% Similarity=0.314 Sum_probs=207.7
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
.+.|+.+++||+|+||.||+|++ .+|+.||+|++.... +....-..+|+.||++|.|||||+|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688899999999999999965 589999999987654 44556678999999999999999999999887 67999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|+|||++. |.-++. ...-.+++.+++.++.||+.||+|+|.++ |+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 196 VFeYMdhD-L~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDHD-LSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccch-hhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99999874 433332 23457999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCC-cchhhcccccccccccc-----
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDR----- 701 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~----- 701 (795)
...... .+..+.|.+|+|||.+.+ ..|+.++|+||.||||.||+.|++.+...++ +++..+-..+.-..+..
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 654333 345678999999998877 5799999999999999999999999987763 22222222111111111
Q ss_pred hh--hccCcccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AW--ELIDPILQ-----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~--~~id~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ..+.+... .+.-...+...++|+..+|..||++|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 10 11111110 01112234567899999999999999999999886
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.97 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=213.3
Q ss_pred cCCcccccccCCCceeEEeee-ccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
..|...++||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 568888899999999999995 4578999999998877777788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999998887 4456999999999999999999999999 99999999999999999999999999988765543
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
...+.+|||.|||||+.....|++|+||||||++++||+-|.+|+-..+.-....+. ...+ .|. -.
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-----a~ng------~P~--lk 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNG------TPK--LK 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-----hhcC------CCC--cC
Confidence 344589999999999999999999999999999999999999998654321111110 0000 011 12
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||+.|+++||++.|+|+|
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 234456678999999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=327.22 Aligned_cols=236 Identities=28% Similarity=0.370 Sum_probs=202.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|+..+.||.|+||.|.+++.+ +|..+|+|+++++. -...+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57999999999999999999876 68899999998753 234677889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||++||.|-.+++ +..++++..++.++.||+.||+|||+++ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999998884 4467999999999999999999999999 9999999999999999999999999999764
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
..+-+.+|||.|+|||++....+..++|.|||||++|||+.|.+||...+....... ++...+
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K--------------I~~~~v 258 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK--------------ILEGKV 258 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH--------------HHhCcc
Confidence 335678999999999999999999999999999999999999999976654222110 011111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCC
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDR 737 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~R 737 (795)
..|......+.+|+..+|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1233345567899999999999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.60 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=218.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. .+...+.+.+|++|++.++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999776 6889999999775 44557779999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+.| +|..++. ....++++.+..++.++..||.|||+.+ |+|||+||.|||++..|.+|++|||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 9999885 4467999999999999999999999998 9999999999999999999999999999876432
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....+.|||-|||||...+++|+..+|+||+|||+||+++|++||-...... ++..++.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------------------Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------------------LVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------------------HHHHHhc
Confidence 34456889999999999999999999999999999999999999986433221 1222222
Q ss_pred ch--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh--hcccCCCCCCCCCCc
Q 040413 712 NE--ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML--TNETVNLPHPQQPAF 762 (795)
Q Consensus 712 ~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L--~~~~~~~~~~~~p~~ 762 (795)
++ .+......+..++...|+.||..|.+-.+++.|- ++.......|..|.+
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 11 2335667889999999999999999999999873 333333334444433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.02 Aligned_cols=273 Identities=22% Similarity=0.300 Sum_probs=217.7
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++++.||+|+||.||+|+.+ +|..+|+|++++. .....+.++.|..+|....+|.||+|+..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999765 7999999999886 34567889999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||++||++..+| .+...|+++.++.++.+++-||..||+.| +|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999888 45578999999999999999999999999 9999999999999999999999999985321
Q ss_pred C----------------------Cccc-----cc------------------eeeecccCCcCChhhhccCCCCccCCee
Q 040413 629 G----------------------DELQ-----SK------------------TKRIVGTYGYMSPEYAQQGLFSIKSDVF 663 (795)
Q Consensus 629 ~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~s~k~Dvw 663 (795)
. .+.. .. ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 00 0135799999999999999999999999
Q ss_pred ehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC---CH
Q 040413 664 SFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRP---TM 740 (795)
Q Consensus 664 slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~ 740 (795)
|||||+||||.|.+||...+..........|+. -+.-........+..++|.+|+. ||++|. .+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999999987764333221111211 11111112233678899999999 999996 58
Q ss_pred HHHHHHh--hc----ccCCCCCCCCCCccc
Q 040413 741 FEVVSML--TN----ETVNLPHPQQPAFSS 764 (795)
Q Consensus 741 ~evl~~L--~~----~~~~~~~~~~p~~~~ 764 (795)
+||-+|- ++ ..-+.+.|..|....
T Consensus 440 ~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 440 EEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred HHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 8888874 22 223445666666544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=343.44 Aligned_cols=256 Identities=29% Similarity=0.429 Sum_probs=205.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--eeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 551 (795)
.++...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 46778899999999999999765 58999999987653333677999999999999999999999855544 6899999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCC-
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGG- 629 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~- 629 (795)
|+++|+|.+++..... .+++..+..+++||++||.|||+++ |+||||||+||||+. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999854422 7999999999999999999999999 999999999999999 79999999999987653
Q ss_pred CccccceeeecccCCcCChhhhccCC-CCccCCeeehhHHHHHHHhCCCCCCCC-CCcc-hhhcccccccccccchhhcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFS-NTDS-LTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwslG~ll~elltg~~p~~~~-~~~~-~~~~~~~~~~~~~~~~~~~i 706 (795)
...........||+.|||||++..+. ...++|||||||++.||+||++||... .... ...+ ....
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i------g~~~------ 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI------GRED------ 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH------hccC------
Confidence 11222334578999999999998643 345999999999999999999998742 1111 1000 0000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+...+.+..+++.+|++.+|+.|||+.++++|.-..
T Consensus 240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11133444667788999999999999999999999986443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.20 Aligned_cols=272 Identities=22% Similarity=0.331 Sum_probs=226.2
Q ss_pred HHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecc
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELE 544 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 544 (795)
.....++|.++++||+|.||+|+++..+ +++.+|||++++. ..+..+..+.|.+|+.... ||.|+.++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3445689999999999999999999876 6789999999886 3566788999999998885 999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
++++||||+.||++..+. +...+++..+..++..|+.||.|||+++ |||||||.+|||||.+|++||+|||++
T Consensus 443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999954443 4567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
+.--. ....+.+.+|||.|||||++.+..|+..+|.|||||+||||+.|..||++.++++..
T Consensus 516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---------------- 577 (694)
T KOG0694|consen 516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---------------- 577 (694)
T ss_pred cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------
Confidence 85332 224567799999999999999999999999999999999999999999876654432
Q ss_pred ccCccccc--hhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHh--hc------ccCCCCCCCCCCccccccc
Q 040413 705 LIDPILQN--EASYLILNRYINVALLCVQEDAVDRPTM-----FEVVSML--TN------ETVNLPHPQQPAFSSIRGL 768 (795)
Q Consensus 705 ~id~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L--~~------~~~~~~~~~~p~~~~~~~~ 768 (795)
|.++.. .+|.-.+.+.+.+++++|..+|++|.-+ .+|.+|- +. +....++|.+|.....++.
T Consensus 578 --dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~ 654 (694)
T KOG0694|consen 578 --DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV 654 (694)
T ss_pred --HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence 222222 2455567888999999999999999754 5666551 11 2346677778877665543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=352.74 Aligned_cols=261 Identities=29% Similarity=0.404 Sum_probs=204.1
Q ss_pred ccCCcccccccCCCceeEEeeec------cCCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc-
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE- 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 544 (795)
.++|++.++||+|+||.||+|.+ ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 36899999999999999999963 235679999987543 23456789999999999 8999999999887654
Q ss_pred eeEEEEeecCCCCcceeeccCCC---------------------------------------------------------
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPK--------------------------------------------------------- 567 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 567 (795)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999888753211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCc
Q 040413 568 --ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645 (795)
Q Consensus 568 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 645 (795)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 235888899999999999999999998 999999999999999999999999999865432222222234567889
Q ss_pred CChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHH
Q 040413 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYIN 724 (795)
Q Consensus 646 ~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
+|||++.+..++.++|||||||++|||++ |..||......... ... ...+.. ...+...+..+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-~~~----~~~~~~---------~~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-CQR----LKDGTR---------MRAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-HHH----HhcCCC---------CCCCCCCCHHHHH
Confidence 99999999999999999999999999997 99898654322110 000 000000 0011223456889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 725 VALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 725 li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
++.+||+.+|++|||+.|+++.|+...
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=348.84 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=210.4
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc----Cc-ccHHHHHHHHHHHHhcC-CCceeeeeeeeeecce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ----SG-QGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 545 (795)
...+|.+.+.||+|+||+|+.|.+. +++.||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++....+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999654 7899999987664 22 34567889999999999 9999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeeccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMA 624 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFGla 624 (795)
.++||||+.+|.|.+++.. ..++.+.++..+++||+.|++|+|+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999854 467889999999999999999999999 9999999999999999 99999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCC-CC-ccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGL-FS-IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
..... ........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+..+......... .+..
T Consensus 169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~------~~~~ 240 (370)
T KOG0583|consen 169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR------KGEF 240 (370)
T ss_pred cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh------cCCc
Confidence 98731 122344579999999999999876 76 78999999999999999999998754333221110 0000
Q ss_pred hhccCccccchhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 703 WELIDPILQNEASYLI-LNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+... ..++.+++.+||+.+|.+|+++.+++++-+-.
T Consensus 241 ----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 241 ----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred ----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 011112 56788999999999999999999999775554
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.59 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=211.6
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecc--cCcccHHHHHHHHHHHHhcCCCceeeeeeeeee-----c
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-----L 543 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 543 (795)
....+|...+.||+|+||.|..|..+ +|+.||||++.. ......++..+|+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34567777899999999999999765 789999999973 455667889999999999999999999998765 4
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...|+|+|+| ..+|...+. .+..++.+.+..++.||++||.|+|+.+ |+||||||.|++++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 5789999999 667888773 3445999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcccccccccccc
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~ 701 (795)
|+...........+.++.|.+|+|||++.. ..|+.++||||.|||+.||++|++-|.+.+ .+++.++........++.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998764433344466889999999998755 689999999999999999999999998766 333333333322222221
Q ss_pred hhhccCcccc--------------chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 AWELIDPILQ--------------NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+..+-.+... ...-+......++++++||..||.+|+|++|.++|-
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 1111100000 000112334578999999999999999999999983
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=331.60 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=212.8
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+++|++||..|+||||+.++++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999965 68999999999764 556677899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||..+|.|.+++ .....|++.++..+++||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45677999999999999999999999998 99999999999999999999999999988765
Q ss_pred CccccceeeecccCCcCChhhhccCCCC-ccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ..+++|++-|.+||++.+.+|. +.+|.||||++||-|+.|..||+..+...+. .+ ...+.
T Consensus 206 ~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv--rQ----Is~Ga------- 269 (668)
T KOG0611|consen 206 KKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV--RQ----ISRGA------- 269 (668)
T ss_pred ccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH--HH----hhccc-------
Confidence 543 3457999999999999998885 7899999999999999999999875522111 00 00010
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...+..+....-||+|||..+|++|.|+.+|..|-+
T Consensus 270 ----YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 ----YREPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111223445677999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=363.32 Aligned_cols=259 Identities=30% Similarity=0.466 Sum_probs=217.3
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.+....+.||+|+||+||+|+.. +.+.||||.+++.... ...+|++|+++|..++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34556689999999999999753 3467999999876554 7889999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 548 LIYEYMPNKSLDIFLFDTP-------K----ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
+|+|||..|+|.+||.... . ..+|+..+...|+.|||.|+.||-++. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999996431 1 334889999999999999999999887 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCC-Ccchhhccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSN-TDSLTLLGRAW 694 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~-~~~~~~~~~~~ 694 (795)
||+|||+++.....++......-.-..+|||||.+..+.|++++|||||||+|||+++ |+-|+.... ++.+..+..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-- 720 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-- 720 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc--
Confidence 9999999998776666554444556789999999999999999999999999999997 666765433 333322211
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
+. + -+.+..++.+++.|+..||+.+|.+||++.||-..|+...+
T Consensus 721 -----g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 721 -----GQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -----CC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11 1 23566778899999999999999999999999999987643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.65 Aligned_cols=264 Identities=24% Similarity=0.362 Sum_probs=210.0
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..+.|++.+.||.|..++||+|+. +.+..||||++.-.. ....+.+++|+..|..++||||++.+..|..++.+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 347899999999999999999965 578999999997643 233689999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc-CC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF-GG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~-~~ 629 (795)
.||.+||+.+++...-. ..+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||....+ ..
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999998866533 34999999999999999999999999 999999999999999999999999986543 33
Q ss_pred Cccccc-eeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 630 DELQSK-TKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~-~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
+..... .+..+||+.|||||++.. ..|+.|+||||||+...||.+|..||.....-...+... .+....+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL------qn~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL------QNDPPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh------cCCCCCcc
Confidence 222221 256789999999999544 469999999999999999999999987544222211110 01111011
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
-..+..+........+.+++..||+.||.+|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111222233345578899999999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.97 Aligned_cols=264 Identities=28% Similarity=0.440 Sum_probs=202.8
Q ss_pred cCCcccccccCCCceeEEeeeccC-----------------CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN-----------------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
.+|.+.++||+|+||.||+|.+++ +..||+|++.... .....++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997432 3469999987643 3345679999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCCcceeeccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 040413 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTP----------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600 (795)
Q Consensus 537 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 600 (795)
++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999988774321 1235788899999999999999999998 999
Q ss_pred CCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCC--CC
Q 040413 601 RDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK--RN 678 (795)
Q Consensus 601 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~--~p 678 (795)
|||||+|||++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998664433322333445678999999998889999999999999999999754 44
Q ss_pred CCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 679 TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
+...... ............... ......+...+..+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4332211 111111110000000 00001112334678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.06 Aligned_cols=285 Identities=22% Similarity=0.325 Sum_probs=210.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc-c-HHHHHHHHHHHHhcCCCceeeeeeeee--ecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-G-LEEFKNEIKLIAKLQHRNLVRLLGCCI--ELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV 549 (795)
++|+.+++|++|+||.||+|+++ +++.||+|+++...+. + .-.-.+|+.+|.+++|||||.+.++.. +-+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57999999999999999999875 7889999999754321 1 234679999999999999999998876 34678999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||||++ +|..++... ..++...+++-+..|+++|++|||.+. |+||||||+|+|+.+.|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999976 455555332 257889999999999999999999988 99999999999999999999999999999875
Q ss_pred CccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCC-cchhhcccccccccccchhh---
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDRAWE--- 704 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~--- 704 (795)
.. ...+..+-|.+|+|||.+.+ ..|++++|+||+|||+.||+++++.|....+ ++...+-....... +.++.
T Consensus 230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt-e~iwpg~~ 306 (419)
T KOG0663|consen 230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS-EAIWPGYS 306 (419)
T ss_pred Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc-cccCCCcc
Confidence 52 23455788999999998877 5699999999999999999999998876653 22222211111110 11111
Q ss_pred ---ccCc---------cccchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc--CCCCCCCCCCccccccc
Q 040413 705 ---LIDP---------ILQNEASYL-ILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET--VNLPHPQQPAFSSIRGL 768 (795)
Q Consensus 705 ---~id~---------~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~--~~~~~~~~p~~~~~~~~ 768 (795)
.+.. .+....... ..+.-.+++..+|.+||.+|.|++|.++|=.-.. ...++...|.|...+..
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~ 385 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQ 385 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccccc
Confidence 0100 011111111 3355678999999999999999999999844332 22222335555554443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.19 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=206.6
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--------------cccHHHHHHHHHHHHhcCCCceeee
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--------------GQGLEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+..++|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999765 78999999997531 1125689999999999999999999
Q ss_pred eeeeee--cceeEEEEeecCCCCcceeeccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC
Q 040413 537 LGCCIE--LEEKILIYEYMPNKSLDIFLFDTPKESP-LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 613 (795)
Q Consensus 537 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~ 613 (795)
+++..+ .+.+|||+|||..|.+...- ...+ +++.+++++++++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 999876 46789999999999875543 3334 999999999999999999999999 9999999999999999
Q ss_pred CCceeeccccccccCCC---ccccceeeecccCCcCChhhhccCC----CCccCCeeehhHHHHHHHhCCCCCCCCCCcc
Q 040413 614 MNPKISDFGMAKMFGGD---ELQSKTKRIVGTYGYMSPEYAQQGL----FSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686 (795)
Q Consensus 614 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwslG~ll~elltg~~p~~~~~~~~ 686 (795)
|++||+|||.+..+... .........+|||.|+|||...++. .+.+.||||+||+||-|+.|+.||-....-.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866321 1122233468999999999887632 3577899999999999999999986433211
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. . .+++...+.-....++.+++.+||.++|+.||+.|.+..+|..|.+-.
T Consensus 327 l--~------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 327 L--F------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred H--H------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 1 1 111222222223335667889999999999999999999999998654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=345.84 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=212.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.-|++++.||.|+.|.|-.|++. +|+.+|||++.+. .......+.+|+.||+.+.|||++++++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 46889999999999999999765 8999999999765 2334567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|-|.+++. ..+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+...+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999988884 5578999999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccceeeecccCCcCChhhhccCCCC-ccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. -.+.||+|.|.|||++.+.+|+ .++||||.|||||.||+|+.||+..+...+.+. + ..+.
T Consensus 166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK--V----~~G~-------- 228 (786)
T KOG0588|consen 166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK--V----QRGV-------- 228 (786)
T ss_pred cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH--H----HcCc--------
Confidence 32 3346999999999999998885 789999999999999999999985543333211 1 0010
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
-+.+..++.++.+|+.+|+..||++|.|++||++|..-
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 12334566788999999999999999999999998543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.66 Aligned_cols=261 Identities=29% Similarity=0.492 Sum_probs=210.1
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.+.+.+.+.||+|.||+||+|++.+ .||||++... .++..+.|++|+.++++-+|.||+-+.|+|..+.. .+|..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 3567788999999999999998864 7999999765 44568899999999999999999999999999888 99999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+|+|.+|..+++.. +.+++..+.+.|++||++|+.|||.++ |||||||..||+|.+++.|||+|||++..-..-.
T Consensus 468 wCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 99999999999654 467999999999999999999999999 9999999999999999999999999996532111
Q ss_pred cccceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
-........|...|||||+++. .+|+..+||||||+++|||++|..|+.....+.. + |..++..-..|.
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-i-------fmVGrG~l~pd~ 614 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-I-------FMVGRGYLMPDL 614 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-E-------EEecccccCccc
Confidence 1111222457788999998854 5799999999999999999999999984333222 1 111111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
. ......++++.+|+..||.+++++||.+.+|+..|+.+...
T Consensus 615 s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 615 S---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred h---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1 12334566788999999999999999999999999887443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=308.47 Aligned_cols=251 Identities=28% Similarity=0.355 Sum_probs=212.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+...++++|++|-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 368999999999999999999765 6788999999764 234467799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+||.++|+|...|... ....+++.....++.|+|.||.|+|.++ ||||||||+|+|++..+.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999998888542 4456889999999999999999999998 9999999999999999999999999987643
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.....+.+||..|.|||...+..++.++|+|++|++.||++.|.+||+..............+.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~------------- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL------------- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-------------
Confidence 2234568999999999999999999999999999999999999999986553222211111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+..++....++|.+|+..+|.+|.+..|+++|-.
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 122345567889999999999999999999998853
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=346.88 Aligned_cols=259 Identities=28% Similarity=0.389 Sum_probs=203.2
Q ss_pred cCCcccccccCCCceeEEeeec------cCCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
++|++.++||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4788999999999999999963 245689999997542 33456789999999999 899999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC------------------------------------------------------------
Q 040413 547 ILIYEYMPNKSLDIFLFDTP------------------------------------------------------------ 566 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 566 (795)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999988774321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 567 ------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 567 ------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1125788999999999999999999998 9999999999999999999999999998664332222
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .... ...+ ....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~----~~~~---------~~~~ 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKM----IKEG---------YRML 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHH----HHhC---------ccCC
Confidence 2222345678999999999999999999999999999998 7777754322111 0000 0000 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+...+.++.+++.+|++.+|++||++.||+++|+..
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1112245788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=341.55 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=206.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999876 68899999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999998843 346889999999999999999999998 99999999999999999999999999986543
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+..... .+..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------~~~~ 222 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-------RPVY 222 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc-------CCCC
Confidence 22345799999999999999999999999999999999999999876543221110000000000 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.......+.++.+++.+||+.+|++||++.++++|.
T Consensus 223 -~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 -DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred -CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 001123456788999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.31 Aligned_cols=267 Identities=23% Similarity=0.301 Sum_probs=208.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+++.. ++..+|+|++.... ....+++.+|+++|++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999776 68889999987642 3345679999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999998843 346889999999999999999999853 3999999999999999999999999999765322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccc------------
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKD------------ 699 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------ 699 (795)
......|++.|+|||.+.+..++.++|||||||++|||++|+.|+....................
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 12335789999999999999999999999999999999999999865442221110000000000
Q ss_pred ----------------cchhhccCccccch----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 700 ----------------DRAWELIDPILQNE----ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 700 ----------------~~~~~~id~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
....+.++...... .......++.+++.+||+.||++|||+.|+++|..-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000001000000 011245678999999999999999999999998644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=346.00 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=203.6
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.+ +|+||+++++++.+....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 57999999999999999998642 34579999997543 33456789999999999 899999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC------------------------------------------------------------
Q 040413 547 ILIYEYMPNKSLDIFLFDTP------------------------------------------------------------ 566 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 566 (795)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999988764311
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeee
Q 040413 567 -------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639 (795)
Q Consensus 567 -------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 639 (795)
...++++..+.+++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1235788999999999999999999998 999999999999999999999999999865433221122223
Q ss_pred cccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.++..|+|||++.+..++.++|||||||++|||++ |+.||......... . ..+........+...
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-~-------------~~~~~~~~~~~~~~~ 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-Y-------------KMVKRGYQMSRPDFA 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-H-------------HHHHcccCccCCCCC
Confidence 45678999999998999999999999999999997 99988643321110 0 000000000111123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 719 LNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+.++.+++.+||+.+|++||++.+|+++|+.+
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 45788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.94 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=204.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.+.||+|+||.||+|+++ +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999876 6889999998754 23345778899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|++++.++.+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc--------c-cccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL--------W-KDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~--------~-~~~~ 701 (795)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ......... + ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 122235789999999999988899999999999999999999999875442111 101000000 0 0000
Q ss_pred hhhccCcccc------chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPILQ------NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+... .......+..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 01111245578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.36 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=202.6
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.|+..++||+|+||.||+|... +++.||+|++.+.. ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999764 78999999986532 2334568899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998777432 2346899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......||..|+|||.+.+..++.++|||||||++|||++|+.||........ ...... +. ..
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------~~-~~ 220 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------VK-ED 220 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH------------hh-cc
Confidence 12235789999999999999999999999999999999999999975442211 000000 00 00
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 746 (795)
....+...+..+.+++.+||+.+|++||+ +.++++|
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 01122234557889999999999999997 8999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.05 Aligned_cols=244 Identities=22% Similarity=0.334 Sum_probs=198.3
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCccc---HHHHHHHHHHHHhcCCCceeeeeeeeee----cceeEEEEeec
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQG---LEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKILIYEYM 553 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~ 553 (795)
..||+|++|.||+|.. +++.||||+++...... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999987 58899999997653333 5778899999999999999999999877 34678999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
++|+|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 35688999999999999999999984 6 8899999999999999999999999998654322
Q ss_pred ccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .. ... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~--i~---~~~---------~ 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL--II---NKN---------N 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH--HH---hcC---------C
Confidence 12467899999999976 6899999999999999999999999975442221110 00 000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0011123456788999999999999999999999999765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.97 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=210.5
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..|+..++||+|.||.||+|.+ +.++.||+|++.-. .+...+.+.+|+.+|..++++||.+.++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4677779999999999999965 47899999999754 455678899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+.||++.+.+. ....+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999988883 3345588888999999999999999998 99999999999999999999999999988765544
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.. .+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+...+......+ +.+-..|.+.+
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-----------Ipk~~PP~L~~ 233 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-----------IPKSAPPRLDG 233 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-----------ccCCCCCcccc
Confidence 33 568999999999999988999999999999999999999999865443111111 11111233333
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....+.+++..||+.+|+.||++.++++|
T Consensus 234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 344568899999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.75 Aligned_cols=248 Identities=23% Similarity=0.236 Sum_probs=204.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999775 68999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999888843 346889999999999999999999998 999999999999999999999999999865422
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||............. .. .
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~------~~--------~- 214 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL------AG--------K- 214 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------C-
Confidence 223578999999999999889999999999999999999999986543221111000 00 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhhc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSMLTN 749 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~ 749 (795)
...+......+.+++.+||+.||.+||+ ++|+++|-.-
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 0111222456789999999999999995 9999988543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.96 Aligned_cols=246 Identities=23% Similarity=0.291 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+|++.+.||+|+||.||+|+++ +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 6889999998753 2234567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999888843 346889999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... . ..... +
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~----i~~~~--------~ 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE--K----ILAGR--------L 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH--H----HhcCC--------c
Confidence 2 23579999999999999999999999999999999999999986433211100 0 00000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 747 (795)
..+.....++.+++.+||+.||.+||+ +.++++|-
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 011123456789999999999999986 79998874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.00 Aligned_cols=242 Identities=24% Similarity=0.284 Sum_probs=198.2
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||+|+.+ +++.||||++.+. .......+.+|+.++++++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 7899999999754 2334567889999999999999999999999999999999999999
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccce
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 636 (795)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888743 356899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhH
Q 040413 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716 (795)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~ 716 (795)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......... . + ...+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~------~----~~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------E------E----IRFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc------C------C----CCCCC
Confidence 346799999999999999999999999999999999999999865432221110000 0 0 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040413 717 LILNRYINVALLCVQEDAVDRP-----TMFEVVSM 746 (795)
Q Consensus 717 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 746 (795)
....++.+++.+||+.||++|| ++.++++|
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3355688999999999999999 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.34 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=201.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCc-eeeeeeeeeecc-----
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRN-LVRLLGCCIELE----- 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 544 (795)
...|..+++||+|+||+||+|+.+ +|+.||+|++.-..+ .......+|+.+|++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345777889999999999999765 789999999976533 24466799999999999999 999999999887
Q ss_pred -eeEEEEeecCCCCcceeeccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 545 -EKILIYEYMPNKSLDIFLFDTPKE-SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 -~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
..++|+||+.. +|..++...... ..++...++.++.||++||+|||+++ |+||||||+||||+..|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999854 566666443221 45777899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccc-----
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWD----- 695 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~----- 695 (795)
+|+.+.-... ....-++|.+|+|||++.+. .|+..+||||+|||+.||+++++.|....+.. ...+-....
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9997653321 13345789999999998775 79999999999999999999998887655322 111111111
Q ss_pred cccccchhhccC---cccc--chhhHHH---HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 696 LWKDDRAWELID---PILQ--NEASYLI---LNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 696 ~~~~~~~~~~id---~~l~--~~~~~~~---~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.|.........+ +... ....... .....+++.+||+++|.+|.|+..+++|
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111100000000 0000 0011111 1367899999999999999999999998
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.08 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=206.9
Q ss_pred cCCcccccccCCCceeEEeeeccC------CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.+.||+|+||.||+|.... .+.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999997642 2579999987543 334567999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC
Q 040413 548 LIYEYMPNKSLDIFLFDTPK-------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~ 614 (795)
++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999888854311 146889999999999999999999998 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccc
Q 040413 615 NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 615 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............+++.|+|||.+....++.++|||||||++|||++ |..|+..........
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~---- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 999999999986543332222333456889999999988899999999999999999998 888876433221111
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+........+...+.++.+++.+|++.+|++||++.||+++|+.
T Consensus 238 -----------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 -----------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 000001111233456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=304.76 Aligned_cols=266 Identities=24% Similarity=0.258 Sum_probs=213.2
Q ss_pred HHHhccCCcccccccCCCceeEEeee-ccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce---
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE--- 545 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 545 (795)
+..+.++|.+.+.||+|||+.||.++ ..+++.+|+|++.-...+..+...+|++.-++++|||+++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34566899999999999999999996 45789999999987777888999999999999999999999998765444
Q ss_pred --eEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 546 --KILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 --~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.||+++|...|+|.+.+... .+...+++.++..|+.+|.+||++||+.. .+++||||||.|||+.+.+.++|+|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 89999999999998888664 34558999999999999999999999986 579999999999999999999999999
Q ss_pred cccccCCCc-----cc--cceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCc--chhhc
Q 040413 623 MAKMFGGDE-----LQ--SKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD--SLTLL 690 (795)
Q Consensus 623 la~~~~~~~-----~~--~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~--~~~~~ 690 (795)
.+....-.. .. .....-..|..|+|||.+. +..++.++|||||||+||+|+.|..||+..-.. ...+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA 254 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA 254 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence 987643111 00 0111235788999999874 456789999999999999999999999732211 11110
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+.+.-......++.+.+++.+||+.||.+||++.+++.++..+
T Consensus 255 --------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 --------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0111111111222567889999999999999999999999998775
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.67 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=200.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999765 68899999987543 23345788999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 985 78777643 2345789999999999999999999998 9999999999999999999999999997643221
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccc-----cccc----cc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWD-----LWKD----DR 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~-----~~~~----~~ 701 (795)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...+..... .+.. ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 11223467999999998865 568999999999999999999999987554221 111110000 0000 00
Q ss_pred hhhccCccccc----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPILQN----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+.... ........++.+++.+||+.||.+|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00011111000 0011234567899999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=333.39 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=198.3
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 6899999999754 2344567889999999999999999999999999999999999999
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccce
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 636 (795)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9987773 3356899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhH
Q 040413 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716 (795)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~ 716 (795)
....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......... . + ...+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~------~----~~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------E------D----IKFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------C------C----ccCCC
Confidence 345799999999999988999999999999999999999999865432221110000 0 0 01112
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 717 LILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 717 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
....++.+++.+||+.+|++|| ++.|+++|.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 2345678999999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.95 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=215.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce-eEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-KILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 550 (795)
++|..++++|+|+||.++.++++ +++.+|+|++.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999876 6789999988654 33445578999999999999999999999999998 89999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
+|++||+|.+.+... +...++++.+..++.||+.|+.|||++. |+|||||+.||+++.++.|||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999988654 3577999999999999999999999877 999999999999999999999999999998765
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+...+... +.+..
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k---------------i~~~~ 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK---------------INRGL 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH---------------Hhhcc
Confidence 4 233457999999999999999999999999999999999999999987664433211 11111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....+.....++..++..|++.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 234455567789999999999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=339.25 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=198.8
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.|+++++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999764 6889999999754 23345678999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999888743 346889999999999999999999998 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------ccceeeecccCCcCChhhhccCCCCccCCeeehh
Q 040413 632 L---------------------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFG 666 (795)
Q Consensus 632 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG 666 (795)
. .......+||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHH--hcccCCCCCCCHHHHH
Q 040413 667 VLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALL--CVQEDAVDRPTMFEVV 744 (795)
Q Consensus 667 ~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl 744 (795)
|++|||++|+.||..............+. ..+..........++.+++.+ |+..+|..||++.|++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~------------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWE------------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccc------------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999997554322111100000 000000111234567788877 4455666699999999
Q ss_pred HHh
Q 040413 745 SML 747 (795)
Q Consensus 745 ~~L 747 (795)
+|-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=335.14 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=203.0
Q ss_pred ccCCcccccccCCCceeEEeeeccC--CceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN--GQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.++||+|+||.||+|..+. +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999997542 468999998653 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999988843 346899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... ... ..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~--~i~----~~-------- 243 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ--KIL----EG-------- 243 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH--HHh----cC--------
Confidence 22 234579999999999998889999999999999999999999987543221110 000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
.. ..+......+.+++.+||+.+|++|+ +++++++|-
T Consensus 244 ~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 244 II--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 00 01122344578999999999999995 899999984
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=330.14 Aligned_cols=240 Identities=23% Similarity=0.264 Sum_probs=195.8
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999765 6889999998753 234456788999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceee
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 888843 356899999999999999999999998 9999999999999999999999999998543221 12234
Q ss_pred ecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .. . ... ...+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~--~~---~---------~~~--~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR--KI---L---------QEP--LRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH--HH---H---------cCC--CCCCCcC
Confidence 679999999999999999999999999999999999999986543221110 00 0 000 0112234
Q ss_pred HHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 040413 719 LNRYINVALLCVQEDAVDRP---TMFEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RP---t~~evl~~ 746 (795)
+..+.+++.+||+.||++|| ++.|+++|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 45678999999999999997 56788776
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=324.79 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=207.0
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
..+|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888999999999999999763 2478999999765443 467899999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC
Q 040413 547 ILIYEYMPNKSLDIFLFDTP-----------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~ 615 (795)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999998885421 2345889999999999999999999998 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccc
Q 040413 616 PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAW 694 (795)
Q Consensus 616 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 694 (795)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........... .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~--~- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC--I- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--H-
Confidence 99999999976543322222223456788999999999999999999999999999998 9988764432221110 0
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..... ...+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 238 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00000 0111234567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.54 Aligned_cols=256 Identities=30% Similarity=0.454 Sum_probs=211.3
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
..+|++.++||+|+||.||+|...+++.+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35789999999999999999998888999999998776656778999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999998654 3356899999999999999999999998 999999999999999999999999999876433221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. ....++..|+|||.+....++.++||||||+++|+|++ |+.|+......... .... .....
T Consensus 161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~--~~~~-------------~~~~~ 223 (261)
T cd05148 161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY--DQIT-------------AGYRM 223 (261)
T ss_pred c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH--HHHH-------------hCCcC
Confidence 1 12345678999999988899999999999999999998 78888644321111 0000 00001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11223456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=339.37 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=205.3
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 545 (795)
.++|.+.++||+|+||.||+|... .+..||||++.... ....+.+.+|+++|+++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 468899999999999999999752 23479999997543 234567999999999996 9999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCC-----------------------------------------------------------
Q 040413 546 KILIYEYMPNKSLDIFLFDTP----------------------------------------------------------- 566 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 566 (795)
.+|||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999988764321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC
Q 040413 567 ----------------------------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 567 ----------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~ 612 (795)
....+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0134788889999999999999999998 999999999999999
Q ss_pred CCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcc
Q 040413 613 DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLG 691 (795)
Q Consensus 613 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~ 691 (795)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.......... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-N 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-H
Confidence 99999999999986543322222233456788999999998899999999999999999997 888876433211100 0
Q ss_pred cccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 692 RAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 692 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. .... .....+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 352 ~----~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 352 K----IKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H----HhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0 0000 00011223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.98 Aligned_cols=261 Identities=30% Similarity=0.413 Sum_probs=209.0
Q ss_pred ccCCcccccccCCCceeEEeeeccC--C--ce-EEEEEecc---cCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN--G--QE-VAVKRLSS---QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++..+.++||+|+||.||+|+++. + .. ||||..+. .......+|.+|+++|+.++|||||+++|++...+.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3556666899999999999998753 2 23 89998875 245677889999999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
+++|||+|+||+|+++|.... ..++..+...++.+.|.||+|||+++ +|||||.++|+|+..++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999996543 26999999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhh
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
.-. .+........-...|+|||.+..+.|+.++|||||||++||+++ |..|+............
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI------------- 375 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI------------- 375 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH-------------
Confidence 643 22221112235678999999999999999999999999999998 67777654422211100
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCC
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 755 (795)
+........+...+..+..++.+|+..+|++||+|.++.+.|+.+.....
T Consensus 376 -~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 -VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 01111112223446677888999999999999999999999988754433
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=336.77 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=205.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999765 78999999997542 244567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999888533 57899999999999999999999998 999999999999999999999999999865433
Q ss_pred c---------------------------cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 631 E---------------------------LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 631 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011233578999999999999999999999999999999999999987554
Q ss_pred CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 040413 684 TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT-MFEVVSML 747 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 747 (795)
.......... +. ..+.-......+..+.+++.+|++ +|.+||+ +.++++|.
T Consensus 235 ~~~~~~~i~~---~~---------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQETYNKIIN---WK---------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHhc---cC---------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 2211100000 00 000000011135678899999998 9999999 99999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.72 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=206.9
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35789999999999999999998888899999986533 34678999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999888543 3456888999999999999999999988 999999999999999999999999999876543221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+....++.++||||||+++|+|++ |+.|+......... ......+ . .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~--~~~~~~~---------~----~ 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM--SALQRGY---------R----M 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH--HHHHcCC---------C----C
Confidence 1122345678999999988889999999999999999998 88888644322111 0000000 0 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.40 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=201.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-----eeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-----EKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 548 (795)
-.|...+++|.|.||.||+|... ++++||||+.-... +.-.+|+++|+++.|||||+|+.+|.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35777889999999999999765 57899999875432 23457999999999999999998886532 2358
Q ss_pred EEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeeccccccc
Q 040413 549 IYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKM 626 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFGla~~ 626 (795)
|||||+. +|.+++.+. ..+..++...++-+..||++||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 566666432 34567888899999999999999999988 9999999999999976 9999999999998
Q ss_pred cCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcccccccccccchhh
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~ 704 (795)
+..++.+ ..+..|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.. .+++..+..+......+++..
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 8655433 44678999999998877 579999999999999999999999998755 333333333333222222211
Q ss_pred c-------cCccccc-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 705 L-------IDPILQN-----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 705 ~-------id~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
. -.|.+.. -.....+.+.++++.++|+++|.+|.++.|++.|
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1 0011111 1233456678999999999999999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=349.30 Aligned_cols=254 Identities=19% Similarity=0.241 Sum_probs=206.1
Q ss_pred cCCcccccccCCCceeEEeeecc-C-CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-N-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..|.+.+.||+|+||.||+|... + ++.||+|.+..........+++|+.+|+.++||||+++++++.+.+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999654 4 678899987655555566788999999999999999999999999999999999
Q ss_pred cCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++|+|.+++... ....++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999998877542 23456899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... . .+. .+
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~--~~~~---~-~~~----~~---- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI--MQQV---L-YGK----YD---- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH---H-hCC----CC----
Confidence 22223446799999999999999999999999999999999999999865432111 0000 0 000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1112234568899999999999999999998764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=346.41 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=210.2
Q ss_pred HhccCCcccccccCCCceeEEeeeccCC-ceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeee-eee------
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLHNG-QEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGC-CIE------ 542 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------ 542 (795)
....++++.+.|-+|||+.||.|++..+ .++|+|++-..++...+.+++|+.+|++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456788899999999999999988755 999999988778889999999999999997 9999999993 221
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.-+.+|.||||.+|+|-+++......+ |++.++++|+.++++|+++||... .+|||||||-|||||..+|++||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 235689999999999999986654433 999999999999999999999985 789999999999999999999999999
Q ss_pred cccccCCCcccc-------ceeeecccCCcCChhhh---ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccc
Q 040413 623 MAKMFGGDELQS-------KTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692 (795)
Q Consensus 623 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~ 692 (795)
.|...-...... ..-...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....-.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 986432111000 00112358999999976 56789999999999999999999999998543211
Q ss_pred ccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+++....-...+.+..++.+||+.||+.+|++||++-+|+..+-.+
T Consensus 266 ------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 266 ------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1222222223356788899999999999999999999999987554
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=333.97 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=203.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|... +++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999765 78999999997642 234567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988542 346899999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccceeeecccCCcCChhhhc------cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .. ....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--~i---~~~~---- 225 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN--NI---MNFQ---- 225 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH--HH---HcCC----
Confidence 221 222347899999999986 4567899999999999999999999986543221100 00 0000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+.-......+..+.+++..|++ +|.+||++.++++|-
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 226 ---RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred ---CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 000000111234567889999998 999999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.24 Aligned_cols=267 Identities=30% Similarity=0.389 Sum_probs=204.0
Q ss_pred CcccccccCCCceeEEeeec-----cCCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEE
Q 040413 477 FSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
|++.+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999987642 357889999987643 23467789999999999999999999988764 35789
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++.. ..+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999988843 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQS-KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
...... ......++..|+|||.+....++.++||||||++++||++|+.|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 322111 1112235667999999988889999999999999999999998875433221111111111111111222222
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.......+...+..+.+++..|++.+|++|||+++++++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222222333456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.53 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=205.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||++.++ +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 6888999988754 23345679999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999998843 346889999999999999999999742 3999999999999999999999999999765322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccc-ccc-ccccc---------
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR-AWD-LWKDD--------- 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~-~~~-~~~~~--------- 700 (795)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.|+............. ... .....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1223578999999999998889999999999999999999999987543222111000 000 00000
Q ss_pred ---------------chhhccCccccchh----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 701 ---------------RAWELIDPILQNEA----SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 701 ---------------~~~~~id~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
....+.+....... ......++.+++.+||+.||++|||+.|+++|-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 00000000000000 0013456889999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=315.20 Aligned_cols=273 Identities=22% Similarity=0.256 Sum_probs=218.3
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|+++++||.|.-|+||+++++ .+..+|+|++.+.. .+...+.+.|-+||+.+.||.++.||..++.++..+|
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3467888999999999999999887 46889999998753 4445678889999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|||||+||+|....+. +..+.++++.++.++.+|+-||+|||-.| ||+|||||+||||.++|++-|+||.++....
T Consensus 155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999887754 46678999999999999999999999999 9999999999999999999999999874331
Q ss_pred C---------------------------------C-c--------------------cccceeeecccCCcCChhhhccC
Q 040413 629 G---------------------------------D-E--------------------LQSKTKRIVGTYGYMSPEYAQQG 654 (795)
Q Consensus 629 ~---------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~ 654 (795)
. . . ........+||-+|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0 00112346899999999999999
Q ss_pred CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccC
Q 040413 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQED 733 (795)
Q Consensus 655 ~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~d 733 (795)
..+.++|.|+||+++|||+.|..||.+.+... ...+ +...+.-......+..+.+||+++|..|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999998776332 2211 1111111111245567889999999999
Q ss_pred CCCCCC----HHHHHHHh--hc----ccCCCCCCCCCCccc
Q 040413 734 AVDRPT----MFEVVSML--TN----ETVNLPHPQQPAFSS 764 (795)
Q Consensus 734 P~~RPt----~~evl~~L--~~----~~~~~~~~~~p~~~~ 764 (795)
|.+|.- +.||-+|- ++ ++....+|.+|....
T Consensus 376 P~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred hhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence 999988 89998873 33 334445555665433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.58 Aligned_cols=243 Identities=24% Similarity=0.272 Sum_probs=197.6
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 7899999999754 2334566788999999999999999999999999999999999999
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccce
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 636 (795)
+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99877743 346899999999999999999999998 9999999999999999999999999987532221 112
Q ss_pred eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhH
Q 040413 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716 (795)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~ 716 (795)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......... . . ...+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~------~--------~--~~~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------E--------E--IRFPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc------C--------C--CCCCC
Confidence 235799999999999999999999999999999999999999865432221110000 0 0 00112
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 717 LILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 717 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
..+..+.+++.+||+.+|++|| ++.++++|-
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 2345678999999999999998 899998873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.61 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=206.5
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45788999999999999999988777899999987543 34577999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999885432 356899999999999999999999998 999999999999999999999999999876532211
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. ......+..|+|||.+....++.++||||||++++||++ |+.|+.......... .... ....
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--~~~~-------------~~~~ 223 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ--QVDQ-------------GYRM 223 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHc-------------CCCC
Confidence 1 111223457999999998899999999999999999999 888876433211110 0000 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=338.21 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=201.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999775 6899999999753 2334566889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999988843 346899999999999999999999998 999999999999999999999999998754321
Q ss_pred cccc------------------------------------ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh
Q 040413 631 ELQS------------------------------------KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674 (795)
Q Consensus 631 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt 674 (795)
.... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHh
Q 040413 675 SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT---MFEVVSML 747 (795)
Q Consensus 675 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L 747 (795)
|+.||.............. +. ..+........+..+.+++.+|+. +|.+|++ +.|+++|-
T Consensus 235 G~~Pf~~~~~~~~~~~i~~---~~---------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNPQETYRKIIN---WK---------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCHHHHHHHHHc---CC---------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999975442211100000 00 000000011224567789999997 8999997 99999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.99 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=209.3
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999642 356699999876665566789999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC
Q 040413 549 IYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~ 615 (795)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999885421 2245899999999999999999999998 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccc
Q 040413 616 PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAW 694 (795)
Q Consensus 616 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 694 (795)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~-- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--C-- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--H--
Confidence 99999999976543322222233456788999999998899999999999999999999 888875443221110 0
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
....... ..+...+..+.+++.+|++.+|++||++.+|+++|+.+..
T Consensus 238 --~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 --ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0001000 0111234568899999999999999999999999998844
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.59 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=203.4
Q ss_pred hccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
..++|++.+.||+|+||.||+|... .+..+|||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998643 35679999986532 2345678999999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 546 KILIYEYMPNKSLDIFLFDTPK-------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999988854221 234678889999999999999999988 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+........... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~--~---- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF--V---- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--H----
Confidence 99999986543332222222345778999999998899999999999999999999 6777754432211110 0
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..... ...+...+..+.+++.+|++.+|++|||+.|++++|+
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00000 0011223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.40 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=199.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|+.+ +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999876 688999999875432 334567899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9964 56555532 2356889999999999999999999998 9999999999999999999999999997543221
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch--hhcccccc-----cccccchh
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL--TLLGRAWD-----LWKDDRAW 703 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~--~~~~~~~~-----~~~~~~~~ 703 (795)
.......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ........ .+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11223568999999998865 4688999999999999999999999975432111 00000000 00000000
Q ss_pred hccCc---------cccch-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 704 ELIDP---------ILQNE-ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 704 ~~id~---------~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...++ .+... ........+.+++.+||+.||++|||+.|+++|-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 00000 00000 00012245789999999999999999999998743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.80 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeec-ce
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL-EE 545 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 545 (795)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57999999999999999999642 35789999987542 23346688899999999 899999999988654 56
Q ss_pred eEEEEeecCCCCcceeeccCCC----------------------------------------------------------
Q 040413 546 KILIYEYMPNKSLDIFLFDTPK---------------------------------------------------------- 567 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 567 (795)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999887743211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCC
Q 040413 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647 (795)
Q Consensus 568 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 647 (795)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999998 99999999999999999999999999987643322222333456778999
Q ss_pred hhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHH
Q 040413 648 PEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVA 726 (795)
Q Consensus 648 PE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li 726 (795)
||++.+..++.++|||||||++|||++ |..|+........ ... ..... .....+.....++.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~----~~~~~---------~~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR----RLKEG---------TRMRAPEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH----HHhcc---------CCCCCCccCCHHHHHHH
Confidence 999999999999999999999999998 9888864322111 000 00000 00011122345688999
Q ss_pred HHhcccCCCCCCCHHHHHHHhhcc
Q 040413 727 LLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 727 ~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+|++.+|++||++.|++++|+..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.78 Aligned_cols=243 Identities=26% Similarity=0.334 Sum_probs=196.4
Q ss_pred ccccCCCceeEEeeec----cCCceEEEEEeccc----CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 481 NKLGEGGFGPVYKGRL----HNGQEVAVKRLSSQ----SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++||+|+||.||+++. ..++.||||++.+. .......+.+|+.+|+.++||||+++++.+.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 35788999998753 223345678999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++. ....+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999988874 3356788999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .....
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~~~~------------~~~~~-- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--IDKI------------LKGKL-- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--HHHH------------HcCCC--
Confidence 122335799999999999988899999999999999999999999875432111 0000 00000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
..+......+.+++.+||+.+|++|| ++.++++|-
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 11222345678999999999999999 899998874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=332.30 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=198.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.+|+..++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 56778899999999999999765 68999999986543 33456799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.... ..++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986432 3567788899999999999999998 9999999999999999999999999998754322
Q ss_pred ccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||.................
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 290 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----------- 290 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----------
Confidence 11233578999999998743 2345689999999999999999999874332221111000000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
............++.+++.+||+.+|++||++.|+++|-.-.
T Consensus 291 -~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 291 -SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred -cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 000111223456788999999999999999999999985443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.72 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=196.9
Q ss_pred cCCcccccccCCCceeEEeeecc--CCceEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeeeee-----
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKL---QHRNLVRLLGCCIE----- 542 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 542 (795)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999763 46889999986532 22345677788887776 69999999998853
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999997 5787777432 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 701 (795)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||........ ..+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99865433 122345789999999999888999999999999999999999999876542211 11110000000000
Q ss_pred hh-------hccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AW-------ELIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~-------~~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ..+.+... .......+..+.+++.+||+.+|++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 00000000 01112244567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.19 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEeeecc----CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.+|++.+.||+|+||.||+|.++ .+..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 57889999999999999999653 35689999987653 23356789999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|++++... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999888532 346899999999999999999999998 99999999999999999999999998765322
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.... ......++..|+|||.+.+..++.++|||||||++||+++ |+.|+........ ..... ..
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~~~~----~~-------- 224 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IKAVE----DG-------- 224 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHH----CC--------
Confidence 2111 1112235678999999999999999999999999999775 9988864432211 10000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+...+..+.+++..|++.+|++||++.++++.|+..
T Consensus 225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00111223456788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.88 Aligned_cols=256 Identities=30% Similarity=0.450 Sum_probs=204.5
Q ss_pred cCCcccccccCCCceeEEeeeccC----CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|.++. ...||||++.... .....++.+|+.++++++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999997642 4579999987543 33456789999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999988542 247899999999999999999999988 99999999999999999999999999987652
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..|+........ .......+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~~~~----------- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IKAVEDGY----------- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--HHHHHcCC-----------
Confidence 221111122345678999999998899999999999999999998 8888753321111 00000000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+|++.+|++||++.|++++|+.+
T Consensus 226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=355.10 Aligned_cols=259 Identities=31% Similarity=0.487 Sum_probs=215.2
Q ss_pred cCCcccccccCCCceeEEeeecc--CCc----eEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--NGQ----EVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...+..+.||+|+||.||.|... .+. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45667789999999999999754 233 4899999775 5667889999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 548 LIYEYMPNKSLDIFLFDTP----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
+++|||++|+|..||++.. +...+...+.+.++.+||+|+.|||++. +|||||.++|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997652 2467889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccch
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
|+.+...++......-.-...|||||.+..+.++.|+|||||||++||++| |..|+...+..+.... ....+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-----~~~gg-- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-----VLEGG-- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-----HHhCC--
Confidence 996666655554444345578999999999999999999999999999998 5667665443222110 01111
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
+-+.+..++..+++|+..||+.+|++||++..+++.+..+.
T Consensus 922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 12345667888999999999999999999999999887763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.16 Aligned_cols=245 Identities=30% Similarity=0.427 Sum_probs=203.8
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCC
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
..++-||+|+.|.||+|+++ ++.||||+++.. -..+++-|++|+|||||.+.|+|.....++||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34568999999999999986 589999998632 2347888999999999999999999999999999999999
Q ss_pred cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccccee
Q 040413 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 637 (795)
|..+| +...++.......+..+||.|+.|||.+. |||||||.-||||..+-.|||+|||.++..... ..+-
T Consensus 199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 99998 35567888999999999999999999987 999999999999999999999999999876533 2333
Q ss_pred eecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHH
Q 040413 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL 717 (795)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
.+.||..|||||++...+.+.|+|||||||+|||||||..|+..-+ .. ...|..+. ..|.-..+..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd--ss------AIIwGVGs------NsL~LpvPst 335 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD--SS------AIIWGVGS------NSLHLPVPST 335 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc--hh------eeEEeccC------CcccccCccc
Confidence 5789999999999999999999999999999999999998874322 11 11121111 1222234556
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 718 ILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 718 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
++..+.-|+.+||+..|..||++++++.||+=...+
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 677888899999999999999999999999655433
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.84 Aligned_cols=254 Identities=23% Similarity=0.291 Sum_probs=199.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+++.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999764 7899999998653 2334567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999988843 356889999999999999999999998 999999999999999999999999999643210
Q ss_pred cc-------------c--------------------------------cceeeecccCCcCChhhhccCCCCccCCeeeh
Q 040413 631 EL-------------Q--------------------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSF 665 (795)
Q Consensus 631 ~~-------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~Dvwsl 665 (795)
.. . ......+||+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012469999999999998899999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCC---CCCHHH
Q 040413 666 GVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVD---RPTMFE 742 (795)
Q Consensus 666 G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~---RPt~~e 742 (795)
||++|||++|+.||..............+ . . .+.-........++.+++.+||+ +|.+ |+++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~---~--~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINW---R--E-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHcc---C--C-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999999998654432211100000 0 0 00000001134567889999998 6665 469999
Q ss_pred HHHHh
Q 040413 743 VVSML 747 (795)
Q Consensus 743 vl~~L 747 (795)
+++|.
T Consensus 302 ~l~hp 306 (377)
T cd05629 302 IKSHP 306 (377)
T ss_pred HhcCC
Confidence 99985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.23 Aligned_cols=251 Identities=30% Similarity=0.463 Sum_probs=202.6
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.+|++.+.||+|+||.||+|+.+++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999888889999988643 3345679999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999887532 235889999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcch-hhcccccccccccchhhccCccccc
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....++..|+|||.+....++.++|+||||+++|||++ |+.|+........ ..+.... . ...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------~---~~~----- 222 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------R---LYR----- 222 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC------C---CCC-----
Confidence 112235668999999988889999999999999999999 8888865432211 1111000 0 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.19 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=207.9
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 34568999998766666778999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCce
Q 040413 548 LIYEYMPNKSLDIFLFDTP----------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 617 (795)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999988875321 2245899999999999999999999998 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..|+......... ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~--~~---- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI--EC---- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HH----
Confidence 999999986543322222223345778999999998899999999999999999998 88887543321110 00
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
........ .+...+..+.+++.+|++.+|.+|||+.|+++.|+.+.
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 00000000 01123456889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=333.58 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=196.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----ceeE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEKI 547 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 547 (795)
+|++.++||+|+||.||+|... +++.||||++... ......++.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999765 7899999998753 223446788999999999999999999987643 3479
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+. ++|.+++. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 57777763 3346899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCcc-ccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc-------
Q 040413 628 GGDEL-QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL------- 696 (795)
Q Consensus 628 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~------- 696 (795)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+......
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 111233578999999999866 6789999999999999999999999865432111 000000000
Q ss_pred -ccccchhhc---cCccccchhh---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 697 -WKDDRAWEL---IDPILQNEAS---YLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 697 -~~~~~~~~~---id~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
......... +.+....... ...+..+.+++.+||+.+|++|||+.|+++|-
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 000000000 0000000000 11234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.00 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=197.6
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
+|+++++||+|+||.||+|+.. +++.+|+|++.+.. ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999765 68899999997542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999888743 346889999999999999999999998 9999999999999999999999999975331000
Q ss_pred ---------------------------------------------cccceeeecccCCcCChhhhccCCCCccCCeeehh
Q 040413 632 ---------------------------------------------LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFG 666 (795)
Q Consensus 632 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG 666 (795)
........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001234799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 040413 667 VLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT---MFEV 743 (795)
Q Consensus 667 ~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev 743 (795)
|++|||++|+.||..............+ ...+..........++.+++.+++ .+|++|++ +.|+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINW------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcc------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999999754422111100000 000001111123445667777766 48999987 9998
Q ss_pred HHHh
Q 040413 744 VSML 747 (795)
Q Consensus 744 l~~L 747 (795)
++|-
T Consensus 303 ~~hp 306 (382)
T cd05625 303 KAHP 306 (382)
T ss_pred hcCC
Confidence 8873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=348.96 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=207.7
Q ss_pred HHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-- 544 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 544 (795)
+.....+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++..++|+|++++.+.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445579999999999999999999754 7899999998654 3345567889999999999999999988765432
Q ss_pred ------eeEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCce
Q 040413 545 ------EKILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 545 ------~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 617 (795)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 367999999999999888543 23457899999999999999999999998 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
|+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~--~~~---- 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM--HKT---- 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHH----
Confidence 99999998765433223334567999999999999999999999999999999999999998654321110 000
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.... .+ ..+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 258 ~~~~----~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGR----YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCC----CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000 00 1122345678899999999999999999999886
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.85 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=197.2
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHH---HhcCCCceeeeeeeeeecceeEEE
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLI---AKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
|++.++||+|+||.||+|... +++.||||++.+.. ....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667899999999999999765 68999999997542 23456677777665 456799999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|...+. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987763 346899999999999999999999998 99999999999999999999999999875322
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........... . .... .
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~--i----~~~~------~- 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS--I----VNDE------V- 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH--H----HhCC------C-
Confidence 11 222346799999999999999999999999999999999999999875442221100 0 0000 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
..+...+..+.+++.+||+.||.+|| ++.+++++.
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 01122345678999999999999999 688888864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.16 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=206.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.+|++.++||+|+||.||+|..+ .++.+|+|++... ....+++.+|++++++++||||+++++++.+....++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999765 5889999998753 344678999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999888543 2346899999999999999999999998 999999999999999999999999999876543221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+..... . ......
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~------~---------~~~~~~ 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------L---------EKGYRM 224 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------H---------HCCCCC
Confidence 1112234668999999998999999999999999999998 8888765432211100 0 000011
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11222346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.73 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=197.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999765 68899999997542 234467889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999988843 356899999999999999999999998 999999999999999999999999998754321
Q ss_pred cc---------------------------------ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCC
Q 040413 631 EL---------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 631 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~ 677 (795)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 000123579999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 040413 678 NTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQ--EDAVDRPTMFEVVSM 746 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 746 (795)
||.............. +... . .+.+ ......++.+++.+++. .++..||+++|+++|
T Consensus 235 Pf~~~~~~~~~~~i~~---~~~~-~--~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVMN---WKET-L--IFPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHHc---CcCc-c--cCCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9975442221110000 0000 0 0000 01123455667766443 334457999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=338.37 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=199.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+|++.++||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999765 68999999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999998843 346889999999999999999999998 999999999999999999999999998533100
Q ss_pred cc-----------------------------------------ccceeeecccCCcCChhhhccCCCCccCCeeehhHHH
Q 040413 631 EL-----------------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669 (795)
Q Consensus 631 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll 669 (795)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001134799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 040413 670 LETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRP---TMFEVVSM 746 (795)
Q Consensus 670 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 746 (795)
|||++|+.||..............+ .. .+...........+.+++.+|+ .+|.+|+ ++.|+++|
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~---~~---------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINW---ET---------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhcc---Cc---------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999765432211110000 00 0000001122345667788766 4999999 99999998
Q ss_pred h
Q 040413 747 L 747 (795)
Q Consensus 747 L 747 (795)
-
T Consensus 302 ~ 302 (376)
T cd05598 302 P 302 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.17 Aligned_cols=257 Identities=29% Similarity=0.425 Sum_probs=203.4
Q ss_pred cCCcccccccCCCceeEEeeec-----cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.++||+|+||.||+|.. ..++.+|+|.+... ..+..+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999974 24678999998753 33445779999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC
Q 040413 549 IYEYMPNKSLDIFLFDTP--------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~ 614 (795)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999988874221 1235788999999999999999999998 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccc
Q 040413 615 NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 615 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986543322222233446778999999988889999999999999999998 8888754332111110000
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
... ...+...+.++.+++.+|++.+|++||++.+|+++|..
T Consensus 242 ------~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 ------RQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------CCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000 00111234568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.42 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=197.1
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+++++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 7899999999754 2334567788999999999999999999999999999999999999
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9987773 33568999999999999999999997 67 9999999999999999999999999987532221 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....+.......... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~----------------~~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------------IRFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC----------------CCCC
Confidence 234579999999999999999999999999999999999999986544322111100000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 716 YLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
.....++.+++.+||+.||++|+ ++.++++|.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 22345678999999999999996 999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.84 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=207.1
Q ss_pred hccCCcccccccCCCceeEEeeecc------CCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
..++|++.+.||+|+||.||++... ....+|+|++... ......++.+|+.+++++ +||||+++++++.+..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467899999999999999999754 2367999998754 233456788999999999 7999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDT-------------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++||||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999998887532 23456899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654332222222345678999999988899999999999999999998 8888764332221110
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. ... .....+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus 247 ~------~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 L------KEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H------HcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0 000 00111223355788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.47 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=197.0
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
++||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999775 78899999886543 34457799999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceee
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.. ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 988843 2346889999999999999999999998 99999999999999999999999999876543221111111
Q ss_pred ecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHH
Q 040413 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL 717 (795)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
...+..|+|||.+..+.++.++||||||+++|||++ |..|+........... +........+..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA---------------IEQGVRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH---------------HHcCCCCCCccc
Confidence 223457999999998899999999999999999998 7777754332111000 000001111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 718 ILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 718 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.+..+.+++.+|++.+|++||++.+++++|.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3557889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.44 Aligned_cols=255 Identities=23% Similarity=0.270 Sum_probs=202.9
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.++||+|+||.||+|+.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999765 6889999998653 22344568899999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988742 35788999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccceeeecccCCcCChhhhccC----CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
.... .......||+.|+|||.+... .++.++|||||||++|||++|+.||.......... .. ....
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~i---~~~~---- 263 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--KI---MDHK---- 263 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH--HH---HcCC----
Confidence 3221 112235799999999988653 47899999999999999999999987544221110 00 0000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSML 747 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 747 (795)
..+.-......+..+.+++.+||+.+|.+ ||++.|+++|-
T Consensus 264 ---~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 264 ---NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ---CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00000111123567889999999999988 99999999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=333.89 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=198.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..+|++.++||+|+||.||++.+. +++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 468999999999999999999764 78899999753 24578999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 85 567666632 346889999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCC-c-------chhhcccccc-----ccc-
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-D-------SLTLLGRAWD-----LWK- 698 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~-------~~~~~~~~~~-----~~~- 698 (795)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... . ....+..... ...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122345799999999999999999999999999999999999987643211 0 0000000000 000
Q ss_pred c-cchhhcc---------Ccccc--chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 699 D-DRAWELI---------DPILQ--NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 699 ~-~~~~~~i---------d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
. ....... .+... .......+.++.+++.+||+.||++|||+.|+++|-.-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0 0000000 00000 00112345678899999999999999999999987543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=332.68 Aligned_cols=256 Identities=22% Similarity=0.270 Sum_probs=201.6
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...++|++.++||+|+||.||+|+.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 6889999998652 2233456889999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999988832 35889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccC----CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
..... .......||+.|+|||.+... .++.++|||||||++|||++|+.||.......... . ......
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~--~---i~~~~~-- 264 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS--K---IMDHKN-- 264 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH--H---HHhCCc--
Confidence 43221 122345799999999998653 37899999999999999999999997544211110 0 000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSML 747 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 747 (795)
.+.-......+..+.+++..|++.++.+ ||++.|+++|-
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 0000111223556778899999866654 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=320.27 Aligned_cols=264 Identities=30% Similarity=0.441 Sum_probs=205.5
Q ss_pred ccCCcccccccCCCceeEEeeeccC-----------------CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN-----------------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVR 535 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 535 (795)
..+|++.++||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3679999999999999999987542 2458999987653 345678999999999999999999
Q ss_pred eeeeeeecceeEEEEeecCCCCcceeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCc
Q 040413 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTP--------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 536 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~N 607 (795)
+++++..++..++|+|++++++|.+++.... ....+++..+..++.|++.||+|||+++ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999998885432 1236899999999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh--CCCCCCCCCCc
Q 040413 608 ILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTD 685 (795)
Q Consensus 608 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt--g~~p~~~~~~~ 685 (795)
|+++.++.++|+|||+++...............+++.|+|||.+....++.++|||||||++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986544333233334456788999999988889999999999999999998 55555432211
Q ss_pred chhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 686 SLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ........+..... ......+...+.++.+++.+|++.+|++|||+.||+++|+
T Consensus 241 ~--~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q--VIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H--HHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11111111111000 0001112223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.50 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=198.2
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|+||+||++... +++.+|+|++.+.. ....+.+..|+.++++++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999765 78899999987532 22346678899999999999999999999999999999999999999
Q ss_pred ceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccccee
Q 040413 559 DIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637 (795)
Q Consensus 559 ~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 637 (795)
..++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8776432 23456899999999999999999999998 99999999999999999999999999986543322 223
Q ss_pred eecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHH
Q 040413 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL 717 (795)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ...+... ...+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----------~~~~~~~--~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----------QRILNDS--VTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----------HhhcccC--CCCccc
Confidence 3578999999999999999999999999999999999999986543211100000 0000000 011223
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 718 ILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 718 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
.+..+.+++.+||+.+|++|| +++++++|-
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 456788999999999999999 788888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.57 Aligned_cols=252 Identities=29% Similarity=0.420 Sum_probs=202.9
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.+.||+|+||.||+|+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999988777789999987533 345779999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999888542 236899999999999999999999998 9999999999999999999999999988654332211
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....++..|+|||.+....++.++||||||+++|+|++ |+.|+........... . .... ...
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~--~----~~~~---------~~~ 221 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK--V----SQGL---------RLY 221 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH--H----hcCC---------CCC
Confidence 112235678999999988889999999999999999998 8888764432211110 0 0000 000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.32 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=201.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc----eEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ----EVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.++||+|+||.||+|.+. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999753 333 48999987543 34567899999999999999999999998764 5679
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|+||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999998888542 345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+............. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~------~~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KG------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh------CC-------
Confidence 4322222222334678999999999999999999999999999997 898886543222111000 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+......+.+++.+|++.+|++||++.+++.+|...
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00001112234678899999999999999999999998766
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.20 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=203.9
Q ss_pred CCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
+|++.+.||+|+||.||+|... ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 23578999887543 2345679999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccC---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCc
Q 040413 549 IYEYMPNKSLDIFLFDT---------------------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~---------------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~N 607 (795)
|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999998876432 12246889999999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcc
Q 040413 608 ILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDS 686 (795)
Q Consensus 608 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~ 686 (795)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+.....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543222112222345678999999988889999999999999999998 888886443222
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.... +........+...+.++.+++.+|++.+|++||++.|+++.|+..
T Consensus 238 ~~~~---------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFNL---------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHH---------------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1110 011011111223345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.02 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=201.8
Q ss_pred CcccccccCCCceeEEeeeccC----CceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce-----
Q 040413 477 FSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
|++.+.||+|+||.||+|.+.. +..+|||+++.. .....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997642 367999998754 23345689999999999999999999998876554
Q ss_pred -eEEEEeecCCCCcceeeccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecc
Q 040413 546 -KILIYEYMPNKSLDIFLFDTP---KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 546 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 621 (795)
.++|+||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999988875432 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccccc
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|+++...............++..|+|||.+....++.++|||||||++|||++ |..|+........ .... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~--~~~~----~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI--YDYL----RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----HcC
Confidence 99987643332222222345678999999988899999999999999999999 7787754332111 1100 000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. ...+...+.++.+++.+|++.+|++||++.|++++|+.+
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011223456789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.63 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=213.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.-|.+.+.||+|.|++|-+|++- +|.+||||++.+. +......+.+|++.|+.++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45888899999999999999875 8999999999876 34456779999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE-cCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DFGla~~~~~~ 630 (795)
+-.+|+|.+||- +....+.++.+.+++.||+.|+.|+|+.. +|||||||+||.+ ..-|.+||.|||++..+..+
T Consensus 98 LGD~GDl~DyIm--KHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIM--KHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHH--hhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999984 34567999999999999999999999988 9999999999976 46799999999999877655
Q ss_pred ccccceeeecccCCcCChhhhccCCCC-ccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
+ ...+.+|+..|-|||++.+..|+ +++||||||||||.|++|++||..-++.+. +..++|-.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDCK 235 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDCK 235 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhccc
Confidence 4 23457999999999999998887 678999999999999999999975543221 11122322
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
-..+.....++.+||..||..||.+|.+.+||+..-+-
T Consensus 236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 23456677889999999999999999999999987543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.75 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=200.1
Q ss_pred CCcccccccCCCceeEEeeecc----CCceEEEEEeccc----CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ----SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
+|++.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999652 5789999998653 223456788999999999 599999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999888743 356899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhh
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 704 (795)
+..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ...+... ..
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~------- 224 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--IL------- 224 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--Hh-------
Confidence 543221 122345799999999998764 47899999999999999999999986443211 1111000 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
..++. .+...+..+.+++.+||+.||++|| +++++++|-
T Consensus 225 ~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 225 KCDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred cCCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 01111 1122345678999999999999999 788998874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=327.96 Aligned_cols=264 Identities=22% Similarity=0.284 Sum_probs=205.4
Q ss_pred CCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcC-C-----CceeeeeeeeeecceeEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-H-----RNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 548 (795)
+|++++.||+|.||.|.+|.+ ++++.||||+++.. +.-..+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 899999999999999999965 57999999999753 445677788999999997 4 389999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC--CCceeeccccccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMAKM 626 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DFGla~~ 626 (795)
|+|.+ ..+|.+++... +...++...++.++.||+.||.+||+.+ |||+|||||||||.+- ..+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99988 45788888554 4456999999999999999999999998 9999999999999754 4699999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccc-------------
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGR------------- 692 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~------------- 692 (795)
.....+ .+..+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.++ ..+..
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 553322 56788999999999999999999999999999999999888876653221 11111
Q ss_pred --ccccccc-cc------hhh------------c----cCcc--------ccchhhHHHHHHHHHHHHHhcccCCCCCCC
Q 040413 693 --AWDLWKD-DR------AWE------------L----IDPI--------LQNEASYLILNRYINVALLCVQEDAVDRPT 739 (795)
Q Consensus 693 --~~~~~~~-~~------~~~------------~----id~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 739 (795)
...++.. .. ..+ . .+.. +...........+++++.+||+.||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0111111 00 000 0 0000 000111134556899999999999999999
Q ss_pred HHHHHHHhhcc
Q 040413 740 MFEVVSMLTNE 750 (795)
Q Consensus 740 ~~evl~~L~~~ 750 (795)
+.++++|-.-.
T Consensus 496 p~qal~Hpfl~ 506 (586)
T KOG0667|consen 496 PAQALNHPFLT 506 (586)
T ss_pred HHHHhcCcccc
Confidence 99999985443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.86 Aligned_cols=257 Identities=29% Similarity=0.402 Sum_probs=203.1
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.+|++.++||+|+||.||+|... .++.||||++...... ..+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45778899999999999999753 2578999999754332 3467899999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC
Q 040413 548 LIYEYMPNKSLDIFLFDT-------------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~ 614 (795)
+++||+++++|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999998887421 12245888999999999999999999998 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccc
Q 040413 615 NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 615 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++ |..|+........ ....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~i 239 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--IEMI 239 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH
Confidence 999999999886543332222233456789999999988889999999999999999998 7777654332111 1000
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
. +.. ....+...+..+.+++..|++.+|++||++.+|++.|+.
T Consensus 240 ----~--------~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 ----R--------NRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----H--------cCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 000 011122345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.96 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=196.8
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|+.+ +++.||||++.+. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 5789999998754 233456678899999876 799999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|...+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99987774 3346889999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . .. . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~-----~-~~---~-------~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL-----H-DD---V-------LYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH-----c-CC---C-------CCC
Confidence 234578999999999999999999999999999999999999997554322111000 0 00 0 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHh
Q 040413 716 YLILNRYINVALLCVQEDAVDRP-------TMFEVVSML 747 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~L 747 (795)
.....++.+++.+||+.+|++|| ++.++++|-
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 12345678999999999999999 899998874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.55 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=203.1
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|++|.||+|.+. .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999764 35678999886543 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---Cceee
Q 040413 547 ILIYEYMPNKSLDIFLFDTP----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKIS 619 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~ 619 (795)
++||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999998875432 1236899999999999999999999998 99999999999998755 58999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||............ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~------~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------H
Confidence 9999987643322222222334568999999999999999999999999999997 88888654322211100 0
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ......+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus 236 ~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 G---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0001112233567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.89 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=198.6
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCC-ceeeeeeeeeecceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHR-NLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 550 (795)
+|++.+.||+|+||.||+|+.+ +++.||||++.+. .....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999765 5789999999753 234456788999999999765 5888999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888743 346889999999999999999999998 999999999999999999999999998753221
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~--i~------------~~~- 217 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS--IM------------EHN- 217 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HH------------cCC-
Confidence 1 123346799999999999999999999999999999999999999875442221110 00 000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTM-----FEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 746 (795)
...+...+.++.+++.+||+.+|.+|++. .++++|
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112234567899999999999999976 677766
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.49 Aligned_cols=271 Identities=27% Similarity=0.398 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEeeec-----cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 547 (795)
.+|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999963 2578999999987666667889999999999999999999998754 34678
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988432 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcccc-ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc-cccccchhhc
Q 040413 628 GGDELQS-KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD-LWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 705 (795)
....... ......++..|+|||.+.+..++.++||||||++++||++|..+................. ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 1111223446999999998899999999999999999999876653322111110000000 0000000011
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+........+...+..+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.19 Aligned_cols=242 Identities=27% Similarity=0.339 Sum_probs=192.8
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 6788999998753 223445566777777654 899999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999887743 346899999999999999999999998 9999999999999999999999999997643222 22
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+....... . ... . ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~--i----~~~------~----~~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS--I----LND------R----PHFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH--H----HcC------C----CCCC
Confidence 2345799999999999998999999999999999999999999875442221110 0 000 0 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMF-EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 746 (795)
.....++.+++.+||+.+|++||++. ++++|
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 22345678999999999999999875 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.37 Aligned_cols=250 Identities=34% Similarity=0.541 Sum_probs=193.9
Q ss_pred ccccccCCCceeEEeeecc-----CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 479 TENKLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+.+.||+|.||.||+|.+. .+..|+||+++.. ..+..+.+.+|++.+++++||||+++++++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999765 3578999999654 334578999999999999999999999999988889999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++|+|++++... ....+++..+..|+.||++||+|||+++ ++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 3456899999999999999999999998 99999999999999999999999999987633322
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
............|+|||.+....++.++||||||+++|||++ |+.|+........ .... ... ..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~--~~~~----~~~---------~~ 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI--IEKL----KQG---------QR 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH--HHHH----HTT---------EE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc----ccc---------cc
Confidence 222223456788999999999999999999999999999999 6777654322111 1000 000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...+...+..+.+++..||..+|++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111222456688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.57 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=201.6
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.+|++.+.||+|+||.||+|..+++..+|+|++.+.. ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4588899999999999999988777889999986532 234678899999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999888532 236899999999999999999999998 9999999999999999999999999998654322111
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+.......... .. .......
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~-------------~~~~~~~ 221 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE--SV-------------SAGYRLY 221 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HH-------------HcCCcCC
Confidence 111223457999999998899999999999999999999 788876433211110 00 0000001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+...+..+.+++.+|++.+|++|||+.|++++|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122455788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=326.39 Aligned_cols=248 Identities=21% Similarity=0.319 Sum_probs=195.3
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|+.+ +++.+|+|++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999764 233456688899988877 799999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99987763 3356899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc---hhhcccccccccccchhhccCccccc
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS---LTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~--~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCC--C
Confidence 234579999999999999999999999999999999999999986322111 00000000000 0000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPT------MFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 746 (795)
..+......+.+++.+||+.||++||+ +.++++|
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 122234456789999999999999998 5788777
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.80 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=195.8
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|+.+ +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 6889999998753 234456778888888877 699999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999887743 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+........ ..... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~~----------~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDEV----------VYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcCCC----------CCC
Confidence 23457999999999999999999999999999999999999999755422211100 00000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTM------FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 746 (795)
.....++.+++.+||+.||++||++ +++++|
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1234567899999999999999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.14 Aligned_cols=271 Identities=27% Similarity=0.397 Sum_probs=202.7
Q ss_pred cCCcccccccCCCceeEEeeec-----cCCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--cee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
..|++.++||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999963 357889999987543 34457899999999999999999999998875 567
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988432 235899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
+..... ........++..|+|||.+.+..++.++||||||+++|||++++.|...........................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643221 1112234567789999999888899999999999999999998765432111000000000000000000000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+........+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000111223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.20 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=200.9
Q ss_pred cCCcccccccCCCceeEEeeeccC---------------CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN---------------GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
.+|++.++||+|+||.||+++... ...||+|+++.. .....+.+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999987532 234899998764 3334567999999999999999999999
Q ss_pred eeeecceeEEEEeecCCCCcceeeccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEE
Q 040413 539 CCIELEEKILIYEYMPNKSLDIFLFDTP---------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 539 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIl 609 (795)
++...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999988874321 1134788999999999999999999998 999999999999
Q ss_pred EcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhC--CCCCCCCCCcch
Q 040413 610 LDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSS--KRNTDFSNTDSL 687 (795)
Q Consensus 610 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg--~~p~~~~~~~~~ 687 (795)
++.++.+||+|||++................++..|+|||.+..+.++.++||||||+++++|+++ ..|+........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765433222222233457789999999888999999999999999999984 445543322111
Q ss_pred hhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.......+.... .......+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 242 --~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 --IENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111000000000 00000111123457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=315.59 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=198.3
Q ss_pred CcccccccCCCceeEEeeeccC-Cc--eEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------ce
Q 040413 477 FSTENKLGEGGFGPVYKGRLHN-GQ--EVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------EE 545 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 545 (795)
|.+.++||+|+||.||+|+... ++ .+|+|.++.. .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998653 33 5899988654 344567899999999999999999999987542 24
Q ss_pred eEEEEeecCCCCcceeeccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 546 KILIYEYMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.++|+||+++++|..++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998876422 22345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+++...............+++.|+|||.+....++.++||||||+++|||++ |+.|+........ ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~----~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI--YDY----LRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH----HHcCC
Confidence 9987653332212222346778999999999999999999999999999999 7888754332111 110 00110
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. ..+...+..+.+++.+||+.+|++|||+.+++++|+..
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=317.59 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|...++||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 356799999887766677889999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 549 IYEYMPNKSLDIFLFDTPK------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999888754321 135889999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchh-hccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLT-LLGRAW 694 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~-~~~~~~ 694 (795)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |++|+......... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-- 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ-- 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc--
Confidence 9999999976543322222223345788999999998899999999999999999998 88887543321111 0000
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.. ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 240 -----~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 -----GR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----Cc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 00111123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.90 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=208.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+|++.++||+|+||.||+|+.. +++.+|||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999765 7899999987642 2334567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||+++++|..++.... ....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988775432 3456889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......+++.|+|||.+.+..++.++|+||||++++||++|+.|+.............. ....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~-------- 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCD-------- 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCC--------
Confidence 321 12234688899999999888899999999999999999999999854332211111110 0000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.........+..+.+++.+|++.+|++||++.+|++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00111223456788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=324.50 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=198.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 550 (795)
+|++.+.||+|+||.||+|+.. +++.+|||++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999765 67899999987542 23345677788888877 5899999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999877743 346889999999999999999999998 999999999999999999999999999754322
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~--~i~------------~~~- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ--SIM------------EHN- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH--HHH------------hCC-
Confidence 1 12234579999999999999999999999999999999999999997544222111 000 000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTM-----FEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 746 (795)
...+.....++.+++.+||+.+|++|++. .++++|
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01122345578899999999999999974 677665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.74 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=203.0
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.+|++.++||+|+||.||+|.. .+++.+|+|++........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5799999999999999999976 478899999997655555677899999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 99999888743 346899999999999999999999998 9999999999999999999999999998654221
Q ss_pred cceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.......+++.|+|||.+. ...++.++|+|||||++|||++|+.|+........... ....... .+..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~--------~~~~ 231 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MSKSNFQ--------PPKL 231 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-eecCCCC--------CCCC
Confidence 1122356889999999874 35578899999999999999999998753321111000 0000000 0111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. ....+..+.+++.+||+.+|++||++++++++|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 112345788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.63 Aligned_cols=254 Identities=26% Similarity=0.313 Sum_probs=213.5
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 547 (795)
....|++.+.||+|.||.||+++.+ +|+.+|+|++.+... ...+.+.+|+.+|++++ |||||.+++.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467999999999999999999876 599999999987543 34578999999999998 999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC----CCCceeecccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDFGM 623 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DFGl 623 (795)
+|||++.||.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999998888554 3999999999999999999999998 999999999999963 35799999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+..... .......+||+.|+|||.+....|+..+||||+|+++|.|++|.+||...............+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------
Confidence 998765 2345668999999999999999999999999999999999999999987664333221111000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
....+.-..+...+.+++..++..||.+|+|+.++++|.+
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1112222334567889999999999999999999999854
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=325.22 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=196.3
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|++. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999765 6889999999764 233456688999999998 699999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99987773 3356999999999999999999999998 9999999999999999999999999987422111 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc---hhhcccccccccccchhhccCccccc
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS---LTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... .......... ......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQI-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCC--
Confidence 234679999999999999999999999999999999999999996432111 0000000000 000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPT------MFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 746 (795)
..+...+..+.+++.+||+.||.+||+ +.++++|
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 112223456889999999999999987 7888877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.26 Aligned_cols=253 Identities=26% Similarity=0.315 Sum_probs=203.4
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999764 68999999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998877532 2346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. .....|++.|+|||.+.+..++.++||||+||++|||++|+.||.......... . ....+.. ..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~---------~~~~~~~-~~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--E---------VERRVKE-DQ 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--H---------HHHHhhh-cc
Confidence 1 123478999999999998899999999999999999999999987543211100 0 0000000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
...+...+..+.+++.+|++.||++|| ++.++++|-
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 112233556788999999999999999 888998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=317.83 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=207.3
Q ss_pred hccCCcccccccCCCceeEEeeeccC-----CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeee-cce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHN-----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEE 545 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 545 (795)
..++|++.+.||+|+||.||+|.+.. ++.|++|++... .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34688999999999999999998764 688999988754 33446778999999999999999999998776 467
Q ss_pred eEEEEeecCCCCcceeeccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKE-----SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
.++++||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999888543222 56899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||+++.+.............++..|+|||.+....++.++||||||+++||+++ |+.|+........ .... ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM--AAYL----KD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH--HHHH----Hc
Confidence 999986643332222222345778999999988889999999999999999999 9988864332111 1100 00
Q ss_pred cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
+. . .......+..+.+++.+|++.+|++|||+.++++.|+.+.
T Consensus 235 ~~-----~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GY-----R----LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC-----C----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 0 0011123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.04 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=217.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
....+.++||+|-||.|.+.+...+..||||+++.... ....+|.+|+++|.+|+||||++++++|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45677899999999999999998889999999987644 44588999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++....... +..+....|+.||+.|++||.+.+ +|||||.++|+|++.++++||+|||+++-+...++.
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999996553333 455667789999999999999988 999999999999999999999999999977777776
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh--CCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
....+.+-..+|||+|.+.-+.++.++|||+||+.+||+++ ...|+....+++. +.....+...... ...
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~------~~~ 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGR------QVV 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCc------cee
Confidence 66677788899999999999999999999999999999875 5556554332221 2222222221111 111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
-..+.-++..+++++.+|+..+-++||+++++..+|...
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 223445677889999999999999999999999998764
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.93 Aligned_cols=254 Identities=30% Similarity=0.439 Sum_probs=205.0
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|..++++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++ ..+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 36789999999999999999998888999999987543 3457899999999999999999999986 456789999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999998887543 3456899999999999999999999998 999999999999999999999999999876532221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. .....++..|+|||.+....++.++||||||+++|||++ |+.|+.......... .. . .....
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--~~----~---------~~~~~ 222 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ--NL----E---------RGYRM 222 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH--HH----H---------cCCCC
Confidence 1 122345678999999998889999999999999999999 998886543222111 00 0 00000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=329.94 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=202.8
Q ss_pred HHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
+....++|++.+.||+|+||.||+++++ +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445589999999999999999999876 6889999998653 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999988742 35788999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccC----CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
....... .......||+.|+|||++... .++.++|||||||++|||++|+.||...+...... .. .....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~i---~~~~~ 264 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--KI---MNHKN 264 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH--HH---HcCCC
Confidence 7643221 122345799999999998653 37899999999999999999999997544211110 00 00000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhh
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSMLT 748 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 748 (795)
.+.-......+..+.+++.+||+.++.+ ||++.|+++|..
T Consensus 265 -------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 265 -------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred -------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0000111234556788999999855443 789999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=323.67 Aligned_cols=242 Identities=27% Similarity=0.335 Sum_probs=193.5
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|+++ +++.||+|++++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 68899999997542 23456677888888765 899999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999887743 356889999999999999999999998 9999999999999999999999999987432111 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||............. . ..+. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~------~------~~~~----~~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR------V------DTPH----YP 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------h------CCCC----CC
Confidence 334679999999999999999999999999999999999999986543221111000 0 0011 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-HHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTM-FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~-~evl~~ 746 (795)
.....++.+++.+||+.||++||++ .++++|
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1234567899999999999999998 467655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.12 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=205.3
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|..+ .+..+|+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357889999999999999999764 24689999987543 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 547 ILIYEYMPNKSLDIFLFDTP-------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999998885432 1235788999999999999999999988 9999999999999999999999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........... . .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--~----~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF--V----I 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH--H----h
Confidence 9999986544332222233456789999999988889999999999999999998 8888764332221110 0 0
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.... ...+...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 0111123567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.56 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=203.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.++||+|+||.||+|.+.+...||+|++.... ...+.+.+|+.++++++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5799999999999999999988776789999997533 34567999999999999999999999875 456799999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||.++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999888542 2345789999999999999999999998 999999999999999999999999999866433221
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||...+..++.++||||||+++|+|++ |..|+.......... .. ... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~--~~----~~~---------~~~~ 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--QV----ERG---------YRMP 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH--HH----hcC---------CCCC
Confidence 1122346678999999988899999999999999999999 777775433221110 00 000 0001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1233456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.43 Aligned_cols=242 Identities=24% Similarity=0.292 Sum_probs=191.3
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHH-HHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.||||++.+.. .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999775 78999999997532 223344555554 56789999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999887743 456889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .. +.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~i------------~~~~~--~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD--NI------------LNKPL--RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH--HH------------HcCCC--CCC
Confidence 234579999999999999999999999999999999999999986543221110 00 00000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTM----FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 746 (795)
...+..+.+++.+||+.+|.+||++ .|++++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1235568899999999999999988 466654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=316.55 Aligned_cols=255 Identities=21% Similarity=0.324 Sum_probs=201.0
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|.+ .+++.+|+|++... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999975 47889999998654 233456799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|+.+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986542 4678899999999999999999998 999999999999999999999999999765432
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............. .......++....
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-------QLLQCIVDEDPPV 219 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-------HHHHHHhccCCCC
Confidence 1223578999999999998899999999999999999999999986432111100000 0000000000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
........++.+++.+|++.+|++||+++|++++..-.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 01112345688999999999999999999999985443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.52 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=202.7
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 57899999999999999999888888999999876432 4567999999999999999999999875 456889999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999988543 2345889999999999999999999998 999999999999999999999999999875433211
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+....++.++|+||||+++|+|++ |..|+........ ..... ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~-------------~~~~~~ 223 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV--LEQVE-------------RGYRMP 223 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHH-------------cCCCCC
Confidence 1112345668999999988889999999999999999999 8888754332111 11100 000011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.08 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=204.1
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++.|++.+.||+|.|+.||+..+ .+|+.+|+|++... .....+++.+|++|-+.|+||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788999999999999999954 58999999987532 3457889999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeecccccccc
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAKMF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGla~~~ 627 (795)
|+|.|+.|-.-|. ++-.+++..+-..++||++||.|+|.++ |||||+||+|+++.. ..-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999998843332 2245778888999999999999999999 999999999999953 345899999999987
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......|||+|||||++...+|+..+|||+-||+||-|+.|.+||-..+...+.....+-.+-...+.+
T Consensus 164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w---- 236 (355)
T KOG0033|consen 164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW---- 236 (355)
T ss_pred CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc----
Confidence 6332 334568999999999999999999999999999999999999999764433322111111110111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+.++..+++++||..||.+|.|+.|.+.|-+
T Consensus 237 --------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 237 --------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred --------CcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 123456778999999999999999999998754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.74 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=194.9
Q ss_pred ccccCCCceeEEeeec----cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 481 NKLGEGGFGPVYKGRL----HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++||+|+||.||+++. .+++.+|+|++.+.. ......+.+|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 357899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++. +...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988873 3356899999999999999999999998 9999999999999999999999999997654321 1
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......|++.|+|||.+....++.++|||||||++|||++|+.||.......... ... ... ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~--~i~------------~~~--~~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT--MIL------------KAK--LGM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH--HHH------------cCC--CCC
Confidence 2234578999999999998889999999999999999999999987543211110 000 000 011
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPT-----MFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 746 (795)
+...+..+.+++.+||+.||++||+ +.+++++
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 2223456789999999999999999 5556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.08 Aligned_cols=246 Identities=29% Similarity=0.417 Sum_probs=195.3
Q ss_pred cccCCCceeEEeeec---cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 482 KLGEGGFGPVYKGRL---HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+||+|+||.||+|.+ ++++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999964 357889999986543 334678999999999999999999999875 45678999999999
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc-c
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS-K 635 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~ 635 (795)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99988842 346899999999999999999999998 9999999999999999999999999998764332111 1
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....++..|+|||.+....++.++|+|||||++|||++ |+.|+........... ++.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---------------i~~~~~~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---------------IESGERMEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHCCCCCCC
Confidence 112234578999999988889999999999999999998 8988865432211110 000000111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
+...+.++.+++.+|++.+|++||++.+|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.48 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=196.5
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|+++ +++.||||++.+. .....+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999775 5789999999754 234456778899999888 699999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999877743 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||............. ... ...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--------------~~~--~~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--------------EDE--VRYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--------------cCC--CCCC
Confidence 233578999999999999999999999999999999999999986544222111000 000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTM-----FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 746 (795)
...+..+.+++.+||+.||.+||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2234568899999999999999999 999886
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.35 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=210.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 7899999988643 2334678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||+++++|..++... .....+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887543 23456899999999999999999999998 99999999999999999999999999886543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.............. ... .
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~--------~ 224 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EKC--------D 224 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhh----hcC--------C
Confidence 221 12234688899999999888899999999999999999999999854332211111100 000 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.........+..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00111123456788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=318.23 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=204.1
Q ss_pred hccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
..++|++.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999999643 24579999886543 2234568899999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 546 KILIYEYMPNKSLDIFLFDTP-------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
.++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999985421 1245677888999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..|+.....+..... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~------~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------H
Confidence 99999986543332222222345678999999999999999999999999999998 6777754332211100 0
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..... ...+...+..+.+++.+|++.+|++|||+.++++.|+..
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00000 001112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.81 Aligned_cols=242 Identities=26% Similarity=0.335 Sum_probs=193.9
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|++. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999997642 23445677788888764 899999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999888743 346889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ...+. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~------------~~~~~----~~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR------------MDNPC----YP 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hCCCC----CC
Confidence 234679999999999999899999999999999999999999986543221110000 00011 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMF-EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 746 (795)
.....++.+++.+||+.+|++||++. ++.+|
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 12345678999999999999999997 77664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.24 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=201.6
Q ss_pred cCCcccccccCCCceeEEeeecc-----------------CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-----------------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
++|++.++||+|+||.||+++.. +...+|+|++... .....+.+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 2346899998754 33445789999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCCcceeeccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcE
Q 040413 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTP--------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNI 608 (795)
Q Consensus 537 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NI 608 (795)
++++...+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999988875431 1234778899999999999999999998 99999999999
Q ss_pred EEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh--CCCCCCCCCCcc
Q 040413 609 LLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS--SKRNTDFSNTDS 686 (795)
Q Consensus 609 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt--g~~p~~~~~~~~ 686 (795)
+++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222223345678999999888889999999999999999998 556664332211
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ............. . .....+..++..+.+++.+|++.+|++||++.||++.|+
T Consensus 242 ~--~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V--IENTGEFFRDQGR-Q-----VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H--HHHHHHHHhhccc-c-----ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 1110000000000 0 000111223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.41 Aligned_cols=271 Identities=28% Similarity=0.413 Sum_probs=206.4
Q ss_pred cCCcccccccCCCceeEEeeecc-----CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeee--ccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 546 (795)
.+|++.+.||+|+||.||+|... .++.+|||++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999753 3678999999765443 56789999999999999999999999887 5578
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999988532 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+....++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 653221 1111123445679999999888999999999999999999999988754322111100000000000011111
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+........+...+.++.+++.+|++.+|++||++.||+++|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111223446788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=336.68 Aligned_cols=264 Identities=19% Similarity=0.260 Sum_probs=194.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec--------c
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--------E 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 544 (795)
..+|++.++||+|+||.||+|... +++.||||++.... ....+|+.+|+.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 468999999999999999999764 68899999885432 2356799999999999999999876432 2
Q ss_pred eeEEEEeecCCCCcceeecc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-Cceeeccc
Q 040413 545 EKILIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFG 622 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFG 622 (795)
.+++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35789999986 45544432 234467899999999999999999999998 99999999999998665 69999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDD 700 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~ 700 (795)
+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||....... ...+.........+
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 998664322 1223578999999998865 468999999999999999999999987544221 11111100000000
Q ss_pred ch-------h-----hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 701 RA-------W-----ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 701 ~~-------~-----~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.. . ..-...+....+...+.++.+++.+||+.+|.+|||+.|+++|-.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 00 0 000001111112223467899999999999999999999998854
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.96 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=204.3
Q ss_pred cCCcccccccCCCceeEEeeecc--------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
++|.+.++||+|+||.||+|... ..+.+|+|.+.... .....++.+|+.+++++ +||||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999642 23569999997542 34456788999999999 7999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++||||+++++|.+++.... ....+++.++..++.||+.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999998885432 1235889999999999999999999988 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+.....+.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999976543222111222234568999999998889999999999999999998 7777754332211110
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. ... .....+...+..+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 255 ~------~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 255 L------KEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred H------HcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 0 000 00111223346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.66 Aligned_cols=250 Identities=35% Similarity=0.520 Sum_probs=203.9
Q ss_pred ccccCCCceeEEeeeccC----CceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|.... +..+|+|++...... ..+.+.+|++++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999997653 788999999765433 368899999999999999999999999999999999999999
Q ss_pred CCcceeeccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 556 KSLDIFLFDTPK------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 556 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
++|.+++..... ...+++..+..++.|+++||+|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367999999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
...........++..|+|||.+....++.++||||||+++|+|++ |..|+.......... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~----~~~-------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE--YL----RKG-------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HH----HcC--------
Confidence 332222334567889999999988889999999999999999999 588886543211110 00 000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.....+...+.++.+++.+|++.+|++||++.|++++|+
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.75 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=208.5
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+|++.+.||+|+||.||+|+. .+++.+|||.+... .....+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999975 47899999988653 2334567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||+++++|.+++... .....+++..++.++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887542 23456899999999999999999999998 99999999999999999999999999886643
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+......... ....+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~- 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QCDYP- 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh---------cCCCC-
Confidence 321 122346889999999998888999999999999999999999998643322111111100 00000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.......+..+.+++.+|++.+|++||||.+|+++++..
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011123456788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.50 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=205.5
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.+.||+|++|.||+|..+ +++.+++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999765 6899999998643 344567799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988643 2457899999999999999999999988 99999999999999999999999999986653321
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||++.+..++.++|+||||+++++|++|+.|+........ .... ... .. .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~----~~-----~ 219 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--ILKI----IRG----VF-----P 219 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----HcC----CC-----C
Confidence 12235688999999999999999999999999999999999999865442111 1000 000 00 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.26 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=201.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|.+.++||+|+||.||+|+.+ +++.+|+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999765 67889999987543 23345688999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 66666533 2345889999999999999999999998 99999999999999999999999999976433221
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccccccc--------ch
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDD--------RA 702 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~--------~~ 702 (795)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... ...+.......... ..
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 568899999999999999999999997654322 11111110000000 00
Q ss_pred hhccC-ccccc----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 703 WELID-PILQN----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 703 ~~~id-~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
....+ +.... ......+.++.+++.+||+.||.+|||+.|+++|-.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 00000 00000 0111235567899999999999999999999987543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.78 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=198.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-----eeE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-----EKI 547 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 547 (795)
+|++.++||+|+||.||+|... +++.||||++... .....+++.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999764 7899999998653 2234567899999999999999999999998776 789
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+|+||+.+ +|...+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 5655552 3456899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccc----
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDR---- 701 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~---- 701 (795)
...... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ..+...........
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 432211 1223467899999999876 4578999999999999999999999975542211 11100000000000
Q ss_pred ---hhhcc-C-----ccccc--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 ---AWELI-D-----PILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 ---~~~~i-d-----~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....+ . +.... ........++.+++.+||+.||++|||+.|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00000 0 00000 01112245688999999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.96 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=206.0
Q ss_pred hccCCcccccccCCCceeEEeeecc--------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
...+|++.+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467889999999999999999631 24579999987542 34457799999999999 89999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEE
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIl 609 (795)
....++||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999998885432 1245788899999999999999999998 999999999999
Q ss_pred EcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchh
Q 040413 610 LDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLT 688 (795)
Q Consensus 610 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~ 688 (795)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..|+.........
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999987654332222223345678999999988889999999999999999998 67776543321111
Q ss_pred hcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 689 LLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. ..... ....+...+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 250 ~~------~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 250 KL------LKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HH------HHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 10 00000 0011123456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.40 Aligned_cols=253 Identities=28% Similarity=0.375 Sum_probs=202.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.++||+|++|.||+|... +++++|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47889999999999999999764 68999999886432 1234578899999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999888743 346889999999999999999999998 9999999999999999999999999997654
Q ss_pred CCccccc-eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSK-TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~------------~~ 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF--KI------------AT 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH--HH------------hc
Confidence 3211111 123467889999999998889999999999999999999999985432211100 00 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.......+......+.+++.+|++.+|++|||+.|++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0001112223455688999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.42 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=201.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc--eEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ--EVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999765 333 4788888743 334456799999999999 799999999999999999999
Q ss_pred EeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 550 YEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
+||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999988885321 1235889999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||++...... ........+..|+|||.+....++.++|||||||++|||++ |+.||.......... .
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~--~--- 230 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE--K--- 230 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--H---
Confidence 99999998643211 01111123557999999988889999999999999999997 988886543221110 0
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
+........+...+..+.+++.+|++.+|.+||++.+++++|+....
T Consensus 231 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 ----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred ----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000011122234568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.74 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=199.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+|+.+ +++.||||++.+. .....+.+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 6899999999753 2334567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999998884 3356899999999999999999999998 999999999999999999999999998754321
Q ss_pred cc---------------------------------ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCC
Q 040413 631 EL---------------------------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 631 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~ 677 (795)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 000113479999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHHh
Q 040413 678 NTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRP---TMFEVVSML 747 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~L 747 (795)
||.............. +. ..+.-........++.+++.+++. +|.+|+ ++.|+++|-
T Consensus 235 Pf~~~~~~~~~~~i~~---~~---------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 235 PFCSETPQETYRKVMN---WK---------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCCCCHHHHHHHHHc---CC---------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 9975443221110000 00 000000001134567778888764 999998 478888873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.26 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=199.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc----eEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ----EVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.+.||+|+||.||+|... +++ ++++|.+.... .....++..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888999999999999999763 444 47888875432 234467888899999999999999999875 455789
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
++||+++++|.+++.. ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999998853 2346899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............++..|+|||.+.++.++.++||||||+++|||++ |+.|+........... ....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~------~~~~~~~--~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL------LEKGERL--AQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HHCCCcC--CC
Confidence 3322222233456788999999998899999999999999999998 8888865432211111 0000000 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+ ......+.+++.+|+..+|++|||+.|+++.|...
T Consensus 233 ~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 233 P-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 11234567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.86 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=206.2
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..+|++.+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46899999999999999999975 47899999999876656678899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++. ...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999998873 235789999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... . .... . +.+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~----~~~~-~-----~~~-- 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-I----ATNG-T-----PEL-- 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-H----hcCC-C-----CCC--
Confidence 12234688999999999988899999999999999999999999865432111100 0 0000 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+......+.+++.+|++.+|++||++.|++++-
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 11223445688999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.69 Aligned_cols=259 Identities=29% Similarity=0.394 Sum_probs=204.5
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|.+.++||+|+||.||+|... .+..+|||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357999999999999999999631 35579999987643 33456799999999999 79999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+++++|.+++... ....+++.++..++.||+.||+|||+++ |+|+||||+||+++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999888542 2234899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhh
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
...............++..|+|||.+....++.++|||||||++|||++ |..|+......... ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-~~------------- 255 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-YK------------- 255 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-HH-------------
Confidence 6543321112222346778999999999999999999999999999998 88887543321110 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.++.......+...+.++.+++.+|++.+|++||++.|+++.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000000011112345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.45 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=196.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 550 (795)
+|+..+.||+|+||.||+|+.+ +++.||||++.+. .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999765 6889999998753 2334566888999998886 577888999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988874 3346899999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~--~~i~------------~~~- 217 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF--QSIM------------EHN- 217 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH--HHHH------------hCC-
Confidence 1 1223356899999999999999999999999999999999999998754322111 0000 000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTM-----FEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 746 (795)
...+...+.++.+++.+||+.+|.+|++. .++.+|
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 01122234567899999999999999974 566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.48 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=203.0
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeeeeeccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 546 (795)
++|.+.++||+|+||.||+|++. .++.||||++.... ....+.+.+|+++|.++. ||||+++++++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46788899999999999999753 34689999997643 233457899999999997 99999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC------------------------------------------------------------
Q 040413 547 ILIYEYMPNKSLDIFLFDTP------------------------------------------------------------ 566 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 566 (795)
++|+||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999988875321
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 567 -----------------------------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 567 -----------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 1134677888999999999999999988 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............++..|+|||.+....++.++||||||++++||++ |+.|+..........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~- 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY- 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH-
Confidence 999999999999986532221111223456788999999998889999999999999999998 888875433211100
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. +........+...+..+.+++.+|++.+|++||++.||++.|+..
T Consensus 353 ~~-------------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 353 NA-------------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH-------------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 000000011222346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.48 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=195.4
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|+.. +++.+|+|++.+. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 6789999999764 233456688999999888 699999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99987773 3346999999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhhccCccccchh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~--~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EKP--IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hCC--CCC
Confidence 234679999999999999999999999999999999999999996432111 000000000000 000 011
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPT------MFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 746 (795)
+...+..+.+++.+||+.||++||+ +.++++|
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 2223456789999999999999998 5688776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=323.99 Aligned_cols=262 Identities=22% Similarity=0.231 Sum_probs=198.6
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-----
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE----- 544 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 544 (795)
..++|++.+.||+|+||.||++... +++.||||++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999765 6899999999653 3344567889999999999999999999886543
Q ss_pred -eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 545 -EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 545 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 579999999765 433331 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc-----
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK----- 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 698 (795)
++...... ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .........
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCcHH
Confidence 97643221 12335789999999999999999999999999999999999999975432110 000000000
Q ss_pred --------------------ccchhhccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 699 --------------------DDRAWELIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 699 --------------------~~~~~~~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.....+....... ..........+.+++.+||+.||++|||+.|+++|-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000000000000 0011123456889999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.46 Aligned_cols=242 Identities=23% Similarity=0.271 Sum_probs=190.6
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHH-HHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|... +++.+|+|++.+. .......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999764 7899999999754 2233445566655 46778999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99987773 3456899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..... ... ... .+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~--~~~----~~~--------~~--~~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY--DNI----LHK--------PL--VLR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH--HHH----HcC--------Cc--cCC
Confidence 23457999999999999999999999999999999999999998654322111 000 000 00 001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMF----EVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~----evl~~ 746 (795)
......+.+++.+|++.+|.+||++. ++++|
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 12345677899999999999999875 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.36 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEeeecc--------CCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
.+|++.++||+|+||.||+|+.. ....+|+|.+... .....+++.+|+.+++++ +||||+++++++.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 47899999999999999999642 1236899988753 234467899999999999 7999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++|+||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999998875421 2345888999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986543322212222334567999999999999999999999999999998 7777754432221110
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.... .....+...+..+.+++.+|++.+|++||++.|++++|+.+..
T Consensus 249 ------~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 249 ------LKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ------HHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 0000 0001112234568899999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.80 Aligned_cols=242 Identities=24% Similarity=0.283 Sum_probs=190.0
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHH-HHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|+.. +++.||+|++.+.. ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 68899999987532 222344555554 67889999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|...+. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99987763 3356889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...... .. +...+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i------------~~~~~--~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD--NI------------LHKPL--QLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH--HH------------hcCCC--CCC
Confidence 334578999999999998899999999999999999999999986543221110 00 00000 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTM----FEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 746 (795)
......+.+++.+||+.+|.+||++ .|++++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 2234568899999999999999875 355554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.89 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=203.0
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.++||+|+||.||+|... ++..+|+|++.... ....+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999753 46789999987643 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCc
Q 040413 547 ILIYEYMPNKSLDIFLFDTP-------------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~N 607 (795)
++|+||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999998885321 1235788999999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcc
Q 040413 608 ILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDS 686 (795)
Q Consensus 608 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~ 686 (795)
|+++.++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322112222345678999999988899999999999999999998 777764332111
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ... ....... ..+...+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 241 ~--~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 V--IYY----VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H--HHH----HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 000 0000000 011123467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.84 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=204.3
Q ss_pred cCCcccccccCCCceeEEeeecc--------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
.+|.+.++||+|+||.||+|+.. ....+|+|++.... ....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999642 24568999987542 34466789999999999 6999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++||||+++++|.+++.... ....+++.++..++.||+.||.|||+++ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999998885431 1245889999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..|+...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986543222111112234567999999998899999999999999999999 7877754332211110
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.. .... ...+...+..+.+++.+|++.+|++||++.|+++.|+....
T Consensus 249 ~~------~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 LR------EGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH------cCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 00 0000 01122234567899999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.78 Aligned_cols=248 Identities=30% Similarity=0.436 Sum_probs=199.2
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcc
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLD 559 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 559 (795)
++||+|+||.||+|.+.+++.||+|++...... ..+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999998766999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred eeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeee
Q 040413 560 IFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639 (795)
Q Consensus 560 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 639 (795)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 887432 346789999999999999999999998 999999999999999999999999999865432222111222
Q ss_pred cccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.++..|+|||.+.++.++.++|+||||+++|||++ |..|+........... +........+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---------------IESGYRMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---------------HhcCCCCCCCccC
Confidence 34667999999988899999999999999999999 7777754332111100 0000001112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 719 LNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+..+.+++.+|++.+|.+||++.|+++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 557889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.56 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=201.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCc----eEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQ----EVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|++.++||+|+||.||+|... +++ .||+|++... .....+.+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357889999999999999999753 444 4899998754 33345678999999999999999999999875 4578
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999998888532 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............++..|+|||...+..++.++|||||||++|||++ |..|+............ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------~~~------ 227 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL------EKG------ 227 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------HCC------
Confidence 53322111112234678999999988899999999999999999998 88887543321111000 000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 228 ---ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 00011122345678999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.73 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=204.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||++.+. +++.+|+|.+... .....+++.+|++++.+++||||+++++.+.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999765 6788999988654 233456788999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++.. ...+++..+..++.||++||.|||+ .+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999998843 3568899999999999999999997 46 999999999999999999999999998754322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-cccccccccc-----------
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWKD----------- 699 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~----------- 699 (795)
......++..|+|||.+.+..++.++|+||||+++++|++|+.|+...+...... ..........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1233578899999999988889999999999999999999999986443222111 0000000000
Q ss_pred ------cchhhccCccccch----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 700 ------DRAWELIDPILQNE----ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 700 ------~~~~~~id~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
....+..+...... .......++.+++.+||+.+|++||++.+++++..-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000000000 001134568899999999999999999999998644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.59 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=195.3
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeeeee-----cc
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKL---QHRNLVRLLGCCIE-----LE 544 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 544 (795)
+|++.+.||+|+||.||+|+++ +++.||+|.+.... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999765 68999999987542 22234567788877776 69999999998864 34
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++||||+++ +|..++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 676666432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccch-
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRA- 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~- 702 (795)
+...... ......+|..|+|||.+.+..++.++|||||||++|+|++|++||........ ..+............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8764322 12234688999999999988999999999999999999999999865432111 110000000000000
Q ss_pred ------hhccCccc---cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 ------WELIDPIL---QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ------~~~id~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....+.. ...........+.+++.+||+.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 011112345667899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.25 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=193.6
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|+||.||+++.+ +++.+|+|++.... ......+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999765 68999999986532 22334567799999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceee
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 638 (795)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8777433 3345889999999999999999999998 9999999999999999999999999998654322 1223
Q ss_pred ecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+........... .... .+...... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~-~~~~---------~~~~~~~~-~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE-LKRR---------TLEDEVKF-EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH-HHHH---------hhcccccc-ccccC
Confidence 5689999999999988899999999999999999999999864332111000 0000 00000000 01123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 719 LNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.++.+++.+||+.+|++||++.|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 55688999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.59 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=198.3
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcc
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLD 559 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 559 (795)
++||+|+||.||+|...+++.+|+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999888889999999876532 33457899999999999999999999999999999999999999998
Q ss_pred eeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeee
Q 040413 560 IFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI 639 (795)
Q Consensus 560 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 639 (795)
+++... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 887432 345789999999999999999999998 999999999999999999999999999764432211 11122
Q ss_pred cccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.++..|+|||.+....++.++||||||+++|+|++ |..|+.......... .... . .....+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~--~~~~----~---------~~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE--QVEK----G---------YRMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHHc----C---------CCCCCCCCC
Confidence 34678999999998889999999999999999998 888886443221110 0000 0 000112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 719 LNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.46 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=201.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CC---ceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NG---QEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..|++.+.||+|+||.||+|... ++ ..||||++... .....++|.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788899999999999999865 23 36999998764 344567899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|++++... ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999888532 346889999999999999999999998 99999999999999999999999999876543
Q ss_pred Cccccceee-e--cccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 630 DELQSKTKR-I--VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
......... . ..+..|+|||.+....++.++|||||||++|||++ |..|+........ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--~~~i~~---------- 226 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INAIEQ---------- 226 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--HHHHHc----------
Confidence 221111111 1 12457999999998999999999999999999886 8888754332111 100000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
......+...+..+.+++.+|++.+|++||++.+++++|+..
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ---DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000011123345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.35 Aligned_cols=259 Identities=29% Similarity=0.390 Sum_probs=199.7
Q ss_pred cCCcccccccCCCceeEEeeec------cCCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeec-ce
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL-EE 545 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 545 (795)
++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++ +||||+++++++.+. ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999963 357889999997543 23456788999999999 689999999988654 45
Q ss_pred eEEEEeecCCCCcceeeccCC-----------------------------------------------------------
Q 040413 546 KILIYEYMPNKSLDIFLFDTP----------------------------------------------------------- 566 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 566 (795)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999988774321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecc
Q 040413 567 -----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641 (795)
Q Consensus 567 -----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 641 (795)
....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0134788889999999999999999998 99999999999999999999999999986533222122222345
Q ss_pred cCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHH
Q 040413 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILN 720 (795)
Q Consensus 642 t~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~ 720 (795)
+..|+|||.+.+..++.++||||||+++|+|++ |..|+........ .... ...... ...+...+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~----~~~~~~---------~~~~~~~~~ 309 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRR----LKEGTR---------MRAPDYTTP 309 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHH----HhccCC---------CCCCCCCCH
Confidence 678999999988899999999999999999997 8888754322111 0000 000000 001111234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 721 RYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 721 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
++.+++..|++.+|++||++.||+++|+.+
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.98 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=202.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|++.++||+|+||.||+|+.. +++.+|+|+++.........+.+|+.+++.++||||+++++.+.+.+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57889999999999999999764 68899999987665555677899999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999988743 346899999999999999999999998 9999999999999999999999999987654221
Q ss_pred cceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.......|+..|+|||.+. ...++.++|+|||||++|+|++|+.|+........... ....... .+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-~~~~~~~--------~~~~ 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQ--------PPKL 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-hhccCCC--------CCcc
Confidence 1223457899999999874 45688999999999999999999998754332111100 0000000 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ....+..+.+++.+|++.+|++||++.++++|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 01123467899999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.16 Aligned_cols=255 Identities=32% Similarity=0.478 Sum_probs=206.6
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46899999999999999999988878899999987543 34578999999999999999999999999989999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999988543 2346899999999999999999999998 999999999999999999999999999876532211
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. .....++..|+|||.+.+..++.++|+||||+++++|++ |+.|+........ ........ ..
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~~~-------------~~ 223 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV--LEQVERGY-------------RM 223 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC-------------CC
Confidence 1 112234578999999998889999999999999999998 8888754332111 11100000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+.++.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.03 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=200.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc--eEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ--EVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|.++ ++. .+|+|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999764 444 4688877643 234556789999999999 899999999999999999999
Q ss_pred EeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 550 YEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
|||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999998885431 1236889999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++..... .......++..|+|||.+....++.++|||||||+++||++ |..||.......... ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~-- 236 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--KL-- 236 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH--HH--
Confidence 99999998643211 11111234667999999988889999999999999999998 998886443222111 00
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
... .....+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 237 --~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 --PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 00001112345678999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.19 Aligned_cols=265 Identities=27% Similarity=0.354 Sum_probs=199.8
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.++||+|++|.||+|..+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999765 68999999986532 23456789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
++ ++|.+++........+++..+..++.||++||+|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 577777654444467899999999999999999999998 9999999999999999999999999997654221
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-cccc-----cccccccc----
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRA-----WDLWKDDR---- 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~-----~~~~~~~~---- 701 (795)
.......+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+.......... .... ...+....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11122356889999998865 457899999999999999999999986543211100 0000 00000000
Q ss_pred hhhccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....++.... .......+.++.+++.+||+.||++|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00111235567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.76 Aligned_cols=256 Identities=21% Similarity=0.271 Sum_probs=198.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 6899999998752 2234566889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999988843 2346889999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.......... .. ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--~i---~~~~~~~~- 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--KI---MNHKEHFQ- 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH--HH---HcCCCccc-
Confidence 211 1122468999999999863 457889999999999999999999986543211100 00 00000000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAV--DRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~L 747 (795)
+.+ .....+..+.+++.+|+..+++ .||++.++++|-
T Consensus 229 ~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 000 0112345677888887765444 488999999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.73 Aligned_cols=238 Identities=25% Similarity=0.278 Sum_probs=187.7
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHH-HHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEI-KLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|+.. +++.+|+|++.+.. ......+.+|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 67889999987532 12233444444 456778999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+.+..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999888743 346788899999999999999999998 9999999999999999999999999997542221 12
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~------------~~~~--~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY--DNIL------------NKPL--QLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH--HHHH------------hCCc--CCC
Confidence 33467999999999999999999999999999999999999998654322111 0000 0000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMFE 742 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~e 742 (795)
...+..+.+++.+||+.+|.+||++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 223456789999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.56 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=207.1
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
...+|++.++||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 347899999999999999999976 4789999999977655566788999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 97 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998873 245789999999999999999999998 9999999999999999999999999997654332
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+........ .... . +.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-----~~~~-~-----~~-- 234 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNG-T-----PE-- 234 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----ccCC-C-----CC--
Confidence 1 122346889999999999888999999999999999999999998654321111100 0000 0 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...+...+..+.+++.+|++.+|++||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 011223445678999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.08 Aligned_cols=270 Identities=20% Similarity=0.261 Sum_probs=196.8
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCC------Cceeeeeeee
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH------RNLVRLLGCC 540 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 540 (795)
..+.....+|++.++||+|+||.||+|.+. .++.||||+++... .....+..|+.++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 334455689999999999999999999765 67889999996432 234556778888888765 4588899888
Q ss_pred eec-ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCC----
Q 040413 541 IEL-EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDM---- 614 (795)
Q Consensus 541 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~---- 614 (795)
... ...++|||++ +++|.+++. +...+++..+..|+.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 764 4678999987 566766663 23568999999999999999999997 47 99999999999998765
Q ss_pred ------------CceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCC
Q 040413 615 ------------NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS 682 (795)
Q Consensus 615 ------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~ 682 (795)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 223468999999999999999999999999999999999999999765
Q ss_pred CCcc-hhhccccccc----cc----ccchhhccC------cccc---------c--hhhHHHHHHHHHHHHHhcccCCCC
Q 040413 683 NTDS-LTLLGRAWDL----WK----DDRAWELID------PILQ---------N--EASYLILNRYINVALLCVQEDAVD 736 (795)
Q Consensus 683 ~~~~-~~~~~~~~~~----~~----~~~~~~~id------~~l~---------~--~~~~~~~~~l~~li~~cl~~dP~~ 736 (795)
+... ...+...... +. ......+++ +... . .........+++||.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 4221 1111110000 00 000000000 0000 0 000112345789999999999999
Q ss_pred CCCHHHHHHHhhcc
Q 040413 737 RPTMFEVVSMLTNE 750 (795)
Q Consensus 737 RPt~~evl~~L~~~ 750 (795)
|||+.|+++|-.-.
T Consensus 429 R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 429 RLNARQMTTHPYVL 442 (467)
T ss_pred CCCHHHHhcCcccc
Confidence 99999999985444
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=306.01 Aligned_cols=253 Identities=30% Similarity=0.433 Sum_probs=202.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|.+.++||+|++|.||+|..+.+..+|+|++.... ...+.+.+|+.++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999988777789999886533 34577899999999999999999998875 456789999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999888543 2345889999999999999999999998 999999999999999999999999999866433221
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||...+..++.++||||||+++|+|++ |+.|+........ ........ ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~~~-------------~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--LEQVERGY-------------RMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC-------------CCC
Confidence 1112345678999999988889999999999999999999 8888764332111 11100000 001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.10 Aligned_cols=264 Identities=22% Similarity=0.253 Sum_probs=198.4
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL----- 543 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 543 (795)
...++|++.+.||+|+||.||++... .++.+|||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999765 6889999999754 233456788999999999999999999988643
Q ss_pred -ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 544 -EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 544 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
...++||||++++ |.+.+. ..+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 3569999999764 444432 24788999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc-------
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW------- 694 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~------- 694 (795)
+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998654322 12235789999999999998999999999999999999999999875431110 0000000
Q ss_pred ---------cccccc------chhhcc-Cccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 ---------DLWKDD------RAWELI-DPIL--QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 ---------~~~~~~------~~~~~i-d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...... ...... +... ...........+.+++.+||+.||++|||+.|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000 000000 0000 0011122345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.97 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=203.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CC---ceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NG---QEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.+|+..++||+|+||.||+|.++ ++ ..+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999865 33 36999998754 234467799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|++++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999988843 2356899999999999999999999998 99999999999999999999999999976543
Q ss_pred Cccccce-eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 630 DELQSKT-KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....... .....+..|+|||.+....++.++|||||||++|||++ |+.|+........... . ...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~--i----~~~------- 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA--I----NDG------- 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH--H----hcC-------
Confidence 2211111 11223457999999988889999999999999999997 9999864432211110 0 000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.........+..+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011122345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=306.39 Aligned_cols=250 Identities=29% Similarity=0.400 Sum_probs=204.4
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357889999999999999999865 78999999976543 5678999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999988543 2236899999999999999999999998 99999999999999999999999999986532211
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
....+..|+|||.+....++.++||||||+++++|++ |+.|+......... ...... ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~~~-------------~~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--PHVEKG-------------YRM 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHhcC-------------CCC
Confidence 2234667999999988889999999999999999997 88887544322111 000000 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+|++.+|++||++.|++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1112235678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=342.77 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=203.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|... +++.||||++.... +...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999765 68999999997542 233567999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 551 EYMPNKSLDIFLFDT--------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 551 E~~~~gsL~~~l~~~--------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
||+++++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999998887532 11234567788999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc----------------ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc
Q 040413 623 MAKMFGGDEL----------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686 (795)
Q Consensus 623 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~ 686 (795)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 001123569999999999999999999999999999999999999986533211
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhcc
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRP-TMFEVVSMLTNE 750 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 750 (795)
..... ...++.. .......+..+.+++.+|++.+|++|| +++++++.|+..
T Consensus 239 i~~~~------------~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYRD------------VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhh------------hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11000 0000000 001123445678999999999999996 677777777665
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=327.78 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=200.5
Q ss_pred ccCCcccccccCCCceeEEeeecc---CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..+|++.++||+|+||.||++... .++.||+|.+... +...+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999643 4678999988643 34578999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|++. ++|.+++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 4666666 23457899999999999999999999998 999999999999999999999999999866543
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccc-------cccc-
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLW-------KDDR- 701 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~-------~~~~- 701 (795)
..........||+.|+|||++....++.++|||||||++|||++|+.||....... ...+....... ....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333334679999999999999999999999999999999999999986543211 00000000000 0000
Q ss_pred --hhhc---cCccccch--hh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 702 --AWEL---IDPILQNE--AS-----YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 702 --~~~~---id~~l~~~--~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+. ........ .+ .....++.+++.+||+.+|++||++.|++.|-.-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0000 00000000 00 1123467889999999999999999999998533
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=311.38 Aligned_cols=252 Identities=27% Similarity=0.352 Sum_probs=201.4
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.|+..++||+|+||.||++... +++.+|+|.+.+.. ....+.+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999765 78999999987542 2234567889999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999998887432 2345899999999999999999999998 9999999999999999999999999987654222
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .... . .++. .
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~---------~~~~-~ 220 (285)
T cd05630 157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---R---------LVKE-V 220 (285)
T ss_pred ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---h---------hhhh-h
Confidence 11234789999999999999999999999999999999999999865332110 0000 0 0000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 747 (795)
....+.....++.+++.+||+.+|++||| +.|+++|-
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 01112223456789999999999999999 89998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.59 Aligned_cols=263 Identities=22% Similarity=0.240 Sum_probs=198.1
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
..++|++.++||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999765 6889999999753 233456788999999999999999999987543
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++||||+++ +|...+. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 4544442 24788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccc-----
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLW----- 697 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~----- 697 (795)
++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+... ...+.......
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654322 1223578999999999999999999999999999999999999997544211 10000000000
Q ss_pred -----------cc-----cc-hhhccCccc---cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 -----------KD-----DR-AWELIDPIL---QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 -----------~~-----~~-~~~~id~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. .. ..+.....+ ...........+.+++.+||+.||.+|||+.|+++|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 00 000000000 0001112245678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.89 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=197.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+++.+ +++.+|+|++.+. .....+.+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999875 5788999998642 2233455889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999988532 346899999999999999999999998 999999999999999999999999999764322
Q ss_pred ccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||......... .... .......
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~--~~i~---~~~~~~~- 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIM---NHKERFQ- 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH--HHHh---CCCcccc-
Confidence 21 1222357999999999886 346889999999999999999999998754321111 0000 0000000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 746 (795)
+. ......+..+.+++.+|+..++.+ |+++.|+++|
T Consensus 229 ~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 001123456788899988665444 7899999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.35 Aligned_cols=256 Identities=19% Similarity=0.234 Sum_probs=199.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+++.+ +++.||+|++.+. .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 6788999998653 2233456888999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999988532 346889999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
... ......||+.|+|||++.+ +.++.++|||||||++|+|++|+.||.......... .. ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~--~i---~~~~~~~~- 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--KI---MNHEERFQ- 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH--HH---HcCCCccc-
Confidence 211 1223569999999998865 567899999999999999999999986543211110 00 00000000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 747 (795)
+.+. ....+.++.+++.+|+..++.+ |++++++++|.
T Consensus 229 ~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 229 FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 0000 1123456888999999876554 57899999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.94 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=205.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|++.++||+|+||.||+|... +++.+|+|.+..... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 67899999999999999999876 478999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999988743 2357899999999999999999999998 99999999999999999999999999987653321
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++||||||+++++|++|+.|+.............. ...+. ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~~--~~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-----------KPPPT--LS 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc-----------CCCCC--CC
Confidence 12234578899999999988999999999999999999999999875432211110000 00000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+|++.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122345678899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=305.09 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=194.5
Q ss_pred cccCCCceeEEeeecc---CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCC
Q 040413 482 KLGEGGFGPVYKGRLH---NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
.||+|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999653 35579999987653 334567999999999999999999999875 457899999999999
Q ss_pred cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc-ce
Q 040413 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS-KT 636 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~ 636 (795)
|.+++.. ....+++..+.+++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988843 2356899999999999999999999998 9999999999999999999999999998654332111 11
Q ss_pred eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
....++..|+|||.+....++.++||||||+++|||++ |..|+........... +........+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---------------~~~~~~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF---------------IEQGKRLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---------------HHCCCCCCCC
Confidence 11223578999999988889999999999999999996 8988864432211100 0000001112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+..+.+++.+|++.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23356788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=304.44 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=202.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788899999999999999765 6899999998643 3345678899999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998877432 3446889999999999999999999998 99999999999999999999999999976543221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+....... . ..... ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--~----~~~~~---------~~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK--V----CQGSY---------KP 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH--H----hcCCC---------CC
Confidence 12235688999999999988899999999999999999999999865432111100 0 00000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+...+..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=306.82 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=201.3
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc---------cHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ---------GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999764 6789999988654221 23568899999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999988843 356889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 626 MFGGDELQ----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 626 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
........ .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~-------- 224 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IFKI-------- 224 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HHHH--------
Confidence 76532111 111234588899999999988899999999999999999999999865332111 0000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..... ...+...+..+.+++.+||+.+|.+||++.|++++
T Consensus 225 -~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 -GENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -hccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00001 11222345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=328.75 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=196.3
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
...+|.+.++||+|+||.||+|.+. .++.||||... ...+.+|+++|++++|+|||++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999999999775 57899999643 2346789999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
++. ++|..++.. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 567666632 2346999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccc-------h-hhcccccc---cccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDS-------L-TLLGRAWD---LWKD 699 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~-------~-~~~~~~~~---~~~~ 699 (795)
.........||+.|+|||++.+..++.++|||||||++|||++|..++.... ... . ..+..... .+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2222234579999999999999999999999999999999999886543211 100 0 00100000 0000
Q ss_pred c---chhhcc--------Cccccch---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 700 D---RAWELI--------DPILQNE---ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 700 ~---~~~~~i--------d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
. +..... .+..... ........+.+|+.+||+.||.+|||+.|+++|-
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 0 000000 0000000 0001234678999999999999999999999873
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=321.33 Aligned_cols=266 Identities=23% Similarity=0.270 Sum_probs=198.2
Q ss_pred HHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec---
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--- 543 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 543 (795)
+....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3345688999999999999999999764 68899999987542 23346688999999999999999999987543
Q ss_pred ---ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 544 ---EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 544 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468999987 778877662 346899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccc-
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLW- 697 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~- 697 (795)
||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ..........
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999865432 223578999999999876 5789999999999999999999999865432111 0000000000
Q ss_pred -------cccchhhccCcc--ccc-h---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 698 -------KDDRAWELIDPI--LQN-E---ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 698 -------~~~~~~~~id~~--l~~-~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
........+... ... . ........+.+++.+||+.||++|||+.|+++|-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000000000000 000 0 00011234679999999999999999999998843
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.26 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=187.9
Q ss_pred cccccCCCceeEEeeecc---CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeEEEEeecC
Q 040413 480 ENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILIYEYMP 554 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 554 (795)
.++||+|+||.||+|+.+ +++.+|+|++.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999754 46789999986532 23567899999999999999999998864 456789999986
Q ss_pred CCCcceeeccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE----cCCCCceeeccccc
Q 040413 555 NKSLDIFLFDT------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMA 624 (795)
Q Consensus 555 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFGla 624 (795)
+ +|..++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 555544221 12346899999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-------hcccccc
Q 040413 625 KMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-------LLGRAWD 695 (795)
Q Consensus 625 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-------~~~~~~~ 695 (795)
+.+..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||.....+... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 87653321 122234578999999999876 46899999999999999999999998654321110 0000000
Q ss_pred cccc--cchh----------hccCcccc---------c---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 696 LWKD--DRAW----------ELIDPILQ---------N---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 696 ~~~~--~~~~----------~~id~~l~---------~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.... ...+ ..+..... . .........+.+++.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000 00000000 0 0000112357899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.19 Aligned_cols=249 Identities=30% Similarity=0.406 Sum_probs=199.3
Q ss_pred ccccCCCceeEEeeeccC--C--ceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLHN--G--QEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|++|.||+|.+.. + ..+|||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999997642 3 3689999987655 567789999999999999999999999988 889999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc-cc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL-QS 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~ 634 (795)
++|.+++..... ..+++..+..++.|+++||+|||+++ ++|+||||+||+++.++.+||+|||+++.+..... ..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999988865432 56899999999999999999999998 99999999999999999999999999987643221 11
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+....++.++|||||||+++||++ |+.|+........... ... ... .. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--~~~---~~~-------~~--~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK--IDK---EGE-------RL--E 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHh---cCC-------cC--C
Confidence 1122456788999999998899999999999999999998 9998864332211100 000 000 00 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.73 Aligned_cols=240 Identities=22% Similarity=0.347 Sum_probs=189.3
Q ss_pred ccccCCCceeEEeeeccC-------------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 481 NKLGEGGFGPVYKGRLHN-------------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
+.||+|+||.||+|.... ...+|+|.+..........+.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997432 2358999887665556678899999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC-------ceeec
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-------PKISD 620 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~-------~kl~D 620 (795)
+||||+++++|+.++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999887743 2356899999999999999999999998 999999999999987664 89999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhc-cCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
||++...... ....++..|+|||.+. ...++.++|||||||++|||++ |+.|+........... ..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------~~ 223 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF------YE 223 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH------Hh
Confidence 9998754321 2245788999999886 4678999999999999999984 7766653321111100 00
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ..... ......+.+++.+||+.||++||++.+++++|+
T Consensus 224 ~--~~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 G--QCMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c--CccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00000 011346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.46 Aligned_cols=250 Identities=33% Similarity=0.506 Sum_probs=200.3
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCcccH--HHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGL--EEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
|++.++||+|+||.||++... +++.+|+|++........ ....+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999776 567899999987644332 23456999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++. ....+++..+..++.||++||.+||+++ |+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999998885 3467899999999999999999999998 99999999999999999999999999976421 12
Q ss_pred cceeeecccCCcCChhhhc-cCCCCccCCeeehhHHHHHHHhCCCCCCCCCC-cchhhcccccccccccchhhccCcccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......++..|+|||.+. ...++.++||||||+++++|++|..|+..... ......... ....+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------~~~~~~ 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI------------LKRPLP 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH------------HHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc------------cccccc
Confidence 2333467899999999998 78899999999999999999999999875421 111111000 000000
Q ss_pred ch--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NE--ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ........+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000112678999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.61 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=204.5
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|....+..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4689999999999999999998777788999988753 2345789999999999999999999999887 7789999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999888543 2356888999999999999999999988 999999999999999999999999999865433221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+....++.++|+||||+++|+|++ |+.|+.......... . ...... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~--~----~~~~~~---------~ 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR--A----LERGYR---------M 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH--H----HhCCCC---------C
Confidence 1122345678999999998889999999999999999999 888886543222110 0 000000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.92 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=203.1
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++.+.+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3678889999999999999775 578899999977666667889999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999887643 2356899999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred ceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 635 KTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
......++..|+|||.+. ...++.++|||||||++|+|++|++|+........... .. . .. .+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~----~-~~-----~~~ 227 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-IA----K-SE-----PPT 227 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH-Hh----h-cC-----CCC
Confidence 223356899999999873 35578899999999999999999999864332111000 00 0 00 000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
+ ..+...+..+.+++.+|++.+|++||++.+++++-.-
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 0 0112234578899999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.46 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=192.8
Q ss_pred ccccCCCceeEEeeecc---CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||+|... .+..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999754 34679999987643 233457889999999999999999999999999999999999999
Q ss_pred CcceeeccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 557 SLDIFLFDTP--KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 557 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9998886432 2235677788899999999999999998 9999999999999999999999999997544332222
Q ss_pred ceeeecccCCcCChhhhccC-------CCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 635 KTKRIVGTYGYMSPEYAQQG-------LFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
......++..|+|||++... .++.++|+||||+++|||++ |+.|+............. ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~------~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV------REQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh------hcccCCCC
Confidence 22334578889999988542 35789999999999999996 998986544222111100 00011111
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
++.+.. .....+.+++..|+ .+|++|||+.||+..|+
T Consensus 232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122111 12345778999998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.26 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=203.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+.|++.++||+|+||.||+|+.. +++.+|+|++........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67999999999999999999775 58899999998776667788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998776432 346899999999999999999999988 9999999999999999999999999987543221
Q ss_pred cceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 634 SKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.......+++.|+|||.+. ...++.++|||||||++|+|++|+.|+........... . .... .+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--~----~~~~-----~~ 233 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--I----AKSE-----PP 233 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH--H----hcCC-----Cc
Confidence 1123356889999999874 34578899999999999999999998854332111000 0 0000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. ..+.....++.+++.+|++.+|++||++.+++++-
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 01122345688999999999999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.08 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=199.1
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeee-ecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI-ELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~ 553 (795)
.+|++.+.||+|+||.||++..+ ++.+|+|.++.. ...+.+.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57889999999999999999765 778999998643 34567999999999999999999999765 456789999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999887543 2345889999999999999999999998 9999999999999999999999999987543221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
....++..|+|||.+....++.++|||||||++|+|++ |+.|+........... . ..+ ...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~--~----~~~---------~~~ 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--V----EKG---------YKM 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--H----hcC---------CCC
Confidence 12344568999999998889999999999999999998 8888764332111100 0 000 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+|++.+|++|||+.+++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112335568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=316.61 Aligned_cols=258 Identities=24% Similarity=0.301 Sum_probs=204.8
Q ss_pred HHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecc--cCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeeccee
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEK 546 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 546 (795)
|......|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|++|+..|.+|+ |.+||+|++|=..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3455678999999999999999999988888999997653 36677888999999999995 99999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
|+|||+= ..+|..+|... ...++.-.++.+..|++.|+.++|++| |||.||||.|+|+ -.|.+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 9999974 55788887543 223333378899999999999999999 9999999999998 568999999999998
Q ss_pred cCCCccccceeeecccCCcCChhhhccC-----------CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG-----------LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 695 (795)
+..+...-.....+||+.||+||.+... ..+.++||||||||||+|+.|++||.......
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--------- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--------- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH---------
Confidence 8776655555668999999999987432 25688999999999999999999986321100
Q ss_pred cccccchhhccCccccchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 696 LWKDDRAWELIDPILQNEASYL-ILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.....+.+|.-.-+++.. ...++++++..||+.||.+||+..|+|+|-
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 112223344322222211 112289999999999999999999999974
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=308.95 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=200.0
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec------
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 543 (795)
.+...|++.++||+|+||.||+|... +++.+|+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 34577899999999999999999765 68899999986543 4456789999999998 699999999998753
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999888542 3356889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
+....... .......|++.|+|||++. ...++.++|||||||++|||++|+.|+........... . ..
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--~---~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--I---PR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--H---hc
Confidence 98654321 1223457899999999885 34688899999999999999999999854321111100 0 00
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. .+.+ .....+..+.+++.+||+.+|.+|||+.++++|
T Consensus 231 -~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 -NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0000 111234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.11 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=205.9
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.+|++.++||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5799999999999999999975 478999999997665556778999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|..++. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 9999998873 235899999999999999999999998 99999999999999999999999999886543321
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......... . ... +.+ .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-----~-~~~-----~~~--~ 236 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----T-NGT-----PEL--Q 236 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----h-cCC-----ccc--C
Confidence 1223468899999999998889999999999999999999999986544221110000 0 000 000 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+...+..+.+++.+||+.+|++||++.+++++=
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 1122345678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=306.26 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=201.7
Q ss_pred CCcccccccCCCceeEEeeeccCCceEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
+|++.+.||+|+||.||+|...+++.+|+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999988788999999886432 22345689999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999998843 246889999999999999999999988 99999999999999999999999999876432
Q ss_pred Cc----cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 630 DE----LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. .........++..|+|||.+.+..++.++||||||+++++|++|+.|+............. ... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----~~~----~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-----AHR----G 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-----hcc----C
Confidence 11 1112223568899999999998889999999999999999999999986433111100000 000 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+ ..+...+..+.+++.+||+.+|++||++.|++++
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 001 1122345667899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=307.08 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=202.5
Q ss_pred cCCcccccccCCCceeEEeeecc-C---CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-N---GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.+|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999764 2 3369999987542 33456799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++... ...+++.++..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999888432 346889999999999999999999998 99999999999999999999999999987653
Q ss_pred Ccccc-ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcch-hhcccccccccccchhhcc
Q 040413 630 DELQS-KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 706 (795)
..... ......++..|+|||.+.+..++.++|+||||+++||+++ |+.|+........ ...... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~--------- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG---Y--------- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---C---------
Confidence 32111 1111223567999999998889999999999999999886 9988764332111 111100 0
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+|++.+|++||++.++++.|...
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011122345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.53 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=206.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|++.++||+|+||.||+|... +++.+|+|++........+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999765 67889999998766667788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ...+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 999999887432 256899999999999999999999998 9999999999999999999999999997654321
Q ss_pred cceeeecccCCcCChhhhccC---CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQG---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.......++..|+|||.+... .++.++|+||||+++++|++|+.|+.............. .. .-.+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~------~~---~~~~~~ 226 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK------SN---FPPPKL 226 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------cc---CCCccc
Confidence 112235688899999998776 889999999999999999999999864432111110000 00 000011
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+.++.+++.+|++.+|.+|||+.+++.|
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.78 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=204.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.+.||.|++|.||+|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999765 68899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999988743 27899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+...+...... .. . ....+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~--~~----~-----~~~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF--LI----P-----KNNPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--Hh----h-----hcCCCCCcc
Confidence 12223568889999999998889999999999999999999999986443211100 00 0 000111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
. ..+..+.+++.+||+.+|++||++++++++-
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 0 1455688999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=291.28 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=201.9
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-----c---ccHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-----G---QGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE 542 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 542 (795)
.-..|.-.+.||.|..++|-+..++ +++++|+|++.... + .-.+.-.+|+.||+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777789999999999988654 78999999986431 1 2245567899999998 59999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
+.-.++|+|.|+.|.|-++|. ..-.+++++...|++|+.+|+.|||.++ |+||||||+|||++++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999984 3456899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhcc------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 696 (795)
+|..+..++. ....+|||+|+|||.+.. ..|+..+|+|+.|||+|-|+.|.+||=...+-.. .+.
T Consensus 169 Fa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------LR~ 239 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------LRM 239 (411)
T ss_pred eeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH------HHH
Confidence 9998765542 345799999999998854 3478889999999999999999999742211000 000
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..++. .+.- ++.=.++.....++|.+||+.||.+|.|+.|+++|-
T Consensus 240 ImeGk-yqF~-----speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 240 IMEGK-YQFR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHhcc-cccC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 00000 0000 111123456678999999999999999999999974
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.98 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=200.9
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
+++.+....+||+|+||.||+|.+. +++.||+|.+........+.+.+|+.++++++|+||+++++++.+++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3455555678999999999999755 678899999887666667889999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~ 630 (795)
|+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 9999999998864322112378889999999999999999998 999999999999976 679999999998765432
Q ss_pred ccccceeeecccCCcCChhhhccCC--CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......+++.|+|||.+.... ++.++||||||+++|+|++|+.|+.............. ..
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--------~~----- 227 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--------MF----- 227 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--------hh-----
Confidence 21 122345789999999986643 78999999999999999999999864322111110000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+.....++.+++.+|++.+|.+|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011222345668899999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.95 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=206.3
Q ss_pred cccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcce
Q 040413 482 KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDI 560 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 560 (795)
+||+|.||+||-|++. +...+|||-+...+.+..+-+.+|+.+-++|+|.|||+.+|.+.++...-+.||.++||||..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999876 456799999988777777889999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCceeeccccccccCCCcccccee
Q 040413 561 FLFDTPKESPL--GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTK 637 (795)
Q Consensus 561 ~l~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~ 637 (795)
++... =+++ ++.+.-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+.. ....+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 98543 3344 78889999999999999999988 99999999999997 579999999999987643 234456
Q ss_pred eecccCCcCChhhhccC--CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 638 RIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 638 ~~~gt~~y~aPE~~~~~--~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
+..||..|||||++..+ .|..++|||||||.+.||.||++||-..+........... + ....+.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm--y-----------KvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM--Y-----------KVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc--e-----------ecCCCCc
Confidence 68999999999999775 4889999999999999999999999654433322211110 0 1223456
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+...+...+|.+|+..+|.+||++.++++-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7788899999999999999999999999874
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.87 Aligned_cols=248 Identities=31% Similarity=0.423 Sum_probs=195.7
Q ss_pred ccccCCCceeEEeeecc-C---CceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-N---GQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|... . +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999643 2 36899999876543 34567999999999999999999999875 5568999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc-c
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ-S 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~ 634 (795)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999988543 36899999999999999999999998 999999999999999999999999999866432211 1
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+....++.++||||||+++|+|++ |+.|+...+...... .... .. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~--~~~~----~~---------~~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA--MLES----GE---------RLP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH--HHHc----CC---------cCC
Confidence 1111223567999999998899999999999999999998 898886543222111 1000 00 001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1222345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.70 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=202.0
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee-cceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 551 (795)
+|++.+.||+|++|.||++..+ +++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999765 5789999998653 23445678999999999999999999988764 446789999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++... ....+++.++..++.|++.||++||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999998888543 2346899999999999999999999998 9999999999999999999999999998664322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+++.|+|||.+.+..++.++|+||||+++++|++|+.|+...+....... ...+. +
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~------~~~~~--------~- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR------IIEGK--------L- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HHhcC--------C-
Confidence 122345688999999999999999999999999999999999998864432111100 00000 0
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223355678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.88 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=205.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357889999999999999999765 68899999886543 3446789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|+++++|..++.. ...+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999888743 3468999999999999999999997 46 999999999999999999999999998754322
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||........... ...... ......+....
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~ 230 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-DPMGIL--DLLQQIVQEPP 230 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-hhhHHH--HHHHHHhhccC
Confidence 12235789999999999888999999999999999999999999875432110000 000000 00000110000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
........+..+.+++.+|++.+|++||++.|++++....
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0001112456788999999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.11 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=195.6
Q ss_pred ccccccCC--CceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 479 TENKLGEG--GFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 479 ~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++++||+| +|++||++..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999764 78999999987542 234466888999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc-
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL- 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~- 632 (795)
++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999888532 2245899999999999999999999998 99999999999999999999999987543321110
Q ss_pred ----ccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccc---cccccc-----
Q 040413 633 ----QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR---AWDLWK----- 698 (795)
Q Consensus 633 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~---~~~~~~----- 698 (795)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||............. ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 001112356778999999876 468999999999999999999999986433211100000 000000
Q ss_pred -------------ccchhh---------ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 699 -------------DDRAWE---------LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 699 -------------~~~~~~---------~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...... .................+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000000 0000000111223455788999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.67 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=202.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.+|++.+.||+|+||.||+|...+++.+|+|++.... ...+.+.+|++++++++|||++++++++.+....++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688889999999999999987778899999986532 335679999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ...++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99998887432 346889999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......... .. .. ......+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~--~~----~~--~~~~~~~----- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE--TI----NA--GFRLYKP----- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH--HH----hC--CCCCCCC-----
Confidence 112235678999999988889999999999999999998 888876433221110 00 00 0001111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...+..+.+++.+|++.+|++||++.|++++|.
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=308.41 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=202.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34677789999999999999764 67899999987543 34456799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++. ...+++..+..++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988873 346889999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+........... +......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---------------~~~~~~~ 219 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---------------IPKNSPP 219 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---------------hhcCCCC
Confidence 12234678899999999988899999999999999999999998753322111100 0000001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
......+..+.+++.+|++.+|++||++.++++|-.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 112234566889999999999999999999999743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.14 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=200.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|..+ +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999765 68899999987543 33345688999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 4777766432 346889999999999999999999998 99999999999999999999999999976432211
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccc--------ccccccccch
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGR--------AWDLWKDDRA 702 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~--------~~~~~~~~~~ 702 (795)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..... .+.. .+........
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1122456889999998865 45788999999999999999999998755422111 0000 0000000000
Q ss_pred hhccC-ccccc----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 WELID-PILQN----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id-~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
....+ +.... ......+..+.+++.+||+.||.+|||+.|+++|-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00000 00000 011123456789999999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.92 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=200.1
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.|+..++||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++|+|++.+.+.+.+++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3667789999999999999764 78899999986542 2234567889999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998877543 2346999999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l 710 (795)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ..... .... . .
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~~~-~------~--- 221 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RVLE-T------E--- 221 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hhhc-c------c---
Confidence 11234789999999999888999999999999999999999999875432211 11100 0000 0 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 746 (795)
...+...+..+.+++..|++.+|++||+ +.+++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0111223456788999999999999999 7787776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.87 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=206.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.+.||.|+||.||+|... +++.+|+|++.... ....+.+.+|+++++.++|+||+++++.+.+.+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999754 67899999987532 33567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999998865433457899999999999999999999998 99999999999999999999999999876654322
Q ss_pred c--cceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 633 Q--SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 633 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .......++..|+|||.+... .++.++|+||||+++++|++|+.|+......... .. ..... .+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-~~----~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-ML----TLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH-HH----HhcCC------CCC
Confidence 1 122334688999999998776 7899999999999999999999998644321110 00 00000 011
Q ss_pred ccchh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 710 LQNEA-SYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+.... ....+..+.+++.+|++.+|++||++.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111 12345678899999999999999999999886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.13 Aligned_cols=249 Identities=29% Similarity=0.428 Sum_probs=194.6
Q ss_pred ccccCCCceeEEeeecc-CCc--eEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQ--EVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|.++ ++. .+|+|.+... .....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36999999999999875 343 4688888753 334557899999999999 799999999999999999999999999
Q ss_pred CCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 556 KSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 556 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99988875421 1235889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
++...... ........+..|+|||++....++.++||||||++++||++ |..||......... ...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~-------- 224 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--EKL-------- 224 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH--HHH--------
Confidence 98632211 11111233567999999988889999999999999999997 88888543321111 000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
........+...+..+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 -----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00000011122345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.01 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=198.5
Q ss_pred ccccCCCceeEEeeeccC-------CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 481 NKLGEGGFGPVYKGRLHN-------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+.||+|+||.||+|+..+ ++.+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997642 2579999886543 34567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-----Cceeecccc
Q 040413 553 MPNKSLDIFLFDTP----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-----NPKISDFGM 623 (795)
Q Consensus 553 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~DFGl 623 (795)
+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999886432 2345789999999999999999999988 99999999999999877 899999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccch
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.......... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~--~~----~~~-- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ--HV----TAG-- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH--HH----hcC--
Confidence 976543332222223355788999999999999999999999999999998 888886433211110 00 000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.....+...+..+.+++.+||+.+|.+||++.+++++|+
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001112234567889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.39 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=204.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|++.++||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++.+.+....++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 57999999999999999999765 68899999998766666778999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|++++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 999999887532 346899999999999999999999998 9999999999999999999999999987643221
Q ss_pred cceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 634 SKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.......+++.|+|||.+. ...++.++|+||||+++|+|++|+.|+......... ... .... .+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~~-----~~ 226 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKI----LKSE-----PP 226 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHH----hcCC-----CC
Confidence 1223356899999999874 345788999999999999999999998654321110 000 0000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+ ..+...+..+.+++.+||+.+|.+||++.+++++-
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 00 01122345688999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.85 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=203.3
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeee---
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCI--- 541 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 541 (795)
+..+....++|++.+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567789999999999999999999765 68899999986532 2346788999999999 6999999999874
Q ss_pred --ecceeEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 542 --ELEEKILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 542 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999998876432 23456889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~ 693 (795)
+|||+++....... ......|++.|+|||.+. ...++.++|||||||++|||++|+.|+......... . .
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-~-~- 240 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-F-K- 240 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-h-h-
Confidence 99999986543221 122346899999999875 345789999999999999999999998644321110 0 0
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
. .........++ ......+.+++.+|++.+|++||++.|+++++
T Consensus 241 --~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 --I-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --c-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00000001111 11234688999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.01 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=205.0
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|+..+.||+|+||.||.++.. +++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999754 6889999987654 344567789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 356899999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+.+..++.++||||||+++++|++|+.|+............ ..... .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~~~~---------~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI------VQGNY---------T 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcCCC---------C
Confidence 223456899999999998888899999999999999999999998653322111000 00000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
......+.++.+++.+|++.+|++||++.++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01123355688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=304.40 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..|+..++||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.+++++.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999765 68899999987542 34567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999988873 245889999999999999999999988 99999999999999999999999999976643321
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++|+||||+++|||++|..|+........... +......
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---------------~~~~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---------------IPKNNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---------------hhcCCCC
Confidence 12234678899999999888899999999999999999999999864332111100 0000111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
......+..+.+++.+||+.+|++||++.+++++-.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 223345677889999999999999999999998843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.48 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=201.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|++|.||+|..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999876 68999999986532 2334668899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|+.++. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2346899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc--------cccccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD--------LWKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~--------~~~~~~ 701 (795)
. ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||........ ........ .+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999998865 5678999999999999999999999875442211 11100000 000000
Q ss_pred hh-hccCccccch-----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AW-ELIDPILQNE-----ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~-~~id~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ....+..... .....+..+.+++.+|++.+|++||++.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 0000000000 011235678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.63 Aligned_cols=256 Identities=30% Similarity=0.426 Sum_probs=202.5
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999754 2467999988764433 4678999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKE------SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 621 (795)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999988654321 26899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccccc
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|+++....... .......++..|+|||.+.+...+.++||||||+++|+|++ |..|+.......... .. ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~--~~----~~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN--RL----QAG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH--HH----HcC
Confidence 99875432221 12223356778999999988888999999999999999999 666764322211111 00 000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.. ....+...+..+.+++.+|++.+|++||++.|++++|+
T Consensus 235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 00011123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.91 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=203.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999876 7899999988654 333457799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++++|..++........+++..+..++.||++||.|||+. + |+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988875433344789999999999999999999974 6 9999999999999999999999999997653221
Q ss_pred cccceeeecccCCcCChhhhccC------CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.......... . ....
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~---------~~~~ 222 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--Q---------LSAI 222 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH--H---------HHHH
Confidence 2234678899999988543 35889999999999999999999986432211100 0 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+.. ....+.....++.+++.+|++.+|++||++.+++++-.-
T Consensus 223 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred hhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 0000 011223356678899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.56 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=203.3
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.|.....||+|+||.||++... +++.+|||++........+.+.+|+.++++++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999764 688999999876655667789999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... .
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 999988773 235889999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ... ....+.+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~---------~~~~~~~~~~~-- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRR---------IRDNLPPRVKD-- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---------HHhcCCCcccc--
Confidence 22335689999999999888899999999999999999999999864332111 000 00011111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.......+.+++.+|++.+|.+|||+.|++++-.-.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 112344678899999999999999999999974443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.10 Aligned_cols=242 Identities=23% Similarity=0.277 Sum_probs=189.1
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc---CCCceeeeeeeeeecceeEEEEeecCC
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL---QHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
||+|+||.||+|+.. +++.||||++.+.. ......+..|..++.++ +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999765 68999999986532 22334455677777665 699999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988774 3456899999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred eeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 636 TKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ .... ..+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~------~~~---~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGK------VRF---P 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCC------CCC---C
Confidence 2345799999999998754 5899999999999999999999998654322211000 0000 000 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHHh
Q 040413 715 SYLILNRYINVALLCVQEDAVDRP----TMFEVVSML 747 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~~L 747 (795)
.......+.+++.+||+.+|.+|| ++.++++|-
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 011345678899999999999998 678887763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.91 Aligned_cols=258 Identities=28% Similarity=0.370 Sum_probs=205.2
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
|+...+||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999765 6899999999765555667899999999999999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++........ .
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99988763 346889999999999999999999998 99999999999999999999999999976543221 1
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....++..|+|||.+.+..++.++|||||||+++||++|+.|+.......... .... .. .+.. ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~~~~----~~-----~~~~--~~~ 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK--RLRD----SP-----PPKL--KNA 240 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHhc----cC-----CCCc--ccc
Confidence 233568999999999998889999999999999999999999986443211110 0000 00 0000 001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCC
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPH 756 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 756 (795)
......+.+++.+|++.+|++||++.+++++-.-....+|.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 12345678899999999999999999999975444333333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.23 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=189.0
Q ss_pred ccccCCCceeEEeeecc---CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999999653 24568888876543 333567889999999999999999999999999999999999999
Q ss_pred CcceeeccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 557 SLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 557 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|.+++..... ....++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99998865322 234567888999999999999999998 9999999999999999999999999987543322212
Q ss_pred ceeeecccCCcCChhhhcc-------CCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 635 KTKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+........ .... .. .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~---~~-~~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQV---VR-EQDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHH---hh-ccCccCC
Confidence 2223346778999998743 456889999999999999999 6777654332111 0000 00 0001111
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
++.+ ....+..+.+++..|+ .+|++||++.+|++.|.
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 1223455667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.62 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=195.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeeeee--ccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 546 (795)
.+|+..+.||+|+||.||+|... +++.+|+|++.... .+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999764 68899999886432 2234678899999999999999999998875 3567
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999888843 345889999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.|+........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~~~~------------ 221 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--IFKI------------ 221 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--HHHH------------
Confidence 532111 1112234588999999999988899999999999999999999999864321111 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.........+......+.+++ +|+..+|++||+++||++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 222 ATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000001112223344556666 6888899999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.14 Aligned_cols=193 Identities=22% Similarity=0.331 Sum_probs=164.6
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
....+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999765 5788999985432 2457999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|++. ++|..++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9996 466666632 3456899999999999999999999998 999999999999999999999999999753322
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~ 679 (795)
. ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 222356899999999999999999999999999999999866554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.77 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=187.9
Q ss_pred cccCCCceeEEeeeccC-------------------------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeee
Q 040413 482 KLGEGGFGPVYKGRLHN-------------------------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 536 (795)
+||+|+||.||+|.... ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13589999876555556778999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC--
Q 040413 537 LGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-- 614 (795)
Q Consensus 537 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-- 614 (795)
++++.+....++||||+++++|+.++.. ....+++..+..++.||++||+|||+++ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999888743 2356889999999999999999999998 99999999999997654
Q ss_pred -----CceeeccccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHH-hCCCCCCCCCCcch
Q 040413 615 -----NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETL-SSKRNTDFSNTDSL 687 (795)
Q Consensus 615 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~ell-tg~~p~~~~~~~~~ 687 (795)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998643221 12356788999998865 56899999999999999995 68888764432221
Q ss_pred hhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
... ... .... +......+.+++.+|++.+|++||++.++++.|+
T Consensus 231 ~~~------~~~-------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERF------YEK-------KHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH------HHh-------ccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 110 000 0000 0111235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.99 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=202.8
Q ss_pred CCcccccccCCCceeEEeeec-cCCceEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
+|+..+.||+|++|.||+|.. .+++.+|+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 478999999986532 1235678999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-Cceeecccccccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMF 627 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~ 627 (795)
|+||+++++|.+++.. ..++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999988843 346889999999999999999999998 99999999999998776 5999999999766
Q ss_pred CCCcc--ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 628 GGDEL--QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
..... ........++..|+|||.+.+..++.++|+||||+++++|++|+.|+........... ..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------~~~~ 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----------IFKI 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------HHHH
Confidence 43311 1112235688999999999888899999999999999999999999864332111000 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.........+.....++.+++.+|++.+|++||++.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00011122334456778899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.10 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=202.0
Q ss_pred ccCCcccccccCCCceeEEeeeccC----CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..+|.+.++||+|+||.||+|...+ ...+|||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999997542 3468999887654 4556789999999999999999999998875 55789
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999988432 335899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
...... .....++..|+|||.+....++.++||||||++++||++ |..||.......... .. .....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~--~~----~~~~~----- 226 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG--RI----ENGER----- 226 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HH----HcCCc-----
Confidence 432211 112234568999999988889999999999999999986 999886544222111 00 00000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. ..+...+..+.+++.+|+..+|++|||+.++++.|++.
T Consensus 227 ~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 L----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01122345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=300.17 Aligned_cols=238 Identities=26% Similarity=0.439 Sum_probs=188.3
Q ss_pred ccccCCCceeEEeeeccCCc-----------eEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 481 NKLGEGGFGPVYKGRLHNGQ-----------EVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++||+|+||.||+|.+.... .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999876422 5788887654333 6789999999999999999999999988 778999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-------Cceeeccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-------NPKISDFG 622 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-------~~kl~DFG 622 (795)
|||+++++|++++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999885432 26899999999999999999999988 99999999999999887 79999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccC--CCCccCCeeehhHHHHHHHhC-CCCCCCCCCcchhhcccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSS-KRNTDFSNTDSLTLLGRAWDLWKD 699 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwslG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
++..... .....++..|+|||.+... .++.++||||||+++++|++| ..|+........... +..
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~------~~~ 221 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF------YQD 221 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH------Hhc
Confidence 9986543 1223567789999998776 789999999999999999995 555543321111000 000
Q ss_pred cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.. .. +......+.+++.+|++.+|++||++.++++.|+
T Consensus 222 ~~-------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH-------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 0001157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.84 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=202.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc----eEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ----EVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|++.++||+|+||.||+|..+ +++ .+|+|.+.... ....+++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 57888999999999999999754 333 58999887553 3445789999999999999999999999887 78899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|+||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999888532 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............++..|+|||.+....++.++|+||||++++||++ |+.|+.............. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------~~------ 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK------GE------ 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC------CC------
Confidence 3321111111223568999999988899999999999999999998 9999865432221111000 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+......+.+++.+|+..+|.+||++.++++.|+..
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011111234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=291.42 Aligned_cols=267 Identities=24% Similarity=0.291 Sum_probs=217.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|..+++||+|.||+|.+++.+ +++.+|||++++. .+.....-..|-++|+..+||.+..+...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 478899999999999999999765 7899999999876 344556677899999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+.||.|.-+| .+...+++...+.+-..|..||.|||+++ ||+||||.+|.|+|.+|++||+|||+.+.-
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-- 318 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence 9999999998777 45677999999999999999999999998 999999999999999999999999999742
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
-.+...+.+.+|||.|+|||++....|..++|.|.+||++|||++|+.||-..+.+.+..+..+.++
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~------------- 385 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL------------- 385 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-------------
Confidence 1233456778999999999999999999999999999999999999999976554443322221111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh--hc------ccCCCCCCCCCCccc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML--TN------ETVNLPHPQQPAFSS 764 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L--~~------~~~~~~~~~~p~~~~ 764 (795)
..+.....+...++..+|..||.+|. .+.||.+|- .+ ..+++++|..|+.-+
T Consensus 386 ---kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS 450 (516)
T KOG0690|consen 386 ---KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS 450 (516)
T ss_pred ---cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence 12333345667888999999999994 567776652 22 125667777776533
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.48 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=199.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC----------cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS----------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE 544 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 544 (795)
+|.+.++||+|+||.||+|... +++.+|+|.++... ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999754 68899999885321 112356889999999999999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999888433 56899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCC--CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+...............++..|+|||.+.... ++.++|+||||+++++|++|..|+........ ... .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~---~~~~-~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK---LGNK-RS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH---hhcc-cc
Confidence 8654322122223356889999999887654 88999999999999999999999853321110 000 0000 00
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+..........+..+.+++.+|++.+|++||++.+|++|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 ----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111112345678899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.00 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=214.5
Q ss_pred CCcccccccCCCceeEEeeeccC----CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..++.++||.|.||.|++|+++. ...||||.++.. .+....+|..|+.||.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45778899999999999998862 345999999865 4556778999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|||++|+||.||+.. ...+.+.+..-++++||.|+.||-+.+ +|||||.++||||+.+...|++|||+++.+.++
T Consensus 710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999654 356899999999999999999999998 999999999999999999999999999987654
Q ss_pred cc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCC-CCCCCcchhhcccccccccccchhhccC
Q 040413 631 EL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNT-DFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.. ...+..-.-..+|.|||.+..+.++.++||||+|+++||.++ |.+|+ +..+++.+..+ +
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----------------e 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----------------E 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----------------H
Confidence 31 111111233578999999999999999999999999999775 87775 33333333333 3
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.-.+-..+.+++..|.+|+..|||.|-.+||.+.+|+.+|...+
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 33344567788899999999999999999999999999998874
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.10 Aligned_cols=248 Identities=29% Similarity=0.407 Sum_probs=201.4
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
+|+..+.||+|++|.||+|... +++.|++|.+.... ++..+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999776 78999999986543 23557799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999988843 245889999999999999999999998 99999999999999999999999999886543
Q ss_pred CccccceeeecccCCcCChhhhccCC-CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+......... . .. .....
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~-~~---~~~~~------- 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-F-KI---GRSKE------- 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-H-HH---Hhccc-------
Confidence 32 223456889999999987766 899999999999999999999998643311110 0 00 00000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....+......+.+++.+|++.+|++||++.+++++
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011122334667889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.02 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=200.9
Q ss_pred CCcccccccCCCceeEEeeeccC--CceEEEEEeccc----------CcccHHHHHHHHHHHHh-cCCCceeeeeeeeee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHN--GQEVAVKRLSSQ----------SGQGLEEFKNEIKLIAK-LQHRNLVRLLGCCIE 542 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 542 (795)
+|++.+.||+|+||.||+|..+. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998754 688999987532 12234567788888875 799999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998877442 234568999999999999999999996 55 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD 700 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......... .. ...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~--~~----~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT--KI----VEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH--HH----hhc
Confidence 99998755332 2234568899999999998889999999999999999999999985433211100 00 000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ..+.. ....+..+.+++.+|++.+|++||++.|+.++++
T Consensus 229 ~----~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V----YEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c----CCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00100 1123456889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.60 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=203.8
Q ss_pred cHHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 040413 466 SLASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.+.++....++|++.+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34555667789999999999999999999764 68899999986532 2346788999999999 799999999998754
Q ss_pred c-----eeEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCce
Q 040413 544 E-----EKILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 544 ~-----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 617 (795)
+ ..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3 579999999999998877532 23456899999999999999999999998 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccC-----CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~ 692 (795)
|+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+........ ....
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~ 245 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKI 245 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHH
Confidence 9999998865432211 1234688999999987543 368999999999999999999999864332111 0000
Q ss_pred ccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.........+ +......+.+++.+|++.+|++||++.|+++|
T Consensus 246 -----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 -----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000000001 11233468899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.63 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=198.6
Q ss_pred CcccccccCCCceeEEeeecc----CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------
Q 040413 477 FSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
|++.+.||+|+||.||+|.+. +++.+|||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 4688999998654 2344677899999999999999999999886543
Q ss_pred eeEEEEeecCCCCcceeeccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecc
Q 040413 545 EKILIYEYMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 621 (795)
..++++||+++++|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 237889999999998776432 12235789999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccccc
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDD 700 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+.......... ... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~--~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN--YLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH--HHH---cCC
Confidence 99986643322222222345678999999998889999999999999999999 777775433211110 000 000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. + ..+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 00112345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.95 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=200.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|+||.||+|..+ +++.+|+|++.+... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 589999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|+.+.. ....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999887653 2345899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccc-ccc-------ccccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRA-WDL-------WKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~-~~~-------~~~~~ 701 (795)
. ......++..|+|||.+.+ ..++.++||||||++++||++|++|+........ ...... ... .....
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1223467899999998865 4578899999999999999999988864332110 000000 000 00000
Q ss_pred hh-hccCccccc-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AW-ELIDPILQN-----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~-~~id~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ....+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 000000000 0111345678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=298.97 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=203.0
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.++||+|+||.||++... +++.+|+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999764 6899999998643 234456899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998877432 2345789999999999999999999998 99999999999999999999999999986643321
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+.+...+.++|+||||+++++|++|+.|+.......... .. . .+.. .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~--~~---~-~~~~---------~ 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL--KI---I-RGSY---------P 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH--HH---h-cCCC---------C
Confidence 1223467889999999998889999999999999999999999986433211110 00 0 0000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+......+.+++.+|++.+|++||++.+|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122345568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.69 Aligned_cols=251 Identities=35% Similarity=0.524 Sum_probs=200.3
Q ss_pred CcccccccCCCceeEEeeeccC-----CceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 477 FSTENKLGEGGFGPVYKGRLHN-----GQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
+++.+.||+|+||.||++.... +..+|+|++...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999997653 378999999765433 5778999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++..... ..+++..+..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999988854321 22899999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
...... ...+++.|+|||.+....++.++|+||||+++++|++ |+.|+........... . ....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~--~----~~~~-------- 221 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY--L----KKGY-------- 221 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--H----hcCC--------
Confidence 222211 2236789999999988889999999999999999998 6777654322111100 0 0000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....+...+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011112456788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.96 Aligned_cols=246 Identities=31% Similarity=0.437 Sum_probs=200.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc---cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ---GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..|+-++.||.|+||.||-|++. +.+.||||+++-..++ -+..+..|+..|++++|||+|.+.++|......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45777889999999999999765 6788999999755443 4667899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|||-| |-.+++.- ..+++-+.++..|..+.+.||+|||+++ .||||||+.|||+.+.|.|||+|||.|.+..
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 99965 44444422 3457889999999999999999999998 9999999999999999999999999998754
Q ss_pred ccccceeeecccCCcCChhhh---ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..+.++|||.|||||++ ..+.|+-|+||||||+.+.||.-.++|....+....... .-. .+ .
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-----IAQ-Ne-----s 242 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQ-NE-----S 242 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-----HHh-cC-----C
Confidence 33468999999999987 458899999999999999999999998765442111111 000 00 1
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
|-+. ..+....++.++..||+.-|.+|||..+++.|
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 34556778999999999999999999998876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=294.83 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=210.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+-|.++++||+|+||.||+|.++ .|+.+|||++.. +...+++.+|+.+|++.+.|++|+.||.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 44788899999999999999765 799999999864 456788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
..|++.+.++. +++++.++++..+++..++||+|||... =||||||+.|||++.+|..||+|||.|-.+.....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999998853 5678999999999999999999999986 89999999999999999999999999987764432
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
..++..|||.|||||++..-.|+.++||||||+...||..|++|+..-+.--. ..... .+|--.-.
T Consensus 185 -KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------IFMIP-------T~PPPTF~ 250 (502)
T KOG0574|consen 185 -KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------IFMIP-------TKPPPTFK 250 (502)
T ss_pred -hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------eEecc-------CCCCCCCC
Confidence 33457899999999999999999999999999999999999999753221110 00000 01111112
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+.+-+.++.++++.||-..|++|.|+.++++|
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 345667789999999999999999999999887
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.78 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=197.8
Q ss_pred CCcccccccCCCceeEEeeecc---CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKI 547 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 547 (795)
+|++.++||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999764 47899999998633 44457788999999999999999999999988 7899
Q ss_pred EEEeecCCCCcceeeccC-C-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC----CCCceeecc
Q 040413 548 LIYEYMPNKSLDIFLFDT-P-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDF 621 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DF 621 (795)
+||||+++. |.+.+... . ....+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCcC-HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999999864 44444322 1 2237899999999999999999999998 999999999999999 999999999
Q ss_pred ccccccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-------hccc
Q 040413 622 GMAKMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-------LLGR 692 (795)
Q Consensus 622 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-------~~~~ 692 (795)
|++........ ........++..|+|||.+.+ ..++.++||||||+++++|++|+.|+......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643321 112233567899999998766 45789999999999999999999998754432200 0000
Q ss_pred ccccccc------------cchhh---c-----cC-ccccchhhH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 693 AWDLWKD------------DRAWE---L-----ID-PILQNEASY--LILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 693 ~~~~~~~------------~~~~~---~-----id-~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....... ..... . .. ..+...... ....++.+++.+||+.+|++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 00000 0 00 000000111 234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=309.46 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=187.3
Q ss_pred cccccCCCceeEEeeecc---CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeEEEEeecC
Q 040413 480 ENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILIYEYMP 554 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 554 (795)
..+||+|+||.||+|+.+ +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999864 45789999987542 23568899999999999999999998854 456789999987
Q ss_pred CCCcceeecc------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE----cCCCCceeeccccc
Q 040413 555 NKSLDIFLFD------TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMA 624 (795)
Q Consensus 555 ~gsL~~~l~~------~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFGla 624 (795)
+ +|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 44444321 122345889999999999999999999998 9999999999999 56679999999999
Q ss_pred cccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-------hccc---
Q 040413 625 KMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-------LLGR--- 692 (795)
Q Consensus 625 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-------~~~~--- 692 (795)
+....... ........+|+.|+|||.+.+ ..++.++|||||||++|||++|++||.....+... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 87653321 112234578999999998876 45899999999999999999999998654321110 0000
Q ss_pred --------ccccccc-cchhhccCc----ccc--------chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 693 --------AWDLWKD-DRAWELIDP----ILQ--------NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 693 --------~~~~~~~-~~~~~~id~----~l~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+..... ......... ... ..........+.+++.+||+.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 000000000 000 00011123457889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.05 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=189.8
Q ss_pred ccccCCCceeEEeeeccC--------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 481 NKLGEGGFGPVYKGRLHN--------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+.||+|+||.||+|..+. ..++|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997542 234888888765555667899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC--------ceeeccccc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--------PKISDFGMA 624 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~DFGla 624 (795)
+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 236889999999999999999999998 999999999999987765 599999988
Q ss_pred cccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCC-CCCCCCCCcchhhcccccccccccch
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+............ ..
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------~~--- 220 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------ED--- 220 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH------Hc---
Confidence 654322 22467889999999876 45799999999999999999995 444322211110000 00
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
. ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ------R--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------c--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0111122346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.76 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=199.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCc----eEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQ----EVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|+..+.||+|+||.||+|.+. +++ .+|+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 357888899999999999999754 444 47899886543 23345788999999999999999999998754 467
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+++||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999888743 2346889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+............ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~------~~~~~---- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL------EKGER---- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HCCCC----
Confidence 43322212223345778999999998899999999999999999997 88887543311111100 00000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. ..+...+..+.+++..|+..+|++||++.+++++|+.+
T Consensus 230 ---~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ---L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=300.07 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=197.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-----cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--cee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|++.++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999765 68999999875321 22356789999999999999999999988764 457
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988743 245788999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~------------ 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKI------------ 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHH------------
Confidence 542211 1122234688999999999888899999999999999999999999864321111 0000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.........+......+.+++.+|+. +|++||+++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00000112234455677889999985 89999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=305.34 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=199.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-----GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
+|++.++||+|+||.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999765 6899999999764322 345678899999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899998885432 36999999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccccc------c
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDD------R 701 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~------~ 701 (795)
... ......+++.|+|||.+.+ ..++.++|||||||+++||++|.+++........ ............. .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 321 1122356788999998855 4678999999999999999999877764432111 0000000000000 0
Q ss_pred hhhccCcccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPILQ-----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.......... ..........+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 01112335678899999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.71 Aligned_cols=253 Identities=26% Similarity=0.329 Sum_probs=211.1
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...+.|+..++||+||||.||-.+.+ +|+.+|.|++.+. ..++.....+|..||.+++.+.||.+-..|+..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567888999999999999999765 7999999998653 3456677889999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
||+..|.||+|.-+|... ....++++.+..++.+|+.||++||... ||+|||||+|||+|+.|+++|+|.|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999999654 3367999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
...+.. ...+||.+|||||++.+..|+...|.|||||++|||+.|+.||....+... . +.+|
T Consensus 338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----------~----eEvd 399 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----------R----EEVD 399 (591)
T ss_pred CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----------H----HHHH
Confidence 765432 234899999999999999999999999999999999999999965432111 1 1111
Q ss_pred cccc---chhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040413 708 PILQ---NEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSM 746 (795)
Q Consensus 708 ~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 746 (795)
.+.. ..++...++++.++.+..|+.||++|. .+.+|-+|
T Consensus 400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 1111 224455667788999999999999995 45677765
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=336.97 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=199.0
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 547 (795)
...+|++.++||+|+||.||+|.+. .++.+|+|++... .......+..|+.+|+.|+|||||++++++.+ ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468999999999999999999765 5778999988653 23345779999999999999999999998865 35689
Q ss_pred EEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CcEEeCCCCCCcEEEcC----------
Q 040413 548 LIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSR----LRVIHRDLKASNILLDK---------- 612 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~~iiH~Dikp~NIll~~---------- 612 (795)
|||||+++++|.++|... .....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999888542 223579999999999999999999998541 24999999999999964
Q ss_pred -------CCCceeeccccccccCCCccccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 613 -------DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 613 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
.+.+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3348999999998654322 1233579999999998854 458899999999999999999999986433
Q ss_pred CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 684 TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.... .+... ... +.+ .....+..+.+||..||+.+|.+||++.|++++
T Consensus 248 ~~~q-li~~l----k~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFSQ-LISEL----KRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHHH-HHHHH----hcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 2111 11000 000 000 001124568899999999999999999999965
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.37 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=204.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|+||.||+|.++ +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999775 6889999998753 33445789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|++++.++.+.. +...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999987766552 2345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc--------cccccc-
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW--------DLWKDD- 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~--------~~~~~~- 700 (795)
. .......++..|+|||++... .++.++||||||+++|+|++|+.|+........ ....... ..+...
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678999999999887 889999999999999999999998865432111 0000000 000000
Q ss_pred -----chhhccCcc-ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 701 -----RAWELIDPI-LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 701 -----~~~~~id~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......++. .....+...+.++.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 0011122236778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.39 Aligned_cols=265 Identities=24% Similarity=0.317 Sum_probs=202.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999764 78999999987653 33457899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+ +++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99998887543 256899999999999999999999998 99999999999999999999999999987653321
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccccc---------c
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDD---------R 701 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~---------~ 701 (795)
.......++..|+|||.+.+ ..++.++||||+|++++||++|.+++........ ............. .
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 11223468899999998865 4568999999999999999999877754332111 0000000000000 0
Q ss_pred hhhccCcccc----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 AWELIDPILQ----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
......+... ..........+.+++.+||+.+|++||+++++++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000 001112347789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.15 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=191.5
Q ss_pred ccccCCCceeEEeeecc----CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeee-cceeEEEEeecC
Q 040413 481 NKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~~ 554 (795)
+.||+|+||.||+|... ....+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999753 2457999998643 33446788999999999999999999998764 456789999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc-
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ- 633 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~- 633 (795)
+++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999988532 234677888999999999999999988 999999999999999999999999999765432211
Q ss_pred -cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCC-CCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 634 -SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 634 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......++..|+|||.+....++.++||||||+++|||++|+ +|+....... ...... . .. .+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~---~-~~-----~~--- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLL---Q-GR-----RL--- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHh---c-CC-----CC---
Confidence 1112234577899999998889999999999999999999965 4444322111 111100 0 00 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+|++.+|++||++.|+++.|+..
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.67 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=203.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|+..++||+|++|.||++.++ +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999776 68999999987653 34556789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885432 678899999999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+.............. ...+.....
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~ 222 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL---------QYIVNEPPP 222 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH---------HHHhcCCCC
Confidence 1 125688899999999988999999999999999999999999864431111100000 000000000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.......+..+.++|.+|+..+|++|||+.+++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00111145678899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=303.98 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=205.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..+|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999754 6789999998765555567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999998873 235789999999999999999999998 99999999999999999999999999876543321
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+++.|+|||.+....++.++|+||||+++|+|++|+.||.......... .. .... . +. .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~~---~~~~-~-----~~--~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LI---ATNG-T-----PE--L 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--eh---hcCC-C-----CC--C
Confidence 1223468889999999988889999999999999999999999986543211110 00 0000 0 00 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+......+.+++.+|++.+|++||++.+++.|-
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11222445688999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.89 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=198.3
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.+.||+|+||.||++.. .++.+|+|+++.. ...+.+.+|+.++++++|||++++++++.+. ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999864 5788999998653 2346799999999999999999999998654 5799999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999888543 2346889999999999999999999988 9999999999999999999999999997643211
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.|+........... . ... ....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--~----~~~---------~~~~ 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC--V----EKG---------YRME 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--H----hCC---------CCCC
Confidence 12234567999999988899999999999999999998 8888764432211100 0 000 0011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122335678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.38 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=195.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.++||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999775 68899999986532 22345688899999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++ +|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 56555532 2356899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc---cc---chhh-
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK---DD---RAWE- 704 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~---~~~~- 704 (795)
.......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+........ .......... .. ...+
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhc
Confidence 112234578899999988664 478999999999999999999988643222111 0000000000 00 0000
Q ss_pred -------ccCcccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 705 -------LIDPILQ-NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 705 -------~id~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....... .........++.+++.+||+.||.+|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 01112234677899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.64 Aligned_cols=246 Identities=26% Similarity=0.326 Sum_probs=202.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||++... +++.+|+|++.+.. ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999765 68999999986532 234577899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999888743 357899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|+.|+.......... .. ....
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~----~~~~--------- 214 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE--KI----LEGK--------- 214 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH----hcCC---------
Confidence 223468899999999988888999999999999999999999986543111100 00 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
...+......+.+++.+||+.+|.+|| ++.|+++|-
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 011122356788999999999999999 788888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=303.05 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=201.7
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeee--
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE-- 542 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 542 (795)
...+......|++.++||+|+||.||+|.+. +++.+|+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444456688999999999999999999764 68899999986543 3446788999999999 69999999999853
Q ss_pred ----cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 543 ----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 543 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999887543 2345888899999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~ 693 (795)
+|||++....... .......+++.|+|||.+. ...++.++|+|||||++|||++|+.||.......... ..
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--~~ 238 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--LI 238 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--hH
Confidence 9999987653221 1123356899999999875 3467889999999999999999999985432111100 00
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....+.. .....+..+.+++.+||+.+|.+||++.|++++
T Consensus 239 ---------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 ---------PRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---------hhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00000000 111234578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=298.54 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=202.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 550 (795)
+|++.+.||+|+||.||+|... +++.+|+|++... .....+++.+|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999754 7889999998653 33445678899999999999999999998764 44678999
Q ss_pred eecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 551 EYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLH-----QYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 551 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH-----~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
||+++++|.+++... .....+++..++.++.||++||.||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999888543 23467899999999999999999999 655 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
......... .....+++.|+|||.+....++.++|+||||+++++|++|+.|+.......... ..
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~----------- 222 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS--KI----------- 222 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH--HH-----------
Confidence 876543321 223568999999999998889999999999999999999999987544221110 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
........+...+..+.+++.+|++.+|++||++.+|++|
T Consensus 223 --~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 --KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000111233445678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=299.50 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=188.8
Q ss_pred ccccCCCceeEEeeeccCC---ceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 481 NKLGEGGFGPVYKGRLHNG---QEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 346677765432 344678999999999999999999999999999999999999999
Q ss_pred CcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 557 SLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 557 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
+|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9998885432 2345677788899999999999999988 99999999999999999999999999864322222122
Q ss_pred eeeecccCCcCChhhhcc-------CCCCccCCeeehhHHHHHHHhC-CCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 636 TKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwslG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....... ..... ..+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~----~~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHV----IKDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HhhcccccCC
Confidence 234567889999998743 2457899999999999999975 55654322211 11110 0111112222
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+.+... ....+.+++..|+ .+|++||++.+|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322221 3345778899999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.85 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=207.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.+.||+|++|.||+|... +++.+|||++..... ...+.+.+|+.++.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999876 589999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999988432 578999999999999999999999 88 9999999999999999999999999998765332
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCC-cchhhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-DSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.. .....++..|+|||.+....++.++|+||||+++|+|++|+.|+..... .......... ....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------~~~~ 220 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------DGPP 220 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh------------cCCC
Confidence 22 1235688999999999988999999999999999999999999865432 1111111100 0000
Q ss_pred cchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYL-ILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+.. .+..+.+++.+|++.+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 45678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.85 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=201.6
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc------
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 544 (795)
..++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999875 678999999876433 457799999999999 6999999999997644
Q ss_pred eeEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999998887542 23467899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
+....... .......++..|+|||.+.. ..++.++||||||+++++|++|+.|+........ .....
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~---- 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKIP---- 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHhh----
Confidence 87654322 12223568899999998753 3477899999999999999999999864321111 00000
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ..+.+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 232 ~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 RN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 00011 1122345678899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=296.66 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=201.7
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999764 6889999998654 234467899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++... ....+++..+..++.|++++|+|||+++ ++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999988542 2345899999999999999999999998 9999999999999865 457999999998764332
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......++..|+|||.+.+..++.++||||||+++++|++|+.|+...+....... .. ....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~--~~----~~~~--------- 218 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK--IM----SGTF--------- 218 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH--HH----hcCC---------
Confidence 12235688999999999988899999999999999999999999865442221110 00 0000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+...+..+.+++.+|++.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111234568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=350.24 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=208.5
Q ss_pred HhccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.....|+..+.||+|+||.||+|+. .+++.||||++..... ...+|++++++++|||||+++++|.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3345678888999999999999986 4789999999865432 2245688999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++. .++|..+.+++.||++||+|||.....+|+||||||+||+++.++.+++. ||.+......
T Consensus 763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999999999883 38899999999999999999996655569999999999999999888875 6655432211
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....+|+.|+|||++.+..++.|+|||||||++|||++|+.|++...........++............+|+.+
T Consensus 836 ------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 ------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 12367899999999999999999999999999999999999985433222222222222222333444556655
Q ss_pred cc--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 711 QN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 711 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.. .....+..++.+++.+|++.+|++||+|.||+++|+...
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 33 234556678899999999999999999999999998873
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.58 Aligned_cols=254 Identities=24% Similarity=0.279 Sum_probs=203.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|++|.||+|... +++.+|+|.+.+... ...+.+.+|+++++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999775 589999999976432 24567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+.+++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999887532 3457899999999999999999999998 999999999999999999999999998754321
Q ss_pred ccc---------------------------cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 631 ELQ---------------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 631 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999998889999999999999999999999986544
Q ss_pred CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 040413 684 TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT----MFEVVSM 746 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~ 746 (795)
...... . .++....-......+..+.+++.+|++.+|++||+ +.|++++
T Consensus 237 ~~~~~~--~------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFS--N------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHH--H------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 221110 0 00000000111114567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.18 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=194.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHH-HHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKL-IAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.+.||+|+||.||+|.+. +++.||+|++.... .....++..|+.+ ++.++||||+++++++.++...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36889999999999999999775 68999999987643 2234456666665 566789999999999999999999999
Q ss_pred ecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 552 YMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 552 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|++ ++|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5676666432 2345789999999999999999999986 6 99999999999999999999999999986543
Q ss_pred CccccceeeecccCCcCChhhhcc----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQ----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.|+........... .. ...
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~----~~~----- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-QV----VEE----- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-HH----Hhc-----
Confidence 21 1122467889999998864 4568999999999999999999999853221111100 00 000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+.+ .....+.++.+++.+||+.+|++||++.+++++-
T Consensus 224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 224 PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00111 1112356788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.44 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 550 (795)
++|...++||.|++|.||++.+. +++.+|+|.+.... ....+++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999875 68899999987543 24567799999999999999999999998654 3689999
Q ss_pred eecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23456889999999999999999999998 99999999999999999999999999875432
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCc---chhhcccccccccccchhhcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD---SLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~i 706 (795)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....+ ......... ....
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~---- 225 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPN---- 225 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCc----
Confidence 21 12345788999999999999999999999999999999999998754321 111111000 0000
Q ss_pred Cccccchhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 707 DPILQNEAS--YLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+.+..... ...+..+.+++.+|++.+|++|||+.|++++-.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 226 -PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 01111111 123567889999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.04 Aligned_cols=264 Identities=25% Similarity=0.306 Sum_probs=196.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999765 688999999875432 2235577899999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 787776432 246889999999999999999999998 99999999999999999999999999875432111
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc--hhhcccccccccccchh------
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS--LTLLGRAWDLWKDDRAW------ 703 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~------ 703 (795)
......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.|+....... .................
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1112346788999998865 568899999999999999999999986443111 10000000000000000
Q ss_pred -------hcc-Cccccchh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 704 -------ELI-DPILQNEA-SYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 704 -------~~i-d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
... ...+.... .......+.+++.+||+.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00000000 00112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.99 Aligned_cols=252 Identities=28% Similarity=0.402 Sum_probs=206.8
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 550 (795)
+|+..+.||+|++|.||+|... +++.+++|++.... ....+.+.+|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 78999999987654 24578899999999999999999999999988 8899999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999988543 37899999999999999999999988 999999999999999999999999999876544
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
..........++..|+|||.+.....+.++||||||+++++|++|+.|+........... .. .....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~---------~~~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY----KI---------GSSGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH----hc---------cccCC
Confidence 321112345688999999999888899999999999999999999999875441111110 00 00011
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....+...+..+.+++.+|++.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111223336778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.78 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=201.1
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
-|++.++||+|+||.||+|... +++.+|||++.... ....+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999764 68899999986542 334567899999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++. ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999988873 346889999999999999999999998 99999999999999999999999999876543221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......++..|+|||.+.+..++.++|+|||||++++|++|..|+........... . .......
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~-------------~~~~~~~ 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--I-------------PKNNPPT 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH--H-------------hcCCCCC
Confidence 12234678899999999888889999999999999999999998864332111100 0 0000011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....+..+.+++.+|++.+|++||++.++++|
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122345668899999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.67 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=209.5
Q ss_pred cCCcccccccCCCceeEEeeecc--CCc--eEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--NGQ--EVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++..+.++||+|.||+|++|.++ .|+ .||||.++..... ....|.+|+.+|.+|+|||+|+|||+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34566789999999999999775 344 4799999875433 67899999999999999999999999887 788999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+|+++.|||.+.|++ .....|.......++.|||.|+.||..+. +|||||..+|+||-....+||+|||+.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 45677889999999999999999999998 99999999999999999999999999998865
Q ss_pred Cc-cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 630 DE-LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.+ +........-...|+|||.+....++.++|||+|||.+|||+| |..||..... ..+.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcc
Confidence 43 2333333345678999999999999999999999999999998 4566644321 11233344
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....-..+..+++++++++..||..+|.+|||+.+|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3333345667889999999999999999999999998544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.17 Aligned_cols=250 Identities=30% Similarity=0.460 Sum_probs=205.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999875 688999999987655567889999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999887442 257899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....++..|+|||.+....++.++|+||||+++++|++|+.|+............. . ... +.+ ..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~----~~~-----~~~--~~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T----NGP-----PGL--RN 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h----cCC-----CCc--Cc
Confidence 234578899999999988889999999999999999999999986543111111000 0 000 000 01
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
....+..+.+++.+|++.+|++|||+.|+++|
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124578899999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.41 Aligned_cols=265 Identities=25% Similarity=0.317 Sum_probs=201.4
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+|++.++||+|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999875 688999999876532 33567889999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 77777654444457899999999999999999999998 99999999999999999999999999976532211
Q ss_pred cceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-cccccccccccch---------
Q 040413 634 SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWKDDRA--------- 702 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~--------- 702 (795)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+.......... .............
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1122457889999998865 457899999999999999999999987554322111 0000000000000
Q ss_pred hhccCc---cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 WELIDP---ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...... ..........+..+.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 00011112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.17 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=201.2
Q ss_pred ccccCCCceeEEee-eccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 481 NKLGEGGFGPVYKG-RLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~-~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
+.||+|+|+.|-.+ .+.++.++|||++.++......++.+|++++...+ |+||++|+++|++++..|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 57999999999988 56789999999999998888999999999999996 99999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---CceeeccccccccCCCc----
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMAKMFGGDE---- 631 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFGla~~~~~~~---- 631 (795)
-.+|. ++..+++.++.+++++|+.||.+||.+| |.||||||+|||..... -+||+||.++.-.....
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 88884 4567999999999999999999999999 99999999999997554 47999999876432111
Q ss_pred -cccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh-
Q 040413 632 -LQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE- 704 (795)
Q Consensus 632 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 704 (795)
......+.+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||-..-.++-. |..++.-+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG--------WdrGe~Cr~ 309 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG--------WDRGEVCRV 309 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC--------ccCCCccHH
Confidence 112223468999999999762 346899999999999999999999999765432211 11111111
Q ss_pred ----ccCccccc--hhh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 705 ----LIDPILQN--EAS----YLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 705 ----~id~~l~~--~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
++..+-.+ +.+ ..++.+..+++..++..++.+|.++.+++.|-
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 11111111 111 13566778999999999999999999999853
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=298.13 Aligned_cols=248 Identities=25% Similarity=0.294 Sum_probs=203.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
+|++.++||+|+||.||+|... +++.+|+|++.+.. ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999875 68999999997542 2456789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|..++.. ...+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999988843 257899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......++..|+|||.+....++.++|+||||+++|+|++|+.|+............... .. ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------~~-~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ------------ET-AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh------------cc-cc
Confidence 122356888999999998888999999999999999999999998755432111111100 00 01
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTM--FEVVS 745 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~ 745 (795)
...+...+..+.+++.+|++.+|.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11222345778899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.71 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=198.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||++... .++.||+|.+.+.. ....+.+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999775 67899999987643 234567889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999998742110
Q ss_pred cc-------------ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 631 EL-------------QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 631 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.|+........ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~--~~~~---- 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQV---- 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----
Confidence 00 0011124578899999999888899999999999999999999999864332211 1000
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.... ...+.. ....+..+.+++.+|++.+|++||++.++.+.|
T Consensus 229 ~~~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 229 ISDD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred Hhcc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 0000 000000 112345678999999999999999855444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.64 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=202.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.++||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888899999999999999764 789999999876544 3678899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998843 345789999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccc--eeeecccCCcCChhhhccCC---CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 633 QSK--TKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 633 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... .....++..|+|||.+.... ++.++||||||+++++|++|+.||............... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-----G-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-----C-----CC
Confidence 111 12346788999999987766 889999999999999999999998643321111100000 0 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+.+. ........+.+++.+|++.+|++||++.|++.+
T Consensus 225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0010 011224567799999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.59 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=200.7
Q ss_pred CCcccccccCCCceeEEeeec-cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcC---CCceeeeeeeeeecceeEEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 550 (795)
.|++.++||+|+||.||+|.+ .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999976 47899999998754 3345677899999999997 999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999888732 36899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.|+.......... . ..... .+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~----~~~~~-----~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--L----IPKSK-----PPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--c----cccCC-----CCC
Confidence 31 2233468899999998865 457899999999999999999999986443211100 0 00000 011
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.. ...+.++.+++.+|++.+|++||++.|++.+-
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 111 01345688999999999999999999998864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.42 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=197.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----cee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
.++|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999754 7899999998753 233456788999999999999999999887654 357
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+||+.+ +|..++ ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 565555 2346899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchh
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAW 703 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 703 (795)
...... ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+...+.... ............+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 543221 111223568899999998754 5688999999999999999999999865432110 0000000000000000
Q ss_pred hccCcc-----------cc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 704 ELIDPI-----------LQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 704 ~~id~~-----------l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+.. .. .........++.+++.+||+.+|++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00 00111235668899999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.42 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=201.6
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.|...++||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999764 788999999876555556778999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999988743 46889999999999999999999998 99999999999999999999999999875543221
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......|++.|+|||.+.+..++.++||||||+++++|++|+.|+...+.... ..... .. ..+... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~--~~~~~----~~-----~~~~~~--~ 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--MKRIR----DN-----LPPKLK--N 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH--HHHHH----hc-----CCCCCc--c
Confidence 12234688999999999888899999999999999999999999854331111 10000 00 000110 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....+..+.+++.+|++.+|++||++.+++++-
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 112345789999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=301.71 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=197.4
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.+.||+|++|.||+|+.. +++.+|||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999765 68899999986542 23346789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+. ++|..++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 5777766432 3456899999999999999999999998 9999999999999999999999999987654321
Q ss_pred ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-cccccccccccchh-------
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWKDDRAW------- 703 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~------- 703 (795)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......... ........ ....+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-DEVVWPGVTSLP 232 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC-ChhhhhhhhHHH
Confidence 111223568899999987664 46889999999999999999999986543211100 00000000 00000
Q ss_pred -------hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 704 -------ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 704 -------~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+ ..........+.+++.+|++.||++||++.++++|
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000 00111234567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.85 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=209.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
...|.+.++||+|.|++|..|++. ++.+||||++.+. +......+.+|+++|+.|+|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467899999999999999999765 7999999999875 3334466899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+.+|.+.+++.. ...+.+..+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999954 345667899999999999999999999 999999999999999999999999999887643
Q ss_pred ccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ...+.+|++.|.|||++.+..| .+++|+||+|+++|-|++|..||+............ ...
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--------------~gk 271 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--------------RGK 271 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--------------eee
Confidence 3 3445799999999999998766 588999999999999999999998655322211000 000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
-..+.....++.++++++|-.+|.+|++++++.++-+
T Consensus 272 --~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 272 --YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred --ecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 1123334556789999999999999999999999853
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.74 Aligned_cols=263 Identities=22% Similarity=0.246 Sum_probs=199.3
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
..++|++.+.||+|+||.||+|... +++.||||++.+. .....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999765 7899999998653 233456788999999999999999999987643
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999965 66655521 2888999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc-------
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD------- 695 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~------- 695 (795)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ..+.....
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987543321 2234678999999999999999999999999999999999999865432110 00000000
Q ss_pred --------cc-------cccchhhccCcc----ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 696 --------LW-------KDDRAWELIDPI----LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 696 --------~~-------~~~~~~~~id~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+ ......+.+... .........+..+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00 000000111111 11111223456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.28 Aligned_cols=273 Identities=25% Similarity=0.344 Sum_probs=201.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
.++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 368999999999999999999765 68999999986432 22234567899999999999999999998765 46899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+.+ +|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 676666432 356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchh---
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAW--- 703 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--- 703 (795)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...+.... ..+....... ....+
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP-NESIWPGF 236 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC-Chhhchhh
Confidence 332 11122345788999998865 5688999999999999999999999875542221 1111000000 00000
Q ss_pred ------hcc--Cc-cccc--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCC
Q 040413 704 ------ELI--DP-ILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755 (795)
Q Consensus 704 ------~~i--d~-~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 755 (795)
... .. .... .........+.+++.+||+.||++|||+.|+++|-.-....++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 000 00 0000 0001124567899999999999999999999998666533333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.77 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=196.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcC-CCceeeeeeeeeecce-----
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 545 (795)
++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999765 68999999886542 223467889999999995 6999999999887666
Q ss_pred eEEEEeecCCCCcceeeccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFG 622 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFG 622 (795)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 67777644322 356899999999999999999999998 999999999999998 8999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWKDD 700 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~ 700 (795)
+++.+..... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..|+.......... +........ .
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT-E 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC-h
Confidence 9986543211 1112356888999998865 457899999999999999999999886543211110 000000000 0
Q ss_pred chhh----c-----c---CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 701 RAWE----L-----I---DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~----~-----i---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+. . . .+............++.++|.+||+.+|.+||++.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0 0 0000001112345678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.24 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=198.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 549 (795)
++|++.+.||+|+||.||+|..+ +++.+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999875 68899999986542 22334678899999999999999999998877 889999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+||+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 787776432 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccc--------cccc--
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRA--------WDLW-- 697 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~--------~~~~-- 697 (795)
.. .......+++.|+|||.+.+. .++.++|+||||+++++|++|+.|+........ ..+... +..+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999988654 468999999999999999999999875442111 100000 0000
Q ss_pred ----cccchhhccCccccchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 698 ----KDDRAWELIDPILQNEASYL-ILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 698 ----~~~~~~~~id~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
............+....+.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000111111111 35667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.98 Aligned_cols=265 Identities=23% Similarity=0.275 Sum_probs=196.4
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++.+|.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3478999999999999999999764 68899999987543 233456789999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 555555432 2345788889999999999999999998 999999999999999999999999999764322
Q ss_pred ccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccccc---------
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD--------- 700 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 700 (795)
.. ......+++.|+|||.+.+ ..++.++||||||+++++|++|+.||........ .+...+......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhh
Confidence 11 1122457889999998875 4578899999999999999999999875432111 111111000000
Q ss_pred ---c-hhhccCccccchh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 701 ---R-AWELIDPILQNEA-----SYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 701 ---~-~~~~id~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
. ............. .......+.+++.+|++.+|++|||+.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 0000000000000 00123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=296.12 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=207.1
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..+.|+..+.||+|++|.||+|.++ +++.+|+|++..... ..+.+.+|+++++.++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888999999999999999876 688999999976544 56789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985432 37999999999999999999999988 9999999999999999999999999987554322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........... .. .... .+ .
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~--~~----~~~~----~~-~- 236 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL--IT----TKGI----PP-L- 236 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HH----hcCC----CC-C-
Confidence 1 12234578899999999888899999999999999999999999864332111100 00 0000 00 0
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
......+..+.+++.+|++.+|.+||++.+++++..-
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 0112245678899999999999999999999986533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.85 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=212.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++.+.++||-|.||.||.|.++ ..-.||||.++. +....++|..|+.+|+.++|||+|+|+++|......|||.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 45667789999999999999876 467799999965 4456899999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
..|+|-+||.... +..++.-...+++.||+.|++||..++ +|||||.++|.|+.++-.+||+|||+++++..+.+.
T Consensus 346 ~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999999996543 345667778899999999999999998 999999999999999999999999999998766543
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.. ....-..-|.|||-+....++.|+|||+|||+||||.| |-.|+..-+ ...++.++..-.+.
T Consensus 422 AH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---------------lSqVY~LLEkgyRM 485 (1157)
T KOG4278|consen 422 AH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYGLLEKGYRM 485 (1157)
T ss_pred cc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------------HHHHHHHHhccccc
Confidence 32 12234567999999999999999999999999999987 445554322 11233444444555
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+.+.-++..+++|++.||++.|.+||++.|+-+.++..
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 56667788899999999999999999999998887654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=292.27 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=197.5
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|++|.||+|... +++.+|+|++.+.. ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999875 58999999987542 23457799999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceee
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 998843 345889999999999999999999988 9999999999999999999999999998765432 1223
Q ss_pred ecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..+++.|+|||.+....++.++|+||||+++|+|++|..|+.....+....... ..+.......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND------------ILKGNGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH------------HhccCCCCCCCccc
Confidence 468899999999988889999999999999999999999987554222111111 00000111122223
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040413 719 LNRYINVALLCVQEDAVDRPT-----MFEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 746 (795)
+..+.+++.+||+.+|++||+ +.|+++|
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=299.42 Aligned_cols=251 Identities=29% Similarity=0.397 Sum_probs=198.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
...|++.++||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356889999999999999999765 68999999986432 23346788999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+||+.+ ++.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999975 55444422 2346899999999999999999999998 99999999999999999999999999876432
Q ss_pred CccccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
. ....+++.|+|||.+. ...++.++||||||+++|||++|+.|+...+....... . .. ..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~--~---~~-~~----- 230 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--I---AQ-ND----- 230 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH--H---hc-CC-----
Confidence 2 2346788999999874 45688999999999999999999998864332111000 0 00 00
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+.+ .....+..+.+++.+||+.+|++||++.+++++..-.
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 231 SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0000 1122456789999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.81 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=198.5
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----ce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
..+|++.++||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999764 6899999998753 233456788999999999999999999987654 34
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++|+||+. ++|.+++. ....+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 56766663 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccc--------c
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAW--------D 695 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~--------~ 695 (795)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+... ........ .
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 654332 11223467889999998865 568999999999999999999999986543211 00000000 0
Q ss_pred cccccchhhcc-------CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 696 LWKDDRAWELI-------DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 696 ~~~~~~~~~~i-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..........+ ++.. .......+.++.+++.+||+.+|++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 0000 00112345678899999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=310.05 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=193.6
Q ss_pred cccccccCCCceeEEeeecc-CCceEEEEEecc----cCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce--eEEEE
Q 040413 478 STENKLGEGGFGPVYKGRLH-NGQEVAVKRLSS----QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE--KILIY 550 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 550 (795)
+...+||+|+|-+||+|.+. +|-+||--.++. +.+...++|..|+.+|+.|+|||||++++.+.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34468999999999999765 577776443322 245566899999999999999999999999988766 67899
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~ 629 (795)
|++..|+|..|+. +.+.++...++.+++||++||.|||++. +||||||||-+||+|+. .|.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999984 4567888999999999999999999986 78999999999999985 59999999999998653
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....|||.|||||... -.|+..+||||||+.++||+|+.+|+..-....+ . ++....+. .|.
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-I----YKKV~SGi-----KP~ 263 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-I----YKKVTSGI-----KPA 263 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-H----HHHHHcCC-----CHH
Confidence 32 23478999999999877 7899999999999999999999999753221111 1 11111111 110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
- ...-...++.++|.+||.. .++|||+.|+|++
T Consensus 264 s---l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 A---LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred H---hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 0 0011123567899999999 9999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=282.95 Aligned_cols=274 Identities=23% Similarity=0.336 Sum_probs=199.4
Q ss_pred ccCCcccccccCCCceeEEeeecc---C--CceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeee-cce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH---N--GQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~---~--~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 545 (795)
...|+...+||+|.||.||+|..+ + ..++|||+++.+.. .......+|+.+++.++||||+.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357999999999999999999432 2 23799999976522 123568899999999999999999999887 778
Q ss_pred eEEEEeecCCCCcceeecc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC----CCceeec
Q 040413 546 KILIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD----MNPKISD 620 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~D 620 (795)
.+|++||.+...++-+-+. ..+...++...++.|+.||+.|+.|||++= |+||||||.||||..+ |.+||+|
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 8999999988655433222 233467999999999999999999999875 9999999999999877 8999999
Q ss_pred cccccccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCc-------chhhcc
Q 040413 621 FGMAKMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-------SLTLLG 691 (795)
Q Consensus 621 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~-------~~~~~~ 691 (795)
||+++.+.+.-. .......+-|.+|+|||.+.+ ..|+.++|||+.|||+.||++-++.|...... ....+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998865421 223445678999999999887 57999999999999999999998877543211 111111
Q ss_pred cccccccc--cchhhccC----------ccc---cchhh-H-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 692 RAWDLWKD--DRAWELID----------PIL---QNEAS-Y-------LILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 692 ~~~~~~~~--~~~~~~id----------~~l---~~~~~-~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+..+++.. +..+.-+. ..- ..... . .-+....+++.++|++||.+|.|+++.+++.=
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 11111100 00111000 000 00000 0 01112678999999999999999999999854
Q ss_pred cc
Q 040413 749 NE 750 (795)
Q Consensus 749 ~~ 750 (795)
-.
T Consensus 340 F~ 341 (438)
T KOG0666|consen 340 FT 341 (438)
T ss_pred cc
Confidence 33
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=297.21 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=196.9
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
|++.++||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999764 78999999987543 233467889999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
+ ++|.+++.... ...+++..+..++.||++||+|||+++ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 57887774322 246899999999999999999999988 99999999999999999999999999976542211
Q ss_pred cceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccc--------c-cch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWK--------D-DRA 702 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~--------~-~~~ 702 (795)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ........... . ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999987654 578999999999999999999999865432111 00000000000 0 000
Q ss_pred hhccC---ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 WELID---PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+. ...........+..+.+++.+|++.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000011112234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=295.08 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=193.0
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCceeeeeeeeeec--ceeEEEEe
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIEL--EEKILIYE 551 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 551 (795)
|++.++||+|+||.||+|... +++.+|+|++++... .......+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667889999999999999765 688999999876422 22234557889999885 99999999999987 88999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++ +|.+.+.. ....+++..+..++.||+.||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 66555532 2346899999999999999999999998 999999999999999 999999999998664332
Q ss_pred cccceeeecccCCcCChhhhc-cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc--------cccccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD--------LWKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~--------~~~~~~ 701 (795)
. .....++..|+|||.+. ...++.++|||||||++|||++|..|+...+.... ........ ......
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1 12245788999999764 45678999999999999999999999875542111 00000000 000000
Q ss_pred hhhccCcc-cc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPI-LQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~-l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+. .. .......+..+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 00 01112346789999999999999999999999886
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=294.80 Aligned_cols=243 Identities=27% Similarity=0.301 Sum_probs=188.8
Q ss_pred cccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHh---cCCCceeeeeeeeeecceeEEEEeecC
Q 040413 482 KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAK---LQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..+++. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 68899999886532 1222334555544444 379999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999888743 346899999999999999999999998 9999999999999999999999999997554221
Q ss_pred ceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||............... ......
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------------~~~~~~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------------LTVNVE 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-------------hcCCcC
Confidence 122468999999998864 56899999999999999999999998644322211111100 000111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
.+...+.++.+++.+||+.+|.+|| ++.|+++|.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 2233456788999999999999999 699999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.71 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=199.1
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------eeE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------EKI 547 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 547 (795)
.+...+.||+||||.||+|+++ +|+.||||.+.+. .....+...+|+++|++++|+|||+++++=.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3456678999999999999865 7999999999764 3456788999999999999999999998755433 568
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc--CCCC--ceeecccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMN--PKISDFGM 623 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~--~~~~--~kl~DFGl 623 (795)
+|||||.+|+|...+.+......|++.+.+.++..+..||.|||+++ |+||||||.||++- .+|. .||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988888889999999999999999999999998 99999999999984 3343 79999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhc-cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccc------
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWD------ 695 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~------ 695 (795)
|+.+..+. .....+||..|++||.+. .+.|+..+|.|||||++|+..||..||.....+. ...+.+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99876554 566789999999999998 5899999999999999999999999996443221 111111000
Q ss_pred ----ccccc--c-hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC
Q 040413 696 ----LWKDD--R-AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRP 738 (795)
Q Consensus 696 ----~~~~~--~-~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 738 (795)
....+ + .++..-|. ..........++...+..+|..+|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 00000 0 00101111 1223344556677788888888888886
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=292.00 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=201.0
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.+.||+|+||.||+|..+ +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999765 6889999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC-ceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-PKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999998887543 2345799999999999999999999998 999999999999998864 6999999998664322
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......|++.|+|||.+....++.++|+||||+++++|++|+.|+...+...... .. . ... +.
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~---~-~~~----~~---- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL--KI---C-QGY----FA---- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--HH---h-ccc----CC----
Confidence 1 1122468899999999988889999999999999999999999986443211110 00 0 000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......+..+.+++.+|++.+|++|||+.|++++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=290.87 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=204.8
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.++||+|+||.||++... +++.+|+|.+... ......++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788899999999999999654 7889999998754 233456788999999999999999999999999999999999
Q ss_pred cCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999887542 22356899999999999999999999998 9999999999999999999999999998765431
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....+++.|+|||.+.+..++.++|+||||+++++|++|+.|+...+....... .. ....
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~---------~~~~ 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK------VQ---------RGKY 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hh---------cCCC
Confidence 1224578899999999998999999999999999999999999865442211110 00 0001
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+.....++.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223456678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=296.44 Aligned_cols=247 Identities=24% Similarity=0.328 Sum_probs=199.1
Q ss_pred ccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCC
Q 040413 479 TENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
...+||+|+||.||++..+ +++.+|||++........+.+.+|+.+++.++|+||+++++.+.+.+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3468999999999999764 789999999876555566779999999999999999999999999999999999999999
Q ss_pred cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccccee
Q 040413 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 637 (795)
|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 988763 235889999999999999999999998 9999999999999999999999999987654322 1123
Q ss_pred eecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHH
Q 040413 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYL 717 (795)
Q Consensus 638 ~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|..|+.......... ... ..+.+.+.. ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~--~~~---------~~~~~~~~~--~~~ 241 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK--MIR---------DNLPPKLKN--LHK 241 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH---------hhCCcccCC--ccc
Confidence 3568899999999988889999999999999999999999986433211100 000 000111100 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 718 ILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 718 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+..+.+++.+||+.+|.+||++.+++++=
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~~ 271 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKHP 271 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence 344578899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.77 Aligned_cols=264 Identities=21% Similarity=0.249 Sum_probs=196.0
Q ss_pred ccccCC--CceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEG--GFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
..||+| +||.||+|.+. +++.||+|++.... ....+.+++|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 99999999865 78999999987532 33457789999999999999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc--
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ-- 633 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 633 (795)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99988875432 235889999999999999999999998 999999999999999999999999865432211100
Q ss_pred ---cceeeecccCCcCChhhhccC--CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc---c-------
Q 040413 634 ---SKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW---K------- 698 (795)
Q Consensus 634 ---~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~---~------- 698 (795)
.......++..|+|||++.+. .++.++|||||||++|+|++|+.|+.................+ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 001112346679999998763 4789999999999999999999998654321111000000000 0
Q ss_pred ---------------------ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 699 ---------------------DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 699 ---------------------~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
........+..+...........+.+++.+||+.||++|||+.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00000111112222233445678899999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=294.99 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=200.7
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
|++.+.||+|++|.||+|... +++.+|+|++..... ...+.+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999765 788999999876432 24577889999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 776666432 257899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchh--------
Q 040413 634 SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAW-------- 703 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~-------- 703 (795)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.... ................
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112234578899999998776 789999999999999999999998865442111 0000000000000000
Q ss_pred ---hccC--ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 704 ---ELID--PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 704 ---~~id--~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+ ...........+.++.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 000011223456788999999999999999999999876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.71 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=198.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec--cee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-----SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|++.+.||+|+||.||+|.+. +++.+|+|++... ..+..+.+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999764 6899999987532 233456789999999999999999999998764 457
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999888743 245889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........++..|+|||.+.+...+.++|+|||||++++|++|+.||....... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~------------ 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI------------ 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH------------
Confidence 542111 111223568899999999988888999999999999999999999986432111 11100
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.........+......+.+++.+|++ +|.+||++.+++.|
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00001112233455678899999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.62 Aligned_cols=249 Identities=29% Similarity=0.400 Sum_probs=197.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
+.|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778899999999999999764 68899999987542 233457889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++ +|.+.+.. ...++++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 56555532 2356899999999999999999999998 999999999999999999999999998754321
Q ss_pred ccccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhhcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 706 (795)
....+++.|+|||++. .+.++.++|||||||++|||++|+.|+....... ......
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 238 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 238 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--------------
Confidence 2346888999999873 4568899999999999999999999875432111 100000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..............+.+++.+|++.+|.+||++.++++++...
T Consensus 239 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 239 -NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0000011122345688999999999999999999999987665
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=297.25 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=196.0
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|+..++||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5667789999999999999765 68999999987543 234567889999999996 99999999999999999999999
Q ss_pred cCCCCcceeecc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 553 MPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
+.. ++..+... ......+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 44332211 12235689999999999999999999975 6 99999999999999999999999999976543
Q ss_pred CccccceeeecccCCcCChhhhccC---CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQG---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
... .....++..|+|||.+.+. .++.++||||||+++++|++|+.||..... ........ .. . .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~---~~-~-----~ 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQV---VK-G-----D 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhh---cC-C-----C
Confidence 221 1234688999999998776 689999999999999999999999864331 11110000 00 0 0
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+.+........+..+.+++.+|++.+|++|||+.+|+++-
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11111222233556789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=303.52 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=202.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeee----ccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 546 (795)
..+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999765 68999999987642 2345778899999999999999999988763 3467
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 57877763 2345899999999999999999999998 99999999999999999999999999976
Q ss_pred cCCCccc--cceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccc--------c
Q 040413 627 FGGDELQ--SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRA--------W 694 (795)
Q Consensus 627 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~--------~ 694 (795)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........ ...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11123578899999998865 5688999999999999999999999865432111 000000 0
Q ss_pred ccccccchhhccCcc---cc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 695 DLWKDDRAWELIDPI---LQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 695 ~~~~~~~~~~~id~~---l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.........+.++.. .. .......+.++.+++.+||+.+|++||++.+++++..-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 000001111111100 00 001122466789999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.20 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=194.6
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|+||.||++... +++.+|+|++.+.. ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999754 68899999986532 23345678899999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceee
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 98885432 246899999999999999999999998 9999999999999999999999999987654321 1223
Q ss_pred ecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhhccCccccchhhHH
Q 040413 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWELIDPILQNEASYL 717 (795)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~ 717 (795)
..++..|+|||.+.+..++.++||||||+++++|++|+.||....... ...+... ... .....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------~~~-~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR------------TLE-MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc------------ccc-ccccCCcc
Confidence 467889999999988889999999999999999999999986543211 1111000 000 00111222
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 718 ILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 718 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
.+..+.+++.+||+.+|++|| ++.++++|-
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 355688999999999999999 777787653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=298.75 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=194.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|++.++||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999765 68999999886432 223445678999999999999999999987654
Q ss_pred --eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 545 --EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
..++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999975 66655532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--cceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccc
Q 040413 623 MAKMFGGDELQ--SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWK 698 (795)
Q Consensus 623 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 698 (795)
++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ..+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432211 112234578899999988654 478899999999999999999988865442211 11111000000
Q ss_pred -----ccchhhccCccc-cch----h-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 699 -----DDRAWELIDPIL-QNE----A-----SYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 699 -----~~~~~~~id~~l-~~~----~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
........+... ... . .......+.+++.+||+.+|++|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000000 000 0 00123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=321.83 Aligned_cols=270 Identities=21% Similarity=0.281 Sum_probs=188.3
Q ss_pred hccCCcccccccCCCceeEEeeeccC--CceEEEEE--------------ecc---cCcccHHHHHHHHHHHHhcCCCce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHN--GQEVAVKR--------------LSS---QSGQGLEEFKNEIKLIAKLQHRNL 533 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~--------------l~~---~~~~~~~~~~~E~~~l~~l~h~ni 533 (795)
...+|+++++||+|+||.||++..+. +...++|. +.+ ........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34789999999999999999986532 22222221 111 122335668899999999999999
Q ss_pred eeeeeeeeecceeEEEEeecCCCCcceeeccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTP--KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 534 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
+++++++.+.+..++|+|++.+ +|..++.... .........+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999865 4444443211 1222345678889999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCC-CCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT-DFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~-~~~~~~~~~~~ 690 (795)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++ ..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987653321 1122357999999999999999999999999999999999988543 32221111111
Q ss_pred cccccc---ccc---c---chhhccCcccc----chhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 691 GRAWDL---WKD---D---RAWELIDPILQ----NEAS-----YLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 691 ~~~~~~---~~~---~---~~~~~id~~l~----~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...... ... + .....++.... ...+ ...+..+.+++.+||+.||.+|||+.|+++|-
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 110000 000 0 00111110000 0000 01234567889999999999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.13 Aligned_cols=263 Identities=25% Similarity=0.317 Sum_probs=198.5
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEEEEe
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIYE 551 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 551 (795)
|++.++||+|++|.||+|... +++.+|+|++.... ......+.+|++++++++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999765 58899999998653 34456788999999999999999999999988 88999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 777766332 247899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccc--------
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDR-------- 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~-------- 701 (795)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ ..............
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 1 11222356788999997765 4678999999999999999999999865442211 11100000000000
Q ss_pred hhh------ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWE------LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~------~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
... .....+.......++..+.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 000011111111125678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.19 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=206.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999765 689999999876532 5567799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999998885432 2467999999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+++.|+|||......++.++|+||+|+++++|++|+.|+........... ..... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~~~----~----- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------ILKGQ----Y----- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH------HhcCC----C-----
Confidence 122335688999999999888899999999999999999999999865442211110 00000 0
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+......+.+++.+||..+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01112334678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.45 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=201.9
Q ss_pred cccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 480 ENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
.+.||+|.||+||-|.++ +|+.||||++.+. .....+++++|+.||+.+.||.||.+.-.|+..+..+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999664 8999999999764 3445588999999999999999999999999999999999999776
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC---CCceeeccccccccCCCccc
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 633 (795)
-|+-+|. .....+++...+.++.||+.||.|||.++ |+|+||||+|||+... ..+||+|||+|+.++.....
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 6655552 34567999999999999999999999999 9999999999999643 56999999999998765443
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
...+|||.|+|||++....|...-|+||.|||+|--++|..||.... +.-..++.+...+.. .
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-dIndQIQNAaFMyPp-~------------ 786 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-DINDQIQNAAFMYPP-N------------ 786 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-chhHHhhccccccCC-C------------
Confidence 35789999999999999999999999999999999999998885322 222223332222211 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.=.++....+++|..+||..-++|.+....+.|.
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1123456678999999999999999999888764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.28 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=206.0
Q ss_pred cCCcccccccCCCceeEEeeeccC-CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+.|.++..||.|+||.||+|..+. +-..|.|++........+.+.-|++||....||+||+|++.|+..+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457788899999999999998764 4456889988888888999999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
.||-.+.++.. -...|.+.++..+++|++.||.|||++. |||||||+.|||++.+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 99999888743 3467999999999999999999999998 999999999999999999999999998643221 1
Q ss_pred cceeeecccCCcCChhhh-----ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 634 SKTKRIVGTYGYMSPEYA-----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....+.|||.|||||+. ...+|+.++||||||+.|.||..+.+|....+..-..+ .....+...++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll------KiaKSePPTLl-- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSEPPTLL-- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH------HHhhcCCCccc--
Confidence 223457899999999976 45789999999999999999999998865332111100 01111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+......+.+++.+||..+|+.||++.++++|
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 123456678999999999999999999999887
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.26 Aligned_cols=248 Identities=31% Similarity=0.432 Sum_probs=202.9
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|++.++||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++.+++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999765 678999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999988743 257899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. .....++..|+|||......++.++|||++|+++++|++|+.|+.......... . .. ... ..
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~--~---~~-~~~---------~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF--R---IV-QDD---------HP 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH--H---Hh-ccC---------CC
Confidence 1 223467889999999988888999999999999999999999886433111100 0 00 000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1112234677899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.96 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=195.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999765 68899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~ 630 (795)
|+++ +|.+++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 666555322 2234678889999999999999999998 999999999999985 557999999999765432
Q ss_pred ccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc-----cccccc---
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW-----DLWKDD--- 700 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~-----~~~~~~--- 700 (795)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+........ ....... ..|...
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 1 11122457889999998866 4578999999999999999999999865432111 1000000 000000
Q ss_pred -chhh---ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 701 -RAWE---LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 701 -~~~~---~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.... ...+..........+.++.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000001112234568899999999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=302.92 Aligned_cols=266 Identities=24% Similarity=0.296 Sum_probs=198.7
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec--cee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 546 (795)
..++|++.++||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3468999999999999999999765 6889999988643 334456688899999999 999999999998654 367
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++ +|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999999974 78776632 26889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc---cceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccc--
Q 040413 627 FGGDELQ---SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKD-- 699 (795)
Q Consensus 627 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-- 699 (795)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+........ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433211 12234568999999998755 5678999999999999999999999865432211 000000000000
Q ss_pred ------cchhhccCcccc------chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 700 ------DRAWELIDPILQ------NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 700 ------~~~~~~id~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....+++.... .......+..+.+++.+|++.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000001110000 00111135678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=288.49 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=192.7
Q ss_pred HHHHhccCCcccccc--cCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 469 SVSAATANFSTENKL--GEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 469 ~i~~~~~~y~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
++....++|++.+.+ |+|+||.||++..+ +++.+|+|.+........ |+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 99999999999765 688899999865422111 22222222 7999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-Cceeecccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGM 623 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGl 623 (795)
..++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999998843 237899999999999999999999998 99999999999999998 999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
++..... ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....+...........
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 223 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ------- 223 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-------
Confidence 8765422 124688999999999988899999999999999999999999874432221111000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT-MFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 746 (795)
... .......+..+.+++.+||+.+|.+||+ ++|+++|
T Consensus 224 ---~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 ---QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000 0111235567889999999999999996 6999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.96 Aligned_cols=267 Identities=26% Similarity=0.350 Sum_probs=197.5
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc----
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE---- 544 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 544 (795)
...++|++.++||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999875 68899999987542 233457889999999999999999999987655
Q ss_pred ------eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 545 ------EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 545 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 45444422 2346899999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDL 696 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~ 696 (795)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||+++||++|++|+....... ...+......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999876433211 1122345788999998765 457899999999999999999999886443211 1111110000
Q ss_pred cc--------ccchhhccCc------cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 697 WK--------DDRAWELIDP------ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 697 ~~--------~~~~~~~id~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ........++ .... .....+..+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000000000 0000 011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=321.29 Aligned_cols=256 Identities=29% Similarity=0.390 Sum_probs=188.3
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
.-..+|+.++.||+||||.||+++.+ +|+.||||+|... .......+.+|+++|.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44578999999999999999999988 8999999999765 344567789999999999999999987521100
Q ss_pred --------------------------------------------------------------------------------
Q 040413 544 -------------------------------------------------------------------------------- 543 (795)
Q Consensus 544 -------------------------------------------------------------------------------- 543 (795)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 040413 544 ---------------------------------EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590 (795)
Q Consensus 544 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L 590 (795)
..+||-||||+...|++++.+..... .....++++++|+.||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 12356678887777777764432211 3678899999999999999
Q ss_pred HhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC----------------CCccccceeeecccCCcCChhhhccC
Q 040413 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG----------------GDELQSKTKRIVGTYGYMSPEYAQQG 654 (795)
Q Consensus 591 H~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 654 (795)
|++| ||||||||.||+++.++.|||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998621 00111133457899999999998764
Q ss_pred ---CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcc
Q 040413 655 ---LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQ 731 (795)
Q Consensus 655 ---~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~ 731 (795)
.|+.|+|+||||++++||+. ||....+....+. . +..+.+..- ..........-..+|+++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~-~----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT-N----LRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH-h----cccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 59999999999999999994 4443322221111 1 111111110 01111222234679999999
Q ss_pred cCCCCCCCHHHHHHH
Q 040413 732 EDAVDRPTMFEVVSM 746 (795)
Q Consensus 732 ~dP~~RPt~~evl~~ 746 (795)
.||.+|||+.|+|..
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=330.72 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=208.9
Q ss_pred HHHhccCCcccccccCCCceeEEeee-ccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
+...+-+++-..+||.|.||.||.|. ..+|.-.|+|-+..+ .....+.+.+|+.++..++|||+|+.+|+=.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34556788889999999999999995 457888999977544 345567789999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+|.||||.+|+|.+.+. ..+..++.....+..|++.|++|||++| ||||||||+||+|+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999883 3345667777788999999999999999 99999999999999999999999999987
Q ss_pred cCCCc--cccceeeecccCCcCChhhhccCC---CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 627 FGGDE--LQSKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 627 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+.+.. .........||+-|||||++.+.. ...+.|||||||++.||+||++||...+.+..-....+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-------- 1455 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-------- 1455 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh--------
Confidence 76542 223334578999999999997643 55789999999999999999999975543322111100
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..-....|.....+-.++++.||+.||+.|-++.|+++|-
T Consensus 1456 ------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1456 ------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 0011233444666778999999999999999999998874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=293.50 Aligned_cols=250 Identities=27% Similarity=0.358 Sum_probs=203.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|... +++.+|+|++.+. .....+.+.+|+.++++++ ||||+++++.+.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999765 7899999998753 2234567889999999998 99999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||++++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999988843 347999999999999999999999998 99999999999999999999999999986643
Q ss_pred Cccc------------------cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcc
Q 040413 630 DELQ------------------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLG 691 (795)
Q Consensus 630 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~ 691 (795)
.... .......++..|+|||.+.....+.++|+||||++++++++|+.|+........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--FQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--HH
Confidence 3211 122234678999999999888899999999999999999999999875442111 00
Q ss_pred cccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 040413 692 RAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTM----FEVVSM 746 (795)
Q Consensus 692 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 746 (795)
... ......+...+..+.+++.+||+.+|++||++ +++++|
T Consensus 233 ~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 KIL--------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHH--------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 000 00011222335678899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.88 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=206.9
Q ss_pred cCCcccccccCCCceeEEeeecc---CCc--eEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH---NGQ--EVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
+.....++||+|.||.||+|... .|+ .||||.-+.. .....+.|..|..+|+.++|||||+++|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 44556679999999999999643 233 4899988763 45568899999999999999999999999976 46799
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|||+++-|.|..+|... ...++......++.||..||+|||+.. +|||||..+|||+...--+||+|||+++.+.
T Consensus 468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999643 456888889999999999999999988 9999999999999999999999999999887
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCC-Ccchhhcccccccccccchhhcc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSN-TDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
...+.... ...-..-|||||.+.-..++.++|||.|||.+||++. |..||..-. .+....+
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i---------------- 605 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI---------------- 605 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----------------
Confidence 66554332 3345678999999999999999999999999999885 888886533 2222111
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..--+-..++.++..++.++.+||.++|.+||.+.|+...|+.+
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 11112235667788899999999999999999999988877654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.06 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=198.5
Q ss_pred HHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-- 544 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 544 (795)
+....++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445688999999999999999999754 7899999998653 2334567889999999999999999999887654
Q ss_pred ----eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 545 ----EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 545 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 678877763 346899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-cccccc---
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWD--- 695 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~--- 695 (795)
||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......... ......
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865322 223467889999998876 458899999999999999999999986543211100 000000
Q ss_pred -----cccccchhhccC--cccc----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 696 -----LWKDDRAWELID--PILQ----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 696 -----~~~~~~~~~~id--~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..........+. +... ..........+.+++.+|++.+|++|||+.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000000000 0000 001112344688999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=299.27 Aligned_cols=269 Identities=22% Similarity=0.260 Sum_probs=201.1
Q ss_pred cHHHHHHhccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 466 SLASVSAATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
...++....++|++.++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677889999999999999999999975 478999999987532 2335678899999999999999999998764
Q ss_pred c------ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 543 L------EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 543 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
. ...+++++++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 3467788876 778877663 235899999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW 694 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~ 694 (795)
||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.|+........ .......
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999764321 223567899999998866 5688999999999999999999999865432111 1100000
Q ss_pred ccccccchhhcc------------Cccccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 695 DLWKDDRAWELI------------DPILQN---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 695 ~~~~~~~~~~~i------------d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
... .......+ ...... ........++.+++.+|++.+|.+||++.++++|-.
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 235 GTP-GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CCC-CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 000 00000000 000000 000012456789999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=288.19 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=196.2
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhc---CCCceeeeeeeeeecce-----
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKL---QHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 545 (795)
|++.+.||+|+||.||+|+.+ +++.+|+|++..... .....+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 667889999999999999876 589999999975422 2234577788887776 59999999999998776
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.+++|||+++ +|.+++... ....+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 677766432 2236899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc-----ccc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL-----WKD 699 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~-----~~~ 699 (795)
.+..... .....++..|+|||.+.+..++.++|+|||||++|+|++|++|+........ ......... +..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 7643321 1223578899999999998999999999999999999999988865432211 000000000 000
Q ss_pred cc--hhhccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 700 DR--AWELIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 700 ~~--~~~~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. .......... ..........+.+++.+||+.+|.+||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000000000 11122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=289.81 Aligned_cols=271 Identities=27% Similarity=0.372 Sum_probs=204.8
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc--CCCceeeeeeeeeecc----eeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL--QHRNLVRLLGCCIELE----EKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~ 547 (795)
....++.++||+|.||.||+|++.+ +.||||++.. +..+.|++|..|.... +|+||+++++.-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4566778899999999999999864 9999999965 4556788888888765 8999999998866555 789
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCcEEeCCCCCCcEEEcCCCCceeecc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS------RLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------~~~iiH~Dikp~NIll~~~~~~kl~DF 621 (795)
||+||.+.|+|.++| +...++|....+|+..+++||+|||+.- ..+|+|||||.+||||..|+...|+||
T Consensus 285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999 4457999999999999999999999742 357999999999999999999999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCC-CC-----ccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcc-cc
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL-FS-----IKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLG-RA 693 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~-~~ 693 (795)
|+|..+............+||.+|||||++.+.. +. .+.||||+|.+||||++......... .+.+...+ .+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999888766666666689999999999997742 22 45899999999999999875553211 11110000 00
Q ss_pred cccccccchhh-----ccCccccch-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 694 WDLWKDDRAWE-----LIDPILQNE-ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 694 ~~~~~~~~~~~-----~id~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
-.-...++.+. ...|.+... ....-+.-+.+.++.||..||+.|.|+.=|-+.+..+..
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00000011111 111111110 111335568899999999999999999999998887733
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=289.12 Aligned_cols=244 Identities=27% Similarity=0.291 Sum_probs=189.1
Q ss_pred cccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHH---HHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 482 KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKL---IAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.||+|+||.||+|... +++.||+|.+.+... .....+..|..+ ++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 688999999875421 222234445444 444579999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|..++. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999988774 3356999999999999999999999998 9999999999999999999999999987654221
Q ss_pred ceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||................ ..++ .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~----~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------TMAV----E 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---------ccCC----C
Confidence 1234689999999998754 68999999999999999999999986543211111100000 0001 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSMLT 748 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 748 (795)
.+...+..+.+++.+|++.+|.+|| ++.+++++-.
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 1122356788999999999999999 9999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=286.53 Aligned_cols=241 Identities=22% Similarity=0.249 Sum_probs=187.5
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHHH-HhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKLI-AKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.||+|+||.||+|... +++.||+|++.+... .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999764 689999999875432 2233445555554 445899999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999988843 346889999999999999999999998 99999999999999999999999999875432
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
.....++..|+|||.+.+..++.++||||||+++|+|++|..|+...+....... ..... ........
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~------~~~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN------ILSRR------INWPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhcc------cCCCCccc
Confidence 2234688899999999888899999999999999999999999865432221100 00000 00011111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040413 716 YLILNRYINVALLCVQEDAVDRPTMFEVVS 745 (795)
Q Consensus 716 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 745 (795)
...+..+.+++.+||+.+|++||++.++.+
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 234567889999999999999997654443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=300.45 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=195.9
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-----
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE----- 544 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 544 (795)
...+|.+.+.||+|+||.||+|... +++.||||++.+. .......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3478999999999999999999764 6899999998753 2233466889999999999999999999987543
Q ss_pred -eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 545 -EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 545 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999864 555443 235889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccc
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDR 701 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 701 (795)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...+...... ....
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 237 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV-PGPE 237 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC-CCHH
Confidence 9764321 123467889999998876 468899999999999999999999987543211 1100000000 0000
Q ss_pred hhhcc---------C--cc-ccchh---hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hhcc
Q 040413 702 AWELI---------D--PI-LQNEA---SYLILNRYINVALLCVQEDAVDRPTMFEVVSM--LTNE 750 (795)
Q Consensus 702 ~~~~i---------d--~~-l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 750 (795)
..+.+ . +. ..... .......+.+++.+||+.+|++||++.+++.| ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 0 00 00000 01234567899999999999999999999987 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=292.81 Aligned_cols=265 Identities=21% Similarity=0.220 Sum_probs=194.8
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
.+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444555555555555544 6899999998754 345567899999999999999999999999999999999999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc---
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL--- 632 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~--- 632 (795)
++|.+++... ....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999988543 2345889999999999999999999998 99999999999999999999999998875432111
Q ss_pred --ccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc----cccccccc---
Q 040413 633 --QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA----WDLWKDDR--- 701 (795)
Q Consensus 633 --~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~--- 701 (795)
........++..|+|||.+.. ..++.++|+|||||+++||++|+.||........ ..... ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhh
Confidence 111223457788999999866 4588999999999999999999999864332111 00000 00000000
Q ss_pred ----hhh----ccCc----cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 702 ----AWE----LIDP----ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 702 ----~~~----~id~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
... ..++ ............++.+++.+||+.+|++|||+.++++|-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000 0000 0111122334567889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=296.46 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=194.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|++.++||+|+||.||+|... +++.+|||++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999765 689999998865322 22356789999999999999999999875543
Q ss_pred --eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 545 --EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 545 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
..++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45999999876 45444432 2346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc---------cceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcc
Q 040413 623 MAKMFGGDELQ---------SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLG 691 (795)
Q Consensus 623 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~ 691 (795)
+++........ .......+++.|+|||.+.+ ..++.++||||||+++|||++|++|+........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 11123457888999998765 4588999999999999999999999865442211 1110
Q ss_pred cccccccc------c--------chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 692 RAWDLWKD------D--------RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 692 ~~~~~~~~------~--------~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
........ . .......+.+.. ........+.+++.+||+.+|++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 0 000000011100 011223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=292.00 Aligned_cols=260 Identities=15% Similarity=0.179 Sum_probs=182.9
Q ss_pred ccCCcccccccCCCceeEEeeeccC----CceEEEEEecccCcccH-----------HHHHHHHHHHHhcCCCceeeeee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQSGQGL-----------EEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
.++|++.++||+|+||.||+|...+ +..+|+|+......... .....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998653 44566665433221110 11223334455678999999998
Q ss_pred eeeecc----eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC
Q 040413 539 CCIELE----EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 539 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~ 614 (795)
++.... ..++++|++.. ++.+.+. .....++..+..++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766543 34677776643 3443332 1233578889999999999999999998 99999999999999999
Q ss_pred CceeeccccccccCCCcc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh
Q 040413 615 NPKISDFGMAKMFGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689 (795)
Q Consensus 615 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~ 689 (795)
.++|+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||+++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999986642211 111223469999999999999999999999999999999999999997543211111
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.....+. ...+..+.+ .....+..+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000000 001111111 01123567889999999999999999999998763
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=288.16 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=195.5
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++||||+++++.+.+....++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 589999999875433 4567899999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc------
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL------ 632 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~------ 632 (795)
.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 8888532 36899999999999999999999998 99999999999999999999999999876433211
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
........++..|+|||.......+.++||||||+++++|++|+.|+............. ... ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~~--------~~~ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------NGK--------IEW 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCC--------cCC
Confidence 112233567889999999988889999999999999999999999986544222110000 000 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
......+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000112567889999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=301.29 Aligned_cols=268 Identities=22% Similarity=0.276 Sum_probs=197.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec---------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--------- 543 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 543 (795)
..+|.+.++||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999764 6899999998776666678899999999999999999999776543
Q ss_pred -----ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCce
Q 040413 544 -----EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPK 617 (795)
Q Consensus 544 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~k 617 (795)
...++|+||++ ++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47766652 346889999999999999999999998 99999999999997 456789
Q ss_pred eeccccccccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccccc
Q 040413 618 ISDFGMAKMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAW 694 (795)
Q Consensus 618 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~ 694 (795)
|+|||+++....... ........++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999976543211 111122357889999997654 56889999999999999999999999654421110 000000
Q ss_pred ccccc---cchhhccCc-----cccc-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 695 DLWKD---DRAWELIDP-----ILQN-----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 695 ~~~~~---~~~~~~id~-----~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..... ......+.. .... ........++.+++.+||+.+|++|||+.|+++|-.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 00000 000000000 0000 0111234568899999999999999999999987433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=299.19 Aligned_cols=265 Identities=25% Similarity=0.300 Sum_probs=202.5
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-----eeE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-----EKI 547 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 547 (795)
+|++.++||+|++|.||+|... +++.+|||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999865 58999999987643 445678999999999999999999999988775 789
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 67776632 347999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCcc-ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccc------
Q 040413 628 GGDEL-QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWK------ 698 (795)
Q Consensus 628 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~------ 698 (795)
..... ........++..|+|||.+.+. .++.++|+||||+++++|++|+.||........ ..+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 0112334678899999999887 889999999999999999999999875542211 11100000000
Q ss_pred --ccchhhccC---cccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 699 --DDRAWELID---PILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 699 --~~~~~~~id---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.......+. .... .......+..+.+++.+||+.+|++||++.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 000000000 0000 001112456788999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=320.05 Aligned_cols=279 Identities=22% Similarity=0.247 Sum_probs=220.2
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecc---cCcccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSS---QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
...+....++|.++++||+|+||.|..++++ +++.||+|++.+ -......-|..|..+|..-..+-|+++...|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3444556689999999999999999999886 688899999987 234455679999999999999999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
..++|+|||||+||+|-.++.. ..+++++.++.++..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999888843 337999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDL 696 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~ 696 (795)
.+-.+..+.. ......+|||.|.+||++.. +.|+..+|.||+||++|||+.|..||-... .+....+..-..
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~- 298 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE- 298 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh-
Confidence 9877664332 23345689999999998842 678999999999999999999999996443 122111111100
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHh--hc----ccCCCCCCCCCCccccc
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT---MFEVVSML--TN----ETVNLPHPQQPAFSSIR 766 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L--~~----~~~~~~~~~~p~~~~~~ 766 (795)
.+.-+.....+.+..+||++.+. +|+.|.. ++++-.|. ++ -+.+..+|-.|.+++..
T Consensus 299 ------------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~ 364 (1317)
T KOG0612|consen 299 ------------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDD 364 (1317)
T ss_pred ------------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCC
Confidence 11111113356678888888774 5677776 99999985 22 23566777888776643
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=291.91 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=194.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|+||.||+|..+ +++.+|||++.+.. .....++.+|+.++.+.. ||||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 67889999999999999999876 48999999997543 234456777887777775 9999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|+++ +|..++.. ....+++..+..++.||++||+|||+ .+ |+||||+|+||+++.++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 55555432 22478999999999999999999997 46 999999999999999999999999999765432
Q ss_pred ccccceeeecccCCcCChhhhccC----CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQG----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
... ....++..|+|||.+... .++.++||||||+++|+|++|+.|+......... .... ... ..
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~---~~~-~~---- 236 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKI---LQE-EP---- 236 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH-HHHH---hcC-CC----
Confidence 211 223578899999988654 3889999999999999999999998643221111 1000 000 00
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+... .....+.++.+++.+||+.+|++||++.+++++..
T Consensus 237 -~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 237 -PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0000 00123456889999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=289.57 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=197.1
Q ss_pred CCcccccccCCCceeEEeeec----cCCceEEEEEecccC----cccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 476 NFSTENKLGEGGFGPVYKGRL----HNGQEVAVKRLSSQS----GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
+|++.++||+|+||.||+|.. .+++.||+|++.... ....+++.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 368899999987532 23356788999999999 599999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999988843 346889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccceeeecccCCcCChhhhccC--CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchh
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 703 (795)
....... ......|+..|+|||.+... .++.++||||||+++|+|++|+.|+....... ...... .....
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~---- 227 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS---- 227 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH--Hhhcc----
Confidence 5433211 12235688999999988753 46789999999999999999999986432111 000000 00000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSM 746 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 746 (795)
....+......+.+++.+|++.+|++|| ++.+++.+
T Consensus 228 -------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0111223445678999999999999997 77888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=286.52 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=202.2
Q ss_pred HHhccCCcccccccCCCceeEEeee-ccCCceEEEEEeccc-------CcccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ-------SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
....++|-++++||+|||+.||+|. +...+.||||+-... .....+...+|..|-+.|.||.||++|+++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3455789999999999999999995 456788999985432 12234567889999999999999999999975
Q ss_pred c-ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc---CCCCcee
Q 040413 543 L-EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKI 618 (795)
Q Consensus 543 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl 618 (795)
+ +..+-|+||++|.+|+-+| +..+.+++.++..|+.||..||.||.+.. .+|||.||||.|||+- ..|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 5 4568999999999999998 45678999999999999999999999875 7899999999999994 4588999
Q ss_pred eccccccccCCCcccc-----ceeeecccCCcCChhhhcc----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh
Q 040413 619 SDFGMAKMFGGDELQS-----KTKRIVGTYGYMSPEYAQQ----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~ 689 (795)
+|||+++.+..+.+.. .+....||.+|++||.+.- ..++.|+||||+|||+|+.+.|+.||+...... ..
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dI 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DI 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HH
Confidence 9999999987655432 2334579999999997743 357899999999999999999999997543211 11
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+.. ....+..++.--.. +....+...+|++||++.-++|....++..+
T Consensus 694 Lqe-NTIlkAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 LQE-NTILKATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred Hhh-hchhcceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 111 11111112211111 2234567789999999999999988777543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=296.75 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=197.7
Q ss_pred cCCc-ccccccCCCceeEEeeecc-CCceEEEEEecccCccc--------------HHHHHHHHHHHHhcCCCceeeeee
Q 040413 475 ANFS-TENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQG--------------LEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 475 ~~y~-~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
++|. +.+.||+|+||.||+|.+. +++.||||++....... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 5665 4577999999999999765 68999999986542211 125789999999999999999999
Q ss_pred eeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 539 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
++...+..++||||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 57777763 3346889999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCcc------------ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCc
Q 040413 619 SDFGMAKMFGGDEL------------QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685 (795)
Q Consensus 619 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~ 685 (795)
+|||+++....... ........++..|+|||.+.+. .++.++|+|||||++|+|++|+.|+...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986642110 1111123467889999988764 4689999999999999999999998755432
Q ss_pred chhh-ccccccc-----cccc---chhh----ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 686 SLTL-LGRAWDL-----WKDD---RAWE----LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 686 ~~~~-~~~~~~~-----~~~~---~~~~----~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.... +...... +... .... ...+.. .......+..+.+++.+||+.+|++||++.|++.+..-.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 2110 0000000 0000 0000 000000 001112345688999999999999999999999976443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=290.87 Aligned_cols=249 Identities=31% Similarity=0.411 Sum_probs=197.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..|+..+.||+|+||.||+|... +++.+|+|.+... ......++.+|+++++.++|+|++++++++.+....++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45778899999999999999865 6788999998643 2233467889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+. ++|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 466555532 2345889999999999999999999998 999999999999999999999999998765322
Q ss_pred ccccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhhcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 706 (795)
....+++.|+|||.+. ...++.++|||||||++++|++|+.|+....... ..... ....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-------hcCC----
Confidence 2346788999999874 3567889999999999999999999875432111 11000 0000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+. .........+.+++.+||+.+|++||++.+++++....
T Consensus 232 -~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 232 -PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred -CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00 01123445678999999999999999999999987665
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=291.02 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=192.7
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
|...++||+|+||.||+|... +++.+|+|++..... ...+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999764 688999999865322 3345688999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+.+ ++.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 965 55555432 2346899999999999999999999998 99999999999999999999999999864321
Q ss_pred ccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.....++..|+|||.+. ...++.++||||||+++++|++|..|+...+...... .. .. ... +.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~--~~---~~-~~~-----~~ 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HI---AQ-NDS-----PT 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HH---Hh-cCC-----CC
Confidence 22356889999999874 4568899999999999999999999875433211110 00 00 000 00
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
. .....+..+.+++.+||+.+|.+||++.+++.+-
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 1112234578999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=287.48 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=196.1
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEeec
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
|++.+.||+|++|.||+|... +++.+|||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999875 578899999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
+++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778877764322 346899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccc-----ccccc-chhhc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWD-----LWKDD-RAWEL 705 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~-----~~~~~-~~~~~ 705 (795)
.....++..|+|||.+.. ..++.++|+||||+++++|++|+.|+......... ....... .+... .....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123467889999998754 56789999999999999999999888654422111 0000000 00000 00000
Q ss_pred cCccc-------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 706 IDPIL-------QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 706 id~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
++..+ ...........+.+++.+|++.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000 001111124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=295.37 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=199.5
Q ss_pred HHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee-ccee
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEK 546 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 546 (795)
...+++|++.++||+|+||.||+|... +++.+|||++.+. .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999755 7899999988653 23345678899999999999999999998876 5678
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 457877663 345788889999999999999999998 99999999999999999999999999975
Q ss_pred cCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccc--------ccc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRA--------WDL 696 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~--------~~~ 696 (795)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+........ ...... ...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 123467889999998766 5689999999999999999999999865432110 000000 000
Q ss_pred ccccchhhccCccc-cchhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 697 WKDDRAWELIDPIL-QNEAS-----YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 697 ~~~~~~~~~id~~l-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.......+.+.... ....+ ...+..+.+++.+|++.+|++||++.+++.+-.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 00000000000000 00001 1234678899999999999999999999988433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=287.72 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=198.0
Q ss_pred CCcccccccCCCceeEEeeec----cCCceEEEEEecccC----cccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 476 NFSTENKLGEGGFGPVYKGRL----HNGQEVAVKRLSSQS----GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
+|++.+.||+|++|.||+++. .+++.+|||.+.+.. ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999964 256889999987532 23456788999999999 599999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888742 346889999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCccccceeeecccCCcCChhhhccCC--CCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchh
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 703 (795)
+...... ......++..|+|||.+.+.. .+.++||||||+++++|++|..|+....... ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 5433211 122346889999999987654 7889999999999999999999985432111 000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..... ....+...+..+.+++.+||+.+|++|||+.++.+.|+-
T Consensus 223 ~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 223 RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00000 011122234567899999999999999998877766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=285.84 Aligned_cols=262 Identities=26% Similarity=0.360 Sum_probs=199.2
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
|+..+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999775 58999999998653 334567889999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 48888874321 46899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccc--------cccccc----
Q 040413 634 SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRA--------WDLWKD---- 699 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~--------~~~~~~---- 699 (795)
......++..|+|||.+... .++.++||||||++++||++|+.|+........ ...... +.....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 11223457789999998776 889999999999999999999988865432111 000000 000000
Q ss_pred cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
......................+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000001111225678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=295.22 Aligned_cols=265 Identities=24% Similarity=0.264 Sum_probs=193.5
Q ss_pred CCcccccccCCCceeEEeeecc-C--CceEEEEEecccC--cccHHHHHHHHHHHHhc-CCCceeeeeeeeeec----ce
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-N--GQEVAVKRLSSQS--GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL----EE 545 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 545 (795)
+|++.+.||+|+||.||+++.. . ++.+|+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999765 4 7789999987532 22356788999999999 599999999875433 45
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++++|++. ++|.+.+. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 57777663 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc--ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccc----
Q 040413 626 MFGGDEL--QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLW---- 697 (795)
Q Consensus 626 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~---- 697 (795)
.+..... ........|+..|+|||.+.+ ..++.++|+||||+++++|++|+.|+...+.... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 111233578999999998765 4689999999999999999999999865442111 0000000000
Q ss_pred ----cccchhhcc---Cc---cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 ----KDDRAWELI---DP---ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ----~~~~~~~~i---d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
........+ .. .............+.+++.+|++.+|++|||+.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000 00 000000111245688999999999999999999998874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=284.15 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=196.4
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-----SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
+|.+.++||+|+||.||++... .+..+++|+++.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999765 3455666665432 223345677899999999999999999999999999999
Q ss_pred EeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 550 YEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
+||+++++|+.++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998887542 23457999999999999999999999998 999999999999975 569999999997654
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.... ......+++.|+|||.+....++.++|+||||+++++|++|..|+........ .... ... ..+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~~~----~~~-----~~~ 223 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRI----VEG-----PTP 223 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH----HcC-----CCC
Confidence 3221 12234678899999999888889999999999999999999998854321111 0000 000 001
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+.++.+++.+|++.+|++||++.|++++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1123445678899999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=298.38 Aligned_cols=263 Identities=24% Similarity=0.297 Sum_probs=199.0
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce---
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE--- 545 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 545 (795)
...++|++.++||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34578999999999999999999875 6889999998653 22344668889999999999999999998876654
Q ss_pred ---eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 546 ---KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 546 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.++|+||+ +++|.+++. ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 568877763 246899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc-----
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD----- 695 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~----- 695 (795)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..+.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99865422 223467889999998865 4678999999999999999999999865432111 10000000
Q ss_pred ---cccccchhhccCc---cccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 696 ---LWKDDRAWELIDP---ILQN---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 696 ---~~~~~~~~~~id~---~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+........+.. .... ......+..+.+++.+||+.+|++|||+.||++|-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 0000000000000 0000 00112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=270.24 Aligned_cols=257 Identities=19% Similarity=0.224 Sum_probs=197.7
Q ss_pred hccCCccc-ccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeee----cce
Q 040413 473 ATANFSTE-NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE----LEE 545 (795)
Q Consensus 473 ~~~~y~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 545 (795)
.+++|++. ++||-|-.|.|-...++ +++++|+|++... ...++|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677654 58999999999999665 7899999998642 4578899877666 59999999999764 345
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeeccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFG 622 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFG 622 (795)
+.+|||.|+||.|...+.+. ....+++.++-.|++||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 68999999999998877553 4567999999999999999999999998 999999999999964 5679999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+|+.-.. .....+.+-||.|.|||++....|+..+|+||+||++|-|++|.+||-......+ .--.......+ .
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~rI~~g-q 283 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKRRIRTG-Q 283 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHhHhhcc-C
Confidence 9986442 2334457889999999999999999999999999999999999999853321111 00000000000 0
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.++- ++.=...++...++|+.+|..+|.+|.|+.++++|-+-
T Consensus 284 y~FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 284 YEFP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred ccCC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 0000 00012345677899999999999999999999998543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=282.26 Aligned_cols=241 Identities=26% Similarity=0.334 Sum_probs=199.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
..+|..+.+||+|+||.|.+|..+ +.+.+|||++++.. ....+--..|-++|... +-|.++++..+|+..+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888899999999999999766 56779999998752 23345566788888777 46789999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+.||+|--+++ +-..+-+..+..++.+||-||-+||++| ||+||||.+|||++.+|++||+|||+.+.--
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999977664 4456778899999999999999999999 9999999999999999999999999997421
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....+.+.+|||.|+|||++...+|+..+|.||+||+||||+.|++||+..+++++... +++.
T Consensus 502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a--------------I~eh 565 (683)
T KOG0696|consen 502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA--------------IMEH 565 (683)
T ss_pred --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------------HHHc
Confidence 112345678999999999999999999999999999999999999999998775554221 1111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCC
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRP 738 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 738 (795)
.. .++...+.+...++...|..+|.+|.
T Consensus 566 nv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 24555667788899999999999994
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=249.39 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=196.2
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+|...++||+|.||+||+|+.. +.+.||+|.++-. ++.......+|+.+|+.++|.|||++++....+..+.||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5677789999999999999765 5788999988654 333456789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
|.. .|..+. + .-+..++.+.+..++.|+++||.++|+++ +.|||+||.|.||+.+|.+|++|||+++.++....
T Consensus 83 cdq-dlkkyf-d-slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYF-D-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHH-H-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 344333 1 24567899999999999999999999998 99999999999999999999999999998864421
Q ss_pred ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHh-CCCCCCCCCCcc-hhhcccccccccccc---hhhcc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDS-LTLLGRAWDLWKDDR---AWELI 706 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~-~~~~~~~~~~~~~~~---~~~~i 706 (795)
....-+-|.+|++|+++.+. -|+...|+||-|||+.|+.. |++.|+..+.++ ...+-+......++. +.++-
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 12234678999999998774 58999999999999999986 555555554322 222212111111111 11111
Q ss_pred Cccccch---------hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 707 DPILQNE---------ASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
|-..... ..+.....=.+++++.+.-+|..|.++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111110 111222234688999999999999999999876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=266.81 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=195.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 551 (795)
++.+.+..||.|.-|.|++++.+ .|..+|||.+.+. +.+..+++...+.++.+-+ .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45566778999999999999776 6889999999775 4556677888888777765 8999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
.|... ++.++.. -..++++..+-++...+.+||.||.++. .|||||+||+|||+|+.|++||+|||++-.+-...
T Consensus 172 lMs~C-~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMSTC-AEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 88532 3333322 2346888888899999999999998764 59999999999999999999999999997654433
Q ss_pred cccceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
. ..+..|-+.|||||.+.. ..|+.++||||||+.++||.||+.|+..-+.+-..+... .. + . .|
T Consensus 247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv----ln-~-e----PP 313 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV----LN-E-E----PP 313 (391)
T ss_pred c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH----Hh-c-C----CC
Confidence 2 234578999999998854 468999999999999999999999998644322211100 01 0 0 12
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+.... ..+..+++++..||+.|+.+||...++++|
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222111 145678899999999999999999999987
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=276.21 Aligned_cols=240 Identities=28% Similarity=0.365 Sum_probs=194.4
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
||+|+||.||++... +++.+|+|++.+.. ....+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999765 58899999987643 23466899999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceee
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 638 (795)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 8888432 36899999999999999999999988 9999999999999999999999999998754332 12234
Q ss_pred ecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 639 ~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
..++..|+|||...+...+.++|+||||+++|+|++|+.|+........ ..... .. ....+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~----~~----------~~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI--YEKIL----KD----------PLRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHh----cC----------CCCCCCCC
Confidence 5688899999999888889999999999999999999999864432111 10000 00 00112222
Q ss_pred HHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 040413 719 LNRYINVALLCVQEDAVDRPTM---FEVVSM 746 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt~---~evl~~ 746 (795)
+..+.+++.+|+..+|++||++ .++++|
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 5677899999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=294.74 Aligned_cols=244 Identities=23% Similarity=0.259 Sum_probs=198.6
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.++.|.+...+|.|+|+.|-.+.+. +++..++|++.+.. ....+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3578888889999999999888654 78999999998752 3345677676666 6999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE-cCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DFGla~~~~~ 629 (795)
|.+.++-+-+.+... +....++..|+.+|+.|+.|||++| +|||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999998776655322 2333778889999999999999999 9999999999999 6899999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ....+-|..|.|||+.....|+.++|+||||++||+|++|+.|+.....+ ..+.. ..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~----------------~i 526 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT----------------RI 526 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH----------------hh
Confidence 3 23356789999999999999999999999999999999999998754322 11111 11
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+......+....+|+.+||+.||.+||+|.++..|-.-
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1122234556778899999999999999999999988655
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=312.20 Aligned_cols=145 Identities=29% Similarity=0.429 Sum_probs=131.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|.+.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++.+......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999776 68999999997542 233567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
||+.+++|.+++.. ...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999988843 345889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=286.90 Aligned_cols=269 Identities=22% Similarity=0.277 Sum_probs=221.4
Q ss_pred hccCCcccccccCCCceeEEeeeccCCc-eEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQ-EVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...+++.+..||-||||.|=++..+... .+|+|++++. .....+.+..|-.||...+.|.||++|..|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3456777889999999999998765433 4889988764 44556789999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
.||-|-||.|-..+. .+..++..++..++..+.+|++|||.++ ||+|||||+|.+++.+|-+||.|||+|+.+.
T Consensus 498 LmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999988884 4467999999999999999999999999 9999999999999999999999999999887
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id 707 (795)
.. ..+.+.+|||.|.|||++.....+.++|.||||+++|||++|.+||...++... .++-... |
T Consensus 572 ~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------------d 636 (732)
T KOG0614|consen 572 SG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------------D 636 (732)
T ss_pred cC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------------h
Confidence 54 356678999999999999999999999999999999999999999987663322 2221111 1
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhhcc--------cCCCCCCCCCCcccc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSMLTNE--------TVNLPHPQQPAFSSI 765 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~--------~~~~~~~~~p~~~~~ 765 (795)
.-..|..+.....+++.++...+|.+|.- +.+|-+|-+-+ ...+++|-+|.....
T Consensus 637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p 704 (732)
T KOG0614|consen 637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP 704 (732)
T ss_pred ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence 12244556777889999999999999975 78888885432 235566666665443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=265.94 Aligned_cols=268 Identities=22% Similarity=0.377 Sum_probs=197.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec--------
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-------- 543 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 543 (795)
..|+...+||+|.||.||+|+.+ ++++||+|++--. .+.-.....+|+.+|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45777789999999999999876 5788999876432 222345678999999999999999999988642
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++||.+++.. |.-++.+ ....++..++.+++.++..||.|+|... |+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~cehD-LaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEHD-LAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhhh-HHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 2468999999763 4444422 3356889999999999999999999887 99999999999999999999999999
Q ss_pred ccccCCCcc--ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccc-------
Q 040413 624 AKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGR------- 692 (795)
Q Consensus 624 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~------- 692 (795)
++.+..... .......+-|.+|++||.+.+ ..|+++.|||.-|||+.||.++.+.+....+.. +.++..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987753322 222334567999999998766 689999999999999999999998876554322 222211
Q ss_pred -ccccccccchhhcc--Cccccchhh--HHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 693 -AWDLWKDDRAWELI--DPILQNEAS--YLI------LNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 693 -~~~~~~~~~~~~~i--d~~l~~~~~--~~~------~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
+|.....-..++.+ .|...+... .+. ..+.+++++.++..||.+|+++++++.|--
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 22222222222222 111111111 111 236789999999999999999999998853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.64 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=201.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-C-C----ceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-H-R----NLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 546 (795)
+.+|.+..++|+|+||.|-+..+. .+..||||+++. .....+..+-|+++|+++. + | -++.+.++|.-..+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 689999999999999999999654 578899999864 3345567888999999993 2 3 278888899999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc---------------
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD--------------- 611 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~--------------- 611 (795)
++|+|.+ |-|+.+++... ...+++...+..++.|+++++++||+.+ ++|-||||+|||+-
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 55788888543 4567999999999999999999999998 99999999999993
Q ss_pred -----CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCC-c
Q 040413 612 -----KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT-D 685 (795)
Q Consensus 612 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~-~ 685 (795)
.+..+||+|||.|..-... ...++.|..|+|||++.+..++.++||||+||||+|+.+|...|..... +
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1345899999999864322 2457899999999999999999999999999999999999988865542 2
Q ss_pred chhhcccccc--------------ccccc--------------chhhccCcc-ccchhhHHHHHHHHHHHHHhcccCCCC
Q 040413 686 SLTLLGRAWD--------------LWKDD--------------RAWELIDPI-LQNEASYLILNRYINVALLCVQEDAVD 736 (795)
Q Consensus 686 ~~~~~~~~~~--------------~~~~~--------------~~~~~id~~-l~~~~~~~~~~~l~~li~~cl~~dP~~ 736 (795)
.+..++.... ....+ .+.+..+|. ........+..+|.+|++.||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2222211111 00000 011111111 011122345667999999999999999
Q ss_pred CCCHHHHHHH
Q 040413 737 RPTMFEVVSM 746 (795)
Q Consensus 737 RPt~~evl~~ 746 (795)
|+|+.|+++|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=273.14 Aligned_cols=219 Identities=19% Similarity=0.124 Sum_probs=176.3
Q ss_pred CCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcceeecc
Q 040413 486 GGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD 564 (795)
Q Consensus 486 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 564 (795)
|.+|.||++++. +++.+|+|++.+.. .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999765 78999999997642 344566666667899999999999999999999999999999888743
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCC
Q 040413 565 TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644 (795)
Q Consensus 565 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 644 (795)
...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 235899999999999999999999998 9999999999999999999999999887654321 12345778
Q ss_pred cCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHH
Q 040413 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYIN 724 (795)
Q Consensus 645 y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
|+|||.+....++.++|+||+|+++|||++|+.++........ .......+......+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------------THTTLNIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------------cccccCCcccCCHHHHH
Confidence 9999999888899999999999999999999977643211000 00000112223456889
Q ss_pred HHHHhcccCCCCCCCH
Q 040413 725 VALLCVQEDAVDRPTM 740 (795)
Q Consensus 725 li~~cl~~dP~~RPt~ 740 (795)
++.+|++.||++||++
T Consensus 208 li~~~l~~dp~~R~~~ 223 (237)
T cd05576 208 LLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHccCCHHHhcCC
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=295.63 Aligned_cols=254 Identities=29% Similarity=0.407 Sum_probs=207.7
Q ss_pred CCcccccccCCCceeEEeeec-cCC----ceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRL-HNG----QEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~-~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.....++||+|+||.||+|.+ ..+ -+||||++... ..+..+++.+|+.+|.++.||||++|+++|.... ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 455668999999999999954 443 36899988653 5566789999999999999999999999998877 8899
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
.+||+.|.|.++++. .+..+..+....|..|||+|+.|||++. ++||||..+||||..-.++||.|||+|+....
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999864 4567888999999999999999999988 99999999999999999999999999998876
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
...........-.+.|||-|.+....|+.++|||||||.+||++| |..|.+....+++ ..++..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI---------------~dlle~ 915 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI---------------PDLLEK 915 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh---------------hHHHhc
Confidence 554433333445677999999999999999999999999999997 7777654432222 111221
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
-.+-..++....++..++.+||..|+..||+++++...+...
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 111234555677889999999999999999999999887654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.32 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=212.9
Q ss_pred cHHHHHHhccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeee-
Q 040413 466 SLASVSAATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE- 542 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 542 (795)
.+.++..-+..|++.+.||.|.+|.||+++. ++++..|+|++... ....+++..|.++|+.+ .|||++.+++++.-
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445556678899999999999999999965 47899999998764 34557899999999998 59999999999863
Q ss_pred ----cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 543 ----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 543 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
+++++||||||.+||..+++.... ...+.|+.+..|++.++.||.+||... ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 678999999999999999886654 778999999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~ 693 (795)
+|||++..++.... ...+..|||.|||||++.. ..|+.++|+||||++..||--|.+|+-..+..-..
T Consensus 165 vDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL----- 237 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL----- 237 (953)
T ss_pred eeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----
Confidence 99999987764432 3345689999999998853 45788999999999999999999997644421110
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+.-.+ +|-..-..+..-.+++.++|..||..|-++||++.++++|
T Consensus 238 ---F~IpR-----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 ---FLIPR-----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---ccCCC-----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 00000 1111112345567889999999999999999999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=263.41 Aligned_cols=282 Identities=23% Similarity=0.346 Sum_probs=215.8
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
...+|.++++||+|+|++|..++++ +.+.+|+|++++. ..+..+-.+.|-.+.... +||.+|.+..+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999876 6889999999875 344556677888888776 6999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+|.||++||+|--++ ++.++++++.+..+..+|..||.|||+.| ||+||||.+|||+|.+|++||+|+|+.+.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999986555 56678999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc-c
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL-I 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-i 706 (795)
-. ....+.+.+|||.|.|||++.+..|...+|.|+|||+++||+.|+.||+.-..+..... .++...+. +
T Consensus 402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n-------tedylfqvil 472 (593)
T KOG0695|consen 402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN-------TEDYLFQVIL 472 (593)
T ss_pred CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc-------hhHHHHHHHh
Confidence 21 22345678999999999999999999999999999999999999999985432111000 00111111 1
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCC------CHHHHHHH--hhc------ccCCCCCCCCCCcccccccccc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRP------TMFEVVSM--LTN------ETVNLPHPQQPAFSSIRGLKNT 771 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP------t~~evl~~--L~~------~~~~~~~~~~p~~~~~~~~~~~ 771 (795)
...+ ..+...+-+...++..-|..||.+|. -..++-.| ++. +.+.+-+|..|.....+++...
T Consensus 473 ekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~f 549 (593)
T KOG0695|consen 473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNF 549 (593)
T ss_pred hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCcccc
Confidence 1111 12333444566788889999999984 23444433 111 2245566777777666655443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.81 Aligned_cols=276 Identities=25% Similarity=0.339 Sum_probs=205.1
Q ss_pred CCCCCCcccHHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHh--cCCCceee
Q 040413 458 RDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAK--LQHRNLVR 535 (795)
Q Consensus 458 ~~~~~~~~~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~ 535 (795)
.++.+|.+--.+ ...+..+.+.||+|-||.||+|+++ |+.||||++...+ .+.+.+|.+|.+. |+|+||+.
T Consensus 197 SGSGlplLVQRT---iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 197 SGSGLPLLVQRT---IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred CCCCchhHhHHh---hhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhh
Confidence 345555443333 3467888999999999999999986 7899999997543 4568888888876 49999999
Q ss_pred eeeeeeec----ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCcEEeCCCCCC
Q 040413 536 LLGCCIEL----EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-----YSRLRVIHRDLKAS 606 (795)
Q Consensus 536 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~iiH~Dikp~ 606 (795)
+++.-..+ .+++||.+|.+.|||.+|| .+..++.+..++++..+|.||+|||. +|.+.|.|||||..
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 98875433 3689999999999999999 44679999999999999999999995 57778999999999
Q ss_pred cEEEcCCCCceeeccccccccCCC--ccccceeeecccCCcCChhhhccCC----C-C-ccCCeeehhHHHHHHHhCC--
Q 040413 607 NILLDKDMNPKISDFGMAKMFGGD--ELQSKTKRIVGTYGYMSPEYAQQGL----F-S-IKSDVFSFGVLLLETLSSK-- 676 (795)
Q Consensus 607 NIll~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-s-~k~DvwslG~ll~elltg~-- 676 (795)
||||..++...|+|+|+|...... ......+..+||.+|||||++.... + + ..+||||||.++||+....
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 999999999999999999876543 3334455679999999999986532 2 2 4589999999999997532
Q ss_pred --------CCCCCCC--CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 677 --------RNTDFSN--TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 677 --------~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.|+...- ++.... +.+..-..+....++.. -.+.+....+.++++.||..+|.-|.|+-.+-+.
T Consensus 426 ggi~eey~~Pyyd~Vp~DPs~ee---MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVPSDPSFEE---MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred CCEehhhcCCcccCCCCCCCHHH---HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 2221100 111111 11111111111111111 2334567788999999999999999999998888
Q ss_pred hhcc
Q 040413 747 LTNE 750 (795)
Q Consensus 747 L~~~ 750 (795)
|..+
T Consensus 500 l~~l 503 (513)
T KOG2052|consen 500 LAKL 503 (513)
T ss_pred HHHH
Confidence 8766
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=251.83 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=198.4
Q ss_pred hccCCcccccccCCCceeEEeee-ccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecc--eeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELE--EKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 548 (795)
..++|++.+++|+|.|+.||.|. ..+.++++||++++ -..+.+++|++||..|. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999995 45788999999975 33567999999999997 999999999998755 4579
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeecccccccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKMF 627 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFGla~~~ 627 (795)
|+||+.+.+...+. ..++...+..++.++++||.|+|+.| |+|||+||.|++||.. ..++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999988765543 45778889999999999999999999 9999999999999965 56999999999988
Q ss_pred CCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh--
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE-- 704 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 704 (795)
..... .+-.+.+..|--||.+.. ..|+..-|+|||||++..|+..+.||.........++ ...+.+..++...
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV-kIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-KIAKVLGTDELYAYL 259 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH-HHHHHhChHHHHHHH
Confidence 65532 223467788999998865 6788999999999999999999999865443221111 1111111111110
Q ss_pred -----ccCccc----------------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 705 -----LIDPIL----------------QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 705 -----~id~~l----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+||.. ..+.......+.++++.++|..|..+|||+.|.+.|-
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 112211 1111112235688999999999999999999998873
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=298.59 Aligned_cols=259 Identities=29% Similarity=0.405 Sum_probs=206.2
Q ss_pred cCCcccccccCCCceeEEeeecc----C----CceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH----N----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~----~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
++.++.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +|+||+.+++.|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 44466679999999999999743 1 456999999765 335678899999999999 6999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-----------KE--SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++|.||+..|+|..+++... .. ..++......++.|||.|++||++.. +|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999986543 00 24888999999999999999999988 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccce-eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKT-KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTL 689 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~ 689 (795)
.+..+||+|||+|+........... ....-...|||||.+....|+.|+||||||++||||+| |..|+..-..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~----- 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP----- 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----
Confidence 9999999999999976554433221 11113445999999999999999999999999999998 5566643110
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..++.+.+.+-.+.+.|..+..+++++++.|++.+|++||++.++++.|+..
T Consensus 528 ---------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ---------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0111122223233344555677889999999999999999999999999884
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-32 Score=264.76 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=194.5
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+.+.+..||.|+||+|++..++ .|+..|||+++.... ...+++..|.....+- +.||||+++|.+..+...++.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3445678999999999999775 799999999987643 5667788888776665 689999999999999999999999
Q ss_pred cCCCCcceeecc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 553 MPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|. .||+.+... ..+...+++.-.-.|.....+||.||... ++|||||+||+||||+..|.+||+|||++-.+.+.
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 84 456544321 13456788888888999999999999874 47999999999999999999999999998765433
Q ss_pred ccccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .+.-.|-..|||||.+.. ..|+.++||||||+.|||+.||+.|...-+. . ..+...... +.. |
T Consensus 222 iA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-v---feql~~Vv~-gdp-----p 288 (361)
T KOG1006|consen 222 IA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-V---FEQLCQVVI-GDP-----P 288 (361)
T ss_pred HH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-H---HHHHHHHHc-CCC-----C
Confidence 21 223468899999998864 3489999999999999999999999764331 1 111111111 111 1
Q ss_pred ccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQ-NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+. .....+....+..+|..||..|.++||...++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 221 12224456678999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.54 Aligned_cols=238 Identities=29% Similarity=0.362 Sum_probs=193.0
Q ss_pred CceeEEeeecc-CCceEEEEEecccCccc-HHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcceeecc
Q 040413 487 GFGPVYKGRLH-NGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD 564 (795)
Q Consensus 487 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 564 (795)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 58999999998765444 78999999999999999999999999999999999999999999988744
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCC
Q 040413 565 TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644 (795)
Q Consensus 565 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 644 (795)
. ..+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 3 22889999999999999999999998 9999999999999999999999999998765432 2234568889
Q ss_pred cCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhH-HHHHHHH
Q 040413 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY-LILNRYI 723 (795)
Q Consensus 645 y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~-~~~~~l~ 723 (795)
|++||.+....++.++|||+||+++++|++|..|+........ .... ... ......... ..+.++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~----~~~--------~~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKK----IGK--------PKPPFPPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH----Hhc--------cCCCCccccccCCHHHH
Confidence 9999999888899999999999999999999998865321111 0000 000 000000000 0446788
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 040413 724 NVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 724 ~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+++.+|+..+|++||++.+++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHccCCchhccCHHHHhhC
Confidence 99999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=294.35 Aligned_cols=265 Identities=19% Similarity=0.200 Sum_probs=169.0
Q ss_pred hccCCcccccccCCCceeEEeeecc-C----CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeee------ee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-N----GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC------CI 541 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 541 (795)
..++|++.++||+|+||.||+|.+. + ++.||||++..... .+....| .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999875 4 68999999864321 1112221 1122222222222111 24
Q ss_pred ecceeEEEEeecCCCCcceeeccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCC
Q 040413 542 ELEEKILIYEYMPNKSLDIFLFDTPK-----------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 542 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dik 604 (795)
+....++|+||+++++|.+++..... ........+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999887753211 011223446689999999999999998 9999999
Q ss_pred CCcEEEcC-CCCceeeccccccccCCCccccceeeecccCCcCChhhhccC----------------------CCCccCC
Q 040413 605 ASNILLDK-DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG----------------------LFSIKSD 661 (795)
Q Consensus 605 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D 661 (795)
|+|||++. ++.+||+|||+|+.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 58999999999986543221 122346789999999965321 2445679
Q ss_pred eeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch------hhHHHHHHHHHHHHHhcccCCC
Q 040413 662 VFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE------ASYLILNRYINVALLCVQEDAV 735 (795)
Q Consensus 662 vwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~------~~~~~~~~l~~li~~cl~~dP~ 735 (795)
||||||++|||+++..+.+.........+... . .........+.+....+ ..........+|+.+||+.||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN-D-YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhc-C-CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999987655331100000000000 0 00000000111110000 0000122345899999999999
Q ss_pred CCCCHHHHHHHh
Q 040413 736 DRPTMFEVVSML 747 (795)
Q Consensus 736 ~RPt~~evl~~L 747 (795)
+|||+.|+++|-
T Consensus 440 kR~ta~e~L~Hp 451 (566)
T PLN03225 440 QRISAKAALAHP 451 (566)
T ss_pred cCCCHHHHhCCc
Confidence 999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=274.99 Aligned_cols=203 Identities=25% Similarity=0.380 Sum_probs=175.1
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.-|..++.||-|+||.|.+++. ++...+|+|.|++.+ ......++.|..||.....+-||+||..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4577788999999999999954 456779999998763 456677899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC--
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG-- 628 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~-- 628 (795)
+|++||++-.+|. +-.-++++.++.++.++..|+++.|..| +|||||||+|||||.+|++||+|||++.-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988874 3457899999999999999999999999 9999999999999999999999999985331
Q ss_pred -------CCcccc-------------------------------ceeeecccCCcCChhhhccCCCCccCCeeehhHHHH
Q 040413 629 -------GDELQS-------------------------------KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLL 670 (795)
Q Consensus 629 -------~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ 670 (795)
.+.... .....+||+.|+|||++....++.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 100000 011357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 040413 671 ETLSSKRNTDFSN 683 (795)
Q Consensus 671 elltg~~p~~~~~ 683 (795)
||+.|+.||....
T Consensus 863 em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 863 EMLVGQPPFLADT 875 (1034)
T ss_pred HHhhCCCCccCCC
Confidence 9999999997655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=282.21 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=181.3
Q ss_pred ccCCcccccccCCCceeEEeeec-----------------cCCceEEEEEecccCcccHHH--------------HHHHH
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-----------------HNGQEVAVKRLSSQSGQGLEE--------------FKNEI 522 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E~ 522 (795)
.++|++.++||+|+||.||+|.. ..++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999953 235679999986543222222 34477
Q ss_pred HHHHhcCCCce-----eeeeeeeee--------cceeEEEEeecCCCCcceeeccCC---------------------CC
Q 040413 523 KLIAKLQHRNL-----VRLLGCCIE--------LEEKILIYEYMPNKSLDIFLFDTP---------------------KE 568 (795)
Q Consensus 523 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~ 568 (795)
.++.+++|.++ ++++++|.. ....+|||||+++++|.+++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77778876654 667777653 356799999999999988875321 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCCh
Q 040413 569 SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648 (795)
Q Consensus 569 ~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 648 (795)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 34567889999999999999999998 999999999999999999999999999765432211 11122357899999
Q ss_pred hhhccCC--------------------C--CccCCeeehhHHHHHHHhCCC-CCCCCC--Ccchhhccc---cccccccc
Q 040413 649 EYAQQGL--------------------F--SIKSDVFSFGVLLLETLSSKR-NTDFSN--TDSLTLLGR---AWDLWKDD 700 (795)
Q Consensus 649 E~~~~~~--------------------~--s~k~DvwslG~ll~elltg~~-p~~~~~--~~~~~~~~~---~~~~~~~~ 700 (795)
|.+.... + ..+.||||+||++++|++|.. |+.... ......... .|+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875322 1 234799999999999999875 543211 001100000 11111100
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHhh
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDA---VDRPTMFEVVSMLT 748 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~L~ 748 (795)
. ..-...........+++.++|..+| .+|+|+.|+++|-.
T Consensus 460 ~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 460 K--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred C--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 0 0001112234567889999998765 68999999999854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=255.67 Aligned_cols=268 Identities=21% Similarity=0.293 Sum_probs=196.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----cee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
.+.+-.+.||.|+||+||.+.+. +|+.||+|++..- +-...+++.+|+++|..++|.|++..+++..-. +++
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34566789999999999999875 8999999998542 223457899999999999999999888776533 345
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
|.+.|.| ..+|+.+|. ....++.+.++-++.||++||.|||+.+ |.||||||.|.|++.+..+||+|||+|+.
T Consensus 133 YV~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 7788887 446777774 3456888999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhccccccccc------
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWK------ 698 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~------ 698 (795)
...++.... +.-+-|..|+|||++.+ ..|+.++||||.|||+.||+-.+-.|...+ .+.+.++.....-..
T Consensus 206 ee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 665443322 23467889999999987 579999999999999999998877766544 222222111100000
Q ss_pred --ccchhhccC--------ccccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 699 --DDRAWELID--------PILQN-EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 699 --~~~~~~~id--------~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
++.-.-++. +.+.. ..+.....+..++...++.++|++|.+..+.+.++-..
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 000000000 00100 01112233567888899999999999999999987443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=230.37 Aligned_cols=110 Identities=54% Similarity=0.765 Sum_probs=81.6
Q ss_pred CCeEEEeecCCCCCCCC--CceEEEeecCCeEEecCCCceeeeecccCC-C-CccEEEEecCCCeeeecCCCCCCCCCce
Q 040413 70 SDTVVWVANRNRPIFDS--NATLTIGSSGNLVILNLKNGTIWSSNMTRK-A-GSPVAQLLDTGNLVLRDNFSSNSSEGHL 145 (795)
Q Consensus 70 ~~~~vW~anr~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~-~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~ 145 (795)
++||||+|||+.|+.+. .++|.|+.||+|+|++..+.++|+|+.+.+ . ..+.|+|+|+|||||+|. .+.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEE
Confidence 46999999999999653 489999999999999999999999944433 3 478999999999999984 68999
Q ss_pred eeccCCCCCccCCCCccccccccCcceEEEeeccCCCCC
Q 040413 146 WQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPS 184 (795)
Q Consensus 146 WqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps 184 (795)
||||||||||+||||+|+.+..++.+..++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888778899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=276.35 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=187.9
Q ss_pred CcccccccCCCce-eEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeecC
Q 040413 477 FSTENKLGEGGFG-PVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 477 y~~~~~LG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
|.-.+.+|.|..| .||+|... +++||||++-. .-.+-..+|+..|+.- +|||||+.++.=.+...+|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445679999988 56899774 68999999854 3345678999999988 5999999998888888899999998
Q ss_pred CCCcceeeccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---C--CCceeeccccccccC
Q 040413 555 NKSLDIFLFDTPKE-SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---D--MNPKISDFGMAKMFG 628 (795)
Q Consensus 555 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~--~~~kl~DFGla~~~~ 628 (795)
..+|++++...... ........+.+..|+++||++||+.+ ||||||||.||||.. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56888888653111 11111455788999999999999988 999999999999975 2 568999999999876
Q ss_pred CCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhC-CCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 629 GDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.+.. ........||.+|+|||++....-+.++|||||||++|+.++| ..||+..-..+...+.....+.. +
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~-------L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH-------L 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee-------e
Confidence 5433 2224456899999999999998888899999999999999987 77887543333332222111110 1
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+ ..+. +..+||.+|+..+|..||++.+|+.|
T Consensus 736 ~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EP------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cc------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 1111 67799999999999999999999886
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=235.29 Aligned_cols=211 Identities=38% Similarity=0.610 Sum_probs=183.9
Q ss_pred ccCCCceeEEeeecc-CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcce
Q 040413 483 LGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDI 560 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 560 (795)
||+|.+|.||++... +++++++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999876 4899999999765432 45789999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCCCccccceeee
Q 040413 561 FLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGGDELQSKTKRI 639 (795)
Q Consensus 561 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 639 (795)
++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 874321 46889999999999999999999998 999999999999999 89999999999987643321 12234
Q ss_pred cccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHH
Q 040413 640 VGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718 (795)
Q Consensus 640 ~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 718 (795)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 678899999998877 888999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 719 LNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 719 ~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+.+++..|++.+|++||++.+++++|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=216.02 Aligned_cols=108 Identities=41% Similarity=0.953 Sum_probs=102.9
Q ss_pred EeeCCCCceeeccCCCC--cccccceEeecCCeeEEEEecCCCCeeEEEEEccCCcEEEEEEecCCCcEEEEEeccCccc
Q 040413 210 LCSGPWNGVAFQAAPSY--SYLYEPTVVDNEDEIYYRYDSYNSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDYFC 287 (795)
Q Consensus 210 ~~sg~w~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 287 (795)
||+|||||..|.++|.+ ...+.+.|+.+.+|+||+|...+.+.++|++|+++|++|++.|++.+++|.+.|++|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999944 4678899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcCCCCCCCCCCCcccccccc
Q 040413 288 QIFGSCGANSVCSIDKTPNCECLMGFKLES 317 (795)
Q Consensus 288 d~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 317 (795)
|+|+.||+||+|+.+..|.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988899999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=258.81 Aligned_cols=273 Identities=19% Similarity=0.226 Sum_probs=210.8
Q ss_pred ccHHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC------CCceeeee
Q 040413 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ------HRNLVRLL 537 (795)
Q Consensus 465 ~~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 537 (795)
|.+.--.....+|.+....|+|-|+.|..|.+. .++.||||+|... +.-.+.=++|++||++|+ .-|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 344444566789999999999999999999765 5889999999753 233345578999999995 34899999
Q ss_pred eeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCc
Q 040413 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNP 616 (795)
Q Consensus 538 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~ 616 (795)
.+|...++++||+|-+ ..+|.++|........|....+..++.|+.-||..|...+ |+|.||||+|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999977 4578888877777778888999999999999999999998 9999999999999976 457
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~ 695 (795)
||||||.|......+ .+.+.-+..|.|||++.+.+|+...|+||.||.||||.||+-.|++.....+ .+......
T Consensus 577 KLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999999998765443 2335567789999999999999999999999999999999998886653332 11111000
Q ss_pred cc-----------------------------ccc---chhhccCc------cc-----cchhhHHHHHHHHHHHHHhccc
Q 040413 696 LW-----------------------------KDD---RAWELIDP------IL-----QNEASYLILNRYINVALLCVQE 732 (795)
Q Consensus 696 ~~-----------------------------~~~---~~~~~id~------~l-----~~~~~~~~~~~l~~li~~cl~~ 732 (795)
.+ .+. .+...+.| .+ ...-...+...+.+|+..||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 00 000 00011111 01 1112234566789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 040413 733 DAVDRPTMFEVVSM 746 (795)
Q Consensus 733 dP~~RPt~~evl~~ 746 (795)
||++|.|..+.|+|
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=230.75 Aligned_cols=203 Identities=28% Similarity=0.388 Sum_probs=167.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 551 (795)
+...-+..||+|++|.|=+.++. +|+..|+|.+... +.+..++..+|+.+..+. ..|.+|.++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34445678999999999998765 7999999999765 345567788888877665 68999999999999999999999
Q ss_pred ecCCCCcceeecc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
.|. .||+.+... ..+...+++...-+|+..+..||.|||++ +.+||||+||+||||+.+|++||+|||++-.+.+.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 984 467655433 24567889999999999999999999996 46999999999999999999999999999766533
Q ss_pred ccccceeeecccCCcCChhhhcc----CCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ----GLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
... +--.|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++...
T Consensus 203 iAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 IAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 221 11357889999998743 479999999999999999999999987544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-28 Score=244.44 Aligned_cols=261 Identities=23% Similarity=0.251 Sum_probs=195.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee------cc
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE------LE 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 544 (795)
..+|..++.+|.|.- .|-.|.+. .++.||+|++... +....++..+|..++..++|+||++++.++.- -.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467888899999998 66666544 6899999988654 44567889999999999999999999999863 34
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
+.|+|||+|.. +|.+.+. -.++-+.+..|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 56999999954 5665553 34677889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC-Ccchhhcccccccc------
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLW------ 697 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~------ 697 (795)
+..... -..+.++.|..|.|||++-+..+...+||||+||++.||++|+--|.+.+ .++...+.....-.
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 865433 23445788999999999988889999999999999999999998776543 22211111100000
Q ss_pred ----------------cccchhhccC-ccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 ----------------KDDRAWELID-PIL--QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ----------------~~~~~~~~id-~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..-...+++. ... ..+.+......+.+++.+||-.+|++|.+++++|+|-
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0000001110 000 0111122344567899999999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-28 Score=257.54 Aligned_cols=198 Identities=24% Similarity=0.379 Sum_probs=168.4
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--------cccHHHHHHHHHHHHhcC---CCceeeeeee
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--------GQGLEEFKNEIKLIAKLQ---HRNLVRLLGC 539 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 539 (795)
....+|..+++||+|+||.|+.|.++ +..+|+||.+.+.. ......+-.|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34457999999999999999999876 56789999987642 111233567999999997 9999999999
Q ss_pred eeecceeEEEEeecC-CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 540 CIELEEKILIYEYMP-NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 540 ~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
|++++.+||++|... +-+|-++| .....+++.++..|++||+-|+++||+++ |||||||-+||.++.+|-+||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 999999999999764 45666776 34567999999999999999999999999 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCC
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~ 679 (795)
+|||.|.....+. ....+||..|.|||++.+..| ...-|||++|++||-++....|+
T Consensus 712 idfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9999998776554 345789999999999998776 45689999999999998877665
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=245.99 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=213.3
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeecc------CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeee
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 539 (795)
.+++.....+++...++-+|.||.||.|.+. +.++|-+|.++.. ++-....+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4555566678888889999999999999543 3466788877653 44567788999999999999999999999
Q ss_pred eeec-ceeEEEEeecCCCCcceeec-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC
Q 040413 540 CIEL-EEKILIYEYMPNKSLDIFLF-----DTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 613 (795)
Q Consensus 540 ~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~ 613 (795)
+.++ +..+.++.++.-|+|..++. +......+...+...++.|++.|++|||.++ |||.||.++|.+|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 45688899999999999997 5555667888889999999999999999999 9999999999999999
Q ss_pred CCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccc
Q 040413 614 MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGR 692 (795)
Q Consensus 614 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~ 692 (795)
.++||+|=.+++.+-..+++.....--....||+||.+....|+.++|||||||++|||+| |+.|...-+..+....
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-- 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-- 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--
Confidence 9999999999997766655544433344668999999999999999999999999999997 6777654332222111
Q ss_pred ccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+..-.+-..+..++.++..++.-||...|++||+.++++..|...
T Consensus 511 -------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 -------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111111123445778899999999999999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=242.59 Aligned_cols=133 Identities=26% Similarity=0.371 Sum_probs=111.3
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcC-----C---Cceeeeeeeeee--
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-----H---RNLVRLLGCCIE-- 542 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 542 (795)
..+|.+.++||-|.|++||++.+ ...+.||+|+.+. .+...+....|+++|+.++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36899999999999999999965 4678899999854 4556678899999999984 3 369999999975
Q ss_pred --cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 543 --LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 543 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
+.++++|+|++ |.+|-.+|... ..+.++...+++|++||+.||.|||.++ .|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56889999998 44555555443 3456889999999999999999999976 799999999999993
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=206.71 Aligned_cols=115 Identities=51% Similarity=0.731 Sum_probs=102.6
Q ss_pred ccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceeeee
Q 040413 32 RFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSS 111 (795)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t 111 (795)
++|.+|++|+|++|.|++|||.+..+...+.+|||++...++||.||++.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 578899999999999999999987664589999998766789999999998 4667899999999999999999999999
Q ss_pred cccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCC
Q 040413 112 NMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHP 152 (795)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (795)
++.+.....+|+|+|||||||++. .+++||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDS-----DGNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECC-----CCCEEEcCCCCC
Confidence 976534667899999999999985 578999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=242.12 Aligned_cols=266 Identities=23% Similarity=0.380 Sum_probs=199.6
Q ss_pred HHHHhccCCcccccccCCCceeEEeeecc----CCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeec
Q 040413 469 SVSAATANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIEL 543 (795)
Q Consensus 469 ~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 543 (795)
.+....+.|..+++||+|.|++||+|.+. ..+.||+|.+... +...++.+|+++|..+. +.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34556678999999999999999999653 4678999998754 34567999999999995 89999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFG 622 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFG 622 (795)
+...+|+||+++....++.. .++...+..+++.+++||.++|.+| ||||||||.|+|.+. .+.-.|+|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999998887773 4668899999999999999999999 999999999999974 5788999999
Q ss_pred cccccCCCc----------------------------------c--------ccceeeecccCCcCChhhhcc-CCCCcc
Q 040413 623 MAKMFGGDE----------------------------------L--------QSKTKRIVGTYGYMSPEYAQQ-GLFSIK 659 (795)
Q Consensus 623 la~~~~~~~----------------------------------~--------~~~~~~~~gt~~y~aPE~~~~-~~~s~k 659 (795)
+|....... + ........||++|+|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997221000 0 000112469999999998755 678999
Q ss_pred CCeeehhHHHHHHHhCCCCCCCCCCcchh------------------hcccccccccccc---hh------hccC--ccc
Q 040413 660 SDVFSFGVLLLETLSSKRNTDFSNTDSLT------------------LLGRAWDLWKDDR---AW------ELID--PIL 710 (795)
Q Consensus 660 ~DvwslG~ll~elltg~~p~~~~~~~~~~------------------~~~~~~~~~~~~~---~~------~~id--~~l 710 (795)
+||||.|+|++.+++++.||....++... +.+. ..+|.... .. +-++ ...
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~-~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGR-ILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCc-eeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999998644322211 1111 00111111 00 0110 001
Q ss_pred c-------c-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 Q-------N-EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~-------~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
. . ......+..+++++++|++.||.+|.|++|.|+|
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1 0 1111234468899999999999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=228.58 Aligned_cols=199 Identities=35% Similarity=0.496 Sum_probs=172.4
Q ss_pred CcccccccCCCceeEEeeeccC-CceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 477 FSTENKLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
|++.+.||+|++|.||++.... ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998764 889999999876544 67889999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999988743221 1789999999999999999999998 99999999999999999999999999987654320 1
Q ss_pred ceeeecccCCcCChhhh-ccCCCCccCCeeehhHHHHHHHhCCCCCCC
Q 040413 635 KTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSSKRNTDF 681 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwslG~ll~elltg~~p~~~ 681 (795)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 667788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=251.62 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|+....+|+|.||.||+|+++ .++..|+|+++-.......-+++|+-+++..+|||||.+++.+...+..++.|||+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 68999999999999999999875 78899999998877777888999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
.+|+|++.-+ ...++++.++....++.++||+|||+.+ =+|||||-.||++++.|.+|+.|||.+..+...-
T Consensus 95 gggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 95 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred CCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--
Confidence 9999998874 3467999999999999999999999998 8999999999999999999999999998765332
Q ss_pred cceeeecccCCcCChhhh---ccCCCCccCCeeehhHHHHHHHhCCCCCCCCC-CcchhhcccccccccccchhhccCc-
Q 040413 634 SKTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWKDDRAWELIDP- 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwslG~ll~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~id~- 708 (795)
.......||+.|||||+. ..+.|..++|||++|+...|+---++|..... .....++.. ...+|
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-----------S~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-----------SGFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-----------cCCCCC
Confidence 233457899999999976 56789999999999999999987776643222 111111110 01111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+++ ...-.+.+-+++..++..+|.+||+++.+++|
T Consensus 236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1111 11223457789999999999999999988775
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=216.98 Aligned_cols=249 Identities=18% Similarity=0.338 Sum_probs=185.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeee-eeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGC-CIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~ 550 (795)
.+.|.+.+.||+|-||.+-+++++ ..+.+++|.+... ....++|.+|...--.| .|.||+.-++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 357999999999999999999887 5788999988653 34467899999876666 48999988765 66677888999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc--CCCCceeeccccccccC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMAKMFG 628 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFGla~~~~ 628 (795)
||++.|+|..-+.+ ..+.+...++++.|++.||.|||+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999877733 56888899999999999999999999 99999999999993 44689999999998654
Q ss_pred CCccccceeeecccCCcCChhhhccC-----CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccccc---
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQG-----LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD--- 700 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 700 (795)
... .....+..|.|||..... ...+.+|+|.||++++.+++|+.|+........... .|..|..+
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~--~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW--EWEQWLKRKNP 247 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH--HHHHHhcccCc
Confidence 221 223346789999976432 245778999999999999999999974332222111 11122211
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....++ ...+.+.++..+-|..+|++|--..++.++
T Consensus 248 ~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1111111 123456778889999999999544444443
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=195.22 Aligned_cols=113 Identities=48% Similarity=0.729 Sum_probs=99.8
Q ss_pred ccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceeeee
Q 040413 32 RFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSS 111 (795)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t 111 (795)
+.|..|++|+|+++.|++|||.+..+ ..+.+|||+..+.++||+|||+.|+.+ ++.|.|+.||+|+|++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56889999999999999999988654 678999998766789999999999854 4899999999999999999999999
Q ss_pred cccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCC
Q 040413 112 NMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDH 151 (795)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
++..+.+..+|+|+|||||||++. .+.++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDS-----DGNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECC-----CCCEEeCCCCC
Confidence 976445667899999999999985 56899999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=264.28 Aligned_cols=198 Identities=19% Similarity=0.248 Sum_probs=139.7
Q ss_pred hcCC-Cceeeeeeee-------eecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 040413 527 KLQH-RNLVRLLGCC-------IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598 (795)
Q Consensus 527 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 598 (795)
.++| +||.++++.| .+.+..++++|++ +++|.+++.. ....+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5777777776 2334567888987 5589988853 2356999999999999999999999998 9
Q ss_pred EeCCCCCCcEEEcC-------------------CCCceeeccccccccCCCc--------------cccceeeecccCCc
Q 040413 599 IHRDLKASNILLDK-------------------DMNPKISDFGMAKMFGGDE--------------LQSKTKRIVGTYGY 645 (795)
Q Consensus 599 iH~Dikp~NIll~~-------------------~~~~kl~DFGla~~~~~~~--------------~~~~~~~~~gt~~y 645 (795)
+||||||+||||+. ++.+||+|||+++...... .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556777777765421100 00011124688999
Q ss_pred CChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHH
Q 040413 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINV 725 (795)
Q Consensus 646 ~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~l 725 (795)
||||++.+..++.++|||||||+||||++|.+|+..... ...... ...+.+.. .........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~~-----------~~~~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSLR-----------HRVLPPQI-----LLNWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHHH-----------HhhcChhh-----hhcCHHHHHH
Confidence 999999999999999999999999999998877542111 000000 00011110 1112335678
Q ss_pred HHHhcccCCCCCCCHHHHHHHh
Q 040413 726 ALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 726 i~~cl~~dP~~RPt~~evl~~L 747 (795)
+.+||+.+|.+||+|.|+++|.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHhCCCChhhCcChHHHhhch
Confidence 8899999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=221.26 Aligned_cols=177 Identities=21% Similarity=0.265 Sum_probs=135.4
Q ss_pred HHHhccCCcccccccCCCceeEEeeecc--CCceEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceee-eeeeee
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLH--NGQEVAVKRLSSQ-----SGQGLEEFKNEIKLIAKLQHRNLVR-LLGCCI 541 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~ 541 (795)
+.....+|.+.+.||+|+||+||+|+++ +++.+|||++... .....+.+.+|+++|++++|+|++. +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3455688999999999999999999764 5777899987533 1223567999999999999999985 443
Q ss_pred ecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCC-CCCcEEEcCCCCceeec
Q 040413 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDL-KASNILLDKDMNPKISD 620 (795)
Q Consensus 542 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Di-kp~NIll~~~~~~kl~D 620 (795)
....+|||||+++++|.... . .. ...++.|++++|.|||+++ |+|||| ||+|||++.++.+||+|
T Consensus 90 -~~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -cCCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 24579999999999996221 1 11 1467899999999999998 999999 99999999999999999
Q ss_pred cccccccCCCcccc------ceeeecccCCcCChhhhccCC------CCccCCee
Q 040413 621 FGMAKMFGGDELQS------KTKRIVGTYGYMSPEYAQQGL------FSIKSDVF 663 (795)
Q Consensus 621 FGla~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~s~k~Dvw 663 (795)
||+|+.+....... ......+++.|+|||.+.... .+...|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999765432111 113467888999999885432 23446666
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-23 Score=203.15 Aligned_cols=167 Identities=21% Similarity=0.141 Sum_probs=124.2
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 635 (795)
|+|.+++.. ....+++.++..++.||++||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 567777743 2356999999999999999999999875 999999999999999 99998654321
Q ss_pred eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhh
Q 040413 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715 (795)
Q Consensus 636 ~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~ 715 (795)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+................ .. . .++.. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~-----~-~~~~~-~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MP-----A-DDPRD-RSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hc-----c-CCccc-cccH
Confidence 258899999999999999999999999999999999999986433211110000000 00 0 00000 0111
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 716 YLILN--RYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 716 ~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..... ++.+++.+|++.+|++||++.|+++++...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22222 689999999999999999999999998664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=216.01 Aligned_cols=260 Identities=22% Similarity=0.256 Sum_probs=193.9
Q ss_pred CCcccccccCCCceeEEeeeccC--CceEEEEEecccCcccHHHHHHHHHHHHhcCC----Cceeeeeeee-eecceeEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHN--GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH----RNLVRLLGCC-IELEEKIL 548 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 548 (795)
+|.+.++||+|+||.||.+.... ...+|+|............+..|..++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999998654 35788888765433333378999999999973 6889999998 47778899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-----CCceeecccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-----MNPKISDFGM 623 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~DFGl 623 (795)
||+.+ |.+|.++..... ...++..++..|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 778888664433 578999999999999999999999999 9999999999999865 3589999999
Q ss_pred cc--ccCCCcc-----ccc-eeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCc-chhhccccc
Q 040413 624 AK--MFGGDEL-----QSK-TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD-SLTLLGRAW 694 (795)
Q Consensus 624 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~-~~~~~~~~~ 694 (795)
++ .+..... ... .....||..|+++..+.+...+.+.|+||++.++.|++.|..|+...... ........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~- 252 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD- 252 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH-
Confidence 98 3321111 111 22356999999999999999999999999999999999999998543321 11111100
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
........ .....+.++.++...+-..+..++|....+...|+....
T Consensus 253 ------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 253 ------PRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred ------hhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00000000 111123345555666666899999999999999876533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=199.63 Aligned_cols=202 Identities=23% Similarity=0.319 Sum_probs=173.3
Q ss_pred ccCCcccccccCCCceeEEeee-ccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 551 (795)
.-.|.+.++||+|.||+++.|. +-+++.||||.-.. +....+++.|.+..+.|. .++|...+.+..++-+..||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3579999999999999999995 45789999997543 334567889999999885 6899999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-----CCceeeccccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-----MNPKISDFGMAKM 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~DFGla~~ 626 (795)
++ |-||+++. + -..+.++..++..++.|++.-++|+|++. +|+|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLF-D-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLF-D-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHH-H-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 88 67887765 2 24567999999999999999999999998 9999999999999744 3589999999998
Q ss_pred cCCCcc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 627 FGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 627 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
+.+... ..+.+...||.+||+=....+.+.+.+.|+-|||-+++..|-|..||....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 865433 234556789999999999999999999999999999999999999998654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-22 Score=190.33 Aligned_cols=258 Identities=19% Similarity=0.232 Sum_probs=195.1
Q ss_pred ccCCcccccccCCCceeEEeee-ccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC-CceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 551 (795)
..+|.++++||+|+||.+|.|. ..+|.+||||+-+.... ..++..|.++.+.|+| ..|..+..+..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999994 67899999999765432 3468889999999985 678888888999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGla~~~~ 628 (795)
.+ |-||+++.. -..+.++..++.-++.|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+.+.
T Consensus 92 LL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 678877663 23457889999999999999999999999 999999999999964 4568999999998775
Q ss_pred CCcc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 629 GDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 629 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+... ........||.+|.+--.+.+...+.+.|+-|+|.+|..+.-|..||........... ++ .+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK---yE-----kI~ 237 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK---YE-----KIS 237 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH---HH-----HHH
Confidence 4322 2334457899999998888888888999999999999999999999976542221110 00 000
Q ss_pred hccCccccch---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 704 ELIDPILQNE---ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 704 ~~id~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+.-. .-.-.+.++.-.+.-|-...-++-|...-+-+.+.-+
T Consensus 238 ---EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 238 ---EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred ---HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 0011000 1111245666777778888888888877666655443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-20 Score=201.05 Aligned_cols=260 Identities=30% Similarity=0.412 Sum_probs=197.6
Q ss_pred CcccccccCCCceeEEeeeccCCceEEEEEecccCcc---cHHHHHHHHHHHHhcCCC-ceeeeeeeeeecceeEEEEee
Q 040413 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ---GLEEFKNEIKLIAKLQHR-NLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 552 (795)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++++++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999876 78999998765333 477899999999999988 799999999777778999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-CceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~ 631 (795)
+.++++.+++........+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999855532211136889999999999999999999999 99999999999999988 79999999998655433
Q ss_pred ccc----ceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCc--chhhcccccccccccch
Q 040413 632 LQS----KTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD--SLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 632 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 702 (795)
... ......|+..|+|||.+.. .......|+|++|++++++++|..|+...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2356789999999999987 57889999999999999999999996554421 11111110000000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.................+.+++..++..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223567789999999999999999887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-22 Score=228.24 Aligned_cols=256 Identities=20% Similarity=0.252 Sum_probs=190.5
Q ss_pred cccccccCCCceeEEeeecc-CCceEEEEEec----cc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 478 STENKLGEGGFGPVYKGRLH-NGQEVAVKRLS----SQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~----~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
...+.+|.|++|.|+.+... .....+.|.+. .. ..+....+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999988887543 33334444332 11 1111222666888888889999999988888877777779
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++ +|..++. ....+...++..++.|++.|+.|||+.| |.|||||++|+++..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 8877662 2346888999999999999999999999 999999999999999999999999999876543
Q ss_pred ccc--cceeeecccCCcCChhhhccCCCCcc-CCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 631 ELQ--SKTKRIVGTYGYMSPEYAQQGLFSIK-SDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ......+|+..|+|||.+....|++. .||||.|+++..|++|+.||......+......... .+.-.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~-------~~~~~ 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS-------DQRNI 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-------ccccc
Confidence 322 34556789999999999999998865 799999999999999999997554332211000000 00000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..-........+.+...++.++|+.+|.+|.|+++|++.=
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 1111223445667788999999999999999999998853
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-21 Score=191.49 Aligned_cols=171 Identities=16% Similarity=0.166 Sum_probs=135.2
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccH---HH------HHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGL---EE------FKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
...+|+..+.||.|+||.||.+.. +++.+|||.+.+...... .. +.+|+..+.+++||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999766 577899999976533222 22 68999999999999999998886643
Q ss_pred --------ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC
Q 040413 544 --------EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 544 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~ 615 (795)
...+|||||++|.+|.++. .+++ ....+++.+|..+|..| ++||||||+||+++.+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997763 1222 34669999999999999 99999999999999988
Q ss_pred ceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHH
Q 040413 616 PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673 (795)
Q Consensus 616 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ell 673 (795)
++|+|||........... ..+.....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999998765322110 11445556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=184.64 Aligned_cols=140 Identities=19% Similarity=0.220 Sum_probs=109.1
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcc--c-------H-----------------HHHHHHHHHHHhcCCCce
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ--G-------L-----------------EEFKNEIKLIAKLQHRNL 533 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 533 (795)
...||+|+||.||+|...+|+.||||+++..... . . ....+|+++|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998888999999999754211 1 1 123459999999988776
Q ss_pred eeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEeCCCCCCcEEEcC
Q 040413 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL-HQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 534 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~iiH~Dikp~NIll~~ 612 (795)
.....+ .....+|||||++++++..... ....++..++..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~--~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPI--LLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEE--EecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 433222 1223489999999987754431 234688999999999999999999 6888 99999999999998
Q ss_pred CCCceeeccccccccC
Q 040413 613 DMNPKISDFGMAKMFG 628 (795)
Q Consensus 613 ~~~~kl~DFGla~~~~ 628 (795)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=178.97 Aligned_cols=141 Identities=22% Similarity=0.284 Sum_probs=111.8
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCccc--------------------------HHHHHHHHHHHHhcCCCce
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQG--------------------------LEEFKNEIKLIAKLQHRNL 533 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 533 (795)
...||+|++|.||+|.+.+|+.||||++....... ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999988789999999987642110 1234689999999999987
Q ss_pred eeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcC
Q 040413 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 534 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~ 612 (795)
.....+... ..+|||||++++++..... ....++...+..++.|++.++.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544333322 3489999999886533221 23457788999999999999999999 88 99999999999998
Q ss_pred CCCceeeccccccccCC
Q 040413 613 DMNPKISDFGMAKMFGG 629 (795)
Q Consensus 613 ~~~~kl~DFGla~~~~~ 629 (795)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-21 Score=186.88 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=188.8
Q ss_pred CcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
..+..+|.+...|..|+|+++ |..+++|++... .......|..|.-.|+-+.||||+.+++.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344568999999999999996 456777877543 22334669999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe-CCCCCCcEEEcCCCCceee--ccccccccCCCc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH-RDLKASNILLDKDMNPKIS--DFGMAKMFGGDE 631 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH-~Dikp~NIll~~~~~~kl~--DFGla~~~~~~~ 631 (795)
-|||...++.. ..-..+..++.+++.+||+|++|||+.. +++- --|....|+||++.+.+|. |--++..
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 99999888643 3345777899999999999999999987 3443 4688999999999887775 3222221
Q ss_pred cccceeeecccCCcCChhhhccCCCC---ccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFS---IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.....-.|.||+||.++..+.+ .++|+|||++++|||.|...||.....-+.. .++.-+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkiale 404 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIALE 404 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhhc
Confidence 1112457889999999876544 5689999999999999999998643311110 001112
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
-++-..++.+...+.+++.-|+..||.+||.+..|+-.|+..
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 233345566677889999999999999999999999888754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=170.59 Aligned_cols=184 Identities=18% Similarity=0.149 Sum_probs=138.4
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecccCc----ccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEee
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG----QGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.+...|++|+||+||.+.. .+++++.+.+..... -....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3557899999999998766 678888887765321 11225899999999995 5789998886 456999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCC-CCCcEEEcCCCCceeeccccccccCCCc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDL-KASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
+.|.+|...+. . ....++.|++++|.++|.+| |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998864331 0 12357889999999999999 999999 7999999999999999999998654322
Q ss_pred c-----c-c-----ceeeecccCCcCChhhhccC-CCC-ccCCeeehhHHHHHHHhCCCCC
Q 040413 632 L-----Q-S-----KTKRIVGTYGYMSPEYAQQG-LFS-IKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 632 ~-----~-~-----~~~~~~gt~~y~aPE~~~~~-~~s-~k~DvwslG~ll~elltg~~p~ 679 (795)
. . . .......++.|+.|+...-. ..+ .+.+.++.|+.+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 1 0 0 01112368888988855332 233 5578899999999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=199.30 Aligned_cols=225 Identities=24% Similarity=0.266 Sum_probs=180.7
Q ss_pred cccCCCceeEEeeec----cCCceEEEEEecccCcc--cHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEeecC
Q 040413 482 KLGEGGFGPVYKGRL----HNGQEVAVKRLSSQSGQ--GLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
.+|+|.||.|+.++. +.++-+|+|++.+.... .....+.|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998853 34677899988765221 1125677889999997 9999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|.|-..+ .....+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+.+..-...
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 99887666 34456778888888999999999999999 9999999999999999999999999998653222
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
..+||..|||||++. .....+|.||||++++||++|..||.. +....+ + ...-..
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~I---------------l--~~~~~~ 206 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRI---------------L--KAELEM 206 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHH---------------h--hhccCC
Confidence 128999999999998 567889999999999999999999865 111110 1 111234
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCH
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTM 740 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~ 740 (795)
+.+....+.+++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 55666778889999999999999644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-19 Score=184.19 Aligned_cols=233 Identities=19% Similarity=0.251 Sum_probs=150.6
Q ss_pred CCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCC----------Cceeeeeeeee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQH----------RNLVRLLGCCI 541 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 541 (795)
.+...+.||.|+++.||.+++. +++++|||++... .....+++++|...+..+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4456678999999999999876 6999999987543 33457778888866666432 12222222221
Q ss_pred ---------ecc--------eeEEEEeecCCCCcceeecc---C-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 040413 542 ---------ELE--------EKILIYEYMPNKSLDIFLFD---T-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600 (795)
Q Consensus 542 ---------~~~--------~~~lV~E~~~~gsL~~~l~~---~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 600 (795)
... ..+++|+-+ .++|..++.. . .....+....+..+..|+++.+++||.+| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677766 5566665421 1 11223444455677799999999999999 999
Q ss_pred CCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhcc--------CCCCccCCeeehhHHHHHH
Q 040413 601 RDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ--------GLFSIKSDVFSFGVLLLET 672 (795)
Q Consensus 601 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwslG~ll~el 672 (795)
+||+|+|++++.+|.++|+||+.....+.... ....+..|.|||.... ..++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998876442211 0234578999997644 2578899999999999999
Q ss_pred HhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCC
Q 040413 673 LSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDR 737 (795)
Q Consensus 673 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 737 (795)
.+++.|++.......... .. ..+. +.++.+..+|..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986542221110 11 2344 678889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.7e-19 Score=205.27 Aligned_cols=199 Identities=20% Similarity=0.239 Sum_probs=161.6
Q ss_pred HHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeeeeecceeE
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 547 (795)
....+.|.|.+.||+|+||.||+|...+++.||+|+-+.... -+|.-=.+++.+|+ -+.|+.+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 445678999999999999999999888899999999765432 22333344555555 234445555555667789
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-------CCCCceeec
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-------KDMNPKISD 620 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-------~~~~~kl~D 620 (795)
||+||.+.|+|-+++. ..+.+++..++.++.|+++.+++||..+ |||+||||+|+||. ....++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999985 5567999999999999999999999998 99999999999995 344689999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCC
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p 678 (795)
||-+-.+..-.........++|-.+-.+|...+.+.+.++|.|.|+-+++-||.|+..
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998654432223455667899999999999999999999999999999999999854
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-19 Score=201.59 Aligned_cols=252 Identities=20% Similarity=0.208 Sum_probs=179.5
Q ss_pred CCcccccccCCCceeEEeeeccCCceEEEEEecccCc-ccHHHHHHHHHH--HHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG-QGLEEFKNEIKL--IAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++...+.||++.|=+|.+|+++.|. |+||++.++.+ -..+.|+++++- ...++|||.+.+.-.-..+.-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777889999999999999998887 99999977653 345555554444 4445899999887776666667888888
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC-Cc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG-DE 631 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~-~~ 631 (795)
..+ +|.+.+ ..+..+...+.+.|+-|++.||..+|..| |+|||||.+||||+.=.=+.|+||.--+...- .+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 755 455555 35566778888999999999999999999 99999999999999888899999977654321 11
Q ss_pred cccceeeeccc----CCcCChhhhccC----------C-CCccCCeeehhHHHHHHHhC-CCCCCCCCCcchhhcccccc
Q 040413 632 LQSKTKRIVGT----YGYMSPEYAQQG----------L-FSIKSDVFSFGVLLLETLSS-KRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 632 ~~~~~~~~~gt----~~y~aPE~~~~~----------~-~s~k~DvwslG~ll~elltg-~~p~~~~~~~~~~~~~~~~~ 695 (795)
.........-| ..|.|||.+... . .+++-||||+||++.||++- +++|.... +. +++
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~--aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LL--AYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HH--hHh
Confidence 11122222222 359999987431 1 57889999999999999874 66665321 00 011
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
........+++. .-+...++.++..|++.||++|.++++.|+.-++.
T Consensus 249 ~~~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGNADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 110111111111 11223678899999999999999999999987665
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.4e-18 Score=168.56 Aligned_cols=136 Identities=21% Similarity=0.305 Sum_probs=106.4
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc-----CCCceeeeeeeeeecc---eeE-E
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-----QHRNLVRLLGCCIELE---EKI-L 548 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 548 (795)
.-.++||+|+||.||. ++.....+||++........+.+.+|+.+++.+ .||||+++++++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 443333479988765455667899999999999 5799999999998874 333 7
Q ss_pred EEee--cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCcEEeCCCCCCcEEEcC----CCCceeecc
Q 040413 549 IYEY--MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL-LYLHQYSRLRVIHRDLKASNILLDK----DMNPKISDF 621 (795)
Q Consensus 549 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~DF 621 (795)
|+|| +++++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 558999999943 235555 35677888777 9999998 999999999999974 347999995
Q ss_pred ccc
Q 040413 622 GMA 624 (795)
Q Consensus 622 Gla 624 (795)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=167.62 Aligned_cols=150 Identities=18% Similarity=0.189 Sum_probs=115.8
Q ss_pred HHHHhccCCcccccccCCCceeEEeee--ccCCceEEEEEecccCcc------------------------cHHHHHHHH
Q 040413 469 SVSAATANFSTENKLGEGGFGPVYKGR--LHNGQEVAVKRLSSQSGQ------------------------GLEEFKNEI 522 (795)
Q Consensus 469 ~i~~~~~~y~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~ 522 (795)
+.......|++.++||+|++|.||+|. ..+|+.||||++...... ....+.+|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 334444568899999999999999998 468999999998753210 012367899
Q ss_pred HHHHhcCCC--ceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 040413 523 KLIAKLQHR--NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIH 600 (795)
Q Consensus 523 ~~l~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH 600 (795)
.++.++.+. .+.+.++. ...++||||+++.+|..... ....+....+..++.||+.+|.+||+.+ .|+|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH 172 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVH 172 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 999999763 33444432 23589999999988866542 2234556677899999999999999886 4999
Q ss_pred CCCCCCcEEEcCCCCceeeccccccccC
Q 040413 601 RDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 601 ~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|||||+||+++ ++.++|+|||.+....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999 8899999999998644
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-18 Score=136.66 Aligned_cols=66 Identities=48% Similarity=1.179 Sum_probs=59.4
Q ss_pred ccCCCceeEecccCCCCchhhHhhhccChHHHHHHHhccCCeeeeeeccccCCCceeeeeccchhhh
Q 040413 335 CTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDI 401 (795)
Q Consensus 335 C~~~~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~~c~~w~~~l~~~ 401 (795)
|..+|+|++|++|++|++....++.++++++|++.||+||||+||+|.+++ ++++|.+|+|+|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999999887776779999999999999999999997665 779999999999985
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-17 Score=169.34 Aligned_cols=197 Identities=21% Similarity=0.274 Sum_probs=132.9
Q ss_pred CCCceeeeeeeeee---------------------------cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHH
Q 040413 529 QHRNLVRLLGCCIE---------------------------LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE 581 (795)
Q Consensus 529 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 581 (795)
+|||||++..+|.+ ...+|+||.-.+ .+|.+++.. ...+.-...-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999887643 234578887653 367777633 2345567788999
Q ss_pred HHHHHHHHHHhcCCCcEEeCCCCCCcEEEc--CCC--CceeeccccccccCCC----ccccceeeecccCCcCChhhhcc
Q 040413 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDM--NPKISDFGMAKMFGGD----ELQSKTKRIVGTYGYMSPEYAQQ 653 (795)
Q Consensus 582 qia~aL~~LH~~~~~~iiH~Dikp~NIll~--~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 653 (795)
|+++|+.|||.+| |.|||+|.+||||. +|+ .+.|+|||.+-.-... .+.+..-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 333 4688999987543221 11111222346777899998865
Q ss_pred CC------CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHH
Q 040413 654 GL------FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVAL 727 (795)
Q Consensus 654 ~~------~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~ 727 (795)
.+ --.|+|.|+.|-+.||++....||-...+..+.... +.+... |. .+...+..+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qL-----Pa----lp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQL-----PA----LPSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhC-----CC----CcccCChHHHHHHH
Confidence 32 236899999999999999999888643322221110 111111 11 12233445778999
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 040413 728 LCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 728 ~cl~~dP~~RPt~~evl~~L 747 (795)
..|+.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999875544443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.5e-17 Score=179.32 Aligned_cols=214 Identities=25% Similarity=0.390 Sum_probs=161.7
Q ss_pred HHhcCCCceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE-EeCCC
Q 040413 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV-IHRDL 603 (795)
Q Consensus 525 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-iH~Di 603 (795)
|+.+.|.|+.++++.+.++...+.|.+|+..|+|.+.+.. ....+++.-...+++.|++||+|||... | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4568899999999999999999999999999999999865 3457888889999999999999999875 4 99999
Q ss_pred CCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccC-------CCCccCCeeehhHHHHHHHhCC
Q 040413 604 KASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-------LFSIKSDVFSFGVLLLETLSSK 676 (795)
Q Consensus 604 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DvwslG~ll~elltg~ 676 (795)
++.|.+++....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876421111111112244568999988653 2467799999999999999999
Q ss_pred CCCCCCC--CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 677 RNTDFSN--TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 677 ~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.||+... ......+....+ .....+.|.+.... +...++..++..|+..+|++||++..|-..++..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9997644 221122222111 11112223332111 3344788999999999999999999998888766
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=159.64 Aligned_cols=145 Identities=21% Similarity=0.219 Sum_probs=114.4
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcc----------------------cHHHHHHHHHHH
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ----------------------GLEEFKNEIKLI 525 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l 525 (795)
.++......|.+.++||+|+||.||++..++++.+|||++...... ....+.+|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444555568889999999999999998888999999987543210 112367899999
Q ss_pred HhcCCCc--eeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCC
Q 040413 526 AKLQHRN--LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDL 603 (795)
Q Consensus 526 ~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Di 603 (795)
..+.|++ +.+.++ ....++||||+++++|..... ......++.+|+.++.++|+.+ |+||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 245589999999999876542 0345678899999999999988 999999
Q ss_pred CCCcEEEcCCCCceeeccccccccC
Q 040413 604 KASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 604 kp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||+||+++.++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=161.29 Aligned_cols=134 Identities=21% Similarity=0.346 Sum_probs=113.1
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCcc--------cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ--------GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986543211 134678899999999999988777777777888999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998887321 12 78899999999999999998 99999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4e-16 Score=157.05 Aligned_cols=130 Identities=23% Similarity=0.370 Sum_probs=106.1
Q ss_pred cccCCCceeEEeeeccCCceEEEEEecccCc--------ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG--------QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.||+|+||.||+|.. +++.+++|+...... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 568899998654211 12366789999999999887665555556667779999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+|++|.+.+.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999987763210 178999999999999998 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-16 Score=180.28 Aligned_cols=140 Identities=20% Similarity=0.322 Sum_probs=113.5
Q ss_pred HhccCCcccccccCCCceeEEeeeccCCceEEEEEe-cccC-------cccHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRL-SSQS-------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l-~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
.....|...++||+|+||.||+|..... .+++|+. .+.. ....+++.+|++++.+++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3345567789999999999999987543 3444432 2211 11245688999999999999998887777777
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ .++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 78899999999999987762 45789999999999999998 9999999999999 678999999999
Q ss_pred cccc
Q 040413 624 AKMF 627 (795)
Q Consensus 624 a~~~ 627 (795)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-16 Score=183.99 Aligned_cols=208 Identities=22% Similarity=0.318 Sum_probs=143.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..+|..++.|..|+||.||.++++ ..+.+|+|+ .+++-- .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee------------------
Confidence 468999999999999999999887 577889954 332110 111 33333455444
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC---
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG--- 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~--- 629 (795)
|+=...+ +.-.+++.+ ++.+++|||+.+ |+|||+||+|.+|..-|++|+.|||+.+...-
T Consensus 136 ---gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 1111111 122233333 277899999999 99999999999999999999999999864310
Q ss_pred -----Ccc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccccccccc
Q 040413 630 -----DEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWK 698 (795)
Q Consensus 630 -----~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~ 698 (795)
... +-..+..+||+.|.|||++....|...+|.|++|+|+||.+.|+.||.....+.+.- +......|.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 000 111234589999999999999999999999999999999999999998766444321 111111111
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRP 738 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 738 (795)
+ .......+..+++.++|+.+|..|-
T Consensus 279 E--------------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 E--------------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred c--------------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 1222345678899999999999994
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-16 Score=172.10 Aligned_cols=175 Identities=26% Similarity=0.375 Sum_probs=130.5
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++.|+++...+|.++|.........++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766666677888999999999999999 66 999999999999999999999999998
Q ss_pred cccCCCc----cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccc
Q 040413 625 KMFGGDE----LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKD 699 (795)
Q Consensus 625 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
....... .........||..||+||++.+..|+.|+||||||+||+|++. -...++-.. .... ...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--t~~d-------~r~ 474 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--TLTD-------IRD 474 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH--hhhh-------hhc
Confidence 7655433 2234455789999999999999999999999999999999997 222221000 0000 000
Q ss_pred cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040413 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 743 (795)
..++|....+.+ .-+.++.+++...|.+||++.++
T Consensus 475 ----g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 475 ----GIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----CCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 011111111111 12478999999999999955444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.9e-15 Score=147.53 Aligned_cols=137 Identities=20% Similarity=0.264 Sum_probs=99.5
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcc--cHHH----------------------HHHHHHHHHhcCCCc--e
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ--GLEE----------------------FKNEIKLIAKLQHRN--L 533 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 533 (795)
.+.||+|+||.||+|.+.++++||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999998888999999998653211 1111 135666666665443 3
Q ss_pred eeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcC
Q 040413 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 534 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~ 612 (795)
.+.++. ...++||||++++.+........ .. ...+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 344432 34689999999965422111110 01 16678899999999999999 87 99999999999999
Q ss_pred CCCceeeccccccccC
Q 040413 613 DMNPKISDFGMAKMFG 628 (795)
Q Consensus 613 ~~~~kl~DFGla~~~~ 628 (795)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 9999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=138.57 Aligned_cols=135 Identities=23% Similarity=0.248 Sum_probs=115.8
Q ss_pred ccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC--CceeeeeeeeeecceeEEEEeecCCC
Q 040413 479 TENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH--RNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++++++.+....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998755 7899999866443 5679999999999986 58899998888888899999999988
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
.+..+ +......++.+++++|++||......++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4567788899999999999986545599999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-15 Score=175.97 Aligned_cols=257 Identities=22% Similarity=0.282 Sum_probs=195.6
Q ss_pred cCCcccccccCCCceeEEeeecc--CCceEEEEEecccC--cccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 549 (795)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46778888999999999888664 34556777776543 344556667888888886 99999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEeCCCCCCcEEEcCCC-Cceeecccccccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH-QYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMF 627 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~ 627 (795)
.||..++++...+... .....+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999987776311 1225666778889999999999999 877 99999999999999999 9999999999887
Q ss_pred CC-Cccccceeeecc-cCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 628 GG-DELQSKTKRIVG-TYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 628 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+............+.. ....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~-----~~~~- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS-----NKGR- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc-----cccc-
Confidence 76 444455556688 9999999998874 5567899999999999999999999876543322222111 1000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..............+++.+++..+|+.|.+.+++...
T Consensus 250 -----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 250 -----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -----cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0001111223445678888999999999999888665
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=146.12 Aligned_cols=135 Identities=24% Similarity=0.307 Sum_probs=104.7
Q ss_pred cccc-CCCceeEEeeeccCCceEEEEEecccC-------------cccHHHHHHHHHHHHhcCCCce--eeeeeeeeecc
Q 040413 481 NKLG-EGGFGPVYKGRLHNGQEVAVKRLSSQS-------------GQGLEEFKNEIKLIAKLQHRNL--VRLLGCCIELE 544 (795)
Q Consensus 481 ~~LG-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 544 (795)
..|| .||.|+||.+... +..++||++.... .....++.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999998775 6789999875321 1223568899999999998875 66776654332
Q ss_pred e----eEEEEeecCC-CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 545 E----KILIYEYMPN-KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 545 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688877632 234443 3678999999999999 9999999999999999999999
Q ss_pred cccccccc
Q 040413 620 DFGMAKMF 627 (795)
Q Consensus 620 DFGla~~~ 627 (795)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99999763
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.50 E-value=3e-14 Score=118.57 Aligned_cols=71 Identities=21% Similarity=0.441 Sum_probs=61.1
Q ss_pred ccCCCceeEecccCCCCchhhHhhhccChHHHHHHHhc---cCCeeeeeeccccCCCceeeeeccch-hhhhhhccCCCC
Q 040413 335 CTNRDRFVMIDDIKLPDLEEVLLNESMNLKECEAECLK---NCTCRAYANSKVTGGGSGCLMWFGDL-VDIRKAIGHNNG 410 (795)
Q Consensus 335 C~~~~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~---nCsC~ay~~~~~~~~~~~c~~w~~~l-~~~~~~~~~~~g 410 (795)
|....+|+++.++++|++.. +++++|+++|++ ||||+||+|.+. +.||++|+++| ++++. ....|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~--~~~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRK--EFSHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHh--ccCCC
Confidence 45567899999999999864 689999999999 999999999643 46899999999 99987 45568
Q ss_pred ccEEEe
Q 040413 411 QSVYIR 416 (795)
Q Consensus 411 ~~lylr 416 (795)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 999997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.9e-13 Score=147.46 Aligned_cols=144 Identities=24% Similarity=0.296 Sum_probs=102.1
Q ss_pred CCcccccccCCCceeEEeeeccCCceEEEEEecccCcccH----------------------------------------
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGL---------------------------------------- 515 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~---------------------------------------- 515 (795)
.|. .+.||+|++|.||+|++++|++||||+.++......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 368999999999999999999999999865421110
Q ss_pred HHHHHHHHHHHhcC----CCceeeeeeeee-ecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHH-HHHH
Q 040413 516 EEFKNEIKLIAKLQ----HRNLVRLLGCCI-ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ-GLLY 589 (795)
Q Consensus 516 ~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~ 589 (795)
-.|.+|...+.++. |.+-+.+-.++. .....+|||||++|++|.++..... ... ....++.++++ .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHH
Confidence 02445666666652 333333333332 2445799999999999987653211 111 23456666666 4688
Q ss_pred HHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 590 LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 89888 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.9e-13 Score=113.13 Aligned_cols=80 Identities=38% Similarity=0.896 Sum_probs=64.9
Q ss_pred cccccCC---CceeEecccCCCCchhhHhhhccChHHHHHHHhccCCeeeeeeccccCCCceeeeeccchhhhhhhccCC
Q 040413 332 LVDCTNR---DRFVMIDDIKLPDLEEVLLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLVDIRKAIGHN 408 (795)
Q Consensus 332 ~l~C~~~---~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~~c~~w~~~l~~~~~~~~~~ 408 (795)
+++|... +.|+.++++++|+..... .+.++++|++.||+||+|+||+|.+ ++++|.+|.+.+++.+. ...
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~--~~~ 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRS--LSS 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEe--ecC
Confidence 3456543 689999999999886543 6789999999999999999999953 46799999999998665 334
Q ss_pred CCccEEEecc
Q 040413 409 NGQSVYIRVP 418 (795)
Q Consensus 409 ~g~~lylrv~ 418 (795)
.+..+||||+
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 4678999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=120.93 Aligned_cols=131 Identities=24% Similarity=0.179 Sum_probs=98.9
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCcee-eeeeeeeecceeEEEEeecCCCCc
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
.+.|+.|.++.||+++.. ++.+++|+...... ....+.+|+.+++.+.+.+++ +++.+. ....++|||++++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999865 77899999765432 234578899999999765544 444433 3345899999999887
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
.... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 112345788999999999986 23369999999999998 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4e-12 Score=129.25 Aligned_cols=204 Identities=20% Similarity=0.229 Sum_probs=141.8
Q ss_pred HHHHhcCCCceeeeeeeeeec-----ceeEEEEeecCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 040413 523 KLIAKLQHRNLVRLLGCCIEL-----EEKILIYEYMPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRL 596 (795)
Q Consensus 523 ~~l~~l~h~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 596 (795)
.-|..+-|-|||++..|+.+. ....++.|||..|++.++|.... ....+....-.+++-||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445566799999999887654 34689999999999999997643 3456778888899999999999999975 7
Q ss_pred cEEeCCCCCCcEEEcCCCCceeeccc--cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh
Q 040413 597 RVIHRDLKASNILLDKDMNPKISDFG--MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674 (795)
Q Consensus 597 ~iiH~Dikp~NIll~~~~~~kl~DFG--la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt 674 (795)
+|+|+++..+.|++..+|.+||.--- .....-.......+..-.+-++|.+||.=.....+.++|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999999985211 1110001111122233457789999998777778889999999999999987
Q ss_pred CCCCCCCCC--CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 675 SKRNTDFSN--TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 675 g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.--..... .........+ +..+-++ .-+.++..|++..|..||+|++++-|.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~--------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV--------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhhhhhhh--------eeeccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 763321111 0000000000 0000011 113567789999999999999988774
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.7e-11 Score=139.00 Aligned_cols=145 Identities=17% Similarity=0.203 Sum_probs=96.2
Q ss_pred ccCCcccccccCCCceeEEeeeccC-CceEEEEEecccCccc----------------------------------HHH-
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQG----------------------------------LEE- 517 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~----------------------------------~~~- 517 (795)
...|+. +.||+|++|.||+|++++ |++||||++++..... .+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999886 9999999997542110 111
Q ss_pred -----HHHHHHHHHhcC----CCceeeeeeeeee-cceeEEEEeecCCCCcceeeccCCCC---CCCCHHHHHHHHHHHH
Q 040413 518 -----FKNEIKLIAKLQ----HRNLVRLLGCCIE-LEEKILIYEYMPNKSLDIFLFDTPKE---SPLGWETRVRVIEEIA 584 (795)
Q Consensus 518 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia 584 (795)
+.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+.+.++..-.... ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 344555555542 4444444444433 45678999999999987642111111 123233333333443
Q ss_pred HHHHHHHhcCCCcEEeCCCCCCcEEEcCCC----CceeeccccccccCC
Q 040413 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFGMAKMFGG 629 (795)
Q Consensus 585 ~aL~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFGla~~~~~ 629 (795)
+..| ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3456 99999999999999888 999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-11 Score=137.21 Aligned_cols=250 Identities=23% Similarity=0.258 Sum_probs=181.1
Q ss_pred cCCcccccccC--CCceeEEeeec--c-CCceEEEEEecc--cCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 475 ANFSTENKLGE--GGFGPVYKGRL--H-NGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~--G~~g~Vy~~~~--~-~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
..|.+.+.+|+ |.+|.||.+.. . ++..+|+|+-+. ..+....+-.+|+....++ .|++.++....+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999976 3 678899998433 2334444455677766667 499999988889999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeecc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ----GLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDF 621 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DF 621 (795)
++-.|++. .+|..+.. .....++....+.+..+..+ ||.++|... ++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 56655543 23345778888889999989 999999998 9999999999999999 88999999
Q ss_pred ccccccCCCccccce---eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc
Q 040413 622 GMAKMFGGDELQSKT---KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 622 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|+...+......... .+..|...|++||... +.++.+.|+|++|.++.+-.++-.......... |.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------W~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------WS 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC----------cc
Confidence 999988765432221 2336778899999654 567888999999999999988875543221111 11
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+.+-.. +..+.-.....++..++..+++.+|..|++.+.+..+
T Consensus 337 ~~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 337 QLRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111000 1111111122344558889999999999999888764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.8e-10 Score=112.45 Aligned_cols=137 Identities=14% Similarity=0.146 Sum_probs=100.1
Q ss_pred ccccCCCceeEEeeeccC-------CceEEEEEeccc-------------C---------cccHHHHH----HHHHHHHh
Q 040413 481 NKLGEGGFGPVYKGRLHN-------GQEVAVKRLSSQ-------------S---------GQGLEEFK----NEIKLIAK 527 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~l~~~-------------~---------~~~~~~~~----~E~~~l~~ 527 (795)
..||.|.-+.||.|...+ +..+|||+.+.. . ....+.++ +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999996543 479999987421 0 01123344 89999999
Q ss_pred cCC--CceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCcEEeCCCC
Q 040413 528 LQH--RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL-HQYSRLRVIHRDLK 604 (795)
Q Consensus 528 l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~iiH~Dik 604 (795)
+.. -++.+.+++ ...+|||||+.+..+.... -+...++.++...+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 964 455566654 5678999999875442111 1122345566778889999999999 8888 9999999
Q ss_pred CCcEEEcCCCCceeeccccccccC
Q 040413 605 ASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 605 p~NIll~~~~~~kl~DFGla~~~~ 628 (795)
+.||++. ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999996 5789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-10 Score=127.76 Aligned_cols=167 Identities=20% Similarity=0.251 Sum_probs=128.4
Q ss_pred eccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHH
Q 040413 495 RLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWE 574 (795)
Q Consensus 495 ~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 574 (795)
+..++.+|.|..++.......+..++-++.|+.++||+|+++++...+....|||.|-+.- |..++. .+...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk------~l~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLK------ELGKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHH------HhHHH
Confidence 3447889999998877665567788999999999999999999999999999999997633 333331 23366
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccC
Q 040413 575 TRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654 (795)
Q Consensus 575 ~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 654 (795)
.+...+.||+.||.|||+.+ .++|++|....|+|+..|..||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 77788999999999999766 599999999999999999999999988865432211 11112223346667655433
Q ss_pred CCCccCCeeehhHHHHHHHhC
Q 040413 655 LFSIKSDVFSFGVLLLETLSS 675 (795)
Q Consensus 655 ~~s~k~DvwslG~ll~elltg 675 (795)
. -..|.|.|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.4e-10 Score=113.58 Aligned_cols=142 Identities=18% Similarity=0.287 Sum_probs=112.3
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCc-ccHHHHHHHHHHHHhcCCC--ceeeeeeeeeecc---eeEEEEeecC
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHR--NLVRLLGCCIELE---EKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~E~~~ 554 (795)
+.|+.|..+.||+++..+|+.+++|+...... .....+.+|+++++.+.+. .+.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57999999999999887678999999765322 2456789999999999763 4566777766543 5689999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS---------------------------------------- 594 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 594 (795)
|.++...+. ...++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 998876542 135777888889999999999999531
Q ss_pred -------------CCcEEeCCCCCCcEEEcC--CCCceeeccccccc
Q 040413 595 -------------RLRVIHRDLKASNILLDK--DMNPKISDFGMAKM 626 (795)
Q Consensus 595 -------------~~~iiH~Dikp~NIll~~--~~~~kl~DFGla~~ 626 (795)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.6e-11 Score=129.98 Aligned_cols=248 Identities=21% Similarity=0.223 Sum_probs=177.4
Q ss_pred hccCCcccccccCCCceeEEeeecc--CCceEEEEEecccCcccHHHH--HHHHHHHHhc-CCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH--NGQEVAVKRLSSQSGQGLEEF--KNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
...+|..+..||.|.|+.|+....+ ++..|++|.+.+.......++ ..|+.+...+ .|.++++.+..+.+.++.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3468899999999999999998543 678899998766543333332 3466666666 5899999888888888888
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeeccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKM 626 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFGla~~ 626 (795)
+=.||+.++++...+ .....+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999886555 23345778889999999999999999988 9999999999999886 7889999999864
Q ss_pred cCCCccccceeeecccCCcC--ChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 627 FGGDELQSKTKRIVGTYGYM--SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
+.-.. ......-+++ +|+......+-.++|+++||.-+.+.+++..-..-.. ..... ..+..
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~~~~i--------~~~~~-- 480 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-QSLTI--------RSGDT-- 480 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-cceee--------ecccc--
Confidence 22110 1112233334 5556667788899999999999999998875332111 11000 00000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+.+ +. ....+..+...++..++..||.+.++..+.+.+
T Consensus 481 ---p~~----~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 ---PNL----PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---cCC----Cc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111 11 114566777888999999999999988776544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.6e-10 Score=104.78 Aligned_cols=131 Identities=21% Similarity=0.344 Sum_probs=101.1
Q ss_pred ccccCCCceeEEeeeccCCceEEEEE-ecccC-------cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKR-LSSQS-------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..+++|+-+.+|.+... |.++++|. +.+.- .-..++..+|+++|.+++--.|....-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46899999999999664 34466663 33321 11245678899999999766665555566778888999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++...+ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998877332 2557777888888999999 99999999999997665 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4e-09 Score=99.91 Aligned_cols=143 Identities=24% Similarity=0.337 Sum_probs=105.0
Q ss_pred ccccccCCCceeEEeeeccCCceEEEE-Eeccc-------CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 479 TENKLGEGGFGPVYKGRLHNGQEVAVK-RLSSQ-------SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK-~l~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+.+|-+|+-+.|+++... |+...|| ++.+. ..-..++.++|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999875 5666666 33332 1223567889999999997555554444566777778999
Q ss_pred eecCC-CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---Cceeeccccccc
Q 040413 551 EYMPN-KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMAKM 626 (795)
Q Consensus 551 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFGla~~ 626 (795)
||+++ .++.+++....... ........++..|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46666665432222 222333678899999999999998 99999999999997554 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-08 Score=108.55 Aligned_cols=169 Identities=22% Similarity=0.334 Sum_probs=129.0
Q ss_pred ceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeee----ecceeEEEEeecCCC-Cccee
Q 040413 488 FGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI----ELEEKILIYEYMPNK-SLDIF 561 (795)
Q Consensus 488 ~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~E~~~~g-sL~~~ 561 (795)
-.+-|++... +|..|++|+++....+.....-.-+++++++.|+|+|++.+++. .+..++|||+|.++. +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4567899654 89999999995443333344556688999999999999999887 345679999999854 55444
Q ss_pred eccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 562 LFDT------------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 562 l~~~------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
-+.. ......++...+.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|+-.|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4332 23456888999999999999999999999 88899999999999999999999988876543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCC
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p 678 (795)
+.. +| +.. -.+-|.=.||.+++.|.+|...
T Consensus 446 d~~--------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT--------------EP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------cc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11 111 1245888999999999999643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.1e-10 Score=128.13 Aligned_cols=250 Identities=19% Similarity=0.195 Sum_probs=173.8
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...+.+.+.+.+-+|.++.++.+.-. .+...++|..... .....+....+-.++-..+||-+++...-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888889999999999988644 3434444433221 1222334444445544456677777666666677889
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
||++|+.+++|..-++.. ...+.+-+...+..+.+++++||... +.|+|++|.|+++..+++.++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999887776433 34666667777788899999999976 999999999999999999999999844322
Q ss_pred CC-------------------------Cccc----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCC
Q 040413 628 GG-------------------------DELQ----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN 678 (795)
Q Consensus 628 ~~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p 678 (795)
.. .... .......+|+.|.+||...+......+|.|++|+.++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0000 112345789999999999999999999999999999999999999
Q ss_pred CCCCCCcchhh-cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040413 679 TDFSNTDSLTL-LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMF 741 (795)
Q Consensus 679 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 741 (795)
+.....+.... +.....-| ...+.+...+..+++...+..+|.+|..|.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~--------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPW--------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccccCCCCC--------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 87655332211 00000000 112233344566788888899999997765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.6e-08 Score=99.75 Aligned_cols=126 Identities=28% Similarity=0.361 Sum_probs=83.9
Q ss_pred eEEeeeccCCceEEEEEecccC--------------c------------ccHHHHHHHHHHHHhcCCC--ceeeeeeeee
Q 040413 490 PVYKGRLHNGQEVAVKRLSSQS--------------G------------QGLEEFKNEIKLIAKLQHR--NLVRLLGCCI 541 (795)
Q Consensus 490 ~Vy~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 541 (795)
.||.|...+++++|||+..... . ......++|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899988889999999874310 0 0134577899999999765 45566544
Q ss_pred ecceeEEEEeecC--CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 542 ELEEKILIYEYMP--NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY-LHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 542 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
....|||||++ |..+..+. +. .++.+....++.+++..+.. +|..| |+|+||.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 34579999998 65554432 11 11134566777888885555 57887 9999999999999887 9999
Q ss_pred eccccccccC
Q 040413 619 SDFGMAKMFG 628 (795)
Q Consensus 619 ~DFGla~~~~ 628 (795)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.6e-07 Score=96.79 Aligned_cols=262 Identities=15% Similarity=0.134 Sum_probs=156.7
Q ss_pred CcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeee------e-eecceeEE
Q 040413 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGC------C-IELEEKIL 548 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~l 548 (795)
....+.||+|+-+.+|..-. -...+.|+++........+. +..|... .||-+-.-+.+ . ..+....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34567899999999996522 23356788876543322222 2223232 45543321111 1 12233567
Q ss_pred EEeecCCCC-cceeecc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 549 IYEYMPNKS-LDIFLFD---TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 549 V~E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
.|..+++.- +..++.. .+.....+|.-..+.++.++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 888877652 2222221 123456889999999999999999999999 889999999999999999999985544
Q ss_pred cccCCCccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhC-CCCCCCCC----Cc-chh-hccc
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSS-KRNTDFSN----TD-SLT-LLGR 692 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg-~~p~~~~~----~~-~~~-~~~~ 692 (795)
....++. ...-.+|...|.+||... +...+...|.|.||+++++++.| +.|+..-. .. ... .+..
T Consensus 165 qi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 3322221 122347899999999764 34556789999999999999887 77875321 00 000 0100
Q ss_pred ccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHhhcc
Q 040413 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQED--AVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~ 750 (795)
..-.+..+.-. -..+--....-.-.+..+..+..+|+... +.-|||++..+..|..+
T Consensus 242 g~f~ya~~~~~-g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 242 GRFAYASDQRR-GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred ceeeechhccC-CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00000000000 00111101111122345666777888654 56899999988877554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.6e-08 Score=100.19 Aligned_cols=134 Identities=17% Similarity=0.167 Sum_probs=97.4
Q ss_pred ceeEEeeeccCCceEEEEEecccCc-----------ccHHHHHHHHHHHHhcCCCce--eeeeeeeee-----cceeEEE
Q 040413 488 FGPVYKGRLHNGQEVAVKRLSSQSG-----------QGLEEFKNEIKLIAKLQHRNL--VRLLGCCIE-----LEEKILI 549 (795)
Q Consensus 488 ~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lV 549 (795)
...|++... +|+.+.||......- .....+.+|...+.++...+| .+++++... ....+||
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334666655 567899997743221 111248899999999964443 345555543 2346899
Q ss_pred EeecCCC-CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-------CCCceeecc
Q 040413 550 YEYMPNK-SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-------DMNPKISDF 621 (795)
Q Consensus 550 ~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-------~~~~kl~DF 621 (795)
+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..| |+|+|+++.|||++. +..+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999986 7888874321 234566778899999999999999999 999999999999975 467999999
Q ss_pred ccccc
Q 040413 622 GMAKM 626 (795)
Q Consensus 622 Gla~~ 626 (795)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-07 Score=95.05 Aligned_cols=146 Identities=19% Similarity=0.214 Sum_probs=102.7
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEeccc------------------C----cccHHHHHHHHHH
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ------------------S----GQGLEEFKNEIKL 524 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~------------------~----~~~~~~~~~E~~~ 524 (795)
+..+.....=..+..+||.|.-+.||.|..+.|.++|||.-+.. . .......++|.++
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 33333333345667899999999999999999999999954211 0 0123447789999
Q ss_pred HHhcCCC--ceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCC
Q 040413 525 IAKLQHR--NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRD 602 (795)
Q Consensus 525 l~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~D 602 (795)
|.+|... .+.+.++ .+...+|||+++|-.|...- ++.+....++..|++-+..+-..| |||+|
T Consensus 163 L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGD 227 (304)
T COG0478 163 LQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGD 227 (304)
T ss_pred HHHhhhcCCCCCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccC
Confidence 9999754 5555554 35668999999997764321 223344444555555444444566 99999
Q ss_pred CCCCcEEEcCCCCceeecccccccc
Q 040413 603 LKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 603 ikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+++-||+++++|.+.++||--+...
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999777543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.9e-06 Score=88.16 Aligned_cols=133 Identities=18% Similarity=0.146 Sum_probs=89.6
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeeeeeecceeEEEEeecCCCC-
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLGCCIELEEKILIYEYMPNKS- 557 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gs- 557 (795)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 25568889876532 3456899999999996443 4667777777777889999999963
Q ss_pred cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------cCCCc
Q 040413 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ----------------------------------------YSRLR 597 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~----------------------------------------~~~~~ 597 (795)
+...+. .+......++.++++.+.-||+ ..+..
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221111 1111222222223332222322 12335
Q ss_pred EEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 598 VIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 598 iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+|+.|.||++++++ +.|+||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 79999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.6e-07 Score=89.56 Aligned_cols=124 Identities=23% Similarity=0.237 Sum_probs=92.3
Q ss_pred CCceEEEEEeccc-C------cccHHHHHHHHHHHHhcCCCc--eeeeeeeeeecc----eeEEEEeecCCC-Ccceeec
Q 040413 498 NGQEVAVKRLSSQ-S------GQGLEEFKNEIKLIAKLQHRN--LVRLLGCCIELE----EKILIYEYMPNK-SLDIFLF 563 (795)
Q Consensus 498 ~~~~vavK~l~~~-~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~ 563 (795)
.++.+.+|.+... . .-...+..+|...+.+|...+ ..+.+++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 3556666654321 1 123456889999999986443 455666655422 348999999884 7888874
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---Cceeecccccccc
Q 040413 564 DTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMAKMF 627 (795)
Q Consensus 564 ~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFGla~~~ 627 (795)
... .++......++.++++.+.-||..| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 111 ~~~---~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE---QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc---ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 422 2566778899999999999999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.8e-07 Score=100.21 Aligned_cols=145 Identities=19% Similarity=0.276 Sum_probs=94.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCccc------------------------------HHH-------
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQG------------------------------LEE------- 517 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------~~~------- 517 (795)
..|.. +.|+.++-|.||+|++++|++||||+.++...+. .++
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 6899999999999999999999999986532110 111
Q ss_pred ---HHHHHHHHHhcC----CCceeeeeeeeee-cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHH-HH
Q 040413 518 ---FKNEIKLIAKLQ----HRNLVRLLGCCIE-LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG-LL 588 (795)
Q Consensus 518 ---~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~ 588 (795)
+.+|...+.++. +..-+++-.++.+ .....|+|||++|..+.+...-.. ..++.+. ++..++++ +.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHH
Confidence 334555555542 2222333333333 466799999999999887742221 2344222 22222221 12
Q ss_pred HHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 589 ~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
.+=..| ++|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 222234 9999999999999999999999999987664
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-07 Score=106.67 Aligned_cols=157 Identities=20% Similarity=0.254 Sum_probs=106.7
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC-c-----ccccee-eecccCCcCCh
Q 040413 576 RVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD-E-----LQSKTK-RIVGTYGYMSP 648 (795)
Q Consensus 576 ~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~-~-----~~~~~~-~~~gt~~y~aP 648 (795)
...-+.+++.|+.|+|..- ++||++|.|++|.++.++..||+.|+.+...... . +..... -..-...|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3344556669999999854 7999999999999999999999999987654331 1 111111 11235689999
Q ss_pred hhhccCCCCccCCeeehhHHHHHHHhC-CCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHH
Q 040413 649 EYAQQGLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVAL 727 (795)
Q Consensus 649 E~~~~~~~s~k~DvwslG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~ 727 (795)
|++.....+.++|+||+|+++|-+..| +.-+...+......... ..+..-....+...+.++.+=+.
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------------~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------------NLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------------cccccccccccccCcHHHHHHHH
Confidence 999998889999999999999999954 44444332211111100 00111111223455677888889
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 040413 728 LCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 728 ~cl~~dP~~RPt~~evl~~ 746 (795)
+++..++..||++.++...
T Consensus 247 k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHhcCCcccCcchhhhhcc
Confidence 9999999999988776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.3e-06 Score=84.95 Aligned_cols=138 Identities=16% Similarity=0.192 Sum_probs=103.1
Q ss_pred ccCCCceeEEeeeccCCceEEEEEeccc------CcccHHHHHHHHHHHHhcCCCc--eeeeeeeeee-----cceeEEE
Q 040413 483 LGEGGFGPVYKGRLHNGQEVAVKRLSSQ------SGQGLEEFKNEIKLIAKLQHRN--LVRLLGCCIE-----LEEKILI 549 (795)
Q Consensus 483 LG~G~~g~Vy~~~~~~~~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lV 549 (795)
-|+||-+.|+.....+ +.+-+|+-... .+.+...|.+|...|.+|..-+ +.+.. ++.. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4668999999987654 46888876521 1446788999999999996433 44444 3321 1235799
Q ss_pred EeecCC-CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC--ceeeccccccc
Q 040413 550 YEYMPN-KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMAKM 626 (795)
Q Consensus 550 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFGla~~ 626 (795)
.|-+++ .+|++++.+. ...+.+......++.+|++.+.-||..| +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 4787776432 2235677888899999999999999999 999999999999986677 99999987764
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.38 E-value=6e-07 Score=75.17 Aligned_cols=72 Identities=35% Similarity=0.801 Sum_probs=54.6
Q ss_pred CceeEecccCCCCchhhHhhhccChHHHHHHHhc-cCCeeeeeeccccCCCceeeeec-cchhhhhhhccCCCCccEEEe
Q 040413 339 DRFVMIDDIKLPDLEEVLLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMWF-GDLVDIRKAIGHNNGQSVYIR 416 (795)
Q Consensus 339 ~~f~~l~~~~~pd~~~~~~~~~~s~~~C~~~Cl~-nCsC~ay~~~~~~~~~~~c~~w~-~~l~~~~~~~~~~~g~~lylr 416 (795)
+.|..++++++++..... ....++++|++.|++ +|+|.||+|.. ++.+|.+|. +.+.+.+. ....+..+|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~--~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARL--FPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCcccccee--cccCCceeEEe
Confidence 569999999999664432 346799999999999 99999999964 567999999 76666542 34455566654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.32 E-value=2e-06 Score=78.02 Aligned_cols=87 Identities=26% Similarity=0.311 Sum_probs=62.1
Q ss_pred eEEEeecCCeEEecCC-CceeeeecccCC-CCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccccc
Q 040413 89 TLTIGSSGNLVILNLK-NGTIWSSNMTRK-AGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDL 166 (795)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~W~t~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~ 166 (795)
++.++.||+||+++.. +.+||++++... ...+.+.|+++|||||++. .+.++|+|=.
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~S~t---------------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-----DGRVVWSSNT---------------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-----CCCEEEEecc----------------
Confidence 4556789999999765 589999997533 2336789999999999974 4678898611
Q ss_pred ccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEee
Q 040413 167 KTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCS 212 (795)
Q Consensus 167 ~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~s 212 (795)
....|.|.+.++.+|...++-.++ .++|.+
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~S 111 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDSDG-NFLWQS 111 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCCC-CEEeCC
Confidence 013456788899888877553333 467754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.5e-06 Score=82.00 Aligned_cols=138 Identities=15% Similarity=0.189 Sum_probs=93.2
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHH---------HHHHHHHHHhcCCCceeeeee---e-
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEE---------FKNEIKLIAKLQHRNLVRLLG---C- 539 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~---~- 539 (795)
...+|...+.+-......|.+-.. +++.+++|..+......... ..+++..+.+++..++..+-. .
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 457788888888877777777665 46899999887654333222 233444455554333222211 1
Q ss_pred ----eeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC
Q 040413 540 ----CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 540 ----~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~ 615 (795)
+.-....+|+|||++|..|.++. .+++ .++..|.+++.-||..| ++|+|+.|.|+++..++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 22234557999999999886653 1222 24566778899999999 99999999999998554
Q ss_pred ceeeccccccc
Q 040413 616 PKISDFGMAKM 626 (795)
Q Consensus 616 ~kl~DFGla~~ 626 (795)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=81.33 Aligned_cols=155 Identities=19% Similarity=0.259 Sum_probs=104.3
Q ss_pred CcccHHHHHHhccCCccccc---ccCCCceeEEeeeccCCceEEEEEecccCcc-------------------c-----H
Q 040413 463 PMFSLASVSAATANFSTENK---LGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ-------------------G-----L 515 (795)
Q Consensus 463 ~~~~~~~i~~~~~~y~~~~~---LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------------------~-----~ 515 (795)
....+..+.....+..+... |+.|.-+.||+|...++..+|||++...... . .
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34556666666666666554 5568888999998888999999998542110 1 1
Q ss_pred HHHHHHHHHHHhcC--CCceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 040413 516 EEFKNEIKLIAKLQ--HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ- 592 (795)
Q Consensus 516 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~- 592 (795)
.-..+|+..|.++. +-.+.+-+.+ .+..|||||+....+..-. -+...+...++..+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 11456888888874 3333444433 2457999999765221110 112223333567777788888777766
Q ss_pred cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 593 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
.+ +||+||+.=|||+. ++.+.|+|||-|....
T Consensus 186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 55 99999999999998 8899999999997654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.7e-06 Score=73.56 Aligned_cols=100 Identities=27% Similarity=0.414 Sum_probs=68.6
Q ss_pred CeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEee-cCCCCCCCCCceEEEeecCCeEEecCCCceeeeecccCC
Q 040413 38 EKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVA-NRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRK 116 (795)
Q Consensus 38 ~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~ 116 (795)
+.+.+.+|.+.|-|-..|+ |-| |+. ..+++|.+ +...... ..+.+.|+.||||||+|..+.++|+|. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~-~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf--~~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YDS-NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSF--DY 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EET-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST--TS
T ss_pred cccccccccccceECCCCe-----EEE-EcC-CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeec--CC
Confidence 4566655889999977664 333 332 35779999 4444421 578999999999999999999999994 34
Q ss_pred CCccEEEEec--CCCeeeecCCCCCCCCCceeeccCCCC
Q 040413 117 AGSPVAQLLD--TGNLVLRDNFSSNSSEGHLWQSFDHPS 153 (795)
Q Consensus 117 ~~~~~~~l~d--~GNlvl~~~~~~~~~~~~~WqSFd~Pt 153 (795)
.....+.+++ +||++ +.. ...+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EES-----TSSEEEESS----
T ss_pred CccEEEeccCcccCCCc-ccc-----ceEEeECCCCCCC
Confidence 4667788888 99998 642 4578898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.1e-06 Score=76.20 Aligned_cols=88 Identities=26% Similarity=0.250 Sum_probs=62.8
Q ss_pred EEEee-cCCeEEecCC-CceeeeecccC-CCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccccc
Q 040413 90 LTIGS-SGNLVILNLK-NGTIWSSNMTR-KAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDL 166 (795)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~W~t~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~ 166 (795)
+.++. ||+||+++.. +.+||++|+.. ....+.+.|+++|||||+|. ++.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~S~~~--------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-----SGTVVWSSNTT--------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-----CCcEEEEeccc---------------
Confidence 45666 9999999765 58999999764 23556789999999999984 46788985321
Q ss_pred ccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 167 KTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 167 ~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
.+.+.+.+.+..+|...++-.+ ..++|.|..
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 1246678888888887755333 456786543
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.3e-06 Score=84.63 Aligned_cols=144 Identities=26% Similarity=0.290 Sum_probs=85.1
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCC--ceeeeeeeeee---cceeEEEEeecC
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHR--NLVRLLGCCIE---LEEKILIYEYMP 554 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~E~~~ 554 (795)
++.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999998877 69999997654 4567888999999998533 34566654432 234689999999
Q ss_pred CCCcce----------------ee---ccC-CCCCCCCHHHH--H-------HH------------HHHHHH-HHHHHHh
Q 040413 555 NKSLDI----------------FL---FDT-PKESPLGWETR--V-------RV------------IEEIAQ-GLLYLHQ 592 (795)
Q Consensus 555 ~gsL~~----------------~l---~~~-~~~~~l~~~~~--~-------~i------------~~qia~-aL~~LH~ 592 (795)
+..+.. .+ +.. .....+..... . .. ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987766 00 000 01111111100 0 00 011111 2233332
Q ss_pred ----cCCCcEEeCCCCCCcEEEc-CCCCceeeccccccc
Q 040413 593 ----YSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKM 626 (795)
Q Consensus 593 ----~~~~~iiH~Dikp~NIll~-~~~~~kl~DFGla~~ 626 (795)
.....++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1234599999999999999 666668999988764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.3e-05 Score=80.31 Aligned_cols=141 Identities=17% Similarity=0.169 Sum_probs=86.5
Q ss_pred cccCCCc-eeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEeecCCCCcc
Q 040413 482 KLGEGGF-GPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSLD 559 (795)
Q Consensus 482 ~LG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 559 (795)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555666 788999765 4788888875432 346788999999884 434557777776666789999999998876
Q ss_pred eeec-------------------cCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 040413 560 IFLF-------------------DTPK-ESPLGWE--TRVRVIE--------------------EIAQGLLYLHQ----Y 593 (795)
Q Consensus 560 ~~l~-------------------~~~~-~~~l~~~--~~~~i~~--------------------qia~aL~~LH~----~ 593 (795)
.... .... ..++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 0011100 0000000 01111111111 1
Q ss_pred CCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 594 ~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999987789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.8e-05 Score=89.38 Aligned_cols=141 Identities=18% Similarity=0.242 Sum_probs=91.7
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCccc-------------------------------HH------HHHHHHH
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQG-------------------------------LE------EFKNEIK 523 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------~~------~~~~E~~ 523 (795)
+.||.-+.|.||+|++++|+.||||+.++.-+.. .+ .|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999876532111 01 1444554
Q ss_pred HHHhc----CCCc---eeeeeeeeee-cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 040413 524 LIAKL----QHRN---LVRLLGCCIE-LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595 (795)
Q Consensus 524 ~l~~l----~h~n---iv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 595 (795)
...+. .|-+ -|.+-.++.+ ...+.|+||||+|..+.+... .....++...+..-+.+...-+- =..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qI--f~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQI--FKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHH--HhcC-
Confidence 44443 3444 1223333333 356799999999998876632 12334555544433333322111 2234
Q ss_pred CcEEeCCCCCCcEEEcC----CCCceeeccccccccC
Q 040413 596 LRVIHRDLKASNILLDK----DMNPKISDFGMAKMFG 628 (795)
Q Consensus 596 ~~iiH~Dikp~NIll~~----~~~~kl~DFGla~~~~ 628 (795)
++|+|-.|.||++.. ++.+.+.|||+...+.
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.8e-05 Score=78.43 Aligned_cols=105 Identities=22% Similarity=0.220 Sum_probs=84.2
Q ss_pred HHHHHHHHhcCC-CceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 040413 519 KNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597 (795)
Q Consensus 519 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 597 (795)
.+|..+|+.+++ +++.+++|+| ..++|.||...+++...-.....-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 6999999999 44789999987765321100012235789999999999999999999866556
Q ss_pred EEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 598 VIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 598 iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+.-.|++|+|+.+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.9e-06 Score=96.00 Aligned_cols=186 Identities=19% Similarity=0.112 Sum_probs=135.6
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc-eeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN-LVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E~~ 553 (795)
.-+...+-+++|++++++|.+-.-.+....+.+... ....-++++|.+++||| .++.++-+..++..+++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 344555678999999999987654444456655432 45667889999999999 666666677777889999999
Q ss_pred CCC-C-cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 554 PNK-S-LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 554 ~~g-s-L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
.++ + ..... ...-.+...+...+.+.-++++++||+.. =+|+| ||+..+ +..|..||+.+..+....
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 877 2 22111 11223444455566677778999999864 47888 776654 688999999998766443
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCC
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~ 679 (795)
..+...+++.++|||......+..+.|+|++|+--.+|--|-+|.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 334567999999999999999999999999998777777666654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00012 Score=89.52 Aligned_cols=79 Identities=16% Similarity=0.374 Sum_probs=58.6
Q ss_pred cccccCCCceeEEeeeccCC---ceEEEEEecccC-cccHHHHHHHHHHHHhcC-CCce--eeeeeeeeec---ceeEEE
Q 040413 480 ENKLGEGGFGPVYKGRLHNG---QEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQ-HRNL--VRLLGCCIEL---EEKILI 549 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 549 (795)
.+.|+.|.+..+|+.+..++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876543 467888764322 223467899999999995 6664 7778887664 356899
Q ss_pred EeecCCCCc
Q 040413 550 YEYMPNKSL 558 (795)
Q Consensus 550 ~E~~~~gsL 558 (795)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.7e-05 Score=73.88 Aligned_cols=128 Identities=19% Similarity=0.306 Sum_probs=92.4
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccC----------------cccHHHHHHHHHHHHhcC------CCceeeee
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS----------------GQGLEEFKNEIKLIAKLQ------HRNLVRLL 537 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 537 (795)
...||+|+.-.||. +++.....||+..... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999995 5566778999887654 223567788887777776 78899999
Q ss_pred eeeeecceeEEEEeecCC--C----CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 538 GCCIELEEKILIYEYMPN--K----SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 538 ~~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
|+...+-...+|+|.+.+ | +|.+++ ....++. ...+.+.++ ..||-++. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998753 3 455555 2334555 444444444 45555555 99999999999996
Q ss_pred CC--C--Cceeec
Q 040413 612 KD--M--NPKISD 620 (795)
Q Consensus 612 ~~--~--~~kl~D 620 (795)
.. + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 43 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=8.2e-05 Score=76.85 Aligned_cols=75 Identities=15% Similarity=0.239 Sum_probs=48.9
Q ss_pred ccccCCCce-eEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCC---ceeeeeeeeeecc---eeEEEEeec
Q 040413 481 NKLGEGGFG-PVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHR---NLVRLLGCCIELE---EKILIYEYM 553 (795)
Q Consensus 481 ~~LG~G~~g-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lV~E~~ 553 (795)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.++|..+... .+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 568877776 58976 23577887553 22356799999999988532 2344444433322 347899999
Q ss_pred CCCCccee
Q 040413 554 PNKSLDIF 561 (795)
Q Consensus 554 ~~gsL~~~ 561 (795)
+|.++...
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99887543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=9.5e-05 Score=70.52 Aligned_cols=130 Identities=20% Similarity=0.256 Sum_probs=90.4
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCcee-eeeeeeeecceeEEEEeecCCC
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~g 556 (795)
...+.|++|++|.||++.... .++|+|+-+. +.....+..|+++|..++-.++- +++.|. ..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 445789999999999998864 5889998654 34557799999999999876664 344443 234559999998
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCC-CCcEEEcCCCCceeecccccccc
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLK-ASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dik-p~NIll~~~~~~kl~DFGla~~~ 627 (795)
.|...-.. .+ .+-+..+++.---|...| |-|+.|. |..++|-.++.+.|+||.-|..-
T Consensus 98 ~L~~~~~~------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 77544310 01 223344555555566666 9999987 45555555569999999999743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=76.40 Aligned_cols=139 Identities=14% Similarity=0.114 Sum_probs=80.6
Q ss_pred cccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEEeecCCCCcce
Q 040413 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYEYMPNKSLDI 560 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~ 560 (795)
.+..|-.+.+|+... +++.+++|+.........-...+|.++++.+....+ .+++.... .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 466788889998873 567888998654322211235789999999864433 23333321 368999999877643
Q ss_pred ee-----------------ccCC-CCCCCCHHH-HHHHHHH---------HHHHHHHHHhc-----CCCcEEeCCCCCCc
Q 040413 561 FL-----------------FDTP-KESPLGWET-RVRVIEE---------IAQGLLYLHQY-----SRLRVIHRDLKASN 607 (795)
Q Consensus 561 ~l-----------------~~~~-~~~~l~~~~-~~~i~~q---------ia~aL~~LH~~-----~~~~iiH~Dikp~N 607 (795)
-. +... ...+++... ...+..+ +.+.+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 20 1100 011112111 1111111 11112222111 12358999999999
Q ss_pred EEEcCCCCceeeccccccc
Q 040413 608 ILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 608 Ill~~~~~~kl~DFGla~~ 626 (795)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00037 Score=74.55 Aligned_cols=80 Identities=13% Similarity=0.084 Sum_probs=59.0
Q ss_pred CCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC---Cceeeeeeeeee---cceeEEE
Q 040413 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH---RNLVRLLGCCIE---LEEKILI 549 (795)
Q Consensus 476 ~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lV 549 (795)
.....+.||+|..+.||.....++ .+++|..+. ......+.+|.+.|+.|.. ..+.++++++.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344456899999999999876655 466677432 1134689999999999953 357788887754 3568999
Q ss_pred EeecCCCCc
Q 040413 550 YEYMPNKSL 558 (795)
Q Consensus 550 ~E~~~~gsL 558 (795)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00024 Score=73.32 Aligned_cols=141 Identities=19% Similarity=0.289 Sum_probs=83.3
Q ss_pred ccccCCCceeEEeeeccC--CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEEeecCCCC
Q 040413 481 NKLGEGGFGPVYKGRLHN--GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
+.|..|-...+|+....+ ++.+++|+....... .-...+|+.+++.+...++ .+++.... ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 578888899999998764 678999987653222 1234579999999864444 34443322 248999999977
Q ss_pred cceee-----------------ccCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 040413 558 LDIFL-----------------FDTPKE--------SPLG-WETRVRVIE----------------------EIAQGLLY 589 (795)
Q Consensus 558 L~~~l-----------------~~~~~~--------~~l~-~~~~~~i~~----------------------qia~aL~~ 589 (795)
+.... +..... .... ++.+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 63210 010110 0111 122112111 11111111
Q ss_pred H----Hhc-CCCcEEeCCCCCCcEEEcC-CCCceeeccccccc
Q 040413 590 L----HQY-SRLRVIHRDLKASNILLDK-DMNPKISDFGMAKM 626 (795)
Q Consensus 590 L----H~~-~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~ 626 (795)
| ... ....++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2345999999999999998 57899999988863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0003 Score=69.43 Aligned_cols=125 Identities=25% Similarity=0.459 Sum_probs=90.1
Q ss_pred cCCcccccccCCCc-eeEEeeeccCCceEEEEEecc---cC---------c---------ccHHHHHHHHHHHHhcC---
Q 040413 475 ANFSTENKLGEGGF-GPVYKGRLHNGQEVAVKRLSS---QS---------G---------QGLEEFKNEIKLIAKLQ--- 529 (795)
Q Consensus 475 ~~y~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~l~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 529 (795)
.+++.++.||.|.- |.||++++. |+.+|+|++.. .. . ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999985 67999999321 10 0 12345888999998885
Q ss_pred CCce--eeeeeeeeec------------------ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 040413 530 HRNL--VRLLGCCIEL------------------EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589 (795)
Q Consensus 530 h~ni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~ 589 (795)
+.++ |+.+|+..-. ..+.||.||++... .+ ...-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4456 8999887422 11356777665432 12 23345667777888
Q ss_pred HHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 590 LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999974 3589999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00062 Score=72.91 Aligned_cols=143 Identities=19% Similarity=0.183 Sum_probs=87.9
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeee------eeecceeEEEEe
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLGC------CIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E 551 (795)
.+.|..|....+|+....+ ..+++|+... ...+.+..|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5678888889999987644 4789998764 34567888999998885433 3444331 123445689999
Q ss_pred ecCCCCcceee--------------c----cCCC----CCCCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 040413 552 YMPNKSLDIFL--------------F----DTPK----ESPLGWETRV----------RVIEEIAQGLLYLHQY----SR 595 (795)
Q Consensus 552 ~~~~gsL~~~l--------------~----~~~~----~~~l~~~~~~----------~i~~qia~aL~~LH~~----~~ 595 (795)
+++|..+...- + .... .....|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 99998764310 0 0000 0011111110 1112233444454431 12
Q ss_pred CcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 596 ~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999988863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00088 Score=73.91 Aligned_cols=74 Identities=16% Similarity=0.242 Sum_probs=55.0
Q ss_pred ccccCCCceeEEeeeccCC-ceEEEEEeccc------C-cccHHHHHHHHHHHHhcC---CCceeeeeeeeeecceeEEE
Q 040413 481 NKLGEGGFGPVYKGRLHNG-QEVAVKRLSSQ------S-GQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 549 (795)
+.||.|.+..||++...+| +.++||.-.+. . +...+++..|.+.|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999988776 58999974321 1 235678888999998873 2356667666 44567899
Q ss_pred EeecCCC
Q 040413 550 YEYMPNK 556 (795)
Q Consensus 550 ~E~~~~g 556 (795)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0022 Score=69.13 Aligned_cols=144 Identities=20% Similarity=0.204 Sum_probs=84.7
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeee------eeecceeEEEEe
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLGC------CIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~E 551 (795)
.+.++.|....+|+....++ .+++|+..... ..+.+..|.+++..|...+ +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 46777888889999876544 67889875421 2455677888888885322 3344332 112345689999
Q ss_pred ecCCCCcceee--------------cc----CCCC--C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 040413 552 YMPNKSLDIFL--------------FD----TPKE--S---PLGWETRV------------RVIEEIAQGLLYLHQ---- 592 (795)
Q Consensus 552 ~~~~gsL~~~l--------------~~----~~~~--~---~l~~~~~~------------~i~~qia~aL~~LH~---- 592 (795)
|++|..+.... +. .... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99986543110 00 0000 0 01111100 011223344555532
Q ss_pred cCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 593 ~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
.-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123599999999999999888778999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0031 Score=68.37 Aligned_cols=143 Identities=20% Similarity=0.179 Sum_probs=79.9
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeee------eeeecceeEEEEe
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLG------CCIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~E 551 (795)
.+.|+.|....+|..+..++ .+++|++.. ...+.+..|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677788889999876554 689998762 22345556777777764222 223332 1123456789999
Q ss_pred ecCCCCcceee------------------ccC--CC--CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 040413 552 YMPNKSLDIFL------------------FDT--PK--ESPLGW-ETRVR------------VIEE-IAQGLLYLHQY-- 593 (795)
Q Consensus 552 ~~~~gsL~~~l------------------~~~--~~--~~~l~~-~~~~~------------i~~q-ia~aL~~LH~~-- 593 (795)
+++|..+...- .+. .. ...+.+ ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99997553210 000 00 001111 11110 1111 11122333211
Q ss_pred --CCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 594 --SRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 594 --~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
-...++|+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 123599999999999998766568999998853
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0012 Score=71.06 Aligned_cols=141 Identities=26% Similarity=0.328 Sum_probs=85.8
Q ss_pred ccccCCCceeEEeeeccC-------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCcee-eeeeeeeecceeEEEEee
Q 040413 481 NKLGEGGFGPVYKGRLHN-------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEY 552 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~ 552 (795)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+...++. ++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 467778888999997654 5789999976543 2334568899999888643333 44444432 368999
Q ss_pred cCCCCccee-e----------------ccCCCCC------CCC--HHHHHH--------------------------HHH
Q 040413 553 MPNKSLDIF-L----------------FDTPKES------PLG--WETRVR--------------------------VIE 581 (795)
Q Consensus 553 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 581 (795)
++|..+... + +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998876431 1 1100000 011 101100 112
Q ss_pred HHHHHHHHHHh------cCCCcEEeCCCCCCcEEEcCC----CCceeeccccccc
Q 040413 582 EIAQGLLYLHQ------YSRLRVIHRDLKASNILLDKD----MNPKISDFGMAKM 626 (795)
Q Consensus 582 qia~aL~~LH~------~~~~~iiH~Dikp~NIll~~~----~~~kl~DFGla~~ 626 (795)
.+.+.+..|.. .....++|+|+.|.||+++.+ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233334432 134569999999999999985 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00055 Score=81.94 Aligned_cols=198 Identities=22% Similarity=0.242 Sum_probs=134.7
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeeeecceeEE----EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 040413 516 EEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL----IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591 (795)
Q Consensus 516 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l----V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH 591 (795)
.....|...+.++.|+|++.++.+..+.....+ .-|++...++...+. .-..++.+..+.+..++.+||.|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence 345567888899999999999998776544432 336777766665553 3356788999999999999999999
Q ss_pred hcCCCcEEeCCCCCC---cEEEcCCCCceee--ccccccccCCCccccceeeecccCCcCChhhhccCCCCc--cCCeee
Q 040413 592 QYSRLRVIHRDLKAS---NILLDKDMNPKIS--DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI--KSDVFS 664 (795)
Q Consensus 592 ~~~~~~iiH~Dikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~Dvws 664 (795)
+.. ..|.-+..+ +.-.+.++.+.++ ||+..+.+....... ...-+..+.+||.......+. ..|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence 975 444444443 4445566777777 998887665432211 123345677888776655554 479999
Q ss_pred hhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040413 665 FGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVV 744 (795)
Q Consensus 665 lG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 744 (795)
+|.++..+..|..+...... ...+++. .....+.+....|+..++++|+++.+++
T Consensus 378 lgll~~~~~~~~~i~~~~~~-----------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV-----------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHHhhhhhcCcccccccc-----------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 99999999988765432110 0001110 0111456788899999999999999999
Q ss_pred HHh
Q 040413 745 SML 747 (795)
Q Consensus 745 ~~L 747 (795)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 985
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0031 Score=68.98 Aligned_cols=141 Identities=18% Similarity=0.252 Sum_probs=84.5
Q ss_pred ccccCCCceeEEeeeccC-----CceEEEEEecccCcccHHHHHHHHHHHHhcCCCcee-eeeeeeeecceeEEEEeecC
Q 040413 481 NKLGEGGFGPVYKGRLHN-----GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV-RLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~ 554 (795)
+.|-.|-...+|++...+ ++.+++|+.........++ .+|..+++.+..-++. ++++++..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 466668889999987532 3689999887654443333 7799999998654443 455554332 5899998
Q ss_pred CCCccee-----------------eccCC-C--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 040413 555 NKSLDIF-----------------LFDTP-K--ESPLGWETRVRVIEEI-----------------AQGLLYL----HQ- 592 (795)
Q Consensus 555 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~qi-----------------a~aL~~L----H~- 592 (795)
+.++..- ++... . .....+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 01111 0 0111223332332211 1111122 11
Q ss_pred cCCCcEEeCCCCCCcEEEcC-CCCceeeccccccc
Q 040413 593 YSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKM 626 (795)
Q Consensus 593 ~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~ 626 (795)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346999999999999986 47899999988864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0059 Score=64.55 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=78.3
Q ss_pred cccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC--Cc-eeeeeeeeeecceeEEEEeecCCCCc
Q 040413 482 KLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH--RN-LVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
..++|-...|+.....+|+.+++|.-.. ......+.+|.++|+.+.. |- +.+.+. . ..-.++|++++|..+
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~---~-~~~~~~y~~i~G~p~ 91 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRV---H-TPELIAYPKLPGVPA 91 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceee---e-cCceEEEeccCCCcc
Confidence 3455555566666555688999998642 2234678999999999953 21 122221 1 123567888877655
Q ss_pred ceeeccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 040413 559 DIFLFDTPK--ESPLGWETRVRVIEEIAQGLLYLHQY------------------------------------------- 593 (795)
Q Consensus 559 ~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------- 593 (795)
..+-..... ...........++.++++.|.-||+.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~la~~la~~La~LH~i~~~~~~~~g~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 171 (276)
T cd05152 92 ATIDPEIGEYVWNFDHKNPPEVFIESLAKALAELHSIPQDEAEAAGIPVETPEEVRQTMADRMDRVKEEFGVSEALWNRW 171 (276)
T ss_pred cccCcccccceecccCCCcCHHHHHHHHHHHHHHhCCChhhccccCCCCCCHHHHHHHHHHHHHHHHHhcCCCHHHHHHH
Confidence 321100000 00000011122344444444444421
Q ss_pred -----------CCCcEEeCCCCCCcEEEcCCCC-ceeeccccccc
Q 040413 594 -----------SRLRVIHRDLKASNILLDKDMN-PKISDFGMAKM 626 (795)
Q Consensus 594 -----------~~~~iiH~Dikp~NIll~~~~~-~kl~DFGla~~ 626 (795)
.+..++|+|++|.||+++.++. .-|+||+.+..
T Consensus 172 ~~~L~~~~~~~~~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 172 QAWLDDDSYWPRHTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred HHHHhhcCCCCCCCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 1234899999999999997555 46999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0016 Score=67.99 Aligned_cols=142 Identities=16% Similarity=0.146 Sum_probs=96.3
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecc---------cC---------ccc----HHHHHHHHHHH
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSS---------QS---------GQG----LEEFKNEIKLI 525 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~---------~~---------~~~----~~~~~~E~~~l 525 (795)
.++..-..=+.+.+.||-|.-+-||.+-...|++.++|.-+. .. ..+ .-...+|+..|
T Consensus 85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 333333345788999999999999999999999999995321 00 011 12245788999
Q ss_pred HhcCC-C-ceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCC
Q 040413 526 AKLQH-R-NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDL 603 (795)
Q Consensus 526 ~~l~h-~-niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Di 603 (795)
+.|.. . -+.+.+++ ...++|||++.+-.|.+.-+ ..+..++..-+ ..-+--|-.+| +||+|.
T Consensus 165 kaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~l---m~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 165 KALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDL---MGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHH---HHHHHHHHHcC---ceeccc
Confidence 98853 2 24444443 45578999999988865431 12233333333 33344555667 999999
Q ss_pred CCCcEEEcCCCCceeecccccc
Q 040413 604 KASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 604 kp~NIll~~~~~~kl~DFGla~ 625 (795)
.-=||++++++.++++||--..
T Consensus 229 NEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred chheeEEecCCCEEEeechHhh
Confidence 9999999999999999996543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0048 Score=65.32 Aligned_cols=76 Identities=16% Similarity=0.246 Sum_probs=49.9
Q ss_pred CcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeeeeecceeEEEEeec
Q 040413 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.+..+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4455689999999999987 567889999875 234467899999999984 345678888887777789999999
Q ss_pred CCC
Q 040413 554 PNK 556 (795)
Q Consensus 554 ~~g 556 (795)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0096 Score=63.36 Aligned_cols=141 Identities=18% Similarity=0.219 Sum_probs=97.7
Q ss_pred ccccccCCCceeEEeeeccCCceEEEEEeccc-----C-----------------cccHH----HHHHHHHHHHhcCCCc
Q 040413 479 TENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ-----S-----------------GQGLE----EFKNEIKLIAKLQHRN 532 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~-----~-----------------~~~~~----~~~~E~~~l~~l~h~n 532 (795)
+-..|..|.-+.||.|...+|..+|||+++-. + ....+ -...|++.|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34578889999999999999999999987421 0 00111 1456888888887544
Q ss_pred eeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC
Q 040413 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 533 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~ 612 (795)
|.-.--+ .-....|||+|+.......- .-+...++...+..+-.|++.-+.-|-+.+ ++||.||.-=|+|+ .
T Consensus 228 IP~PePI--lLk~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 228 IPCPEPI--LLKNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCCce--eeecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence 3211100 01234799999975433211 123456777788888888888888887776 59999999999988 6
Q ss_pred CCCceeecccccccc
Q 040413 613 DMNPKISDFGMAKMF 627 (795)
Q Consensus 613 ~~~~kl~DFGla~~~ 627 (795)
+|.+.|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 788999998877643
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.015 Score=62.01 Aligned_cols=140 Identities=19% Similarity=0.250 Sum_probs=91.2
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecc--cCcccHHHHHHHHHHHHhcCC--Cceeeeeeeeeecc--eeEEEEe
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSS--QSGQGLEEFKNEIKLIAKLQH--RNLVRLLGCCIELE--EKILIYE 551 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~E 551 (795)
.+.+.+..|..-.+|..... ++++++. ... ..........+|+++|+.+.- .-+.+.++.|.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 34444544444455555443 7788888 321 233456677889999988853 23455667777666 5699999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHH-HHHHHHHHHHHhcC------------------------------------
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYS------------------------------------ 594 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qia~aL~~LH~~~------------------------------------ 594 (795)
+++|..+...+... ... .+++ ..+++.|+.||+-.
T Consensus 106 ~veGe~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 106 WVEGEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EecceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 99996443333111 111 2223 36667777777431
Q ss_pred -------------------CCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 595 -------------------RLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 595 -------------------~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+..++|+|+.+.||+++.++.+-|+||+++..-
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 346999999999999999988999999999763
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0025 Score=52.59 Aligned_cols=49 Identities=12% Similarity=0.360 Sum_probs=34.3
Q ss_pred cccCCCCchhhHhhhccChHHHHHHHhccCCeeeeeeccccCCCceeeeeccc
Q 040413 345 DDIKLPDLEEVLLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGD 397 (795)
Q Consensus 345 ~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~~c~~w~~~ 397 (795)
.++.++..+.... ...+.++|+..|+.||+|.||.|.. +...|.++.+.
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 3445544333222 2458899999999999999999953 35678887664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0031 Score=46.73 Aligned_cols=45 Identities=33% Similarity=0.582 Sum_probs=37.2
Q ss_pred cCCCCCCCCCCcccccccccccCCCCCC-CCcccccceeeecccCC
Q 040413 751 TVNLPHPQQPAFSSIRGLKNTILPANGE-TGACSVSCLTLSVMDAR 795 (795)
Q Consensus 751 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 795 (795)
...+|.|.+|.|...|............ .+.++.|.+|+|+++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999999877776554333 36899999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.037 Score=61.07 Aligned_cols=73 Identities=11% Similarity=0.075 Sum_probs=51.9
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEeccc----C---cccHHHHHHHHHHHHhcC---CCceeeeeeeeeecceeEEE
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ----S---GQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 549 (795)
.+.||.|....||+.... ++.++||.-... . +...++-..|++.|+.+. ..++.+++.++. +..++|
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467999999999999874 457999975421 1 124556666777777664 246777888776 456889
Q ss_pred EeecCC
Q 040413 550 YEYMPN 555 (795)
Q Consensus 550 ~E~~~~ 555 (795)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.024 Score=61.65 Aligned_cols=141 Identities=16% Similarity=0.271 Sum_probs=81.4
Q ss_pred ccccCCCceeEEeeeccC----CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~ 555 (795)
+.|..|=...+|+....+ +..|++|+........ -.-.+|..+++.+..-++ .++++++.. . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence 456668888899986543 3479999887644322 224678999999875555 345555432 2 58999987
Q ss_pred CCccee-------e----------ccCC--CCC-CCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 040413 556 KSLDIF-------L----------FDTP--KES-PLGWETRVRVIEEI----------------------AQGLLYLHQ- 592 (795)
Q Consensus 556 gsL~~~-------l----------~~~~--~~~-~l~~~~~~~i~~qi----------------------a~aL~~LH~- 592 (795)
..|..- + +... ... +-.+..+.++..++ .+-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 0 1100 001 11222222222221 111111111
Q ss_pred ----cCCCcEEeCCCCCCcEEEcC-CCCceeeccccccc
Q 040413 593 ----YSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKM 626 (795)
Q Consensus 593 ----~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~ 626 (795)
.....++|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11235899999999999975 57899999998864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.015 Score=58.95 Aligned_cols=31 Identities=42% Similarity=0.579 Sum_probs=22.1
Q ss_pred CcEEeCCCCCCcEEE-cCCCCceeeccccccc
Q 040413 596 LRVIHRDLKASNILL-DKDMNPKISDFGMAKM 626 (795)
Q Consensus 596 ~~iiH~Dikp~NIll-~~~~~~kl~DFGla~~ 626 (795)
..++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999988864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.041 Score=59.65 Aligned_cols=73 Identities=15% Similarity=0.251 Sum_probs=50.3
Q ss_pred cccCCCceeEEeeeccCC-ceEEEEEecc-------cCcccHHHHHHHHHHHHhcC--CCc-eeeeeeeeeecceeEEEE
Q 040413 482 KLGEGGFGPVYKGRLHNG-QEVAVKRLSS-------QSGQGLEEFKNEIKLIAKLQ--HRN-LVRLLGCCIELEEKILIY 550 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lV~ 550 (795)
.||.|....||++..+++ +.++||.-.+ .-+...++...|.+.|+... -|. +.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999987654 6899996321 12445677788888887764 343 444443 3555667999
Q ss_pred eecCCC
Q 040413 551 EYMPNK 556 (795)
Q Consensus 551 E~~~~g 556 (795)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 795 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-47 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-32 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 414 bits (1066), Expect = e-139
Identities = 122/293 (41%), Positives = 176/293 (60%), Gaps = 6/293 (2%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLE-EFKNEIK 523
FSL + A+ NFS +N LG GGFG VYKGRL +G VAVKRL + QG E +F+ E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 524 LIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK-ESPLGWETRVRVIEE 582
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + P+ + PL W R R+
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT 642
A+GL YLH + ++IHRD+KA+NILLD++ + DFG+AK+ + T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFS---NTDSLTLLGRAWDLWKD 699
G+++PEY G S K+DVF +GV+LLE ++ +R D + N D + LL L K+
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752
+ L+D LQ + + I VALLC Q ++RP M EVV ML + +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-138
Identities = 111/308 (36%), Positives = 162/308 (52%), Gaps = 18/308 (5%)
Query: 456 KTRDSWFPMFSLASVSAATANFSTE------NKLGEGGFGPVYKGRLHNGQEVAVKRLSS 509
+ D+ F FS + T NF NK+GEGGFG VYKG + N VAVK+L++
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 510 ----QSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDT 565
+ + ++F EIK++AK QH NLV LLG + ++ L+Y YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 566 PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625
PL W R ++ + A G+ +LH+ IHRD+K++NILLD+ KISDFG+A+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD 685
T RIVGT YM+PE +G + KSD++SFGV+LLE ++ D
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 686 SLTLLGRAWDLWKDDRAWE-LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVV 744
LL ++ +++ E ID + N+A + +VA C+ E RP + +V
Sbjct: 241 Q-LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 745 SMLTNETV 752
+L T
Sbjct: 299 QLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-122
Identities = 104/285 (36%), Positives = 167/285 (58%), Gaps = 5/285 (1%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG+EEF+ EI+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKES-PLGWETRVRVIEEI 583
++ +H +LV L+G C E E ILIY+YM N +L L+ + + + WE R+ +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY 643
A+GL YLH + +IHRD+K+ NILLD++ PKI+DFG++K + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN-TDSLTLLGRAWDLWKDDRA 702
GY+ PEY +G + KSDV+SFGV+L E L ++ S + + L A + + +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+++DP L ++ L ++ + A+ C+ + DRP+M +V+ L
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-90
Identities = 63/310 (20%), Positives = 120/310 (38%), Gaps = 33/310 (10%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
++ + G FG V+K + + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 525 IAKLQHRNLVRLLGCCIE----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
+ ++H N+++ +G + LI + SL FL K + + W +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 581 EEIAQGLLYLHQ-------YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633
E +A+GL YLH+ + + HRD+K+ N+LL ++ I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 634 SKTKRIVGTYGYMSPEYAQQGL-----FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT 688
T VGT YM+PE + + ++ D+++ G++L E S D + +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 689 LLGRAWDLWKDDRAWELID---------PILQNEASYLILNRYINVALLCVQEDAVDRPT 739
++ + ++ + + + + C DA R +
Sbjct: 248 PF--EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 740 MFEVVSMLTN 749
V +T
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-74
Identities = 69/336 (20%), Positives = 124/336 (36%), Gaps = 44/336 (13%)
Query: 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNE--I 522
+ + S N +G G +G VYKG L + VAVK S + Q F NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58
Query: 523 KLIAKLQHRNLVRLLGCCIE-----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
+ ++H N+ R + E +L+ EY PN SL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 578 RVIEEIAQGLLYLHQ------YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG-- 629
R+ + +GL YLH + + + HRDL + N+L+ D ISDFG++ G
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 630 ----DELQSKTKRIVGTYGYMSPEYAQQGL-------FSIKSDVFSFGVLLLETLSSKRN 678
E + VGT YM+PE + + + D+++ G++ E +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 679 TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN----------EASYLILNRYINVALL 728
+ + ++ ++ + + + + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 729 CVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSS 764
C +DA R T + + + + ++
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-61
Identities = 75/288 (26%), Positives = 135/288 (46%), Gaps = 25/288 (8%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLL 537
+ K+G G FG V++ H G +VAVK L Q + + EF E+ ++ +L+H N+V +
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
G + ++ EY+ SL L + L R+ + ++A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFS 657
++HR+LK+ N+L+DK K+ DFG++++ L SK+ GT +M+PE + +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217
Query: 658 IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR--AWELIDPILQNEAS 715
KSDV+SFGV+L E + + N + ++ +K R ++P +
Sbjct: 218 EKSDVYSFGVILWELAT--LQQPWGNLNPAQVVAAV--GFKCKRLEIPRNLNPQVAA--- 270
Query: 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN-ETVNLPHPQQPAF 762
+I C + RP+ ++ +L +P P +
Sbjct: 271 -IIEG--------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-61
Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 24/282 (8%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
E +G G FG V K + ++VA+K++ S+S + F E++ ++++ H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAK-WRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
C+ L+ EY SL L + + +QG+ YLH +I
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 600 HRDLKASNILLDKDMN-PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
HRDLK N+LL KI DFG A ++Q+ G+ +M+PE + +S
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 659 KSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLI 718
K DVFS+G++L E ++ R F W + R P+++N +
Sbjct: 183 KCDVFSWGIILWEVIT--RRKPFDEIGG-PAFRIMWAVHNGTRP-----PLIKN-----L 229
Query: 719 LNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQP 760
++ C +D RP+M E+V ++T+ P +P
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-59
Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRL----SSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
E +G GGFG VY+ G EVAVK Q +E + E KL A L+H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L G C++ L+ E+ L+ L + + V +IA+G+ YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 596 LRVIHRDLKASNILLDKDMNP--------KISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
+ +IHRDLK+SNIL+ + + KI+DFG+A+ ++ G Y +M+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMA 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
PE + +FS SDV+S+GVLL E L+ F D L +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLT--GEVPFRGIDGLAVAYGV--AMNKLAL----- 233
Query: 708 PILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
PI E ++ C D RP+ ++ LT
Sbjct: 234 PIPSTCPEPFAKLMED-------CWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-59
Identities = 72/285 (25%), Positives = 131/285 (45%), Gaps = 37/285 (12%)
Query: 480 ENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQG-------LEEFKNEIKLIAKLQHR 531
E ++G+GGFG V+KGR + + VA+K L +G +EF+ E+ +++ L H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
N+V+L G ++ E++P L L D K P+ W ++R++ +IA G+ Y+
Sbjct: 84 NIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 592 QYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
++HRDL++ NI L + K++DFG+++ + ++G + +M
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 647 SPE--YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
+PE A++ ++ K+D +SF ++L L+ F + + R
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILT--GEGPFDEYSYGKIKFINMIREEGLRP-- 249
Query: 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
I ++ R NV LC D RP +V L+
Sbjct: 250 ---TIPED-----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-58
Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 51/305 (16%)
Query: 480 ENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+G FG K G+ + +K L + F E+K++ L+H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
+ + I EY+ +L + +S W RV ++IA G+ YLH + +
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR------------IVGTYGYM 646
IHRDL + N L+ ++ N ++DFG+A++ ++ Q + R +VG +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706
+PE + K DVFSFG++L E + A +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIG---------------RVNADPDYLPRTM---- 230
Query: 707 DPILQNEASYLILNR----------YINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPH 756
D L + + + C D RP+ ++ L ++L
Sbjct: 231 DFGLNVRGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286
Query: 757 PQQPA 761
Sbjct: 287 HLPLG 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-58
Identities = 68/275 (24%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLL 537
++G G FG VYKG+ H +VAVK L+ + Q L+ FKNE+ ++ K +H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
G + ++ ++ SL L E+ + + + + A+G+ YLH
Sbjct: 87 GYSTA-PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE---YAQQG 654
+IHRDLK++NI L +D KI DFG+A + +++ G+ +M+PE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 655 LFSIKSDVFSFGVLLLETLSSKR-NTDFSNTDS-LTLLGRAWDLWKDDRAWELIDPILQN 712
+S +SDV++FG++L E ++ + ++ +N D + ++GR
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR-----GSLSPDLSKVRSNCP 255
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ ++ C+++ +RP+ +++ +
Sbjct: 256 KRMKRLMAE-------CLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-57
Identities = 61/275 (22%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLL 537
KL E G ++KGR G ++ VK L + S + +F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 538 GCCIELEEKIL--IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
G C I +MP SL L + + V+ ++A+G+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE---YAQ 652
L + L + ++++D+DM +IS + F QS + + +++PE
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGR--MYAPAWVAPEALQKKP 184
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+ +D++SF VLL E ++ R F++ ++ + + + R I
Sbjct: 185 EDTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKV--ALEGLRP-----TIPPG 235
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
I + +C+ ED RP +V +L
Sbjct: 236 -----ISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 36/284 (12%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLL 537
+G+G FG VY GR H EVA++ + + + L+ FK E+ + +H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
G C+ +I ++L + D + L ++ +EI +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI---VGTYGYMSPE----- 649
++H+DLK+ N+ D + I+DFG+ + G + + ++ G +++PE
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 650 ----YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
+ FS SDVF+ G + E + R F + + W + +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHA--REWPFKTQPAEAI---IWQMGTGMKP--N 262
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+ I + IL C + +RPT +++ ML
Sbjct: 263 LSQIGMGKEISDILLF-------CWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-52
Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 43/300 (14%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNE--IKLIAKLQHRNLVRLL 537
+G+G +G V++G G+ VAVK SS+ + + E + L+H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68
Query: 538 GCCIELEEKI----LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH-- 591
+ LI Y SL +L + + L + +R++ IA GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 592 ---QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYM 646
+ + HRDLK+ NIL+ K+ I+D G+A M ++L VGT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 647 SPE------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAW-DLWKD 699
+PE + D+++FG++L E R + + D+ +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMVSNGIVEDYKP---PFYDVVPN 239
Query: 700 DRAWELID----------PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
D ++E + I S L + C ++ R T + LT
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 70/300 (23%), Positives = 118/300 (39%), Gaps = 43/300 (14%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNE--IKLIAKLQHRNLVRLL 537
++G+G +G V+ G+ G++VAVK + + E I ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFI 97
Query: 538 GCCIELEEKI----LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH-- 591
I+ LI +Y N SL +L K + L ++ +++ GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 592 ---QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYM 646
+ + HRDLK+ NIL+ K+ I+D G+A F +E+ VGT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 647 SPE------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAW-DLWKD 699
PE I +D++SFG++L E R + L + DL
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR--RCVSGGIVEEYQL---PYHDLVPS 268
Query: 700 DRAWELID----------PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
D ++E + +S L + + C + R T V L
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-48
Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 39/298 (13%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNE--IKLIAKLQHRNLVRLL 537
+ +G+G FG V++G+ G+EVAVK SS+ + E I L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102
Query: 538 GCCIELEEKI----LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ- 592
+ L+ +Y + SL FD + E +++ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 593 ----YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYM 646
+ + HRDLK+ NIL+ K+ I+D G+A D + VGT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 647 SPE------YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD 700
+PE + ++D+++ G++ E R + + L + D
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIAR--RCSIGGIHEDYQLPYYDL-VPSDP 275
Query: 701 RAWELID---------PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
E+ I S L + C + R T + L+
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-47
Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 25/278 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ ++G G FG V+ GRL + VAVK + +F E +++ + H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
VRL+G C + + ++ E + FL + + L +T ++++ + A G+ YL
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES- 231
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
IHRDL A N L+ + KISDFGM++ + + +PE
Sbjct: 232 --KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
G +S +SDV+SFG+LL ET S + + SN + + ++ L P L
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---------EKGGRLPCPELC 340
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+A + ++ + C + RP+ + L +
Sbjct: 341 PDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 40/292 (13%)
Query: 480 ENKLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+LG+G FG V R G+ VAVK+L + + L +F+ EI+++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 535 RLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ G C + LI EY+P SL +L + + ++ +I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG-----YMS 647
R IHRDL NIL++ + KI DFG+ K+ D+ K K G + +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYA 185
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
PE + FS+ SDV+SFGV+L E + + + + ++G D + LI+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFHLIE 243
Query: 708 PILQNE----------ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+ N Y+I+ C + RP+ ++ +
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-47
Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 44/294 (14%)
Query: 480 ENKLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+LG+G FG V R G+ VAVK+L + + L +F+ EI+++ LQH N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 535 RLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ G C + LI EY+P SL +L + + ++ +I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE----LQSKTK---RIVGTYGY 645
R IHRDL NIL++ + KI DFG+ K+ D+ ++ + +
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------W 214
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
+PE + FS+ SDV+SFGV+L E + + + + ++G D + L
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFHL 272
Query: 706 IDPILQNE----------ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
I+ + N Y+I+ C + RP+ ++ +
Sbjct: 273 IELLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 83/292 (28%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 480 ENKLGEGGFGPVYKGRLHN-----GQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNL 533
LGEG FG V G+ VAVK L + +G Q +K EI ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 534 VRLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
++ GCC + L+ EY+P SL +L +G + ++I +G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE----LQSKTK---RIVGTYG 644
IHRDL A N+LLD D KI DFG+AK ++
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------ 202
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
+ +PE ++ F SDV+SFGV L E L+ ++ T L L+G A R E
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 705 LID-----PILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
L++ P Y ++ C + +A RPT ++ +L
Sbjct: 263 LLERGERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 480 ENKLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNL 533
LGEG FG V R G++VAVK L +SG + + K EI+++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 534 VRLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
V+ G C E LI E++P+ SL +L ++ + + +++ +I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYL- 142
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE----LQSKTK---RIVGTYG 644
+ +HRDL A N+L++ + KI DFG+ K D+ ++
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------ 194
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
+ +PE Q F I SDV+SFGV L E L+ + L ++G
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT---VTR 251
Query: 705 LIDPILQNE----------ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
L++ + + + Y ++ C + +R + ++
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEVYQLM-------RKCWEFQPSNRTSFQNLIEGF 297
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 480 ENKLGEGGFGPVYKGRLHNG------QEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ +LGEG FG V+ +N VAVK L + ++F+ E +L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETRVRVI 580
V+ G C + + I+++EYM + L+ FL + LG + +
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGD--ELQSKTK 637
+IA G++YL + +HRDL N L+ ++ KI DFGM++ ++ D + T
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 638 ---RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M PE F+ +SDV+SFGV+L E +
Sbjct: 197 LPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 72/199 (36%), Positives = 107/199 (53%), Gaps = 15/199 (7%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+LG G FG V+ G + +VAVK L S + F E L+ +LQH+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 540 CIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
+E I I EYM N SL FL TP L + + +IA+G+ ++
Sbjct: 77 V--TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNY 130
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQGL 655
IHRDL+A+NIL+ ++ KI+DFG+A++ +E ++ G + +PE G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGT 186
Query: 656 FSIKSDVFSFGVLLLETLS 674
F+IKSDV+SFG+LL E ++
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 71/315 (22%), Positives = 120/315 (38%), Gaps = 57/315 (18%)
Query: 480 ENKLGEGGFGPVYKGRLH-----NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
++LG+G FG V R G VAVK+L +F+ EI+++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 535 RLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ G + L+ EY+P+ L FL + L + +I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGS 145
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE----LQSKTK---RIVGTYGY 645
R +HRDL A NIL++ + + KI+DFG+AK+ D+ ++ + +
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------W 196
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA--WDLWKDDRAW 703
+PE +FS +SDV+SFGV+L E + + R
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFT---------------YCDKSCSPSAEFLRMM 241
Query: 704 ELIDPILQNEASYLILNR--------------YINVALLCVQEDAVDRPTMFEVVSMLTN 749
+ +L + + LC DRP+ + L
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGPQLDM 300
Query: 750 ETVNLPHPQQPAFSS 764
+ AF++
Sbjct: 301 LWSGSRGCETHAFTA 315
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ ++G G FG V+ G N +VA+K + + E+F E +++ KL H LV+
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L G C+E L+ E+M + L +L + ET + + ++ +G+ YL
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQ 652
VIHRDL A N L+ ++ K+SDFGM + D+ S T GT + SPE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
+S KSDV+SFGVL+ E S + + SN++ + + + L+K P L
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------PRL 229
Query: 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ Y I+ C +E DRP ++ L
Sbjct: 230 ASTHVYQIM-------NHCWRERPEDRPAFSRLLRQL 259
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE------VAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ +LGEG FG V+ HN VAVK L S ++F+ E +L+ LQH+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFL------------FDTPKESPLGWETRVRVIE 581
VR G C E ++++EYM + L+ FL + PLG + V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGD--ELQSKTK- 637
++A G++YL + L +HRDL N L+ + + KI DFGM++ ++ D + +T
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 638 --RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M PE F+ +SDV+SFGV+L E +
Sbjct: 223 PIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 540 CIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
+E + + I EYM SL +L + S LG + ++ ++ + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG------YMSPEYAQ 652
+HRDL A N+L+ +D K+SDFG+ K + + + +PE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+ FS KSDV+SFG+LL E S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ + +LG G FG V G+ +VA+K + S +EF E K++ L H LV+
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQ 83
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L G C + +I EYM N L +L + + + + +++ + + YL
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---ES 138
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQ 652
+ +HRDL A N L++ K+SDFG+++ DE S G+ + PE
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLM 194
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
FS KSD+++FGVL+ E S + F+N+++ + + L P L
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHL 245
Query: 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+E Y I+ C E A +RPT ++S +
Sbjct: 246 ASEKVYTIM-------YSCWHEKADERPTFKILLSNI 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-44
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 25/271 (9%)
Query: 480 ENKLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
++KLG G +G VY+G VAVK L + + +EEF E ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
C +I E+M +L +L + + + +I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
IHR+L A N L+ ++ K++DFG++++ GD + + +PE FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716
KSDV++FGVLL E + + + LL + + + + P E Y
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---------PEGCPEKVY 449
Query: 717 LILNRYINVALLCVQEDAVDRPTMFEVVSML 747
++ C Q + DRP+ E+
Sbjct: 450 ELM-------RACWQWNPSDRPSFAEIHQAF 473
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 75/221 (33%), Positives = 108/221 (48%), Gaps = 35/221 (15%)
Query: 480 ENKLGEGGFGPVYKGRLHNG------QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRN 532
+LGE FG VYKG L Q VA+K L G EEF++E L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETRVRV 579
+V LLG + + +I+ Y + L FL D +S L V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGD--ELQSKT 636
+ +IA G+ YL S V+H+DL N+L+ +N KISD G+ +++ D +L +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 637 K---RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M+PE G FSI SD++S+GV+L E S
Sbjct: 191 LLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-43
Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 540 CIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
+E + + ++ EYM SL +L + S LG + ++ ++ + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+HRDL A N+L+ +D K+SDFG+ K Q K V + +PE ++ FS
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFST 365
Query: 659 KSDVFSFGVLLLETLS 674
KSDV+SFG+LL E S
Sbjct: 366 KSDVWSFGILLWEIYS 381
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ +LG G FG V G+ +VAVK + S +EF E + + KL H LV+
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVK 67
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
G C + ++ EY+ N L +L K L + + ++ +G+ +L
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFL---ES 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQ 652
+ IHRDL A N L+D+D+ K+SDFGM + D+ S GT + +PE
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFH 178
Query: 653 QGLFSIKSDVFSFGVLLLETLS 674
+S KSDV++FG+L+ E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-43
Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG G FG V+ + +VAVK + S +E F E ++ LQH LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 540 CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVI 599
+ E +I E+M SL FL + + S + +IA+G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSPEYAQQGLF 656
HRDL+A+NIL+ + KI+DFG+A++ +E ++ G + +PE G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362
Query: 657 SIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN-- 712
+IKSDV+SFG+LL+E ++ R SN + + L R + + P +N
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----------PRPENCP 411
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
E Y I+ + C + +RPT + S+L
Sbjct: 412 EELYNIM-------MRCWKNRPEERPTFEYIQSVL 439
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 480 ENKLGEGGFGPVYKGRLHNG-QEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
++KLG G +G VY+G VAVK L + + +EEF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
C +I E+M +L +L + + + +I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK-----RIVGTYGYMSPEYAQQ 653
IHRDL A N L+ ++ K++DFG++++ GD + + + +PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 654 GLFSIKSDVFSFGVLLLETLS 674
FSIKSDV++FGVLL E +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE-----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNL 533
LG G FG VYKG E VA+K L + S + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
RLLG C L + LI + MP L ++ + + +G + + +IA+G+ YL
Sbjct: 80 CRLLGIC--LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG-----YMS 647
R++HRDL A N+L+ + KI+DFG+AK+ G +E + + G +M+
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMA 187
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
E +++ +SDV+S+GV + E ++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE---VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ +LG G FG V +G ++ VA+K L EE E +++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 536 LLGCCIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
L+G C E +++ E L FL +E + ++ +++ G+ YL
Sbjct: 75 LIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---E 127
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG------YMSP 648
+HRDL A N+LL KISDFG++K G D+ + + +P
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAP 182
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E FS +SDV+S+GV + E LS
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 481 NKLGEGGFGPVYKGRLHNGQE------VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNL 533
+LG+G FG VY+G + VA+K + + S + EF NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFL-------FDTPKESPLGWETRVRVIEEIAQG 586
VRLLG + + ++I E M L +L + P +P +++ EIA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTK-----RIV 640
+ YL + + +HRDL A N ++ +D KI DFGM ++ D + K R
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+MSPE + G+F+ SDV+SFGV+L E +
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 8e-43
Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 27/271 (9%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG+G FG V+ G + VA+K L + E F E +++ KL+H LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 540 CIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
EE I I EYM SL FL L V + +IA G+ Y+ R+
Sbjct: 248 V--SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+HRDL+A+NIL+ +++ K++DFG+A++ +E ++ + +PE A G F+I
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 360
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716
KSDV+SFG+LL E + R N + L + +R + + P E+ +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECPESLH 411
Query: 717 LILNRYINVALLCVQEDAVDRPTMFEVVSML 747
++ C +++ +RPT + + L
Sbjct: 412 DLM-------CQCWRKEPEERPTFEYLQAFL 435
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 480 ENKLGEGGFGPVYKGRL----HNGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
E +G G G V GRL VA+K L + + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
RL G +++ EYM N SLD FL + V ++ + G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY--------- 645
L +HRDL A N+L+D ++ K+SDFG++++ D
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTTGGKIP 217
Query: 646 ---MSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+PE FS SDV+SFGV++ E L+
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 48/285 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+F +G GGFG V+K + +G+ +KR+ + E+ + E+K +AKL H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 535 RLLGCCIELEEKI----------------LIYEYMPNKSLDIFLFDTPKESPLGWETRVR 578
GC + + E+ +L+ ++ + + L +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638
+ E+I +G+ Y+H ++I+RDLK SNI L KI DFG+ D K R
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRTR 180
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698
GT YMSPE + + D+++ G++L E L T R
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLRD----- 233
Query: 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
+I I + L+ + + DRP E+
Sbjct: 234 -----GIISDIFDKKEKTLLQK--------LLSKKPEDRPNTSEI 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQE-----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQ 529
+ + +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
H N++RL G + + ++I EYM N +LD FL + K+ V ++ IA G+ Y
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKY 162
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG----- 644
L + + +HRDL A NIL++ ++ K+SDFG++++ D + T G
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPI 214
Query: 645 -YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +PE F+ SDV+SFG+++ E ++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 480 ENKLGEGGFGPVYKGRLHNG---QEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V KG + VAVK L + +E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
R++G C E L+ E L+ +L + + + + ++ +++ G+ YL
Sbjct: 82 RMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL--- 133
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE----LQSKTKRIVGTYGYMSPE 649
+HRDL A N+LL KISDFG++K DE Q+ K V + +PE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPE 190
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLS 674
FS KSDV+SFGVL+ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE----VAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNL 533
LGEG FG V +G L VAVK + + S + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 534 VRLLGCCIELE-----EKILIYEYMPNKSLDIFL---FDTPKESPLGWETRVRVIEEIAQ 585
+RLLG CIE+ + ++I +M L +L + +T ++ + +IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK-MFGGDELQSKTK-----RI 639
G+ YL S +HRDL A N +L DM ++DFG++K ++ GD + +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ E +++ KSDV++FGV + E +
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-42
Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 27/271 (9%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
E KLG+G FG V+ G + VA+K L + E F E +++ KL+H LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 540 CIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598
EE I I EYM SL FL L V + +IA G+ Y+ R+
Sbjct: 331 V--SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 384
Query: 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSI 658
+HRDL+A+NIL+ +++ K++DFG+A++ +E ++ + +PE A G F+I
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 443
Query: 659 KSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASY 716
KSDV+SFG+LL E + R N + L + +R + + P E+ +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECPESLH 494
Query: 717 LILNRYINVALLCVQEDAVDRPTMFEVVSML 747
++ C +++ +RPT + + L
Sbjct: 495 DLM-------CQCWRKEPEERPTFEYLQAFL 518
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE-----VAVKRLSSQSG-QGLEEFKNEIKLIAKLQHRNL 533
LG G FG V+KG E V +K + +SG Q + + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
VRLLG C + L+ +Y+P SL + LG + + +IA+G+ YL
Sbjct: 78 VRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL-- 131
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG-----YMS 647
++HR+L A N+LL +++DFG+A + D+ Q +M+
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMA 185
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
E G ++ +SDV+S+GV + E ++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-42
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQE----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQH 530
N S + +G G FG V GRL + VA+K L + + +F E ++ + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
N++RL G + + +++ EYM N SLD FL ++ V ++ IA G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYL 163
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMS 647
S + +HRDL A NIL++ ++ K+SDFG+ ++ D + T R G + S
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTS 218
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
PE F+ SDV+S+G++L E +S
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE---VAVKRL-SSQSGQGLEEFKNEIKLIAKL-QHRNLV 534
++ +GEG FG V K R+ A+KR+ S +F E++++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETRVRVIE 581
LLG C L EY P+ +L FL S L + +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK---- 637
++A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG+++ G + KT
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 638 -RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
R +M+ E +++ SDV+S+GVLL E +S
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 75/287 (26%), Positives = 119/287 (41%), Gaps = 42/287 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQE----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQH 530
+ LGEG FG VY+G N + VAVK + E+F +E ++ L H
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 531 RNLVRLLGCCIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
++V+L+G EE I E P L +L ++ L T V +I + + Y
Sbjct: 73 PHIVKLIGII--EEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE--LQSKTK---RIVGTYG 644
L + +HRD+ NIL+ K+ DFG+++ ++ S T+ +
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------ 179
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRA 702
+MSPE F+ SDV+ F V + E LS + N D + +L ++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---------EKG 230
Query: 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
L P L Y ++ C D DRP E+V L++
Sbjct: 231 DRLPKPDLCPPVLYTLM-------TRCWDYDPSDRPRFTELVCSLSD 270
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 480 ENKLGEGGFGPVYKGRLH----NGQEVAVKRL---SSQSGQGLEEFKNEIKLIAKLQHRN 532
KLG+G FG V +G VAVK L + +++F E+ + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
L+RL G L + ++ E P SL L L T R ++A+G+ YL
Sbjct: 83 LIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYL- 137
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGT---YGYMSP 648
R IHRDL A N+LL KI DFG+ + ++ + + + +P
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E + FS SD + FGV L E +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN--------GQEVAVKRLSSQSGQGLEEFKNEIKLIAK 527
+ LG+G F ++KG EV +K L E F +++K
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
L H++LV G C+ +E IL+ E++ SLD +L ++ + ++ V +++A +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAM 126
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNP--------KISDFGMAKMFGGDELQSKTKRI 639
+L +IH ++ A NILL ++ + K+SD G++ + +RI
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQERI 181
Query: 640 VGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLS 674
++ PE + ++ +D +SFG L E S
Sbjct: 182 ----PWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ +G+G FG VY G + + A+K L Q +E F E L+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 535 RLLGCCIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
L+G + E + YM + L F+ + + + ++A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY--GYMSPEYA 651
+ + +HRDL A N +LD+ K++DFG+A+ E S + + + E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
Q F+ KSDV+SFGVLL E L+
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 480 ENKLGEGGFGPVYKGRLHNG----QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+G G FG VY G L + AVK L + +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 535 RLLGCCIELEEKIL-IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
LLG C+ E L + YM + L F+ + + + + ++A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG------YMS 647
+ + +HRDL A N +LD+ K++DFG+A+ D + + G +M+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
E Q F+ KSDV+SFGVLL E ++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 480 ENKLGEGGFGPVYKGRLHNG----QEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNL 533
LG+G FG V + +L +VAVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 534 VRLLGCCIELEEKI------LIYEYMPNKSLDIFLFD---TPKESPLGWETRVRVIEEIA 584
+L+G + K +I +M + L FL L +T VR + +IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTK-----R 638
G+ YL S IHRDL A N +L +DM ++DFG++ K++ GD + +
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 639 IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ E L+++ SDV++FGV + E ++
Sbjct: 205 ------WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQE----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQH 530
+GEG FG V++G + + VA+K + S E+F E + + H
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 531 RNLVRLLGCCIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
++V+L+G E + I E L FL ++ L + + +++ L Y
Sbjct: 76 PHIVKLIGVI--TENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE--LQSKTKRIVGTYGYMS 647
L R +HRD+ A N+L+ + K+ DFG+++ SK K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
PE F+ SDV+ FGV + E L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 43/229 (18%)
Query: 480 ENKLGEGGFGPVYKGRLHNG------QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRN 532
+GEG FG V++ R VAVK L S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL---------------------FDTPKESPL 571
+V+LLG C + L++EYM L+ FL +P PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 572 GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGD 630
++ + ++A G+ YL S + +HRDL N L+ ++M KI+DFG++ ++ D
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 631 ELQSKTK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
++ R +M PE ++ +SDV+++GV+L E S
Sbjct: 229 YYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 43/229 (18%)
Query: 480 ENKLGEGGFGPVYKGRLHNG------QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRN 532
LGEG FG V K + VAVK L + S L + +E ++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL---------------------FDTPKESPL 571
+++L G C + +LI EY SL FL D P E L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 572 GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGD 630
+ +I+QG+ YL + ++++HRDL A NIL+ + KISDFG++ ++ D
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 631 ELQSKTK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+++ + +M+ E +++ +SDV+SFGVLL E ++
Sbjct: 205 SYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 480 ENKLGEGGFGPVYKGRLH--------NGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKL-Q 529
LGEG FG V VAVK L + + L + +E++++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETR 576
H+N++ LLG C + +I EY +L +L + E + ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSK 635
V ++A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+A + D +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 636 TK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
T + +M+PE +++ +SDV+SFGVL+ E +
Sbjct: 217 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL---SSQSGQGLEEFKNEIKLIAKLQHR 531
NF E K+G G F VY+ L +G VA+K++ + + EI L+ +L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 532 NLVRLLGCCIELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLY 589
N+++ IE + ++ I E L + K+ L E V ++ L +
Sbjct: 93 NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
+H RV+HRD+K +N+ + K+ D G+ + F + + +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKR--NTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
+ ++ KSD++S G LL E + + D N SL + D
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----QCD-----YP 256
Query: 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
P+ + S L + +N +C+ D RP + V
Sbjct: 257 PLPSDHYSE-ELRQLVN---MCINPDPEKRPDVTYV 288
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNL 533
+F LG GGFG V++ + + A+KR+ E+ E+K +AKL+H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 534 VRLLGCCIE---------LEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIE 581
VR +E K+ +Y + ++L ++ + +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR--- 638
+IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 639 -------IVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
VGT YMSPE +S K D+FS G++L E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI 541
LG+G +G VY GR L N +A+K + + + + EI L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 542 ELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLRVI 599
E I I+ E +P SL L E + ++I +GL YLH +++
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDN-EQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 600 HRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL--F 656
HRD+K N+L++ KISDFG +K G + T+ GT YM+PE +G +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 657 SIKSDVFSFGVLLLETLSSKR 677
+D++S G ++E + K
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 56/301 (18%)
Query: 480 ENKLGEGGFGPVYKGRLH--------NGQEVAVKRL-SSQSGQGLEEFKNEIKLIAKL-Q 529
LGEG FG V VAVK L + + L + +E++++ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETR 576
H+N++ LLG C + +I EY +L +L + E + ++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSK 635
V ++A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+A + D +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 636 TK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE--TLSSKRNTDFSNTDSLT 688
T + +M+PE +++ +SDV+SFGVL+ E TL +
Sbjct: 263 TNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 689 LLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
LL + K P Y+++ C RPT ++V L
Sbjct: 317 LLKEGHRMDK---------PANCTNELYMMM-------RDCWHAVPSQRPTFKQLVEDLD 360
Query: 749 N 749
Sbjct: 361 R 361
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
++G G F VYKG EVA + + + FK E +++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 539 CCIELEEK----ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ +L+ E M + +L +L + + + +I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 595 RLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+IHRDLK NI + + KI D G+A + S K ++GT +M+PE ++
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAPEMYEE 204
Query: 654 GLFSIKSDVFSFGVLLLETLSSK 676
+ DV++FG+ +LE +S+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 481 NKLGEGGFGPVYKGRLHN------GQEVAVKRL-SSQSGQGLEEFKNEIKLIAKL-QHRN 532
LG G FG V + + VAVK L + +E+K++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 533 LVRLLGCCIELEEKI-LIYEYMPNKSLDIFL-------------FDTPKESPLGWETRVR 578
+V LLG C + + +I E+ +L +L + + L E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTK 637
++A+G+ +L + + IHRDL A NILL + KI DFG+A ++ + K
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 638 -----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +M+PE +++I+SDV+SFGVLL E S
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE-----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNL 533
LG G FG VYKG E VA+K L + S + +E +E ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
RLLG C L + LI + MP L ++ + + +G + + +IA+G+ YL
Sbjct: 80 CRLLGIC--LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG-----YMS 647
R++HRDL A N+L+ + KI+DFG+AK+ G +E + + G +M+
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMA 187
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLS 674
E +++ +SDV+S+GV + E ++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 480 ENKLGEGGFGPVYKGRLHNG------QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRN 532
LG G FG VY+G++ +VAVK L S Q +F E +I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL----FDTPKESPLGWETRVRVIEEIAQGLL 588
+VR +G ++ + ++ E M L FL + S L + V +IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 589 YLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAK-MFGGD--ELQSKTK---RI 639
YL IHRD+ A N LL KI DFGMA+ ++ +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK- 210
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE +G+F+ K+D +SFGVLL E S
Sbjct: 211 -----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 480 ENKLGEGGFGPVYKGRLHNG----QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+G G FG VY G L + AVK L + +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 535 RLLGCCIELEEKIL-IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
LLG C+ E L + YM + L F+ + + + + ++A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG-----YMSP 648
+ + +HRDL A N +LD+ K++DFG+A+ E S + T +M+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 265
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLS 674
E Q F+ KSDV+SFGVLL E ++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 480 ENKLGEGGFGPVYKGRLHNG------QEVAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRN 532
LG G FG VY+G++ +VAVK L S Q +F E +I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFL----FDTPKESPLGWETRVRVIEEIAQGLL 588
+VR +G ++ + ++ E M L FL + S L + V +IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 589 YLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAK-MFGGD--ELQSKTK---RI 639
YL IHRD+ A N LL KI DFGMA+ ++ +
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK- 251
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M PE +G+F+ K+D +SFGVLL E S
Sbjct: 252 -----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-40
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 35/293 (11%)
Query: 479 TENKLGEGGFGPVYKGRLHNGQE---VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V +G ++ VA+K L EE E +++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
RL+G C E +L+ E L FL +E + ++ +++ G+ YL
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---E 453
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE----LQSKTKRIVGTYGYMSPEY 650
+HR+L A N+LL KISDFG++K G D+ +S K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRN--TDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708
FS +SDV+S+GV + E LS + + + + ++ + P
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---------EQGKRMECP 561
Query: 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPA 761
Y ++ C DRP V + +L +
Sbjct: 562 PECPPELYALM-------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE------VAVKRL-SSQSGQGLEEFKNEIKLIAKL-QHR 531
LG G FG V + + + VAVK L S E +E+K+++ L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFL---------------FDTPKESPLGWETR 576
N+V LLG C ++I EY L FL E L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSK 635
+ ++A+G+ +L + IHRDL A NILL KI DFG+A + K
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +M+PE +++ +SDV+S+G+ L E S
Sbjct: 205 GNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+ K+GEG FG + +G++ +K +S S + EE + E+ ++A ++H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+V+ E ++ +Y L + K + + +I L ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD 143
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+++HRD+K+ NI L KD ++ DFG+A++ ++ +GT Y+SPE +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICE 198
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKR 677
++ KSD+++ G +L E + K
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKH 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE------VAVKRL-SSQSGQGLEEFKNEIKLIAKL-QHR 531
LG G FG V + + VAVK L S+ E +E+K+++ L QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFL-----------FDTPKESPLGWETRVRVI 580
N+V LLG C ++I EY L FL S +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSKTKRI 639
++AQG+ +L + IHRD+ A N+LL KI DFG+A + K
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ +M+PE +++++SDV+S+G+LL E S
Sbjct: 228 L-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+F LG+G FG V K R + + A+K++ + L +E+ L+A L H+ +V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVV 65
Query: 535 RLLGCCIE----------LEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRV--RV 579
R +E +++K ++ EY N +L +D L + R+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRL 121
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF------------ 627
+I + L Y+H +IHRDLK NI +D+ N KI DFG+AK
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 628 GGDELQSKTKRIVGTYGYMSPE-YAQQGLFSIKSDVFSFGVLLLE 671
+GT Y++ E G ++ K D++S G++ E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 480 ENKLGEGGFGPVYKGRLHN--------GQEVAVKRL-SSQSGQGLEEFKNEIKLIAKL-Q 529
LGEG FG V +VAVK L S + + L + +E++++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETR 576
H+N++ LLG C + +I EY +L +L E L +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGDELQSK 635
V ++A+G+ YL + + IHRDL A N+L+ +D KI+DFG+A + D +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 636 TK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
T + +M+PE +++ +SDV+SFGVLL E +
Sbjct: 251 TNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+S ++G GG V++ Q A+K L Q L+ ++NEI + KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 534 --VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLY 589
+RL ++ I ++ E +I L K+ + R + + + +
Sbjct: 89 KIIRLYDY-EITDQYIYMVMECG-----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
+HQ+ ++H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 143 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 650 -----------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ S KSDV+S G +L K
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
++ +G G +G K R +G+ + K S + + +E+ L+ +L+H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 533 LVRLLGCCIELEEKIL--IYEYMPNKSLDIFLFDTPKESPLGWETRV-RVIEEIAQGLLY 589
+VR I+ L + EY L + KE E V RV+ ++ L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 590 LHQ--YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
H+ V+HRDLK +N+ LD N K+ DFG+A++ D +KT VGT YMS
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMS 184
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677
PE + ++ KSD++S G LL E +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+S ++G GG V++ Q A+K L Q L+ ++NEI + KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 534 --VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
+RL ++ I ++ E N L+ +L K+ + R + + + + +
Sbjct: 70 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE- 649
HQ+ ++H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 650 ----------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ S KSDV+S G +L K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE------VAVKRL-SSQSGQGLEEFKNEIKLIAKL-QHR 531
LG G FG V + + VAVK L E +E+K++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFL--------------------FDTPKESPL 571
N+V LLG C LI+EY L +L + + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 572 GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA-KMFGGD 630
+E + ++A+G+ +L +HRDL A N+L+ KI DFG+A +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 631 ELQSKTK-----RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+ + +M+PE +G+++IKSDV+S+G+LL E S
Sbjct: 227 NYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKR--LSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+S ++G GG V++ Q A+K L Q L+ ++NEI + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 534 --VRLLGCCIELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
+RL ++ I + E N L+ +L K+ + R + + + + +
Sbjct: 117 KIIRLYDY-EITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE- 649
HQ+ ++H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 172 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 650 ----------YAQQGLFSIKSDVFSFGVLLLETLSSK 676
+ S KSDV+S G +L K
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 69/310 (22%), Positives = 114/310 (36%), Gaps = 52/310 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
++ KLGEGGF V LH+G A+KR+ Q EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 535 RLLGCCIELEEK----ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLY 589
RL+ C+ L+ + +L + + E ++ + I +GL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV-------GT 642
+H HRDLK +NILL + P + D G S+ + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 643 YGYMSPE------YAQQGLFSIKSDVFSFGVLLLETLSSKR--NTDFSNTDSLTLLGRAW 694
Y +PE + ++DV+S G +L + + + F DS+ L
Sbjct: 207 ISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258
Query: 695 DLWKDDRAWELIDPILQNEASYLILNRY----INVALLCVQEDAVDRPTMFEVVSMLTNE 750
+QN+ S R+ + + D RP + ++S L E
Sbjct: 259 --------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL--E 302
Query: 751 TVNLPHPQQP 760
+ P P Q
Sbjct: 303 ALQPPAPGQH 312
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 6e-38
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQE----VAVKRL-SSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+GEG FG V++G + + VA+K + S E+F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+L+G E +I E L FL ++ L + + +++ L YL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYL---E 508
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
R +HRD+ A N+L+ + K+ DFG+++ +K + +M+PE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFR 567
Query: 655 LFSIKSDVFSFGVLLLETLS 674
F+ SDV+ FGV + E L
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 20/204 (9%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
++G G FG V++ + G + AVK++ + + E+ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 540 CIELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYSRLR 597
E + I+ E + SL + E R + +GL YLH R
Sbjct: 119 VRE-GPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQALEGLEYLHT---RR 170
Query: 598 VIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDELQ---SKTKRIVGTYGYMSPEYAQQ 653
++H D+KA N+LL D + + DFG A D L I GT +M+PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 654 GLFSIKSDVFSFGVLLLETLSSKR 677
K D++S ++L L+
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 65/296 (21%), Positives = 102/296 (34%), Gaps = 53/296 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKL-QHR 531
+F ++LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYL 590
VRL E L E SL P E +V + L +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAHL 173
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H ++H D+K +NI L K+ DFG+ G + G YM+PE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPEL 227
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
Q + +DVFS G+ +LE + +L W+ +
Sbjct: 228 LQGS-YGTAADVFSLGLTILE------------------VACNMELPHGGEGWQ---QLR 265
Query: 711 QNEASYLILNRY----INVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHP--QQP 760
Q +V ++ ++ D R T + L P +QP
Sbjct: 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL----------LALPVLRQP 311
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
++ K+G+G G VY + GQEVA+++++ Q E NEI ++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYS 594
L + +E ++ EY+ SL D E+ + E ++ + E Q L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVCRECLQALEFLHS-- 134
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+VIHRD+K+ NILL D + K++DFG QSK +VGT +M+PE +
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 655 LFSIKSDVFSFGVLLLE 671
+ K D++S G++ +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 63/196 (32%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ K+GEG G V R H+G++VAVK + + Q E NE+ ++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
+ + EE ++ E++ +L D + L E V E + Q L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
VIHRD+K+ +ILL D K+SDFG + K K +VGT +M+PE + L
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 656 FSIKSDVFSFGVLLLE 671
++ + D++S G++++E
Sbjct: 218 YATEVDIWSLGIMVIE 233
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVK---RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGF ++ + A K + E+ EI + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
E + + ++ E +SL + K E R + +I G YLH+
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHR---N 160
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
RVIHRDLK N+ L++D+ KI DFG+A D + K + GT Y++PE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218
Query: 657 SIKSDVFSFGVLL 669
S + DV+S G ++
Sbjct: 219 SFEVDVWSIGCIM 231
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVK---RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGF ++ + A K + E+ EI + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
E + + ++ E +SL + K E R + +I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
RVIHRDLK N+ L++D+ KI DFG+A D + K + GT Y++PE +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192
Query: 657 SIKSDVFSFGVLL 669
S + DV+S G ++
Sbjct: 193 SFEVDVWSIGCIM 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEE-FKNEIKLIAKLQHRNLVRLLG 538
LG+G F VY+ +H G EVA+K + + G+ + +NE+K+ +L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFD--TPKESPLG-WETRVRVIEEIAQGLLYLHQYS 594
E + L+ E N + + P E R + +I G+LYLH +
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH- 131
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
++HRDL SN+LL ++MN KI+DFG+A + T + GT Y+SPE A +
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRS 187
Query: 655 LFSIKSDVFSFGVLLLETL 673
++SDV+S G + L
Sbjct: 188 AHGLESDVWSLGCMFYTLL 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 482 KLGEGGFGPVYKGRLHNGQEVAVKRLS-----------------SQSGQGLEEFKNEIKL 524
L +G F + + + A+K+ ++FKNE+++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 525 IAKLQHRNLVRLLGCCIELEEKI-LIYEYMPNKSL-----DIFLFDTPKESPLGWETRVR 578
I +++ + G I +++ +IYEYM N S+ F+ D + +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR 638
+I+ + Y+H + + HRD+K SNIL+DK+ K+SDFG ++ +++
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG---- 209
Query: 639 IVGTYGYMSPE--YAQQGLFSIKSDVFSFGVLLLETL 673
GTY +M PE + K D++S G+ L
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-35
Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 47/295 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLV 534
+F ++ LG G G + + + ++VAVKR+ + E++L+ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
R C + + + E + + LG E ++++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCAATLQEYVE--QKDFAHLGLEPI-TLLQQTTSGLAHLHS- 136
Query: 594 SRLRVIHRDLKASNILL-----DKDMNPKISDFGMAKMFGGDEL-QSKTKRIVGTYGYMS 647
L ++HRDLK NIL+ + ISDFG+ K S+ + GT G+++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 648 PEYAQQGLF---SIKSDVFSFGVLLLETLSSKR--NTDFSNTDSLTLLGRAWDLWKDDRA 702
PE + + D+FS G + +S + LLG L
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC-SL-DCLHP 252
Query: 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHP 757
+ D A LI + D RP+ V L HP
Sbjct: 253 EKHEDV----IARELIEK--------MIAMDPQKRPSAKHV----------LKHP 285
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 477 FSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFK---NEIKLIAKLQHRN 532
F ++LG G G V+K +G +A K + + E++++ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPY 92
Query: 533 LVRLLGCCIELEEKILIY-EYMPNKSLDIFLFDTPK--ESPLGWETRVRVIEEIAQGLLY 589
+V G + +I I E+M SLD L + E LG +V + +GL Y
Sbjct: 93 IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 146
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
L + +++HRD+K SNIL++ K+ DFG++ G + S VGT YMSPE
Sbjct: 147 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE 200
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
Q +S++SD++S G+ L+E
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVE 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNL 533
+ + LG+G V++GR G A+K + + ++ E +++ KL H+N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 534 VRLLGCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
V+L E E+ P SL L + L + V+ ++ G+ +L
Sbjct: 70 VKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 591 HQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+ ++HR++K NI+ D K++DFG A+ DE + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 647 SPE--------YAQQGLFSIKSDVFSFGVLLLETLS 674
P+ Q + D++S GV +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 56/202 (27%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ +LG+G FG VYK + G A K + ++S + LE++ EI+++A H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQYS 594
LLG + ++ E+ P ++D + + + L E +++V+ ++ + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLT-EPQIQVVCRQMLEALNFLHS-- 135
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE----- 649
R+IHRDLKA N+L+ + + +++DFG++ + K +GT +M+PE
Sbjct: 136 -KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
+ + K+D++S G+ L+E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLV 534
F+ K+G+G FG V+KG + VA+K + + + +E+ + EI ++++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLHQY 593
+ G ++ + +I EY+ S D + PL ET++ I EI +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYLH-- 136
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ IHRD+KA+N+LL + K++DFG+A + Q K VGT +M+PE +Q
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 654 GLFSIKSDVFSFGVLLLE 671
+ K+D++S G+ +E
Sbjct: 194 SAYDSKADIWSLGITAIE 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 51/232 (21%), Positives = 91/232 (39%), Gaps = 36/232 (15%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKR--LSSQSGQGLEEFKNEI 522
++ S T F K+G G FG V+K +G A+KR + E+
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 523 KLIAKL-QHRNLVRLLGCCIELEEKILIY-EYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
A L QH ++VR E ++ +LI EY SL + + + E ++ +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 581 -EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-------------------KISD 620
++ +GL Y+H + ++H D+K SNI + + P KI D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLE 671
G S + G +++ E Q+ K+D+F+ + ++
Sbjct: 178 LGHVTRI------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNL 533
+ + LG+G V++GR G A+K + + ++ E +++ KL H+N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 534 VRLLGCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
V+L E E+ P SL L + L + V+ ++ G+ +L
Sbjct: 70 VKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 591 HQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+ ++HR++K NI+ D K++DFG A+ DE + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYL 182
Query: 647 SPE--------YAQQGLFSIKSDVFSFGVLL 669
P+ Q + D++S GV
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532
F KLGEG +G VYK GQ VA+K++ + L+E EI ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLH 591
+V+ G + + ++ EY S+ + K L E + I + +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLT-EDEIATILQSTLKGLEYLH 142
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+R IHRD+KA NILL+ + + K++DFG+A + +K ++GT +M+PE
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVI 197
Query: 652 QQGLFSIKSDVFSFGVLLLE 671
Q+ ++ +D++S G+ +E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNL 533
++ + +G G V ++VA+KR++ + ++E EI+ +++ H N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 534 VRLLGCCIELEEKILIYEYMPNKSL-DIFLFDTPKESPLGW---ETRVRVI-EEIAQGLL 588
V + +E L+ + + S+ DI K E+ + I E+ +GL
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM-AKMFGGDELQSKTKR--IVGTYGY 645
YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ R VGT +
Sbjct: 136 YLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 646 MSPEYAQQGL-FSIKSDVFSFGVLLLE 671
M+PE +Q + K+D++SFG+ +E
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEE-FKNEIKLIAKLQHRNL 533
+ + +LG GGFG V + G++VA+K+ + E + EI+++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 534 VRLLGCCIELEEKI-------LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG 586
V + +K+ L EY L +L L ++ +I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 587 LLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAKMFGGDELQSKTKRIVGTY 643
L YLH+ R+IHRDLK NI+L + + KI D G AK EL ++ VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTL 187
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLL 669
Y++PE +Q +++ D +SFG L
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS----SQSGQGLEEFKNEIKLIAKLQH 530
+F LG+G FG VY R + +A+K L ++G + + E+++ + L+H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRH 68
Query: 531 RNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLL 588
N++RL G ++ LI EY P ++ + K S + I E+A L
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
Y H RVIHRD+K N+LL KI+DFG + S+ + GT Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPP 176
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETL 673
E + + K D++S GVL E L
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 70/323 (21%), Positives = 118/323 (36%), Gaps = 49/323 (15%)
Query: 480 ENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLL 537
L EGGF VY+ + + +G+E A+KRL S + E+ + KL H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 538 GCCIELEEK-------ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLY 589
+E+ L+ + L FL PL V I + + + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-SCDTVLKIFYQTCRAVQH 151
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI---------- 639
+H + +IHRDLK N+LL K+ DFG A S + +
Sbjct: 152 MH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 640 VGTYGYMSPE----YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD 695
T Y +PE Y+ + K D+++ G +L R F + L ++ +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCF--RQHPFEDGAKLRIVNGKY- 266
Query: 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVV----SMLTNET 751
I ++ Y + + I +Q + +R ++ EVV +
Sbjct: 267 ------------SIPPHDTQYTVFHSLIRA---MLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 752 VNLPHPQQPAFSSIRGLKNTILP 774
VN P G + L
Sbjct: 312 VNPKSPITELLEQNGGYGSATLS 334
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHRN 532
FS ++G G FG VY R + N + VA+K++S QS + ++ E++ + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQGLLYLH 591
++ GC + L+ EY + D+ + PL E + + QGL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQ-EVEIAAVTHGALQGLAYLH 171
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGM-AKMFGGDELQSKTKRIVGTYGYMSPE- 649
+IHRD+KA NILL + K+ DFG + M + VGT +M+PE
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWMAPEV 221
Query: 650 --YAQQGLFSIKSDVFSFGVLLLE 671
+G + K DV+S G+ +E
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSG-QGLEEFKNEIK-LIAKLQHRNL 533
+LG G +G V K R + +GQ +AVKR+ + Q + ++ + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK------ESPLGWETRVRVIEEIAQGL 587
V G + + E M + SLD F E LG ++ I + L
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKAL 122
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI-VGTYGYM 646
+LH S+L VIHRD+K SN+L++ K+ DFG++ G + K I G YM
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKDIDAGCKPYM 176
Query: 647 SPE----YAQQGLFSIKSDVFSFGVLLLE 671
+PE Q +S+KSD++S G+ ++E
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKL-QHRN 532
+ ++G G +G V K +GQ +AVKR+ S + ++ ++ ++ +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV--RVIEEIAQGLLYL 590
+V+ G + + E M + S D F + ++ + L +L
Sbjct: 83 IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRI-VGTYGYMSPE 649
L++IHRD+K SNILLD+ N K+ DFG++ G + S K G YM+PE
Sbjct: 142 K--ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPE 195
Query: 650 ----YAQQGLFSIKSDVFSFGVLLLE 671
A + + ++SDV+S G+ L E
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 482 KLGEGGFGPVYKG---RLHNGQEVAVKRLSSQSGQG---LEEFKNEIKLIAKLQHRNLVR 535
KLG GG VY L +VA+K + + L+ F+ E+ ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 536 LL--GCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
++ EE Y EY+ +L ++ PL +T + +I G+ +
Sbjct: 76 MIDVD-----EEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHA 127
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H +R++HRD+K NIL+D + KI DFG+AK L ++T ++GT Y SPE
Sbjct: 128 H---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQ 183
Query: 651 AQQGLFSIKSDVFSFGVLLLETL 673
A+ +D++S G++L E L
Sbjct: 184 AKGEATDECTDIYSIGIVLYEML 206
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 7e-32
Identities = 32/275 (11%), Positives = 63/275 (22%), Gaps = 47/275 (17%)
Query: 438 SIATRANEFCKGNKAANSKTRDSWFPMFSLASV----SAATANFSTENKLGEGGFGPVYK 493
I E K A + +P + +V S L G V+
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFL 80
Query: 494 GR-LHNGQEVAVKRL---SSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543
R + ++ A+K + S LE A+L + L
Sbjct: 81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140
Query: 544 --------------------EEKILIYEYMP---NKSLDIFLFDTPKESPLGWETRVRVI 580
+L+ F G +
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
++ + L ++H N+ + D + D G ++
Sbjct: 201 AQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASS 252
Query: 641 GTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETL 673
Y E+ F+ + + G+ +
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 69/310 (22%), Positives = 114/310 (36%), Gaps = 58/310 (18%)
Query: 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVR 535
+E LG G G V G+ VAVKR+ + EIKL+ + H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 536 LLGCCIELEEKI-LIYEYMPNKSLDIFL---FDTPKESPLGWETRVRVIEEIAQGLLYLH 591
C + + + E D+ + ++ +IA G+ +LH
Sbjct: 74 YY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 592 QYSRLRVIHRDLKASNILLD-------------KDMNPKISDFGMAKMFGGDE--LQSKT 636
L++IHRDLK NIL+ +++ ISDFG+ K + ++
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 637 KRIVGTYGYMSPEYAQQGLFSI-------KSDVFSFGVLLLETLSSKRN--TDFSNTDSL 687
GT G+ +PE ++ D+FS G + LS ++ D + +S
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ G + EA+ LI ++ D + RPT +V
Sbjct: 250 IIRGIFSLDEMKCLHDRSLIA----EATDLISQ------MIDH--DPLKRPTAMKV---- 293
Query: 748 TNETVNLPHP 757
L HP
Sbjct: 294 ------LRHP 297
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 20/220 (9%)
Query: 466 SLASVSAATANFSTENKLGEG--GFGPVYKGR-LHNGQEVAVKR--LSSQSGQGLEEFKN 520
++S + +G+G V R G+ V V+R L + S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 521 EIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSL-DIFLFDTPKESPLGWETRVRV 579
E+ + H N+V I E ++ +M S D+ E +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAY 132
Query: 580 I-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT-- 636
I + + + L Y+H + +HR +KAS+IL+ D +S + +
Sbjct: 133 ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 637 ---KRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLE 671
K V ++SPE QQ L + KSD++S G+ E
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 21/203 (10%)
Query: 480 ENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQG---LEEFKNEIKLIAKLQHRNLVR 535
+G GG G VY+ + VA+K +S + E + +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 536 L--LGCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
+ G E +Y + L L ++ PL V ++ +I L
Sbjct: 99 IHDFG-----EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H HRD+K NIL+ D + DFG+A ++L ++ VGT YM+PE
Sbjct: 151 H---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPER 206
Query: 651 AQQGLFSIKSDVFSFGVLLLETL 673
+ + ++D+++ +L E L
Sbjct: 207 FSESHATYRADIYALTCVLYECL 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS----SQSGQGLEEFKNEIKLIAKLQH 530
+F LG+G FG VY R N +A+K L + G + + EI++ + L+H
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRH 73
Query: 531 RNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLL 588
N++R+ ++I L+ E+ P L + ++ E R +EE+A L
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALH 128
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
Y H +VIHRD+K N+L+ KI+DFG + + + + GT Y+ P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPP 181
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETL 673
E + K D++ GVL E L
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 452 AANSKTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ 510
++ S + + + A + ++G G G V+K R G +AVK++
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 511 SG-QGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK- 567
+ + ++ ++ K +V+ G I + + E M +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP 120
Query: 568 --ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625
E LG ++ I + L YL + VIHRD+K SNILLD+ K+ DFG++
Sbjct: 121 IPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS- 172
Query: 626 MFGGDELQSKTKRI-VGTYGYMSPE-----YAQQGLFSIKSDVFSFGVLLLE 671
G + K K G YM+PE + + I++DV+S G+ L+E
Sbjct: 173 ---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 43/205 (20%), Positives = 81/205 (39%), Gaps = 26/205 (12%)
Query: 482 KLGEGGFGPVYKG---RLHNGQEVAVKRLSSQSGQGLEE-FKNEIKLIAKLQHRNLVRLL 537
+ GG G +Y + NG+ V +K L + E + +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 538 --GCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ + Y EY+ +SL L + + EI L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH- 199
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+ +++ DLK NI+L ++ K+ D G + GT G+ +PE +
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVR 250
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKR 677
G ++ +D+++ G L
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-30
Identities = 28/230 (12%), Positives = 65/230 (28%), Gaps = 43/230 (18%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQH-------- 530
LG+ + G+ V +++ K E+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 531 --------RNLVRLLGCCIELEEK--------ILIYEYMPNKSLDIF-----LFDTPKES 569
+LV+ + + + + P ++ L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 570 -PLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
L R+++ ++ + L LH ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 629 GDELQSKTKRIVGTYGYMSPE-----YAQQGLFSIKSDVFSFGVLLLETL 673
G S R + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 482 KLGEGGFGPVYKG---RLHNGQEVAVKRLSSQSGQG---LEEFKNEIKLIAKLQHRNLVR 535
LG GG V+ R ++VAVK L + + F+ E + A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 536 LLGCCIELEEKILIY----EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
+ + EY+ +L + E P+ + + VI + Q L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ-SKTKRIVGTYGYMSPEY 650
+ +IHRD+K +NI++ K+ DFG+A+ ++T ++GT Y+SPE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKR 677
A+ +SDV+S G +L E L+ +
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 26/185 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIA 526
NF K+GEG +G VYK R G+ VA+K++ L+ EI L+
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLLK 57
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPN--KSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+L H N+V+LL + L++E++ K D + + + ++
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLL 113
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
QGL + H + RV+HRDLK N+L++ + K++DFG+A+ F G +++ T +V T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLW 168
Query: 645 YMSPE 649
Y +PE
Sbjct: 169 YRAPE 173
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLV 534
F +G G +G VYKGR + GQ A+K + +G EE K EI ++ K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 535 RLLGC-----CIELEEKI-LIYEYMPNKSL-DIFLFDTPKESPLGWETRVRVI-EEIAQG 586
G +++++ L+ E+ S+ D L K + L E + I EI +G
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK-EEWIAYICREILRG 141
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
L +LHQ +VIHRD+K N+LL ++ K+ DFG++ D + +GT +M
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWM 196
Query: 647 SPEYAQQGLFS-----IKSDVFSFGVLLLE 671
+PE KSD++S G+ +E
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 58/262 (22%), Positives = 86/262 (32%), Gaps = 66/262 (25%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNL 533
+F +G GGFG V++ + + A+KR+ E+ E+K +AKL+H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-------------- 579
VR +E + E D V++
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 580 -IEEIAQGLLY----------LHQYSRLR-----------------------------VI 599
+ LY L + R ++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 600 HRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK----------RIVGTYGYMSPE 649
HRDLK SNI D K+ DFG+ DE + VGT YMSPE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 650 YAQQGLFSIKSDVFSFGVLLLE 671
+S K D+FS G++L E
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFE 268
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 57/263 (21%), Positives = 105/263 (39%), Gaps = 18/263 (6%)
Query: 412 SVYIRVPASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVS 471
+ + +P E + ++ D+ D I ++P
Sbjct: 97 TAPVLIPGDERKRRRGYDV---DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 472 AATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH 530
++ +LG G FG V++ G A K + + E + EI+ ++ L+H
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLL 588
LV L + E ++IYE+M LF+ + + + + V + ++ +GL
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 589 YLHQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
++H+ +H DLK NI+ K N K+ DFG+ + K GT +
Sbjct: 270 HMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFA 323
Query: 647 SPEYAQQGLFSIKSDVFSFGVLL 669
+PE A+ +D++S GVL
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLS 346
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 37/254 (14%), Positives = 70/254 (27%), Gaps = 22/254 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR------LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ 529
+ LGEG F VY+ N Q+ +K + ++ +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLD--IFLFDTPKESPLGWETRVRVIEEIAQGL 587
++ + +L+ E +L I L+ E + + + +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 588 LYLHQYSRLRVIHRDLKASNILL-----------DKDMNPKISDFGMAKMFGGDELQSKT 636
+H +IH D+K N +L D + D G + +
Sbjct: 186 EQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696
T G+ E ++ + D F + L + G L
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302
Query: 697 WKDDRAWELIDPIL 710
D E +L
Sbjct: 303 PHLDMWNEFFHVML 316
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 45/221 (20%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS--------------------------SQSGQGL 515
+G+G +G V ++ A+K LS Q +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 516 EEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLG 572
E+ EI ++ KL H N+V+L+ ++ + +Y E + + + P PL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 573 WETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF-GGDE 631
+ +++ +G+ YLH ++IHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 632 LQSKTKRIVGTYGYMSPE--YAQQGLFS-IKSDVFSFGVLL 669
L S T VGT +M+PE + +FS DV++ GV L
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
S LG G FG V+K G ++A K + ++ + EE KNEI ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+L + +L+ EY+ LFD + L + +++I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 593 YSRLRVIHRDLKASNILL-DKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
+ ++H DLK NIL ++D KI DFG+A+ + E K K GT +++PE
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 651 AQQGLFSIKSDVFSFGVLL 669
S +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+ +LG G FG V++ G+ K +++ KNEI ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLLYL 590
L+ L + E +LI E++ LFD ++ + + + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 591 HQYSRLRVIHRDLKASNILL-DKDMNP-KISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
H+ ++H D+K NI+ K + KI DFG+A DE K T + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 649 EYAQQGLFSIKSDVFSFGVLL 669
E + +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 50/207 (24%), Positives = 83/207 (40%), Gaps = 23/207 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVK-----RLSSQSGQGLEEFKNEIKLIAKLQH 530
+ +G+G F V + GQ+ AVK + +S G E+ K E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGW--ETRVR-VIEEIAQ 585
++V LL +++E+M L + E + +I +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 586 GLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGT 642
L Y H +IHRD+K +LL + K+ FG+A G VGT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGT 196
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+M+PE ++ + DV+ GV+L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQH 530
+ + KLG G +G V R E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLLY 589
N+++L + L+ E LFD E +I+++ G+ Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 590 LHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
LH+ ++HRDLK N+LL +KD KI DFG++ +F + K K +GT Y+
Sbjct: 152 LHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYI 205
Query: 647 SPEYAQQGLFSIKSDVFSFGVLL 669
+PE + + K DV+S GV+L
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVIL 227
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 54/182 (29%), Positives = 91/182 (50%), Gaps = 22/182 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIAK 527
+ K+GEG +G VYK + G+ VA+KR+ L+ EI L+ +
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKE 75
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
L H N+V L+ L++E+M K L L + L + ++ +G+
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGV 132
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
+ HQ+ R++HRDLK N+L++ D K++DFG+A+ F G ++S T +V T Y +
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRA 187
Query: 648 PE 649
P+
Sbjct: 188 PD 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHR 531
F + KLG G FG V+ +G E +K ++ +S +E+ + EI+++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGW--ETRVR-VIEEIAQG 586
N++++ + ++ E L + ++ E V +++++
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 587 LLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY 643
L Y H V+H+DLK NIL KI DFG+A++F DE + GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTA 190
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLL 669
YM+PE ++ + + K D++S GV++
Sbjct: 191 LYMAPEVFKRDV-TFKCDIWSAGVVM 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS----SQSGQGLEEFKNEIKLIAKLQHRNLVRLL 537
LGEG +G V + AVK L + G K EI+L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 538 GCCIELEEKILIY---EYMPNKSLDIFLFDTPKESPLG-WETRVRVIEEIAQGLLYLHQY 593
+ EEK +Y EY + + D+ E + ++ GL YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLH-- 126
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ- 652
++H+D+K N+LL KIS G+A+ + G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 653 QGLFS-IKSDVFSFGVLL 669
FS K D++S GV L
Sbjct: 186 LDTFSGFKVDIWSAGVTL 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 48/184 (26%), Positives = 92/184 (50%), Gaps = 25/184 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIA 526
+ K+GEG +G V+K + + VA+KR+ L++ EI L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLK 56
Query: 527 KLQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ 585
+L+H+N+VRL ++K+ L++E+ + L + L E + ++ +
Sbjct: 57 ELKHKNIVRLHDVLHS-DKKLTLVFEFCD-QDLKKYFDSCNG--DLDPEIVKSFLFQLLK 112
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
GL + H V+HRDLK N+L++++ K+++FG+A+ F G ++ + +V T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 646 MSPE 649
P+
Sbjct: 168 RPPD 171
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 38/315 (12%), Positives = 86/315 (27%), Gaps = 88/315 (27%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSS---QSGQGLEEFKNEIKLIAKLQ--------- 529
LG+ + G+ V +++ K E+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 530 ----------------HRNLVRLLGCC--IELEEKILIYEYMPNKSLDIF--LFDTPKES 569
+ ++R+ + + + +Y M + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 570 -PLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
L R+++ ++ + L LH Y ++H L+ +I+LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 629 GDELQSKTKRIVGTYGYMSPEY-----------AQQGLFSIKSDVFSFGVLLLETLSSKR 677
+ G+ PE ++ L + D ++ G+++
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC--- 308
Query: 678 NTDFSNTDSLTLLGRAWDL-WKDDRAWELIDPILQN------EASYLILNRYINVALLCV 730
L D A + I ++ L+ L
Sbjct: 309 -------------AD---LPITKDAALGGSEWIFRSCKNIPQPVRALLEG------FLRY 346
Query: 731 QEDAVDRPTMFEVVS 745
DR + +
Sbjct: 347 --PKEDRLLPLQAME 359
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 43/201 (21%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+ LG G FG V++ + + K + G K EI ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLLYL 590
++ L +EE ++I+E++ +F+ L V + ++ + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 591 HQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
H + H D++ NI+ + KI +FG A+ + + + Y +P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAP 172
Query: 649 EYAQQGLFSIKSDVFSFGVLL 669
E Q + S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 22/182 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIAK 527
+ K+GEG +G VYK + + G+ A+K++ LE+ EI ++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKE 56
Query: 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
L+H N+V+L + +L++E++ + L L L T + ++ G+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEG--GLESVTAKSFLLQLLNGI 113
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
Y H RV+HRDLK N+L++++ KI+DFG+A+ F G ++ T IV T Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRA 168
Query: 648 PE 649
P+
Sbjct: 169 PD 170
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQH 530
++ LG+G FG V K + QE AVK + +S + E++L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLLY 589
N+++L + ++ E LFD + E +I+++ G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 590 LHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+H+ ++HRDLK NILL +KD + KI DFG++ F + K K +GT Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYI 190
Query: 647 SPEYAQQGLFSIKSDVFSFGVLL 669
+PE +G + K DV+S GV+L
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVIL 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQ 529
+ + + LG+G FG V + GQE AVK +S + E E++L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR-VIEEIAQGLL 588
H N+++L + L+ E L FD E +I ++ G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 589 YLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
Y+H+ +++HRDLK N+LL KD N +I DFG++ F + K K +GT Y
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYY 194
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLL 669
++PE G + K DV+S GV+L
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN-----EIKLIAKLQ 529
F KLG G + VYKG G VA+K + S +G EI L+ +L+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMKELK 61
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPN--KSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
H N+VRL + L++E+M N K L ++ QGL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
+ H+ +++HRDLK N+L++K K+ DFG+A+ F G + + + +V T Y +
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRA 176
Query: 648 PE 649
P+
Sbjct: 177 PD 178
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQH 530
++ LG+G FG V K + QE AVK + +S + E++L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEE 582
N+++L + ++ E LFD + ++ R+I++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDA-------ARIIKQ 129
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRI 639
+ G+ Y+H+ ++HRDLK NILL +KD + KI DFG++ F + K K
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDR 183
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+GT Y++PE + + K DV+S GV+L
Sbjct: 184 IGTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532
++ EN +G G +G V A K++ + ++ FK EI+++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEEIA 584
++RL + + L+ E LF+ ++ R+++++
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDA-------ARIMKDVL 116
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
+ Y H+ L V HRDLK N L D K+ DFG+A F + + VG
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVG 170
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T Y+SP+ + + + D +S GV++
Sbjct: 171 TPYYVSPQVLEGL-YGPECDEWSAGVMM 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 30/208 (14%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532
F LG G F V+ + G+ A+K + +NEI ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEEIA 584
+V L L+ + + L FD T K++ VI+++
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDA-------SLVIQQVL 116
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
+ YLH+ ++HRDLK N+L +++ I+DFG++KM + + G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACG 169
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T GY++PE Q +S D +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQH 530
+ N+ + +LG+G F V + G E A K + S + ++ + E ++ KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEE 582
N+VRL E L+++ + LF+ + ++ I++
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADA-------SHCIQQ 113
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRI 639
I + + Y H ++HR+LK N+LL K K++DFG+A E
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGF 167
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT GY+SPE ++ +S D+++ GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVK------RLSSQSGQGLEEFKNEIKLIA 526
+ +LG G F V K R G E A K +S+ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIA 584
++ H N++ L + +LI E + LFD KES E I++I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGDELQSKTKRIV 640
G+ YLH ++ H DLK NI+L + K+ DFG+A + K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIF 179
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT +++PE +++D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 32/232 (13%)
Query: 457 TRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--------RL 507
TRD+ P S N+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 508 SSQSGQGLEE-FKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD- 564
S++ Q L E E+ ++ K+ H N+++L L+++ M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 565 -TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623
T K + ETR +++ + + + LH+ L ++HRDLK NILLD DMN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 624 AKMFGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLL 669
+ E K + + GT Y++PE + + D++S GV++
Sbjct: 171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVK------RLSSQSGQGLEEFKNEIKLIA 526
++ +LG G F V K R G+E A K SS+ G EE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVR 578
+++H N++ L + +LI E + LFD T E+ +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEA-------TQ 112
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGDELQS 634
+++I G+ YLH R+ H DLK NI+L + K+ DFG+A
Sbjct: 113 FLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--- 166
Query: 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ K I GT +++PE +++D++S GV+
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-------------SQSGQGLEEFK 519
++ KLG G +G V + + E A+K + + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 520 NEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV-R 578
NEI L+ L H N+++L + + L+ E+ L F+ E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAAN 150
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSK 635
++++I G+ YLH+ ++HRD+K NILL + +N KI DFG++ F D K
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---K 204
Query: 636 TKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ +GT Y++PE + ++ K DV+S GV++
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 61/186 (32%), Positives = 96/186 (51%), Gaps = 26/186 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKN--------EIKL 524
+ + LGEG F VYK R + Q VA+K +L + E K+ EIKL
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-----SEAKDGINRTALREIKL 65
Query: 525 IAKLQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEI 583
+ +L H N++ LL + I L++++M L++ + D L +
Sbjct: 66 LQELSHPNIIGLLDAFGH-KSNISLVFDFME-TDLEVIIKDNSL--VLTPSHIKAYMLMT 121
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY 643
QGL YLHQ+ ++HRDLK +N+LLD++ K++DFG+AK F G ++ T ++V T
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TR 176
Query: 644 GYMSPE 649
Y +PE
Sbjct: 177 WYRAPE 182
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVK------RLSSQSGQGLEEFKNEIKLIA 526
+ +LG G F V K R G E A K +S+ G EE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIA 584
++ H N++ L + +LI E + LFD KES E I++I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP---KISDFGMAKMFGGDELQSKTKRIV 640
G+ YLH ++ H DLK NI+L DK++ K+ DFG+A + K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIF 179
Query: 641 GTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT +++PE +++D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 53/269 (19%), Positives = 92/269 (34%), Gaps = 55/269 (20%)
Query: 450 NKAANSKTRDSWFPMFSLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--- 505
+ +S + +F SL + + + +G+G +G V A+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 506 --RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC---------------IELEEKIL 548
++ + + +E K E++L+ KL H N+ RL L +K+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 549 IYEYMPNKSLDIFLFDTPKESPLGWETRV----------------------RVIEEIAQG 586
++ + + T ++ +I
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 587 LLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMAKMFGGDEL--QSKTKRIVGT 642
L YLH + HRD+K N L +K K+ DFG++K F GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 643 YGYMSPEYAQQGLFSI--KSDVFSFGVLL 669
+++PE S K D +S GVLL
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 17/193 (8%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+G+G F V R + G+EVA+K + + + L++ E++++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 540 CIELEEKI-LIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLR 597
IE E+ + LI EY + FD + + +I + Y H + R
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQQGLF 656
++HRDLKA N+LLD DMN KI+DFG + F G Y +PE + +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYD 191
Query: 657 SIKSDVFSFGVLL 669
+ DV+S GV+L
Sbjct: 192 GPEVDVWSLGVIL 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL------SSQSGQGLEEFKNEIKLIA 526
+ T +LG G F V K R G + A K + SS+ G E+ + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVR 578
++QH N++ L + ILI E + L FD T +E+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEA-------TE 118
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAKMFGGDELQS 634
+++I G+ YLH L++ H DLK NI+L KI DFG+A
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--- 172
Query: 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ K I GT +++PE +++D++S GV+
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKN----EIKLIAKL 528
+ +GEG +G V K R G+ VA+K S + K EIKL+ +L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQL 81
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
+H NLV LL C + + L++E++ + ++ L P L ++ + + +I G+
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN--GLDYQVVQKYLFQIINGIG 138
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
+ H + +IHRD+K NIL+ + K+ DFG A+ + + T Y +P
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAP 193
Query: 649 E 649
E
Sbjct: 194 E 194
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
LGEG +G V + VAVK + ++ E K EI + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 541 IELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ--------GLLYLH 591
L EY L FD E + + E AQ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-Y 650
+ + HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 651 AQQGLFSIKSDVFSFGVLL 669
++ + DV+S G++L
Sbjct: 180 KRREFHAEPVDVWSCGIVL 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK-----RLSSQS---GQGLEEFKNEIKLIA 526
+ST + LG G FG V+ +EV VK ++ L + EI +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 527 KLQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ 585
+++H N++++L E + L+ E + LD+F F + ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVS 141
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
+ YL +IHRD+K NI++ +D K+ DFG A +L GT Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEY 195
Query: 646 MSPEYAQQGLFSIKS------DVFSFGVLL 669
+PE + +++S GV L
Sbjct: 196 CAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIA 526
+ K+GEG +G V+K R GQ VA+K+ E EI+++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLK 57
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG 586
+L+H NLV LL L++EY + ++ L + + + + Q
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR--GVPEHLVKSITWQTLQA 114
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+ + H++ IHRD+K NIL+ K K+ DFG A++ + T Y
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYR 169
Query: 647 SPE 649
SPE
Sbjct: 170 SPE 172
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQH 530
+ N+ + +LG+G F V + G E A K + S + ++ + E ++ KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEE 582
N+VRL E L+++ + L F+ + ++ I++
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADA-------SHCIQQ 136
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRI 639
I + + Y H ++HR+LK N+LL K K++DFG+A E
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGF 190
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
GT GY+SPE ++ +S D+++ GV+L
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 55/189 (29%), Positives = 82/189 (43%), Gaps = 31/189 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIA 526
+ KLGEG +G VYK + VA+KR+ LE + E+ L+
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLK 88
Query: 527 KLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI-EEIAQ 585
+LQHRN++ L LI+EY L ++ P S ++ ++
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSM----RVIKSFLYQLIN 143
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNP-----KISDFGMAKMFGGDELQSKTKRIV 640
G+ + H R +HRDLK N+LL KI DFG+A+ F G ++ T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199
Query: 641 GTYGYMSPE 649
T Y PE
Sbjct: 200 -TLWYRPPE 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS--------SQSGQGLEEFKNEIKL 524
+ LG G G V ++VA+K +S ++ + EI++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD------TPKESPLGWETRVR 578
+ KL H ++++ + E+ ++ E M L FD KE+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA----TCK-L 118
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSK 635
++ + YLH +IHRDLK N+LL ++D KI+DFG +K+ G L
Sbjct: 119 YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 172
Query: 636 TKRIVGTYGYMSPE---YAQQGLFSIKSDVFSFGVLL 669
+ + GT Y++PE ++ D +S GV+L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHR-NLVRLL 537
+LG G F V + GQE A K + + E +EI ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETR---VRVIEEIAQGLLYLHQYS 594
E ILI EY + F + +R+I++I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 595 RLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
++H DLK NILL + KI DFGM++ G + + I+GT Y++PE
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 652 QQGLFSIKSDVFSFGVLL 669
+ +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN-----EIKLIAKLQ 529
+ +KLGEG + VYKG+ VA+K + + +G E+ L+ L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDLK 58
Query: 530 HRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
H N+V L E+ + L++EY+ +K L +L D + + ++ +GL
Sbjct: 59 HANIVTLHDIIHT-EKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLA 114
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
Y H+ +V+HRDLK N+L+++ K++DFG+A+ ++ +V T Y P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169
Query: 649 E 649
+
Sbjct: 170 D 170
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 37/209 (17%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLS--------SQSGQGLEEFKNEIKLIAKLQHRN 532
LG G G V ++VA++ +S ++ + EI+++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD------TPKESPLGWETRVRVIEEIAQG 586
++++ + E+ ++ E M L FD KE+ + ++
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA----TCK-LYFYQMLLA 251
Query: 587 LLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTY 643
+ YLH+ +IHRDLK N+LL ++D KI+DFG +K+ G L + + GT
Sbjct: 252 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTP 305
Query: 644 GYMSPE---YAQQGLFSIKSDVFSFGVLL 669
Y++PE ++ D +S GV+L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC 540
LGEG +G V + VAVK + ++ E K EI + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 541 IELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQ--------GLLYLH 591
L EY L FD E + + E AQ G++YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-Y 650
+ + HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 651 AQQGLFSIKSDVFSFGVLL 669
++ + DV+S G++L
Sbjct: 180 KRREFHAEPVDVWSCGIVL 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 467 LASVSAA--TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNE 521
+A+++ T + +LG+G F V + + GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 522 IKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGW 573
++ L+H N+VRL E LI++ + L F+ + ++
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADA---- 112
Query: 574 ETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGD 630
I++I + +L+ HQ + V+HR+LK N+LL K K++DFG+A G+
Sbjct: 113 ---SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
Q GT GY+SPE ++ + D+++ GV+L
Sbjct: 167 --QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 54/288 (18%)
Query: 416 RVPASEVETKKSQDMLQFDINMSIATRANEFCKGNKAANSKTRDSWFPMFSLASVSAA-- 473
+P E +++ D A E K N A T + +F
Sbjct: 28 HLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWA 87
Query: 474 -----TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVK-------RLSSQSGQGLEE-FK 519
+ ++ +G G V + G E AVK RLS + + + E +
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 520 NEIKLIAKL-QHRNLVRLLGCCIELEEKILIY---EYMPNKSLDIFLFD--------TPK 567
E ++ ++ H +++ L+ E ++ + M L FD + K
Sbjct: 148 RETHILRQVAGHPHIITLIDSY---ESSSFMFLVFDLMRKGEL----FDYLTEKVALSEK 200
Query: 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627
E+ ++ + + + +LH ++HRDLK NILLD +M ++SDFG +
Sbjct: 201 ET-------RSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 628 GGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLL 669
E K + + GT GY++PE + + D+++ GV+L
Sbjct: 251 EPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 53/210 (25%), Positives = 83/210 (39%), Gaps = 30/210 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL------SSQSGQGLEEFKNEIKLIAKL 528
+ LG GGFG VY G + + VA+K + E+ L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 529 QHR--NLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPK----ESPLGWETRVRVIE 581
++RLL E + LI E P D+F F T + E R
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQDLFDFITERGALQEE----LAR-SFFW 156
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKMFGGDELQSKTKRIV 640
++ + + + H V+HRD+K NIL+D + K+ DFG +
Sbjct: 157 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFD 209
Query: 641 GTYGYMSPEYAQQGLFS-IKSDVFSFGVLL 669
GT Y PE+ + + + V+S G+LL
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG GGFG V+ ++ ++ A K+L+ + +G + E K++AK+ R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
E + + L+ M + +++ +++P E R +I GL +LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---R 308
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF 656
+I+RDLK N+LLD D N +ISD G+A + +KTK GT G+M+PE +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEY 366
Query: 657 SIKSDVFSFGVLLLETL 673
D F+ GV L E +
Sbjct: 367 DFSVDYFALGVTLYEMI 383
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 18/194 (9%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVK---RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG G FG V G G +VAVK R +S + + K EI+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
I ++ EY+ L FD K + R+ ++I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---RH 130
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQQGL 655
V+HRDLK N+LLD MN KI+DFG++ M E +T G+ Y +PE + +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTS--CGSPNYAAPEVISGRLY 187
Query: 656 FSIKSDVFSFGVLL 669
+ D++S GV+L
Sbjct: 188 AGPEVDIWSCGVIL 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL------SSQSGQGLEEFKNEIKLIAKL 528
+ LG+GGFG V+ G L + +VA+K + E+ L+ K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 529 ----QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPK----ESPLGWETRVRV 579
H ++RLL E +E L+ E P + D+F + T K E +R
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEG----PSR-CF 144
Query: 580 IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDELQSKTKR 638
++ + + H V+HRD+K NIL+D K+ DFG + +
Sbjct: 145 FGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TD 197
Query: 639 IVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLL 669
GT Y PE+ + + + + V+S G+LL
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 50/168 (29%), Positives = 87/168 (51%), Gaps = 21/168 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKN----EIKLIAKL 528
+ ++G G +G VYK R H+G VA+K R+ + G G E+ L+ +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALLRRL 68
Query: 529 Q---HRNLVRLL----GCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
+ H N+VRL+ + E K+ L++E++ ++ L +L D L ET ++
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 126
Query: 581 EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
+ +GL +LH ++HRDLK NIL+ K++DFG+A+++
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 48/171 (28%), Positives = 90/171 (52%), Gaps = 29/171 (16%)
Query: 476 NFSTENKLGEGGFGPVYKGR--LHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLI 525
+ ++GEG +G V+K R + G+ VA+KR+ ++ + E+ ++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVL 65
Query: 526 AKLQ---HRNLVRLL----GCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
L+ H N+VRL + E K+ L++E++ ++ L +L D E + ET
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIK 123
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628
++ ++ +GL +LH + RV+HRDLK NIL+ K++DFG+A+++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 37/196 (18%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN--------EIKLIA 526
+ K+G+G FG V+K R GQ+VA+K++ +E K EIK++
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQ 71
Query: 527 KLQHRNLVRLLGCCIELEEKI--------LIYEYMPN--KSLDIFLFDTPKESPLGWETR 576
L+H N+V L+ C L++++ + L
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLV-KFTLSEI 126
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG---GDELQ 633
RV++ + GL Y+H+ +++HRD+KA+N+L+ +D K++DFG+A+ F +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 634 SKTKRIVGTYGYMSPE 649
T R+V T Y PE
Sbjct: 184 RYTNRVV-TLWYRPPE 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LGEG F V R +E A+K L + + E ++++L H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRV-IEEIAQGLLYLH 591
+ +EK+ Y N L ++ FD ET R EI L YLH
Sbjct: 98 TF-QDDEKLYFGLSYAKNGELLKYIRKIGSFD---------ETCTRFYTAEIVSALEYLH 147
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK NILL++DM+ +I+DFG AK+ + Q++ VGT Y+SPE
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
+ SD+++ G ++ + ++
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVA 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 42/230 (18%)
Query: 468 ASVSAATANFS-----TENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNE 521
S + + F E+ LGEG V L QE AVK + Q G E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 522 IKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLG 572
++++ + Q HRN++ L+ E + L++E M S+ E+
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEA--- 113
Query: 573 WETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMF-- 627
V++++A L +LH + HRDLK NIL ++ KI DF +
Sbjct: 114 ----SVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
Query: 628 ---GGDELQSKTKRIVGTYGYMSPE-----YAQQGLFSIKSDVFSFGVLL 669
+ G+ YM+PE + ++ + D++S GV+L
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 42/167 (25%), Positives = 79/167 (47%), Gaps = 18/167 (10%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKN-EIKLIAKLQHRN 532
++ +G G FG V++ +L EVA+K++ + FKN E++++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 533 LVRLLGCCIELEEKI------LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQ 585
+V L +K L+ EY+P +++ K +++ + ++ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDE 631
L Y+H + + HRD+K N+LLD K+ DFG AK+ E
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVK---RLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LGEG FG V Q+VA+K R + + EI + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 539 CCIELEEKILIYEYMPNKSLDIF---------LFD-TPKESPLGWETRVRVIEEIAQGLL 588
Y+ + + DI LFD ++ + + R ++I +
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
Y H R +++HRDLK N+LLD ++N KI+DFG++ + + G+ Y +P
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAP 176
Query: 649 E-YAQQGLFSIKSDVFSFGVLL 669
E + + DV+S G++L
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVL 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 18/194 (9%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG G FG V G+ G +VAVK L+ Q S + + + EI+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRL 596
I I ++ EY+ L FD K L + R+ ++I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---RH 135
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQQGL 655
V+HRDLK N+LLD MN KI+DFG++ M E +T G+ Y +PE + +
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-RTS--CGSPNYAAPEVISGRLY 192
Query: 656 FSIKSDVFSFGVLL 669
+ D++S GV+L
Sbjct: 193 AGPEVDIWSSGVIL 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 482 KLGEGGFGPVYKGR---LHNGQEVAVKRLS----SQSGQGLEEFKNEIKLIAKLQHRNLV 534
K+G G +G VYK + + ++ A+K++ S S EI L+ +L+H N++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVI 81
Query: 535 RLLGCCIE-LEEKI-LIYEYMPN---KSLDIFLFDTPKESPLGWETRVR--VIEEIAQGL 587
L + + K+ L+++Y + + + P+ + ++ +I G+
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMAKMFG--GDELQSKTKRIVG 641
YLH V+HRDLK +NIL+ + KI+D G A++F L +V
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197
Query: 642 TYGYMSPE 649
T+ Y +PE
Sbjct: 198 TFWYRAPE 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 478 STENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVR 535
+ LGEG F K + Q AVK +S + + EI + + H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEEIAQGL 587
L + L+ E + L F+ + E+ ++ ++ +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEA-------SYIMRKLVSAV 119
Query: 588 LYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
++H + V+HRDLK N+L + ++ KI DFG A++ D KT T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLH 174
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLL 669
Y +PE Q + D++S GV+L
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNE---IKLIAKLQHRNLVR 535
+G GGFG VY R G+ A+K L + QG NE + L++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 536 LLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQY 593
+ +K+ I + M L L S E +R EI GL ++H
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGLEHMHN- 310
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
V++RDLK +NILLD+ + +ISD G+A F K VGT+GYM+PE Q+
Sbjct: 311 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQK 364
Query: 654 GLFSIKS-DVFSFGVLLLETL 673
G+ S D FS G +L + L
Sbjct: 365 GVAYDSSADWFSLGCMLFKLL 385
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+ F E++LG G VY+ + + A+K L + + + EI ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEEIA 584
+++L E L+ E + L FD + +++ +++I
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDA-------ADAVKQIL 158
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
+ + YLH+ ++HRDLK N+L D KI+DFG++K+ K + G
Sbjct: 159 EAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCG 212
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T GY +PE + + + D++S G++
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKN-EIKLIAKLQHR 531
+++ +G G FG VY+ +L +G+ VA+K++ + FKN E++++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 532 NLVRLLGCCIELEEKI------LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE-EIA 584
N+VRL EK L+ +Y+P +++ + V++ ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDE 631
+ L Y+H + HRD+K N+LLD D K+ DFG AK E
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
LG+GGFG V ++ ++ A K+L + +G NE +++ K+ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGW-ETRVRV-IEEIAQGLLYLHQYSR 595
E ++ + L+ M L F G+ E R EI GL LH R
Sbjct: 251 YAYETKDALCLVLTLMNGGDL---KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---R 304
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
R+++RDLK NILLD + +ISD G+A + K VGT GYM+PE +
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 361
Query: 656 FSIKSDVFSFGVLLLETL 673
++ D ++ G LL E +
Sbjct: 362 YTFSPDWWALGCLLYEMI 379
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 54/216 (25%)
Query: 479 TENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRL 536
++ LG G G V + GQ+ A+K L + + E+ + ++V +
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87
Query: 537 LGCCIELEEKILIYEYMPNKSLDIF----------LFD----------TPKESPLGWETR 576
L +YE M + + LF T +E+
Sbjct: 88 LD----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA------- 130
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQ 633
++ +I + +LH + HRD+K N+L +KD K++DFG AK + LQ
Sbjct: 131 AEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
+ T Y++PE + D++S GV++
Sbjct: 188 T----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHR 531
T + + +G G + + E AVK + + EI+++ + QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHP 76
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD--------TPKESPLGWETRVRVIEEI 583
N++ L + + ++ E M L D + +E+ V+ I
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREA-------SAVLFTI 125
Query: 584 AQGLLYLHQYSRLRVIHRDLKASNILL-DKDMNP---KISDFGMAKMFGGDELQSKTKRI 639
+ + YLH V+HRDLK SNIL D+ NP +I DFG AK + T
Sbjct: 126 TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--P 180
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T +++PE ++ + D++S GVLL
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 58/199 (29%), Positives = 84/199 (42%), Gaps = 30/199 (15%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEE-FKNEIKLIAKLQHRNLVRLLGCC 540
+G G FG R + VAVK + G ++E + EI L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV- 84
Query: 541 IELEEKI-LIYEYMPNKSLDIFLFDT------PKESPLGWETRVRVIEEIAQGLLYLHQY 593
I + +I EY L ++ E E R +++ G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSED----EAR-FFFQQLLSGVSYCH-- 133
Query: 594 SRLRVIHRDLKASNILLDKD--MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-Y 650
+++ HRDLK N LLD KI DFG +K K+ VGT Y++PE
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KST--VGTPAYIAPEVL 189
Query: 651 AQQGLFSIKSDVFSFGVLL 669
+Q +DV+S GV L
Sbjct: 190 LRQEYDGKIADVWSCGVTL 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 42/210 (20%), Positives = 81/210 (38%), Gaps = 41/210 (19%)
Query: 479 TENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRL 536
T LG G G V + ++ A+K L + + E++L + ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 537 LGCC---IELEEKI-LIYEYMPNKSLDIFLFD----------TPKESPLGWETRVRVIEE 582
+ + + ++ E + L F T +E+ +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREA-------SEIMKS 169
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRI 639
I + + YLH + + HRD+K N+L + K++DFG AK
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTP 223
Query: 640 VGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669
T Y++PE + D++S GV++
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 25/174 (14%)
Query: 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKN----EIKLIAKL 528
F E G+G FG V G+ G VA+K++ F+N ++ +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVL 76
Query: 529 QHRNLVRLLGCCIELEEK-------ILIYEYMP---NKSLDIFLFDTPKESPLGWETRVR 578
H N+V+L L E+ ++ EY+P ++ + ++
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY---YRRQVAPPPILIKV 133
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP-KISDFGMAKMFGGDE 631
+ ++ + + LH S + V HRD+K N+L+++ K+ DFG AK E
Sbjct: 134 FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 25/198 (12%), Positives = 56/198 (28%), Gaps = 45/198 (22%)
Query: 482 KLGEGGFGPVYKG---RLHNGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKLQHRNLVR 535
G ++ L ++VA+ + Q L+E + ++++ + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
+L +++ E++ SL ++ +R ++ +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
V S + + D G + M
Sbjct: 148 AGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPDA------ 179
Query: 656 FSIKSDVFSFGVLLLETL 673
+ + D+ G L L
Sbjct: 180 -NPQDDIRGIGASLYALL 196
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 35/210 (16%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEE---FKNEIKLIAKLQHRNLVRLLG 538
+G G FG V +L N +V A+K L+ E F+ E ++ + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 539 CCIELEEKI-LIYEYMP--------NKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLL 588
+ + + L+ +Y +K D E R + E+ +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-----------EEMARFYLAEMVIAID 189
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
+HQ L +HRD+K NIL+D + + +++DFG D ++ VGT Y+SP
Sbjct: 190 SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISP 245
Query: 649 E-----YAQQGLFSIKSDVFSFGVLLLETL 673
E +G + + D +S GV + E L
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 48/204 (23%), Positives = 82/204 (40%), Gaps = 21/204 (10%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLG 538
+G G F V ++ +V A+K ++ + F+ E ++ R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
+ E + L+ EY L L K R + EI + +H+ L
Sbjct: 128 FAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---L 181
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE------- 649
+HRD+K NILLD+ + +++DFG D ++ VGT Y+SPE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGG 240
Query: 650 YAQQGLFSIKSDVFSFGVLLLETL 673
G + + D ++ GV E
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMF 264
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKN---EIKLIAKLQHRNLVRLLG 538
+G+G FG V + + A+K ++ Q E +N E++++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRV-IEEIAQGLLYLH 591
+ EE + ++ + + L L F E V++ I E+ L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---------EETVKLFICELVMALDYLQ 132
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-- 649
R+IHRD+K NILLD+ + I+DF +A M + + + GT YM+PE
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMF 186
Query: 650 YAQQGLFSIKS-DVFSFGVLLLETLSSKR 677
+++G + D +S GV E L +R
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++A+G+ +L + + IHRDL A NILL + KI DFG+A+ D +
Sbjct: 201 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
+M+PE +++I+SDV+SFGVLL E S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 33/159 (20%), Positives = 54/159 (33%), Gaps = 19/159 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQSGQG-LEEFKNEIKLIAKL 528
LG G FG V + + VAVK L + +E+K++ +
Sbjct: 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 529 -QHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG 586
H N+V LLG C + + +I E+ +L +L R + +G
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKG 132
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625
+ + I DLK + + S F K
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEF---KNEIKLIAKLQHRNLVRLLG 538
LG+G FG V + A+K L + +E E +++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
+ +++ + EY L F +E E R R EI L YLH S
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--SEK 268
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
V++RDLK N++LDKD + KI+DFG+ K + G K GT Y++PE +
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----TMKTFCGTPEYLAPEVLEDN 324
Query: 655 LFSIKSDVFSFGVLLLETL 673
+ D + GV++ E +
Sbjct: 325 DYGRAVDWWGLGVVMYEMM 343
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 35/198 (17%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ + +G G +G V + + VA+K++ F++ EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 524 LIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMP---NKSLDIFLFDTPKESPLGWET 575
++ +L H ++V++L I + +E ++ E K LF TP L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-----LFRTPV--YLTELH 157
Query: 576 RVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635
++ + G+ Y+H S ++HRDLK +N L+++D + K+ DFG+A+ E +
Sbjct: 158 IKTLLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 636 TKRIVGTYGYMSPEYAQQ 653
I M+
Sbjct: 215 QLPISPREDDMNLVTFPH 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLS----SQSGQGLEEFKNEIKLIAKLQH 530
F LG G FG V + +G A+K L + Q +E NE +++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNF 100
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRV-IEEIA 584
LV+L + ++ EY+ + L F E R +I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS---------EPHARFYAAQIV 151
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
YLH +I+RDLK N+L+D+ +++DFG AK ++ +T + GT
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674
++PE ++ D ++ GVL+ E +
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 46/247 (18%), Positives = 94/247 (38%), Gaps = 57/247 (23%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN-EIKLIAKLQHR 531
+ +S LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGW------------------ 573
N+++L+ ++ P+ + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 574 -ETRVRVIEE-------------------IAQGLLYLHQYSRLRVIHRDLKASNILLD-K 612
+T +V++ + + + ++H L + HRD+K N+L++ K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 613 DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY---AQQGLFSIKSDVFSFGVLL 669
D K+ DFG AK + I + Y +PE A + ++ D++S G +
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVF 232
Query: 670 LETLSSK 676
E + K
Sbjct: 233 GELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HR 531
++ KLG G + V++ + N ++V VK L + + K EIK++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 532 NLVRLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
N++ L + + L++E++ N L + EI + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDY 145
Query: 590 LHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
H S ++HRD+K N+++D + ++ D+G+A+ Q R+ Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 649 E---YAQQGLFSIKSDVFSFGVLLLETLSSKR 677
E Q +S+ D++S G +L + K
Sbjct: 200 ELLVDYQMYDYSL--DMWSLGCMLASMIFRKE 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 20/199 (10%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEF---KNEIKLIAKLQHRNLVRLLG 538
LG+G FG V R A+K L + +E E +++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
+ +++ + EY L F +E E R R EI L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHS---R 124
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
V++RD+K N++LDKD + KI+DFG+ K + G K GT Y++PE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDN 180
Query: 655 LFSIKSDVFSFGVLLLETL 673
+ D + GV++ E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMM 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 483 LGEGGFGPVY---KGRLHNGQEV-AVKRLS----SQSGQGLEEFKNEIKLIAKLQHRNLV 534
LG+GG+G V+ K N ++ A+K L ++ + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 535 RLLGCCIELEEKI-LIYEYMPNKSLDIF-------LFDTPKESPLGWETRVRV-IEEIAQ 585
L+ + K+ LI EY+ ++F +F E + EI+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGG--ELFMQLEREGIFM---------EDTACFYLAEISM 132
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTY 643
L +LHQ +I+RDLK NI+L+ + K++DFG+ K + G T GT
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHTFCGTI 185
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
YM+PE + + D +S G L+ + L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEE---FKNEIKLIAKLQHRNLVRLLG 538
+G G FG V R + ++V A+K LS + F E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSRL 596
+ + + ++ EYMP L + + E R E+ L +H +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVP-EKWARFYTAEVVLALDAIHS---M 187
Query: 597 RVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ---- 652
IHRD+K N+LLDK + K++DFG + + VGT Y+SPE +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGG 246
Query: 653 QGLFSIKSDVFSFGVLLLETL 673
G + + D +S GV L E L
Sbjct: 247 DGYYGRECDWWSVGVFLYEML 267
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 36/208 (17%)
Query: 483 LGEGGFGPVY---KGRLHNGQEV-AVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRL 536
LG+G FG V+ K + +++ A+K L + + K E ++ ++ H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 537 LGCCIELEEKI-LIYEYMPNKSLDIF-------LFDTPKESPLGWETRVRV-IEEIAQGL 587
+ E K+ LI +++ L F +F E V+ + E+A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFT---------EEDVKFYLAELALAL 139
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGY 645
+LH L +I+RDLK NILLD++ + K++DFG++K + K GT Y
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK----KAYSFCGTVEY 192
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETL 673
M+PE + + +D +SFGVL+ E L
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 483 LGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEF---KNEIKLIAKLQHRNLVRLLG 538
LG G FG V+ R HNG+ A+K L + L++ +E +++ + H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 539 CCIELEEKI-LIYEYMPNKSLDIFL-----FDTPKESPLGWETRVRV-IEEIAQGLLYLH 591
+ ++I +I +Y+ L L F + E+ L YLH
Sbjct: 74 TF-QDAQQIFMIMDYIEGGELFSLLRKSQRFP---------NPVAKFYAAEVCLALEYLH 123
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+I+RDLK NILLDK+ + KI+DFG AK + T + GT Y++PE
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVV 175
Query: 652 QQGLFSIKSDVFSFGVLLLETLS 674
++ D +SFG+L+ E L+
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLA 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 41/210 (19%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIK--------------LIAK 527
LG+G FG V R+ ++ AVK L K+ I L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLK----------KDVILQDDDVECTMTEKRILSLA 80
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQ 585
H L +L CC + +++ + E++ L +F K E R R EI
Sbjct: 81 RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEIIS 135
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTY 643
L++LH +I+RDLK N+LLD + + K++DFGM K + G T GT
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV----TTATFCGTP 188
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
Y++PE Q+ L+ D ++ GVLL E L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 58/217 (26%), Positives = 85/217 (39%), Gaps = 55/217 (25%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIK--------------LIAK 527
LG+G FG V E+ AVK L K+ + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILK----------KDVVIQDDDVECTMVEKRVLALP 77
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSL-------DIFLFDTPKESPLGWETRVRV 579
+ L +L C + +++ + EY+ L F E
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----------EPHAVF 125
Query: 580 -IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKT 636
EIA GL +L +I+RDLK N++LD + + KI+DFGM K ++ G T
Sbjct: 126 YAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TT 178
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
K GT Y++PE + D ++FGVLL E L
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIK--------LIAKLQHRNL 533
+G G + V RL + A+K + + +I H L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND----DEDIDWVQTEKHVFEQASNHPFL 72
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLH 591
V L C + E ++ + EY+ L +F ++ L E R EI+ L YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLH 127
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPE 649
+ +I+RDLK N+LLD + + K++D+GM K + GD T GT Y++PE
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPE 180
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLS 674
+ + D ++ GVL+ E ++
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 62/217 (28%), Positives = 87/217 (40%), Gaps = 55/217 (25%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIK--------------LIAK 527
LG+G FG V+ + A+K L K+ + L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALK----------KDVVLMDDDVECTMVEKRVLSLA 74
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSL-------DIFLFDTPKESPLGWETRVRV 579
+H L + C + +E + + EY+ L F +R
Sbjct: 75 WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-----------LSRATF 122
Query: 580 -IEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKT 636
EI GL +LH +++RDLK NILLDKD + KI+DFGM K M G KT
Sbjct: 123 YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KT 175
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
GT Y++PE ++ D +SFGVLL E L
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQ---SGQGLEEFKNEIK-LIAKLQHRNLVRLL 537
+G G + V RL + A++ + + + ++ + E H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 538 GCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQGLLYLHQYSR 595
C + E ++ + EY+ L +F ++ L E R EI+ L YLH+
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE--- 171
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+I+RDLK N+LLD + + K++D+GM K + GD T GT Y++PE +
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRG 227
Query: 654 GLFSIKSDVFSFGVLLLETLS 674
+ D ++ GVL+ E ++
Sbjct: 228 EDYGFSVDWWALGVLMFEMMA 248
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEE--FKN---------EI 522
+ ++ + + G +G V G G VA+KR+ + G + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 523 KLIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMPN------KSLDIFLFDTPKESPL 571
+L+ H N++ L + + + L+ E M I + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-- 138
Query: 572 GWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631
+ I GL LH+ V+HRDL NILL + + I DF +A+ D
Sbjct: 139 -------FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
++ V Y +PE + K D++S G ++ E + K
Sbjct: 189 NKTHY---VTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 43/211 (20%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIK--------LIAKLQHRNL 533
+G+G FG V R + AVK L ++ K E K L+ ++H L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVLLKNVKHPFL 101
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFL-------FDTPKESPLGWETRVRV-IEEIA 584
V L + +K+ + +Y+ ++F F E R R EIA
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGG--ELFYHLQRERCFL---------EPRARFYAAEIA 149
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGT 642
L YLH L +++RDLK NILLD + ++DFG+ K + T GT
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGT 202
Query: 643 YGYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
Y++PE + + D + G +L E L
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 41/210 (19%)
Query: 483 LGEGGFGPVYKGRLHNGQEV-AVKRLSSQSGQGLEEFKNEIK--------------LIAK 527
LG+G FG V E+ AVK L K+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK----------KDVVIQDDDVECTMVEKRVLALP 398
Query: 528 LQHRNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRV-IEEIAQ 585
+ L +L C + +++ + EY+ L ++ + E EIA
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK-EPHAVFYAAEIAI 453
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK--MFGGDELQSKTKRIVGTY 643
GL +L +I+RDLK N++LD + + KI+DFGM K ++ G TK GT
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTP 506
Query: 644 GYMSPEYAQQGLFSIKSDVFSFGVLLLETL 673
Y++PE + D ++FGVLL E L
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ +G G G V + VA+K+LS F+N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
L+ + H+N++ LL E ++ L+ E M + + L E
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMS 167
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
++ ++ G+ +LH +IHRDLK SNI++ D KI DFG+A+ G + +
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 223
Query: 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
V T Y +PE + D++S G ++ E + K
Sbjct: 224 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 38/212 (17%)
Query: 483 LGEGGFGPVY---KGRLHNGQEV-AVKRLS----SQSGQGLEEFKNEIKLIAKLQHRN-L 533
LG G +G V+ K H+ ++ A+K L Q + E + E +++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 534 VRLLGCCIELEEKI-LIYEYMPNKSLDIFL-------FDTPKESPLGWETRVRV-IEEIA 584
V L + E K+ LI +Y+ L F F E V++ + EI
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFT---------EHEVQIYVGEIV 169
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
L +LH+ L +I+RD+K NILLD + + ++DFG++K F DE + GT
Sbjct: 170 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIE 225
Query: 645 YMSPE---YAQQGLFSIKSDVFSFGVLLLETL 673
YM+P+ G D +S GVL+ E L
Sbjct: 226 YMAPDIVRGGDSG-HDKAVDWWSLGVLMYELL 256
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 36/172 (20%), Positives = 66/172 (38%), Gaps = 50/172 (29%)
Query: 479 TENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRL 536
T LG G G V + ++ A+K L + + E++L + Q ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 537 LGCCIELEEKILIYEYMPNKSLDIF----------LFD----------TPKESPLGWETR 576
+ +YE + + LF T +E+
Sbjct: 77 VD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA------- 119
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAK 625
+++ I + + YLH + + HRD+K N+L + K++DFG AK
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 35/219 (15%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ +G G G V + VA+K+LS F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
L+ + H+N++ LL E ++ ++ E M +L + + L E
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMS 130
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
++ ++ G+ +LH +IHRDLK SNI++ D KI DFG+A+ G + +
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 186
Query: 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
V T Y +PE + D++S G ++ E +
Sbjct: 187 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 8e-15
Identities = 36/199 (18%), Positives = 56/199 (28%), Gaps = 46/199 (23%)
Query: 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRL--------SSQSGQGLEEFKNEIKL 524
T K+GEG FG V++ + VA+K + + + EE EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 525 IAKLQ---------HRNLVRLLG--CCIELEEKILIYEYMPNKSLDIFLFDTPKESP--- 570
+L + L C +L+ + S D P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 571 ---------------------LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNIL 609
T ++ ++ L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 610 LDKDMNPKISDFGMAKMFG 628
L K K+ K
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 31/173 (17%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
A + +G G +G V G +VA+K+L F++ E++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
L+ ++H N++ LL + + L+ +M L K LG +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630
++ ++ +GL Y+H +IHRDLK N+ +++D KI DFG+A+ +
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 54/235 (22%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ + LG GG G V+ + VA+K++ + EIK
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 524 LIAKLQHRNLVRLL--------------GCCIELEEKILIYEYMPNKSLDIFLFDTPKES 569
+I +L H N+V++ G EL ++ EYM + L + ++
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115
Query: 570 PLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFG 628
PL E + ++ +GL Y+H + V+HRDLK +N+ ++ +D+ KI DFG+A++
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 629 GDELQSK--TKRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
++ +V T Y SP L S + D+++ G + E L+ K
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 43/225 (19%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
++ + +GEG +G V N VA+K++S F++ EIK
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 524 LIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR 578
++ + +H N++ + ++++ ++ + M + L+ K L +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY 132
Query: 579 VIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK--T 636
+ +I +GL Y+H S V+HRDLK SN+LL+ + KI DFG+A++ D + T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 637 KRIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
+ V T Y +PE + + K D++S G +L E LS++
Sbjct: 190 EY-VATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 46/224 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ + +G G +G V +G++VA+K+LS F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
L+ +QH N++ LL + L+ +M I E
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM------GLKFSEEKIQ 129
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
++ ++ +GL Y+H V+HRDLK N+ +++D KI DFG+A+ + T
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTG 182
Query: 638 RIVGTYGYMSPEYAQQGLFSIKS-----DVFSFGVLLLETLSSK 676
V T Y +PE + S D++S G ++ E L+ K
Sbjct: 183 Y-VVTRWYRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 38/208 (18%), Positives = 79/208 (37%), Gaps = 53/208 (25%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
N+ ++ +G G +G VY + + VA+K+++ F++ EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 524 LIAKLQHRNLVRLLGCCI-----ELEEKILIYEYMP---------NKSLDIFLFDTPKES 569
++ +L+ ++RL I + +E ++ E L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT---------- 127
Query: 570 PLGWETRVRVIEEIAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626
E ++ I + G ++H +IHRDLK +N LL++D + K+ DFG+A+
Sbjct: 128 ----EEHIKTI--LYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG 654
++ + + +
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 40/195 (20%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+++F ++ LGEG +G V G+ VA+K++ F EIK
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 524 LIAKLQHRNLVRLL-----GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVR 578
++ +H N++ + E +I E M L L + ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHIQ 115
Query: 579 VIEEIAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSK 635
I Q + LH + VIHRDLK SN+L++ + + K+ DFG+A++ DE +
Sbjct: 116 YF--IYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAAD 168
Query: 636 TKRIVGTYGYMSPEY 650
G M E+
Sbjct: 169 NSEPTGQQSGMV-EF 182
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 18/182 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH-RNL 533
+ K+G G FG +Y G + G+EVA+K ++ E K+ +Q +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGI 67
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
+ C E + +++ E + SL+ ++ L +T + + +++ + Y+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSK 124
Query: 594 SRLRVIHRDLKASNILLDKDMNPK---ISDFGMAKMFGGDE-----LQSKTKRIVGTYGY 645
+ IHRD+K N L+ I DFG+AK + + K + GT Y
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 646 MS 647
S
Sbjct: 182 AS 183
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 34/198 (17%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ KLG+G +G V+K G+ VAVK++ + F+N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 524 LIAKLQ-HRNLVRLLGCCI--ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVI 580
++ +L H N+V LL + L+++YM + L + + L + +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQYV 114
Query: 581 EEIAQ---GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
+ Q + YLH S ++HRD+K SNILL+ + + K++DFG+++ F +
Sbjct: 115 --VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 638 RIVGTYGYMSPEYAQQGL 655
+ + + Q L
Sbjct: 170 PLSINENTENFDDDQPIL 187
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-13
Identities = 22/126 (17%), Positives = 45/126 (35%), Gaps = 19/126 (15%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFD 85
+ +T + G+ L + + Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYD--HSTSVWASNTGILG-K 50
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHL 145
+ S GN V+ + + ++W+S+ R G+ V L + GN+V+ + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DI 102
Query: 146 WQSFDH 151
W + +
Sbjct: 103 WSTGTY 108
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 31/167 (18%)
Query: 474 TANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKN---------EIK 523
+ + +G G +G V G VAVK+LS F++ E++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 524 LIAKLQHRNLVRLL------GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRV 577
L+ ++H N++ LL E + L+ M L + K L +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624
+I +I +GL Y+H +IHRDLK SN+ +++D KI DFG+A
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-12
Identities = 25/128 (19%), Positives = 42/128 (32%), Gaps = 19/128 (14%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFD 85
++++ + G L + L + Y S VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYD--SGKPVWASNTGGLGSG 52
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHL 145
TL ++GNLVI + N IW + K V L N+V+ +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQSFDHPS 153
W + P+
Sbjct: 103 WATGSGPA 110
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 20/183 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
F K+G G FG +Y G + +EVA+K + ++ E K+ LQ +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGI 65
Query: 535 -RLLGCCIELEEKILIYEYMPNKSL-DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ +E + +L+ + + SL D+F F + K S +T + + +++ + ++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHS 121
Query: 593 YSRLRVIHRDLKASNILLDKDMNPK---ISDFGMAKMFGGDELQS-----KTKRIVGTYG 644
S +HRD+K N L+ I DFG+AK + + K + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 645 YMS 647
Y S
Sbjct: 179 YAS 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 41/184 (22%), Positives = 78/184 (42%), Gaps = 20/184 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH-RNL 533
NF K+G G FG + G+ L+ + VA+K +S + E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
++ + ++ E + SL+ + L +T + + ++ + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHSK 124
Query: 594 SRLRVIHRDLKASNILLDKDMNPK-----ISDFGMAKMFGGDELQS-----KTKRIVGTY 643
+ +I+RD+K N L+ + N I DF +AK + E + + K + GT
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 644 GYMS 647
YMS
Sbjct: 182 RYMS 185
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 39/184 (21%), Positives = 80/184 (43%), Gaps = 20/184 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH-RNL 533
++ ++GEG FG +++G L N Q+VA+K +S ++E + L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 68
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
+ E +L+ + + SL+ L ++ + +T +++ + +H+
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHEK 125
Query: 594 SRLRVIHRDLKASNILLDKDMNPK-----ISDFGMAKMFGGDE-----LQSKTKRIVGTY 643
S +++RD+K N L+ + + + DFGM K + + K + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 644 GYMS 647
YMS
Sbjct: 183 RYMS 186
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 58/225 (25%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ----------- 529
KLG G F V+ + + N VA+K + E ++EIKL+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 530 HRNLVRLLGC-----------CIELEEKILIYEYMPNKSLDIFLFDTPKES-----PLGW 573
++++LL + E L L K+ PL
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE------------VLGENLLALIKKYEHRGIPL-- 130
Query: 574 ETRVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP------KISDFGMAKM 626
V+ I +++ GL Y+H R +IH D+K N+L++ +P KI+D G A
Sbjct: 131 -IYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-C 186
Query: 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+ + + + T Y SPE + +D++S L+ E
Sbjct: 187 WYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 8e-12
Identities = 27/124 (21%), Positives = 51/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIF 84
+D + + G L + + L ++ ++ VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK-- 48
Query: 85 DSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGH 144
S L + + GNLVI + + IW+SN R+ G+ L N+V+ D +SN++
Sbjct: 49 ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYD--NSNNA--- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 38.8 bits (90), Expect = 9e-04
Identities = 15/69 (21%), Positives = 31/69 (44%), Gaps = 1/69 (1%)
Query: 83 IFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSE 142
+ + I + NLV+ + N +W+S KA V ++ + GNLV+ + +
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 GHLWQSFDH 151
Q+ ++
Sbjct: 75 NTNRQNGNY 83
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-11
Identities = 24/123 (19%), Positives = 41/123 (33%), Gaps = 20/123 (16%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFD 85
+ + + + L + + L + + Y+ + +W +N +R
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQ--NGRQIWASNTDRR--G 50
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHL 145
S LT+ S GNLVI + N +W S G L G V+ L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 28/201 (13%), Positives = 67/201 (33%), Gaps = 36/201 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGR---------LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIA 526
+ ++ G +Y+ Q+ ++K L ++ G+ E +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 527 KLQHRNLVRLLGC---CI---------ELEEKILIYEYMPNKSL-DIFLFDTPKESPLGW 573
LQ +L I + + + L+ + +SL
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE-- 158
Query: 574 ETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMAKMF--GG 629
+ ++V + L +LH+ +H ++ A NI +D + ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 630 DEL---QSKTKRIVGTYGYMS 647
+ + G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 49/219 (22%), Positives = 81/219 (36%), Gaps = 56/219 (25%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVK------RLSSQSGQGLEEFKNEIKLIAKLQHR-- 531
+ +G+G FG V K + VA+K +Q+ + E++L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLELMNKHDT 112
Query: 532 ----NLVRLLGC-------CIELEEKILIYEYMPNKSLDIFLFDTPKES-----PLGWET 575
+V L C+ E L L+D + + L
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE------------MLSYNLYDLLRNTNFRGVSL---N 157
Query: 576 RVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMAKMFGGDEL 632
R +++ LL+L L +IH DLK NILL KI DFG + G +
Sbjct: 158 LTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI 215
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+ + Y SPE + + D++S G +L+E
Sbjct: 216 YQ----YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 8e-11
Identities = 26/121 (21%), Positives = 49/121 (40%), Gaps = 15/121 (12%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFD 85
+ + + GE L ++ R+ + Y D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYD--VDKPIWATNTGGL--D 49
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDN--FSSNSSEG 143
L++ S GNLV+ + +N IW+SN + G+ V L N+V+ +++ ++
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTN-I 108
Query: 144 H 144
H
Sbjct: 109 H 109
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 38/200 (19%), Positives = 73/200 (36%), Gaps = 34/200 (17%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQ------EVAVKRLSSQSGQGLEEFKNEIKL----- 524
+ +G+GGFG +Y +++ + VK S +G E K +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 525 IAKLQHRNLVRLLG----------CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWE 574
I K ++ LG + +I + L K +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR--K 152
Query: 575 TRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMAKMFGGDEL 632
T +++ I L Y+H++ +H D+KASN+LL+ ++ D+G+A + + +
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 633 -----QSKTKRIVGTYGYMS 647
+ GT + S
Sbjct: 210 HKAYAADPKRCHDGTIEFTS 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 58/217 (26%)
Query: 483 LGEGGFGPVYKGR-LHNGQEVAVK------RLSSQSGQGLEEFKNEIKLIAKLQHR---- 531
+G+G FG V K Q VA+K R Q+ EI+++ L+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLRKQDKDN 157
Query: 532 --NLVRLLGC-------CIELEEKILIYEYMPNKSLDIFLFDTPKES-----PLGWETRV 577
N++ +L C+ E L + L++ K++ L V
Sbjct: 158 TMNVIHMLENFTFRNHICMTFE------------LLSMNLYELIKKNKFQGFSL---PLV 202
Query: 578 RVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP--KISDFGMAKMFGGDELQS 634
R I Q L LH + R+IH DLK NILL + K+ DFG + + + +
Sbjct: 203 RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVYT 258
Query: 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLE 671
+ + Y +PE + + D++S G +L E
Sbjct: 259 ----YIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 37/198 (18%), Positives = 74/198 (37%), Gaps = 33/198 (16%)
Query: 476 NFSTENKLGEGGFGPVYKG-RLHNGQEVA---VKRLSSQSGQGLEEFKNEIKL-----IA 526
+ K+G GGFG +Y + ++ A VK ++G E K ++ I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 527 KLQHRNLVRLLG----------CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETR 576
K R + LG + ++ E + L + T
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKK--STV 153
Query: 577 VRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI--SDFGMAKMFGGDEL-- 632
+++ + L Y+H+ +H D+KA+N+LL ++ +D+G++ + +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 633 ---QSKTKRIVGTYGYMS 647
++ K GT + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-09
Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 10/79 (12%)
Query: 70 SDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGN 129
++ +W N + + G LV++ +N T+W S + KAG V L N
Sbjct: 47 NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 130 LVLRDNFSSNSSEGHLWQS 148
+V+ + LW +
Sbjct: 105 VVIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 73 VVWVANRNRPIFDSNA-TLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLV 131
++ +F ++ + + NLV+ + N IW++N A L G LV
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYD-NNNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 132 LRDNFSSNSSEGHLWQS 148
+ N + +WQS
Sbjct: 75 VITNENVT-----VWQS 86
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 3e-09
Identities = 50/349 (14%), Positives = 114/349 (32%), Gaps = 75/349 (21%)
Query: 492 YKGRLHNGQEVAVKRLSSQSGQGLEEF------KNEIKLIAKLQHR--NLVRLLGCCIEL 543
YK L ++ V + +++ K EI I + +RL +
Sbjct: 18 YKDILSVFEDAFVDNFDCKD---VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 544 EEKILI----------YEYM----------PNKSLDIF------LFDTPKESPLGWETRV 577
+E+++ Y+++ P+ ++ L++ + +R+
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDL---K---ASNILLDKDMNPKISDFGMAKM-FGG- 629
+ ++ Q LL L + +I L K A ++ L + K+ DF + +
Sbjct: 135 QPYLKLRQALLELRPAKNV-LIDGVLGSGKTWVALDVCLSYKVQCKM-DFKIFWLNLKNC 192
Query: 630 DELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
+ ++ + + + P + + +IK + S L L SK + L
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-----CL 247
Query: 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+L ++ + +AW + L+ R+ V + ++ L
Sbjct: 248 LVLL---NVQ-NAKAWNAFN----LSCKILLTTRFKQVTDF-LSAATTTHISLDHHSMTL 298
Query: 748 T-NETVNLPHPQQPAFSSIRGLKNTILPANGETGACSVSCLTLSVMDAR 795
T +E +L + LP + + LS++
Sbjct: 299 TPDEVKSL-------LLKYLDCRPQDLPRE----VLTTNPRRLSIIAES 336
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 6e-06
Identities = 51/311 (16%), Positives = 96/311 (30%), Gaps = 85/311 (27%)
Query: 492 YKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRL---LGC---CIELE- 544
+ RL+N +V K S+ L+ + + + +L+ V + LG + L+
Sbjct: 115 QRDRLYNDNQVFAKYNVSR----LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 545 ---EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY-----LHQYS-- 594
K+ M K IF + L + E+ Q LLY S
Sbjct: 171 CLSYKVQ--CKMDFK---IFWLN------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 595 -------------RLRVI--HRDLKASNILLDKDM-NPKISDFGMAKMFGGDELQSK--- 635
LR + + + ++L ++ N K F L K
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-NVQNAKA-----WNAF---NLSCKILL 270
Query: 636 TKR--------IVGTYGYMSPEYAQQGLFSIKS-DVFSFGVLLLETLSSKRNTDFSNTDS 686
T R T ++S ++ L + + L R +N
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCRPQDLPREVLTTNPRR 329
Query: 687 LTLLGRA-------WDLWKDDRAWEL---IDPILQNEASYLILNRYINVALLCVQEDAVD 736
L+++ + WD WK +L I+ L + +++
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF--PPS-AH 386
Query: 737 RPTMFEVVSML 747
PT ++S++
Sbjct: 387 IPT--ILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 9e-05
Identities = 68/415 (16%), Positives = 111/415 (26%), Gaps = 135/415 (32%)
Query: 15 FLLSIKLSIAADTITPS----RFIRDGEKLVSSSQRF-------------------EL-- 49
FL+S I + PS +I ++L + +Q F EL
Sbjct: 93 FLMS---PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149
Query: 50 ----------GFFSPGKS-----KYRYLGIWYKQISDTVVW--VANRNRP---------- 82
G GK+ + ++ + W + N N P
Sbjct: 150 AKNVLIDGVLGS---GKTWVALDVCLSYKV-QCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 83 --IFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNS 140
D N T S N+ L + + + + L LVL + ++
Sbjct: 206 LYQIDPNWTSRSDHSSNI-KLRIHSIQAELRRLLKSKPYENC--L----LVLLNVQNAK- 257
Query: 141 SEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRS-ADDPSPGNYTHRLDIHVLPK 199
W +F+ LL T T ++ D S TH H
Sbjct: 258 ----AWNAFNLSCKILL----------T------TRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 200 LCTYNGSVKLLCSGPWNGVAFQAAPSYSYLYEPTVV--------DNEDEI-YYRY---DS 247
L T + LL + Q P P + D +++ D
Sbjct: 298 L-TPDEVKSLLLK--YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 248 YNSPIIMMLK-LNPSGKIQRLIWNERNNGWEVFFSGPDYF--CQIFGSCGANSVCSIDKT 304
+ I L L P+ R F +F S
Sbjct: 355 LTTIIESSLNVLEPA--EYR-----------------KMFDRLSVFPP-------SAHIP 388
Query: 305 PNCECLMGFKLESQLNQTRPRSCVRSHLVDCTNRDRFVMIDDIKLPDLEEVLLNE 359
L+ F + + LV+ ++ + I I L +L+ L NE
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL-ELKVKLENE 442
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-09
Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 10/109 (9%)
Query: 24 AADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPI 83
+ + S+ + D +L +++ + L + K +VW + +
Sbjct: 5 VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 84 FDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVL 132
+ + +G SG L I + + T++ SN + G V L G V+
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 4e-09
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 15/117 (12%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFD 85
+ + + + +L + + +L + Y W +N +
Sbjct: 7 NLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYGG---KYGWQSNTHGN--G 53
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDN--FSSNS 140
+ L + G L+I + TIWSS + K G V L D G V+ F ++S
Sbjct: 54 EHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPAIFETSS 110
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 5e-08
Identities = 23/137 (16%), Positives = 42/137 (30%), Gaps = 28/137 (20%)
Query: 23 IAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRP 82
+ + + + + L + F+L Y G W ++
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNLVL-YNGNWQSNTANN---------- 47
Query: 83 IFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSE 142
+ LT+ G LVI N T+W S G+ A + G LV+
Sbjct: 48 --GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP------- 98
Query: 143 GHLWQSFDHPSDTLLPG 159
+++ D + G
Sbjct: 99 -SVFK-----IDPWVRG 109
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 49/246 (19%), Positives = 88/246 (35%), Gaps = 42/246 (17%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ--------HRN 532
KLG G F V+ + + VA+K + S E +EI+L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 533 LVRLLGC-----------CIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIE 581
+V+LL C +++E + L ++ + L ++I+
Sbjct: 103 VVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQ 153
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
++ QGL YLH ++ R+IH D+K NILL + A + + V
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 642 TYGYMSPEYAQQGLFSIKSDVFS--FGVLLLETLSSKRNTDFSNTDSL----TLLGRAW- 694
T + + L ++ L K T+ T L+G +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN 271
Query: 695 ---DLW 697
D+W
Sbjct: 272 TPADIW 277
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 39/182 (21%), Positives = 66/182 (36%), Gaps = 50/182 (27%)
Query: 482 KLGEGGFGPVYKGR-LHNGQEVAVK------RLSSQSGQGLEEFKNEIKLIAKLQHR--- 531
K+G+G FG V + + N + AVK + + + K E ++ K+Q+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILKKIQNDDIN 94
Query: 532 --NLVRLLGC-------CIELEEKILIYEYMPNKSLDIFLFDTPKES-----PLGWETRV 577
N+V+ G C+ E L L++ + + +
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFE------------PLGPSLYEIITRNNYNGFHI---EDI 139
Query: 578 RVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636
++ EI + L YL ++ + H DLK NILLD K G +T
Sbjct: 140 KLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 637 KR 638
K
Sbjct: 197 KS 198
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 55/242 (22%), Positives = 87/242 (35%), Gaps = 88/242 (36%)
Query: 482 KLGEGGFGPVYKGRLH--NGQEVAVK------RLSSQSGQGLEEFKNEIKLIAKLQHR-- 531
LGEG FG V + H G+ VAVK R + ++EI+++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVLEHLNTTDP 73
Query: 532 ----NLVRLLGC-------CIELEEKILIYEYMPNKSLDIFLFDTPKES-----PLGWET 575
V++L CI E L + +D KE+ L
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFE------------LLGLSTYDFIKENGFLPFRL---D 118
Query: 576 RVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP------------------ 616
+R + +I + + +LH ++ H DLK NIL +
Sbjct: 119 HIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 617 -KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLL 669
K+ DFG A + + + +V T Y +PE + S DV+S G +L
Sbjct: 176 IKVVDFGSA-TYDDEHHST----LVSTRHYRAPEVILALGW------SQPCDVWSIGCIL 224
Query: 670 LE 671
+E
Sbjct: 225 IE 226
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 53/242 (21%), Positives = 82/242 (33%), Gaps = 88/242 (36%)
Query: 482 KLGEGGFGPVYKGRLH--NGQEVAVK------RLSSQSGQGLEEFKNEIKLIAKLQHR-- 531
LGEG FG V + H +VA+K + + + EI ++ K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVLKKIKEKDK 78
Query: 532 ----NLVRLLGC-------CIELEEKILIYEYMPNKSLDIFLFDTPKES-----PLGWET 575
V + CI E L F+ KE+ PL
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFE------------LLGKNTFEFLKENNFQPYPL---P 123
Query: 576 RVRVI-EEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP------------------ 616
VR + ++ L +LH ++ H DLK NIL
Sbjct: 124 HVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 617 -KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE------YAQQGLFSIKSDVFSFGVLL 669
+++DFG A F + + IV T Y PE + + DV+S G +L
Sbjct: 181 IRVADFGSA-TFDHEHHTT----IVATRHYRPPEVILELGW------AQPCDVWSIGCIL 229
Query: 670 LE 671
E
Sbjct: 230 FE 231
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 7e-06
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 71 DTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNL 130
D VW N A L +G + +L +N +W+S +R AG V L NL
Sbjct: 168 DDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 225
Query: 131 VLRDN 135
+
Sbjct: 226 AIYGG 230
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 1e-05
Identities = 31/198 (15%), Positives = 58/198 (29%), Gaps = 18/198 (9%)
Query: 70 SDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGN 129
SD VW +N + + S G LVIL +N WSS G+ V L
Sbjct: 43 SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRT 99
Query: 130 LVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYT 189
+ + +S + + + G D S
Sbjct: 100 VTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDN--------HPQTLHATQSLQLSP 151
Query: 190 HRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSYSYLYE---PTVVDNEDEIYYRYD 246
+RL + L ++ ++ + + + L V+ N++ +
Sbjct: 152 YRLSMETDCNLVLFDRDDRVWSTNTAG----KGTGCRAVLQPNGRMDVLTNQNIAVWTSG 207
Query: 247 SYNSPIIMMLKLNPSGKI 264
+ S + L P +
Sbjct: 208 NSRSAGRYVFVLQPDRNL 225
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.0 bits (97), Expect = 4e-04
Identities = 28/148 (18%), Positives = 50/148 (33%), Gaps = 19/148 (12%)
Query: 22 SIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNR 81
+ + + + G+ L+S +QRF+L G L I VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQDNG---ATVWVANEQQ 62
Query: 82 PIF------DSNATLTIGSSGNLVILNLKNGTIWSSNMTR-----KAGSPVAQLLDTGNL 130
P + A L + + +W ++ + + L D GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VLRDNFSSNSSEGHLWQSFDHPSDTLLP 158
VL D+ + + + LL
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLA 150
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 5e-04
Identities = 10/68 (14%), Positives = 26/68 (38%), Gaps = 4/68 (5%)
Query: 87 NATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLW 146
+A + NLV+ N + SN + +L + G L + +++++ ++
Sbjct: 21 SAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHS--ANSNTPVWVY 76
Query: 147 QSFDHPSD 154
+
Sbjct: 77 PRSVNTVR 84
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 795 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.82 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.79 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.74 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.66 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.59 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.57 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.32 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.24 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.12 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.76 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.51 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.36 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 90.85 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=441.45 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=215.2
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|.+.++||+|+||.||+|++. +++.||||+++....+..++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999753 477899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 549 IYEYMPNKSLDIFLFDT----------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
|||||++|+|.++|... .....+++.++..|+.||++||+|||+++ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999998643 23457999999999999999999999998 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.......... ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~--~i---- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE--CI---- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--HH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HH----
Confidence 99999987654443333344579999999999999999999999999999999998 899987544222111 00
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+.. ...+...+.++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 244 ~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00000 1122234567889999999999999999999999998873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=443.61 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=208.0
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|.+.++||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999753 478899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 549 IYEYMPNKSLDIFLFDTP------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
|||||++|+|.+++.... ...++++.++..|+.||++||+|||+++ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999986532 2356999999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||........ ....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~~i-- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--IDCI-- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--HHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--HHHH--
Confidence 9999999997655444444455789999999999999999999999999999999999 8999875442221 1110
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
..+. ....+...+.++.+|+.+||+.||++|||+.||+++|+.+.
T Consensus 274 --~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 --TQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp --HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 0000 01112234567889999999999999999999999999873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=432.04 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=205.9
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
+++++.++||+|+||+||+|++++ .||||+++.. ..+..++|.+|+.+|++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 678889999999999999998753 6999998753 34556789999999999999999999998865 568999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
|++|+|.+++... ...+++.++..|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999998543 356999999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.......+||+.|||||++.. ..|+.++|||||||++|||+||+.||...+....... ...... ..|.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~-~~~~~~--------~~p~ 258 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF-MVGRGY--------ASPD 258 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH-HHHTTC--------CCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH-HHhcCC--------CCCC
Confidence 334455789999999999864 4689999999999999999999999975443221111 000000 1111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
+ ...+..++..+.+++.+||+.||++||||.||+++|+.+...+
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1 1122234567889999999999999999999999998874443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=435.44 Aligned_cols=258 Identities=29% Similarity=0.398 Sum_probs=212.6
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++++.++||+|+||.||+|++. +++.||||+++.. .....++|.+|+.+|++++|||||+++++|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35667889999999999999752 4678999999764 3345688999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC
Q 040413 548 LIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~ 614 (795)
||||||++|+|.++|.... ....+++.++.+|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999986432 1246999999999999999999999998 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccc
Q 040413 615 NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRA 693 (795)
Q Consensus 615 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 693 (795)
.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.......... ..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~--~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE--MI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH--HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH--HH
Confidence 999999999987654443334455689999999999999999999999999999999998 888987554322111 10
Q ss_pred cccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 694 ~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+. ....+..++.++.+++.+||+.||++|||+.||+++|+..
T Consensus 261 ----~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 ----RNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----HcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0000 0112334456788999999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=436.29 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=212.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
..|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999765 79999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998843 46999999999999999999999999 9999999999999999999999999998765432
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... ...... ...+.+.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~---------~~~~~~~-- 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRD---------NLPPRLK-- 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH---------SSCCCCS--
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHc---------CCCCCCC--
Confidence 223457899999999999999999999999999999999999999975442221 111000 0011111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.....+.++.+++.+||+.||++|||+.|+++|-.-
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 112234578899999999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=436.20 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=204.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|+++++||+|+||.||+|++. +++.||||++.+. .....+++.+|+++|++|+|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999765 7999999999764 33456789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++|+|.+++... +...+++.+++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998543 3456899999999999999999999999 9999999999999999999999999998764321
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+......... . ... .
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-----~-~~~----~---- 243 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-----S-GSF----P---- 243 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----H-TCC----C----
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-----c-CCC----C----
Confidence 22334689999999999999999999999999999999999999997654322211100 0 000 0
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+.++.+||.+||+.||++|||+.|+++|
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112234568899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=428.81 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=211.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||+||+|+++ +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999765 7899999999754 3445688999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999853 357999999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.......... .. .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------~~------~-- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK------LE------Y-- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TC------C--
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CC------C--
Confidence 444445567999999999999999999999999999999999999999976543222111000 00 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+.++.++|.+||+.||++|||+.|++.+
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 0111234567899999999999999999986443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=428.53 Aligned_cols=262 Identities=22% Similarity=0.237 Sum_probs=209.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+.|++.++||+|+||.||+|+++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888899999999999999865 789999999976432 257999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-CceeeccccccccCCCcc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~ 632 (795)
++|+|.+++.. ...+++.++..++.||+.||+|||+++ ||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999853 356999999999999999999999998 99999999999999988 699999999987654322
Q ss_pred c---cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 633 Q---SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 633 ~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+......... ......
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-----~~~~~~------ 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-----SEPPPI------ 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-----HSCCGG------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-----cCCCCc------
Confidence 1 12234679999999999999999999999999999999999999997654332211100 000000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc---CCCCCCCCC
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET---VNLPHPQQP 760 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~---~~~~~~~~p 760 (795)
...+...+..+.+++.+||+.||++|||+.|++++|.... ..+.+|-..
T Consensus 276 --~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~ 327 (336)
T 4g3f_A 276 --REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG 327 (336)
T ss_dssp --GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred --hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence 1122334567889999999999999999999999986542 234455443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=437.83 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=212.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.++||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999765 79999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 99999998843 46999999999999999999999999 9999999999999999999999999998765432
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.... +..... ...+.+.
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~---------~~~~~~~-- 368 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRD---------NLPPRLK-- 368 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH---------SCCCCCS--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHc---------CCCCCCc--
Confidence 223457899999999999999999999999999999999999999975442221 111000 0011111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.....+.++.+||.+||+.||++|||+.|+++|-.-
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 111234568899999999999999999999997443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=415.15 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=199.3
Q ss_pred cccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee----cceeEEEE
Q 040413 478 STENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKILIY 550 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 550 (795)
++.++||+|+||.||+|.+. +++.||||++... .....++|.+|+++|++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999765 6899999999654 34456789999999999999999999999875 35579999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~ 629 (795)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999853 357999999999999999999999875 35999999999999984 79999999999986443
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||........ ..... ..+. .+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i----~~~~-----~~- 248 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRV----TSGV-----KP- 248 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHH----TTTC-----CC-
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHH----HcCC-----CC-
Confidence 2 2345789999999998865 699999999999999999999999964432211 11110 0000 00
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...+...+.++.+++.+||+.||++|||+.|+++|-
T Consensus 249 --~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 011111234578999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=410.00 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=192.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+|++. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999765 7999999999764 2344678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6788877743 357999999999999999999999999 999999999999999999999999999876433
Q ss_pred ccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
. .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...+...... .... .. .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~--~i~~----~~------~- 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK--NISN----GV------Y- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH----TC------C-
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHc----CC------C-
Confidence 2 2334689999999999988776 579999999999999999999997644222111 1000 00 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+...+.++.+++.+||+.||++|||+.|+++|-.
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 011123456789999999999999999999999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=425.58 Aligned_cols=261 Identities=28% Similarity=0.379 Sum_probs=212.5
Q ss_pred hccCCcccccccCCCceeEEeeeccC------CceEEEEEecccC-cccHHHHHHHHHHHHhcCC-Cceeeeeeeeeec-
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQH-RNLVRLLGCCIEL- 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~- 543 (795)
..++|++.++||+|+||.||+|.+.. ++.||||++.... ....+.|.+|+++|.+++| ||||+++++|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 34789999999999999999997542 4679999997653 3345779999999999965 8999999999764
Q ss_pred ceeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll 610 (795)
+..+||||||++|+|.++|.... ....+++.++..++.|||+||+|||+++ ||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 56899999999999999986432 2356899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 040413 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTL 689 (795)
Q Consensus 611 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~ 689 (795)
++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999997755444344455789999999999999999999999999999999998 899987644222110
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. ...+ .....+...+.++.+++.+||+.||++|||+.||+++|+.+
T Consensus 299 -~~----i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 299 -RR----LKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp -HH----HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HH----HHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 00 0000 00111223345788999999999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=415.88 Aligned_cols=249 Identities=24% Similarity=0.283 Sum_probs=199.2
Q ss_pred cCCcccccccCCCceeEEeeecc----CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.++||+|+||+||+|+.. .++.||||++++.. .....++.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 47889999997642 2334578899999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||++||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999853 357999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+......... . .. .
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~----~~------~ 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--K----AK------L 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--H----CC------C
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--c----CC------C
Confidence 322 22345789999999999999999999999999999999999999997654322211100 0 00 0
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 747 (795)
..+...+.++.+++.+||+.||++||| ++|+++|-
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 011223456889999999999999998 57888763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=413.88 Aligned_cols=270 Identities=23% Similarity=0.280 Sum_probs=201.3
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc----eeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE----EKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 550 (795)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999987 589999999975432 1223345666667889999999999998764 579999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS-----RLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
|||++|+|.+++.. ..++++.+.+++.|+++||+|||++. ..+||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 46899999999999999999999861 2349999999999999999999999999998
Q ss_pred ccCCCcc--ccceeeecccCCcCChhhhccC------CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 626 MFGGDEL--QSKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 626 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
....... .......+||+.|||||++.+. .++.++|||||||++|||+||++|+..................
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7654322 1223346899999999998754 4678999999999999999999887543322111111000000
Q ss_pred cccc-----hhhccCccccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 698 KDDR-----AWELIDPILQN-EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 698 ~~~~-----~~~~id~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.... ..+.++|.+.. ..+.+.+..+.+++.+||+.||++||||.||+++|+.+
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0000 11112222222 12335667889999999999999999999999999876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=405.97 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=191.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--------
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-------- 544 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 544 (795)
.+|++++.||+|+||.||+|+++ +++.||||+++... ....+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999765 78999999997543 334578999999999999999999999987654
Q ss_pred ----eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 545 ----EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 545 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
..++||||+++|+|.+++.........++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999966544445667788999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccc----------cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhc
Q 040413 621 FGMAKMFGGDELQ----------SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690 (795)
Q Consensus 621 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~ 690 (795)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.... +....+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-HHHHHH
Confidence 9999876543221 11234579999999999999999999999999999999996 553211 111111
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
... .+... ..........+.+++.+||+.||++|||+.|+++|-
T Consensus 238 ~~~------------~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 238 TDV------------RNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HHH------------HTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHH------------hcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 000 00000 111222334567899999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=406.83 Aligned_cols=268 Identities=21% Similarity=0.281 Sum_probs=204.5
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeee------cc
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE------LE 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 544 (795)
.++|+++++||+|+||.||+|++. +|+.||||++.+.. ....+++.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999765 79999999997642 3345778999999999999999999998764 36
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
.++||||||+ |+|.+++. ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 56887774 3467999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCc--cccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccccc
Q 040413 625 KMFGGDE--LQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDD 700 (795)
Q Consensus 625 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 700 (795)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...+.... ..+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764321 12233457899999999998775 569999999999999999999999976653221 1111110000000
Q ss_pred --------chhh---ccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 701 --------RAWE---LIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 701 --------~~~~---~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.... .+.+... .......+.++.+|+.+||+.||++|||+.|+++|-.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 0000 0000000 0001123456889999999999999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=398.24 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=203.3
Q ss_pred HHHHhccCCcccccccCCCceeEEeeecc----CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 040413 469 SVSAATANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 469 ~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.+....++|++.++||+|+||.||+|+.+ .++.||||++.+.. ...++.+|+++|+.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34455688999999999999999999753 46889999987543 456789999999998 699999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeeccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFG 622 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFG 622 (795)
+..++||||+++++|.+++ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999887 24899999999999999999999999 9999999999999876 899999999
Q ss_pred cccccCCCccc--------------------------cceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhC
Q 040413 623 MAKMFGGDELQ--------------------------SKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSS 675 (795)
Q Consensus 623 la~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg 675 (795)
+|+........ ......+||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432110 112345799999999999775 589999999999999999999
Q ss_pred CCCCCCCCCcchhh--cccccc-------------------cccccchhhcc---------Ccccc---------chhhH
Q 040413 676 KRNTDFSNTDSLTL--LGRAWD-------------------LWKDDRAWELI---------DPILQ---------NEASY 716 (795)
Q Consensus 676 ~~p~~~~~~~~~~~--~~~~~~-------------------~~~~~~~~~~i---------d~~l~---------~~~~~ 716 (795)
+.||.....+...+ +..... ........... .+.+. .....
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 99986544321110 000000 00000000000 00000 00011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 717 LILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 717 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+.++.+|+.+||+.||++|||++|+++|-.
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 23456789999999999999999999998743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=384.74 Aligned_cols=281 Identities=37% Similarity=0.608 Sum_probs=235.7
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
+.++...+++|++.+.||+|+||.||+|.+++++.||||++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33445577899999999999999999999888999999999877767788999999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
++||||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999986542 2346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhh
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 704 (795)
...............||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+...........+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 6543322222334568999999999999999999999999999999999999987554322 112222222223334445
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+++.+........+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5666666667778889999999999999999999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=411.76 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=212.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|++.+.||+|+||.||+|.++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+...++||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999765 79999999998766666788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC--CCceeeccccccccCCCc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~~ 631 (795)
++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999888843 3457999999999999999999999999 9999999999999854 899999999999875443
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+............ ....
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~------------~~~~ 376 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD------------WNMD 376 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC------------CCCC
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC------------CCCC
Confidence 2345689999999999999999999999999999999999999997655322211110000 0011
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.......+.++.+||.+||+.||++|||+.|+++|-.
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 1111223456789999999999999999999999743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=381.15 Aligned_cols=289 Identities=41% Similarity=0.686 Sum_probs=240.8
Q ss_pred CCCcccHHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeee
Q 040413 461 WFPMFSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGC 539 (795)
Q Consensus 461 ~~~~~~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 539 (795)
.+..+++.++....++|++.++||+|+||.||+|+.++++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 345688899999999999999999999999999998889999999997643 2233468999999999999999999999
Q ss_pred eeecceeEEEEeecCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 540 CIELEEKILIYEYMPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 540 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
+.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||++...+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999986643 3456999999999999999999999991112999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC---Ccchhhcccccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN---TDSLTLLGRAWD 695 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~---~~~~~~~~~~~~ 695 (795)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ........+...
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987653322 22334569999999999999899999999999999999999999986321 222222233334
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...........+..+........+..+.+++.+||+.+|.+|||+.||+++|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4445555666677777777888899999999999999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=410.97 Aligned_cols=266 Identities=27% Similarity=0.295 Sum_probs=210.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHH---HHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNE---IKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|+++++||+|+||.||+|+++ +|+.||||++.+. .......+.+| +.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999765 7999999999753 12233344444 5666677899999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+|||||++||+|..+|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999853 357999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
+.... ....+||+.|||||++.. ..|+.++|+|||||++|||++|++||..........+.... .. .
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~-~----- 409 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LT-M----- 409 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HH-C-----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cC-C-----
Confidence 65432 234689999999999975 57999999999999999999999999754322221111000 00 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhh--cc------cCCCCCCCCCCc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSMLT--NE------TVNLPHPQQPAF 762 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~--~~------~~~~~~~~~p~~ 762 (795)
. ...+...+.++.+||.+||+.||.+|++ +.||++|-. ++ ...+++|..|..
T Consensus 410 -~----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 410 -A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp -C----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred -C----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 0 0112223456889999999999999998 799998742 21 234566666754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=368.32 Aligned_cols=235 Identities=20% Similarity=0.235 Sum_probs=181.7
Q ss_pred hhhcccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCC----CceEEEeecC
Q 040413 21 LSIAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDS----NATLTIGSSG 96 (795)
Q Consensus 21 ~~~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~----~~~l~~~~~g 96 (795)
++++.|+|++|++|++|++|+|++|.|+||||+++ ++|+ |+ ..+ +||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 46788999999999999999999999999999543 5676 77 445 99999999999775 7899999999
Q ss_pred CeEE--ecCCCceeeeecccCC-----CCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCccccccccC
Q 040413 97 NLVI--LNLKNGTIWSSNMTRK-----AGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLKTG 169 (795)
Q Consensus 97 ~l~l--~~~~~~~~W~t~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~~tg 169 (795)
+||| .|+++.+||+|+++.. ..+.+|+|+|+|||||+| +.+|||| |||||||||||||.+.++|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccC
Confidence 9999 7888999999997642 345689999999999995 4689999 9999999999999999988
Q ss_pred cceEEEeeccCCCCCCCceEEEeeccCcceEEEec-CceeEEeeCCCCceeeccCCCCcccccceEeecCCeeEEEEecC
Q 040413 170 LERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYN-GSVKLLCSGPWNGVAFQAAPSYSYLYEPTVVDNEDEIYYRYDSY 248 (795)
Q Consensus 170 ~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~-~~~~~~~sg~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (795)
.. | ++.+||++|.|+++++++|. +++++ ++.+||++|+|++..... ......++.+.++.. ..+.++..
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l--~l~~dGnLvl~d~~~-~~vWsS~t 222 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRA--VFQGDGNLVVYGAGN-AVLWHSHT 222 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEE--EECTTSCEEEECTTS-CEEEECSC
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEE--EEcCCCeEEEEeCCC-cEEEEecC
Confidence 75 5 67899999999999999985 44564 568999999997532110 011111222223322 22223322
Q ss_pred CCCeeEEEEEccCCcEEEEEEecCCCcEEEEEeccCc
Q 040413 249 NSPIIMMLKLNPSGKIQRLIWNERNNGWEVFFSGPDY 285 (795)
Q Consensus 249 ~~~~~~rl~L~~~G~l~~~~w~~~~~~W~~~~~~p~~ 285 (795)
.....+|++|+.||++++|.| ...|..++.+|..
T Consensus 223 ~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 223 GGHASAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 233358999999999999998 3457766666554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=361.66 Aligned_cols=285 Identities=38% Similarity=0.553 Sum_probs=230.5
Q ss_pred CCCcccHHHHHHhccCCccc------ccccCCCceeEEeeeccCCceEEEEEeccc----CcccHHHHHHHHHHHHhcCC
Q 040413 461 WFPMFSLASVSAATANFSTE------NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ----SGQGLEEFKNEIKLIAKLQH 530 (795)
Q Consensus 461 ~~~~~~~~~i~~~~~~y~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h 530 (795)
.++.|++.++..++.+|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568889999999988877 8999999999999987 5789999998753 23446789999999999999
Q ss_pred CceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE
Q 040413 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 531 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll 610 (795)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+++ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999998865545567999999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhc
Q 040413 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL 690 (795)
Q Consensus 611 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~ 690 (795)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.|+...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987654332223334579999999998764 588999999999999999999999876543221110
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
...............+++.+ ...+...+..+.+++.+||+.+|.+|||+.+++++|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 00000011122233344433 2345667788999999999999999999999999998863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.30 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=212.6
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..++|++.++||+|+||.||+|.+ .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999976 4789999999987666677889999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999998843 35899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||................ .+.+
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------~~~~- 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-----------TPEL- 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-----------SCCC-
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------CCCC-
Confidence 2 2334679999999999999999999999999999999999999986544221111000000 0000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+||+.||++|||+.|+++|-.-.
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 11223345688999999999999999999999875443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=363.42 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=213.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|.+.++||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367999999999999999999765 6899999999877777788999999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998542 356899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc------------ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccccc
Q 040413 633 QS------------KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD 700 (795)
Q Consensus 633 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~------- 236 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------- 236 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-------
Confidence 11 11145799999999999999999999999999999999999988865432221111000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
....+ ...+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 237 --~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 237 --RGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --HHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000 11112234568899999999999999999999999988743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.21 Aligned_cols=268 Identities=26% Similarity=0.413 Sum_probs=205.3
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
...+|++.++||+|+||.||+|+. .++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346899999999999999999976 57899999997653 344567999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++........+++..+..++.||++||+|||+++ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999865433334899999999999999999999875 34999999999999999999999999999865432
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ....
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~------------ 256 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKCK------------ 256 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--HSCC------------
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCC------------
Confidence 2 12234679999999999999999999999999999999999999987544222111000 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCC
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQ 758 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 758 (795)
....+...+..+.+++.+||+.+|++|||+.++++.|+........|+
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 001122234568899999999999999999999999998865544333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=371.80 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=212.2
Q ss_pred ccCCcccccccCCCceeEEeeecc--------CCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|++.+.||+|+||.||+|++. ++..||||++.... ....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 368999999999999999999752 35679999997653 34567899999999999 899999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll 610 (795)
+..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999986532 1245899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 040413 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTL 689 (795)
Q Consensus 611 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987654433233333567889999999999999999999999999999999 999987544322211
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. ... .....+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 317 ~~------~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 317 LL------KEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH------HTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH------hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 000 00111223445788999999999999999999999999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=361.34 Aligned_cols=265 Identities=27% Similarity=0.350 Sum_probs=216.8
Q ss_pred cccHHHHHHhccC----------CcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc
Q 040413 464 MFSLASVSAATAN----------FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN 532 (795)
Q Consensus 464 ~~~~~~i~~~~~~----------y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n 532 (795)
.++..++..+++. |+..++||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3556666655543 777889999999999999876 79999999998777777888999999999999999
Q ss_pred eeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC
Q 040413 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK 612 (795)
Q Consensus 533 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~ 612 (795)
|+++++++...+..++||||+++++|.+++. ...+++..+..++.||++||.|||+++ |+||||||+||+++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999873 346999999999999999999999998 999999999999999
Q ss_pred CCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccc
Q 040413 613 DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692 (795)
Q Consensus 613 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~ 692 (795)
++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--~~~ 252 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKR 252 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 99999999999987654321 22346799999999999999999999999999999999999999865432111 100
Q ss_pred ccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. .....+.+. .....+..+.+++.+||+.||++|||+.|++++..-.
T Consensus 253 ~---------~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 253 L---------RDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp H---------HHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred H---------hcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 0 000011111 1112345688999999999999999999999986554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=363.52 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=209.2
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
...+|++.+.||+|+||.||+|++ .+++.||||++.+. .....+++.+|+++|+.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 357899999999999999999976 57999999999754 334567789999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999988853 346899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCCC-ccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFS-IKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....+||+.|+|||.+.+..++ .++|||||||++|+|++|+.||...+.......... ..
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------~~------- 230 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------GK------- 230 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC-------
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CC-------
Confidence 32 22346799999999999887765 789999999999999999999976542222111000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+||+.||.+|||+.|+++|-.-
T Consensus 231 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 231 ---YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 00111234567899999999999999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.36 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=207.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999765 78999999986542 23346789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999998884 3456999999999999999999999998 99999999999999999999999999987643333
Q ss_pred ccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
........||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||................ ...
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------------~~~ 227 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------------KTY 227 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-------------CTT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-------------ccc
Confidence 333345689999999999987765 788999999999999999999997654332221111000 000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.......+..+.+++.+||+.||++|||+.|++++..-
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 00112234567899999999999999999999998644
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=364.11 Aligned_cols=269 Identities=24% Similarity=0.323 Sum_probs=209.0
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc----eeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE----EKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 549 (795)
..+|++.++||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999875 7899999997543 33455677999999999999999999998754 36999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY----------SRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----------~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
|||+++++|.+++.. ..+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999843 3589999999999999999999998 7 9999999999999999999999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc-
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA- 693 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~- 693 (795)
|||+++...............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987665443333344679999999999876 3566789999999999999999999875443221111000
Q ss_pred cccccccch-----hhccCccccch-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 694 WDLWKDDRA-----WELIDPILQNE-ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 694 ~~~~~~~~~-----~~~id~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
......... .....+.+... .....+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000000 01111111111 12345667999999999999999999999999998763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.89 Aligned_cols=254 Identities=24% Similarity=0.276 Sum_probs=208.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG------QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|..+ +++.||+|++.+... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 468999999999999999999765 689999999976432 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC----Cceeeccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFG 622 (795)
++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999884 3457999999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------- 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS------- 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-------
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------
Confidence 998765432 2234679999999999999999999999999999999999999997544222111000000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...........+..+.++|.+||+.||++|||+.|+++|-.
T Consensus 235 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 235 -----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred -----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 00001111223456889999999999999999999998743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=358.36 Aligned_cols=250 Identities=24% Similarity=0.274 Sum_probs=208.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.+.||+|+||.||+|+.+ +++.||||++++. .....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999765 6899999999764 344567899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999888843 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......... .. .
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~------~- 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EE------I- 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC------C-
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------CC------C-
Confidence 21 123456899999999999999999999999999999999999999875442221110000 00 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
..+...+.++.+++.+||+.||++|| ++.|+++|-
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 01122345688999999999999999 999999984
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=367.66 Aligned_cols=268 Identities=27% Similarity=0.359 Sum_probs=213.7
Q ss_pred cHHHHHHhccCCcccccccCCCceeEEeeec------cCCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeee
Q 040413 466 SLASVSAATANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLL 537 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~ 537 (795)
.........++|++.++||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444455668999999999999999999963 356889999997643 34457799999999999 799999999
Q ss_pred eeeeecce-eEEEEeecCCCCcceeeccCCC-------------------------------------------------
Q 040413 538 GCCIELEE-KILIYEYMPNKSLDIFLFDTPK------------------------------------------------- 567 (795)
Q Consensus 538 ~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------- 567 (795)
+++.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 8999999999999998865422
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 568 --------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 568 --------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 223899999999999999999999998 999999999999999999999999999876543333
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......||+.|+|||.+.+..++.++||||||+++|||++ |+.||............. ... ...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-----~~~---------~~~ 315 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-----KEG---------TRM 315 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-----HHT---------CCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-----HcC---------CCC
Confidence 33445678999999999999999999999999999999998 999987654322111000 000 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+.++.+++.+||+.+|++|||+.|++++|+.+
T Consensus 316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11112345688999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.39 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=208.8
Q ss_pred ccCCcccccccCCCceeEEeeecc----CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..+|++.++||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874 3446999999764 34456789999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999853 2356999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 629 GDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... ...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--~~~----------- 269 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--VEE----------- 269 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--HHT-----------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--HHc-----------
Confidence 4321 112223356778999999999999999999999999999999 9999865442221110 000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
......+...+..+.+++.+||+.||++|||+.||+++|+.+..
T Consensus 270 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 270 --GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00011122334578899999999999999999999999988743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.84 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=210.8
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36799999999999999999998888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999854 3356899999999999999999999998 999999999999999999999999999876533221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+|+.|+|||.+....++.++||||||+++|+|++ |+.|+........... ... . .. .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~--~~~----~-----~~----~ 226 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--IST----G-----FR----L 226 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--HHT----T-----CC----C
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--Hhc----C-----cc----C
Confidence 2223456788999999999999999999999999999999 8988875442221110 000 0 00 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11112245688999999999999999999999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.95 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=204.2
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|++.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999998889999999997542 2335778999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9986 66665543 3356899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccc--------
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDR-------- 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~-------- 701 (795)
.......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+...........
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 12233578999999999876 5689999999999999999999999976553322 11111000000000
Q ss_pred -----hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 -----AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 -----~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.....+.............++.+++.+||+.||++|||+.|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 0000011000111122345788999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=352.78 Aligned_cols=271 Identities=20% Similarity=0.254 Sum_probs=214.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--eeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 549 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999775 58999999997643 345678899999999999999999999998765 77999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE----cCCCCceeecccccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAK 625 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFGla~ 625 (795)
|||+++++|.+++........+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976544555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhc--------cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc--hhhcccccc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQ--------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS--LTLLGRAWD 695 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~--~~~~~~~~~ 695 (795)
....... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||....... .........
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7654322 23357999999999886 5788999999999999999999999986433211 111100000
Q ss_pred cccccc---hhhc------cCc--cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWKDDR---AWEL------IDP--ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~~~~---~~~~------id~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...... .... +.+ .............+.+++.+||+.||++|||+.|++++..+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000000 0000 000 111234567778899999999999999999999999999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.12 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=211.7
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|+.++++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46899999999999999999998888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999988542 345899999999999999999999998 999999999999999999999999999876544322
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+.............. . ....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------~--~~~~------ 225 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ------G--HRLY------ 225 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------T--CCCC------
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc------C--CCCC------
Confidence 2 223456778999999999899999999999999999999 9999875442221110000 0 0000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.+...+..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 226 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 -RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 011123468899999999999999999999999998843
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.42 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=207.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.++||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999765 7899999998543 234457899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999998853 346899999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||............ . .. . .+.
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~----~~-~-----~~~ 231 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-I----QD-S-----VPN 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-H----SS-C-----CCC
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-h----hc-c-----CCC
Confidence 322 2233457999999999999999999999999999999999999999754422211100 0 00 0 001
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhccc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRP-TMFEVVSMLTNET 751 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 751 (795)
.........+..+.+++.+||+.||.+|| +++++.+.|+...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11111223456788999999999999998 9999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.90 Aligned_cols=275 Identities=26% Similarity=0.392 Sum_probs=208.8
Q ss_pred ccCCcccccccCCCceeEEeeec-----cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec--cee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999973 36889999999877777778899999999999999999999998654 458
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc-cccccccchhh
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA-WDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 704 (795)
...... ........++..|+|||.+.+..++.++||||||+++|||++|..|+.....+........ ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 653321 1122234577789999999999999999999999999999999988754321111100000 00000000001
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
.+........+...+.++.+++.+||+.+|++|||+.|++++|+.+...
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111112233456789999999999999999999999999887443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=354.76 Aligned_cols=265 Identities=18% Similarity=0.187 Sum_probs=210.0
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..+|++.++||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999975 578999999987543 234689999999999 99999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC-----ceeeccccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISDFGMAKM 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DFGla~~ 626 (795)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999988543 457999999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 627 FGGDELQS-----KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 627 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---GDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH---HHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH---Hhhh
Confidence 64332211 123568999999999999999999999999999999999999999765432221110000 0000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCC
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 755 (795)
.. ... .......+ ++.+++..|++.+|.+||++.+|++.|+.+.....
T Consensus 237 ~~--~~~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 237 RA--TPI---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HH--SCH---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cc--CCH---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 00 000 00001123 78899999999999999999999999987644433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=366.97 Aligned_cols=267 Identities=27% Similarity=0.374 Sum_probs=216.1
Q ss_pred ccCCcccccccCCCceeEEeeecc--------CCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|.+.++||+|+||.||+|+.. .++.||||++... .....+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999752 2357999999764 334557899999999999 899999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPK-------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll 610 (795)
+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999998865321 346999999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 040413 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTL 689 (795)
Q Consensus 611 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |+.|+..........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654433333344567899999999999999999999999999999999 999987544222111
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCC
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQ 758 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 758 (795)
.. ... .....+...+.++.+++.+||+.+|++|||+.||+++|+.+........
T Consensus 305 ~~------~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 305 LL------KEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HH------HTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HH------HcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 00 000 0001112234568899999999999999999999999988754443333
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.73 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=208.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.++||+|+||.||+|.+. +++.+|+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999765 6889999998754 33456789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC--CCCceeeccccccccCCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~ 630 (795)
+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999988843 2346899999999999999999999998 999999999999987 789999999999876543
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||................ . ..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~-----------~~ 222 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-Y-----------TF 222 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-C-----------CC
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC-C-----------CC
Confidence 2 2344679999999999998889999999999999999999999997644222111000000 0 00
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
........+.++.+++.+||+.||.+|||+.|+++|-.
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 00111123567889999999999999999999999854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.05 Aligned_cols=254 Identities=24% Similarity=0.300 Sum_probs=208.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG------QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999765 689999999875422 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC----Cceeeccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFG 622 (795)
++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999884 3457999999999999999999999998 99999999999999887 89999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+++...... ......||+.|+|||.+....++.++|||||||++|+|++|+.||..............
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--------- 231 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------- 231 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---------
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh---------
Confidence 998765332 22345799999999999989999999999999999999999999865432211100000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.............+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 232 ---VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp ---TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ---cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000001111223456889999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.22 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=198.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--------------------------ccHHHHHHHHHHHH
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--------------------------QGLEEFKNEIKLIA 526 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 526 (795)
.++|++.++||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999764 689999999865421 12356899999999
Q ss_pred hcCCCceeeeeeeeee--cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCC
Q 040413 527 KLQHRNLVRLLGCCIE--LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 527 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dik 604 (795)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998865 3457999999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCC---CCccCCeeehhHHHHHHHhCCCCCCC
Q 040413 605 ASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDF 681 (795)
Q Consensus 605 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwslG~ll~elltg~~p~~~ 681 (795)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 223457999999999987654 47889999999999999999999865
Q ss_pred CCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 682 SNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
........ .... .. .. .......+..+.+++.+||+.||++|||+.|+++|-
T Consensus 243 ~~~~~~~~--~~~~----~~----~~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 243 ERIMCLHS--KIKS----QA----LE----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SSHHHHHH--HHHH----CC----CC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred ccHHHHHH--HHhc----cc----CC----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 43211110 0000 00 00 000112345688999999999999999999998763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=370.79 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=209.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|.+. +++.||||++.... ....+++.+|+++|++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468899999999999999999876 78999999987543 3344578999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999988532 345889999999999999999999998 9999999999999999999999999998754433
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.........+++.|+|||.+....++.++|||||||++|||++ |+.|+............ ... .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~------~~~---------~ 332 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV------EKG---------G 332 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH------HTT---------C
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HcC---------C
Confidence 2222222345778999999999999999999999999999998 89888654422211100 000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0011222345688999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=360.15 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=209.8
Q ss_pred ccCCcccccccCCCceeEEeeec------cCCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 47899999999999999999975 24668999999754 334457899999999999 89999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCC
Q 040413 546 KILIYEYMPNKSLDIFLFDTPK--------------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp 605 (795)
.++||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999865422 134899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCC
Q 040413 606 SNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNT 684 (795)
Q Consensus 606 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~ 684 (795)
+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654333233344567889999999999999999999999999999998 9999875542
Q ss_pred cchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 685 DSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
...... .. . .......+...+..+.+++.+||+.||.+|||+.|++++|+......
T Consensus 281 ~~~~~~-~~----~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 DANFYK-LI----Q---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SHHHHH-HH----H---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHH-HH----h---------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 221100 00 0 00001111223467889999999999999999999999999875443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=361.84 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=214.0
Q ss_pred HHhccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
....++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345688999999999999999999764 34789999997653 34467899999999999999999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCC
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPK---------------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRD 602 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~D 602 (795)
+..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999998865321 257999999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCC
Q 040413 603 LKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDF 681 (795)
Q Consensus 603 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~ 681 (795)
|||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654333233344578899999999999999999999999999999999 9988865
Q ss_pred CCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 682 SNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.......... ..... ...+...+..+.+++.+||+.+|++||++.+++++|+.+..
T Consensus 280 ~~~~~~~~~~------~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEVIYYV------RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHHHHHH------HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHHHHHH------hCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 4322211100 00000 01112234568899999999999999999999999998744
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=360.86 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=210.6
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.++||+|+||.||+|+++ +++.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999765 6899999999764 334567789999999998 7999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999988853 356999999999999999999999998 999999999999999999999999999854
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......... .
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~------- 239 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------D------- 239 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C-------
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc------C-------
Confidence 3222 223456899999999999998999999999999999999999999976543222111000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhhcc--------cCCCCCCCCCCcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTM------FEVVSMLTNE--------TVNLPHPQQPAFS 763 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L~~~--------~~~~~~~~~p~~~ 763 (795)
. ...+......+.+++.+||+.||++||++ .|+++|-.-. ....++|..|...
T Consensus 240 -~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 240 -E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred -C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 0 00111234567899999999999999998 8898874221 1345556666543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.40 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=201.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCce----EEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQE----VAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999754 4443 588887543 3456788999999999999999999999998754 78
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+|+||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999988543 356899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..............
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------------- 234 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------- 234 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-------------
Confidence 65443333334567889999999999999999999999999999999 9999876543322111100
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
......+...+..+.+++.+||+.+|++||++.|++++|+.+.
T Consensus 235 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 235 --GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0001112223456889999999999999999999999997753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.60 Aligned_cols=260 Identities=28% Similarity=0.388 Sum_probs=212.9
Q ss_pred ccCCcccccccCCCceeEEeeec------cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46899999999999999999975 24578999999764 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCC
Q 040413 547 ILIYEYMPNKSLDIFLFDTPK---------------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp 605 (795)
++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999865432 234899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCC
Q 040413 606 SNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNT 684 (795)
Q Consensus 606 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~ 684 (795)
+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333334567889999999999999999999999999999999 9999875543
Q ss_pred cchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 685 DSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
........ ... ....+...+..+.+++.+||+.||++||++.|++++|+.+.
T Consensus 259 ~~~~~~~~------~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ERLFNLLK------TGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGHHHHHH------TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhh------cCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22211100 000 00111233467889999999999999999999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.99 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=198.9
Q ss_pred ccCCcccccccCCCceeEEeeecc----CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..+|++.++||+|+||.||+|+++ +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368999999999999999999764 5778999999764 33456789999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999854 2346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 629 GDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........... +
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~---------------i 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA---------------V 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH---------------H
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------H
Confidence 33211 11122345788999999999999999999999999999998 9999865432211100 0
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
........+...+..+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 264 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 000111112234567889999999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=361.97 Aligned_cols=276 Identities=26% Similarity=0.362 Sum_probs=213.9
Q ss_pred ccCCcccccccCCCceeEEeeec-----cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeee--eccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI--ELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 546 (795)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999973 368899999998877677788999999999999999999999887 45568
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999988542 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........+|+.|+|||.+.+..++.++||||||+++|+|++|+.|+.....+..................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 654322 1222334678889999999999999999999999999999999998764332211111110000000111111
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
+........+...+..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111112223344567899999999999999999999999998875443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=355.74 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=202.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------- 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 544 (795)
.++|++.++||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367999999999999999999876 78999999997543 345678999999999999999999999986643
Q ss_pred --------------------------------------------------eeEEEEeecCCCCcceeeccCCCCCCCCHH
Q 040413 545 --------------------------------------------------EKILIYEYMPNKSLDIFLFDTPKESPLGWE 574 (795)
Q Consensus 545 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 574 (795)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999766555667777
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc----------cceeeecccCC
Q 040413 575 TRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ----------SKTKRIVGTYG 644 (795)
Q Consensus 575 ~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 644 (795)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999876543211 12233579999
Q ss_pred cCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHH
Q 040413 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYIN 724 (795)
Q Consensus 645 y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
|+|||.+.+..++.++||||||+++|||++|..|+.. ....... .... ............+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~------------~~~~-~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITD------------VRNL-KFPLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHH------------HHTT-CCCHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHH------------hhcc-CCCcccccCChhHHH
Confidence 9999999999999999999999999999998655321 0000000 0000 011122334456789
Q ss_pred HHHHhcccCCCCCCCHHHHHHHh
Q 040413 725 VALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 725 li~~cl~~dP~~RPt~~evl~~L 747 (795)
++.+||+.||++|||+.|+++|-
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHST
T ss_pred HHHHHccCCCCcCCCHHHHhhch
Confidence 99999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=349.18 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=207.6
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|++.+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46899999999999999999998888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999988542 346999999999999999999999998 999999999999999999999999999876533221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .... .
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-----------~~~~----~ 240 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-----------QGLR----L 240 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----------TTCC----C
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-----------cccC----C
Confidence 1222456788999999999999999999999999999998 999987544222111000 0000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11112235688999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=344.96 Aligned_cols=253 Identities=31% Similarity=0.456 Sum_probs=198.0
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccC----cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..+|++.++||+|+||.||+|.+. ++.+|||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999875 7899999987542 23467899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC--------CCCceeecc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK--------DMNPKISDF 621 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~--------~~~~kl~DF 621 (795)
|||+++++|.+++. ...+++..+..++.||++||.|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998883 357999999999999999999999987566999999999999986 778999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------- 227 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA--------- 227 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---------
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh---------
Confidence 9998654332 223578999999999999999999999999999999999999987544222111000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
........+...+..+.+++.+||+.+|.+|||+.|++++|+.
T Consensus 228 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 -----MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -----cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0000111122234568899999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=359.54 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=206.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-----SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
.++|++.+.||+|+||.||+|.++ +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999765 7899999998642 1234688999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC---ceeecccc
Q 040413 548 LIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGM 623 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFGl 623 (795)
+||||+++++|.+.+... .....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998776442 23346899999999999999999999998 999999999999986654 99999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........+... ...
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~--~~~----- 250 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG--KYK----- 250 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHT--CCC-----
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcC--CCC-----
Confidence 987654322 22345799999999999999999999999999999999999999875322111110000 000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+ ......+..+.+++.+||+.||++|||+.|+++|-
T Consensus 251 --~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 251 --MNP----RQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp --CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --CCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 000 01112345788999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.49 Aligned_cols=260 Identities=29% Similarity=0.401 Sum_probs=209.6
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999842 4678999999754 344556799999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---Cceee
Q 040413 547 ILIYEYMPNKSLDIFLFDTP----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKIS 619 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~ 619 (795)
++||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999886432 2356999999999999999999999998 99999999999999555 59999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.............
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~------ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence 9999986533222223334568999999999999999999999999999999998 988887544222111100
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
... ....+...+..+.+++.+||+.+|++|||+.+|+++|+...
T Consensus 301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000 00111223456889999999999999999999999998763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=348.37 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=202.1
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999988889999999986543 23357789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++ +|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 77777643 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccccc-----ccccccchhhc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAW-----DLWKDDRAWEL 705 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~ 705 (795)
.......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+.... ..+........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 12233578999999999876 46899999999999999999999999765422111 100000 00000000000
Q ss_pred cCccc-------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 706 IDPIL-------QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.++.. ........+.++.+++.+||+.||++|||+.|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 11100 0111122356688999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=362.19 Aligned_cols=275 Identities=21% Similarity=0.300 Sum_probs=211.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.++||+|+||.||+|+.+ +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999865 68899999997642 23345688999999887 89999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999888853 356999999999999999999999998 9999999999999999999999999998532
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh-ccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE-LID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~id 707 (795)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............. .....+ ...
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~------~~~~~~~i~~ 276 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT------EDYLFQVILE 276 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC------HHHHHHHHHH
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh------HHHHHHHHhc
Confidence 221 22345689999999999999999999999999999999999999996433111000000 000000 000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHhhc--c------cCCCCCCCCCCccc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTM------FEVVSMLTN--E------TVNLPHPQQPAFSS 764 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L~~--~------~~~~~~~~~p~~~~ 764 (795)
.. ...+...+.++.+++.+||+.||.+||++ .|+++|-.- + ...+.+|..|....
T Consensus 277 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~ 345 (396)
T 4dc2_A 277 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISG 345 (396)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred cc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCC
Confidence 00 01122245568899999999999999985 788887422 1 23455666665543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.67 Aligned_cols=266 Identities=22% Similarity=0.265 Sum_probs=202.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999775 68999999997543 3345788999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|++++.++.+. . ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444433 2 2456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccceeeecccCCcCChhhhccCC-CCccCCeeehhHHHHHHHhCCCCCCCCCCcch--hhcccccccccccc---hhhc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL--TLLGRAWDLWKDDR---AWEL 705 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwslG~ll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~---~~~~ 705 (795)
.......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.|+........ ..+........... ....
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 1223457899999999997765 89999999999999999999888643322111 11100000000000 0000
Q ss_pred cC---------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 706 ID---------PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 706 id---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.+ ...........+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 00 00001111234567889999999999999999999998743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.44 Aligned_cols=262 Identities=27% Similarity=0.374 Sum_probs=213.2
Q ss_pred ccCCcccccccCCCceeEEeeec------cCCceEEEEEecccCc-ccHHHHHHHHHHHHhc-CCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQSG-QGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999974 3578899999976532 3467899999999999 99999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE
Q 040413 546 KILIYEYMPNKSLDIFLFDTPK---------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll 610 (795)
.++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999998865422 235899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 040413 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTL 689 (795)
Q Consensus 611 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987765433333334567889999999999999999999999999999999 998886544322111
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.. +........+...+..+.+++.+||+.||.+|||+.|++++|+....
T Consensus 259 ~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 KM--------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HH--------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH--------------hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 00 00000011112234568899999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.22 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=206.4
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..++|++.++||+|+||.||+|.++ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999765 6899999999754 234457799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC---CCceeeccccccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMAKM 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFGla~~ 626 (795)
|||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999988874 3356899999999999999999999998 9999999999999865 4599999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+............ ..
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~-------- 248 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-YD-------- 248 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CC--------
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CC--------
Confidence 65332 1234679999999999999899999999999999999999999986544222111000000 00
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.........+.++.+++.+||+.||++||++.|+++|-
T Consensus 249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 00000112345688999999999999999999999873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.79 Aligned_cols=256 Identities=23% Similarity=0.280 Sum_probs=206.2
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...++|++.++||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999764 78999999987643 3345678999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc---CCCCceeecccccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAK 625 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFGla~ 625 (795)
||||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999888754 356999999999999999999999998 99999999999998 46889999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-------~ 232 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-------F 232 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------C
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-------C
Confidence 7654321 223467999999999999999999999999999999999999998654422211110000000 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+ .....+.++.+++.+||+.||++|||+.|+++|-
T Consensus 233 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 233 PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 000 0012345688999999999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=369.83 Aligned_cols=263 Identities=19% Similarity=0.223 Sum_probs=210.2
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
+..+....++|++.++||+|+||.||+|+++ +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999876 57899999997531 2223448999999999999999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.+..+|||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999998542 356999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDL 696 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~ 696 (795)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..... .+......
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 9987644322 1223468999999999987 567899999999999999999999999765422211 11000000
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSML 747 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 747 (795)
.. +.+. ....+.++.+++.+||+.+|++ ||+++|+++|-
T Consensus 300 ~~-------~p~~-----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 300 FQ-------FPTQ-----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CC-------CCSS-----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred cc-------CCcc-----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 00 0000 0113456789999999888888 99999999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.65 Aligned_cols=261 Identities=26% Similarity=0.335 Sum_probs=201.6
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHh--cCCCceeeeeeeeeec----ceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAK--LQHRNLVRLLGCCIEL----EEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 547 (795)
.++|++.++||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 5889999999653 34567777777777 7999999999987653 4579
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH--------QYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
+||||+++++|.+++. ...+++..+..++.||++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346999999999999999999999 776 9999999999999999999999
Q ss_pred ccccccccCCCccc--cceeeecccCCcCChhhhccC------CCCccCCeeehhHHHHHHHhC----------CCCCCC
Q 040413 620 DFGMAKMFGGDELQ--SKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSS----------KRNTDF 681 (795)
Q Consensus 620 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwslG~ll~elltg----------~~p~~~ 681 (795)
|||+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999865433221 112334799999999999876 456799999999999999999 666643
Q ss_pred CCCcchhhcccccccccccchhhccCccc-cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 682 SNTDSLTLLGRAWDLWKDDRAWELIDPIL-QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.......... ........ ...+.+ ........+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 236 ~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFED-MRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHH-HHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhh-hhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3211110000 00000000 001111 1123345677899999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.26 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=206.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|+.+ +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999765 7899999999754 2245678899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999998854 346899999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...... ... . ..+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~i~---~---------~~~ 220 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KIL---N---------AEL 220 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHH---H---------CCC
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH--HHH---h---------CCC
Confidence 234689999999999999999999999999999999999999997544221110 000 0 000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
..+...+.++.+++.+||+.||++|| +++|+++|-
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 01112345688999999999999999 899999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=366.44 Aligned_cols=276 Identities=22% Similarity=0.249 Sum_probs=216.5
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
..+....++|++.++||+|+||.||+|+++ +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455689999999999999999999876 6889999999652 122345588999999999999999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCC----CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccccccccc
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL----FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWK 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~ 698 (795)
++....... ......+||+.|+|||++.... ++.++|||||||++|||++|+.||...+...... +.....
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--- 290 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--- 290 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc---
Confidence 987654322 1233568999999999997655 8899999999999999999999997554222111 100000
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhhcc--------cCCCCCCCCCCccc
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVD--RPTMFEVVSMLTNE--------TVNLPHPQQPAFSS 764 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~~~--------~~~~~~~~~p~~~~ 764 (795)
. +.-......+.++.++|.+||+.+|.+ ||++.||++|-.-. ..+.+.|..|....
T Consensus 291 -----~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~ 356 (410)
T 3v8s_A 291 -----S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 356 (410)
T ss_dssp -----H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred -----c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence 0 000001123456889999999999998 99999999985332 12345555665443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=359.99 Aligned_cols=257 Identities=25% Similarity=0.330 Sum_probs=201.1
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCC--CceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQH--RNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 548 (795)
..++|++.++||+|+||.||+|...+++.||||++... ..+..+.+.+|+.+|.+++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45679999999999999999999888999999998754 34456789999999999986 999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||| +.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899888854 356899999999999999999999998 99999999999996 6789999999998765
Q ss_pred CCccccceeeecccCCcCChhhhcc-----------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQ-----------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------- 230 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-------- 230 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH--------
Confidence 4433333345689999999999865 678999999999999999999999986432211111
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+++......+...+..+.+++.+||+.||.+|||+.|+++|..-.
T Consensus 231 -----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 231 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -----HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 011111111111222235678999999999999999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.44 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=209.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.++||+|+||.||+|... +++.+|+|++..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999765 7899999999876655667899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC--CCCceeeccccccccCCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK--DMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~ 630 (795)
+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999888743 2346899999999999999999999998 999999999999974 578999999999876543
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... +...
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--~~i~~~----------~~~~ 269 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL--QNVKRC----------DWEF 269 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHHC----------CCCC
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH--HHHHhC----------CCCC
Confidence 2 223457999999999999999999999999999999999999999754422111 100000 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
........+.++.+++.+||+.||++|||+.|+++|-.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 01111123456889999999999999999999999843
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.21 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=195.1
Q ss_pred hccCCcccccccCCCceeEEeeeccC-Cc---eEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHN-GQ---EVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
..++|++.+.||+|+||.||+|++.. ++ .||||++... .....+++.+|+.++++++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45789999999999999999998753 32 7999999764 344568899999999999999999999999887665
Q ss_pred ------EEEEeecCCCCcceeeccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCce
Q 040413 547 ------ILIYEYMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 547 ------~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~k 617 (795)
++||||+++++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 9999999999999888543 12236899999999999999999999998 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.|+..............
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~--- 254 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG--- 254 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc---
Confidence 999999987654433333334567889999999999999999999999999999999 8988875443222111000
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.. ....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 255 ---~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 ---GN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 001112234568899999999999999999999999988743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.08 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=206.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999765 6889999998753 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999988853 456999999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||................. .
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~------- 235 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T------- 235 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C-------
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c-------
Confidence 2 2345689999999999864 4589999999999999999999999975443222111100000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPT-MFEVVSM 746 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 746 (795)
....+...+..+.+++.+||+.+|.+||+ +.++++|
T Consensus 236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 00112223457889999999999999998 8888875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.68 Aligned_cols=270 Identities=30% Similarity=0.394 Sum_probs=208.8
Q ss_pred CcccccccCCCceeEEeeec-----cCCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEE
Q 040413 477 FSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKIL 548 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 548 (795)
|++.++||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 49999999999999987753 268899999997653 34567799999999999999999999999874 67899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ........+|+.|+|||.+.+..++.++||||||+++|+|++|+.|+........................+.++
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4322 122334567888999999999999999999999999999999999876432211111111100001111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
.......+...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 1111222333456789999999999999999999999999887443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.93 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=204.7
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.++||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 57899999999999999999875 688999998643 346789999999999999999999998874 4799999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC-ceeeccccccccCCCccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-PKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DFGla~~~~~~~~~ 633 (795)
+++|.+++........+++..+..++.||++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999876544456889999999999999999999932223999999999999998887 799999999765322
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||............... . . ..+.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~-~-----~~~~---- 224 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH---N-G-----TRPP---- 224 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH---T-T-----CCCC----
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh---c-C-----CCCC----
Confidence 22346899999999999999999999999999999999999998754432221110000 0 0 0001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCCCC
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQP 760 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p 760 (795)
.....+..+.+++.+||+.+|++|||+.|++++|+.+....+.+..|
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 11123456889999999999999999999999999876655555444
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=352.87 Aligned_cols=271 Identities=26% Similarity=0.384 Sum_probs=207.3
Q ss_pred cCCcccccccCCCceeEEeeec-----cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec--cee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 546 (795)
.+|++.++||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999972 36889999999754 344568899999999999999999999999876 668
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999988432 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ........+|..|+|||.+.+..++.++||||||+++|+|++|+.|+..........................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 654322 1223345678889999999999999999999999999999999987542211000000000000000001111
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+........+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111111112233456788999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=356.52 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=203.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCce----EEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQE----VAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
++|++.++||+|+||.||+|.+. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67999999999999999999764 4544 788877543 2334466889999999999999999999886 567899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999888542 346889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............+|..|+|||.+.+..++.++||||||+++|+|++ |+.||.................
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 235 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----------- 235 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-----------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------
Confidence 5443333445678889999999999999999999999999999999 9999876543322111110000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
...+...+..+.+++.+||+.+|.+||++.|++++|+...
T Consensus 236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001112335678999999999999999999999998763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.05 Aligned_cols=262 Identities=21% Similarity=0.232 Sum_probs=214.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999865 7899999999754 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999998853 246899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ... .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~------~-- 255 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------SGK------V-- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC------C--
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH------cCC------C--
Confidence 234679999999999999999999999999999999999999997544222111000 000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhhcc--------cCCCCCCCCCCcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSMLTNE--------TVNLPHPQQPAFS 763 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~~~--------~~~~~~~~~p~~~ 763 (795)
..+...+..+.+++.+||+.||.+||+ +.|+++|-.-. ....+.|..|...
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~ 319 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCC
Confidence 011223456889999999999999998 99999875321 1344555566543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=371.98 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=212.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..+|++.++||+|+||.||+|.++ +++.||||++.... ...++|.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467889999999999999999876 48899999997643 3578899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999998653 2356899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......++..|+|||.+....++.++|||||||++|||++ |+.|+........... +.....
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---------------~~~~~~ 437 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---------------LEKDYR 437 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---------------HHTTCC
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------------HHcCCC
Confidence 2 1223456788999999999999999999999999999999 8888875442221110 000111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
...+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1122234567889999999999999999999999998873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.55 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=204.7
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999986 57899999998653 223346799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6777776643 346899999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ....+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||............ ....
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------~~~~------- 224 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------NSCV------- 224 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC------CSSC-------
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcCC-------
Confidence 332 234579999999999988776 68999999999999999999999754422211100 0000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+||+.||.+|||+.|+++|-.-
T Consensus 225 ---~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 225 ---YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp ---CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 00111234567899999999999999999999998644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=339.75 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=208.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999765 7899999998754 33456789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988843 356899999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.........||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||............... ... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~--~~---- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKT--YL---- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT-----TCT--TS----
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh-----ccc--cc----
Confidence 2223344678999999999987665 78899999999999999999999765432221111100 000 00
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
......+..+.+++.+||+.||++|||+.|++++..
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 011123456789999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=357.20 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=207.2
Q ss_pred HHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecce
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
....++|++.+.||+|+||.||+|+++ +++.||||++++.. ....+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999875 68999999997642 34567788999999987 89999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999988853 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......... .
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~----- 233 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------D----- 233 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C-----
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------C-----
Confidence 643222 223456899999999999999999999999999999999999999975443221110000 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMF-EVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~L 747 (795)
.+. .+...+.++.+++.+||+.||++||++. |+++|-
T Consensus 234 -~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 234 -NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp -CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred -CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 000 1112345688999999999999999998 887763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=370.76 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=211.1
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..++|++.++||+|+||.||+|.+++++.||||++.... ...+.|.+|+.+|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346899999999999999999998888999999997643 45788999999999999999999999986 6678999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999998532 1235789999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchh-hcccccccccccchhhccCccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLT-LLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~id~~l 710 (795)
.. .....++..|+|||.+....++.++||||||+++|||++ |+.|+......... .+... .
T Consensus 340 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------------~ 402 (454)
T 1qcf_A 340 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG----------------Y 402 (454)
T ss_dssp HT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT----------------C
T ss_pred ec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------------C
Confidence 11 122356788999999999999999999999999999999 99998754422211 11000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
....+...+..+.+++.+||+.||++|||+.+|++.|+....
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 011122345678899999999999999999999999998743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.63 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=196.1
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee---
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK--- 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 546 (795)
.++|++.++||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999986 578999999997642 33456789999999999999999999998876543
Q ss_pred -EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 547 -ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 547 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999998853 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 626 MFGGDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
....... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ...
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-----~~~---- 235 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-----RED---- 235 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----HCC----
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-----cCC----
Confidence 7653321 122334579999999999999999999999999999999999999997544222111000 000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...........+.++.+++.+||+.||++||++.+++.+
T Consensus 236 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 236 ---PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp ---CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 000001111234568899999999999999977666654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.75 Aligned_cols=269 Identities=25% Similarity=0.337 Sum_probs=192.5
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..+|++.++||+|+||.||+|..+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 368999999999999999999765 68999999987543 3345778999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|++ ++|.+++... .....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5887777432 22346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc-----cccccc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD-----LWKDDR 701 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~-----~~~~~~ 701 (795)
... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+..... .+....
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 322 12234578999999999876 4689999999999999999999999976543221 11100000 000000
Q ss_pred hhhccC------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 702 AWELID------------PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 702 ~~~~id------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...... ..+........+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 000000 00000111123457889999999999999999999998743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=369.63 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=207.1
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.++||+|+||.||+|.++.++.||||+++... ...+.|.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 46789999999999999999998878889999997643 346789999999999999999999999876 6789999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999998532 2245899999999999999999999998 999999999999999999999999999876543221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchh-hcccccccccccchhhccCcccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLT-LLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
......++..|+|||.+....++.++||||||+++|||++ |+.|+......... .+... ..
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------------~~ 399 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------------YR 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------------CC
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------------CC
Confidence 1223456789999999999999999999999999999999 89888654322211 11000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCC
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPH 756 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 756 (795)
...+...+..+.+++.+||+.+|++|||+.+++++|+......+.
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111223456788999999999999999999999999988554433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.79 Aligned_cols=268 Identities=17% Similarity=0.206 Sum_probs=213.1
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999975 578999999986542 234688999999999 79999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC-----ceeeccccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISDFGMAKM 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DFGla~~ 626 (795)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 346999999999999999999999998 999999999999987776 99999999987
Q ss_pred cCCCccc-----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccccc
Q 040413 627 FGGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDD 700 (795)
Q Consensus 627 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 700 (795)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 123446799999999999999999999999999999999999999976442211 1111000000000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCC
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQ 758 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 758 (795)
.. .......+..+.+++.+|++.+|++||++.+|++.|+.+...+....
T Consensus 241 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 241 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 00 00111235678899999999999999999999999998765544443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=357.56 Aligned_cols=271 Identities=17% Similarity=0.210 Sum_probs=207.1
Q ss_pred hccCCcccccccCC--CceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEG--GFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
...+|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 99999999876 78999999997643 344577889999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999988543 2356999999999999999999999998 999999999999999999999999998654
Q ss_pred CCCcc-----ccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc---
Q 040413 628 GGDEL-----QSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW--- 697 (795)
Q Consensus 628 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~--- 697 (795)
..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 22111 111223478999999999987 67999999999999999999999999764432221110000000
Q ss_pred cc-----cc-------------hhhcc---------CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 KD-----DR-------------AWELI---------DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ~~-----~~-------------~~~~i---------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. .. ....+ ............+..+.+++.+||+.||++|||+.|+++|-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 00 00 00000 00000012223455789999999999999999999999883
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.07 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=194.5
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecc--ee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELE--EK 546 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 546 (795)
..++|++.++||+|+||.||+|.+. +++.||||++.+. .....+++.+|+.+++++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999764 7899999998653 3445677889999999997 999999999997544 68
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 578777743 46899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCc-------------------cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc
Q 040413 627 FGGDE-------------------LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686 (795)
Q Consensus 627 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~ 686 (795)
+.... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 0112234689999999999876 678999999999999999999999997654222
Q ss_pred h-hhcccccccccccchhhccCc------------------cccchh------------hHHHHHHHHHHHHHhcccCCC
Q 040413 687 L-TLLGRAWDLWKDDRAWELIDP------------------ILQNEA------------SYLILNRYINVALLCVQEDAV 735 (795)
Q Consensus 687 ~-~~~~~~~~~~~~~~~~~~id~------------------~l~~~~------------~~~~~~~l~~li~~cl~~dP~ 735 (795)
. ..+...............-.+ ...... ....+..+.+++.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 1 111111111100000000000 000000 002245688999999999999
Q ss_pred CCCCHHHHHHHh
Q 040413 736 DRPTMFEVVSML 747 (795)
Q Consensus 736 ~RPt~~evl~~L 747 (795)
+|||+.|+++|-
T Consensus 319 ~R~t~~e~l~Hp 330 (388)
T 3oz6_A 319 KRISANDALKHP 330 (388)
T ss_dssp GSCCHHHHTTST
T ss_pred cCCCHHHHhCCH
Confidence 999999999983
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.38 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=210.9
Q ss_pred ccCCcccccccCCCceeEEeeecc--------CCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL 543 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 543 (795)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999752 4678999999764 334567899999999999 899999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPK-------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL 610 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll 610 (795)
+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999865421 235899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 040413 611 DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTL 689 (795)
Q Consensus 611 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~ 689 (795)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987665433333334567889999999998899999999999999999999 999886544222111
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
. . .... ....+...+..+.+++.+||+.+|.+|||+.|++++|+.+.
T Consensus 271 ~--~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 271 L--L----KEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp H--H----HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--H----hcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0 0000 00111223456889999999999999999999999998874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.38 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=202.8
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-----cccHHHHHHHHHHHHhcC---CCceeeeeeeeeec
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-----GQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 543 (795)
..++|++.++||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3579999999999999999999864 78999999986432 222456778888888775 99999999999875
Q ss_pred c-----eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 544 E-----EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 544 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
. ..++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 5888887543 2344999999999999999999999999 999999999999999999999
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccccc
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDLW 697 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~ 697 (795)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......... .+.......
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998764332 223457899999999999999999999999999999999999999765432211 111100000
Q ss_pred cccchh-------hccC---ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 698 KDDRAW-------ELID---PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 698 ~~~~~~-------~~id---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...... ..+. +..........+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 000000 0000 00001111234567889999999999999999999998743
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.89 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|+++ +++.||||++.+. .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999875 6899999999764 233456788999999988 899999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999988853 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh-ccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE-LIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~id~ 708 (795)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............. .....+ ....
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~~~~~~i~~~ 234 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT------EDYLFQVILEK 234 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C------HHHHHHHHHHC
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc------HHHHHHHHHcC
Confidence 21 22345689999999999999999999999999999999999999996532111000000 000000 0000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTM------FEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~L 747 (795)
. ...+...+..+.+++.+||+.||.+||++ .|+++|-
T Consensus 235 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 235 Q--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred C--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 0 01122334568899999999999999995 7888874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.99 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=200.5
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcC--CCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQ--HRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV 549 (795)
..+|++.++||+|+||.||+|...+++.||||++... .....+.+.+|+.+|++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999998888999999998654 3445678999999999996 59999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|| +.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788998888543 46889999999999999999999998 99999999999995 58999999999987654
Q ss_pred CccccceeeecccCCcCChhhhcc-----------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQ-----------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~--------- 277 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------- 277 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---------
Confidence 433223345679999999999865 468899999999999999999999996433211110
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...+++......+...+..+.+++.+||+.||++|||+.|+++|..-
T Consensus 278 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 278 ----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp ----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 01111111111111124568899999999999999999999998644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=352.19 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=206.7
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.++||+|+||.||+|+.+ +++.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3478999999999999999999876 5889999999764 234567889999999988 7999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999988853 246899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... .
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~--i~~----~------- 236 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS--IME----H------- 236 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH----C-------
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH--HHh----C-------
Confidence 3221 123456899999999999999999999999999999999999999975442221110 000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 747 (795)
.+ ..+...+.++.+++.+||+.||.+||+ +.|+++|-
T Consensus 237 -~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 237 -NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -CC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -CC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 00 011223457889999999999999994 68898874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.27 Aligned_cols=254 Identities=23% Similarity=0.253 Sum_probs=195.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999876 78999999997643 3346789999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC--ceeeccccccccCCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMAKMFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFGla~~~~~~ 630 (795)
+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999888843 346899999999999999999999998 999999999999987765 999999999753322
Q ss_pred ccccceeeecccCCcCChhhhccCCCCcc-CCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchhhccCc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIK-SDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~ 708 (795)
.......||+.|+|||.+.+..++.+ +|||||||++|+|++|+.||........ ..... .....
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----------~~~~~ 237 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ-----------RILSV 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH-----------HHHTT
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH-----------HHhcC
Confidence 12234579999999999988877655 8999999999999999999975442211 11000 00000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..........+..+.+++.+||+.+|++|||+.|+++|-.
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 0000011123456789999999999999999999999854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=348.74 Aligned_cols=251 Identities=25% Similarity=0.285 Sum_probs=196.9
Q ss_pred ccCCcccccccCCCceeEEeeec----cCCceEEEEEecccC----cccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL----HNGQEVAVKRLSSQS----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++|++.++||+|+||.||+|+. .+++.||||++.+.. ......+.+|+.+|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999976 468999999997642 2345668899999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999888843 346889999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .... .
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~----~----- 236 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID--KILK----C----- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH----T-----
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHh----C-----
Confidence 543221 12234579999999999999899999999999999999999999997544222110 0000 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSMLT 748 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~ 748 (795)
. ...+...+..+.+++.+||+.||++|| ++.|+++|-.
T Consensus 237 ---~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 237 ---K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp ---C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred ---C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 0 001122345688999999999999999 8899998743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.87 Aligned_cols=250 Identities=26% Similarity=0.307 Sum_probs=199.4
Q ss_pred cccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCCC
Q 040413 478 STENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNK 556 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 556 (795)
...++||+|+||.||+|... +++.||+|++........+.+.+|+.+|++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33578999999999999764 78999999998766666788999999999999999999999999999999999999999
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE--cCCCCceeeccccccccCCCcccc
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL--DKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll--~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 998877532 346899999999999999999999998 9999999999999 5678899999999987654322
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
.....||+.|+|||++....++.++|||||||++|||++|+.||............. ...+. .....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~~-----------~~~~~ 311 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL-ACRWD-----------LEDEE 311 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HTCCC-----------SCSGG
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCC-----------CChhh
Confidence 223579999999999999999999999999999999999999997654222110000 00000 00111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....+.++.+++.+||+.||.+|||+.|+++|-
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 122345788999999999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=351.24 Aligned_cols=264 Identities=20% Similarity=0.216 Sum_probs=204.3
Q ss_pred HHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-----CcccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 469 SVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-----SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 469 ~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
++....++|++.++||+|+||.||+|... +++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566789999999999999999999764 6889999998653 34556789999999999999999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTP-------------------------------------KESPLGWETRVRVIEEIAQ 585 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~ 585 (795)
.+..++||||+++++|.+++.... ....+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999988874210 0123467788899999999
Q ss_pred HHHHHHhcCCCcEEeCCCCCCcEEEcCCC--CceeeccccccccCCCcc--ccceeeecccCCcCChhhhcc--CCCCcc
Q 040413 586 GLLYLHQYSRLRVIHRDLKASNILLDKDM--NPKISDFGMAKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQ--GLFSIK 659 (795)
Q Consensus 586 aL~~LH~~~~~~iiH~Dikp~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~k 659 (795)
||+|||+++ |+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 899999999986532111 112334679999999999865 678999
Q ss_pred CCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCC
Q 040413 660 SDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPT 739 (795)
Q Consensus 660 ~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 739 (795)
+||||||+++|||++|+.||................. ..........+..+.+++.+||+.+|.+||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL------------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc------------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999875542221110000000 0001111123456889999999999999999
Q ss_pred HHHHHHHh
Q 040413 740 MFEVVSML 747 (795)
Q Consensus 740 ~~evl~~L 747 (795)
+.|+++|-
T Consensus 325 ~~~~l~hp 332 (345)
T 3hko_A 325 AMRALQHP 332 (345)
T ss_dssp HHHHHHSH
T ss_pred HHHHhcCh
Confidence 99999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.51 Aligned_cols=266 Identities=28% Similarity=0.370 Sum_probs=212.4
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeec------cCCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeee
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGC 539 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 539 (795)
.......++|++.++||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444568999999999999999999963 356889999997643 33456799999999999 79999999999
Q ss_pred eeecc-eeEEEEeecCCCCcceeeccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCC
Q 040413 540 CIELE-EKILIYEYMPNKSLDIFLFDTPK-------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605 (795)
Q Consensus 540 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp 605 (795)
+.+.+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+++ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88755 48999999999999999865432 223889999999999999999999998 99999999
Q ss_pred CcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCC
Q 040413 606 SNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNT 684 (795)
Q Consensus 606 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~ 684 (795)
+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987654433333344568899999999999999999999999999999998 9999865442
Q ss_pred cchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 685 DSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...... .. .... . ...+...+..+.+++.+||+.+|.+|||+.|++++|+.+
T Consensus 257 ~~~~~~-~~----~~~~-----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 257 DEEFCR-RL----KEGT-----R----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SHHHHH-HH----HHTC-----C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHH-Hh----ccCc-----c----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 221110 00 0000 0 001112345688999999999999999999999999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.96 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=201.1
Q ss_pred cCCccc-ccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTE-NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++. ++||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 578874 78999999999999764 7899999999877666788899999999995 79999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC---ceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFGla~~~~ 628 (795)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999988854 246899999999999999999999998 999999999999998776 9999999997654
Q ss_pred CCcc-----ccceeeecccCCcCChhhhcc-----CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcc-cccccc
Q 040413 629 GDEL-----QSKTKRIVGTYGYMSPEYAQQ-----GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLG-RAWDLW 697 (795)
Q Consensus 629 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~-~~~~~~ 697 (795)
.... ........||+.|+|||.+.. ..++.++|||||||++|||++|+.||............ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223469999999999875 56889999999999999999999999765422210000 000000
Q ss_pred cccchhhcc-Cccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 698 KDDRAWELI-DPIL--QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 698 ~~~~~~~~i-d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.....+.+ .... ........+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 246 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 246 -QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp -HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred -HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 00000000 0000 00001123457889999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.43 Aligned_cols=260 Identities=27% Similarity=0.461 Sum_probs=195.5
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|+... .+|||++... .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4789999999999999999998653 5999998754 334567899999999999999999999965 5567899999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999888843 3456999999999999999999999998 9999999999999999999999999998655332
Q ss_pred cccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.........||+.|+|||.+. ...++.++||||||+++|+|++|+.||........... ... ... ..+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~----~~~----~~~ 245 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE-MVG----RGS----LSP 245 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH-HHH----HTS----CCC
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH-Hhc----ccc----cCc
Confidence 223334467999999999986 56788999999999999999999999975443221110 000 000 000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.+ .......+.++.+++.+||+.+|++|||+.|++++|+.+.
T Consensus 246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00 0011223467889999999999999999999999998873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=364.36 Aligned_cols=262 Identities=22% Similarity=0.224 Sum_probs=198.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------c
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------E 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 544 (795)
.++|++.++||+|+||.||+|.+. +++.||||++.+. .....+++.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999765 6899999999764 344567899999999999999999999998654 4
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++||||++++ |.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999876 434331 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccc------
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLW------ 697 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~------ 697 (795)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..+.......
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8765332 23346899999999999999999999999999999999999999976542111 1110000000
Q ss_pred ----------------cccchhhccCccc---cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 ----------------KDDRAWELIDPIL---QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ----------------~~~~~~~~id~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
........+...+ ...........+.+++.+||+.||++|||+.|+++|-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0000000111000 0112223366789999999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=338.34 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=207.3
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..++|++.++||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999765 578999999987766778899999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~~~ 628 (795)
|+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999887743 345899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.................
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 224 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF------------ 224 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 432 22345799999999988654 89999999999999999999999875442221110000000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..........+..+.+++.+||+.||++|||+.|+++|-
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000000012345788999999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=359.22 Aligned_cols=262 Identities=20% Similarity=0.231 Sum_probs=208.8
Q ss_pred HHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 467 LASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 467 ~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
+..+....++|++.++||+|+||.||+|+.+ +++.||||++.+.. ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4444556789999999999999999999875 78999999997532 2234558899999999999999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998532 246899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhc-------cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAW 694 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~ 694 (795)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..... .+....
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 9987654322 1223458999999999987 357899999999999999999999999765422211 110000
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDR---PTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~L 747 (795)
... --+. .....+.++.++|.+||+ +|.+| |+++|+++|-
T Consensus 287 ~~~--------~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 287 EHL--------SLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHC--------CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred cCc--------CCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 000 0010 112234678899999999 99988 6999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=346.38 Aligned_cols=246 Identities=25% Similarity=0.262 Sum_probs=194.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.++||+|+||.||+|++. +++.||||++.... .....++..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999876 78999999986542 23344555666666555 8999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 66787776442 346999999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..++..... ... +.....
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~---------------~~~~~~ 269 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--WQQ---------------LRQGYL 269 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--HHH---------------HTTTCC
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHH---------------HhccCC
Confidence 2 2233569999999998875 789999999999999999999766542110 000 011111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
........+.++.+++.+||+.||++|||+.|+++|-
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 1122223456789999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.58 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=191.6
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..++|++.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3578999999999999999999876 67899999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGla~~~~ 628 (795)
|+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999888843 356899999999999999999999998 999999999999975 8999999999998754
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... .... ....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~i~----~~~~-~~~~- 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR-RIL----NCEY-YFIS- 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH-HHH----TTCC-CCCT-
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH-HHH----hCCC-ccCC-
Confidence 322 22345799999999999999999999999999999999999999865443221110 000 0000 0000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
......+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 273 ----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 273 ----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred ----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 011123456889999999999999999999999743
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.01 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=212.2
Q ss_pred HHhccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
....++|++.+.||+|+||.||+|.+. .++.||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345578999999999999999999754 36789999997543 33456799999999999999999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDT-------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
+..++||||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 9999999999999999988542 12256789999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+............
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 253 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 253 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH----
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH----
Confidence 9999999986654333233334467889999999999999999999999999999999 78887654322211100
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..... ...+...+..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 254 --~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 254 --MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 00000 001122345688999999999999999999999999887
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=353.66 Aligned_cols=273 Identities=23% Similarity=0.243 Sum_probs=210.2
Q ss_pred cccHHHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-----CCceeeee
Q 040413 464 MFSLASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-----HRNLVRLL 537 (795)
Q Consensus 464 ~~~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~ 537 (795)
.+++.......++|++.++||+|+||.||+|++. +++.||||++... ....+.+..|+.+++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3455555556789999999999999999999764 7889999999742 344567888999999997 99999999
Q ss_pred eeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-----
Q 040413 538 GCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK----- 612 (795)
Q Consensus 538 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~----- 612 (795)
+++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 99999888643 2345899999999999999999999998 999999999999975
Q ss_pred --------------------CCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHH
Q 040413 613 --------------------DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLET 672 (795)
Q Consensus 613 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~el 672 (795)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999864432 2345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCcch-hhccccccccc-----------------ccchhhccCcccc------------chhhHHHHHHH
Q 040413 673 LSSKRNTDFSNTDSL-TLLGRAWDLWK-----------------DDRAWELIDPILQ------------NEASYLILNRY 722 (795)
Q Consensus 673 ltg~~p~~~~~~~~~-~~~~~~~~~~~-----------------~~~~~~~id~~l~------------~~~~~~~~~~l 722 (795)
++|+.||........ ..+........ .......+..... ..........+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999975442211 11100000000 0000000000000 00111112567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 723 INVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 723 ~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+++.+||+.||++|||+.|+++|-
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCc
Confidence 8999999999999999999998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.28 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=212.8
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
...+|++.++||+|+||.||+|.+. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999876 5889999999753 3456789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999988653 3456899999999999999999999999 9999999999999999999999999998765433
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|+............. ...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---------------~~~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDY 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---------------TTC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---------------ccC
Confidence 2 22233467889999999999999999999999999999999 888887544322211100 000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999775
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.42 Aligned_cols=267 Identities=26% Similarity=0.404 Sum_probs=201.4
Q ss_pred HHhccCCcccccccCCCceeEEeeecc----CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE 544 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 544 (795)
....++|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345578999999999999999999654 3458999998754 3344677999999999999999999999998765
Q ss_pred e-----eEEEEeecCCCCcceeeccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 545 E-----KILIYEYMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 545 ~-----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
. .++||||+++++|.+++... .....+++..++.++.||++||.|||+++ |+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3 49999999999999888432 23467999999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..|+.............
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL--- 263 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH---
Confidence 9999999987654433233334567889999999999999999999999999999999 888886544322211000
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCC
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 755 (795)
... . ...+...+..+.+++.+||+.+|++|||+.+++++|+.+...+|
T Consensus 264 ---~~~-----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 264 ---HGH-----R----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ---TTC-----C----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---cCC-----C----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 000 0 01112234568899999999999999999999999988755443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.25 Aligned_cols=261 Identities=28% Similarity=0.384 Sum_probs=209.4
Q ss_pred hccCCcccccccCCCceeEEeeecc-CC-----ceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NG-----QEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
..++|++.+.||+|+||.||+|... .+ +.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3578999999999999999999764 23 479999997653 34567799999999999 8999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-----------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD 613 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~ 613 (795)
..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999998885321 1346899999999999999999999998 9999999999999999
Q ss_pred CCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccc
Q 040413 614 MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGR 692 (795)
Q Consensus 614 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~ 692 (795)
+.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........... .
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-L 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH-H
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH-H
Confidence 9999999999986643332223334567889999999999999999999999999999998 8888865432221100 0
Q ss_pred ccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 693 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+........+...+..+.+++.+||+.+|.+|||+.|++++|+..
T Consensus 280 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 280 -------------VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 000000011112245688999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.06 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=210.0
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999998888899999997643 34578999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999988543 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.......+++.|+|||.+....++.++||||||+++|+|++ |+.|+.......... .... . .. .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~i~~----~-----~~----~ 224 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE--DIST----G-----FR----L 224 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHT----T-----CC----C
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH--HHhc----C-----Cc----C
Confidence 11223456788999999998899999999999999999999 888886543221110 0000 0 00 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01112345688999999999999999999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=359.78 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=207.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|.+.+.||+|+||.||+|++. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999875 79999999997542 23467899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999884 3456999999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ....+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||........... .. +.
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~--i~------------~~ 231 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK--IC------------DG 231 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH--HH------------TT
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH--Hh------------cC
Confidence 322 234579999999999988765 6899999999999999999999975543222110 00 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. ..+...+.++.+++.+||+.||++|||+.|+++|-
T Consensus 232 ~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 232 IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 00 01112235678999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=362.73 Aligned_cols=249 Identities=29% Similarity=0.419 Sum_probs=205.6
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc-eeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE-EKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 552 (795)
.++|++.++||+|+||.||+|..+ ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 468899999999999999999875 6799999997643 4578999999999999999999999987765 78999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999998643 2345789999999999999999999998 999999999999999999999999999854322
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchh-hcccccccccccchhhccCccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLT-LLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......... .+... .
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~----------------~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------Y 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT----------------C
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------------C
Confidence 122357889999999999999999999999999999998 99998754422211 11000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111223456788999999999999999999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.99 Aligned_cols=257 Identities=30% Similarity=0.421 Sum_probs=208.5
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46899999999999999999998888899999997543 35678999999999999999999999886 45689999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999988432 1226899999999999999999999998 999999999999999999999999999876543321
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......... .... . ...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--~~~~----~-----~~~---- 229 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ--NLER----G-----YRM---- 229 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--HHHT----T-----CCC----
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH--HHhc----c-----cCC----
Confidence 1223456789999999998899999999999999999999 888886543222110 0000 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
..+...+..+.+++.+|++.+|++|||+.++++.|+....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1112234578899999999999999999999999988643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.73 Aligned_cols=265 Identities=24% Similarity=0.293 Sum_probs=201.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.++||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999875 689999999865432 335678899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999887743 356899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccccccc--------ccccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDL--------WKDDR 701 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~--------~~~~~ 701 (795)
. ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ........ +....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 2234578999999999876 67899999999999999999999999765432211 11000000 00000
Q ss_pred hh---hccCccccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 AW---ELIDPILQN---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 ~~---~~id~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. ..-++.... ......+..+.+++.+||+.||++|||+.|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 00 000000000 00112455688999999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.43 Aligned_cols=267 Identities=21% Similarity=0.270 Sum_probs=197.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc-cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 7899999999754322 122456899999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++ +|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 985 777776432 346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchhh------
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAWE------ 704 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~------ 704 (795)
.......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+..............
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12233578999999999876 6789999999999999999999999976553221 11111000000000000
Q ss_pred ---ccCcccc----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 705 ---LIDPILQ----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 705 ---~id~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...+... .......+..+.+++.+||+.||++|||+.|+++|-.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 0000000 01112234568899999999999999999999997544
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.14 Aligned_cols=255 Identities=27% Similarity=0.494 Sum_probs=204.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc-------cHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-------GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999764 7899999998654321 1267999999999999999999999987655
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC-----ceeec
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN-----PKISD 620 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~D 620 (795)
++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ .+|+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999887754 3457999999999999999999999875 34999999999999988776 99999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhh--ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYA--QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|+|++|+.||.................
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 245 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-- 245 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--
Confidence 999985432 23346799999999998 445678999999999999999999999976553332211111000
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+ ..+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 246 ------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 ------GLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------CCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------CCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0011 11223345788999999999999999999999999753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=347.23 Aligned_cols=263 Identities=23% Similarity=0.243 Sum_probs=206.0
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee----cceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 547 (795)
..++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999976 5789999999977666677889999999999999999999999873 44779
Q ss_pred EEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+||||+++++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999888542 23467999999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCccc-------cceeeecccCCcCChhhhccCC---CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccc
Q 040413 627 FGGDELQ-------SKTKRIVGTYGYMSPEYAQQGL---FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 627 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 696 (795)
....... .......||+.|+|||.+.... ++.++||||||+++|+|++|+.||...............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-- 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-- 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--
Confidence 5321110 0112245799999999987543 689999999999999999999998531100000000000
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
...........+..+.+++.+||+.||.+|||+.|++++|+.+.
T Consensus 262 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 262 -----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00000111223456889999999999999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=365.04 Aligned_cols=250 Identities=23% Similarity=0.254 Sum_probs=196.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.++||+|+||.||+|... +++.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999764 7899999999753 334456788999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999888843 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+............
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------- 365 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------- 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 222 22334689999999999999999999999999999999999999997544322211100000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
...+...+..+.+++.+||+.||.+|| ++.|+++|-
T Consensus 366 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 366 ---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 001112345688999999999999999 999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.47 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=200.5
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCce----EEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQE----VAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|++.++||+|+||.||+|.+. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 368999999999999999999754 4554 577777543 4456788999999999999999999999998754 78
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+|+|++++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988543 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..............
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------------- 234 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------- 234 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 54433333334467889999999999999999999999999999999 9999876543322111100
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
......+...+..+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 235 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 235 --GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0001111223456889999999999999999999999998874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.46 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=208.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc------ccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG------QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999865 689999999875422 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC----Cceeeccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFG 622 (795)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999998853 356899999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........... ....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--i~~~------ 233 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--ITSV------ 233 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--HHTT------
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHhc------
Confidence 998765432 22345799999999999999999999999999999999999999865442221100 0000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
............+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 234 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 234 ----SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp ----CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred ----ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000001111223456889999999999999999999999743
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.11 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=186.5
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346899999999999999999976 478999999996532 2345789999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999998853 2356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+............ ... +.
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~-------~~ 229 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-----VLA-------DY 229 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C-----CSS-------CC
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH-----hhc-------cc
Confidence 3221 122357899999999999889999999999999999999999998754422211000 000 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+...+.++.+++.+||+.||++|||+.++++|-
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 230 ----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 01112345678999999999999999999998864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=341.02 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=208.7
Q ss_pred cCCcccc-cccCCCceeEEeeecc---CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTEN-KLGEGGFGPVYKGRLH---NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++|.+.+ .||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5666666 9999999999999753 5788999999764 334567899999999999999999999999 56678999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999998853 3456999999999999999999999998 99999999999999999999999999987653
Q ss_pred Ccc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 630 DEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||............. ...
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~------~~~------ 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGK------ 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH------TTC------
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh------cCC------
Confidence 322 112223456889999999998899999999999999999998 999987554322211100 000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
....+...+..+.+++.+||+.+|++||++.+++++|+.+..+
T Consensus 231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111223456788999999999999999999999999887443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.36 Aligned_cols=279 Identities=17% Similarity=0.202 Sum_probs=208.1
Q ss_pred hccCCcccccccCCCceeEEeeeccC------CceEEEEEecccCccc-----------HHHHHHHHHHHHhcCCCceee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQSGQG-----------LEEFKNEIKLIAKLQHRNLVR 535 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 535 (795)
..++|++.++||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999997754 4789999987643211 122344556677778999999
Q ss_pred eeeeeeec----ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 536 LLGCCIEL----EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 536 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
+++++.+. ...++||||+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 4579999999 9999998854 2356999999999999999999999998 99999999999999
Q ss_pred --CCCCceeeccccccccCCCccc-----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCC
Q 040413 612 --KDMNPKISDFGMAKMFGGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNT 684 (795)
Q Consensus 612 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~ 684 (795)
.++.+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432211 111334699999999999999999999999999999999999999974332
Q ss_pred cchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCCCCCc
Q 040413 685 DSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAF 762 (795)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p~~ 762 (795)
...... .. .........+++++.+. ....+.++.+++..|++.+|++||++.+|++.|+........+....+
T Consensus 267 ~~~~~~-~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 267 DPKYVR-DS-KIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp CHHHHH-HH-HHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CHHHHH-HH-HHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 211110 00 00001111122222111 012245788999999999999999999999999887555444443333
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=341.54 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=195.8
Q ss_pred ccCCcccccccCCCceeEEeeeccC----CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.++||+|+||.||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4689999999999999999997642 457999998764 3345677999999999999999999999984 567899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999988543 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... ......+|+.|+|||.+....++.++||||||+++|||++ |..||............. ....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------~~~~----- 235 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER----- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC-----
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------cCCC-----
Confidence 43221 1223456789999999999999999999999999999996 888887544322111000 0000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122345688999999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=363.98 Aligned_cols=195 Identities=24% Similarity=0.370 Sum_probs=154.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----ce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999765 7899999999764 334567899999999999999999999998543 56
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+. ++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999974 67877774 3356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcc-------------------------ccceeeecccCCcCChhhh-ccCCCCccCCeeehhHHHHHHHhC
Q 040413 626 MFGGDEL-------------------------QSKTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSS 675 (795)
Q Consensus 626 ~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwslG~ll~elltg 675 (795)
....... .......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7642211 0123346789999999976 556799999999999999999993
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.43 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=205.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.++|++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999765 6899999998654 3344577899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC---ceeecccccccc
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFGMAKMF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFGla~~~ 627 (795)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999877743 346899999999999999999999998 999999999999986655 999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. .... ...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~------~~~ 228 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA-GAYD------YPS 228 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCC------CCT
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh-cccc------CCc
Confidence 53322 2335799999999999999999999999999999999999999865442221111000 0000 000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+ .....+..+.+++.+||+.||++|||+.|+++|-
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 229 P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 0 0112345678999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.99 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=204.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CC-------ceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NG-------QEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
.++|++.++||+|+||.||+|... ++ +.||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 368999999999999999999765 33 4799999987777778899999999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC--------ce
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--------PK 617 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~--------~k 617 (795)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998543 234899999999999999999999998 999999999999998887 99
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+........... ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~-- 232 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYE-- 232 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHH--
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-Hhh--
Confidence 9999999764322 23468899999999987 7789999999999999999996655432221111100 000
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.... + +...+.++.+++.+||+.||++|||+.|++++|+.+.
T Consensus 233 -~~~~----~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 233 -DRHQ----L--------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp -TTCC----C--------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred -ccCC----C--------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0000 0 0011235778999999999999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.71 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=204.0
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
+.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3468999999999999999999765 6789999998653 22345779999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999998887432 46899999999999999999999998 9999999999999999999999999986543
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||............. . ..
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~----------~~- 223 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--R----------VE- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--H----------TC-
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--h----------CC-
Confidence 222 234578999999999999999999999999999999999999987544222111000 0 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...+...+..+.+++.+||+.+|++|||+.|+++|-.-
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 01111234567899999999999999999999998543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.56 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=201.8
Q ss_pred HHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc--CCCceeeeeeeeeec----c
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL--QHRNLVRLLGCCIEL----E 544 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 544 (795)
....++|++.++||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++.+. .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999875 899999998643 334556666666655 899999999999887 6
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCcEEeCCCCCCcEEEcCCCCc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY--------SRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence 78999999999999999843 3689999999999999999999988 6 9999999999999999999
Q ss_pred eeeccccccccCCCccc--cceeeecccCCcCChhhhccCCCCcc------CCeeehhHHHHHHHhCCC----------C
Q 040413 617 KISDFGMAKMFGGDELQ--SKTKRIVGTYGYMSPEYAQQGLFSIK------SDVFSFGVLLLETLSSKR----------N 678 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k------~DvwslG~ll~elltg~~----------p 678 (795)
||+|||+++.+...... .......||+.|+|||.+.+...+.+ +|||||||++|||++|.. |
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999766433221 11224579999999999987766665 999999999999999944 4
Q ss_pred CCCCCCcchhhcccccccccccchhhccCcccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 679 TDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ-NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
+........... ..... .......+... .......+.++.+++.+||+.||++|||+.|++++|+.+..+
T Consensus 262 ~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 262 YHDLVPSDPSYE-DMREI----VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTTSCSSCCHH-HHHHH----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HhhhcCCCCchh-hhHHH----HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 432211110000 00000 00001111111 112336678899999999999999999999999999887443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.31 Aligned_cols=266 Identities=16% Similarity=0.182 Sum_probs=200.1
Q ss_pred ccCCcccccccCCCceeEEeeecc----CCceEEEEEecccCcc-----------cHHHHHHHHHHHHhcCCCceeeeee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQSGQ-----------GLEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
.++|++.++||+|+||.||+|... .++.+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999865 5788999998764321 1234667888999999999999999
Q ss_pred eeee----cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC
Q 040413 539 CCIE----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM 614 (795)
Q Consensus 539 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~ 614 (795)
++.+ ....++||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 77889999999 99999998543 37999999999999999999999998 99999999999999887
Q ss_pred --CceeeccccccccCCCcc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch
Q 040413 615 --NPKISDFGMAKMFGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687 (795)
Q Consensus 615 --~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~ 687 (795)
.+||+|||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643211 1112345799999999999999999999999999999999999999954222111
Q ss_pred hhcccccccccccchhhccCccccch-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 688 TLLGRAWDLWKDDRAWELIDPILQNE-ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
....... .....+.+.+... .....+.++.+++.+||+.+|++||++.+|++.|+....
T Consensus 269 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKT------NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHH------HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHH------hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1110000 0000011100000 000234578999999999999999999999999988743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=336.89 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=205.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeec--ceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL--EEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 550 (795)
++|++.++||+|+||.||+|+++ ++.+|||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 68999999999999999999885 7899999997643 34467799999999999999999999999887 7789999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++... ....+++..+..++.||++||+|||+++ .+|+||||||+||+++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999653 2346899999999999999999999865 3599999999999999999999999998765322
Q ss_pred ccccceeeecccCCcCChhhhccCCCCc---cCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSI---KSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||............ .. ....
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~-----~~~~ 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-----AL-----EGLR 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-----HH-----SCCC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-----Hh-----cCCC
Confidence 1246899999999998765544 799999999999999999998754422211100 00 0001
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
+ ..+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 230 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 112223456889999999999999999999999998763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.26 Aligned_cols=253 Identities=22% Similarity=0.227 Sum_probs=182.7
Q ss_pred cccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEeecCCCC
Q 040413 480 ENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
.++||+|+||.||+|.++ +++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999775 6899999999643 4567889999999997 9999999999999999999999999999
Q ss_pred cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---CceeeccccccccCCCcccc
Q 040413 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---NPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DFGla~~~~~~~~~~ 634 (795)
|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 9998854 356999999999999999999999998 99999999999998765 79999999998654332 1
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ...........+. ......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD------FSFEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC------CCCCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC------CCCCcc
Confidence 223457899999999999999999999999999999999999999754321100 0000000000000 011111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.....+.++.+++.+||+.||++|||+.|+++|-.-
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 122345678999999999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.98 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=203.9
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
.+|.....||+|+||.||+|.+ .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556899999999999976 468899999998776666788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccccccccCCCcc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~ 632 (795)
++++|.+++........+++..+..++.||++||.|||+++ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999876544556789999999999999999999998 999999999999987 8999999999998764322
Q ss_pred ccceeeecccCCcCChhhhccCC--CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.......||+.|+|||.+.... ++.++||||||+++|+|++|+.||.............. .....+.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~~~~- 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG---------MFKVHPE- 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH---------HHCCCCC-
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc---------ccccccc-
Confidence 1223457899999999987643 88999999999999999999999864332211111000 0000111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+.++.+++.+||+.||++||++.|++++-.-
T Consensus 247 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 247 ---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp ---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 122234568899999999999999999999987433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=352.61 Aligned_cols=266 Identities=24% Similarity=0.264 Sum_probs=201.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHH-HHhcCCCceeeeeeeeeecceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKL-IAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.++|++.++||+|+||.||+|+.+ +++.||||++.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999875 68899999997643 2334566777776 467899999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999888843 346889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . .
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~----~-------- 254 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--N----K-------- 254 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--H----S--------
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--h----c--------
Confidence 221 22345689999999999999999999999999999999999999997544222111000 0 0
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHhh--c------ccCCCCCCCCCCcc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTM----FEVVSMLT--N------ETVNLPHPQQPAFS 763 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~L~--~------~~~~~~~~~~p~~~ 763 (795)
.+ ..+...+..+.+++.+||+.||.+||++ .|+++|-. + ....++.|..|...
T Consensus 255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~ 319 (373)
T 2r5t_A 255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVS 319 (373)
T ss_dssp CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCC
T ss_pred cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCC
Confidence 00 0111234567899999999999999997 45665531 1 11345556666543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.39 Aligned_cols=271 Identities=20% Similarity=0.255 Sum_probs=212.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--eeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 549 (795)
.++|.+.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367999999999999999999775 58999999997643 345678899999999999999999999998765 67999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE----cCCCCceeecccccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKISDFGMAK 625 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DFGla~ 625 (795)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999865544455999999999999999999999998 9999999999999 777889999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhcc--------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCc--chhhcccccc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQ--------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTD--SLTLLGRAWD 695 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~--~~~~~~~~~~ 695 (795)
...... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... ....+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 765432 2234579999999998865 56788999999999999999999998643311 1111110000
Q ss_pred cccccc---hhh------ccCc--cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWKDDR---AWE------LIDP--ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~~~~---~~~------~id~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...... ... .+.. .............+.+++.+||+.||++||++.|++++++.+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 000000 000 0000 111234466778899999999999999999999999998775
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=371.68 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=211.3
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
..++|++.++||+|+||.||+|.++.++.||||+++... ...+.|.+|+++|++++||||+++++++.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346789999999999999999998888889999997643 346789999999999999999999999876 678999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999998532 2245889999999999999999999998 99999999999999999999999999987653322
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcch-hhcccccccccccchhhccCccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSL-TLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......++..|+|||.+....++.++|||||||++|||++ |+.|+........ ..+... .
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~----------------~ 481 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------------Y 481 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT----------------C
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------------C
Confidence 1 1222456788999999999999999999999999999999 8888865432221 111000 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
....+...+..+.+++.+||+.+|++|||+.+|+++|+......
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 00112234567889999999999999999999999999875443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.21 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=203.4
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCc--------ccHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSG--------QGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
..++|++.++||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999975 4789999999976421 1344678899999999999999999999999
Q ss_pred ceeEEEEeecCCC-CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 544 EEKILIYEYMPNK-SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 544 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
+..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 88888743 346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+++....... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------- 238 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------- 238 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------
Confidence 9987654322 234679999999999988776 8899999999999999999999853211000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.... .+...+.++.+++.+||+.||++|||+.|++++-.
T Consensus 239 --~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 239 --AAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp --TCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred --hccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0000 01113456889999999999999999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=348.81 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=194.9
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeee--------
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCI-------- 541 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 541 (795)
....+|++.++||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34468999999999999999999864 78999999997766666788999999999996 999999999984
Q ss_pred ecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecc
Q 040413 542 ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 542 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 621 (795)
.....++||||+. |+|.+++........+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3445789999996 688787755444567999999999999999999999875 34999999999999999999999999
Q ss_pred ccccccCCCccc----------cceeeecccCCcCChhhh---ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh
Q 040413 622 GMAKMFGGDELQ----------SKTKRIVGTYGYMSPEYA---QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT 688 (795)
Q Consensus 622 Gla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~---~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~ 688 (795)
|+++........ .......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 999876532211 111234689999999998 566789999999999999999999999864332111
Q ss_pred hcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCCCC
Q 040413 689 LLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQP 760 (795)
Q Consensus 689 ~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p 760 (795)
...... ..........+.+++.+||+.+|++|||+.|++++|+.+....+.++.+
T Consensus 262 -~~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 262 -VNGKYS----------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp -----CC----------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred -hcCccc----------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 000000 0001111234678999999999999999999999998875544444433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.20 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|.+.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999765 68899999987643 3457889999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeecccccccc
Q 040413 552 YMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMF 627 (795)
Q Consensus 552 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~~ 627 (795)
|+++++|.+++... .....+++..+..++.||++||+|||+++ |+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999998887542 23457999999999999999999999998 9999999999999 45688999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||.............. ..
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~-------- 241 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY----KE-------- 241 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CC--------
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc----CC--------
Confidence 5332 223457899999999875 5689999999999999999999999975542222111000 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.... .....+..+.+++.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 280 (285)
T 3is5_A 242 PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00000 0001235678999999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=358.16 Aligned_cols=199 Identities=24% Similarity=0.380 Sum_probs=166.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----ce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 545 (795)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+++.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999765 6889999999764 334567899999999999999999999999876 57
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 588888743 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------cceeeecccCCcCChhhh-ccCCCCccCCeeehhHHHHHHHhCCCCC
Q 040413 626 MFGGDELQ--------------------SKTKRIVGTYGYMSPEYA-QQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 626 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DvwslG~ll~elltg~~p~ 679 (795)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76533211 123456899999999986 5567999999999999999999865444
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.71 Aligned_cols=266 Identities=23% Similarity=0.365 Sum_probs=201.0
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.+|++.++||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5799999999999999999976 47899999999753 3345677999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||+++++|.+++... .....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999888542 23456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||............... .... .+.
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~----~~~ 258 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----QCDY----PPL 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH----TTCS----CCC
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh----cccC----CCC
Confidence 32 1223357899999999999999999999999999999999999998654322211111100 0000 000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCC
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHP 757 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 757 (795)
.....+.++.+++.+||+.||++|||+.+++++|+.+.+....|
T Consensus 259 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 259 ----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp ----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 01123456889999999999999999999999998875444333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.67 Aligned_cols=261 Identities=27% Similarity=0.345 Sum_probs=205.9
Q ss_pred cCCcccccccCCCceeEEeeecc-C---CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee-EE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-N---GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK-IL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 548 (795)
..|++.++||+|+||.||+|.+. + +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667789999999999999753 2 3379999997643 34567899999999999999999999999877665 99
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+.+++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999998854 3456899999999999999999999998 9999999999999999999999999998664
Q ss_pred CCcc--ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCC-CCCCcchhhcccccccccccchhhc
Q 040413 629 GDEL--QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTD-FSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 629 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|+.|+. ............. ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------~~---- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------GR---- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT------TC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc------CC----
Confidence 4322 122234567899999999999999999999999999999999665543 2222111110000 00
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCC
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 755 (795)
....+...+..+.+++.+||+.+|.+|||+.+++++|+.+...+.
T Consensus 246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 001111234568899999999999999999999999988754443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.09 Aligned_cols=253 Identities=14% Similarity=0.141 Sum_probs=205.5
Q ss_pred HhccCCcccccccCCCceeEEeee------ccCCceEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeeeee
Q 040413 472 AATANFSTENKLGEGGFGPVYKGR------LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIE 542 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 542 (795)
...++|.+.++||+|+||.||+|. ...++.||||++... ...++.+|++++.+++ |+||+++++++.+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 346889999999754 4567888888888886 9999999999999
Q ss_pred cceeEEEEeecCCCCcceeeccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC--------
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDT--PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-------- 612 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-------- 612 (795)
.+..++||||+++|+|.+++... .....+++..++.++.||++||+|||+++ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999998642 23467999999999999999999999998 999999999999998
Q ss_pred ---CCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh
Q 040413 613 ---DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689 (795)
Q Consensus 613 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~ 689 (795)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999997654322223344568999999999999999999999999999999999999997532211110
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhhcc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDR-PTMFEVVSMLTNE 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~ 750 (795)
+...+... .....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 295 ----------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 ----------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ----------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ----------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111110 123456789999999999998 6888888888775
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=340.40 Aligned_cols=265 Identities=23% Similarity=0.275 Sum_probs=209.7
Q ss_pred cHHHHHHhccCCccc-ccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcC-CCceeeeeeee
Q 040413 466 SLASVSAATANFSTE-NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCC 540 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 540 (795)
.+.......++|.+. ++||+|+||.||+|... +++.||||++... .......+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455666788887 89999999999999765 6899999998764 3345788999999999995 69999999999
Q ss_pred eecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCce
Q 040413 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPK 617 (795)
Q Consensus 541 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~k 617 (795)
.+.+..++||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999888442 3457999999999999999999999998 999999999999987 78999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
|+|||+++...... ......||+.|+|||.+....++.++||||||+++|+|++|+.||...............
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--- 248 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--- 248 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc---
Confidence 99999998765332 223457999999999999999999999999999999999999999765432221110000
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
............+..+.+++.+||+.||++|||+.|+++|-.-
T Consensus 249 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 249 ---------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp ---------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred ---------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 0000011112234568899999999999999999999998544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=348.33 Aligned_cols=268 Identities=23% Similarity=0.291 Sum_probs=197.0
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999754 78999999997543 2335678899999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-----CCCCceeecccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-----KDMNPKISDFGM 623 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-----~~~~~kl~DFGl 623 (795)
||||+++ +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 88887743 345899999999999999999999998 99999999999994 455699999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccccc-
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDD- 700 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~- 700 (795)
++...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..+..........
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98764332 122335789999999999774 589999999999999999999999976542211 1110000000000
Q ss_pred ------------chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 701 ------------RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 701 ------------~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.........+..........++.+++.+||+.||++|||+.|+++|-.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 000001111111112224467889999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.66 Aligned_cols=254 Identities=21% Similarity=0.239 Sum_probs=201.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.+.||+|+||.||+|.++ +++.||||++.+.... ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999765 6899999999765432 45788888888 79999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC----CCceeecccccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD----MNPKISDFGMAKMF 627 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DFGla~~~ 627 (795)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+..+ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999888853 356999999999999999999999998 9999999999998543 34999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
..... .....+||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+.... ..+.
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~------ 239 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---GSGK------ 239 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---HHCC------
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---ccCC------
Confidence 43321 223467899999999998888999999999999999999999999754322211110000 0000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+........+..+.+++.+||+.||++||++.|+++|-.
T Consensus 240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 00001111223456889999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.37 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=197.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
..+|++.++||+|+||.||+|.+. +++.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999764 7899999999653 3334577899999999999999999999988653
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899888743 46899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccccc----
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWK---- 698 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~---- 698 (795)
+..... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||...+... ...+........
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 875432 234578999999999877 689999999999999999999999997654221 111110000000
Q ss_pred ----ccchhhc---c----CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 699 ----DDRAWEL---I----DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 699 ----~~~~~~~---i----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....... + ...+ ..........+.+++.+||+.||++|||+.|+++|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0000000 0 0000 011122345688999999999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=363.55 Aligned_cols=255 Identities=26% Similarity=0.345 Sum_probs=209.8
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.++||+|+||.||+|+++ +++.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999775 7899999999753 23456778999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999888543 2345999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~id 707 (795)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.... . . ..
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---~-----~-~~ 405 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---K-----E-VP 405 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---H-----H-CC
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---h-----c-cc
Confidence 432 2234589999999999999899999999999999999999999997644211 11010000 0 0 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 747 (795)
...+...+.++.+++.+||+.||.+|| ++.|+++|-
T Consensus 406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 011122345788999999999999999 789999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.22 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=205.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCce--EEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQE--VAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|++. +++. +|||++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999765 5554 499988753 334566799999999999 899999999999999999999
Q ss_pred EeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 550 YEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
|||+++++|.+++.... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2357999999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........... .
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~--~-- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--L-- 254 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--G--
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH--h--
Confidence 99999999743211 11223457889999999998899999999999999999998 9999865442221110 0
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
... .....+...+..+.+++.+||+.+|++|||+.|++++|+.+..+
T Consensus 255 --~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 255 --PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp --GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 00011122345688999999999999999999999999886443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.76 Aligned_cols=260 Identities=20% Similarity=0.225 Sum_probs=200.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999865 78899999997643 23357799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999998853 246899999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||............. .. ...
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~---~~~------- 253 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN--QA---IPR------- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH--SC---CCC-------
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc--cC---CCC-------
Confidence 322 12234578999999999999999999999999999999999999987543221111000 00 000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhcccCC
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRP-TMFEVVSMLTNETVN 753 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 753 (795)
....+...+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0011222345688999999999999999 999999999887443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.33 Aligned_cols=260 Identities=29% Similarity=0.409 Sum_probs=205.0
Q ss_pred ccCCcccccccCCCceeEEeeec------cCCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999974 25778999999754 344567799999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceee
Q 040413 547 ILIYEYMPNKSLDIFLFDTP----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKIS 619 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~ 619 (795)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999986542 2245899999999999999999999998 999999999999984 4569999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhccccccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+........... . .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~----~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF--V----T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--H----H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH--H----h
Confidence 9999986543333233334567899999999999999999999999999999998 8888865432221110 0 0
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
... ....+...+..+.+++.+||+.+|.+||++.+++++|+...
T Consensus 260 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 000 00111223456889999999999999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.46 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=204.4
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee---------
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--------- 542 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 542 (795)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999875 78999999997543 357899999999999999999998864
Q ss_pred -------cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC
Q 040413 543 -------LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 543 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~ 615 (795)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 45579999999999999998543 2356899999999999999999999998 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc
Q 040413 616 PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 616 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 695 (795)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ... .
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~----~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KFF----T 229 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HHH----H
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HHH----H
Confidence 99999999987654321 223568999999999999999999999999999999999987753110 000 0
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
.+.+..+ +...+..+.+++.+||+.||++|||+.|++++|+.....
T Consensus 230 --------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 --------DLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --------HHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --------Hhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0001111 111234578999999999999999999999999988443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.37 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=202.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 368999999999999999999775 68999999986543 233566889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887632 346899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccccc--------------
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAW-------------- 694 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~-------------- 694 (795)
.. ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.......... .....
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 21 22345789999999998775 78999999999999999999999987654222110 00000
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+......+..............+..+.+++.+||+.||++|||+.|+++|-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000000000000111123456789999999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=347.86 Aligned_cols=272 Identities=26% Similarity=0.395 Sum_probs=209.3
Q ss_pred ccCCcccccccCCCceeEEeeec-----cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc--ee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-----HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE--EK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 546 (795)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36799999999999999999973 368899999998776677788999999999999999999999987654 67
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc-cccccchhh
Q 040413 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD-LWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 704 (795)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+.......... ........+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 11223456778999999998889999999999999999999998865321110000000000 000000001
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+........+...+.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111112223456788999999999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.77 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=203.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999876 68999999987542 124788999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC----Cceeecccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFGM 623 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFGl 623 (795)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999998843 346899999999999999999999998 99999999999998877 899999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+....... ......+++.|+|||.+....++.++||||||+++|+|++|+.|+..............
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------- 225 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA---------- 225 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----------
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh----------
Confidence 98764332 22345789999999999999999999999999999999999999875442211100000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.............+..+.+++.+||+.||++||++.|+++|-
T Consensus 226 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 226 --VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp --TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred --cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 000001111122345688999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=351.81 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=194.0
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--------cccHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE 542 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 542 (795)
...++|.+.++||+|+||.||+|.+. +++.||||++.+.. ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999765 68999999987532 122335889999999999999999999975
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC---CCceee
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKIS 619 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~ 619 (795)
.+..++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 455799999999999988874 3457999999999999999999999998 9999999999999754 459999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........... ..
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~-~i--- 357 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-QI--- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH-HH---
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH-HH---
Confidence 999998765332 233467999999999885 36788999999999999999999999975432211000 00
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..... ..........+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 358 -~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 358 -TSGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp -HTTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -hcCCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 00000 0000111123557889999999999999999999999743
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=345.02 Aligned_cols=271 Identities=24% Similarity=0.282 Sum_probs=199.9
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-----GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
...++|++.++||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999875 6899999998753221 13468899999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+++ +|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 77777643 3346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccccccc---
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDD--- 700 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~--- 700 (795)
...... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|.+|+........ ..+..........
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 764332 12234578999999999866 4589999999999999999999998875542211 1110000000000
Q ss_pred ---chhhccCcccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 701 ---RAWELIDPILQ-----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 701 ---~~~~~id~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+.+..... .......+..+.+++.+||+.||++|||+.|+++|..-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 00000000000 001122346789999999999999999999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.46 Aligned_cols=261 Identities=27% Similarity=0.368 Sum_probs=203.9
Q ss_pred ccCCcccccccCCCceeEEeeeccC----CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeee-ecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI-ELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 547 (795)
..+|++.++||+|+||.||+|.+.+ ...+|+|++... .....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999997542 235899998764 3345678999999999999999999999865 456789
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999854 3456889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhC-CCCCCCCCCcchhhcccccccccccchhh
Q 040413 628 GGDELQ--SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSS-KRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 628 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+|+.............. ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~------~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------GR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT------TC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc------CC---
Confidence 543321 122334678899999999999999999999999999999995 455544332221111000 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
. ...+...+..+.+++.+||+.+|++|||+.|+++.|+.+...+
T Consensus 250 --~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 --R----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --C----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 0001112356889999999999999999999999998875443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=333.24 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=205.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999765 6789999998653 233457899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999998888532 46899999999999999999999998 99999999999999999999999999976543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||............. . .+.
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~-------~~~- 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-----N-------VDL- 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----T-------TCC-
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh-----c-------ccc-
Confidence 22 234578999999999999999999999999999999999999987544222110000 0 000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+...+..+.+++.+||+.+|.+||++.|+++|-
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 01122345678999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=348.47 Aligned_cols=256 Identities=18% Similarity=0.198 Sum_probs=193.8
Q ss_pred ccCCccc-ccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHh-cCCCceeeeeeeeee----ccee
Q 040413 474 TANFSTE-NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAK-LQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~y~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 546 (795)
.++|.+. ++||+|+||.||+|.+. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 68999999999999765 6899999998632 467889988755 489999999999876 6678
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeecccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGl 623 (795)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998543 2346999999999999999999999998 999999999999997 78999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... .........
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i~~~~-- 283 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQ-- 283 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHHHHTC--
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHHHcCc--
Confidence 98654322 22346789999999999999999999999999999999999999975442211000 000000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
. ..........+.++.+++.+||+.||++|||+.|+++|..-
T Consensus 284 --~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 284 --Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp --C--CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred --c--cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0 00000011234568899999999999999999999998644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.83 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=208.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.+.|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 367999999999999999999764 78999999997543 4557889999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999883 356899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+............ .....+.+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~~~~- 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-----------PKNNPPTL- 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----------HHSCCCCC-
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-----------hcCCCCCC-
Confidence 2 223457899999999999999999999999999999999999998654322111100 00001111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
....+..+.+++.+||+.+|++|||+.|++++..-
T Consensus 240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 11223568899999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.44 Aligned_cols=256 Identities=27% Similarity=0.372 Sum_probs=203.2
Q ss_pred hccCCcccccccCCCceeEEeeeccC----CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999997532 346999999765 33456789999999999999999999999765 4568
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999988542 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.............. ..
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~------~~----- 231 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK------GD----- 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH------TC-----
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc------CC-----
Confidence 543221 1223457889999999998999999999999999999998 9999865443222111000 00
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. ...+...+..+.+++.+||+.+|++||++.|++++|+.+
T Consensus 232 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 R----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 001112345688999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=333.05 Aligned_cols=266 Identities=20% Similarity=0.246 Sum_probs=207.2
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeee-eecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC-IELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~E 551 (795)
.++|++.+.||+|+||.||+|++ .+++.||||++..... .+++.+|+.+++.++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999986 5789999999875432 34689999999999988876666555 56677899999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~~~ 628 (795)
|+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999988532 346999999999999999999999998 9999999999999 488999999999998765
Q ss_pred CCccc-----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccch
Q 040413 629 GDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRA 702 (795)
Q Consensus 629 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 702 (795)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc----ccc
Confidence 43221 112346799999999999999999999999999999999999999975432111 11100000 000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCC
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPH 756 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 756 (795)
. .+ ........+.++.+++.+||+.+|++|||+.++++.|+.+......
T Consensus 236 ~---~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 236 S---TP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp H---SC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred C---Cc--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 00 0001122346788999999999999999999999999887544433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=359.40 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=209.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|.+.++||+|+||.||+|+++ +++.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999875 6899999999754 234567899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 550 YEYMPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999998886542 2457999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc--hhhcccccccccccchhhcc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS--LTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~i 706 (795)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... +
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i------------~ 406 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV------------L 406 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH------------H
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH------------h
Confidence 4322 2234589999999999999999999999999999999999999997643211 1111000 0
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTM-----FEVVSML 747 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L 747 (795)
... ...+...+..+.+++.+||+.||++||++ .++++|-
T Consensus 407 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 407 EQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred hcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 000 01122335678899999999999999964 7888763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=334.48 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=203.0
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeee-eecceeEEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCC-IELEEKILIY 550 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 550 (795)
..++|++.+.||+|+||.||+|++ .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999976 5789999998765322 24588999999999988877666655 5677789999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeecccccccc
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~~ 627 (795)
||+ +++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999988532 346999999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCccc-----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccc
Q 040413 628 GGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDR 701 (795)
Q Consensus 628 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 701 (795)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KK 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc----cc
Confidence 543221 122346799999999999999999999999999999999999999975432211 11100000 00
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
.. .+ ........+..+.+++.+||+.+|++|||+.++++.|+.+..+.
T Consensus 235 ~~---~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 235 MS---TP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HH---SC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cc---ch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 00 00 00001122467889999999999999999999999998875443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.29 Aligned_cols=255 Identities=28% Similarity=0.393 Sum_probs=204.1
Q ss_pred ccCCcccc-cccCCCceeEEeeec--c-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTEN-KLGEGGFGPVYKGRL--H-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~-~LG~G~~g~Vy~~~~--~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|.+.+ .||+|+||.||+|.. + .++.||||++.... ....+++.+|+.+++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999953 2 47889999997643 33367899999999999999999999999 667789
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999854 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 628 GGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+............. ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~---- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------KGE---- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TTC----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCC----
Confidence 543221 11222346788999999998889999999999999999999 999987544322111100 000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011223356788999999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.74 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=201.5
Q ss_pred ccCCcccccccCCCceeEEeeeccC-----CceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN-----GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..+|++.++||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999997642 2459999997643 344567999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999998542 356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 628 GGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||.......... .... .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~--~~~~----~----- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK--AIND----G----- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHT----T-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH--HHHC----C-----
Confidence 533211 11222346788999999999999999999999999999999 999986443221110 0000 0
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.....+...+..+.+++.+||+.+|++||++.+++++|+.+.
T Consensus 267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000111223456889999999999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.87 Aligned_cols=271 Identities=21% Similarity=0.318 Sum_probs=202.8
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeee--------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-------- 542 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 542 (795)
..+|++.++||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999987 478999999986543 2335678899999999999999999999987
Q ss_pred cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccc
Q 040413 543 LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFG 622 (795)
Q Consensus 543 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFG 622 (795)
.+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 55454432 2346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc--ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hccccccc--
Q 040413 623 MAKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDL-- 696 (795)
Q Consensus 623 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~-- 696 (795)
+++.+..... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .+......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987643221 122234578999999998876 56899999999999999999999998765432211 11110000
Q ss_pred ------ccccchhhccCcccc--chhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 697 ------WKDDRAWELIDPILQ--NEAS-----YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 697 ------~~~~~~~~~id~~l~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.......+.+..... .... ......+.+++.+||+.||++|||+.|+++|-.-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 000000000000000 0000 01134588999999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.47 Aligned_cols=263 Identities=23% Similarity=0.294 Sum_probs=187.2
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------ 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 543 (795)
..++|++.++||+|+||.||+|.+ .+++.||||++... .....+++.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999975 47899999999753 334567789999999999999999999998654
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++|+|++ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999998 688888873 256999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccccc---
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWK--- 698 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~--- 698 (795)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ...+........
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865422 234679999999999877 678999999999999999999999997654221 111111000000
Q ss_pred -----ccchhhc---cCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 699 -----DDRAWEL---IDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 699 -----~~~~~~~---id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
....... +..... ..........+.+++.+||+.||++|||+.|+++|-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0000000 000000 0001122456889999999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=337.29 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=204.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|.+.++||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 468999999999999999999765 7899999999876555567799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeeccccccccCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~~~~ 629 (795)
+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999888743 346899999999999999999999998 9999999999999 7889999999999976543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .... .. ..
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~----~~-~~----- 225 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE--KIKE----GY-YE----- 225 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHH----CC-CC-----
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHc----CC-CC-----
Confidence 21 223468999999999999999999999999999999999999986543222110 0000 00 00
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.........+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 000111223456889999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.36 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=206.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 368999999999999999999775 7899999999765 33446789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|+++++|.+++.. ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999998854 24689999999999999999999996 7 99999999999999999999999999975432
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc---------------
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD--------------- 695 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~--------------- 695 (795)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||................
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 12234579999999999999999999999999999999999999997654322211100000
Q ss_pred ---------cccccchhhccCcccc----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 696 ---------LWKDDRAWELIDPILQ----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 696 ---------~~~~~~~~~~id~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
........+.++.... .......+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000000000000000 0011123456889999999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.14 Aligned_cols=255 Identities=21% Similarity=0.228 Sum_probs=201.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC----cccHHHHHHHHHHHHhcCCCceeeeeeeee--eccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS----GQGLEEFKNEIKLIAKLQHRNLVRLLGCCI--ELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 546 (795)
.++|++.++||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999875 68899999997542 345678999999999999999999999984 45678
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||++++ |.+++... ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 55555432 3457999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCC--CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
..............||+.|+|||.+.+.. ++.++||||||+++|+|++|+.|+........... . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--i----~~~~--- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--I----GKGS--- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--H----HHCC---
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--H----hcCC---
Confidence 65433333334467999999999987644 47899999999999999999999875432211100 0 0000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
. ..+...+..+.+++.+||+.||++|||+.|+++|..-
T Consensus 230 ---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 230 ---Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp ---C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred ---C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 0 0111234567899999999999999999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=340.95 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=207.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..+|.+.++||+|+||.||++.+. +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999775 6789999998754 234567799999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999888743 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. . ...
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~------~~~ 259 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------N------EYS 259 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------T------CCC
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc------C------CCC
Confidence 221 22345799999999999998999999999999999999999999875442221110000 0 000
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.+......+.+++.+||+.||++||++.|++++-.
T Consensus 260 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 260 ----IPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 11122346788999999999999999999999743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=347.55 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=196.2
Q ss_pred cCCcccccccCCCceeEEeeecc--C--CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeee-cceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--N--GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 548 (795)
..|++.++||+|+||.||+|... + +..||||.+... .....+++.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999753 2 246899998754 33456789999999999999999999998765 457899
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 3346889999999999999999999998 9999999999999999999999999998664
Q ss_pred CCcccc--ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 629 GDELQS--KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 629 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+............. ... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------~~~--~~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RL 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------TTC--CC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------cCC--CC
Confidence 332211 1223457889999999999999999999999999999999 566665443222111100 000 00
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCC
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNL 754 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 754 (795)
..+...+..+.+++.+||+.+|++|||+.|++++|+.+...+
T Consensus 316 -------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 011123456889999999999999999999999998875443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=341.20 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=206.5
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcc-----------------cHHHHHHHHHHHHhcCCCceeee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQ-----------------GLEEFKNEIKLIAKLQHRNLVRL 536 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 536 (795)
.++|++.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999988 8999999998653211 12889999999999999999999
Q ss_pred eeeeeecceeEEEEeecCCCCccee------eccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEE
Q 040413 537 LGCCIELEEKILIYEYMPNKSLDIF------LFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNIL 609 (795)
Q Consensus 537 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIl 609 (795)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ ++ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 432 225679999999999999999999999 88 999999999999
Q ss_pred EcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccC-CCCc-cCCeeehhHHHHHHHhCCCCCCCCCC-cc
Q 040413 610 LDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSI-KSDVFSFGVLLLETLSSKRNTDFSNT-DS 686 (795)
Q Consensus 610 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DvwslG~ll~elltg~~p~~~~~~-~~ 686 (795)
++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|+|++|+.||..... ..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876433 23345789999999999877 6666 99999999999999999999976543 11
Q ss_pred hh-hcccc-cccccc-cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 687 LT-LLGRA-WDLWKD-DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 687 ~~-~~~~~-~~~~~~-~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. .+... ...... ........+..........+..+.+++.+||+.||.+|||+.|+++|-
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 11 11100 000000 000000000000111133456788999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.94 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=204.2
Q ss_pred cCCcccccccCCCceeEEeeec----cCCceEEEEEecccC----cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecce
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL----HNGQEVAVKRLSSQS----GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEE 545 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 545 (795)
++|++.++||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999976 368999999987532 23456688899999999 69999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+++++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999998854 246899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccch
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRA 702 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 702 (795)
.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+... ..
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~----- 279 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--IL----- 279 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HH-----
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH--Hh-----
Confidence 7643322 22234579999999999985 4578999999999999999999999975442211 111000 00
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhhc
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSMLTN 749 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~ 749 (795)
. .. ...+...+..+.+++.+||+.||++|| ++.|+++|..-
T Consensus 280 -~-~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 280 -K-SE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp -H-CC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred -c-cC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 0 00 011223345678999999999999999 99999998744
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.46 Aligned_cols=250 Identities=30% Similarity=0.409 Sum_probs=201.5
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999976 578999999997542 233567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+. |+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 566665532 2356899999999999999999999998 999999999999999999999999999865422
Q ss_pred ccccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
....||+.|+|||++. ...++.++|||||||++|||++|+.|+.......... .. .... .
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~---~~~~------~ 270 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HI---AQNE------S 270 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HH---HHSC------C
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HH---HhcC------C
Confidence 2357999999999884 5678999999999999999999999986543211100 00 0000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+.+ .....+..+.+++.+||+.+|++|||+.+++++..-.
T Consensus 271 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 271 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 101 0112245678999999999999999999999986554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.43 Aligned_cols=252 Identities=25% Similarity=0.303 Sum_probs=207.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..+|.+.++||+|+||.||+|.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 368999999999999999999876 6889999998654 234567789999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999888743 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+............. ... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~------~- 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KNE------Y- 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TTC------C-
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------hcc------C-
Confidence 221 2233578999999999998889999999999999999999999987544222111000 000 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+...+..+.+++.+||+.||++|||+.|++++..-
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 0111223567899999999999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.40 Aligned_cols=269 Identities=25% Similarity=0.361 Sum_probs=196.4
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHH--HhcCCCceeeeeeeeee-----ccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLI--AKLQHRNLVRLLGCCIE-----LEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~-----~~~~ 546 (795)
.++|++.++||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999976 5789999999653 234455555554 45899999999975542 3356
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCcEEeCCCCCCcEEEcCCCCce
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY---------SRLRVIHRDLKASNILLDKDMNPK 617 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~---------~~~~iiH~Dikp~NIll~~~~~~k 617 (795)
++||||+++++|.+++.. ...++..+..++.||++||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999843 3458899999999999999999998 7 99999999999999999999
Q ss_pred eeccccccccCCCcc------ccceeeecccCCcCChhhhcc-------CCCCccCCeeehhHHHHHHHhCCCCCCCCC-
Q 040413 618 ISDFGMAKMFGGDEL------QSKTKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLSSKRNTDFSN- 683 (795)
Q Consensus 618 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwslG~ll~elltg~~p~~~~~- 683 (795)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221 112223579999999999876 456788999999999999999977664322
Q ss_pred Ccchhhc-cc-ccccccccchhh-----ccCccccc--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCC
Q 040413 684 TDSLTLL-GR-AWDLWKDDRAWE-----LIDPILQN--EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVN 753 (795)
Q Consensus 684 ~~~~~~~-~~-~~~~~~~~~~~~-----~id~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 753 (795)
....... .. ............ ...+.+.. ......+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1111000 00 000000000000 00111111 01223566799999999999999999999999999887443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.72 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=205.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKIL 548 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 548 (795)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999765 7899999999754 33456779999999999999999999998854 567899
Q ss_pred EEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 549 IYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYS--RLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
||||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999988643 23345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+........... . .....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--i----~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--I----REGKF--- 233 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--H----HHTCC---
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH--H----hhccc---
Confidence 7643321 12235789999999999998999999999999999999999999875442211100 0 00000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+ ..+...+.++.+++.+||+.+|++||++.|+++++...
T Consensus 234 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 --R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred --c----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 0 11122345788999999999999999999999987554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=339.97 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=206.4
Q ss_pred HHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHh--cCCCceeeeeeeeeecc---
Q 040413 470 VSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAK--LQHRNLVRLLGCCIELE--- 544 (795)
Q Consensus 470 i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--- 544 (795)
.....++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++.+..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999987 4899999999643 45678889999988 78999999999998876
Q ss_pred -eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEeCCCCCCcEEEcCCCC
Q 040413 545 -EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH--------QYSRLRVIHRDLKASNILLDKDMN 615 (795)
Q Consensus 545 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~iiH~Dikp~NIll~~~~~ 615 (795)
..++||||+++++|.+++.. ..+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 78999999999999999843 35899999999999999999999 666 999999999999999999
Q ss_pred ceeeccccccccCCCccc--cceeeecccCCcCChhhhccC------CCCccCCeeehhHHHHHHHhC----------CC
Q 040413 616 PKISDFGMAKMFGGDELQ--SKTKRIVGTYGYMSPEYAQQG------LFSIKSDVFSFGVLLLETLSS----------KR 677 (795)
Q Consensus 616 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DvwslG~ll~elltg----------~~ 677 (795)
+||+|||++......... .......||+.|+|||.+.+. .++.++||||||+++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876543221 122345799999999998765 234789999999999999999 55
Q ss_pred CCCCCCCcchhhcccccccccccchhhccCccccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 678 NTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN-EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 678 p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
|+............ ...... .....+.+.. ......+..+.+++.+||+.+|++|||+.||+++|+.+.
T Consensus 266 p~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 266 PYYDLVPSDPSVEE-MRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTTSCSSCCHHH-HHHHHT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCcCcccHHH-HHHHHH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 55432211100000 000000 0011111111 123456778999999999999999999999999998874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.14 Aligned_cols=262 Identities=22% Similarity=0.244 Sum_probs=195.1
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999764 6899999999753 3344577899999999999999999999987655
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999985 5666653 34889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc-------
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL------- 696 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~------- 696 (795)
+...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ..+......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8654322 22345799999999999999999999999999999999999999976542211 100000000
Q ss_pred ---------------ccccchhhccCccc---cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 697 ---------------WKDDRAWELIDPIL---QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 697 ---------------~~~~~~~~~id~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+........+.... ...........+.+++.+||+.||++|||+.|+++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00000000011000 0112234467899999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.99 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=200.7
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 548 (795)
..++|++.++||+|+||.||+|... +++.||||++... ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3468999999999999999999775 7899999998764 334467788999999999 99999999999999999999
Q ss_pred EEeecCCCCcceeeccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC--------------
Q 040413 549 IYEYMPNKSLDIFLFDTP-KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-------------- 613 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-------------- 613 (795)
||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999885431 1256899999999999999999999998 9999999999999844
Q ss_pred -----CCceeeccccccccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch
Q 040413 614 -----MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687 (795)
Q Consensus 614 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~ 687 (795)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+++.... ..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--QW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--HH
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--HH
Confidence 479999999998765332 23589999999998765 66789999999999999999987653221 11
Q ss_pred hhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+. .... + ..+...+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 238 ~~~~-------~~~~-----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 238 HEIR-------QGRL-----P----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HHHH-------TTCC-----C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred HHHH-------cCCC-----C----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 1000 0000 0 111123456889999999999999999999998743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=367.56 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=202.2
Q ss_pred cCCcccc-cccCCCceeEEeeecc---CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTEN-KLGEGGFGPVYKGRLH---NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++.+.+ +||+|+||.||+|.++ ++..||||+++.. .....+++.+|+++|++++||||+++++++.+ +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999754 4667999999765 33467889999999999999999999999876 568999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999998853 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 630 DEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ........+++.|+|||++....++.++|||||||++|||++ |+.||............ ..+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i------~~~------- 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------EQG------- 555 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH------HTT-------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH------HcC-------
Confidence 321 111222345789999999999999999999999999999998 99998765433221110 000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+...+.++.+++.+||+.+|++||++.+|++.|+..
T Consensus 556 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 556 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00112223456788999999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.91 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=203.2
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeee--cceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIE--LEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 549 (795)
.++|++.++||+|+||.||+|.+ .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999975 47899999999743 4578999999999997 9999999999988 6678999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-CceeeccccccccC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~~ 628 (795)
|||+++++|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988873 3889999999999999999999998 99999999999999776 89999999998765
Q ss_pred CCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch-----
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA----- 702 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 702 (795)
.... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............ ..........
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~-~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR-IAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH-HHHHHCHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH-HHHhcCCchhhhHHH
Confidence 4322 233578999999999877 67899999999999999999999998544322111100 0000000000
Q ss_pred ------------------hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 ------------------WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ------------------~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...+............+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0001111111222234567899999999999999999999999743
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=369.91 Aligned_cols=267 Identities=24% Similarity=0.291 Sum_probs=215.2
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 547 (795)
...+|++.++||+|+||.||+|+++ +++.||||++.+. .....+.+.+|..+|..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999865 6888999999753 234567788999999988 7999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
|||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999988854 246999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... .
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--------------~ 556 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--------------E 556 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------------S
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--------------h
Confidence 3222 22345789999999999999999999999999999999999999997654322211100 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHh--hcc------cCCCCCCCCCCcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTM-----FEVVSML--TNE------TVNLPHPQQPAFS 763 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~L--~~~------~~~~~~~~~p~~~ 763 (795)
..+ ..+...+.++.+||.+||+.||++||++ +||++|- +++ ..++++|..|...
T Consensus 557 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 557 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp SCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred CCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 000 1122345678899999999999999997 8888763 221 2345566666543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.42 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=199.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.++|++.++||+|+||.||+|+.+ +++.+|||++.+.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999875 78899999997642 344678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeecccccccc
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGMAKMF 627 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGla~~~ 627 (795)
||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999877743 346899999999999999999999998 999999999999976 455999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.................... .
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD-------S 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------S
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------c
Confidence 5432 223457999999999876 5689999999999999999999999976543222111000000000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+ .....+..+.+++.+||+.+|.+|||+.|+++|-
T Consensus 259 ~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 259 P-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp G-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred h-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 0 0112345678999999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=357.07 Aligned_cols=255 Identities=25% Similarity=0.309 Sum_probs=205.1
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..++|++.++||+|+||.||+|.+. +++.||||++.+. .....+.+.+|+.+|++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999765 7899999998653 234567899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc---CCCCceeeccccccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAKM 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFGla~~ 626 (795)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999887743 346899999999999999999999998 99999999999995 566799999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..................
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 240 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA--------- 240 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 65332 2234579999999999875 5899999999999999999999999755432211110000000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.........+..+.+++.+||+.+|.+|||+.|+++|-.-
T Consensus 241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 0000111234568899999999999999999999998543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.56 Aligned_cols=267 Identities=24% Similarity=0.356 Sum_probs=188.8
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999765 68999999986542 34467789999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 550 YEYMPNKSLDIFLFDT-----PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
|||+++++|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999888531 23456899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc---ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccccc
Q 040413 625 KMFGGDEL---QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD 700 (795)
Q Consensus 625 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 700 (795)
........ ........||+.|+|||.+.. ..++.++||||||+++|+|++|+.||................. ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--PS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC--CC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC--Cc
Confidence 86543211 112234578999999999876 5689999999999999999999999875443221110000000 00
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
......++.. ....+..+.+++.+||+.||.+||++.|+++|-
T Consensus 247 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 247 LETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp TTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred cccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0000001111 112235688999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.47 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=203.5
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-------------cccHHHHHHHHHHHHhcCCCceeeeee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-------------GQGLEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
..++|++.++||+|+||.||+|..+ +++.+|||++.+.. ....+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999765 68899999987542 134578999999999999999999999
Q ss_pred eeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC---C
Q 040413 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM---N 615 (795)
Q Consensus 539 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~---~ 615 (795)
++.+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999887743 346999999999999999999999998 99999999999998776 6
Q ss_pred ceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc
Q 040413 616 PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 616 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 695 (795)
+||+|||++....... ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||................
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999998765432 223457999999999887 468999999999999999999999997654322211100000
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.. .........+.++.+++.+||+.||.+|||+.|+++|-.
T Consensus 264 ~~------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 264 YY------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp CC------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CC------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 00 000001123456889999999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.38 Aligned_cols=269 Identities=14% Similarity=0.148 Sum_probs=206.6
Q ss_pred ccCCcccccccCCCceeEEeeeccC---------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCceee---------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHN---------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR--------- 535 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 535 (795)
.++|++.++||+|+||.||+|+... ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998753 789999998754 46889999999999999987
Q ss_pred ------eeeeeee-cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcE
Q 040413 536 ------LLGCCIE-LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNI 608 (795)
Q Consensus 536 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NI 608 (795)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5666665 67889999999 99999998643 2357999999999999999999999998 99999999999
Q ss_pred EEcCCC--CceeeccccccccCCCccc-----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCC
Q 040413 609 LLDKDM--NPKISDFGMAKMFGGDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDF 681 (795)
Q Consensus 609 ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~ 681 (795)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876532211 112334799999999999999999999999999999999999999875
Q ss_pred CCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCC
Q 040413 682 SNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHP 757 (795)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 757 (795)
................ .....+.+.... ....+..+.+++.+||+.||++||++.+++++|+.+.......
T Consensus 271 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GTTCHHHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcCHHHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 4322211111100000 000011111000 0112456889999999999999999999999998875544433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.37 Aligned_cols=250 Identities=28% Similarity=0.400 Sum_probs=197.3
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-ceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-EEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~ 552 (795)
.++|++.+.||+|+||.||+|+.+ ++.||||++... ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 468999999999999999999875 789999999754 3567899999999999999999999997654 478999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999988532 1223789999999999999999999998 999999999999999999999999999865422
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+........... . ... ..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--~----~~~---------~~ 232 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--V----EKG---------YK 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--H----TTT---------CC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--H----hcC---------CC
Confidence 122467889999999999999999999999999999998 9998865432221110 0 000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111222345688999999999999999999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.34 Aligned_cols=256 Identities=11% Similarity=0.056 Sum_probs=184.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc---ccHHHHHHHHHHHHhc--CCCceeeee-------eee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---QGLEEFKNEIKLIAKL--QHRNLVRLL-------GCC 540 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 540 (795)
..+|++.++||+|+||.||+|++. +++.||||++..... ...+.+++|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999865 789999999987532 3456788886666666 599988755 333
Q ss_pred eec-----------------ceeEEEEeecCCCCcceeeccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 040413 541 IEL-----------------EEKILIYEYMPNKSLDIFLFDTPKESPLGWETR------VRVIEEIAQGLLYLHQYSRLR 597 (795)
Q Consensus 541 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~~ 597 (795)
... ...++||||++ ++|.+++... ...+++..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 322 34799999999 8999988543 123444555 677899999999999998
Q ss_pred EEeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhC
Q 040413 598 VIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSS 675 (795)
Q Consensus 598 iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg 675 (795)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875422 113467799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 676 KRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 676 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.||.............. ..................+..+.+++.+||+.||++|||+.|+++|-
T Consensus 290 ~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRP-------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp SCSTTBCCTTCTTCCCBC-------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CCCCCCcCcccccchhhh-------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 999976543221111100 00000000111111123356788999999999999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.85 Aligned_cols=275 Identities=20% Similarity=0.226 Sum_probs=201.7
Q ss_pred cHHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCc-----------ccHHHHHHHHHHHHhcCCCcee
Q 040413 466 SLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG-----------QGLEEFKNEIKLIAKLQHRNLV 534 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 534 (795)
....+....++|++.++||+|+||.||+|.+.+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35567778899999999999999999999888899999999865321 1247899999999999999999
Q ss_pred eeeeeeee-----cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEE
Q 040413 535 RLLGCCIE-----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNIL 609 (795)
Q Consensus 535 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIl 609 (795)
++++++.. ....++||||++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999854 335799999998 466666643 3457999999999999999999999998 999999999999
Q ss_pred EcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-
Q 040413 610 LDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL- 687 (795)
Q Consensus 610 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~- 687 (795)
++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998544322 2234578999999999877 6789999999999999999999999976542211
Q ss_pred hhcccccccc--------cccchhhccCc-------cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 688 TLLGRAWDLW--------KDDRAWELIDP-------ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 688 ~~~~~~~~~~--------~~~~~~~~id~-------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..+....... ........+.. .............+.+++.+||+.||++|||+.|+++|-.-
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 1110000000 00000000000 00011112234568899999999999999999999998543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=344.05 Aligned_cols=268 Identities=21% Similarity=0.241 Sum_probs=203.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----cee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
..+|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999765 78899999997543 33457799999999999999999999998765 368
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+.+ +|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999985 78777733 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccchh
Q 040413 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRAW 703 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 703 (795)
....... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+.............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 6533211 11234589999999998654 5689999999999999999999999976553221 1111000000000000
Q ss_pred hcc------------Cccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 704 ELI------------DPIL--QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 704 ~~i------------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
... .+.. ........+..+.+++.+||+.||++|||+.|+++|-.-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 000 0000 000111234568899999999999999999999998543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.61 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=205.5
Q ss_pred HHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--------ccHHHHHHHHHHHHhc-CCCceeeeeeee
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--------QGLEEFKNEIKLIAKL-QHRNLVRLLGCC 540 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 540 (795)
....++|++.++||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445578999999999999999999875 799999999875431 1245688999999999 799999999999
Q ss_pred eecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 541 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999998853 346899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhcc------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAW 694 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~ 694 (795)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ...
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~i~ 318 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR--MIM 318 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHH
Confidence 99998765432 2234679999999998863 358899999999999999999999986543211110 000
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
. .. .. .........+..+.+++.+||+.||++|||+.|+++|-
T Consensus 319 ~----~~----~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 319 E----GQ----YQ--FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp H----TC----CC--CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred h----CC----CC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0 00 00 00000012245688999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=357.46 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=206.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.++||+|+||.||+|... +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999875 78999999996542 34578899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeeccccccc
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKM 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~ 626 (795)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999888743 356999999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
+..... .....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||..................
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 245 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT--------- 245 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 654321 233579999999998865 6899999999999999999999999765432211110000000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.........+..+.+++.+||+.+|.+|||+.|+++|-.
T Consensus 246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 000111123456889999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.36 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=200.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee----cceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 547 (795)
..|.+.++||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999764 6889999998754 34456789999999999999999999998875 35689
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCceeeccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKM 626 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFGla~~ 626 (795)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ .+|+||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999853 256889999999999999999999875 3499999999999997 789999999999976
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
..... .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||........... .. ...
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~----~~~------ 245 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-RV----TSG------ 245 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-HH----TTT------
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH-HH----hcc------
Confidence 54332 23457999999999876 4589999999999999999999999865432221110 00 000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
......+...+..+.+++.+||+.+|++|||+.|+++|-
T Consensus 246 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 246 --VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp --CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred --CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 000011112234688999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.28 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=200.6
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.+.||+|+||.||+|.+. +++.+|+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 478999999999999999999875 6899999999877777788999999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++++|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999998887532 346899999999999999999999998 999999999999999999999999998643211
Q ss_pred ccceeeecccCCcCChhhh-----ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 633 QSKTKRIVGTYGYMSPEYA-----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
........||+.|+|||.+ ....++.++||||||+++|+|++|+.|+.......... ... ... .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~---~~~------~ 239 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIA---KSD------P 239 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH---HSC------C
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHh---ccC------C
Confidence 1112235789999999988 36678999999999999999999999987544221110 000 000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.. ..+...+..+.+++.+||+.||++|||+.++++|-
T Consensus 240 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 240 PTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp CCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred ccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 000 01122345688999999999999999999998863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.99 Aligned_cols=243 Identities=14% Similarity=0.185 Sum_probs=189.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHH---HHHhcCCCceeeee-------ee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIK---LIAKLQHRNLVRLL-------GC 539 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 539 (795)
.++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|+. +|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999864 6899999999743 3345688999994 55555899999998 55
Q ss_pred eeecc-----------------eeEEEEeecCCCCcceeeccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 040413 540 CIELE-----------------EKILIYEYMPNKSLDIFLFDTP----KESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598 (795)
Q Consensus 540 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 598 (795)
+.+.+ ..++||||+ +|+|.+++.... ....+++..+..++.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 679998885421 1123445888899999999999999998 9
Q ss_pred EeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccC-----------CCCccCCeeehhH
Q 040413 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-----------LFSIKSDVFSFGV 667 (795)
Q Consensus 599 iH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DvwslG~ 667 (795)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 668 LLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 668 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
++|||++|+.||.......... .. .. . ....+..+.+++.+||+.||++|||+.|+++|
T Consensus 302 il~elltg~~Pf~~~~~~~~~~--~~------------~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE--WI------------FR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSG--GG------------GS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchh--hh------------hh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999986543221110 00 00 0 01123568899999999999999999999985
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=314.12 Aligned_cols=216 Identities=14% Similarity=0.187 Sum_probs=165.7
Q ss_pred hcccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEec
Q 040413 23 IAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILN 102 (795)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (795)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 677999999999999999 48999999987654 233 432 799999999988 57899999999999999
Q ss_pred CCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCcc-CCCCcccccc-ccCc-----ceEEE
Q 040413 103 LKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTL-LPGMKLGWDL-KTGL-----ERYQT 175 (795)
Q Consensus 103 ~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtl-Lpg~~l~~~~-~tg~-----~~~l~ 175 (795)
.+|.+||+|++....+...|+|+|+|||||++ . ++||||||||||+ |||| |.|. .+|. ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~------~--~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG------P--GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC------S--EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec------C--CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999997654456689999999999995 1 8999999999877 5554 5554 4444 56777
Q ss_pred eeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCCCCceeeccCCCCccccc-ceEeecCCeeEEEEecCCCCeeE
Q 040413 176 SWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGVAFQAAPSYSYLYE-PTVVDNEDEIYYRYDSYNSPIIM 254 (795)
Q Consensus 176 Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~w~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 254 (795)
+..||++|.|++.++++| ++++++++.+||++|+|++. +...+.....-. ..+..+.++++++|..... ..+
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~~ 215 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRY 215 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CCE
Confidence 478999999999999998 67788888899999999753 333332111111 1122234455555554433 468
Q ss_pred EEEEccCCcEEEEE
Q 040413 255 MLKLNPSGKIQRLI 268 (795)
Q Consensus 255 rl~L~~~G~l~~~~ 268 (795)
|++|++||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=339.98 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=203.2
Q ss_pred ccHHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcC--CCceeeeeeee
Q 040413 465 FSLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQ--HRNLVRLLGCC 540 (795)
Q Consensus 465 ~~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 540 (795)
+.+.++....++|++.++||+|+||.||+|...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3444455567889999999999999999999888999999998654 3445678999999999997 59999999999
Q ss_pred eecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 541 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
.+.+..++||| +.+++|.+++.. ...+++..+..++.||++||.|||+++ |+||||||+||+++ ++.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEee
Confidence 99999999999 678899888854 346899999999999999999999998 99999999999996 48999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhcc-----------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ-----------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL 689 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~ 689 (795)
||+++...............||+.|+|||.+.. ..++.++||||||+++|+|++|+.||..........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 999987654333223334579999999999865 468889999999999999999999986433221111
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
. ..+++......+...+..+.+++.+||+.||++||++.|++++..-.
T Consensus 250 ~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 250 H-------------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp H-------------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred H-------------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 0 01111111111111245688999999999999999999999976543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.71 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=198.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999875 7899999998653 234567899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999888532 45899999999999999999999999 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.|+............. ... .
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~------~ 228 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR------GGV------F 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC------C
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh------cCc------c
Confidence 321 223578999999999987665 689999999999999999999986543221110000 000 0
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+...+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 229 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 229 ----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 011122456789999999999999999999999743
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.65 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=197.9
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce------eE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE------KI 547 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 547 (795)
..+|++.++||+|+||.||+|++..+..+|+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777799998865322 23479999999999999999999965443 78
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCceeeccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKM 626 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFGla~~ 626 (795)
+||||++++.+............+++..+..++.||++||+|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655443322233467999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhccccccccc------
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWK------ 698 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~------ 698 (795)
...... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ...+........
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643322 2245789999999998764 58999999999999999999999997654221 111111000000
Q ss_pred ------ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 699 ------DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 699 ------~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.......-...+........+.++.+++.+||+.||.+|||+.|+++|-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 0000000000000111122445789999999999999999999999984
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.86 Aligned_cols=265 Identities=20% Similarity=0.233 Sum_probs=197.7
Q ss_pred HhccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-------
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------- 543 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 543 (795)
....+|++.++||+|+||.||+|.+ .+++.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4457899999999999999999976 4789999999865422 235799999999999999999998543
Q ss_pred -------------------------------ceeEEEEeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 040413 544 -------------------------------EEKILIYEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLH 591 (795)
Q Consensus 544 -------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH 591 (795)
...++||||+++ +|.+.+... .....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 337899999985 666665431 23467999999999999999999999
Q ss_pred hcCCCcEEeCCCCCCcEEEc-CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHH
Q 040413 592 QYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLL 669 (795)
Q Consensus 592 ~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll 669 (795)
+++ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 99999999999998 688999999999987644322 2345789999999988764 589999999999999
Q ss_pred HHHHhCCCCCCCCCCcc-hhhccccccccc------------ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCC
Q 040413 670 LETLSSKRNTDFSNTDS-LTLLGRAWDLWK------------DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVD 736 (795)
Q Consensus 670 ~elltg~~p~~~~~~~~-~~~~~~~~~~~~------------~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~ 736 (795)
|||++|+.||....... ...+........ ................+...+..+.+++.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999997654222 111111000000 00000000011111122234556889999999999999
Q ss_pred CCCHHHHHHHh
Q 040413 737 RPTMFEVVSML 747 (795)
Q Consensus 737 RPt~~evl~~L 747 (795)
|||+.|+++|-
T Consensus 313 R~t~~e~l~hp 323 (383)
T 3eb0_A 313 RINPYEAMAHP 323 (383)
T ss_dssp SCCHHHHHTSG
T ss_pred CCCHHHHhcCH
Confidence 99999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=350.51 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=194.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------ceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------EEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 547 (795)
.+|++.++||+|+||.||+|++. +++.||||++.... ..+.+|+++|++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999875 68999999986532 2245799999999999999999998642 2367
Q ss_pred EEEeecCCCCcceeecc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-CCceeecccccc
Q 040413 548 LIYEYMPNKSLDIFLFD-TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAK 625 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DFGla~ 625 (795)
+||||++++ |.+.+.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 999999864 4433322 123467999999999999999999999998 9999999999999965 568999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc-hhhcccccccccccch-
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-LTLLGRAWDLWKDDRA- 702 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~- 702 (795)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...+.........+.+
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 7643321 2335789999999998764 78999999999999999999999997654211 1111110000000000
Q ss_pred ------hhccCcccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 703 ------WELIDPILQ-----NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 703 ------~~~id~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.+..-+.+. .......+.++.+|+.+||+.||++|||+.|+++|-.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 000000000 0011223467899999999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.36 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=188.9
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
..++|++.++||+|+||.||+|.. .+++.||||++..... ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 347899999999999999999976 4789999999976422 2233455566668888999999999999999999999
Q ss_pred EeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 550 YEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
|||+++ +|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 776665431 2346799999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhh----ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYA----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
.... ......||+.|+|||.+ ....++.++||||||+++|+|++|+.|+................ .
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~--- 230 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE----P--- 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS----C---
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc----C---
Confidence 4332 22234799999999996 55678999999999999999999999987543222211111000 0
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+ .......+.++.+++.+||+.+|++|||+.|+++|-
T Consensus 231 ---~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 231 ---SP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp ---CC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ---CC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 00 001112345688999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.91 Aligned_cols=268 Identities=24% Similarity=0.316 Sum_probs=198.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeee-----------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCI----------- 541 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 541 (795)
..+|++.++||+|+||.||+|... +++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 368999999999999999999876 58999999998777677788999999999999999999998873
Q ss_pred ---ecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCce
Q 040413 542 ---ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPK 617 (795)
Q Consensus 542 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~k 617 (795)
+....++||||++ ++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+||+++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 58888873 356899999999999999999999998 99999999999997 567999
Q ss_pred eeccccccccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc
Q 040413 618 ISDFGMAKMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW 694 (795)
Q Consensus 618 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~ 694 (795)
|+|||+++....... ........+|+.|+|||.+.. ..++.++||||||+++|||++|+.||........ ..+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643211 112233467999999998865 6789999999999999999999999976542211 1111000
Q ss_pred ccccccchhhccC---ccc----------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 695 DLWKDDRAWELID---PIL----------QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 695 ~~~~~~~~~~~id---~~l----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.........++.. ..+ ........+.++.+++.+||+.||++|||+.|+++|-.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 0000000000000 000 000112245678999999999999999999999997543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.58 Aligned_cols=199 Identities=23% Similarity=0.292 Sum_probs=172.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc------CCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL------QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 546 (795)
..+|++.++||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999765 6899999999753 33456788899999888 467999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC--ceeeccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN--PKISDFGMA 624 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DFGla 624 (795)
++||||+. ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 5787777543 2345899999999999999999999998 999999999999999887 999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
...... .....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 764422 223578999999999999999999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.24 Aligned_cols=273 Identities=20% Similarity=0.228 Sum_probs=193.4
Q ss_pred HHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce--
Q 040413 469 SVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-- 545 (795)
Q Consensus 469 ~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 545 (795)
......++|++.++||+|+||.||+|++. +++.||||++.... ...+.+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556689999999999999999999875 68999999986532 334567788889999999999999999976443
Q ss_pred -----eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCcEEeCCCCCCcEEEcC-CCCce
Q 040413 546 -----KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH--QYSRLRVIHRDLKASNILLDK-DMNPK 617 (795)
Q Consensus 546 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~~iiH~Dikp~NIll~~-~~~~k 617 (795)
.++||||++++.+..+.........+++..+..++.||+.||.||| +++ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543322222234567899999999999999999999 887 999999999999996 89999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD 695 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~ 695 (795)
|+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ..+.....
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999999987654322 2235789999999998664 489999999999999999999999976542221 11110000
Q ss_pred cccccchhhccCcc----------------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 696 LWKDDRAWELIDPI----------------LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 696 ~~~~~~~~~~id~~----------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
... ......+++. .........+..+.+++.+||+.||.+|||+.|+++|-.-
T Consensus 250 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 250 CPS-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp CCC-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred CCC-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 000 0000000000 0001111245678999999999999999999999998543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.51 Aligned_cols=257 Identities=27% Similarity=0.383 Sum_probs=197.3
Q ss_pred ccCCcccccccCCCceeEEeeecc--CCc--eEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH--NGQ--EVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.++||+|+||.||+|++. +++ .||||++... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999753 333 6899998754 3345678999999999999999999999988765 8
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++|+||+++++|.+++... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999888542 245889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhh
Q 040413 627 FGGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 627 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.|+.......... ... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~~~---~~~~--- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KID---KEGE--- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHH---TSCC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH--HHH---ccCC---
Confidence 6543221 12233467888999999998889999999999999999999 999987544222111 000 0000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.+|++|||+.+++++|+..
T Consensus 243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0011122346788999999999999999999999999887
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.68 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=197.1
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC--------cccHHHHHHHHHHHHhcCCCceeeeeeeeeec
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS--------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL 543 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 543 (795)
..++|++.++||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999765 68999999986532 12234588999999999999999999998765
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC---ceeec
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISD 620 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~D 620 (795)
+ .++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999988874 3457899999999999999999999998 999999999999987654 99999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
||+++...... ......||+.|+|||.+. ...++.++||||||+++|+|++|+.||.......... ...
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~---- 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-DQI---- 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH-HHH----
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH-HHH----
Confidence 99998765332 122357899999999874 4678899999999999999999999987543221100 000
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.... . ..........+..+.+++.+||+.||++||++.|+++|
T Consensus 233 ~~~~----~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGK----Y--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTC----C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCc----c--ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 0 00001112235678899999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=367.66 Aligned_cols=248 Identities=28% Similarity=0.379 Sum_probs=198.1
Q ss_pred ccccCCCceeEEeeecc---CCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999542 46789999997643 344688999999999999999999999986 4568899999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc-cc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL-QS 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~ 634 (795)
++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999853 356899999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+|+.|+|||++....++.++|||||||++|||++ |+.||............. ......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---------------~~~~~~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---------------KGERMG 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---------------TTCCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------cCCCCC
Confidence 2223456789999999999999999999999999999998 999987654322211100 000011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+...+.++.+++.+||+.||++||++.+|+++|+..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1223456788999999999999999999999999865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.98 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=202.2
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
..++|++.++||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999765 68999999997543 45779999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999988842 2356899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+............. ....+..
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~- 245 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-----------TNPPPTF- 245 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----------HSCCCCC-
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-----------cCCCccc-
Confidence 1 2234578999999999999899999999999999999999999986543211110000 0000000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
..+...+..+.+++.+||+.||.+|||+.++++|-.
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 011223456889999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.36 Aligned_cols=263 Identities=21% Similarity=0.227 Sum_probs=201.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC--------CCceeeeeeeee---
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ--------HRNLVRLLGCCI--- 541 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 541 (795)
.++|++.++||+|+||.||+|++. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 378999999999999999999754 6889999999753 345678899999999996 788999999988
Q ss_pred -ecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCC-----
Q 040413 542 -ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDM----- 614 (795)
Q Consensus 542 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~----- 614 (795)
+....++||||+.++.++.++ .. ....+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~-~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWII-KS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHH-HT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHH-hc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 566889999999554444443 22 235699999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------CceeeccccccccCCCccccceeeecccCCcCChhh
Q 040413 615 --------------------------------------------NPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650 (795)
Q Consensus 615 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 650 (795)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875422 233578999999999
Q ss_pred hccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh----hcccccc------------------ccccc-chhhccC
Q 040413 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT----LLGRAWD------------------LWKDD-RAWELID 707 (795)
Q Consensus 651 ~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~----~~~~~~~------------------~~~~~-~~~~~id 707 (795)
+.+..++.++|||||||++|||++|+.||......... ....... .+... ......+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999755422110 0000000 00000 0000000
Q ss_pred cc---------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PI---------LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.. -....+......+.+++.+||+.||++|||+.|+++|-
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 00 00123456677899999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.63 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=205.1
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---------cccHHHHHHHHHHHHhcC-CCceeeeeeee
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---------GQGLEEFKNEIKLIAKLQ-HRNLVRLLGCC 540 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 540 (795)
...++|++.++||+|+||.||+|.++ +++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999775 68999999986542 123467889999999996 99999999999
Q ss_pred eecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 541 IELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 541 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
.+....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999998853 346899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhc------cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAW 694 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~ 694 (795)
||++....... ......+++.|+|||.+. ...++.++||||||+++|+|++|+.|+..............
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~- 243 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS- 243 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc-
Confidence 99998765332 223457899999999885 45688999999999999999999999865432211100000
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
... ..........+..+.+++.+||+.||++|||+.|+++|-
T Consensus 244 -----~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 244 -----GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp -----TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred -----CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 000 000011122345688999999999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=340.51 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=198.5
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee----
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK---- 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 546 (795)
.++|.+.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999765 7899999999764 333467889999999999999999999999887665
Q ss_pred --EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 547 --ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 547 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 5676655 234899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccc-----
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLW----- 697 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~----- 697 (795)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ..+.......
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 865422 234578999999999887 7889999999999999999999999976542211 1110000000
Q ss_pred ---cccchhh---ccCccccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 698 ---KDDRAWE---LIDPILQN---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 698 ---~~~~~~~---~id~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
....... .+...... ......+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0000000 00000000 011123567899999999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=348.07 Aligned_cols=260 Identities=20% Similarity=0.258 Sum_probs=205.4
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCC-CceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|.+ .+++.||||++..... .+++.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999976 5789999998865432 2458899999999987 556666677778888999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---cCCCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DFGla~~~~ 628 (795)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999988532 346999999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCccc-----cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccccccccch
Q 040413 629 GDELQ-----SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDLWKDDRA 702 (795)
Q Consensus 629 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 702 (795)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ....... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----KKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----HHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----ccc
Confidence 43221 1223567999999999999999999999999999999999999999764432211 1111000 000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+ .......+.++.+++..||+.+|++||++.+|+++|+.+
T Consensus 234 ~~~~-----~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCH-----HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccH-----HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 011112346789999999999999999999999998776
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.60 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=204.8
Q ss_pred ccCCcccccccCCCceeEEeeec--cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc------eeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL--HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN------LVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 545 (795)
.++|++.++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999975 36889999999753 344677999999999997664 9999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-------------
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK------------- 612 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~------------- 612 (795)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88888887543 2346899999999999999999999998 999999999999987
Q ss_pred ------CCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc
Q 040413 613 ------DMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686 (795)
Q Consensus 613 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~ 686 (795)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864422 234578999999999999999999999999999999999999997654322
Q ss_pred h-hhcccccccccc--------cc------------------hhhccCcccc-chhhHHHHHHHHHHHHHhcccCCCCCC
Q 040413 687 L-TLLGRAWDLWKD--------DR------------------AWELIDPILQ-NEASYLILNRYINVALLCVQEDAVDRP 738 (795)
Q Consensus 687 ~-~~~~~~~~~~~~--------~~------------------~~~~id~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RP 738 (795)
. ..+......... .. ......+... .......+..+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1 111100000000 00 0000000000 011234567889999999999999999
Q ss_pred CHHHHHHHh
Q 040413 739 TMFEVVSML 747 (795)
Q Consensus 739 t~~evl~~L 747 (795)
|+.|+++|-
T Consensus 322 t~~ell~hp 330 (339)
T 1z57_A 322 TLREALKHP 330 (339)
T ss_dssp CHHHHTTSG
T ss_pred CHHHHhcCH
Confidence 999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=338.06 Aligned_cols=266 Identities=24% Similarity=0.407 Sum_probs=200.4
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
..++|++.++||+|+||.||+|..+. .+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999998753 5999998754 2334466889999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999854 2346899999999999999999999998 99999999999998 689999999998765321
Q ss_pred c---cccceeeecccCCcCChhhhcc---------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc
Q 040413 631 E---LQSKTKRIVGTYGYMSPEYAQQ---------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698 (795)
Q Consensus 631 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 698 (795)
. .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||.............
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------ 256 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG------ 256 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH------
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc------
Confidence 1 1122233468999999998864 457889999999999999999999987544222111000
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCCCC
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQP 760 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p 760 (795)
.. ..+... ....+.++.+++.+||+.+|++|||+.+++++|+.+.........|
T Consensus 257 ~~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~ 310 (319)
T 2y4i_B 257 TG-----MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310 (319)
T ss_dssp TT-----CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred cC-----CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence 00 001110 0112345789999999999999999999999999986555444444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=342.22 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=184.4
Q ss_pred cCCcc-cccccCCCceeEEeeecc---CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeEE
Q 040413 475 ANFST-ENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKIL 548 (795)
Q Consensus 475 ~~y~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 548 (795)
+.|++ .++||+|+||.||+|+++ +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44665 458999999999999864 57899999997543 23578899999999999999999999954 678899
Q ss_pred EEeecCCCCcceeeccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE----cCCCCcee
Q 040413 549 IYEYMPNKSLDIFLFDT------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL----DKDMNPKI 618 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl 618 (795)
||||+.+ +|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 555554311 12335999999999999999999999998 9999999999999 67899999
Q ss_pred eccccccccCCCcc-ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-------hh
Q 040413 619 SDFGMAKMFGGDEL-QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-------TL 689 (795)
Q Consensus 619 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-------~~ 689 (795)
+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653211 122344689999999999887 4589999999999999999999999975443210 00
Q ss_pred ccccccccc--ccchhhcc-------------Cccccchhh---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040413 690 LGRAWDLWK--DDRAWELI-------------DPILQNEAS---------YLILNRYINVALLCVQEDAVDRPTMFEVVS 745 (795)
Q Consensus 690 ~~~~~~~~~--~~~~~~~i-------------d~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 745 (795)
+........ ....+..+ ......... ......+.+|+.+||+.||.+|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00000000 000000000 001346789999999999999999999999
Q ss_pred Hhhcc
Q 040413 746 MLTNE 750 (795)
Q Consensus 746 ~L~~~ 750 (795)
|-.-.
T Consensus 334 hp~f~ 338 (405)
T 3rgf_A 334 DPYFL 338 (405)
T ss_dssp SGGGT
T ss_pred Chhhc
Confidence 86554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.60 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=200.0
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeee---
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE--- 542 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 542 (795)
..+....++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 334455689999999999999999999764 78999999987543 3457899999999999 79999999999987
Q ss_pred ---cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 543 ---LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 543 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999988543 2356899999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccc
Q 040413 620 DFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAW 694 (795)
Q Consensus 620 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~ 694 (795)
|||++....... .......||+.|+|||.+. ...++.++||||||+++|+|++|+.|+........... .
T Consensus 172 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~- 246 (326)
T 2x7f_A 172 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--I- 246 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--H-
T ss_pred eCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH--h-
Confidence 999998654321 1223457899999999986 56789999999999999999999999864432111100 0
Q ss_pred ccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 DLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
. ... .+.. .....+..+.+++.+||+.||.+||++.++++|-
T Consensus 247 --~-~~~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 247 --P-RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp --H-HSC-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred --h-cCc-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 0 000 0000 0111245688999999999999999999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=335.23 Aligned_cols=268 Identities=23% Similarity=0.267 Sum_probs=201.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeec-----cee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-----EEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 546 (795)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999765 68999999997543 33456788999999999999999999988764 678
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 578777743 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc--------ceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccccccc
Q 040413 627 FGGDELQS--------KTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDL 696 (795)
Q Consensus 627 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~ 696 (795)
........ ......||+.|+|||.+.. ..++.++|||||||++|+|++|+.||.......... +......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65322111 1223578999999998765 778999999999999999999999997654221110 0000000
Q ss_pred c---------cccchhhccCc---cc---cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 697 W---------KDDRAWELIDP---IL---QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 697 ~---------~~~~~~~~id~---~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
. ......+.+.. .. ........+..+.+++.+||+.||++|||+.|+++|-.-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0 00000000000 00 000112345678899999999999999999999997533
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.50 Aligned_cols=267 Identities=25% Similarity=0.355 Sum_probs=202.7
Q ss_pred hccCCcccccccCCCceeEEeeec--cCCceEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeeee----
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL--HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKL---QHRNLVRLLGCCI---- 541 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 541 (795)
..++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999986 367899999986532 22234577888888777 8999999999987
Q ss_pred -ecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 542 -ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 542 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
.....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999998 5888887543 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc----
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD---- 695 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~---- 695 (795)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ..+.....
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998654322 22345789999999999999999999999999999999999999876542211 11100000
Q ss_pred -cccccc--hhhccC---ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 696 -LWKDDR--AWELID---PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 696 -~~~~~~--~~~~id---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+.... ....+. ...........+..+.+++.+||+.||++|||+.|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000000 000000 0000111223456788999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.33 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=198.0
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce-----
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE----- 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 545 (795)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 368999999999999999999765 7899999999764 23345778999999999999999999999987654
Q ss_pred -eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 546 -KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 546 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 57766652 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccc-----
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLW----- 697 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~----- 697 (795)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.... ..+.......
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865422 234578999999999877 6789999999999999999999999975542111 1110000000
Q ss_pred ---cccchhh---ccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 698 ---KDDRAWE---LIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 698 ---~~~~~~~---~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
....... .+..... .......+..+.+++.+||+.||++|||+.|+++|-.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0000000 0000000 0111234567889999999999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.09 Aligned_cols=200 Identities=25% Similarity=0.349 Sum_probs=171.5
Q ss_pred hccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-CC-----ceeeeeeeeeecce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HR-----NLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 545 (795)
..++|++.++||+|+||.||+|.+. +++.||||++... ....+++.+|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999765 6889999999753 344577888999999885 44 49999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCcEEeCCCCCCcEEEc--CCCCceeecc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ--YSRLRVIHRDLKASNILLD--KDMNPKISDF 621 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~--~~~~~iiH~Dikp~NIll~--~~~~~kl~DF 621 (795)
.++||||+++ +|.+++... ....+++..+..++.||+.||.|||. .+ |+||||||+||||+ .++.+||+||
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999965 888887543 23458999999999999999999995 45 99999999999995 5788999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCC
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSN 683 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~ 683 (795)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432 234578999999999999999999999999999999999999997654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.40 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=193.5
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee----------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE---------- 542 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 542 (795)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999864 7899999999643 3456789999999999999999999998865
Q ss_pred ---cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceee
Q 040413 543 ---LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKIS 619 (795)
Q Consensus 543 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~ 619 (795)
....++||||+++++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 45679999999999999998542 345788999999999999999999998 9999999999999999999999
Q ss_pred ccccccccCCCcc------------ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcc
Q 040413 620 DFGMAKMFGGDEL------------QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686 (795)
Q Consensus 620 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~ 686 (795)
|||++........ ........||+.|+|||.+.+. .++.++||||||+++|+|++ |+..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H
Confidence 9999986542210 1122345789999999998764 78999999999999999998 3321111 0
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
......... .........+...+..+.+++.+||+.||.+|||+.|+++|-.
T Consensus 235 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 235 VNILKKLRS----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHHHS----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHHHhccc----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 000000000 0001111122333456789999999999999999999998743
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.67 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=203.6
Q ss_pred HhccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
...++|++.++||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 7899999998654 23457889999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC---CCceeecccccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD---MNPKISDFGMAK 625 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DFGla~ 625 (795)
|+||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999887743 246899999999999999999999998 9999999999999754 479999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... ......+|+.|+|||.+.+ .++.++||||||+++|+|++|+.|+.......... .. ......
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~----~~~~~~-- 240 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK--RV----ETGKYA-- 240 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH----HHCCCC--
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--HH----HcCCCC--
Confidence 764332 1223468999999998865 48999999999999999999999987544222111 00 000000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+ .......+.++.+++.+||+.+|++|||+.|++++-
T Consensus 241 ~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 241 FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 00 000112345688999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.69 Aligned_cols=255 Identities=23% Similarity=0.290 Sum_probs=190.1
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+.|.+.++||+|+||+||.+...+++.||||++... ..+.+.+|+.+|+++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999998776668999999998653 346788999999987 8999999999999999999999999
Q ss_pred CCCCcceeeccCCCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC-------------CCc
Q 040413 554 PNKSLDIFLFDTPKE----SPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD-------------MNP 616 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~----~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~-------------~~~ 616 (795)
. ++|.+++...... ....+..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999888643221 11234456789999999999999998 9999999999999754 479
Q ss_pred eeeccccccccCCCccc--cceeeecccCCcCChhhhcc-------CCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcc
Q 040413 617 KISDFGMAKMFGGDELQ--SKTKRIVGTYGYMSPEYAQQ-------GLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDS 686 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~ 686 (795)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 12234579999999999865 678999999999999999999 898986543322
Q ss_pred hhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 687 LTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
........ .. +..........+.++.+++.+||+.||.+|||+.|+++|-
T Consensus 248 ~~i~~~~~---~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 248 SNIIRGIF---SL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp HHHHHTCC---CC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHhcCCC---Cc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 21111110 00 0011112345567889999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=327.84 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=200.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CC-ceEEEEEecccCcccHHHHHHHHHHHHhcCCCc------eeeeeeeeeecce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NG-QEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN------LVRLLGCCIELEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 545 (795)
.++|++.++||+|+||.||+|... ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999764 44 78999999753 344677899999999998766 8999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEE---------------
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILL--------------- 610 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll--------------- 610 (795)
.++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEeccC-CChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 999999994 4555555332 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc
Q 040413 611 ----DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS 686 (795)
Q Consensus 611 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~ 686 (795)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999864322 233579999999999999999999999999999999999999997654222
Q ss_pred h-hhcccccccc---------------cccch-----------hhccCccc-cchhhHHHHHHHHHHHHHhcccCCCCCC
Q 040413 687 L-TLLGRAWDLW---------------KDDRA-----------WELIDPIL-QNEASYLILNRYINVALLCVQEDAVDRP 738 (795)
Q Consensus 687 ~-~~~~~~~~~~---------------~~~~~-----------~~~id~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RP 738 (795)
. ..+....... ..... .+...+.. ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 1 1110000000 00000 00000000 0011223456789999999999999999
Q ss_pred CHHHHHHHh
Q 040413 739 TMFEVVSML 747 (795)
Q Consensus 739 t~~evl~~L 747 (795)
|+.|+++|-
T Consensus 327 t~~e~l~hp 335 (355)
T 2eu9_A 327 TLAEALLHP 335 (355)
T ss_dssp CHHHHTTSG
T ss_pred CHHHHhcCh
Confidence 999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.09 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=179.4
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHH-HHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIK-LIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|++.+.||+|+||.||+|... +++.||||++.... .....++.+|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 68999999999999999999775 78999999997643 233445666665 6777899999999999999999999999
Q ss_pred ecCCCCcceeecc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFD--TPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
|+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 66666532 12246789999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCccccceeeecccCCcCChhhh----ccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYA----QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
... ......||+.|+|||.+ .+..++.++||||||+++|+|++|+.|+........... . ... ...
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~---~~~-~~~-- 247 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-Q---VVK-GDP-- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C-C---CCC-SCC--
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH-H---Hhc-CCC--
Confidence 332 12234789999999998 456789999999999999999999999875332111100 0 000 000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.+........+..+.+++.+||+.||++||++.|++++.
T Consensus 248 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 248 ---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp ---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 0111111112345688999999999999999999998863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=329.34 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=193.0
Q ss_pred HHhccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc------ccHHHHHHHHHHHHhc----CCCceeeeeee
Q 040413 471 SAATANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG------QGLEEFKNEIKLIAKL----QHRNLVRLLGC 539 (795)
Q Consensus 471 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~ 539 (795)
....++|++.++||+|+||.||+|++. +++.||||++..... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999764 788999999975432 1233466899999999 89999999999
Q ss_pred eeecceeEEEEee-cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCce
Q 040413 540 CIELEEKILIYEY-MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPK 617 (795)
Q Consensus 540 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~k 617 (795)
+.+.+..++|+|+ +.+++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999998854 346899999999999999999999998 99999999999999 889999
Q ss_pred eeccccccccCCCccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccc
Q 040413 618 ISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL 696 (795)
Q Consensus 618 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 696 (795)
|+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~--- 249 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----ILEAE--- 249 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHHTC---
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----Hhhhc---
Confidence 99999998765432 234568999999999877665 4589999999999999999999853210 00000
Q ss_pred ccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 697 WKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 697 ~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
. ..+...+..+.+++.+||+.+|++|||+.|++++-.-
T Consensus 250 -----------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 250 -----------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp -----------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred -----------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0 0111234567899999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=329.98 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=201.4
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcC-----------CCceeeeeeeee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-----------HRNLVRLLGCCI 541 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 541 (795)
..+|++.++||+|+||.||+|++ .+++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999976 47899999999753 334577899999999986 899999999998
Q ss_pred ecc----eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEc-----
Q 040413 542 ELE----EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLD----- 611 (795)
Q Consensus 542 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~----- 611 (795)
... ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 754 789999999 88998888543 234589999999999999999999998 8 99999999999995
Q ss_pred -CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch---
Q 040413 612 -KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL--- 687 (795)
Q Consensus 612 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~--- 687 (795)
..+.+||+|||++...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999875432 2235789999999999999999999999999999999999999975432110
Q ss_pred -hhcccccccc------------------cccchhhccCc--------c--ccchhhHHHHHHHHHHHHHhcccCCCCCC
Q 040413 688 -TLLGRAWDLW------------------KDDRAWELIDP--------I--LQNEASYLILNRYINVALLCVQEDAVDRP 738 (795)
Q Consensus 688 -~~~~~~~~~~------------------~~~~~~~~id~--------~--l~~~~~~~~~~~l~~li~~cl~~dP~~RP 738 (795)
.......... ........+.. . .....+...+..+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0000000000 00000000000 0 00123456778899999999999999999
Q ss_pred CHHHHHHHhh
Q 040413 739 TMFEVVSMLT 748 (795)
Q Consensus 739 t~~evl~~L~ 748 (795)
|+.|+++|-.
T Consensus 327 t~~ell~hp~ 336 (373)
T 1q8y_A 327 DAGGLVNHPW 336 (373)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhhChh
Confidence 9999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=326.31 Aligned_cols=257 Identities=18% Similarity=0.194 Sum_probs=176.2
Q ss_pred hccCCcccc-cccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee----ccee
Q 040413 473 ATANFSTEN-KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 473 ~~~~y~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 546 (795)
..++|.+.+ +||+|+||.||+|.+. +++.||||++... .....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346898855 6999999999999776 7899999998653 1222333344667799999999999876 4558
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeecccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGl 623 (795)
++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998643 2357999999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
++...... .....+|+.|+|||.+....++.++||||||+++|+|++|+.||............. .......
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~-- 249 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RRIRLGQ-- 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hhhhccc--
Confidence 98654322 234578999999999988889999999999999999999999986543222110000 0000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
...........+..+.+++.+||+.||++|||+.|+++|-.-
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 000000111234568899999999999999999999997543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=357.54 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=203.3
Q ss_pred hccCCcccccccCCCceeEEeeecc----CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
..++|++.+.||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4578999999999999999999764 2457999998764 3344578999999999999999999999985 45689
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++++|.+++... ...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998542 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
...... ......+|+.|+|||.+....++.++||||||+++|||++ |..||.......... .... ..
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~--~i~~----~~----- 609 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--RIEN----GE----- 609 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHHH----TC-----
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHc----CC-----
Confidence 543221 2223457789999999999999999999999999999997 888886544222110 0000 00
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 610 ----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011223345788999999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=336.38 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=189.0
Q ss_pred hccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEEEe
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 551 (795)
...+|.+.++||+|+||.||.....+++.||||++...... .+.+|+.+|+++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34578999999999999976655567899999999764332 367899999999 79999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-----CCCceeeccccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMAKM 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFGla~~ 626 (795)
|+. ++|.+++.... ..+.+..+..++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 58888875432 33455567899999999999999998 999999999999953 33578999999987
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhc---cCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccc
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQ---QGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |..|+...............
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~------- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC------- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC-------
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC-------
Confidence 653321 12233467999999999987 4567889999999999999999 88888544332222111100
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..... .........+.+++.+||+.||++|||+.|+++|
T Consensus 246 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 SLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Ccccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00000 0112344567899999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=329.87 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=200.6
Q ss_pred HhccCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcc------cHHHHHHHHHHHHhcC--CCceeeeeeeeee
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQ------GLEEFKNEIKLIAKLQ--HRNLVRLLGCCIE 542 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 542 (795)
...++|++.++||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999975 47899999999754221 2355788999999996 5999999999999
Q ss_pred cceeEEEEeecCC-CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCceeec
Q 040413 543 LEEKILIYEYMPN-KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISD 620 (795)
Q Consensus 543 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~D 620 (795)
.+..++|+|++.+ ++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 889888753 356899999999999999999999998 99999999999999 789999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .... . .
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~-~-~--- 260 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIRG-Q-V--- 260 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHHC-C-C---
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----hhcc-c-c---
Confidence 99998765332 223578999999999887665 6889999999999999999999863210 0000 0 0
Q ss_pred cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.. +...+.++.+++.+||+.||++|||+.|++++-.-
T Consensus 261 -----~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 261 -----FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp -----CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred -----cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 00 11123567899999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=320.40 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=180.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc--ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG--QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
.++|++.++||+|+||.||+|.+. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367999999999999999999875 789999999976432 22334555566788889999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
||+ ++.+..+... ....+++..+..++.||++||.|||++ + |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4444444321 235689999999999999999999995 8 99999999999999999999999999976543
Q ss_pred CccccceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
.. ......+|+.|+|||.+. ...++.++||||||+++|+|++|+.||.......... ..... .
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~---~----- 245 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQ---E----- 245 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-HHHHH---S-----
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH-HHHhc---c-----
Confidence 32 122357899999999984 5678899999999999999999999987533221111 00000 0
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..+.+.. ....+..+.+++.+||+.||.+||++.|+++|-
T Consensus 246 -~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 246 -EPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp -CCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred -CCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 0000000 011345688999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=347.53 Aligned_cols=264 Identities=26% Similarity=0.326 Sum_probs=200.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeee------cce
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE------LEE 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 545 (795)
.++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999764 6899999998764 34456779999999999999999999998765 667
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCC---ceeeccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMN---PKISDFG 622 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DFG 622 (795)
.++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999998 999999999999997765 8999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccc-----cccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA-----WDLW 697 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~-----~~~~ 697 (795)
++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ..... ....
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------CC
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhhh
Confidence 9987654322 2346799999999999999999999999999999999999999864321100 00000 0000
Q ss_pred cccchhh--ccCcc--ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040413 698 KDDRAWE--LIDPI--LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVV 744 (795)
Q Consensus 698 ~~~~~~~--~id~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 744 (795)
....... .+... .........+..+.+++.+||+.||++|||+.|++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000000 00000 01123334567889999999999999999997743
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=346.08 Aligned_cols=237 Identities=21% Similarity=0.333 Sum_probs=192.8
Q ss_pred cCCcccccccCCCceeEEeeecc--CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecce-----e
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE-----K 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 546 (795)
++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999765 5899999998754 33455678999999999999999999999988765 6
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+|||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887632 6999999999999999999999998 9999999999999885 999999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.... ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+.......
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------- 283 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------- 283 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------
Confidence 6432 3457999999999987764 889999999999999999987764311000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhhc
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPT-MFEVVSMLTN 749 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~ 749 (795)
.............+.+++.+||+.||++||+ ++++.+.|..
T Consensus 284 --~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 --LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0011112233467889999999999999995 5666665554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.10 Aligned_cols=232 Identities=15% Similarity=0.061 Sum_probs=184.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 368999999999999999999875 58999999997653 33457899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. . ....++.+++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 355678999999999999999998 9999999999999999999998543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
|++| ++.++|||||||++|||++|+.||.......... .......... .
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--~~~~~~~~~~-------~ 223 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--PAERDTAGQP-------I 223 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--ECCBCTTSCB-------C
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--HHHHHhccCC-------C
Confidence 3333 6789999999999999999999997654322110 0000000000 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
.........+..+.+++.+||+.||++| |+.|+++.|+....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0001112334568899999999999999 99999999988643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.63 Aligned_cols=234 Identities=18% Similarity=0.206 Sum_probs=181.2
Q ss_pred ccCCccc-ccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHH-HhcCCCceeeeeeeeee----ccee
Q 040413 474 TANFSTE-NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLI-AKLQHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~y~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 546 (795)
..+|.+. +.||+|+||.||+|... +++.||||++.. ...+.+|+.++ +.++||||+++++++.+ ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567777 78999999999999764 789999999864 24678899888 55689999999999887 6778
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeecccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGl 623 (795)
++||||+++++|.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998653 3346999999999999999999999998 999999999999998 78999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
+.... +..++.++|||||||++|||++|+.||........... .........
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~~~~~-- 218 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQ-- 218 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSSCTTC--
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHHhhcc--
Confidence 97533 13467789999999999999999999865432211100 000000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
...........+..+.+++.+||+.||++|||+.|+++|..
T Consensus 219 ----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 219 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp ----CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 00000011223567889999999999999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.45 Aligned_cols=244 Identities=15% Similarity=0.128 Sum_probs=185.9
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEecccC--------cccHHHHHHHHHHHHhcC---------CCceeee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQS--------GQGLEEFKNEIKLIAKLQ---------HRNLVRL 536 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 536 (795)
.++|++.++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999987 67999999997642 234588999999999996 6666665
Q ss_pred eee-----------------eee-------------cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHH
Q 040413 537 LGC-----------------CIE-------------LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG 586 (795)
Q Consensus 537 ~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a 586 (795)
.+. +.+ .+..++||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 554 333 678999999999997655552 2568999999999999999
Q ss_pred HHHHH-hcCCCcEEeCCCCCCcEEEcCCC--------------------CceeeccccccccCCCccccceeeecccCCc
Q 040413 587 LLYLH-QYSRLRVIHRDLKASNILLDKDM--------------------NPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645 (795)
Q Consensus 587 L~~LH-~~~~~~iiH~Dikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 645 (795)
|+||| +++ |+||||||+||||+.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 898 99999999999999887 8999999999875422 35799999
Q ss_pred CChhhhccCCCCccCCeeehhHH-HHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHH
Q 040413 646 MSPEYAQQGLFSIKSDVFSFGVL-LLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYIN 724 (795)
Q Consensus 646 ~aPE~~~~~~~s~k~DvwslG~l-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~ 724 (795)
+|||++.+.. +.++|||||+++ .+++++|..|+...... ........ .. ...............+.++.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~~~~~~---~~----~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-HYLTDKML---KQ----MTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHHHHHHH---HT----CCCSSCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-hHHHHhhh---hh----hccCcccchhhhhhcCHHHHH
Confidence 9999998766 899999998777 77788898886321000 00000000 00 001111112234567788999
Q ss_pred HHHHhcccCCCCCCCHHHHH-HH
Q 040413 725 VALLCVQEDAVDRPTMFEVV-SM 746 (795)
Q Consensus 725 li~~cl~~dP~~RPt~~evl-~~ 746 (795)
++.+||+.| |+.|++ +|
T Consensus 315 li~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHhccC-----CHHHHHhcC
Confidence 999999976 999999 76
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=319.38 Aligned_cols=243 Identities=14% Similarity=0.184 Sum_probs=180.0
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC---cccHHHHHHHHHHHHhcCC-Ccee---------eee--
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQH-RNLV---------RLL-- 537 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv---------~l~-- 537 (795)
..+|...++||+|+||.||+|.+ .+++.||||++.... ....+.+++|+.+++.++| +|.. ..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34678889999999999999985 478999999987432 2336789999999999987 2211 111
Q ss_pred ----------eeeee-----cceeEEEEeecCCCCcceeecc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 040413 538 ----------GCCIE-----LEEKILIYEYMPNKSLDIFLFD----TPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRV 598 (795)
Q Consensus 538 ----------~~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 598 (795)
.++.. ....+++|+++ +++|.+++.. ......+++..+..++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12345666654 6788877731 123456888899999999999999999998 9
Q ss_pred EeCCCCCCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhh----------ccCCCCccCCeeehhHH
Q 040413 599 IHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA----------QQGLFSIKSDVFSFGVL 668 (795)
Q Consensus 599 iH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DvwslG~l 668 (795)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865422 334577 999999998 55568889999999999
Q ss_pred HHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 669 LLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 669 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+|||++|+.||.......... . .+... ...+..+.+++.+||+.||++||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~--~------------~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE--W------------IFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG--G------------GGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHH--H------------HHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999986543211100 0 00000 0123568899999999999999998777654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=283.66 Aligned_cols=184 Identities=17% Similarity=0.150 Sum_probs=131.2
Q ss_pred cccCCCceeEEeeecc-CCceEEEEEecccC----------cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEE
Q 040413 482 KLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS----------GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 482 ~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 549 (795)
.++.|++|.+..++.. .|+.+|+|++.+.. +...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4677888877777543 68999999996531 23456799999999999 799999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||++|++|.++|.. ..+++.. +|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3456654 58999999999999999 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCC
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR 677 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~ 677 (795)
.. ......+||+.|||||++.+ .+..++|+|++|+++++|.++..
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 22334689999999998875 46778999999999988876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-25 Score=253.51 Aligned_cols=184 Identities=20% Similarity=0.236 Sum_probs=144.4
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecccCc--------ccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG--------QGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
...++||+|+||.||+|.. .++.+|+|+...... ...+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999944 468899998654311 1245689999999999999999776677778888999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998843 5689999999999999998 999999999999998 999999999998754
Q ss_pred Ccccc-----ceeeecccCCcCChhhhcc--CCCCccCCeeehhHHHHHHHhCCCC
Q 040413 630 DELQS-----KTKRIVGTYGYMSPEYAQQ--GLFSIKSDVFSFGVLLLETLSSKRN 678 (795)
Q Consensus 630 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DvwslG~ll~elltg~~p 678 (795)
..... ......||+.|+|||++.. ..|+.++|+|+..+-..+.+.++.+
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 32211 1235689999999999976 5678889999998888887766644
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.2e-22 Score=174.59 Aligned_cols=105 Identities=20% Similarity=0.418 Sum_probs=91.9
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
.|+|.+||.|.+|++|+| |.|.|.|..+++ |.++. ..++||+|||+.|. ...+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCC-CccEEEEEeCCccEEEECCC
Confidence 478999999999999998 889999987765 66654 36999999999997 44689999999999999999
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeec
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+.+||+|+++...+..+|+|+|||||||++. +||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9999999987666777899999999999962 59998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=213.35 Aligned_cols=155 Identities=19% Similarity=0.174 Sum_probs=124.9
Q ss_pred cHHHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCc------------------ccHHHHHHHHHHHHh
Q 040413 466 SLASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG------------------QGLEEFKNEIKLIAK 527 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~ 527 (795)
.+..+......|++.+.||+|+||.||+|...+++.||||+++.... .....+.+|+.+|++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455556677888899999999999999887799999999964321 134678999999999
Q ss_pred cCCCceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCc
Q 040413 528 LQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASN 607 (795)
Q Consensus 528 l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~N 607 (795)
++ | +++.+++. .+..++||||+++++|.+ +. ......++.||++||.|||+++ |+||||||+|
T Consensus 161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 99 5 66666543 456799999999999987 41 1235579999999999999998 9999999999
Q ss_pred EEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhcc
Q 040413 608 ILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653 (795)
Q Consensus 608 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 653 (795)
||++ ++.+||+|||+++. +..++|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9999 99999999999964 234688998753
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=172.33 Aligned_cols=110 Identities=24% Similarity=0.399 Sum_probs=96.1
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
+|+|.+||.|.+|++|+ ++|.|+|+|+.+|+ -++|+ ..++||.||++.| +..+.|.|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999988775 26776 4799999999877 44689999999999999999
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCC
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPS 153 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Pt 153 (795)
+.++|+|++....+...++|+|+|||||++ . ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~------~--~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG------P--VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC------S--EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEEC------C--CEecCCCcCC
Confidence 999999997766567789999999999995 1 7999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=174.49 Aligned_cols=108 Identities=19% Similarity=0.346 Sum_probs=95.9
Q ss_pred hcccccCCCccccCCCeEe--cCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEE
Q 040413 23 IAADTITPSRFIRDGEKLV--SSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVI 100 (795)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l 100 (795)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ -+||++ +++||+||++.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 6789999999999999999 999999999998775 268876 799999999877 4568999999999999
Q ss_pred ecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeec
Q 040413 101 LNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148 (795)
Q Consensus 101 ~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+|.++.++|+|++....+...++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999997665567789999999999995 279998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-20 Score=168.23 Aligned_cols=110 Identities=23% Similarity=0.403 Sum_probs=94.2
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
.|||.+||+|.+|++|+ +|.|+|+|+.+|+ + ++|+ ..++||+||++.| +.++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 58999999999999998 7999999987664 2 2465 4799999999988 35689999999999999988
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCC
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSD 154 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtD 154 (795)
+.++|+|++....+...++|+|+|||||++ . ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~------~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG------P--VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC------S--EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC------C--CEEECCCCCCc
Confidence 899999987655566789999999999995 2 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=166.82 Aligned_cols=110 Identities=25% Similarity=0.456 Sum_probs=94.2
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
+|||.+||.|.+|++| ++|.|+|+|+.+|+ -+||++ .++||+||++.+ +.++.|.|..||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 47999999998876 246765 799999999864 456899999999999999 8
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCC
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHP 152 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (795)
+.++|+|.+....+...++|+++|||||++. .+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECC-----CCceEEECCCcc
Confidence 8899999876555667899999999999973 467999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=159.32 Aligned_cols=105 Identities=26% Similarity=0.427 Sum_probs=88.7
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
.+||.|||.|.+|++|+ +|.|+|+|+.+|+ +. .|+. .++||++|++.+ +..+.|.|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lv-ly~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LV-LYDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EE-EEET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EE-EEeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999997 6999999988775 32 3654 699999999876 45689999999999999998
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeecc
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSF 149 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (795)
+.++|+|++.+.....+|+|+||||||||+. ++|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeCC
Confidence 8999999976554557899999999999962 799984
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-18 Score=152.79 Aligned_cols=105 Identities=21% Similarity=0.333 Sum_probs=87.2
Q ss_pred hcccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEec
Q 040413 23 IAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILN 102 (795)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (795)
.|.|||.|||.|.+|+.|+| |.|.|.|...|+ |.+ |.. ++||.+|+... +..+.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 58899999999999999998 569997755553 444 554 58999999863 456899999999999999
Q ss_pred CCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeec
Q 040413 103 LKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148 (795)
Q Consensus 103 ~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
.++.++|+|++....+..+|+|+||||||||+ .++|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~--------~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG--------PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec--------CCEecC
Confidence 99999999997654455789999999999995 379987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=181.39 Aligned_cols=138 Identities=14% Similarity=0.182 Sum_probs=107.0
Q ss_pred cCCcccccccCCCceeEEeeec-cCCce--EEEEEecccCcc------------------------cHHHHHHHHHHHHh
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQE--VAVKRLSSQSGQ------------------------GLEEFKNEIKLIAK 527 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~ 527 (795)
.-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999987 67888 999997543111 12368899999999
Q ss_pred cCCCce--eeeeeeeeecceeEEEEeecCC-C----CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEE
Q 040413 528 LQHRNL--VRLLGCCIELEEKILIYEYMPN-K----SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH-QYSRLRVI 599 (795)
Q Consensus 528 l~h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ii 599 (795)
++|+++ ..+++. ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 988864 333332 467899999942 4 44443311 234577899999999999999 888 99
Q ss_pred eCCCCCCcEEEcCCCCceeecccccccc
Q 040413 600 HRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 600 H~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999988 9999999999764
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.5e-17 Score=149.17 Aligned_cols=108 Identities=19% Similarity=0.315 Sum_probs=90.5
Q ss_pred hcccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEec
Q 040413 23 IAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILN 102 (795)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (795)
.+.|+|.+||.|.+|+.|.+ |.|.|.|...|+ |.++.. ...++||.+|+..+ +..+.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 46799999999999999986 889999977665 555432 24789999999876 446899999999999999
Q ss_pred CCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeec
Q 040413 103 LKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148 (795)
Q Consensus 103 ~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
.++.++|+|++....+..+|+|+||||||||+ ..+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 98999999997655455789999999999995 479997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=144.88 Aligned_cols=109 Identities=22% Similarity=0.388 Sum_probs=89.0
Q ss_pred hcccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEec
Q 040413 23 IAADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILN 102 (795)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (795)
.|.|||.|||.|.+|+.| .+|.|.|.|...|+ | +.|.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----L-vl~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----L-VLYNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----E-EEETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----E-EEEeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 378999999999999999 46999999976665 2 23432 699998865 457899999999999999
Q ss_pred CCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCC
Q 040413 103 LKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPG 159 (795)
Q Consensus 103 ~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg 159 (795)
.++.++|+|++.......+|+|+|||||||++ .++|+| +|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC-----CCccCC
Confidence 98999999987654456789999999999995 479997 555554
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=141.14 Aligned_cols=96 Identities=23% Similarity=0.382 Sum_probs=78.9
Q ss_pred CCCCCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCc
Q 040413 82 PIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMK 161 (795)
Q Consensus 82 p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~ 161 (795)
|+.+...+|.|+.||+|+|++. +.+||++++.....+++|+|+++|||||+| .+.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d------~~~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS------GSRAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE------TTEEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc------CCEEEEECCc-----------
Confidence 4445568899999999999987 789999997543345789999999999997 2469999994
Q ss_pred cccccccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEec-CceeEEeeCCCCc
Q 040413 162 LGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYN-GSVKLLCSGPWNG 217 (795)
Q Consensus 162 l~~~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~-~~~~~~~sg~w~~ 217 (795)
+|++|.|++.++++|. ++++. +..+||++++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4467899999999998 45565 5789999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4e-16 Score=139.21 Aligned_cols=90 Identities=21% Similarity=0.350 Sum_probs=74.9
Q ss_pred CCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccc
Q 040413 85 DSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGW 164 (795)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~ 164 (795)
+...+|.|+.||||||++ .+.+||++++......++|+|+|+|||||+|. .+.++||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~-----~~~~~W~S~t-------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ-----SNRVIWQTKT-------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECCC--------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC-----CCcEEEecCC--------------
Confidence 446789999999999998 57899999976444557899999999999984 5689999993
Q ss_pred ccccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCCC
Q 040413 165 DLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPW 215 (795)
Q Consensus 165 ~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~w 215 (795)
+|++|.|++.++.+|. ++++++ +||+++++
T Consensus 79 -----------------~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 79 -----------------NGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------------CCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------------CCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 4567999999999997 556775 79999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=173.12 Aligned_cols=146 Identities=13% Similarity=0.141 Sum_probs=105.0
Q ss_pred HHHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCc--------------ccHHH--------HHHHHHHH
Q 040413 468 ASVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG--------------QGLEE--------FKNEIKLI 525 (795)
Q Consensus 468 ~~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~--------~~~E~~~l 525 (795)
.++.....=|++.++||+|++|.||+|...+|+.||||+++.... ..... ..+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344444445999999999999999999988999999998753210 01111 23566666
Q ss_pred HhcCCCceeeeeeeeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCC
Q 040413 526 AKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKA 605 (795)
Q Consensus 526 ~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp 605 (795)
.++.+.++....-+ .....+|||||++|.+|.++.. ......++.||+.+|.+||+.| ||||||||
T Consensus 168 ~rL~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp 233 (397)
T 4gyi_A 168 KALYEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNE 233 (397)
T ss_dssp HHHHHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred HHHHhcCCCCCeee--eccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 66654443211111 1123479999999988866541 1234678899999999999998 99999999
Q ss_pred CcEEEcCCCC----------ceeecccccccc
Q 040413 606 SNILLDKDMN----------PKISDFGMAKMF 627 (795)
Q Consensus 606 ~NIll~~~~~----------~kl~DFGla~~~ 627 (795)
.|||+++++. +.|+||+-+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999988773 899999987653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.59 E-value=5e-15 Score=132.12 Aligned_cols=103 Identities=15% Similarity=0.273 Sum_probs=83.3
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
.|+|.|||.|.+|+.|. +|.|.|.|...|+ |.+ |.. .. ||.+|+..+ +..+.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 48999999999999995 6999999976665 333 443 23 999999876 44689999999999999988
Q ss_pred Cc-eeeeeccc--CCCCccEEEEecCCCeeeecCCCCCCCCCceeec
Q 040413 105 NG-TIWSSNMT--RKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148 (795)
Q Consensus 105 ~~-~~W~t~~~--~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+. ++|+|++. ...+..+|+|++|||||||+ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 59999963 23356789999999999995 479997
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-15 Score=133.66 Aligned_cols=87 Identities=24% Similarity=0.306 Sum_probs=72.6
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccccc
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~ 166 (795)
..+|.|+.||+|+|++. +.+||++++.....+++|+|+|+|||||+|. ++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-----~~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-----CCcEEEcCC-----------------
Confidence 46789999999999987 7899999976444457899999999999984 568999999
Q ss_pred ccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 167 KTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 167 ~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
.+|++|.|++.++++|. +++++ .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34578999999999998 45665 38999987
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=8.1e-15 Score=131.94 Aligned_cols=91 Identities=31% Similarity=0.421 Sum_probs=75.9
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccccc
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~ 166 (795)
...|.|+.||||+|++ .+.+||++++.....++.++|+++|||||+|. ++.++||||++|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~-----~~~~vW~S~~~~-------------- 80 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH-----NNNDVWGSACWG-------------- 80 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC-----CceEEEEcCCCC--------------
Confidence 5679999999999998 57899999975444457899999999999984 467999999973
Q ss_pred ccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCCCCce
Q 040413 167 KTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPWNGV 218 (795)
Q Consensus 167 ~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~w~~~ 218 (795)
++|.|++.++.+|. ++++++ .||++++|...
T Consensus 81 -----------------~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 81 -----------------DNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------SSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 56889999999997 556765 89999999764
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.32 E-value=5.8e-12 Score=112.66 Aligned_cols=95 Identities=19% Similarity=0.299 Sum_probs=72.6
Q ss_pred CCCCCCCCceEEEeecCCeEEecC-CCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCC
Q 040413 80 NRPIFDSNATLTIGSSGNLVILNL-KNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLP 158 (795)
Q Consensus 80 ~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLp 158 (795)
+.|+++...+|.|+.||||||++. .+.++|++++.....++.|+|+++|||||+|. .+.++|||=.+-
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~-----~~~~iW~S~t~~------ 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD-----RLNTVFVSNTVG------ 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TSCEEEECSCCC------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC-----CCCEEEECCCcC------
Confidence 345556678999999999999998 48899999976443457899999999999984 457899973310
Q ss_pred CCccccccccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 159 GMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 159 g~~l~~~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
..|.|.+.++.+|...+ +. .++|.+|+
T Consensus 87 -------------------------~~~~~~~~L~~dGnlvl--y~--~~~W~s~~ 113 (113)
T 3mez_B 87 -------------------------QEGDYVLILQINGQAVV--YG--PAVWSTAA 113 (113)
T ss_dssp -------------------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred -------------------------CCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence 13458889999988764 44 57898875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9e-12 Score=129.55 Aligned_cols=112 Identities=21% Similarity=0.369 Sum_probs=84.5
Q ss_pred cccccCCCcc----ccCCCeEecCCCeEEEEEeCCC--CCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCC
Q 040413 24 AADTITPSRF----IRDGEKLVSSSQRFELGFFSPG--KSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGN 97 (795)
Q Consensus 24 ~~~~~~~~~~----l~~~~~l~s~~g~f~lgf~~~~--~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~ 97 (795)
-+||+.||+. |..|+.|.|+ ..++.|+|... ..... -+ |.+ ..+++|.+++..+ +. +.|.|+.+|+
T Consensus 135 ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnl--vL-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~dGn 206 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNL--VA-YGP-NGAATWNAGTQGK--GA-VRAVFQGDGN 206 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCE--EE-ECT-TSSEEEECCCTTT--TC-CEEEECTTSC
T ss_pred cccccccccccccccccCcccccC-CCCCCceEEEeecCCceE--EE-EeC-CCeEEEECCCCCC--cc-EEEEEcCCCe
Confidence 5699999999 8899999764 34444444321 11122 23 332 3689999999876 33 7899999999
Q ss_pred eEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCC
Q 040413 98 LVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDH 151 (795)
Q Consensus 98 l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
|+++|.++.++|+|++... ...+|+|++||||||++ . .++||||||
T Consensus 207 Lvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~------~-~~~Wqsf~~ 252 (276)
T 3m7h_A 207 LVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILD------E-KPVWARFGF 252 (276)
T ss_dssp EEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEE------E-EEEEESSSC
T ss_pred EEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEc------C-CCeEEccCc
Confidence 9999988889999996543 45789999999999996 2 589999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=8.5e-12 Score=129.68 Aligned_cols=146 Identities=15% Similarity=0.078 Sum_probs=115.6
Q ss_pred HhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEE
Q 040413 472 AATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 472 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 550 (795)
.....|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467888888999999999999764 6899999987532233456999999999995 677888999998888999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS------------------------------------ 594 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------ 594 (795)
|+++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999998876531 11234578899999999999811
Q ss_pred --------------------CCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 595 --------------------RLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 595 --------------------~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13499999999999998766667999998753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.9e-11 Score=107.68 Aligned_cols=94 Identities=18% Similarity=0.232 Sum_probs=70.2
Q ss_pred CCCCCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCc
Q 040413 82 PIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMK 161 (795)
Q Consensus 82 p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~ 161 (795)
++.+....|.|+.||||||++..+ +|+|++......+.|+|+++|||||++.+ .+.++|||..+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~----~~~~vW~S~t~---------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN----SNTPVWVYPRS---------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS----CSSCSEEESSS----------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC----CCEEEEEeccc----------
Confidence 344456789999999999999876 99999764444578999999999999842 23359998731
Q ss_pred cccccccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 162 LGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 162 l~~~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
.....|.|.+.++.+|...+ |. .++|.+++
T Consensus 80 -------------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 -------------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp -------------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred -------------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 01134779999999998774 44 67898765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.16 E-value=9.4e-11 Score=104.13 Aligned_cols=87 Identities=21% Similarity=0.336 Sum_probs=66.2
Q ss_pred CCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCccccc
Q 040413 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWD 165 (795)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~ 165 (795)
.+..|.|+.||||||++. .++|++++......+.++|+++|||||+|. .+.++|||-.+-
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~-----~~~~iW~S~t~~------------- 83 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD-----DFKTIWSSRSSS------------- 83 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT-----TCCEEEECCCCC-------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC-----CCCEEEEcCCcC-------------
Confidence 457899999999999986 589999976543456899999999999984 467899975421
Q ss_pred cccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 166 LKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 166 ~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
..|.|.+.++.+|...+ ++ .++|.+|+
T Consensus 84 ------------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~~ 110 (110)
T 3r0e_B 84 ------------------KQGEYVLILQDDGFGVI--YG--PAIFETSS 110 (110)
T ss_dssp ------------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred ------------------CCCCEEEEEcCCccEEE--ec--CCEecCCC
Confidence 13458888998888664 44 47887763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=8.2e-11 Score=121.70 Aligned_cols=138 Identities=18% Similarity=0.187 Sum_probs=104.0
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~ 552 (795)
.++.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++..+.+..++|||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455554333456669999998777888999997653 2356889999999996544 45688888877788999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS-------------------------------------- 594 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 594 (795)
++|.+|. . . .. ....++.++++.|..||...
T Consensus 97 i~G~~l~--~-~-----~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--S-S-----HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--T-S-----CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--c-C-----cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 2 1 11 12367888889999999753
Q ss_pred -----------------CCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 595 -----------------RLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 595 -----------------~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
...++|+|++|.||+++.++.+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999999864
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.9e-10 Score=102.17 Aligned_cols=88 Identities=19% Similarity=0.302 Sum_probs=66.5
Q ss_pred CCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCccccc
Q 040413 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWD 165 (795)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~ 165 (795)
....|.|+.||||||++. +.++|++++......+.++|+++|||||+|. .+.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~-----~~~~~W~S~t~~------------- 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP-----RNNPIWASNTGG------------- 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT-----TSCEEEECCCCC-------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC-----CCCEEEECCCCC-------------
Confidence 357899999999999987 6899999975443457899999999999984 467899975421
Q ss_pred cccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 166 LKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 166 ~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
..+.|.+.++.+|...++ +. ++|.+|.
T Consensus 80 ------------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 ------------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp ------------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred ------------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124678889888876643 32 5676664
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.5e-10 Score=101.20 Aligned_cols=91 Identities=22% Similarity=0.390 Sum_probs=69.1
Q ss_pred CCCCCCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCC
Q 040413 81 RPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGM 160 (795)
Q Consensus 81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~ 160 (795)
.|+.+....|.|+.||||||+++ +|+|++......+.++|+++|||||+|. .+.++|+|-..
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~-----~~~~vWss~t~--------- 77 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG-----DGSTVWKSGAQ--------- 77 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT-----TSCEEEECCCC---------
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC-----CCCEEEcCCCc---------
Confidence 34445577899999999999984 7999976544467899999999999974 45789975210
Q ss_pred ccccccccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCCC
Q 040413 161 KLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPW 215 (795)
Q Consensus 161 ~l~~~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~w 215 (795)
...+.|.+.++.+|...+ +. .++|.+++|
T Consensus 78 ----------------------~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 ----------------------SVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW 106 (109)
T ss_dssp ----------------------CSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred ----------------------CCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence 023568899999987664 44 689999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.7e-09 Score=116.17 Aligned_cols=142 Identities=12% Similarity=0.229 Sum_probs=108.0
Q ss_pred ccccccCCCceeEEeeeccCCceEEEEEec--ccC-cccHHHHHHHHHHHHhcC--CCceeeeeeeeeec---ceeEEEE
Q 040413 479 TENKLGEGGFGPVYKGRLHNGQEVAVKRLS--SQS-GQGLEEFKNEIKLIAKLQ--HRNLVRLLGCCIEL---EEKILIY 550 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 550 (795)
..+.|+.|.++.||+....+ +.+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45789999999999998754 688899875 321 123457889999999997 45578888888776 3479999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS------------------------------------ 594 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~------------------------------------ 594 (795)
|+++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874321 234678888999999999999999731
Q ss_pred -------------------CCcEEeCCCCCCcEEEcCCCC--ceeeccccccc
Q 040413 595 -------------------RLRVIHRDLKASNILLDKDMN--PKISDFGMAKM 626 (795)
Q Consensus 595 -------------------~~~iiH~Dikp~NIll~~~~~--~kl~DFGla~~ 626 (795)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.85 E-value=1.2e-08 Score=89.68 Aligned_cols=77 Identities=26% Similarity=0.349 Sum_probs=58.9
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccC-CCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCccccc
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTR-KAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWD 165 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~ 165 (795)
.-+|.|+.||||||++. +.+||++++.. ....+.++|+++|||||+|. +++++|+|-.
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-----~~~~vWss~t--------------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS-----SGRSLWASHS--------------- 78 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT-----TCCEEEECCC---------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC-----CcEEEEEecC---------------
Confidence 35799999999999984 58999999753 33456899999999999984 5678998621
Q ss_pred cccCcceEEEeeccCCCCCCCceEEEeeccCcceE
Q 040413 166 LKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKL 200 (795)
Q Consensus 166 ~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~ 200 (795)
....+.|.+.+..+|...+
T Consensus 79 ----------------~~~~~~~~l~L~ddGNlVl 97 (105)
T 4h3o_A 79 ----------------TRGSGNYILILQDDGNVII 97 (105)
T ss_dssp ----------------CCCSSCEEEEECTTSCEEE
T ss_pred ----------------CCCCCCEEEEEeCCCeEEE
Confidence 1134568888888887664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.76 E-value=3.3e-09 Score=112.61 Aligned_cols=187 Identities=18% Similarity=0.225 Sum_probs=123.6
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCc--eeeeeeeeeecc---eeEEEEeec
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRN--LVRLLGCCIELE---EKILIYEYM 553 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~ 553 (795)
.+.++.|....||+.. +.+++|+.... .....+.+|+++|+.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999874 56899986532 34678999999999884 332 344444443333 347899999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS--------------------------------------- 594 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--------------------------------------- 594 (795)
+|.+|..... ..++.+++..++.++++.|..||...
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864321 24677888899999999999999621
Q ss_pred ----------------CCcEEeCCCCCCcEEEcC--CCCceeeccccccccCCCccccce------------eeecccCC
Q 040413 595 ----------------RLRVIHRDLKASNILLDK--DMNPKISDFGMAKMFGGDELQSKT------------KRIVGTYG 644 (795)
Q Consensus 595 ----------------~~~iiH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~------------~~~~gt~~ 644 (795)
...++|+|++|.||+++. ...+.|+||+.+..-......... .......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 135899999999999998 456789999998653211000000 00000111
Q ss_pred cCC-hhhhccCCCCccCCeeehhHHHHHHHhCCCCC
Q 040413 645 YMS-PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNT 679 (795)
Q Consensus 645 y~a-PE~~~~~~~s~k~DvwslG~ll~elltg~~p~ 679 (795)
... |+..... ....+.|+++.+++.+.+|..++
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 122 2222111 12257899999999999998654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.74 E-value=3.1e-08 Score=100.88 Aligned_cols=58 Identities=26% Similarity=0.345 Sum_probs=48.3
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCC
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDH 151 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
..+|.|+.||+|+|++. +.+||.+|+... ..+.++|+++|||||+|. .+.++|+|+.+
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~-----~~~~vW~s~~~ 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTA-----QNTIRWSSGTK 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCT-----TTCCSCCCCCC
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcC-----CCcEEEeCCcc
Confidence 45677888999999986 789999996544 566889999999999984 57799999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.9e-06 Score=91.31 Aligned_cols=136 Identities=22% Similarity=0.208 Sum_probs=99.8
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCC---ceeeeeeeee-ecceeEEEEeecCC
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHR---NLVRLLGCCI-ELEEKILIYEYMPN 555 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~ 555 (795)
.+.++.|....||+. ++.+++|+-. .......+.+|+.+|+.+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 457888999999988 5788999853 233457899999999999752 3456666654 34457899999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS----------------------------------------- 594 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------------------------------- 594 (795)
..+..... ..++..+...++.++++.|..||+..
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88765321 12456667777777777777777532
Q ss_pred ----------------CCcEEeCCCCCCcEEEcC---CCCc-eeeccccccc
Q 040413 595 ----------------RLRVIHRDLKASNILLDK---DMNP-KISDFGMAKM 626 (795)
Q Consensus 595 ----------------~~~iiH~Dikp~NIll~~---~~~~-kl~DFGla~~ 626 (795)
...++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999987 4554 8999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.2e-06 Score=90.81 Aligned_cols=135 Identities=18% Similarity=0.178 Sum_probs=101.1
Q ss_pred cccCCCce-eEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 482 KLGEGGFG-PVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 482 ~LG~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
.+..|..| .||+.... +++.+++|+-.. .....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556665 58988765 567899998643 24567889999999885 33467788888888999999999999877
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS-------------------------------------------- 594 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 594 (795)
.+.... .......+..++++.|..||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654421 12344567778888888888531
Q ss_pred -----------CCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 595 -----------RLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 595 -----------~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.1e-06 Score=93.02 Aligned_cols=147 Identities=11% Similarity=0.042 Sum_probs=94.5
Q ss_pred cccc-cCCCceeEEeeecc-------CCceEEEEEecccC---cccHHHHHHHHHHHHhcC-C--Cceeeeeeeeeec--
Q 040413 480 ENKL-GEGGFGPVYKGRLH-------NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQ-H--RNLVRLLGCCIEL-- 543 (795)
Q Consensus 480 ~~~L-G~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 543 (795)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4678 88999999998754 26789999865422 111256889999999885 3 3567778777654
Q ss_pred -ceeEEEEeecCCCCcceeeccC---CCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------
Q 040413 544 -EEKILIYEYMPNKSLDIFLFDT---PKESPLGWETRVRVIEEIAQGLLYLHQ--------------------------- 592 (795)
Q Consensus 544 -~~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~--------------------------- 592 (795)
...++|||+++|..+.+.+... .....++..+...++.++++.|.-||.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW 184 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence 3468999999998876432000 000012333333334444444433332
Q ss_pred ---------------------------c-------CCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 593 ---------------------------Y-------SRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 593 ---------------------------~-------~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
. ....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 1 134699999999999999654578999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=2.8e-05 Score=83.22 Aligned_cols=142 Identities=16% Similarity=0.185 Sum_probs=83.2
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC--Cceeeeee------eeeecceeEEEEe
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH--RNLVRLLG------CCIELEEKILIYE 551 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~E 551 (795)
.+.|+.|..+.||+....++ .+++|+.... .+++..|+.+++.|.. -.+.+++. +....+..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34676677899999977654 5999998752 3455567777776642 12333332 1234567789999
Q ss_pred ecCCCCcce--------------eecc----C--CCC-----CCCCHHHH------------------------------
Q 040413 552 YMPNKSLDI--------------FLFD----T--PKE-----SPLGWETR------------------------------ 576 (795)
Q Consensus 552 ~~~~gsL~~--------------~l~~----~--~~~-----~~l~~~~~------------------------------ 576 (795)
|++|..+.. .++. . ... ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999876531 0000 0 000 01122110
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 577 -VRVIEEIAQGLLYLHQ----------YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 577 -~~i~~qia~aL~~LH~----------~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
..+..++.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112234446666653 1234599999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=3e-05 Score=85.25 Aligned_cols=75 Identities=11% Similarity=0.201 Sum_probs=51.1
Q ss_pred cccccCCCceeEEeeecc-CCceEEEEEecccCc-------ccHHHHHHHHHHHHhcCC--Cc-eeeeeeeeeecceeEE
Q 040413 480 ENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG-------QGLEEFKNEIKLIAKLQH--RN-LVRLLGCCIELEEKIL 548 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 548 (795)
.+.||.|..+.||++... +++.++||....... ...+++..|.++|+.+.+ +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 468899998653211 234567889999998843 33 3455543 3455689
Q ss_pred EEeecCCC
Q 040413 549 IYEYMPNK 556 (795)
Q Consensus 549 V~E~~~~g 556 (795)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.84 E-value=4.5e-05 Score=79.81 Aligned_cols=80 Identities=16% Similarity=0.218 Sum_probs=60.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCC---ceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHR---NLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~E 551 (795)
.+....+.+|.|..+.||+.+..+|+.+++|+...........|..|+..|+.|..- .+.+++.+ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 456667889999999999999999999999987655444556789999999998421 23444443 23478999
Q ss_pred ecCCCCc
Q 040413 552 YMPNKSL 558 (795)
Q Consensus 552 ~~~~gsL 558 (795)
+++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00024 Score=75.12 Aligned_cols=77 Identities=19% Similarity=0.137 Sum_probs=62.2
Q ss_pred cccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC---CCceeeeeeeeeecceeEEEEeecC
Q 040413 478 STENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ---HRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 478 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
...+.|+.|....+|+... +++.+++|+.... ....+..|+..|+.|. ...+.+++.++...+..++|||+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456899999999999976 4678899987532 3677999999999984 3567888888887788999999999
Q ss_pred CCCc
Q 040413 555 NKSL 558 (795)
Q Consensus 555 ~gsL 558 (795)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 9865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00034 Score=74.15 Aligned_cols=158 Identities=15% Similarity=0.130 Sum_probs=88.1
Q ss_pred cHHHHHHhccCCcc-----cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeee
Q 040413 466 SLASVSAATANFST-----ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLG 538 (795)
Q Consensus 466 ~~~~i~~~~~~y~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 538 (795)
+...+.....+|.+ .+.|+.|....+|+....++ .+++|+.... ...+.+..|+.+++.+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 35677888899999977655 7889988652 12245677888888885322 233332
Q ss_pred e------eeecceeEEEEeecCCCCccee--------------ec----cCCCC--CCC---CHHHHHH-----------
Q 040413 539 C------CIELEEKILIYEYMPNKSLDIF--------------LF----DTPKE--SPL---GWETRVR----------- 578 (795)
Q Consensus 539 ~------~~~~~~~~lV~E~~~~gsL~~~--------------l~----~~~~~--~~l---~~~~~~~----------- 578 (795)
. ....+..++++++++|..+... ++ ..... ... .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223567899999998765321 00 00000 001 1211000
Q ss_pred -HHHHHHHHHHHHHhc----CCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 579 -VIEEIAQGLLYLHQY----SRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 579 -i~~qia~aL~~LH~~----~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+...+.+.+..++.. ....++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011134445555432 123599999999999998876668999988753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00044 Score=76.47 Aligned_cols=73 Identities=11% Similarity=0.123 Sum_probs=45.3
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEeccc----C---c--ccHHHHHHHHHHHHh-cCCCceeeeeeeeeecceeEEE
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ----S---G--QGLEEFKNEIKLIAK-LQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~----~---~--~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV 549 (795)
.+.||.|..+.||++.. +++.++||..... . . .....+..|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46899999999999965 4678999943221 1 1 122334444433322 1234556666654 4667999
Q ss_pred Eeec-CC
Q 040413 550 YEYM-PN 555 (795)
Q Consensus 550 ~E~~-~~ 555 (795)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00042 Score=76.81 Aligned_cols=73 Identities=19% Similarity=0.277 Sum_probs=51.5
Q ss_pred cccccCCCceeEEeeeccC--------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEE
Q 040413 480 ENKLGEGGFGPVYKGRLHN--------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIY 550 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 550 (795)
.+.|+.|....||++...+ ++.+++|+.... ...+.+.+|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578889999999997653 478999998532 122566689999999854344 456665432 3899
Q ss_pred eecCCCCc
Q 040413 551 EYMPNKSL 558 (795)
Q Consensus 551 E~~~~gsL 558 (795)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00078 Score=70.76 Aligned_cols=128 Identities=16% Similarity=0.152 Sum_probs=79.0
Q ss_pred cccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEEeec-CCCC
Q 040413 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYEYM-PNKS 557 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 557 (795)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+...++ .+++.+ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 578999886532211 123578888888853333 355543 333457899999 6655
Q ss_pred cceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 040413 558 LDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-------------------------------------------- 593 (795)
Q Consensus 558 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-------------------------------------------- 593 (795)
+..... .....++.++++.|.-||..
T Consensus 95 l~~~~~----------~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKF----------KTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHH----------HHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhH----------hhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 431000 00011233333333334332
Q ss_pred ------CCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 594 ------SRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 594 ------~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
....++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1234899999999999 5667889999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0015 Score=69.22 Aligned_cols=142 Identities=13% Similarity=0.147 Sum_probs=84.2
Q ss_pred ccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc--eeeeeee-----eeecceeEEEEeec
Q 040413 481 NKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN--LVRLLGC-----CIELEEKILIYEYM 553 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~E~~ 553 (795)
..|+ |....||+....+|+.+++|+..... ...+.+..|..+++.+.... +.+++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 88889999887777789999986431 24567888999998885322 3444432 12244567899999
Q ss_pred CCCCccee--------------ec----cC--CCCCCCCHHHH----HH---------------HHHHHHHHHHHHHhc-
Q 040413 554 PNKSLDIF--------------LF----DT--PKESPLGWETR----VR---------------VIEEIAQGLLYLHQY- 593 (795)
Q Consensus 554 ~~gsL~~~--------------l~----~~--~~~~~l~~~~~----~~---------------i~~qia~aL~~LH~~- 593 (795)
+|..++.. ++ .. ......++... .. +...+.+.+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 98654310 00 00 00111222111 00 011111222333221
Q ss_pred ---CCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 594 ---SRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 594 ---~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999998 4 899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00086 Score=74.73 Aligned_cols=74 Identities=14% Similarity=0.114 Sum_probs=49.6
Q ss_pred cccccCCCceeEEeeeccC-CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEEeecCCCC
Q 040413 480 ENKLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
.+.|+.|-...+|+....+ ++.+++|+......... .-.+|..+++.|...++ .++++.+. + .+|+||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678889999999998764 57899998754322211 12689999999975444 45666653 2 35999999865
Q ss_pred c
Q 040413 558 L 558 (795)
Q Consensus 558 L 558 (795)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0011 Score=71.78 Aligned_cols=141 Identities=22% Similarity=0.279 Sum_probs=84.4
Q ss_pred ccccCCCceeEEeeecc--------CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCc-eeeeeeeeeecceeEEEEe
Q 040413 481 NKLGEGGFGPVYKGRLH--------NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRN-LVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 551 (795)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.|..-+ ..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 57888889999999764 2478999986432 234567779999999885322 3456666543 29999
Q ss_pred ecCCCCccee-e----------------ccC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 040413 552 YMPNKSLDIF-L----------------FDT--PKESPLG--WETRVRVIEEIAQ-------------------GLLYLH 591 (795)
Q Consensus 552 ~~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~qia~-------------------aL~~LH 591 (795)
|++|..|..- + +.. .-..... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998765421 0 110 0111122 3444444443321 122222
Q ss_pred ----hc-CCCcEEeCCCCCCcEEEcCC----CCceeeccccccc
Q 040413 592 ----QY-SRLRVIHRDLKASNILLDKD----MNPKISDFGMAKM 626 (795)
Q Consensus 592 ----~~-~~~~iiH~Dikp~NIll~~~----~~~kl~DFGla~~ 626 (795)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23469999999999999876 7899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0011 Score=70.80 Aligned_cols=141 Identities=16% Similarity=0.134 Sum_probs=72.7
Q ss_pred ccccCCCcee-EEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCC--ceeeeeeeeeecceeEEEEeecCCCC
Q 040413 481 NKLGEGGFGP-VYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHR--NLVRLLGCCIELEEKILIYEYMPNKS 557 (795)
Q Consensus 481 ~~LG~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gs 557 (795)
+.|+.|+... +|+....+++.+++|...... .+.+..|+.+++.+... .+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4676665554 677765446778887654322 13456778888777432 345566553322 278999987755
Q ss_pred cceeec---------------------cCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 040413 558 LDIFLF---------------------DTPK--ESPLGWETRV-------R-------------VIEEIAQGLLYLH--- 591 (795)
Q Consensus 558 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~qia~aL~~LH--- 591 (795)
+.+.+. .... ...++..... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 532221 0000 0112221100 0 0011112222221
Q ss_pred hcCCCcEEeCCCCCCcEEEcCC----CCceeeccccccc
Q 040413 592 QYSRLRVIHRDLKASNILLDKD----MNPKISDFGMAKM 626 (795)
Q Consensus 592 ~~~~~~iiH~Dikp~NIll~~~----~~~kl~DFGla~~ 626 (795)
......++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999874 6789999998865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0015 Score=70.77 Aligned_cols=74 Identities=14% Similarity=0.154 Sum_probs=45.7
Q ss_pred cccccCCCceeEEeeeccC---------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEE
Q 040413 480 ENKLGEGGFGPVYKGRLHN---------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILI 549 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV 549 (795)
.+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...++ .++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3578888899999997653 268889987643221 1224678888888853333 3555443 1 3689
Q ss_pred EeecCCCCc
Q 040413 550 YEYMPNKSL 558 (795)
Q Consensus 550 ~E~~~~gsL 558 (795)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.011 Score=63.11 Aligned_cols=68 Identities=12% Similarity=0.103 Sum_probs=44.9
Q ss_pred cCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC---Cceeeeeee------eeecceeEEEEeecC
Q 040413 484 GEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH---RNLVRLLGC------CIELEEKILIYEYMP 554 (795)
Q Consensus 484 G~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lV~E~~~ 554 (795)
|.|....||+....++ .+++|+..... ..+|+.+++.|.. |++.+.+.. ....+..++||||++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444789999987766 89999876533 1467777777642 224444432 233466789999999
Q ss_pred CCCc
Q 040413 555 NKSL 558 (795)
Q Consensus 555 ~gsL 558 (795)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.013 Score=64.38 Aligned_cols=141 Identities=17% Similarity=0.230 Sum_probs=84.9
Q ss_pred cccccCCCceeEEeeeccC--------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEE
Q 040413 480 ENKLGEGGFGPVYKGRLHN--------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIY 550 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 550 (795)
.+.|..|-...+|+....+ ++.+++|+....... .-...+|..+++.+...++ .++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3578888899999997653 578999987543222 1224688999988853333 44554322 37899
Q ss_pred eecCCCCccee-e----------------cc--C-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 040413 551 EYMPNKSLDIF-L----------------FD--T-----P---KESPLGWETRVRVIEEI-------------------A 584 (795)
Q Consensus 551 E~~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~qi-------------------a 584 (795)
||++|..|..- + +. . . ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765310 0 00 0 0 11111234433333322 1
Q ss_pred HHHHHHH---------------------hcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 585 QGLLYLH---------------------QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 585 ~aL~~LH---------------------~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
..+..|+ ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 1223322 111346899999999999 7888999999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.62 E-value=0.016 Score=56.85 Aligned_cols=98 Identities=17% Similarity=0.125 Sum_probs=62.2
Q ss_pred CcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccccce
Q 040413 557 SLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT 636 (795)
Q Consensus 557 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 636 (795)
+|.++|.. ...++++++++.++.|.+++|.-+-.. +.+ ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 56666632 457899999999999999998776221 111 1334457899999999988764 1110
Q ss_pred eeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh
Q 040413 637 KRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS 674 (795)
Q Consensus 637 ~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt 674 (795)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123456888653 344677789999999998874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.36 E-value=0.098 Score=57.05 Aligned_cols=30 Identities=27% Similarity=0.392 Sum_probs=25.4
Q ss_pred cEEeCCCCCCcEEE------cCCCCceeeccccccc
Q 040413 597 RVIHRDLKASNILL------DKDMNPKISDFGMAKM 626 (795)
Q Consensus 597 ~iiH~Dikp~NIll------~~~~~~kl~DFGla~~ 626 (795)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999988864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=90.85 E-value=15 Score=37.07 Aligned_cols=81 Identities=14% Similarity=0.179 Sum_probs=47.4
Q ss_pred CCeEEEeecCCCC--C----CCCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCC-CC----
Q 040413 70 SDTVVWVANRNRP--I----FDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNF-SS---- 138 (795)
Q Consensus 70 ~~~~vW~anr~~p--~----~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~-~~---- 138 (795)
..+++|...+..+ + ....+.+-++.++.+..+|++|..+|............+..+.+||+++-+.. ..
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~~~~~~v~~ 103 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWCGHPSTILE 103 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEESTTEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEecCCCCEEEE
Confidence 5678888877541 1 12244455555566667788889999987431122234567778887776531 00
Q ss_pred -CCCCCceeeccCC
Q 040413 139 -NSSEGHLWQSFDH 151 (795)
Q Consensus 139 -~~~~~~~WqSFd~ 151 (795)
+.+++.+|+ |..
T Consensus 104 vd~~Gk~l~~-~~~ 116 (276)
T 3no2_A 104 VNMKGEVLSK-TEF 116 (276)
T ss_dssp ECTTSCEEEE-EEE
T ss_pred EeCCCCEEEE-Eec
Confidence 135667776 443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 795 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-27 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-22 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-16 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-13 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-07 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 2e-73
Identities = 66/283 (23%), Positives = 136/283 (48%), Gaps = 19/283 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ ++G G FG VYKG+ H V + +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
+G + ++ ++ SL L E+ + + + AQG+ YLH
Sbjct: 69 FMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA--- 122
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ--- 652
+IHRDLK++NI L +D+ KI DFG+A + + +++ G+ +M+PE +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+ +S +SDV++FG++L E ++ + +SN ++ + + + + N
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI---IFMVGRGYLSPDLSKVRSN 237
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755
+ C+++ +RP ++++ + +LP
Sbjct: 238 -----CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 1e-67
Identities = 82/272 (30%), Positives = 129/272 (47%), Gaps = 21/272 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+LG G FG V+ G + +VAVK L Q + F E L+ +LQH+ LVR
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L + E +I EYM N SL FL P L + + +IA+G+ ++ +
Sbjct: 73 LYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
IHRDL+A+NIL+ ++ KI+DFG+A++ +E ++ + +PE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGT 186
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715
F+IKSDV+SFG+LL E ++ R T+ + +R + ++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------IQNLERGYRMVRP------- 232
Query: 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ LC +E DRPT + S+L
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 6e-67
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 21/272 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ ++G G FG V+ G N +VA+K + + E+F E +++ KL H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L G C+E L++E+M + L +L ET + + ++ +G+ YL +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEE--- 119
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
VIHRDL A N L+ ++ K+SDFGM + D+ + + + SPE
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 178
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715
+S KSDV+SFGVL+ E S + + ++S + + L P L +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRLYKPRLAST-- 229
Query: 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ C +E DRP ++ L
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-66
Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 21/274 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ + +LG G FG V G+ +VA+K + S +EF E K++ L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L G C + +I EYM N L +L + + + +++ + + YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+ +HRDL A N L++ K+SDFG+++ DE S + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSK 177
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715
FS KSD+++FGVL+ E S + ++ + + E I L+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRP 223
Query: 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+L + + C E A +RPT ++S + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-66
Identities = 74/286 (25%), Positives = 129/286 (45%), Gaps = 21/286 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ E KLG+G FG V+ G + VA+K L + E F E +++ KL+H LV+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L E ++ EYM SL FL L V + +IA G+ Y+ +
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERM-- 132
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGL 655
+HRDL+A+NIL+ +++ K++DFG+A++ +E ++ + +PE A G
Sbjct: 133 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGR 190
Query: 656 FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEAS 715
F+IKSDV+SFG+LL E + R + + + ++ +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGR--------------VPYPGMVNREVLDQVERGYRMPCP 236
Query: 716 YLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPA 761
++ C +++ +RPT + + L + + QP
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 9e-65
Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 29/293 (9%)
Query: 480 ENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGC 539
+ +G+G FG V++G+ G+EVAVK SS+ + + EI L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 540 CIE----LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ--- 592
+ + L+ +Y + SL +L + E +++ A GL +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 593 --YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF--GGDELQSKTKRIVGTYGYMSP 648
+ + HRDLK+ NIL+ K+ I+D G+A D + VGT YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 649 EYAQQGL------FSIKSDVFSFGVLLLETLSSKRNTDFSNTDS-----LTLLGRAWDLW 697
E + ++D+++ G++ E L + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 698 KDDRAWELIDP-ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+ + + P I S L + C + R T + L+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (546), Expect = 2e-64
Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 21/273 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN-GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ + ++KLG G +G VY+G VAVK L + + +EEF E ++ +++H NLV
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+LLG C +I E+M +L +L + ++ + + + +I+ + YL
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE--- 132
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+ IHRDL A N L+ ++ K++DFG++++ GD + + +PE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYN 191
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714
FSIKSDV++FGVLL E + + + +EL++ + E
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGM--------------SPYPGIDLSQVYELLEKDYRMER 237
Query: 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ + C Q + DRP+ E+
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (546), Expect = 4e-64
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 36/300 (12%)
Query: 465 FSLASVSAATANFSTE---------NKLGEGGFGPVYKGRLH----NGQEVAVKRL-SSQ 510
F+ + A F+ E +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 511 SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESP 570
+ + +F +E ++ + H N++ L G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 571 LGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630
V ++ IA G+ YL +HRDL A NIL++ ++ K+SDFG+++ D
Sbjct: 127 --VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 631 ELQSKTKRIVG---TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
+G + +PE Q F+ SDV+S+G+++ E +S
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
R + + I+ + + + L C Q+D RP ++V+ L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 7e-64
Identities = 73/273 (26%), Positives = 120/273 (43%), Gaps = 27/273 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+G+G FG V G + G +VAVK + + + + F E ++ +L+H NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 536 LLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
LLG +E + + ++ EYM SL +L + S LG + ++ ++ + + YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQG 654
+HRDL A N+L+ +D K+SDFG+ K E S + +PE ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 175
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714
FS KSDV+SFG+LL E S R + ++ + +A
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKDVVPRVEKGYKMDA 221
Query: 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
V C DA RP+ ++ L
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-63
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGL-EEFKNEIKLIAKLQHRNL 533
+F ++LG G G V+K +G +A K + + + + E++++ + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
V G E + E+M SLD L K + + +V + +GL YL
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR-- 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ +++HRD+K SNIL++ K+ DFG++ S VGT YMSPE Q
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLL----------------------- 690
+S++SD++S G+ L+E + + L L+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 691 -GRAWDLWKDDRAWELIDPILQNEASYLILNRY----INVALLCVQEDAVDRPTMFEV 743
D +EL+D I+ L + + C+ ++ +R + ++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 5e-63
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 30/286 (10%)
Query: 480 ENKLGEGGFGPVYKGRLHN---GQEVAVKRLSSQSGQG--LEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V KG + VAVK L +++ +E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
R++G C E E +L+ E L+ +L + + + + ++ +++ G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD-ELQSKTKRIVGTYGYMSPEYAQQ 653
+HRDL A N+LL KISDFG++K D + +PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713
FS KSDV+SFGVL+ E S + + + K +++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN---ETVNLPH 756
++ LC D +RP V L N + VN H
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-63
Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 25/288 (8%)
Query: 480 ENKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLVR 535
+ +LG G FG V +G +VA+K L + + EE E +++ +L + +VR
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSR 595
L+G C + E +L+ E L FL K + ++ +++ G+ YL +
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 596 LRVIHRDLKASNILLDKDMNPKISDFGMAKMFG-GDELQSKTKRIVGTYGYMSPEYAQQG 654
+HRDL A N+LL KISDFG++K G D + + +PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 655 LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714
FS +SDV+S+GV + E LS + + + K I+ + E
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQGKRMEC 233
Query: 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAF 762
+ C DRP V + +L +
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 3e-61
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 45/300 (15%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQSGQGLE-EFKNEIKLIAKL 528
N +GEG FG V++ R VAVK L ++ ++ +F+ E L+A+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD---------------------TPK 567
+ N+V+LLG C + L++EYM L+ FL +P
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627
PL ++ + ++A G+ YL + + +HRDL N L+ ++M KI+DFG+++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
+ +M PE ++ +SDV+++GV+L E S +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 249
Query: 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+D + N+ LC + DRP+ + +L
Sbjct: 250 ----EVIYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (526), Expect = 4e-61
Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 37/305 (12%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHRN 532
FS ++G G FG VY R + N + VA+K++S QS + ++ E++ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
++ GC + L+ EY + D+ + PL V QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+IHRD+KA NILL + K+ DFG A + + VGT +M+PE
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 653 ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
+G + K DV+S G+ +E K N ++++ L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM--LTNE--TVNLPHPQQPAFSSI 765
+ N C+Q+ DRPT ++ + E + Q ++
Sbjct: 243 FR------------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
Query: 766 RGLKN 770
R L N
Sbjct: 291 RELDN 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 9e-61
Identities = 65/273 (23%), Positives = 116/273 (42%), Gaps = 22/273 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS-SQSGQGLEEFKNEIKLIAKLQHRNL 533
++ LGEG +G V + VAVK + ++ E K EI + L H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
V+ G E + L EY L + + + R ++ G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ 653
+ + HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE ++
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 654 GLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
F + DV+S G++L L+ + D + WK+ + + + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTYLNPWKKIDS 234
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
L+ + E+ R T+ ++
Sbjct: 235 APLALLHK--------ILVENPSARITIPDIKK 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-60
Identities = 63/274 (22%), Positives = 121/274 (44%), Gaps = 30/274 (10%)
Query: 480 ENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRL 536
+ ++G G F VYKG EVA L + + + FK E +++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 537 LGCCIELEEK----ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ +L+ E M + +L +L + + + +I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 593 YSRLRVIHRDLKASNILL-DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+ +IHRDLK NI + + KI D G+A + S K ++GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMY 185
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
++ + DV++FG+ +LE +S+ +S + + + D +
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI---YRRVTSGVKPASFDKVAI 239
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVS 745
E +I C++++ +R ++ ++++
Sbjct: 240 PEVKEIIEG--------CIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 39/298 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKL 528
S LG G FG V + + VAVK L + E +E+K+++ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 529 -QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFD---------------TPKESPLG 572
H N+V LLG C ++I EY L FL E L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 573 WETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632
E + ++A+G+ +L IHRDL A NILL KI DFG+A+ D
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692
+M+PE +++ +SDV+S+G+ L E S +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------------ 248
Query: 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750
+ D + +++I + + ++ C D + RPT ++V ++ +
Sbjct: 249 -PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-60
Identities = 71/303 (23%), Positives = 117/303 (38%), Gaps = 44/303 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLSSQSGQG-LEEFKNEIKLIAKL 528
N LG G FG V + +VAVK L ++ E +E+K++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 529 -QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPK-------------------- 567
H N+V LLG C LI+EY L +L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 568 ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627
+ L +E + ++A+G+ +L +HRDL A N+L+ KI DFG+A+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 628 GGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL 687
D +M+PE +G+++IKSDV+S+G+LL E S +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPVD 273
Query: 688 TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
++LI + + + + C D+ RP+ + S L
Sbjct: 274 ANF------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 748 TNE 750
+
Sbjct: 322 GCQ 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-60
Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 31/280 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRN 532
++ +G G +G K R +G+ + K L S + + +E+ L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 533 LVRLLGCCIELEEKIL--IYEYMPNKSLDIFLFDTPKES-PLGWETRVRVIEEIAQGLLY 589
+VR I+ L + EY L + KE L E +RV+ ++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 590 LHQYSR--LRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
H+ S V+HRDLK +N+ LD N K+ DFG+A++ D S K VGT YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMS 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
PE + ++ KSD++S G LL E L + EL
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYE------------------LCALMPPFTAFSQKELAG 224
Query: 708 PILQNEASYL---ILNRYINVALLCVQEDAVDRPTMFEVV 744
I + + + + + + RP++ E++
Sbjct: 225 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 35/284 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQH 530
+F +G G FG VY G L + AVK L+ + G + +F E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 531 RNLVRLLGCCIELEEKI-LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
N++ LLG C+ E ++ YM + L F + + + ++A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGM-- 143
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR--IVGTYGYMS 647
+ + +HRDL A N +LD+ K++DFG+A+ E S + +M+
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
E Q F+ KSDV+SFGVLL E ++ + D +++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----------------PYPDVNTFDITV 245
Query: 708 PILQNE---ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748
+LQ + V L C A RP+ E+VS ++
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-59
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ +LG+G FG VYK + A K + ++S + LE++ EI ++A H N+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+LL ++ E+ ++D + + E PL V ++ L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD-- 128
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ-- 652
++IHRDLKA NIL D + K++DFG++ + +GT +M+PE
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCE 185
Query: 653 ---QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
+ K+DV+S G+ L+E + + ++ I
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLLKI 227
Query: 710 LQNEASYLILNRYINVALL-----CVQEDAVDRPTMFEV 743
++E L + C++++ R T ++
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 26/279 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQE-----VAVKRLSSQSGQG-LEEFKNEIKLIAKLQ 529
+ + +G G FG VYKG L VA+K L + + +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
H N++RL G + + ++I EYM N +LD FL + K+ V ++ IA G+ Y
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKY 125
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT-KRIVGTYGYMSP 648
L + +HRDL A NIL++ ++ K+SDFG++++ D + T + +P
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 649 EYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708
E F+ SDV+SFG+++ E ++ R + + + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAIND 228
Query: 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ + + + C Q++ RP ++VS+L
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-59
Identities = 71/285 (24%), Positives = 107/285 (37%), Gaps = 35/285 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKL 528
+ KLG+G FG V +G VAVK L + +++F E+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
HRNL+RL G + ++ E P SL L + T R ++A+G+
Sbjct: 69 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMG 125
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG-GDELQSKTKRIVGTYGYMS 647
YL R IHRDL A N+LL KI DFG+ + D+ + + + +
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
PE + FS SD + FGV L E + + W +++
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWE-----------------MFTYGQEPWIGLNGSQILH 225
Query: 708 PILQNEASYLILNRY----INVALLCVQEDAVDRPTMFEVVSMLT 748
I + NV + C DRPT + L
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-59
Identities = 73/308 (23%), Positives = 136/308 (44%), Gaps = 40/308 (12%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQE----VAVKRLS-SQSGQGLEEFKNEIKLIAKLQH 530
F LG G FG VYKG + G++ VA+K L + S + +E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
++ RLLG C+ LI + MP L ++ + + +G + + +IA+G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
R++HRDL A N+L+ + KI+DFG+AK+ G +E + + +M+ E
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
+++ +SDV+S+GV + E ++ + +D +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230
Query: 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT--------------NETVNLPH 756
+ + + + C DA RP E++ + +E ++LP
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 757 PQQPAFSS 764
P F
Sbjct: 291 PTDSNFYR 298
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 8e-58
Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 34/276 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHR 531
+F LG+G FG VY R + +A+K L + + + E+++ + L+H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
N++RL G + LI EY P ++ L K S + I E+A L Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH 123
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
RVIHRD+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMI 176
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
+ + K D++S GVL E L K ++ + E I +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYKRISR 218
Query: 712 NEASY--LILNRYINVALLCVQEDAVDRPTMFEVVS 745
E ++ + ++ ++ + RP + EV+
Sbjct: 219 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 38/290 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNG---QEVAVKRLS-SQSGQGLEEFKNEIKLIAKL-QH 530
+ ++ +GEG FG V K R+ + A+KR+ S +F E++++ KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFL-------------FDTPKESPLGWETRV 577
N++ LLG C L EY P+ +L FL S L + +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 578 RVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTK 637
++A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG+++ E+ K
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKT 184
Query: 638 RIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697
+M+ E +++ SDV+S+GVLL E +S +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------TPYCGM 230
Query: 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+E + + E + ++ C +E +RP+ +++ L
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 25/280 (8%)
Query: 466 SLASVSAATANFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKL 524
S+ SV ++ K+G+G G VY + GQEVA+++++ Q E NEI +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 525 IAKLQHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+ + ++ N+V L + +E ++ EY+ SL + +T + V E
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
Q L +LH +VIHRD+K+ NILL D + K++DFG + QSK +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDD-RAW 703
+M+PE + + K D++S G++ +E + + + N + L L + +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNP 239
Query: 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
E + I ++ LNR C+ D R + E+
Sbjct: 240 EKLSAIFRD-----FLNR-------CLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 33/302 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN------GQEVAVKRLS-SQSGQGLEEFKNEIKLIAKL 528
+ +LG+G FG VY+G VA+K ++ + S + EF NE ++ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLF-------DTPKESPLGWETRVRVIE 581
++VRLLG + + ++I E M L +L + P +P +++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 582 EIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVG 641
EIA G+ YL+ + +HRDL A N ++ +D KI DFGM + + K + +
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701
+MSPE + G+F+ SDV+SFGV+L E + + + +++
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNEQ 243
Query: 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPA 761
+ + + + +C Q + RP+ E++S + E P ++ +
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM--EPGFREVS 301
Query: 762 FS 763
F
Sbjct: 302 FY 303
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 7e-53
Identities = 60/282 (21%), Positives = 109/282 (38%), Gaps = 32/282 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQSGQGL-EEFKNEIKLIAKLQH 530
+GEG FG V++G + VA+K + + + E+F E + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
++V+L+G E +I E L FL ++ L + + +++ L YL
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL 124
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
R +HRD+ A N+L+ + K+ DFG+++ K + +M+PE
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPES 180
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
F+ SDV+ FGV + E L ++ + ++I I
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRIE 223
Query: 711 QNEASYL---ILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
E + ++ C D RP E+ + L+
Sbjct: 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (470), Expect = 7e-53
Identities = 61/271 (22%), Positives = 110/271 (40%), Gaps = 23/271 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
++ +LG G FG V++ G A K + + E + EI+ ++ L+H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
L + E ++IYE+M L + D + + + + V + ++ +GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH--- 141
Query: 595 RLRVIHRDLKASNILLDKDMNP--KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+H DLK NI+ + K+ DFG+ + K GT + +PE A+
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAE 198
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+D++S GVL LS N D ++ D DD A+ I ++
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEV 743
+ + + D R T+ +
Sbjct: 259 -----FIRK-------LLLADPNTRMTIHQA 277
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 72/296 (24%), Positives = 109/296 (36%), Gaps = 38/296 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQSGQG-LEEFKNEIKLIAK- 527
LG G FG V + + VAVK L + +E+K++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 528 LQHRNLVRLLGCCIELEEKILI-YEYMPNKSLDIFLFDTPKE-------------SPLGW 573
H N+V LLG C + +++ E+ +L +L E L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 574 ETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633
E + ++A+G+ +L + IHRDL A NILL + KI DFG+A+ D
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRA 693
+ +M+PE +++I+SDV+SFGVLL E S +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246
Query: 694 WDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
K+ D L C + RPT E+V L N
Sbjct: 247 CRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 30/274 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHR 531
+F LGEG F V R L +E A+K L + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
V+L + E+ Y N L ++ K EI L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK NILL++DM+ +I+DFG AK+ + Q++ VGT Y+SPE
Sbjct: 126 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
+ SD+++ G ++ + ++ ++ + + I++
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIK 224
Query: 712 NEASYL--ILNRYINVALLCVQEDAVDRPTMFEV 743
E + + ++ + DA R E+
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGRL--------HNGQEVAVKRLSSQ-SGQGLEEFKNEIKLIA 526
LGEG FG V + +VAVK L S + + L + +E++++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 527 KL-QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLF-------------DTPKESPLG 572
+ +H+N++ LLG C + +I EY +L +L E L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 573 WETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632
+ V ++A+G+ YL + IHRDL A N+L+ +D KI+DFG+A+ +
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR 692
KT +M+PE +++ +SDV+SFGVLL E +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--------------S 236
Query: 693 AWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747
+ + ++L+ + + N + C RPT ++V L
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (451), Expect = 4e-50
Identities = 54/271 (19%), Positives = 107/271 (39%), Gaps = 23/271 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ +LG G FG V++ G+ K +++ KNEI ++ +L H L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
L + E +LI E++ L + ++ + + + + +GL ++H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH--- 144
Query: 595 RLRVIHRDLKASNILLDKDMNP--KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
++H D+K NI+ + KI DFG+A DE+ K T + +PE
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVD 201
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+ +D+++ GVL LS + + D D+ A+ + P ++
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEV 743
+ +Q++ R T+ +
Sbjct: 262 -----FIKN-------LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 3e-47
Identities = 64/281 (22%), Positives = 116/281 (41%), Gaps = 28/281 (9%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHRN 532
+ LG GG V+ R L ++VAVK L ++ F+ E + A L H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 533 LVRLLGCCIELEEKI----LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
+V + ++ EY+ +L + E P+ + + VI + Q L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALN 125
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG-GDELQSKTKRIVGTYGYMS 647
+ H + +IHRD+K +NI++ K+ DFG+A+ ++T ++GT Y+S
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
PE A+ +SDV+S G +L E L+ + + S+ D E +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 708 PILQNEASYLILNRYINVALLCVQEDAVDRP-TMFEVVSML 747
L ++ + + ++ +R T E+ + L
Sbjct: 243 ADLDA-----VVLK-------ALAKNPENRYQTAAEMRADL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 6e-47
Identities = 71/275 (25%), Positives = 109/275 (39%), Gaps = 31/275 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ---SGQGLEEFKNE---IKLIAKL 528
+FS +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
+V + ++ I + M L L + EI GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLE 121
Query: 589 YLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSP 648
++H V++RDLK +NILLD+ + +ISD G+A F + K VGT+GYM+P
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAP 174
Query: 649 EYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707
E Q+G+ + +D FS G +L + L T + R L +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFS 233
Query: 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFE 742
P L++ +L +Q D R
Sbjct: 234 PELRS-----LLEG-------LLQRDVNRRLGCLG 256
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 9e-47
Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 28/297 (9%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEE-FKNEIKLIAKLQHRNLV 534
+ + LG G F V + VA+K ++ ++ +G E +NEI ++ K++H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
L LI + + L + ++ R+I ++ + YLH
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL- 126
Query: 595 RLRVIHRDLKASNILL---DKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
++HRDLK N+L D+D ISDFG++KM S GT GY++PE
Sbjct: 127 --GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVL 181
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
Q +S D +S GV+ L N L + D W+ I +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM--LTNETVNLPHPQQPAFSSIR 766
+ + +++D R T + + + +T + Q I+
Sbjct: 242 D-----FIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-46
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 22/286 (7%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQG-LEEFKNEIKLIAKLQHRNLV 534
++ + +GEG +G V N VA+K++S Q + EIK++ + +H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ + + Y+ + L+ K L + + +I +GL Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS-- 127
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKT-KRIVGTYGYMSPEYAQQ 653
V+HRDLK SN+LL+ + KI DFG+A++ D + V T Y +PE
Sbjct: 128 -ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 654 GLFSIKS-DVFSFGVLLL---------------ETLSSKRNTDFSNTDSLTLLGRAWDLW 697
KS D++S G +L + L+ S +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
+ + + N ++ +++ + + R + +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 3e-46
Identities = 51/271 (18%), Positives = 103/271 (38%), Gaps = 24/271 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+ LG G FG V++ + + K + + G K EI ++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNIL 64
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
L +EE ++I+E++ + + L V + ++ + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 595 RLRVIHRDLKASNILLDKDMNP--KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
+ H D++ NI+ + KI +FG A+ + + + Y +PE Q
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+ S +D++S G L+ LS + + D+ A++ I +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 713 EASYLILNRYINVALLCVQEDAVDRPTMFEV 743
++R + ++ R T E
Sbjct: 237 -----FVDR-------LLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 4e-46
Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 38/285 (13%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGL---------EEFKNEIKLI 525
N+ + LG G V + +E AVK + G E E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 526 AKLQ-HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
K+ H N+++L L+++ M L +L ++ L + +++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYG 644
+ + LH +L ++HRDLK NILLD DMN K++DFG + E K + + GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 645 YMSPEYAQ------QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK 698
Y++PE + + + D++S GV++ L+ + + + +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
W+ +++ +++R + R T E
Sbjct: 235 GSPEWDDYSDTVKD-----LVSR-------FLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 165 bits (418), Expect = 5e-46
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAKLQHR 531
+F LG G FG V+ R HNG+ A+K L + +E +E +++ + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
++R+ G + ++ +I +Y+ LF ++S + A+ L L
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY--AAEVCLALE 118
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+I+RDLK NILLDK+ + KI+DFG AK + T + GT Y++PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVV 173
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKR 677
++ D +SFG+L+ E L+
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 2e-45
Identities = 54/283 (19%), Positives = 99/283 (34%), Gaps = 26/283 (9%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ K+G G FG +Y G + G+EVA+K ++ + E K+ +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 536 LLGCCIELEEK-ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ C + +++ E + D+F F +T + + +++ + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH--- 120
Query: 595 RLRVIHRDLKASNIL---LDKDMNPKISDFGMAKMFGGDELQS-----KTKRIVGTYGYM 646
IHRD+K N L K I DFG+AK + + K + GT Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706
S S + D+ S G +L+ + K E++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
+E + + C D+P + + N
Sbjct: 241 CKGYPSEFATYL--------NFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 2e-43
Identities = 59/284 (20%), Positives = 117/284 (41%), Gaps = 24/284 (8%)
Query: 476 NFSTENKLGEGGFGPVYKGRLHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ K+GEG +G VYK + + G+ A+K RL + EI ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 534 VRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY 593
V+L + +L++E++ + E L T + ++ G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 594 SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YAQ 652
RV+HRDLK N+L++++ KI+DFG+A+ FG K + T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMG 174
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712
+S D++S G + E ++ + + + + W + + +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 713 EASYLILNRYINVALL-------------CVQEDAVDRPTMFEV 743
+ ++ + + L ++ D R T +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 64/272 (23%), Positives = 100/272 (36%), Gaps = 33/272 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS---SQSGQGLEEFKNEIKLIAK-LQH 530
+F LG+G FG V+ Q A+K L +E E ++++ +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
L + E + EY+ L + EI GL +L
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
H +++RDLK NILLDKD + KI+DFGM K + +KT GT Y++PE
Sbjct: 120 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEI 174
Query: 651 AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710
++ D +SFGVLL E L + + EL I
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHSIR 216
Query: 711 QNEASY--LILNRYINVALLCVQEDAVDRPTM 740
+ Y + ++ + + R +
Sbjct: 217 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-43
Identities = 70/301 (23%), Positives = 115/301 (38%), Gaps = 29/301 (9%)
Query: 481 NKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEE-----FKNEIKLIAKLQHRNLV 534
+ LGEG F VYK R + Q VA+K++ ++ EIKL+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
LL L++++M I L + QGL YLHQ+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 595 RLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQ- 653
++HRDLK +N+LLD++ K++DFG+AK FG V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 654 GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713
++ + D+++ G +L E L + + W + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 714 ASYLILNRYINVALLCVQEDAVD------------RPTMFEVVSM--LTNETVNLPHPQQ 759
++ +D +D R T + + M +N P Q
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
Query: 760 P 760
P
Sbjct: 296 P 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 1e-42
Identities = 45/285 (15%), Positives = 97/285 (34%), Gaps = 26/285 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
++ ++GEG FG +++G L N Q+VA+K +S + ++E + L +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63
Query: 535 RLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS 594
+ + ++ + SL+ L + +T +++ + +H+
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE-- 119
Query: 595 RLRVIHRDLKASNILLDKDMNP-----KISDFGMAKMFGGDELQS-----KTKRIVGTYG 644
+++RD+K N L+ + + + DFGM K + + + K + GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 645 YMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
YMS S + D+ + G + + L + K +R E
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--------KQKYERIGE 230
Query: 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749
E + P + + +
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 32/278 (11%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL------SSQSGQGLEEFKNEIKLIAKLQ 529
+ T +LG G F V K R G + A K + SS+ G E+ + E+ ++ ++Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 530 HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLY 589
H N++ L + ILI E + L ++ L E +++I G
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG--- 125
Query: 590 LHQYSRLRVIHRDLKASNILLDKDMNP----KISDFGMAKMFGGDELQSKTKRIVGTYGY 645
++ L++ H DLK NI+L P KI DFG+A ++ K I GT +
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEF 182
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
++PE +++D++S GV+ LS A + +D +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
+ ++ + R + +D R T+ +
Sbjct: 243 TSALAKD-----FIRR-------LLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-42
Identities = 66/310 (21%), Positives = 117/310 (37%), Gaps = 35/310 (11%)
Query: 476 NFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLV 534
+++ +G G FG VY+ +L +G+ VA+K++ E++++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 535 RLLGCCIELEEK------ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLL 588
RL EK L+ +Y+P + + + L + ++ + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 589 YLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
Y+H + HRD+K N+LLD D K+ DFG AK E I Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAP 191
Query: 648 PEYAQQGLFSIKSDVFSFGVLLLETLSSKRN-TDFSNTDSLTLLGRAWDLWKDDRAWELI 706
++ DV+S G +L E L + S D L + + ++ E+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 707 DPILQNEASYLILNRYINVALLCVQEDAVD------------RPTMFEV-----VSMLTN 749
+ + + + + V +A+ R T E L +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 750 ETVNLPHPQQ 759
V LP+ +
Sbjct: 312 PNVKLPNGRD 321
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 69/302 (22%), Positives = 121/302 (40%), Gaps = 30/302 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
NF K+GEG +G VYK R G+ VA+K RL +++ EI L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+V+LL + L++E++ D + + + ++ QGL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE-YA 651
+ RV+HRDLK N+L++ + K++DFG+A+ FG V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGR-----------AWDLWKDD 700
+S D++S G + E ++ + F + L R W
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 701 RAWELIDPILQNEASYLILNRYINVAL----LCVQEDAVDRPTMFEVVSM--LTNETVNL 754
++ P + ++ + D R + ++ + T +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
Query: 755 PH 756
PH
Sbjct: 294 PH 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-42
Identities = 68/291 (23%), Positives = 120/291 (41%), Gaps = 31/291 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR--LHNGQEVAVKRLSSQSGQG--LEEFKNEIKLIAKL--- 528
+ ++GEG +G V+K R + G+ VA+KR+ Q+G+ E+ ++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 529 QHRNLVRLLGCCIELEEKILIYEYMPNKSLD---IFLFDTPKESPLGWETRVRVIEEIAQ 585
+H N+VRL C + + +D D E + ET ++ ++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 586 GLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGY 645
GL +LH RV+HRDLK NIL+ K++DFG+A+++ Q +V T Y
Sbjct: 128 GLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWY 181
Query: 646 MSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL--------W 697
+PE Q ++ D++S G + E K F + + LG+ D+ W
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP--LFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 698 KDDRAWELIDPILQNEASYLILNRYINVALL-----CVQEDAVDRPTMFEV 743
D A ++ I+ C+ + R + +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 57/278 (20%), Positives = 94/278 (33%), Gaps = 42/278 (15%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEE------FKNEIKLIAKLQ 529
+ LG GGFG VY G + + VA+K + E E+ L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 530 --HRNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
++RLL + +LI E + L E ++ + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAV 123
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKD-MNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+ H V+HRD+K NIL+D + K+ DFG + + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYS 176
Query: 647 SPEY-AQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705
PE+ + V+S G+LL + + F + + + + L
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVSSECQHL 234
Query: 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
I C+ DRPT E+
Sbjct: 235 IR--------------------WCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 50/274 (18%), Positives = 98/274 (35%), Gaps = 29/274 (10%)
Query: 479 TENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRL 536
T LG G G V + ++ A+K L + + E++L + Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 70
Query: 537 LGCCIELEEK----ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+ L +++ E + L + D + +++ I + + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129
Query: 593 YSRLRVIHRDLKASNILLDKDMNP---KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPE 649
+ + HRD+K N+L K++DFG AK T Y++PE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPE 183
Query: 650 YAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709
+ D++S GV++ L ++ +++ +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMFEV 743
+ E LI N ++ + R T+ E
Sbjct: 244 VSEEVKMLIRN--------LLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 58/298 (19%), Positives = 119/298 (39%), Gaps = 36/298 (12%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRN 532
+ K+G+G FG V+K R GQ+VA+K++ ++ EIK++ L+H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 533 LVRLLGCCIELEEKI--------LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIA 584
+V L+ C L++++ + + RV++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLL 127
Query: 585 QGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKR--IVGT 642
GL Y+H+ +++HRD+KA+N+L+ +D K++DFG+A+ F + + V T
Sbjct: 128 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 643 YGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKR-NTDFSNTDSLTLLGRAW-----D 695
Y PE + D++ G ++ E + + L L+ + +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 696 LWKDDRAWELIDPILQNEASYLILNRYINVALL----------CVQEDAVDRPTMFEV 743
+W + +EL + + + + + + + D R +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 16/244 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHR 531
+F LG+G FG V R G+ A+K L + + + E +++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
L L + + EY L L + E R R A+ + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSALE 119
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
V++RD+K N++LDKD + KI+DFG+ K D + K GT Y++PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL----WKDDRAWELID 707
+ + D + GV++ E + + + + L L ++ A L+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 708 PILQ 711
+L+
Sbjct: 238 GLLK 241
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 26/286 (9%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVK--RLSSQSGQGLEEFKNEIKLIAKLQHRN 532
+ K+GEG +G V+K + + VA+K RL EI L+ +L+H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 533 LVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ 592
+VRL ++ L++E+ F G V + Q L L
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGF 116
Query: 593 YSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQ 652
V+HRDLK N+L++++ K+++FG+A+ F G ++ + +V +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 653 QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDL--------WKDDRAWE 704
L+S D++S G + E ++ R F D L R + L W
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR-PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 705 LIDPILQNEASYLILNRYINVA-----LL--CVQEDAVDRPTMFEV 743
P A+ ++N + LL ++ + V R + E
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-37
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 38/292 (13%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRL--SSQSGQGLEEFKNEIKLIAKLQHRNL 533
+ +G G +G V G +VA+K+L QS + E++L+ ++H N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 534 VRLLGCCIELE------EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGL 587
+ LL E + L+ +M + K LG + ++ ++ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLKGL 134
Query: 588 LYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMS 647
Y+H +IHRDLK N+ +++D KI DFG+A+ + S+ V T Y +
Sbjct: 135 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRA 186
Query: 648 PEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL---------TLLGRAWDLW 697
PE + ++ D++S G ++ E ++ K S+ T
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 698 KDDRAWELIDPILQNEASYL--ILNRYINVAL----LCVQEDAVDRPTMFEV 743
+ D A + + + E IL +A+ + DA R T E
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-36
Identities = 59/299 (19%), Positives = 107/299 (35%), Gaps = 18/299 (6%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHR 531
F LG G FG V + +G A+K L Q + +E NE +++ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 532 NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
LV+L + ++ EY+ + L + +I YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
L +I+RDLK N+L+D+ +++DFG AK + +T + GT ++PE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEII 210
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711
++ D ++ GVL+ E + + + + + +L+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQPAFSSIRGLKN 770
N + R+ N+ D + F + + P P F N
Sbjct: 271 NLLQVDLTKRFGNLKNGV--NDIKNHK-WFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 8e-34
Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGRL----HNGQEVAVKRLS----SQSGQGLEEFKNEIKLIAK 527
NF LG G +G V+ R G+ A+K L Q + E + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 528 LQHR-NLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG 586
++ LV L + LI +Y+ L L + + V + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEI 138
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+L L +L +I+RD+K NILLD + + ++DFG++K F DE + GT YM
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYM 197
Query: 647 SPEYAQQGL--FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704
+P+ + G D +S GVL+ E L+ + L + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTM 740
+ + ++ ++ R + +D R
Sbjct: 258 EMSALAKD-----LIQR-------LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-33
Identities = 54/296 (18%), Positives = 109/296 (36%), Gaps = 43/296 (14%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNL 533
++ KLG G + V++ + N ++V VK L ++ K EIK++ L+ N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92
Query: 534 VRLLGCCIELEEK--ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
+ L + + L++E++ N L + EI + L Y H
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 146
Query: 592 QYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
+ ++HRD+K N+++D + ++ D+G+A+ + + + V + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 651 AQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL------LGRAWDLWKDDRAW 703
++ D++S G +L + K + + L LG D+
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 704 ELIDPILQNEASYLILNRYINVALL----------------CVQEDAVDRPTMFEV 743
+DP + R+ ++ D R T E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS--SQSGQGLEEFKNEIKLIAKLQHRN 532
+ +G G G V + VA+K+LS Q+ + E+ L+ + H+N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 533 LVRLLGCCI------ELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQG 586
++ LL E ++ L+ E M + + E ++ ++ G
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCG 131
Query: 587 LLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYM 646
+ +LH +IHRDLK SNI++ D KI DFG+A+ G V T Y
Sbjct: 132 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185
Query: 647 SPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
+PE + D++S G ++ E + K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 8e-31
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 476 NFSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLS--SQSGQGLEEFKNEIKLIAKLQHRN 532
+ + +G G +G V G VAVK+LS QS + E++L+ ++H N
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 533 LVRLLGCCIELEEKILI-YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLH 591
++ LL Y+ + L + K L + +I +I +GL Y+H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 592 QYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYA 651
+IHRDLK SN+ +++D KI DFG+A+ T + +
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML 191
Query: 652 QQGLFSIKSDVFSFGVLLLETLSSK 676
++ D++S G ++ E L+ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 8e-29
Identities = 40/215 (18%), Positives = 81/215 (37%), Gaps = 18/215 (8%)
Query: 477 FSTENKLGEGGFGPVYKGR-LHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR 535
+ KLG G F V+ + + N VA+K + E ++EIKL+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 536 LLGCCIELEEKILIYEYMPNKSLDIF-------------LFDTPKESPLGWETRVRVIEE 582
K+L + + L + + ++ ++
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 583 IAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFGMAKMFGGDELQSKTKRIVG 641
+ GL Y+H+ R +IH D+K N+L++ D + +A + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 642 TYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK 676
T Y SPE + +D++S L+ E ++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 107 bits (267), Expect = 3e-27
Identities = 36/201 (17%), Positives = 75/201 (37%), Gaps = 25/201 (12%)
Query: 481 NKLGEGGFGPVYKGRLHNGQEVAVK--RLSSQSGQ--------GLEEFKNEIKLIAKLQH 530
+GEG V+ E VK ++ S + G F A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 531 RNLVRLLGCCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYL 590
R L +L G + +Y + N ++ + L D + + E V++ I + +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 591 HQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEY 650
+ ++H DL N+L+ + I DF + G + + +R V + +
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV---RNIITYF 172
Query: 651 AQQGLFSIKSDVFSFGVLLLE 671
++ + + D+ S +L+
Sbjct: 173 SRT--YRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 91.2 bits (226), Expect = 1e-22
Identities = 23/118 (19%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIG 93
+ +GE L + Q ++ + + L ++ T VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 SSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDH 151
S GN V+ + + ++W+S+ R G+ V L + GN+V+ + +W + +
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 72.4 bits (177), Expect = 5e-16
Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 20/126 (15%)
Query: 26 DTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFD 85
+ + + GE L + F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 SNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHL 145
+ L++ + GNLV+ N N IW+SN + G+ V L N+V+
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DR 101
Query: 146 WQSFDH 151
W + H
Sbjct: 102 WATGTH 107
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 68.3 bits (166), Expect = 1e-14
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIF 84
+D + + G L + + + Y ++ VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNL------VLYD--NNRAVWASGTNGKA- 49
Query: 85 DSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGH 144
S L + + GNLVI + + IW+SN R+ G+ L N+V+ DN ++
Sbjct: 50 -SGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNN-----A 102
Query: 145 LWQSFDHPSD 154
+W + + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 64.9 bits (158), Expect = 3e-13
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 9/97 (9%)
Query: 64 IWYKQIS-DTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVA 122
I Y D + + + S L++ + NLV+ + ++ +WS+N K A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRA 70
Query: 123 QLLDTGNLVLRDNFSSNSSEGHLWQSFD--HPSDTLL 157
L G + + N +W S + +
Sbjct: 71 VLQPNGRMDVLTN-----QNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.8 bits (116), Expect = 1e-07
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 2/65 (3%)
Query: 70 SDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGN 129
D VW N A L +G + +L +N +W+S +R AG V L N
Sbjct: 52 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109
Query: 130 LVLRD 134
L +
Sbjct: 110 LAIYG 114
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 63.9 bits (155), Expect = 6e-13
Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 18/109 (16%)
Query: 40 LVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLV 99
++ + + + + Y ++ +W N A L G LV
Sbjct: 25 ILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATNTGGLGNGCRAVLQ--PDGVLV 74
Query: 100 ILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148
++ +N T+W S + KAG V L N+V+ + LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.8 bits (116), Expect = 1e-07
Identities = 18/111 (16%), Positives = 31/111 (27%), Gaps = 33/111 (29%)
Query: 64 IWY-KQISDTVVWVANRNRPIFDSNATLTIGSSGNL------------------------ 98
I + + + + + S+ T+ S NL
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 99 ------VILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDN--FSSNSS 141
VIL +N WSS G+ V L + + + S +S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTS 113
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 795 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.85 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.85 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.66 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.63 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.53 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.5 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.27 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.03 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.0 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.33 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.48 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=416.74 Aligned_cols=254 Identities=25% Similarity=0.312 Sum_probs=206.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|+++ +++.||||++.... .+..+++.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999875 78999999997643 33456799999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++|+|.+++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999884 3457999999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||................ ...
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-------------~~~ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------------KTY 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-------------CTT
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------------CCC
Confidence 333455789999999999988776 578999999999999999999997654332211111000 000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.......+.++.+++.+||+.||++|||+.|+++|-
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 261 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 261 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 011122345678999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=413.63 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=210.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999764 79999999998766667788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999987743 46999999999999999999999998 99999999999999999999999999987654332
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....... ... .. .+.+ .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~---~~------~~~~--~ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IAT---NG------TPEL--Q 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHH---HC------SCCC--S
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH--HHh---CC------CCCC--C
Confidence 23446899999999999999999999999999999999999999965442211100 000 00 0000 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+...+..+.+++.+||+.||++|||+.|+++|-
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 1223456788999999999999999999998873
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=413.48 Aligned_cols=264 Identities=27% Similarity=0.453 Sum_probs=207.2
Q ss_pred ccCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|+.+ ..||||+++.. ..+..+.|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 368999999999999999999865 36999998754 45567889999999999999999999998754 56899999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+++|+|.+++.. ....+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999998854 3356999999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.........||+.|||||++.. ..++.++|||||||++|||+||+.||........... ..... ...+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~-~~~~~--------~~~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF-MVGRG--------YLSP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH-HHHHT--------SCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH-HHhcC--------CCCC
Confidence 3334455789999999999864 4589999999999999999999999875443221110 00000 0111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCC
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLP 755 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 755 (795)
.+ ...+...+.++.+++.+||+.||++|||+.||+++|+.+...+|
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11222345678899999999999999999999999998865554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=408.79 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=200.2
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++++|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999888889999999764 3456789999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999998754 3456899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCC-CCCCCCCcch-hhcccccccccccchhhccCccccc
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR-NTDFSNTDSL-TLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~-p~~~~~~~~~-~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
......||+.|+|||.+.+..++.++|||||||++|||+|++. |+........ ..+.... ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------------~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------------RL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC----------------CC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC----------------CC
Confidence 2233578999999999999999999999999999999999654 4443322111 1111000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+.++.+++.+||+.||++||||+||+++|+.+
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11122345788999999999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=406.17 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=207.9
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+|+++ +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 6899999998653 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999988843 356999999999999999999999998 999999999999999999999999999866533
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ... . +.
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--i~~----~------~~-- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR--ISR----V------EF-- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHT----T------CC--
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH--HHc----C------CC--
Confidence 2 3346899999999999999999999999999999999999999975542221110 000 0 00
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+.++.+++.+||+.||++|||+.|+++|
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0112234568899999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-48 Score=408.83 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=211.7
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.++||+|+||.||+|.++ +++.||||+++.. ....++|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 367899999999999999999775 6889999999754 34567899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999988543 3457999999999999999999999998 99999999999999999999999999997654432
Q ss_pred ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
. ......|++.|+|||.+.+..++.++|||||||++|||++|+.|+........ .... +......
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~-------------i~~~~~~ 235 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYEL-------------LEKDYRM 235 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHH-------------HHTTCCC
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHH-------------HhcCCCC
Confidence 2 22334688999999999999999999999999999999997776543222111 1000 0000111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
..+...+.++.+++.+||+.||++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12223456788999999999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=415.31 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=206.9
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||+||+|++. +++.||||+++... ....+++.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999764 78999999997653 3445789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 9999999999853 34699999999999999999999974 7 99999999999999999999999999986532
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhccccccccc------------
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWK------------ 698 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~------------ 698 (795)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+...............
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22335689999999999999999999999999999999999999997655332211110000000
Q ss_pred ------------ccchhhccCccccc----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 699 ------------DDRAWELIDPILQN----EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 699 ------------~~~~~~~id~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.....+.++..... ......+.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000000000 0001123568899999999999999999999987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=408.35 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=208.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
+.|++.++||+|+||.||+|++. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999765 78999999998777777788999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999988743 2356999999999999999999999998 9999999999999999999999999997643221
Q ss_pred cceeeecccCCcCChhhhc-----cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 634 SKTKRIVGTYGYMSPEYAQ-----QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.......||+.|+|||++. ...|+.++|||||||++|||++|+.||...+....... . .. ... +
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~--i---~~-~~~-----~ 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK--I---AK-SEP-----P 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--H---HH-SCC-----C
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH--H---Hc-CCC-----C
Confidence 1233468999999999883 45689999999999999999999999975543222110 0 00 000 0
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.+ ..+...+.++.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01 1122345678899999999999999999999886
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=406.03 Aligned_cols=255 Identities=31% Similarity=0.433 Sum_probs=206.4
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.++||+|+||.||+|++++++.||||+++.. ....++|.+|+.+|++++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 678999999999999999999988899999999764 3456789999999999999999999998754 56799999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|+|.+++... ....+++..+..|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 99998876432 2335899999999999999999999998 999999999999999999999999999987644322
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......||+.|+|||.+.+..++.++|||||||++|||+||+.|+........ ....... ...+ ..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~---------~~~~----~~ 231 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLER---------GYRM----VR 231 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHT---------TCCC----CC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh---------cCCC----CC
Confidence 22335789999999999999999999999999999999997665432221111 1111000 0001 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+...+.++.+++.+||+.||++||||+||+++|+..
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 122345688999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=408.09 Aligned_cols=250 Identities=24% Similarity=0.297 Sum_probs=205.2
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++.+.||+|+||.||+|+++ +++.||||++.+. .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999764 7899999999753 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999888743 357999999999999999999999998 999999999999999999999999999987644
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......... .. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------~~------~-- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LE------Y-- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT------TC------C--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc------CC------C--
Confidence 433444456899999999999999999999999999999999999999976543222110000 00 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..+...+.++.++|.+||+.||++|||++|++++
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0111234568899999999999999999997554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=407.87 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=196.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee--cceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--LEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 549 (795)
++|++.+.||+|+||.||+|+++ +|+.||||++... .+...+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999765 7899999999764 33446779999999999999999999999865 4567999
Q ss_pred EeecCCCCcceeeccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 550 YEYMPNKSLDIFLFDT-PKESPLGWETRVRVIEEIAQGLLYLHQYSR--LRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~--~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
|||+++|+|.+++... .....+++..++.++.||+.||+|||+++. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988542 234579999999999999999999998652 3599999999999999999999999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .. .....
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~--~i----~~~~~---- 231 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG--KI----REGKF---- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HH----HHTCC----
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH--HH----HcCCC----
Confidence 65432 22334689999999999999999999999999999999999999997544322111 00 00000
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+...+.++.+++.+||+.||++|||+.|+++|
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01112234578899999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=398.46 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=212.3
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.++||+|+||.||+|+++++++||||++++.. ...++|.+|+.++++++||||++++++|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888999999997643 456789999999999999999999999999999999999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|+|.+++.. ....+++..+.+++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999888743 3456889999999999999999999998 999999999999999999999999999876544332
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......+|+.|+|||.+....++.++|||||||++|||+| |+.||........... .. .+ ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~--i~----~~---------~~~~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--IA----QG---------LRLY 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--HH----TT---------CCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH--HH----hC---------CCCC
Confidence 2233578999999999999999999999999999999998 7888876543322111 00 00 0011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
.+...+.++.+++.+||+.||++|||++|++++|..
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122234578899999999999999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=411.72 Aligned_cols=256 Identities=28% Similarity=0.399 Sum_probs=206.6
Q ss_pred cCCcccccccCCCceeEEeeeccC-C-----ceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN-G-----QEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
++|++.++||+|+||.||+|++.. + ..||+|++... .......+.+|+.+|.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999997642 2 36999998654 334456799999999998 899999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCC
Q 040413 547 ILIYEYMPNKSLDIFLFDTPK--------------------ESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKAS 606 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~ 606 (795)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999865321 246899999999999999999999998 999999999
Q ss_pred cEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCc
Q 040413 607 NILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTD 685 (795)
Q Consensus 607 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~ 685 (795)
|||++.++.+||+|||+|+...............||+.|||||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433333445678999999999999999999999999999999998 89998754432
Q ss_pred ch-hhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 040413 686 SL-TLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLT 748 (795)
Q Consensus 686 ~~-~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 748 (795)
.. ..... . ....+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~~~~~~~------~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQ------N---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHH------T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHh------c---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 11100 0 0011122234567889999999999999999999999995
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=407.23 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=198.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc---eEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ---EVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
.+|++.++||+|+||.||+|+++ +++ .||||++... .....++|.+|+++|++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999875 332 5899988654 444567899999999999999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++|+|++++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999988753 3456999999999999999999999998 99999999999999999999999999987654
Q ss_pred Ccccc---ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcch-hhcccccccccccchhh
Q 040413 630 DELQS---KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSL-TLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 630 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 704 (795)
..... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||........ ..+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~------------ 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------------ 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 32211 1222457899999999999999999999999999999998 8988865442221 11110
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
......+...+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 249 ----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 249 ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 000112233456788999999999999999999999999876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-46 Score=406.13 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=211.4
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999764 7899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc--CCCCceeeccccccccCCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~ 630 (795)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999888843 3456999999999999999999999999 99999999999996 4688999999999876543
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...+........... +...
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------~~~~ 244 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------------DWNM 244 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------CCCS
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CCCC
Confidence 3 234568999999999999999999999999999999999999999755432211100000 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
........+.++.+++.+||+.||++|||+.|+++|
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234568899999999999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=401.38 Aligned_cols=265 Identities=29% Similarity=0.415 Sum_probs=207.4
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecC
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMP 554 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 554 (795)
++|++.+.||+|+||.||+|+++++++||||+++.. ....+.|.+|+.+|++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 579999999999999999999988889999999754 3456789999999999999999999999854 56899999999
Q ss_pred CCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcccc
Q 040413 555 NKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQS 634 (795)
Q Consensus 555 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 634 (795)
+|+|..++... ....+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99998887542 2346999999999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccccchh
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNEA 714 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~ 714 (795)
......||+.|+|||.+..+.++.++|||||||++|||++|+.|+........ ....... ....+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~-------------~~~~~~ 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVER-------------GYRMPC 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHT-------------TCCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHHHHh-------------cCCCCC
Confidence 23345789999999999999999999999999999999997766543322111 1111000 001112
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccCCCCCCCCC
Q 040413 715 SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETVNLPHPQQP 760 (795)
Q Consensus 715 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~p 760 (795)
+...+.++.+++.+||+.||++||++++|+++|+......+++..|
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 2234567889999999999999999999999998875554433333
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=395.44 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=198.2
Q ss_pred CcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee----cceeEEE
Q 040413 477 FSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE----LEEKILI 549 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV 549 (795)
|++.++||+|+||+||+|.+. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999765 6889999998654 34456789999999999999999999999875 3457999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc-CCCCceeeccccccccC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD-KDMNPKISDFGMAKMFG 628 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DFGla~~~~ 628 (795)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ .++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999998853 356899999999999999999999875 4599999999999996 57999999999998654
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
.. .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||........ ....... +. .+
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~----~~-----~~ 231 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTS----GV-----KP 231 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTT----TC-----CC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHc----CC-----CC
Confidence 32 2335689999999998865 599999999999999999999999964432221 1111100 00 00
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+...+.++.+++.+||+.||++|||+.|+++|
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 01111223457899999999999999999999886
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-47 Score=402.35 Aligned_cols=252 Identities=23% Similarity=0.245 Sum_probs=192.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
.+.|++.+.||+|+||.||+|+++ +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999865 68999999997643 2334678899999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc---CCCCceeeccccccccC
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAKMFG 628 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFGla~~~~ 628 (795)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+. .++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999998843 457999999999999999999999998 99999999999995 57899999999998765
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||................ .
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~------------~ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE------------Y 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC------------C
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC------------C
Confidence 332 2234689999999999999999999999999999999999999997544222111100000 0
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
..........+.++.+++.+||+.||++|||+.|+++|
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00111112334568899999999999999999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=397.57 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=206.8
Q ss_pred cCCcccc-cccCCCceeEEeeecc---CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTEN-KLGEGGFGPVYKGRLH---NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++|.+.+ +||+|+||.||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||++++++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999754 3557999999765 34456789999999999999999999999864 568999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3457999999999999999999999998 99999999999999999999999999997754
Q ss_pred Ccc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 630 DEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 630 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
... ........||+.|+|||.+....++.++|||||||++|||+| |+.||............ ..+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i------~~~~------ 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------EQGK------ 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH------HTTC------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH------HcCC------
Confidence 332 222334568999999999999999999999999999999998 89998755432221110 0000
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
....+...+.++.+++.+||+.+|++|||+.+|++.|+..
T Consensus 230 ---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0112223456788999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-46 Score=404.28 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=212.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 553 (795)
++|+++++||+|+||.||+|++. +++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999764 79999999998766566678999999999999999999999999999999999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc--CCCCceeeccccccccCCCc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD--KDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~~ 631 (795)
++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999776632 3456999999999999999999999998 99999999999998 67899999999998876443
Q ss_pred cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccccccccchhhccCccc
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~id~~l 710 (795)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... .+... +...
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------~~~~ 247 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------DWEF 247 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------------CCCC
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------CCCC
Confidence 234468999999999999999999999999999999999999999755432211 11100 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hhcc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM--LTNE 750 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 750 (795)
........+.++.+|+.+||+.||++|||+.|+++| +++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 111112234568899999999999999999999997 5443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=398.13 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=200.7
Q ss_pred cCCcccccccCCCceeEEeeeccC-C----ceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN-G----QEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~-~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
..|++.++||+|+||.||+|.++. + ..||||++... .....++|.+|+.+|++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 568889999999999999997653 2 46999999754 33445679999999999999999999999999999999
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
||||+.++++.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887643 3357999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcc-ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDEL-QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.... ........||+.|+|||.+.+..++.++|||||||++|||++++.|+........ .... +.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~-------------i~ 227 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKA-------------IN 227 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHH-------------HH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHH-------------Hh
Confidence 4322 1222335689999999999999999999999999999999997666543221111 1111 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.......+...+.++.+|+.+||+.+|++||||.||+++|+.+.
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11111122234567889999999999999999999999998763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=396.63 Aligned_cols=248 Identities=28% Similarity=0.393 Sum_probs=198.5
Q ss_pred ccccCCCceeEEeeecc---CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEeecCC
Q 040413 481 NKLGEGGFGPVYKGRLH---NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEYMPN 555 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~---~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 555 (795)
++||+|+||.||+|.++ .++.||||+++.. .+...++|.+|+++|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999754 3578999999754 23345789999999999999999999999854 567899999999
Q ss_pred CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc-cc
Q 040413 556 KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL-QS 634 (795)
Q Consensus 556 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~ 634 (795)
|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999998853 356999999999999999999999998 99999999999999999999999999987654322 22
Q ss_pred ceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccch
Q 040413 635 KTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQNE 713 (795)
Q Consensus 635 ~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~~ 713 (795)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+. ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i------~~~~---------~~~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML------EKGE---------RMG 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH------HTTC---------CCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH------HcCC---------CCC
Confidence 2334578999999999999999999999999999999998 89998754422211110 0000 011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 714 ASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 714 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.+...+.++.+++.+||+.||++|||+.+|+++|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1223456788999999999999999999999988653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-47 Score=403.79 Aligned_cols=247 Identities=31% Similarity=0.432 Sum_probs=202.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
+.|+.+++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999764 78999999997643 234567899999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|+.++. ....+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999976653 2357999999999999999999999998 99999999999999999999999999986542
Q ss_pred ccccceeeecccCCcCChhhhcc---CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQ---GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ ..... . .. .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i~---~-~~-----~ 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA---Q-NE-----S 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHH---H-SC-----C
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH---h-CC-----C
Confidence 234679999999999854 5689999999999999999999999865432211 10000 0 00 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
+.+ .+...+..+.+++.+||+.||++|||+.|+++|-
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 111 0112245688999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=395.21 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=208.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccC------cccHHHHHHHHHHHHhcCCCceeeeeeeeeeccee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQS------GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 546 (795)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999864 78999999986531 23468899999999999999999999999999999
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC----Cceeeccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM----NPKISDFG 622 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DFG 622 (795)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999998853 346999999999999999999999998 99999999999998776 59999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccch
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRA 702 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 702 (795)
+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..........
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------- 230 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--------- 230 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---------
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh---------
Confidence 998765432 22345789999999999999999999999999999999999999975442221110000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.............+..+.+++.+||+.||++|||+.|+++|-
T Consensus 231 ---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 231 ---VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp ---TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred ---cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 000111112223456788999999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=398.48 Aligned_cols=249 Identities=24% Similarity=0.268 Sum_probs=209.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|++++.||+|+||.||+|+.+ +++.||||++.+. .....+++.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999764 7999999999754 3445788999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999888843 457899999999999999999999999 999999999999999999999999999865432
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+............
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--------------- 221 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------- 221 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC---------------
Confidence 2 22345789999999999999999999999999999999999999997655332211111000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSML 747 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 747 (795)
-..+...+.++.++|.+||+.||.+||+ ++|+++|-
T Consensus 222 -~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 0011223456789999999999999994 89999873
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=393.92 Aligned_cols=245 Identities=26% Similarity=0.322 Sum_probs=206.7
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|+++++||+|+||.||+|+++ +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999865 7899999999753 2345688999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888743 456889999999999999999999998 999999999999999999999999999876532
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... .. . ..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--i~---~-~~--------- 217 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--IL---N-AE--------- 217 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HH---H-CC---------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH--HH---c-CC---------
Confidence 2346899999999999999999999999999999999999999976542221110 00 0 00
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 746 (795)
...+...+.++.+++.+||+.||.+|| |++|+++|
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 011122345688999999999999996 99999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=396.69 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=210.5
Q ss_pred hccCCcccccccCCCceeEEeeecc------CCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecce
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEE 545 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 545 (795)
..++|++.++||+|+||.||+|+.+ +++.||||++.... .+..++|.+|+.+|++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999753 45789999997643 3346779999999999999999999999999999
Q ss_pred eEEEEeecCCCCcceeeccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCC
Q 040413 546 KILIYEYMPNKSLDIFLFDTP---------------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLK 604 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dik 604 (795)
.++||||+++|+|.+++.... ....+++..+..|+.||+.||+|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999998885321 2345899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCC-CCCCCC
Q 040413 605 ASNILLDKDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR-NTDFSN 683 (795)
Q Consensus 605 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~-p~~~~~ 683 (795)
|+||||+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++|.. |+....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999987654443444445678999999999999999999999999999999999964 555433
Q ss_pred CcchhhcccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 684 TDSLTLLGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.... .... ..+.. ...+...+.++.+|+.+||+.+|++||||.||+++|+.+
T Consensus 248 ~~e~--~~~v----~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HEEV--IYYV----RDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHH--HHHH----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHH--HHHH----HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2221 1111 00100 011223345788999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=395.77 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=202.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc----eEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ----EVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 548 (795)
.+|+++++||+|+||.||+|.+. +++ +||+|+++.. ..+..++|.+|+.+|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999764 444 5899988653 445678899999999999999999999999865 5678
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccC
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFG 628 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~ 628 (795)
++|++.+++|.+++.. ....+++..+.+++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999877654 3457999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccC
Q 040413 629 GDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELID 707 (795)
Q Consensus 629 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id 707 (795)
............||+.|+|||.+.++.++.++|||||||++|||+| |+.|+............. .+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~------~~------- 229 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KG------- 229 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH------HT-------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------cC-------
Confidence 5444334444578999999999999999999999999999999998 788876544322211110 00
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 708 PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 708 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.....+...+.++.+++.+||+.||++|||+.||+++|+..
T Consensus 230 --~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 00111223446788999999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-45 Score=393.93 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=215.3
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 550 (795)
++|+++++||+|+||.||+|+++ +|+.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999765 7999999998653 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGD 630 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 630 (795)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999888843 346999999999999999999999998 999999999999999999999999999876532
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...+...... .... .. .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~----~~------~-- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KIVS----GK------V-- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH----CC------C--
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH--HHhc----CC------C--
Confidence 234689999999999999999999999999999999999999997544222111 1000 00 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh--hcc------cCCCCCCCCCCccc
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSML--TNE------TVNLPHPQQPAFSS 764 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L--~~~------~~~~~~~~~p~~~~ 764 (795)
..+...+.++.+++.+||+.||.+|+ |++|+++|- .+. ...++.|..|.+..
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCC
Confidence 01122345688999999999999994 999999863 221 23456666666543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=392.13 Aligned_cols=260 Identities=28% Similarity=0.378 Sum_probs=198.4
Q ss_pred ccCCcccccccCCCceeEEeeecc------CCceEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeec-c
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIEL-E 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 544 (795)
.++|++.++||+|+||.||+|++. +++.||||+++.. .....+.+.+|..++.++ +|+||+++++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 368999999999999999999753 3568999999754 334456788888888887 689999999988765 4
Q ss_pred eeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 6899999999999999985432 2346899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCC-CCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~-~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +|+......... .
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~-~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-C 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH-H
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH-H
Confidence 99999999999998765444333444568999999999999999999999999999999999975 466543322211 0
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.. ...+ ..+ ..+...+.++.+++.+||+.||++|||+.||++||+.+
T Consensus 248 ~~----~~~~-----~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 248 RR----LKEG-----TRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HH----HHHT-----CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HhcC-----CCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 0000 001 11122345688999999999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=387.01 Aligned_cols=261 Identities=25% Similarity=0.287 Sum_probs=197.7
Q ss_pred ccccccCCCceeEEeeecc-CCceEEEEEecccCcc-----cHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 479 TENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQ-----GLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 479 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.+++||+|+||+||+|+++ +++.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999875 6899999998654221 235689999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+.++++..+. .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998776554 34467899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccc-----ccc---ccch
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWD-----LWK---DDRA 702 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~-----~~~---~~~~ 702 (795)
.....+||+.|+|||.+.. ..++.++|||||||++|||++|++||........ ..+..... .+. ....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2234579999999998865 4689999999999999999999999876542221 11110000 000 0000
Q ss_pred hhccC---ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 703 WELID---PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 703 ~~~id---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
..... .............++.+++.+||+.||++|||++|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 00000 0000011112345789999999999999999999999973
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-45 Score=381.83 Aligned_cols=259 Identities=25% Similarity=0.337 Sum_probs=201.1
Q ss_pred ccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC---cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc----e
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS---GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE----E 545 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 545 (795)
.++|++.+.||+|+||.||+|++ .+++.||||++++.. ....+++.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999976 479999999997643 334567999999999999999999999988754 3
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.+|||||+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999887743 356999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCc-cccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 626 MFGGDE-LQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 626 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
...... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~-----~~~~~--- 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDP--- 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-----HHCCC---
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH-----HhcCC---
Confidence 654322 222334568999999999999999999999999999999999999999754422211100 00000
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRP-TMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 750 (795)
..........+.++.+++.+||+.||++|| |++++++.|..+
T Consensus 232 ----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 ----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 000111122345788999999999999999 899998887643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=384.87 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred cCCcccccccCCCceeEEeeeccC----CceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN----GQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|+.+|++++|||||++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 579999999999999999997642 356899998654 3444677999999999999999999999986 4678999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++|+|.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999887643 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDP 708 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~ 708 (795)
... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+|+............. .+..
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------~~~~------ 227 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER------ 227 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC------
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCC------
Confidence 322 22334578999999999999999999999999999999998 788887654332211100 0000
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 709 ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 709 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+...+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 011223456788999999999999999999999999765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=382.63 Aligned_cols=249 Identities=28% Similarity=0.397 Sum_probs=197.1
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeee-cceeEEEEeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-LEEKILIYEYM 553 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 553 (795)
++|++.++||+|+||.||+|+++ +++||||+++.. ...+.|.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 57888999999999999999885 688999999753 345789999999999999999999999865 45689999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998542 2235899999999999999999999998 999999999999999999999999999865432
Q ss_pred cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhccCccccc
Q 040413 634 SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQN 712 (795)
Q Consensus 634 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~~ 712 (795)
.....+|..|+|||.+.+..++.++|||||||++|||+| |+.|+........... . .. ....
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~--i----~~---------~~~~ 219 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--V----EK---------GYKM 219 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--H----TT---------TCCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH--H----Hc---------CCCC
Confidence 233468899999999999999999999999999999998 6777665432222111 0 00 0111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 713 EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 713 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+.+...+.++.+++.+||+.||++|||+.|++++|+.+
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12223345788999999999999999999999999865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=383.89 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=201.7
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|+++++||+|+||+||+|.+ .+++.||||+++... +...+++.+|+++|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999976 478999999996542 3346789999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
|+.++.+..... .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765543322 23456999999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccceeeecccCCcCChhhhccCC-CCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc-----ccc----c
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL-----WKD----D 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~-----~~~----~ 700 (795)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+.... ......... +.. .
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 2223457999999999877655 57899999999999999999999976542211 100000000 000 0
Q ss_pred chhhccCccccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 701 RAWELIDPILQN---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 701 ~~~~~id~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
............ ......+.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000000 0111234578899999999999999999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-44 Score=378.32 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=205.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc---------ccHHHHHHHHHHHHhcC-CCceeeeeeeeeec
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG---------QGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIEL 543 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 543 (795)
++|++.+.||+|+||+||+|++. +++.||||++.+... ...+.+.+|+.+|++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999764 789999999976421 12356889999999997 99999999999999
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
+..+|||||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999853 357999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhcc------CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccc
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQ------GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLW 697 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 697 (795)
++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..............
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~---- 229 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS---- 229 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh----
Confidence 987654322 234689999999998853 4578899999999999999999999976543222110000
Q ss_pred cccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 698 KDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 698 ~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.. ...........+.++.+++.+||+.+|++|||+.||++|
T Consensus 230 --~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 --GN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --TC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --CC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 000111112344678899999999999999999999887
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=384.85 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=207.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
.++|++.+.||+|+||.||+|.++ +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999765 78999999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCC--CCceeeccccccccCCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKD--MNPKISDFGMAKMFGGD 630 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~ 630 (795)
+++++|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2346999999999999999999999998 9999999999999854 57999999999876543
Q ss_pred ccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCccc
Q 040413 631 ELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPIL 710 (795)
Q Consensus 631 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l 710 (795)
. ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+........... ....
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~------------~~~~ 222 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------------EYTF 222 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------------CCCC
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CCCC
Confidence 2 234467999999999999999999999999999999999999999765432211100000 0000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 711 QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 711 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
........+.++.+++.+||+.||++|||+.|+++|
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111234568899999999999999999999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=388.39 Aligned_cols=258 Identities=28% Similarity=0.382 Sum_probs=210.7
Q ss_pred cCCcccccccCCCceeEEeeec------cCCceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeeccee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL------HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEK 546 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 546 (795)
++|++.++||+|+||.||+|++ ..++.||||+++... .....+|.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 6889999999999999999974 246789999997643 34556799999999999 699999999999999999
Q ss_pred EEEEeecCCCCcceeeccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 547 ILIYEYMPNKSLDIFLFDTP---------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999886432 2346999999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCC-CCCCCCCCcch-hh
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTDSL-TL 689 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~-~p~~~~~~~~~-~~ 689 (795)
.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|++ +|+........ ..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999999876544444445578999999999999999999999999999999999954 44444332221 11
Q ss_pred cccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 690 LGRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 690 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+ ++.......+...+..+.+|+.+||+.||++|||+.||+++|+..
T Consensus 260 ~---------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 260 M---------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp H---------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 011111111222346789999999999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.6e-45 Score=394.87 Aligned_cols=249 Identities=27% Similarity=0.299 Sum_probs=201.1
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHH---HHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNE---IKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.++||+|+||.||+|++. +|+.||||++.+. .......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999865 7899999998643 12233444444 66667778999999999999999999
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999998853 356889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhcc
Q 040413 628 GGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELI 706 (795)
Q Consensus 628 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~i 706 (795)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+..... ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~-------- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TM-------- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-SC--------
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cC--------
Confidence 5432 234579999999999875 568999999999999999999999997654333221111000 00
Q ss_pred CccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040413 707 DPILQNEASYLILNRYINVALLCVQEDAVDRPT-----MFEVVSM 746 (795)
Q Consensus 707 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 746 (795)
. ...+...+.++.++|.+||+.||++||| ++|+++|
T Consensus 225 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp C----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred C----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 0011123456889999999999999999 7999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=387.15 Aligned_cols=259 Identities=28% Similarity=0.395 Sum_probs=207.8
Q ss_pred cCCcccccccCCCceeEEeeeccC--------CceEEEEEecccC-cccHHHHHHHHHHHHhc-CCCceeeeeeeeeecc
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHN--------GQEVAVKRLSSQS-GQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELE 544 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 544 (795)
++|++.++||+|+||.||+|+... +..||||++++.. .....++.+|+..+.++ +|||||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 689999999999999999997532 3479999997653 34567899999999998 7999999999999999
Q ss_pred eeEEEEeecCCCCcceeeccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTP-------------KESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD 611 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~ 611 (795)
..++||||+++|+|.+++.... ....+++.++..++.||+.||+|||+++ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 9999999999999999986442 2356899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhc
Q 040413 612 KDMNPKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLL 690 (795)
Q Consensus 612 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~ 690 (795)
.++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |.+|+..........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~- 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH-
Confidence 999999999999997765444444455679999999999999999999999999999999998 677776544322111
Q ss_pred ccccccccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 691 GRAWDLWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 691 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
....+. ....+...+.++.+++.+||+.||++|||+.||+++|+.+.
T Consensus 249 -----~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 249 -----LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -----HHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111110 01111223456889999999999999999999999998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=382.74 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=196.8
Q ss_pred cCCcccccccCCCceeEEeeecc--CC--ceEEEEEeccc---CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH--NG--QEVAVKRLSSQ---SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.+.||+|+||.||+|+.. ++ .+||||++.+. ..+..++|.+|+.+|++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999753 22 47899998754 34456789999999999999999999999965 4678
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMF 627 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~ 627 (795)
+||||++++++.+++.. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999877643 2346999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccc-cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHh-CCCCCCCCCCcchhhcccccccccccchhhc
Q 040413 628 GGDELQ-SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLS-SKRNTDFSNTDSLTLLGRAWDLWKDDRAWEL 705 (795)
Q Consensus 628 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (795)
...... .......|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+...... ... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~--~i~---~~~----- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH--KID---KEG----- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HHH---TSC-----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH--HHH---hCC-----
Confidence 544322 22334567889999999999999999999999999999998 899987554322211 100 000
Q ss_pred cCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 706 IDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 706 id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
...+.+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00111122345688999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=385.97 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=204.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCc--eEEEEEeccc-CcccHHHHHHHHHHHHhc-CCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQ--EVAVKRLSSQ-SGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.++||+|+||.||+|+++ ++. .||||++... ..+..+.|.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 68899999999999999999875 444 5788887643 344567899999999999 799999999999999999999
Q ss_pred EeecCCCCcceeeccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCc
Q 040413 550 YEYMPNKSLDIFLFDT-------------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNP 616 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~ 616 (795)
|||+++|+|.+++... .....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999998 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCC-CCCCCCCcchhhcccccc
Q 040413 617 KISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKR-NTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 617 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~-p~~~~~~~~~~~~~~~~~ 695 (795)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+...+.... ......
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~--~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHGGG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH--HHHHHh
Confidence 999999998654221 2223568999999999999999999999999999999999765 5554332221 111100
Q ss_pred cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 696 LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 696 ~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
+ .....+...+.++.+++.+||+.||++||||.||+++|+.+..
T Consensus 242 ----~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 242 ----G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----c---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 0011122234678899999999999999999999999988744
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=385.28 Aligned_cols=252 Identities=18% Similarity=0.219 Sum_probs=201.0
Q ss_pred ccCCcccc-cccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhc-CCCceeeeeeeeee----ccee
Q 040413 474 TANFSTEN-KLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKL-QHRNLVRLLGCCIE----LEEK 546 (795)
Q Consensus 474 ~~~y~~~~-~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 546 (795)
.++|++.+ .||+|+||.||+|++ .+++.||||++++. +.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36898875 599999999999976 47899999999642 5688999987665 89999999999875 4668
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC---CCCceeecccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK---DMNPKISDFGM 623 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DFGl 623 (795)
++||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998643 2357999999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhcccccccccccch
Q 040413 624 AKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDLWKDDRA 702 (795)
Q Consensus 624 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 702 (795)
|+...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.... ..+.. .....
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---~i~~~-- 232 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIRMG-- 232 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC--
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---HHhcC--
Confidence 98765433 22346899999999999999999999999999999999999999965432221 10000 00000
Q ss_pred hhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 WELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
............+.++.+++.+||+.||++|||+.|+++|
T Consensus 233 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 ----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0001111223456678999999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-45 Score=389.30 Aligned_cols=248 Identities=26% Similarity=0.344 Sum_probs=205.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc---CcccHHHHHHHHHHHH-hcCCCceeeeeeeeeecceeEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ---SGQGLEEFKNEIKLIA-KLQHRNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 549 (795)
++|++.+.||+|+||+||+|+++ +++.||||++++. .....+.+.+|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999765 7899999999753 2345667778877765 68999999999999999999999
Q ss_pred EeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCC
Q 040413 550 YEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 550 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 629 (795)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999853 356899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcc
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPI 709 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~ 709 (795)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......... . .+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------~------~~- 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------D------NP- 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C------CC-
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc------C------CC-
Confidence 32 223346899999999999999999999999999999999999999976553322111100 0 01
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 040413 710 LQNEASYLILNRYINVALLCVQEDAVDRPTMF-EVVSM 746 (795)
Q Consensus 710 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~~ 746 (795)
..+...+.++.+++.+||+.||++||++. |+++|
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 01122345688999999999999999995 78765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=384.17 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=211.3
Q ss_pred cCCcccccccCCCceeEEeeecc------CCceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH------NGQEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 547 (795)
++|++.++||+|+||.||+|.+. .++.||||++++. ..+....|.+|+.++++++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 68899999999999999999763 3578999999764 3344567999999999999999999999999999999
Q ss_pred EEEeecCCCCcceeeccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeec
Q 040413 548 LIYEYMPNKSLDIFLFDT-------PKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISD 620 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D 620 (795)
+||||+++|+|.+++... .....+++..+.+++.||++||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 999999999998887532 23356889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCC-CCCCCCCCcchhhcccccccccc
Q 040413 621 FGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSK-RNTDFSNTDSLTLLGRAWDLWKD 699 (795)
Q Consensus 621 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 699 (795)
||+++...............||+.|+|||.+.+..++.++||||||+++|||++|+ +|+......... .... .
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~--~~i~----~ 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--RFVM----E 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH--HHHH----T
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH--HHHH----h
Confidence 99998775544444444567899999999999999999999999999999999985 555543322211 1100 0
Q ss_pred cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 700 DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 700 ~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
+.. ...+...+..+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 251 ~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 000 011122345789999999999999999999999999887
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-44 Score=377.92 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=203.9
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 552 (795)
++|+++++||+|+||+||+|++++++.||||++... .....+++.+|+.+|++++||||+++++.+.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999888999999999654 233467899999999999999999999999999999999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCcc
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDEL 632 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 632 (795)
+.++.+..+. .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988777665 33467999999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc-----cccc-------
Q 040413 633 QSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW-----DLWK------- 698 (795)
Q Consensus 633 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~-----~~~~------- 698 (795)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ..+.... ..+.
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2233568999999998865 5679999999999999999999999975542211 1000000 0000
Q ss_pred ccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 699 DDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 699 ~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.........+..........+..+.+++.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000001111111122234568899999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=381.05 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=201.5
Q ss_pred cccccCCCceeEEeeeccC--C--ceEEEEEeccc-CcccHHHHHHHHHHHHhcCCCceeeeeeeeeec-ceeEEEEeec
Q 040413 480 ENKLGEGGFGPVYKGRLHN--G--QEVAVKRLSSQ-SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL-EEKILIYEYM 553 (795)
Q Consensus 480 ~~~LG~G~~g~Vy~~~~~~--~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~~ 553 (795)
.++||+|+||+||+|++.+ + ..||||++++. .....++|.+|+++|++++||||+++++++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998643 2 25899999753 455668899999999999999999999998764 5789999999
Q ss_pred CCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCccc
Q 040413 554 PNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDELQ 633 (795)
Q Consensus 554 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 633 (795)
++++|.+++.. ....+++..+.+++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998754 3456788899999999999999999998 999999999999999999999999999876543322
Q ss_pred --cceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhhccCcccc
Q 040413 634 --SKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWELIDPILQ 711 (795)
Q Consensus 634 --~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~id~~l~ 711 (795)
.......||+.|+|||.+....++.++||||||+++|||++|+.|+........ ..... ..+. ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~i----~~g~--~~------ 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYL----LQGR--RL------ 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH----HTTC--CC------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-HHHHH----HcCC--CC------
Confidence 122235789999999999999999999999999999999998887754321110 00000 0000 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcccC
Q 040413 712 NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNETV 752 (795)
Q Consensus 712 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 752 (795)
..+...+.++.+++.+||+.||++||+|.||+++|+.+..
T Consensus 254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0112234568899999999999999999999999988743
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=380.10 Aligned_cols=268 Identities=23% Similarity=0.302 Sum_probs=199.9
Q ss_pred cCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHH--HHHHHHhcCCCceeeeeeeeeecc----eeEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKN--EIKLIAKLQHRNLVRLLGCCIELE----EKIL 548 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 548 (795)
++|.+.++||+|+||.||+|++ +|+.||||+++... .+++.+ |+..+..++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4677889999999999999986 57899999996532 334444 555556789999999999998754 5789
Q ss_pred EEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 549 IYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQY-----SRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 549 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
||||+++|+|.+++.. ..+++..+.+++.|++.||+|||+. .+.+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999954 3689999999999999999999974 123499999999999999999999999999
Q ss_pred ccccCCCcc--ccceeeecccCCcCChhhhccCC------CCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccc
Q 040413 624 AKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQGL------FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWD 695 (795)
Q Consensus 624 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 695 (795)
++....... ........||+.|+|||++.... ++.++|||||||++|||+||..|+................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987654322 22334568999999999987542 6788999999999999999998875433221111110000
Q ss_pred ccc-----ccchhhccCccccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 696 LWK-----DDRAWELIDPILQN-EASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 696 ~~~-----~~~~~~~id~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
... .....+.++|.+.. ..+.+.+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 000 00011112222222 22345667799999999999999999999999999765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=374.71 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=199.8
Q ss_pred ccCCcccccccCCCceeEEeeec-cC-CceEEEEEecccC--cccHHHHHHHHHHHHhc---CCCceeeeeeeeee----
Q 040413 474 TANFSTENKLGEGGFGPVYKGRL-HN-GQEVAVKRLSSQS--GQGLEEFKNEIKLIAKL---QHRNLVRLLGCCIE---- 542 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 542 (795)
.++|+++++||+|+||+||+|++ ++ ++.||||+++... ......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999976 34 6679999986532 22234567888887776 79999999999863
Q ss_pred -cceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecc
Q 040413 543 -LEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDF 621 (795)
Q Consensus 543 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DF 621 (795)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346799999999987654432 34467899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc----
Q 040413 622 GMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL---- 696 (795)
Q Consensus 622 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~---- 696 (795)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.... ..+......
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 999865432 233456899999999999999999999999999999999999999976542221 111000000
Q ss_pred -ccc-----cchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 697 -WKD-----DRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 697 -~~~-----~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
+.. ...................+..+.+|+.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000000011112234567899999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=373.01 Aligned_cols=242 Identities=23% Similarity=0.353 Sum_probs=196.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCc------ccHHHHHHHHHHHHhcC--CCceeeeeeeeeecc
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSG------QGLEEFKNEIKLIAKLQ--HRNLVRLLGCCIELE 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 544 (795)
.++|++.++||+|+||.||+|++. +++.||||++.+... ....++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999764 789999999875321 12244778999999996 899999999999999
Q ss_pred eeEEEEeecCC-CCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-CCCceeeccc
Q 040413 545 EKILIYEYMPN-KSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-DMNPKISDFG 622 (795)
Q Consensus 545 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DFG 622 (795)
..++||||+.+ +++.+++. ....+++.+++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 46656553 2356999999999999999999999998 999999999999985 4789999999
Q ss_pred cccccCCCccccceeeecccCCcCChhhhccCCC-CccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccc
Q 040413 623 MAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLF-SIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDR 701 (795)
Q Consensus 623 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 701 (795)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . .. ....
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~--i~-~~~~------ 221 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E--II-RGQV------ 221 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H--HH-HCCC------
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H--Hh-hccc------
Confidence 998754332 234689999999999987665 677999999999999999999986421 0 00 0000
Q ss_pred hhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 702 AWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 702 ~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
.+.+ ..+.++.+++.+||+.||++|||++|+++|-
T Consensus 222 ---~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 222 ---FFRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp ---CCSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ---CCCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 0111 1245688999999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=374.44 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=196.3
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecc------
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE------ 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 544 (795)
.++|+++++||+|+||+||+|.+. +++.||||++++. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999764 7999999999754 3344678999999999999999999999998655
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++||||+ +.+|..++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 556666552 346999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccccc------
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAWDL------ 696 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~------ 696 (795)
+..... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.... .........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876432 234679999999998876 4578999999999999999999999976542211 100000000
Q ss_pred --cccc---chhhccCc---cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hhcc
Q 040413 697 --WKDD---RAWELIDP---ILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM--LTNE 750 (795)
Q Consensus 697 --~~~~---~~~~~id~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 750 (795)
.... .....+.+ .-...........+.+|+.+||+.||++|||+.|+++| |+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000 00000000 00001112234567899999999999999999999998 4443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=368.14 Aligned_cols=269 Identities=21% Similarity=0.318 Sum_probs=200.0
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee--------c
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE--------L 543 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 543 (795)
++|+++++||+|+||+||+|++ ++++.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999986 47999999998654 33456779999999999999999999998865 3
Q ss_pred ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccc
Q 040413 544 EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGM 623 (795)
Q Consensus 544 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGl 623 (795)
...++||||+.++.+.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999988776443 34457899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcc--ccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccc----
Q 040413 624 AKMFGGDEL--QSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWD---- 695 (795)
Q Consensus 624 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~---- 695 (795)
++.+..... .......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+..... .+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987653322 1222335799999999998764 6899999999999999999999999754422211 1111000
Q ss_pred ----cccccchhhccCccccch--h-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhc
Q 040413 696 ----LWKDDRAWELIDPILQNE--A-----SYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTN 749 (795)
Q Consensus 696 ----~~~~~~~~~~id~~l~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 749 (795)
..........+....... . .......+.+++.+||+.||++|||++|+++|-.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 000000111010000000 0 11123467789999999999999999999998543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=372.13 Aligned_cols=267 Identities=20% Similarity=0.232 Sum_probs=199.0
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC-cccHHHHHHHHHHHHhcCCCceeeeeeeeeecc----ee
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS-GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELE----EK 546 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 546 (795)
...+|+++++||+|+||+||+|.+ .+++.||||++.+.. ....+++.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346899999999999999999975 589999999997643 344678999999999999999999999987643 33
Q ss_pred EEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 547 ILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 547 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+++++++.+++|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667789999998843 36999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcc-ccceeeecccCCcCChhhhc-cCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchh-hcccccccccccch-
Q 040413 627 FGGDEL-QSKTKRIVGTYGYMSPEYAQ-QGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLT-LLGRAWDLWKDDRA- 702 (795)
Q Consensus 627 ~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~- 702 (795)
...... .......+||+.|+|||.+. ...++.++||||+||++|||++|+.||......... ..............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 643322 12234467999999999884 456789999999999999999999999765422111 11000000000000
Q ss_pred ----------hhccCcccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 703 ----------WELIDPILQ---NEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 703 ----------~~~id~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
...+..... .........++.+++.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00111223468899999999999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=371.06 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=196.8
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceeeeeeeeeec------ceeE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIEL------EEKI 547 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 547 (795)
.+|+..++||+|+||+||+|++. +++.||||++.+... .+.+|+++|++++||||+++++++... ...+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 36889999999999999999875 789999999976432 245799999999999999999998643 2468
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-Cceeeccccccc
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKM 626 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~ 626 (795)
|||||++++.++.+.........+++.+++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999987755444332234567999999999999999999999998 99999999999999775 899999999987
Q ss_pred cCCCccccceeeecccCCcCChhhhcc-CCCCccCCeeehhHHHHHHHhCCCCCCCCCCcch-hhccccc--------c-
Q 040413 627 FGGDELQSKTKRIVGTYGYMSPEYAQQ-GLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL-TLLGRAW--------D- 695 (795)
Q Consensus 627 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~-~~~~~~~--------~- 695 (795)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..+.... .
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 654332 234579999999998765 5789999999999999999999999976542211 1110000 0
Q ss_pred ---cccccchhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040413 696 ---LWKDDRAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSM 746 (795)
Q Consensus 696 ---~~~~~~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 746 (795)
.......................+.++.+|+.+||+.||++|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000011112234568899999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-41 Score=362.57 Aligned_cols=258 Identities=20% Similarity=0.310 Sum_probs=199.5
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeee--cceeEEEE
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIE--LEEKILIY 550 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 550 (795)
++|+++++||+|+||+||+|++. +++.||||++++. ..+++.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999864 7899999999753 3567999999999995 9999999999874 35689999
Q ss_pred eecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCC-CceeeccccccccCC
Q 040413 551 EYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDM-NPKISDFGMAKMFGG 629 (795)
Q Consensus 551 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DFGla~~~~~ 629 (795)
||+.+++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 35899999999999999999999999 99999999999998665 589999999987654
Q ss_pred CccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcc--cc------------c
Q 040413 630 DELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLG--RA------------W 694 (795)
Q Consensus 630 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~--~~------------~ 694 (795)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............ .. .
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 22345789999999998764 5799999999999999999999998765432211000 00 0
Q ss_pred ccccccchh--------hccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 DLWKDDRAW--------ELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 ~~~~~~~~~--------~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
......... ...............+.++.+|+.+||+.||++|||++|+++|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 000000000 00011111112223345688999999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=357.00 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=204.6
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeeecceeEEEEe
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 551 (795)
++|+++++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999864 7899999998654 33456889999999999999999999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccccccCCCc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAKMFGGDE 631 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 631 (795)
++.+++|..++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998877763 3457889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceeeecccCCcCChhhhccCC-CCccCCeeehhHHHHHHHhCCCCCCCCCCcch--hhccccccccccc--------
Q 040413 632 LQSKTKRIVGTYGYMSPEYAQQGL-FSIKSDVFSFGVLLLETLSSKRNTDFSNTDSL--TLLGRAWDLWKDD-------- 700 (795)
Q Consensus 632 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DvwslG~ll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~-------- 700 (795)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.|+........ ..+..........
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 222346788899999887654 68999999999999999999998743332111 1110000000000
Q ss_pred ---chhhccC-ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 701 ---RAWELID-PILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 701 ---~~~~~id-~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
....... ..............+.+++.+||+.||.+|||++|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence 0000000 0000111223345678999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-41 Score=353.77 Aligned_cols=261 Identities=17% Similarity=0.199 Sum_probs=205.8
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcCC-CceeeeeeeeeecceeEEEEe
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH-RNLVRLLGCCIELEEKILIYE 551 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 551 (795)
.++|++.++||+|+||.||+|++. +++.||||++.... ..+.+++|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999865 78999999986543 22457889999999975 899999999999999999999
Q ss_pred ecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcC-----CCCceeeccccccc
Q 040413 552 YMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDK-----DMNPKISDFGMAKM 626 (795)
Q Consensus 552 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DFGla~~ 626 (795)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6788877743 3346899999999999999999999999 999999999999974 57899999999987
Q ss_pred cCCCcc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccccccccccc
Q 040413 627 FGGDEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLWKDD 700 (795)
Q Consensus 627 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~ 700 (795)
+..... ........||+.|||||.+.+..++.++|||||||++|||++|+.||.......... .......-...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 653321 122334679999999999999999999999999999999999999997654322211 11100000000
Q ss_pred chhhccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhccc
Q 040413 701 RAWELIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNET 751 (795)
Q Consensus 701 ~~~~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 751 (795)
.. .+.....+.++.+++..|++.+|++||+++.+.+.|+...
T Consensus 236 ~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 236 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred Ch---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 0111123456889999999999999999999988887653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-41 Score=355.37 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=196.3
Q ss_pred cCCcccccccCCCceeEEeeec-cCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCceee-eeeeeeecceeEEEEee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNLVR-LLGCCIELEEKILIYEY 552 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~E~ 552 (795)
++|++.++||+|+||.||+|++ .+++.||||++..... .+++.+|++++++++|+|++. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999976 4789999999875432 245889999999998776554 55666778888999999
Q ss_pred cCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEc---CCCCceeeccccccccCC
Q 040413 553 MPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLD---KDMNPKISDFGMAKMFGG 629 (795)
Q Consensus 553 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DFGla~~~~~ 629 (795)
+.+ +|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 955 45444422 3457999999999999999999999999 99999999999986 456799999999997754
Q ss_pred Ccc-----ccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchhh
Q 040413 630 DEL-----QSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAWE 704 (795)
Q Consensus 630 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (795)
... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||................ . ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~---~---~~ 232 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---E---KK 232 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH---H---HH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh---c---cc
Confidence 322 122345689999999999999999999999999999999999999997544222111100000 0 00
Q ss_pred ccCccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhcc
Q 040413 705 LIDPILQNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSMLTNE 750 (795)
Q Consensus 705 ~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 750 (795)
.-.+ ........+.++.+++..|++.+|++||++.++.+.|+..
T Consensus 233 ~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 233 MSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 0001112346788999999999999999999998888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=362.14 Aligned_cols=271 Identities=23% Similarity=0.296 Sum_probs=211.1
Q ss_pred cCCcccccccCCCceeEEeeecc----CCceEEEEEeccc----CcccHHHHHHHHHHHHhcCC-Cceeeeeeeeeecce
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH----NGQEVAVKRLSSQ----SGQGLEEFKNEIKLIAKLQH-RNLVRLLGCCIELEE 545 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 545 (795)
++|++.++||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999642 5789999998753 22345678999999999976 899999999999999
Q ss_pred eEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 546 KILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 546 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.++||||+.+++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999988843 345788999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeecccCCcCChhhhccC--CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhhcccccccccccchh
Q 040413 626 MFGGDELQSKTKRIVGTYGYMSPEYAQQG--LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTLLGRAWDLWKDDRAW 703 (795)
Q Consensus 626 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (795)
.+...... ......|++.|+|||.+... .++.++|||||||++|||++|+.||...................
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~----- 251 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 251 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----
Confidence 76543322 23346799999999998654 46889999999999999999999997654332211100000000
Q ss_pred hccCccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH--hhc------ccCCCCCCCCCCccc
Q 040413 704 ELIDPILQNEASYLILNRYINVALLCVQEDAVDRP-----TMFEVVSM--LTN------ETVNLPHPQQPAFSS 764 (795)
Q Consensus 704 ~~id~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~--L~~------~~~~~~~~~~p~~~~ 764 (795)
. ...+...+.++.+++.+||+.||++|| |++|+++| ++. ...+++.|..|....
T Consensus 252 ---~----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~ 318 (322)
T d1vzoa_ 252 ---E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRD 318 (322)
T ss_dssp ---C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred ---C----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCC
Confidence 0 011223456788999999999999999 58999986 322 223556666665433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=361.89 Aligned_cols=262 Identities=21% Similarity=0.230 Sum_probs=195.2
Q ss_pred ccCCcccccccCCCceeEEeeecc-CCceEEEEEeccc--CcccHHHHHHHHHHHHhcCCCceeeeeeeeee------cc
Q 040413 474 TANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ--SGQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE------LE 544 (795)
Q Consensus 474 ~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 544 (795)
.++|+++++||+|+||+||+|++. +|+.||||++.+. ......++.+|+.+|++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999865 7999999999754 33445678999999999999999999999864 36
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++||||+.++.+..+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999877665432 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-ccc--------cc-
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGR--------AW- 694 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~--------~~- 694 (795)
+...... ......+|+.|+|||.+.+..++.++||||+||++++|++|+.||...+...... +.. .+
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8765332 2334579999999999999999999999999999999999999987554221100 000 00
Q ss_pred -------------ccccccchhhccCccc---cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 695 -------------DLWKDDRAWELIDPIL---QNEASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 695 -------------~~~~~~~~~~~id~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
...........+.... ........+.++.+|+.+||+.||++|||++|+++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000000111111111 1123345677899999999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=363.49 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=198.0
Q ss_pred hccCCcccccccCCCceeEEeeec-cCCceEEEEEecccC--cccHHHHHHHHHHHHhcCCCceeeeeeeeee-----cc
Q 040413 473 ATANFSTENKLGEGGFGPVYKGRL-HNGQEVAVKRLSSQS--GQGLEEFKNEIKLIAKLQHRNLVRLLGCCIE-----LE 544 (795)
Q Consensus 473 ~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 544 (795)
..++|+++++||+|+||+||+|++ .+++.||||++++.. ....+++.+|+.+|++++|||||++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999976 479999999997643 3345678999999999999999999999864 33
Q ss_pred eeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCceeeccccc
Q 040413 545 EKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMA 624 (795)
Q Consensus 545 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DFGla 624 (795)
..++++|++.+++|.+++. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4577788889999999883 346999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccceeeecccCCcCChhhhccC-CCCccCCeeehhHHHHHHHhCCCCCCCCCCcchhh-cccccccc-----
Q 040413 625 KMFGGDELQSKTKRIVGTYGYMSPEYAQQG-LFSIKSDVFSFGVLLLETLSSKRNTDFSNTDSLTL-LGRAWDLW----- 697 (795)
Q Consensus 625 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DvwslG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~----- 697 (795)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+...... +.......
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 76432 22346789999999987665 56899999999999999999999997654222111 10000000
Q ss_pred ---cccchhhc---cCccccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 040413 698 ---KDDRAWEL---IDPILQN---EASYLILNRYINVALLCVQEDAVDRPTMFEVVSML 747 (795)
Q Consensus 698 ---~~~~~~~~---id~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 747 (795)
........ +...... ........++.+|+.+||+.||++|||+.|+++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence 00000000 0000000 00112345678999999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-36 Score=328.91 Aligned_cols=280 Identities=19% Similarity=0.236 Sum_probs=200.0
Q ss_pred cCCcccccccCCCceeEEeeecc-CCceEEEEEecccCcccHHHHHHHHHHHHhcC-----------CCceeeeeeeeee
Q 040413 475 ANFSTENKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-----------HRNLVRLLGCCIE 542 (795)
Q Consensus 475 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 542 (795)
.+|+++++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999864 79999999997542 33567889999998885 4789999988865
Q ss_pred c--ceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEeCCCCCCcEEEcCCCC----
Q 040413 543 L--EEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQ-YSRLRVIHRDLKASNILLDKDMN---- 615 (795)
Q Consensus 543 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~iiH~Dikp~NIll~~~~~---- 615 (795)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4566777776655443333333455678999999999999999999998 76 999999999999986654
Q ss_pred --ceeeccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHHHHHHhCCCCCCCCCCcc----hhh
Q 040413 616 --PKISDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLLLETLSSKRNTDFSNTDS----LTL 689 (795)
Q Consensus 616 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll~elltg~~p~~~~~~~~----~~~ 689 (795)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||++++|++|+.||....... ...
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865422 234579999999999999999999999999999999999999986433110 000
Q ss_pred ccccccc------------------ccccchhhccCcc----------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040413 690 LGRAWDL------------------WKDDRAWELIDPI----------LQNEASYLILNRYINVALLCVQEDAVDRPTMF 741 (795)
Q Consensus 690 ~~~~~~~------------------~~~~~~~~~id~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 741 (795)
....... +........+... ...........++.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000 0000000000000 01122345677899999999999999999999
Q ss_pred HHHHH--hhcc--cCCCCCCCCCCcc
Q 040413 742 EVVSM--LTNE--TVNLPHPQQPAFS 763 (795)
Q Consensus 742 evl~~--L~~~--~~~~~~~~~p~~~ 763 (795)
|+++| +++. ..+...|..|.+.
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HHhcCcccCCCCCcccCCCCCcccCC
Confidence 99998 4432 2344444544443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.87 E-value=4.3e-22 Score=176.58 Aligned_cols=112 Identities=24% Similarity=0.439 Sum_probs=96.7
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
+|||.|||.|.+|++|+| |.|+|+|+.+|+ |.++. ..++||.||++.| ...+.|.|+.||+|+|++.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence 589999999999999986 999999988776 66655 3689999999988 4457899999999999996
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCC
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSD 154 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtD 154 (795)
+.++|+++++...+..+|+|+|+|||||++. .+.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECC-----CCcEEecCCCccCC
Confidence 5788888877666677899999999999984 57799999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=8.7e-23 Score=200.40 Aligned_cols=170 Identities=19% Similarity=0.186 Sum_probs=121.9
Q ss_pred CcccccccCCCceeEEeeeccCCceEEEEEecccCc------------------ccHHHHHHHHHHHHhcCCCceeeeee
Q 040413 477 FSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSG------------------QGLEEFKNEIKLIAKLQHRNLVRLLG 538 (795)
Q Consensus 477 y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~ 538 (795)
+.+.++||+|+||.||+|.+.+|++||||+++.... .....+.+|...+.++.|+++++.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998753210 01234567889999999999988876
Q ss_pred eeeecceeEEEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEeCCCCCCcEEEcCCCCcee
Q 040413 539 CCIELEEKILIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKI 618 (795)
Q Consensus 539 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl 618 (795)
+. ..+++|||+++..+.+ ++...+..++.|++++|.|||+++ |+||||||+|||+++++ ++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 52 3479999998875533 334556789999999999999998 99999999999998654 899
Q ss_pred eccccccccCCCccccceeeecccCCcCChhhhccCCCCccCCeeehhHHH
Q 040413 619 SDFGMAKMFGGDELQSKTKRIVGTYGYMSPEYAQQGLFSIKSDVFSFGVLL 669 (795)
Q Consensus 619 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DvwslG~ll 669 (795)
+|||+|.............+-+. .-.|. ..+.|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~----~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVR----NIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHH----HHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHHHHH----HHHHH-HcCCCCCcccHHHHHHHH
Confidence 99999976543221110000000 00111 235678889999975443
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.85 E-value=1.3e-21 Score=171.76 Aligned_cols=107 Identities=24% Similarity=0.393 Sum_probs=93.8
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
.|+|.+||.|.+|++|. +|.|+|+|+.+|+ |.||. ..++||.||++.| +..+.|.|+.||+|+|++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47999999999999996 5999999998886 67765 3689999999988 55678999999999999999
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCC
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDH 151 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
|.+||+|++.......+|+|+|||||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999976666667899999999999963 48999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.85 E-value=2.9e-21 Score=169.49 Aligned_cols=108 Identities=20% Similarity=0.374 Sum_probs=93.0
Q ss_pred ccccCCCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCC
Q 040413 25 ADTITPSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLK 104 (795)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (795)
.|+|.|||.|.+|++|.+ |.|.|+|...|+ |.++. ..++||+||++.|. ...+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence 378999999999999986 899999987765 55543 36899999999997 44788999999999999999
Q ss_pred CceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCC
Q 040413 105 NGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDH 151 (795)
Q Consensus 105 ~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (795)
|.+||+|+++...+..+|+|+|||||||++. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9999999977666777899999999999962 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=6.1e-17 Score=143.98 Aligned_cols=101 Identities=22% Similarity=0.299 Sum_probs=85.9
Q ss_pred EEEeccC-CCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCC
Q 040413 63 GIWYKQI-SDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSS 141 (795)
Q Consensus 63 ~iw~~~~-~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~ 141 (795)
-|||.++ .++.+|++|++.|+.....+|.|+.||||||++. +.++|++++......++|.|+++|||||+|. +
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-----~ 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-----Q 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-----T
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC-----C
Confidence 5899887 7899999999999987778999999999999985 6899999977655667899999999999984 5
Q ss_pred CCceeeccCCCCCccCCCCccccccccCcceEEEeeccCCCCCCCceEEEeeccCcceE
Q 040413 142 EGHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKL 200 (795)
Q Consensus 142 ~~~~WqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~ 200 (795)
++++||||. +.++|.|.+.++++|...+
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 789999984 2357889999999988764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=7.7e-16 Score=136.31 Aligned_cols=101 Identities=22% Similarity=0.415 Sum_probs=82.2
Q ss_pred ccccCCCeE--ecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceee
Q 040413 32 RFIRDGEKL--VSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIW 109 (795)
Q Consensus 32 ~~l~~~~~l--~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W 109 (795)
|.|.++|.| .+..|.|.|.|..+|+ |.+ |. ..++||.||+..+ +..+.|.|+.||+|+|+|+++.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEEE
Confidence 455555554 5679999999988887 444 33 3689999999877 4468899999999999999999999
Q ss_pred eecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccC
Q 040413 110 SSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFD 150 (795)
Q Consensus 110 ~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (795)
++++.+..+..+|+|+|||||||++ .++|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 9997766667789999999999995 26999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.53 E-value=3.5e-15 Score=131.02 Aligned_cols=110 Identities=25% Similarity=0.251 Sum_probs=89.1
Q ss_pred EEeccC-CCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCC
Q 040413 64 IWYKQI-SDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSE 142 (795)
Q Consensus 64 iw~~~~-~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~ 142 (795)
|||.-. ..+..|+.+.++++.+...+|.|+.||||||++ .+.++|++++.+ ..+..|.|+++|||||++. ++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~-----~~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTA-----QN 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCT-----TT
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEcc-----CC
Confidence 566643 567779999999998878899999999999998 468999998654 4567899999999999984 57
Q ss_pred CceeeccCCCCCccCCCCccccccccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCCC
Q 040413 143 GHLWQSFDHPSDTLLPGMKLGWDLKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPW 215 (795)
Q Consensus 143 ~~~WqSFd~PtDtlLpg~~l~~~~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~w 215 (795)
.+||||+. +.++|.|.+.|+++|... +|. .++|.+|.-
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY~--~~~Wssgt~ 113 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IYG--PGLWDSGTS 113 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EEC--SEEEECSCC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--EeC--CCeecCCCC
Confidence 89999863 346899999999999865 453 468988763
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.50 E-value=1.7e-14 Score=126.58 Aligned_cols=98 Identities=26% Similarity=0.365 Sum_probs=80.2
Q ss_pred ccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceeeee
Q 040413 32 RFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIWSS 111 (795)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W~t 111 (795)
|.|.++|.|. +|.|.|.|..+|+ |.++. ..++||.+|...+ ..+.+.|+.||||||+|..+.+||++
T Consensus 15 ~tl~~~~~l~--~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSLE--LSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEEC--STTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcEE--cCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEc
Confidence 6666667773 5889999988876 66654 3678999997643 36789999999999999999999999
Q ss_pred cccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccC
Q 040413 112 NMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFD 150 (795)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (795)
++....+..+++|++|||||||+ .++|+|-.
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt 112 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGT 112 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEEC--------SEEEECSC
T ss_pred CCCCCCCCEEEEECCCCcEEEeC--------CCeecCCC
Confidence 98777777889999999999995 26999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.27 E-value=4.5e-12 Score=112.07 Aligned_cols=99 Identities=22% Similarity=0.399 Sum_probs=77.1
Q ss_pred CCccccCCCeEecCCCeEEEEEeCCCCCCceEEEEEeccCCCeEEEeecCCCCCCCCCceEEEeecCCeEEecCCCceee
Q 040413 30 PSRFIRDGEKLVSSSQRFELGFFSPGKSKYRYLGIWYKQISDTVVWVANRNRPIFDSNATLTIGSSGNLVILNLKNGTIW 109 (795)
Q Consensus 30 ~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~W 109 (795)
+.+.|..++.|. .|.|.|.|...|+ |.++. ...+||.++.... +..+.+.|+.+|||||+|.++.++|
T Consensus 22 ~~~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCCB--CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCeeE--cCCEEEEEcCCCc-----EEEec---CCcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 345666666664 4778888877665 55543 3577899986543 5568899999999999999999999
Q ss_pred eecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeec
Q 040413 110 SSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQS 148 (795)
Q Consensus 110 ~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (795)
+|++....+..+++|++|||||||+ ..+|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeC--------CCcccC
Confidence 9998776677789999999999995 258876
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.03 E-value=5.1e-10 Score=96.84 Aligned_cols=87 Identities=22% Similarity=0.346 Sum_probs=65.1
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccccc
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~ 166 (795)
.-+|.|+.||||||++ .+.+||++++.+....+.++|+++|||||++. .+.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~-----~g~~vWsS------------------ 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNP-----SNKPIWAS------------------ 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEEC------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECC-----CccceEEc------------------
Confidence 3568899999999998 45899999976655567899999999999984 57889986
Q ss_pred ccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 167 KTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 167 ~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
....+++.|.+.++.+|...++ . .+.|.++.
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t 106 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATGT 106 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred -------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCCC
Confidence 1112456788889988876643 2 24665553
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.00 E-value=7.8e-10 Score=97.07 Aligned_cols=86 Identities=24% Similarity=0.311 Sum_probs=67.0
Q ss_pred ceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCccccccc
Q 040413 88 ATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDLK 167 (795)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~~ 167 (795)
-+|.|+.||||||+++ +.++|++++.+...++.+.|+++|||||+|. .+.++|+|.-
T Consensus 32 y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~-----~g~~vWsS~t----------------- 88 (119)
T d1b2pa_ 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSPV----------------- 88 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECSC-----------------
T ss_pred EEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC-----CCcEEEECCC-----------------
Confidence 4688999999999975 5789999976555567899999999999984 5778897531
Q ss_pred cCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 168 TGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 168 tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
.-+.|.|.+.++.+|...+ + ..++|.++.
T Consensus 89 --------------~~~~~~~~l~Lq~DGNlvl--Y--g~~~W~S~T 117 (119)
T d1b2pa_ 89 --------------AGKAGHYVLVLQPDRNVVI--Y--GDALWATQT 117 (119)
T ss_dssp --------------CCCSSCEEEEECTTSCEEE--E--ESEEEECCC
T ss_pred --------------cCCCCceEEEEcCCCCEEE--E--CCCEeccCC
Confidence 1145778899999998765 4 246888775
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.83 E-value=9.4e-09 Score=88.73 Aligned_cols=88 Identities=24% Similarity=0.381 Sum_probs=65.7
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccC-CCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCccccc
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTR-KAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWD 165 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~-~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~ 165 (795)
.-.|.|+.||||||+. .+.+||++++.. ......+.|+++|||||++. .+.++|+|=
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-----~g~~vW~s~---------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-----EGRSLWASH---------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-----SSCEEEECC----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-----CCcEEEEEe----------------
Confidence 4568899999999997 568999998653 33456799999999999984 578899861
Q ss_pred cccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCCC
Q 040413 166 LKTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGPW 215 (795)
Q Consensus 166 ~~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~w 215 (795)
...+.|.|.+.++.+|...+ ++ .++|.|+.+
T Consensus 78 ---------------t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ---------------SVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY 108 (109)
T ss_dssp ---------------CCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred ---------------eECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence 11134678899999988764 43 358877764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.62 E-value=8.7e-08 Score=83.15 Aligned_cols=89 Identities=24% Similarity=0.386 Sum_probs=66.0
Q ss_pred CceEEEeecCCeEEecCCCceeeeecccCCCCccEEEEecCCCeeeecCCCCCCCCCceeeccCCCCCccCCCCcccccc
Q 040413 87 NATLTIGSSGNLVILNLKNGTIWSSNMTRKAGSPVAQLLDTGNLVLRDNFSSNSSEGHLWQSFDHPSDTLLPGMKLGWDL 166 (795)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~W~t~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~~l~~~~ 166 (795)
...|.|+.||||||+. .+.+||++++.....+..++|+.+|||||++. ++.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~------~~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG------SRAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET------TEEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec------CCeEEEE------------------
Confidence 4679999999999997 56899999876555667899999999999973 3456653
Q ss_pred ccCcceEEEeeccCCCCCCCceEEEeeccCcceEEEecCceeEEeeCC
Q 040413 167 KTGLERYQTSWRSADDPSPGNYTHRLDIHVLPKLCTYNGSVKLLCSGP 214 (795)
Q Consensus 167 ~tg~~~~l~Sw~s~~dps~G~ys~~~d~~g~~~~~~~~~~~~~~~sg~ 214 (795)
...-..|.|.+.++.+|...++- ....++|.|+.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 22224567889999999876442 23457888775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=1.7e-07 Score=94.32 Aligned_cols=149 Identities=15% Similarity=0.082 Sum_probs=107.3
Q ss_pred HHHHhccCCcccccccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcC-CCceeeeeeeeeecceeE
Q 040413 469 SVSAATANFSTENKLGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQ-HRNLVRLLGCCIELEEKI 547 (795)
Q Consensus 469 ~i~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 547 (795)
++....+.|+..+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3445556777766655555678998864 45678899887655555567889999998884 434667888888888899
Q ss_pred EEEeecCCCCcceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 040413 548 LIYEYMPNKSLDIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS--------------------------------- 594 (795)
Q Consensus 548 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--------------------------------- 594 (795)
+||++++|..+.+... +......++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999987754331 11223446677777777787531
Q ss_pred -----------------------CCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 595 -----------------------RLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 595 -----------------------~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999877677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=5e-06 Score=82.72 Aligned_cols=131 Identities=20% Similarity=0.191 Sum_probs=92.8
Q ss_pred cccCCCc-eeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCC--CceeeeeeeeeecceeEEEEeecCCCCc
Q 040413 482 KLGEGGF-GPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQH--RNLVRLLGCCIELEEKILIYEYMPNKSL 558 (795)
Q Consensus 482 ~LG~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL 558 (795)
.+..|.. +.||+...+++..+++|.-.... ...+..|+..++.+.. -.+.+++.+..+.+..++|||+++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 67899988888889999865432 2357888888888753 3356678888888888999999998766
Q ss_pred ceeeccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 040413 559 DIFLFDTPKESPLGWETRVRVIEEIAQGLLYLHQYS-------------------------------------------- 594 (795)
Q Consensus 559 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 594 (795)
.+.. ... ..++.++++.|.-||...
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 111 223445566666666421
Q ss_pred -----------CCcEEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 595 -----------RLRVIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 595 -----------~~~iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
...++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12389999999999999877778999988864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.38 E-value=0.00015 Score=76.73 Aligned_cols=75 Identities=12% Similarity=0.205 Sum_probs=50.5
Q ss_pred ccccCCCceeEEeeecc-CCceEEEEEeccc-------CcccHHHHHHHHHHHHhcC-C--CceeeeeeeeeecceeEEE
Q 040413 481 NKLGEGGFGPVYKGRLH-NGQEVAVKRLSSQ-------SGQGLEEFKNEIKLIAKLQ-H--RNLVRLLGCCIELEEKILI 549 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~-~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 549 (795)
+.||.|....||++... +++.++||.-... -+...++...|++.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 57899999999999875 4678999964321 1223456778998888773 2 335555543 45567899
Q ss_pred EeecCCCC
Q 040413 550 YEYMPNKS 557 (795)
Q Consensus 550 ~E~~~~gs 557 (795)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.0012 Score=69.57 Aligned_cols=72 Identities=19% Similarity=0.287 Sum_probs=50.7
Q ss_pred ccccCCCceeEEeeeccC--------CceEEEEEecccCcccHHHHHHHHHHHHhcCCCce-eeeeeeeeecceeEEEEe
Q 040413 481 NKLGEGGFGPVYKGRLHN--------GQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL-VRLLGCCIELEEKILIYE 551 (795)
Q Consensus 481 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 551 (795)
+.|+.|-.-.+|++..++ .+.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 578889999999997643 34577777653 2334456789999998854344 467776643 68999
Q ss_pred ecCCCCc
Q 040413 552 YMPNKSL 558 (795)
Q Consensus 552 ~~~~gsL 558 (795)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0022 Score=65.61 Aligned_cols=136 Identities=12% Similarity=0.106 Sum_probs=80.8
Q ss_pred ceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCce--eeee-----eeeeecceeEEEEeecCCCCcce
Q 040413 488 FGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL--VRLL-----GCCIELEEKILIYEYMPNKSLDI 560 (795)
Q Consensus 488 ~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~E~~~~gsL~~ 560 (795)
--.||+++.++|+.+++|+.+.. ....+++..|...+..|....+ +..+ ..+......+.++++++|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 45899999999999999998753 3356778899999998853322 1111 12234556788999998764421
Q ss_pred ee------------------cc--CCCCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----cCCCc
Q 040413 561 FL------------------FD--TPKESPLGW-------------------ETRVRVIEEIAQGLLYLHQ----YSRLR 597 (795)
Q Consensus 561 ~l------------------~~--~~~~~~l~~-------------------~~~~~i~~qia~aL~~LH~----~~~~~ 597 (795)
.- .. ......++. .....+...+.+.++.+.. .....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 00 001111111 1111222222333333322 22345
Q ss_pred EEeCCCCCCcEEEcCCCCceeeccccccc
Q 040413 598 VIHRDLKASNILLDKDMNPKISDFGMAKM 626 (795)
Q Consensus 598 iiH~Dikp~NIll~~~~~~kl~DFGla~~ 626 (795)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899988863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.33 E-value=0.0072 Score=61.12 Aligned_cols=157 Identities=13% Similarity=0.048 Sum_probs=82.6
Q ss_pred cHHHHHHhccCCccccc-----ccCCCceeEEeeeccCCceEEEEEecccCcccHHHHHHHHHHHHhcCCCce--eeeee
Q 040413 466 SLASVSAATANFSTENK-----LGEGGFGPVYKGRLHNGQEVAVKRLSSQSGQGLEEFKNEIKLIAKLQHRNL--VRLLG 538 (795)
Q Consensus 466 ~~~~i~~~~~~y~~~~~-----LG~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~ 538 (795)
+.+++.....+|.+.+. |..|---..|+.+..+| .+++|++.... ..+++..|+++|..|.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 44556666677766443 44666678899887654 58999986532 23456778888888853322 11111
Q ss_pred ------eeeecceeEEEEeecCCCCcceeec--------------------cCCCCCCCCH------------------H
Q 040413 539 ------CCIELEEKILIYEYMPNKSLDIFLF--------------------DTPKESPLGW------------------E 574 (795)
Q Consensus 539 ------~~~~~~~~~lV~E~~~~gsL~~~l~--------------------~~~~~~~l~~------------------~ 574 (795)
+.........++.++.+........ .......... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1122344566676666643321110 0000000000 0
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCcEEeCCCCCCcEEEcCCCCceeecccccc
Q 040413 575 TRVRVIEEIAQGLLYLHQY-SRLRVIHRDLKASNILLDKDMNPKISDFGMAK 625 (795)
Q Consensus 575 ~~~~i~~qia~aL~~LH~~-~~~~iiH~Dikp~NIll~~~~~~kl~DFGla~ 625 (795)
.....+..+...+...+.. -+..+||+|+.++||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222222211 12359999999999999988777899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.48 E-value=0.052 Score=34.03 Aligned_cols=32 Identities=28% Similarity=0.594 Sum_probs=25.9
Q ss_pred cccccccccCCCCcCCCC-CCCCCCCcccccccc
Q 040413 285 YFCQIFGSCGANSVCSID-KTPNCECLMGFKLES 317 (795)
Q Consensus 285 ~~Cd~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 317 (795)
|+|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999997 7899743 456899999999853
|